Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.838878061378153,-1.9235889735033775,0.0,0.05095639837846191,0.07,9/51,6.34%,CD44;IRF4;PRKCD;OAS3;HLA-DRB1;TRIM5;CAMK2A;CIITA;OAS1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8763648678948228,-1.8963593282088698,0.0,0.058235883861099326,0.13,1/41,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.8611412562384663,-1.8875045039395806,0.0,0.050956398378461915,0.16,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9674931054195137,-1.8677703863925863,0.0,0.05095639837846191,0.2,1/13,0.01%,CD44
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8673758738128801,-1.8490091042698693,0.0,0.053868192571516885,0.26,1/24,0.01%,CD44
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7824298571961797,-1.835707926366592,0.0,0.05823588386109933,0.31,3/59,1.95%,CD44;IL10RB;CXCL13
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8313836304849851,-1.8126073969729386,0.0,0.09463331127428641,0.46,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.802387990132113,1.8055889315834848,0.01694915254237288,1.0,0.38,3/50,4.13%,CPA1;CYP4F12;PTGS1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.811326590750225,-1.7941491483424183,0.02040816326530612,0.11010221792489092,0.53,1/33,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8341323094980687,-1.7867201079229427,0.0,0.11485410428161258,0.62,1/33,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.953163848405614,-1.7865125193293117,0.0,0.10336869385345132,0.62,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.8294891166835703,-1.7826440994504376,0.0,0.09728039690433637,0.64,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.9570930739478783,1.7744200449363037,0.0,0.9962278562641064,0.5,3/10,2.74%,SULT2A1;HS3ST5;SULT6B1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9240368689105527,1.7736130951225082,0.0,0.6722513176416328,0.51,1/20,0.00%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.8544100746271689,-1.7689473416146715,0.0,0.11404527256131952,0.72,3/34,1.95%,CD44;SIRPG;CXCL13
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9100592304322681,-1.7537840085864602,0.0,0.13439050121792154,0.79,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.9302644734926262,-1.7521132154531698,0.0,0.1273909959461548,0.79,2/17,0.03%,UGT2B15;CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8922183683019187,-1.7282385282565171,0.0,0.16548696997195728,0.83,2/23,1.82%,CD44;SIRPG
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.874156237524344,-1.7263010238109622,0.0,0.16060364846068798,0.83,3/10,2.74%,GPX3;MPO;PXDN
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6783117984066831,-1.715582267196225,0.0,0.17342303649812668,0.88,4/84,1.71%,CD44;GAB3;ICAM3;GYPB
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.8616267994056406,1.712242399312814,0.017857142857142856,1.0,0.84,4/18,5.18%,SULT2A1;ENPP1;SULT6B1;SLC35B2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.9545944091926122,-1.7049802752544885,0.0,0.19492844459062417,0.94,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9394314708832409,-1.7003759755528418,0.023255813953488372,0.18562687980725412,0.94,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9394314708832409,-1.7003759755528418,0.023255813953488372,0.18562687980725412,0.94,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.8917345930174605,1.6887189468827288,0.0,1.0,0.92,2/12,5.08%,MT4;GLRA1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.903794864131791,-1.6868909679719433,0.0,0.21942449097664213,0.97,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6949273469650075,-1.6837585240603539,0.0,0.22235519292419745,0.97,5/78,3.17%,CD44;SHCBP1;FGF1;NR4A1;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9348658089811208,-1.6814648617311851,0.0,0.2212330587984154,0.98,1/14,0.01%,CD44
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.872190917378716,-1.679941273451227,0.0,0.2147448217378038,0.98,2/22,2.14%,CD44;COL5A1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.6561101964793785,1.678525275194674,0.0,1.0,0.94,30/183,9.26%,CPA1;MXRA5;MITF;CXCL12;CFH;HGF;LSAMP;IL2RA;ALDH1A1;RIN2;IL4;ADGRL4;ROR1;SOCS2;ST6GALNAC3;HS3ST1;PLSCR4;POSTN;RIOK2;CYBRD1;ACHE;PDGFRA;HPGDS;UNC13B;ESYT3;NEO1;ABCA1;RAMP3;HS2ST1;CYP27A1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.8968534811308613,1.6749388029901344,0.0,1.0,0.94,3/13,2.74%,SULT2A1;ENPP1;SULT6B1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9253844278697239,-1.674810715646008,0.0,0.22100517925287194,0.99,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7288402660438185,-1.6690565611451778,0.0,0.23098367396830263,0.99,9/74,6.34%,CD44;IRF4;PRKCD;OAS3;HLA-DRB1;TRIM5;CAMK2A;CIITA;OAS1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.8999021566379763,-1.6652416974655808,0.0,0.23510042003184545,1.0,2/12,3.82%,RFX6;HLA-DRB1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.6999599535282397,-1.6640747343926114,0.0,0.23060370082497814,1.0,2/59,0.36%,CD44;IRF4
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.946095236526505,1.6576580919132293,0.0,1.0,0.95,1/14,0.02%,CLEC2A
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.9239827366713433,1.6573496251275048,0.0,1.0,0.95,2/13,4.74%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9410480738496608,1.655534375054393,0.0,1.0,0.96,2/13,1.18%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.8430377320929685,-1.6495184469655577,0.021739130434782608,0.28138976641505326,1.0,4/17,2.74%,GPX3;MPO;DUOX1;PXDN
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.9037447604315733,-1.645693114506678,0.0,0.28875292414461756,1.0,1/10,0.70%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9783233594609964,-1.6400073608927237,0.0,0.30761696716951664,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.8921098844701137,-1.6394006075294187,0.0,0.3009612279227907,1.0,3/12,3.05%,CYP1A2;CYP2E1;CYP2A6
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8505406913468208,-1.6379497562804746,0.047619047619047616,0.2977971333806216,1.0,1/11,0.27%,ALB
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8921064307505988,-1.6374302432120365,0.0,0.29096531679130144,1.0,3/13,3.05%,CYP1A2;CYP2E1;CYP2A6
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.946115222266238,-1.6354217832090914,0.0,0.290139492807977,1.0,1/6,1.25%,RTF1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.6890767075370255,1.6305008793631388,0.017543859649122806,1.0,1.0,14/75,7.84%,IGF1;HEMGN;SMAD6;SMOC1;HGF;PPARG;WNT4;RORB;BMP2;CRIM1;ACVR2A;WWTR1;CCN4;FBXO5
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8719556781767636,-1.62994790641793,0.0,0.3103891726624565,1.0,4/31,4.40%,CD44;CLDN4;WTIP;ZMYM6
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7124525227966357,-1.6291131170463686,0.0,0.30652536167429983,1.0,3/64,2.29%,CD44;TERF2IP;IL11
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.9886168568597993,1.6284400978341818,0.0,1.0,1.0,1/7,0.36%,IRGM
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8980144150596037,-1.6245817829382379,0.0,0.3187648379765437,1.0,1/20,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.8499983219311549,1.6231205664174693,0.01639344262295082,1.0,1.0,6/18,10.64%,F2;CALCR;F2R;RAMP3;SNCA;ANK2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9447165690717741,-1.6227820049882127,0.0,0.3195507473403912,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9677554742412473,-1.619583543144294,0.0,0.3259389624850903,1.0,1/5,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6885005204707452,-1.6156542841399426,0.0,0.33503388062772693,1.0,3/82,2.29%,CD44;TERF2IP;IL11
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8465481828083443,1.6135744211653527,0.0,1.0,1.0,4/32,2.36%,SGO1;ESPL1;TOP2A;NDC80
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8957214798236433,1.6125401287766987,0.0,1.0,1.0,3/12,2.44%,IRS1;SIRT1;ZBTB7B
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.873770362255236,-1.6096980951424553,0.0,0.3539216513225144,1.0,1/15,0.26%,NTRK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8186378753077856,1.608569454631741,0.03571428571428571,1.0,1.0,1/13,2.36%,NDC80
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.9578906066740945,1.6076383670730239,0.0,1.0,1.0,1/9,0.08%,TNFSF14
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.7062862626114442,1.6059696605149496,0.019230769230769232,1.0,1.0,14/62,13.65%,NPC1L1;SULT2A1;IL4;INSIG1;MSMO1;FDFT1;ABCA1;CYP27A1;HMGCS1;FDX1;IDI2;CEL;MVD;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8960354522121159,1.6033797898554902,0.0,1.0,1.0,3/11,6.06%,GATA4;SOX5;SOX6
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.9685385112830787,1.6023282718272975,0.0,1.0,1.0,2/10,0.38%,STK26;GATA4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6839225913056991,-1.6016302441061987,0.0,0.3854741498596604,1.0,2/68,2.22%,CD44;NLRP3
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9046711231183641,-1.6003494680990256,0.0,0.38200754498658623,1.0,3/10,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.8050115403057718,1.5976727907289026,0.0,1.0,1.0,4/28,3.00%,VAPB;TOP2A;NR5A2;CCL5
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.8169785513251371,1.5967331102314817,0.0,1.0,1.0,7/24,6.39%,FGF10;SMOC1;LRP4;KAT2B;RSPO2;CHD7;PCSK5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9225891977089127,-1.5958689419685896,0.0,0.37729418373839885,1.0,2/10,3.20%,CYP1A2;AKR7A3
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9225891977089127,-1.5958689419685896,0.0,0.37729418373839885,1.0,2/10,3.20%,CYP1A2;AKR7A3
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9225891977089127,-1.5958689419685896,0.0,0.37729418373839885,1.0,2/10,3.20%,CYP1A2;AKR7A3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.9074827454421419,1.594623427436627,0.0,0.9552245755946996,1.0,1/7,2.36%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.9074827454421419,1.594623427436627,0.0,0.9552245755946996,1.0,1/7,2.36%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.9056431951611685,1.5935670415574268,0.0,0.8589877947643085,1.0,2/12,2.86%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.9056431951611685,1.5935670415574268,0.0,0.8589877947643085,1.0,2/12,2.86%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.9056431951611685,1.5935670415574268,0.0,0.8589877947643085,1.0,2/12,2.86%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.9489722346401965,-1.5933278545987877,0.0,0.3836895473140139,1.0,1/5,1.25%,RTF1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7345837798322383,-1.593035239266868,0.0,0.37808756231249435,1.0,1/42,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6467690050436603,-1.5917896849535205,0.0,0.3766405788716599,1.0,8/74,4.20%,CD44;BST1;IL11;PRKCD;SFRP1;ENPP2;TEC;IL6R
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.8447097123585217,1.5911922491402264,0.0,0.853475693933579,1.0,3/14,3.59%,CTDNEP1;C3;LDLR
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.7620126055559592,1.5862331894649775,0.0,0.8709662376674001,1.0,4/27,3.40%,IRGM;LGALS9;CCL5;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8957230937375433,1.5846596631179224,0.0,0.8638024461021703,1.0,3/11,2.44%,IRS1;SIRT1;ZBTB7B
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.9155507869984846,1.5826329339575835,0.0,0.857884648844268,1.0,1/11,3.50%,RAB27A
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.9244979068124459,-1.5824085716215996,0.0,0.4187845177658467,1.0,2/6,2.99%,NUPR1;NR4A1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.776121448934271,-1.5798350813847082,0.075,0.4215102074657935,1.0,2/19,6.65%,ALB;NFE2L1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.6907293620522481,-1.579588533638325,0.04878048780487805,0.41451862616225893,1.0,6/44,4.04%,CYP1A2;PTGES;AWAT1;CYP2E1;CYP2A6;ALOX5
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.9743131508193964,1.5795376886888584,0.0,0.8663841341443181,1.0,1/5,0.36%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7272448333683954,-1.5778685570892945,0.04878048780487805,0.418705220538367,1.0,3/36,6.50%,EPN1;MVP;PTPN3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.8641588010961967,1.5740215286915076,0.01639344262295082,0.8938807224720067,1.0,2/14,3.18%,AASS;CTCFL
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.9542163310670446,-1.5711395068003684,0.0,0.4440486144408824,1.0,1/5,0.60%,ANXA8
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8343137177672805,-1.570820584136966,0.0,0.43806903708014455,1.0,1/23,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7222910562119131,-1.569951583960772,0.022727272727272728,0.43395950298249025,1.0,8/66,2.99%,CD44;P2RY10;SELL;SIRPG;TRAF3IP3;CD53;CYTH4;NR4A1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.7879720092429875,1.5695881417671742,0.0,0.9194025373628213,1.0,2/22,5.08%,MT4;GLRA1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.8699280070225865,1.5690266465390812,0.03571428571428571,0.8997291301172695,1.0,1/11,0.07%,MT4
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.7559497336438616,-1.566158484977615,0.047619047619047616,0.44618225673751755,1.0,2/21,6.65%,ALB;NFE2L1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7780923188039767,1.563981446372754,0.016666666666666666,0.9307575974174815,1.0,3/27,2.86%,ESPL1;IGF1;DLGAP5
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7002213365875606,-1.5636306020492254,0.046511627906976744,0.4518216243630207,1.0,9/68,6.54%,UGT2B15;CYP1A2;AMACR;CYP2E1;CYP2A6;CYP21A2;SLC22A24;HSD11B1;CYP24A1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.570122260723069,-1.5629850340611076,0.03125,0.4484163057304649,1.0,8/167,3.31%,CD44;IRF4;SELP;AMACR;HK2;SELL;CD86;ETV4
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7095651841899331,-1.5593545824988713,0.021739130434782608,0.4619489885785154,1.0,8/40,13.50%,NARS1;TARS3;WARS1;SARS1;CARS1;DARS2;PPA1;SARS2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.899332260688268,1.5588881754967394,0.018518518518518517,0.9568253042694813,1.0,1/9,0.53%,REP15
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7371148231558831,1.5571020143128746,0.034482758620689655,0.9575424998430677,1.0,9/20,17.56%,HIF1A;BMP2;RELA;RBPJ;SMAD1;SMAD4;VEGFA;SMAD5;NFE2L2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7773931102992507,-1.5552027851993686,0.0,0.4775107654497802,1.0,1/22,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.877078900018676,-1.5545411772604967,0.024390243902439025,0.4739753880917251,1.0,3/11,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.9321964262321859,1.5539887498182217,0.015873015873015872,0.9700605204522912,1.0,2/8,0.72%,VEGFC;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8156522832007902,-1.5537228711707973,0.0,0.4713466850007727,1.0,1/29,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.7544503812492136,1.553486302345909,0.016129032258064516,0.9509723835252795,1.0,4/25,7.84%,ESPL1;DLGAP5;RIOK2;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.8020791820228353,1.553147256394523,0.031746031746031744,0.9310374551998283,1.0,3/25,1.59%,IGF1;C3;IRS1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9725772270886112,-1.552353094241164,0.0,0.47294257220273556,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.8597771925844673,1.5514003475077618,0.0,0.9077935627273322,1.0,1/15,0.41%,FHDC1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.8597771925844673,1.5514003475077618,0.0,0.9077935627273322,1.0,1/15,0.41%,FHDC1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.7323799385398804,1.5511832530607232,0.0,0.8888185890560307,1.0,10/49,12.33%,IRGM;SIRT1;IL4;FYCO1;STING1;PIP4K2A;GPSM1;GNAI3;EPM2A;BNIP3L
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.839543942099595,1.5509331291124213,0.0,0.8728467911387144,1.0,3/14,5.03%,SASH3;SIRT1;SAMSN1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.6172605047245722,1.5495817452768401,0.03333333333333333,0.8720955411940825,1.0,39/117,18.56%,FGF10;ZNF385D;PDZRN4;LSAMP;PRKG1;RAB27A;ANGPT1;CADM2;RSPO2;SLC17A6;PENK;ROBO2;UNC5D;RAB3C;NRXN1;PDGFRA;PTPRD;OLFM3;NOVA1;FGF14;SCN3A;MAGI2;PABPC5;ADGRB3;TMEM196;INTS6L;ZNF536;MAGEL2;PCDH18;COL11A1;NREP;RUNX1T1;SEMA6D;FRZB;MAPK10;CNTN4;FMN2;PCSK2;PDZRN3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6433998387447979,-1.5491394982358113,0.02631578947368421,0.4865122797562674,1.0,1/86,0.01%,CD44
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),-0.9452974191876982,-1.5490248091639125,0.0,0.4800114457058523,1.0,1/6,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.993073558179493,1.5477955910290546,0.0,0.8698253078175189,1.0,1/5,0.36%,IRGM
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.8809278335288633,-1.5477479641692375,0.0,0.48076719562536235,1.0,1/9,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8024650242907765,1.5474201732005262,0.0,0.8552474406291707,1.0,8/20,10.33%,FLT1;FGFR1;FGF2;FGFR3;CCL5;ESR1;PDGFRA;ABL2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7177711691774136,-1.5462042040142567,0.044444444444444446,0.4836110355421727,1.0,8/47,7.79%,EHF;DUOXA1;ANXA8;ENTPD2;CD24;C6ORF132;LAMB3;FLG
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8843213038821875,-1.5418981826692273,0.046511627906976744,0.5005166232561983,1.0,1/12,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.5948809697027938,-1.5398294561466652,0.0,0.5038224177701446,1.0,7/134,2.22%,CD44;IL10RB;SELE;LTB4R;PTGDR;CXCL13;NLRP3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.6898350019387789,1.5366453560574485,0.01694915254237288,0.9548216710983259,1.0,18/55,13.72%,SLC26A3;ACE2;TMPRSS2;MOGAT2;FLI1;CD99;APOBEC1;HNF4G;AGR2;GOLT1A;MUC13;DSP;PPP1R14D;EFNA2;CGN;NR1H4;HSD11B2;BCO1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.7158606833893267,1.5357909367307585,0.10714285714285714,0.9427717273913983,1.0,7/31,15.80%,IRGM;FYCO1;HTRA2;LMAN1;LIG4;SHCBP1L;SORBS3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.7669713086966451,1.5348196386945163,0.017241379310344827,0.9338147289706593,1.0,5/23,11.61%,PNP;SHMT2;AMPD1;ADA;GMPS
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8544328472444349,-1.5344309467814559,0.037037037037037035,0.5307958164423117,1.0,2/11,1.06%,NLRP1;APIP
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.9259680975266932,1.533919472463568,0.0,0.9230994981471587,1.0,1/7,1.04%,DRD5
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8407025094937288,-1.5334386156618949,0.02631578947368421,0.5301060935027467,1.0,3/17,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.8467387432648104,-1.5327505106272554,0.0,0.5274675832148895,1.0,1/14,0.70%,DDX11
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.9097558623040115,-1.531418392265889,0.075,0.5286847656523468,1.0,3/7,7.05%,TEKT3;TEKT5;RSPH9
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8935037542994013,1.5311306176529045,0.03773584905660377,0.9396083715661693,1.0,3/7,7.86%,SOX5;SOX6;PDGFRA
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5993104609467393,-1.5302294833061794,0.0,0.5276669147874937,1.0,11/181,6.35%,CD44;LDHC;HK2;COL5A1;XYLT2;BIK;AGRN;TGFBI;GPC1;IER3;GPC3
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6050610863807526,-1.5291647689667198,0.0,0.5282826607399725,1.0,8/132,6.95%,CD44;GPX3;BCL2L2;BIK;PLCB2;IER3;CAV1;JUN
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7765085293141475,1.5290121795053024,0.01639344262295082,0.950331179959256,1.0,6/20,9.04%,CXCL12;LGALS9;IL4;CCL5;MOSPD2;HMGB1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8240005538000138,1.52751968080254,0.05454545454545454,0.9522701304555572,1.0,5/9,11.72%,LRP4;NLGN1;NRXN1;NLGN4X;CEL
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.9133430638554785,-1.52673475851889,0.045454545454545456,0.5362554305542897,1.0,2/6,4.00%,CD200R1;C5
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.88044695730414,1.5261008032307566,0.023809523809523808,0.9539228841448771,1.0,1/15,0.19%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9683785632017491,-1.5258571177460483,0.0,0.5348118195092098,1.0,2/5,2.91%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.966834737299007,1.5250841293050412,0.02127659574468085,0.9474182330111153,1.0,2/7,0.79%,CXCL12;FERMT3
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6191112916060867,-1.522927866861015,0.0,0.5459614111978062,1.0,6/99,2.73%,CD44;SELE;SELL;CD86;CD53;CYTH4
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7941427021336428,-1.5226464002350748,0.024390243902439025,0.5404793295380422,1.0,2/21,0.27%,SLC28A2;ALB
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7489766276062741,1.5202071249193658,0.0,0.9859639443724032,1.0,9/19,16.79%,ACSM2A;THEM5;SCD;SCD5;SLC25A1;DGAT2;FASN;ACACA;FAR2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7505256271480958,1.520067898976934,0.03636363636363636,0.9711059467014316,1.0,5/24,12.31%,F2;GSTM2;F2R;SNCA;HAP1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5736221115848127,1.5196431542752942,0.0,0.9597804956690781,1.0,19/221,6.39%,CPA1;PRSS57;TMPRSS2;MMP23B;MME;HGF;CAPN13;KLKB1;ANPEP;NAALAD2;CPN1;MMP16;TRHDE;ADGRV1;CTSF;HGFAC;F12;PRSS3;PCSK5
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.8740179168277826,-1.519512187516907,0.020833333333333332,0.5530633482540378,1.0,1/12,0.26%,NTRK1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.7689211674893556,-1.5169778874825655,0.022727272727272728,0.5614851332511416,1.0,1/18,0.27%,ALB
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.8230360991620589,1.5169739022171917,0.015625,0.9709337863429667,1.0,7/23,8.71%,PPP1R3A;IGF1;IRS1;ENPP1;PPP1R3B;PPP1R3D;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7810331832555617,1.5146672442127083,0.0,0.9846665967205223,1.0,4/16,6.06%,SOX5;GDF6;BMP2;SOX6
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.8144078716731328,1.513967584351218,0.0,0.9796433429774798,1.0,4/21,6.21%,ZDHHC11;IL4;IL23R;STING1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.739345475097284,1.5125279047146833,0.043478260869565216,0.9844583960719618,1.0,7/31,5.36%,F2;C6;CFH;C3;CPN1;C9;CD59
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7350110703649138,1.5115113172439318,0.02127659574468085,0.9795929070694523,1.0,3/33,3.72%,GATA4;TGFBR1;DAPK2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7537691363986461,1.511501428502183,0.016129032258064516,0.9647505902956728,1.0,7/22,16.99%,TGFBR1;SOX5;GDF6;SOX6;GREM1;LOXL2;TRPS1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8640776044209523,-1.5114113185531377,0.02127659574468085,0.5919781587130499,1.0,1/14,0.27%,TERT
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6343797328295327,1.5093205779656254,0.017543859649122806,0.9722922761718492,1.0,19/81,10.43%,CXCL12;EPHA7;FRAS1;MYCN;LIN28A;CNTNAP2;TMEM200C;IL17RD;CLDN6;UNC5D;EPHA8;ZDHHC22;L1TD1;SYT6;SPSB4;ADAMTS19;IGDCC3;NLGN4X;VRTN
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7784871986539328,1.5088121615598813,0.017857142857142856,0.9642470839772924,1.0,5/21,9.42%,F2;CALCR;F2R;RAMP3;SNCA
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.8473430439546564,1.5083244306519648,0.05263157894736842,0.955378640524751,1.0,1/14,0.07%,MT4
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8560126946079671,-1.5069261728571484,0.041666666666666664,0.6142172927232418,1.0,4/10,9.11%,KCNE2;KCNA5;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.8548181469055381,1.5052590722944068,0.01639344262295082,0.970367586127634,1.0,2/14,4.36%,ESPL1;LLGL1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5839962139558673,-1.5035571458785946,0.023809523809523808,0.6306912364085046,1.0,3/169,0.30%,CD44;TRIP10;DUSP4
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7818611898481779,1.5029188290575977,0.016666666666666666,0.9823675923758562,1.0,3/15,7.15%,SIRT1;ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.9070595932610885,1.5027412480705387,0.017543859649122806,0.9702422380620954,1.0,3/10,2.44%,PNP;RUNX1;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.7788537996599499,1.5026909947897316,0.01639344262295082,0.9574505274118617,1.0,4/28,6.21%,ZDHHC11;IL4;IL23R;STING1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.8843480536325786,1.5022456912560862,0.037037037037037035,0.9504223895703547,1.0,1/7,1.04%,DRD5
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7118904566031388,-1.5022371742887093,0.05128205128205128,0.6319764810386254,1.0,7/48,6.35%,CD44;HGSNAT;ACAN;GPC2;AGRN;GPC1;GPC3
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),-0.9432730137612187,-1.5020228894622039,0.0,0.6263666372105741,1.0,1/5,3.38%,SLC17A9
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5962833110468659,1.4994690638635644,0.0392156862745098,0.9656120733642827,1.0,31/139,12.75%,CRX;PCDH15;VWC2L;LSAMP;PCBP3;CDH20;SAG;CADM2;SLC17A6;CNTNAP2;RNF152;VSX2;RCVRN;ZDHHC22;RAB3C;NRXN1;SYNPR;FRMD3;SLC24A2;OLFM3;RS1;LIN7A;PROX1;QPCT;MAGI2;GRM5;CTNNA2;ADGRB3;PAK5;TMEM196;HCN1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7058991202590215,-1.4993586257666698,0.047619047619047616,0.6370776676883465,1.0,3/23,11.11%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.8706612510818078,1.4993423901888385,0.03333333333333333,0.9540256492593369,1.0,3/11,7.86%,F2;LDLR;PDGFRA
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.8529020631462298,1.4993308997694506,0.0,0.9421090481078523,1.0,6/19,7.94%,IGF1;LGALS9;FGF10;MYC;ZFP36L2;ITGAV
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.7519580724762289,-1.4992161823714365,0.046511627906976744,0.6242758758956307,1.0,4/26,6.11%,ACTC1;MYH7;TMOD1;NEB
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.7519580724762289,-1.4992161823714365,0.046511627906976744,0.6242758758956307,1.0,4/26,6.11%,ACTC1;MYH7;TMOD1;NEB
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.835253662964652,1.498783149834925,0.03225806451612903,0.935949529126175,1.0,3/9,6.06%,SOX5;GDF6;SOX6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.7667576466579621,1.4978125786468584,0.018867924528301886,0.9351746826091434,1.0,7/22,9.04%,SYK;LGALS9;CD40;IL23R;PLCG2;TLR2;HMGB1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6975545831244219,-1.497083162434197,0.0,0.6314953656187958,1.0,7/36,13.50%,NARS1;WARS1;SARS1;CARS1;DARS2;PPA1;SARS2
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.8550010332671846,1.4970479220123203,0.0,0.9312300632029725,1.0,1/10,0.45%,F2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8563164019891327,1.4961015028634357,0.018867924528301886,0.9303826245718537,1.0,2/10,11.26%,SIRT1;LEPR
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.8274166941199389,1.495458010814429,0.019230769230769232,0.9279260951490332,1.0,4/18,8.85%,TNFRSF18;IL2RA;RUNX1;VSIR
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.9259144993485022,1.4943437620280051,0.0,0.9300663824128904,1.0,2/5,4.93%,IRGM;FYCO1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8531700921155784,1.4935703320469793,0.017241379310344827,0.9269489446568899,1.0,4/14,7.14%,VEGFC;ITGA11;ITGA2;EPHA8
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8669552588447382,-1.4934322750709592,0.08888888888888889,0.6481873041045209,1.0,2/9,4.04%,EPN1;ALOX5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.8352318509001452,1.4930995238412177,0.017543859649122806,0.9217608959895583,1.0,8/15,13.66%,FLT1;FGFR1;FGF2;PPARG;SP1;HMGB1;SIRT6;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6613142723858548,1.4930578815210174,0.0,0.9114665525547383,1.0,14/67,13.08%,ADRA1A;ZDHHC12;TSHZ3;CLSTN2;NLGN1;LGI1;SYT1;NRXN1;SLC24A2;GRIK2;RIMS2;ZDHHC2;HAP1;GRIN2D
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.7536459585311331,1.492596299434904,0.030303030303030304,0.9067153729636729,1.0,3/30,2.63%,IGF1;IRS1;ENPP1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7894961749961876,1.490800083600071,0.05454545454545454,0.9154638185819415,1.0,4/16,9.70%,C3;SIRT1;ITGAV;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8507270869096925,1.4906415613116057,0.05660377358490566,0.9062697640089618,1.0,2/14,1.52%,IGF1;HGF
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7061093869347752,-1.490512006216371,0.024390243902439025,0.6528549085481136,1.0,3/22,11.11%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7061093869347752,-1.490512006216371,0.024390243902439025,0.6528549085481136,1.0,3/22,11.11%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.7342403118063933,1.4897051881857162,0.0,0.9048394743276836,1.0,4/25,6.08%,SMYD1;CTCFL;PRMT1;SMYD2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7265431258608998,1.4894351919611912,0.0425531914893617,0.8975663197083338,1.0,9/35,8.89%,F2;RUNX1;CCL5;RAB27A;WNT4;F2R;ZBTB20;PLCG2;HDAC2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.9236549380546111,1.4889283301131229,0.0,0.892168000652214,1.0,2/7,3.00%,IDO1;CCL5
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.8610384137714009,1.4884718272880042,0.04,0.8854487817673895,1.0,1/11,1.04%,DRD5
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8071350714496343,1.48812905814622,0.047619047619047616,0.8795187547842817,1.0,4/18,7.90%,TNFSF14;CD40;FLT3;ELF4
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.774329660204264,1.4877766983905505,0.0,0.8738414559502747,1.0,2/18,1.20%,SGO1;KASH5
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7563402443609818,1.4873731869293407,0.0,0.8684089875107086,1.0,7/22,11.32%,ACE2;CALCR;PPARG;CBLB;CNRIP1;RAMP3;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6801543129825679,1.4873041013587809,0.0,0.8603330581692415,1.0,11/46,13.71%,LAMA4;ALDH1A1;BTN2A2;RBPJ;MAP2K6;NOVA1;IL15;ARRDC3;IL18R1;LNPEP;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.9190454593922555,-1.4870286468121516,0.0,0.6708500840093045,1.0,1/6,0.91%,HK2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7521250958103652,1.4867046348364854,0.06557377049180328,0.8584965038114655,1.0,1/21,0.36%,IRGM
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8584587006366948,1.4860558062038136,0.03773584905660377,0.8548562757742997,1.0,2/11,1.59%,IGF1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.898174520763731,1.4858102044776833,0.03225806451612903,0.8393718885548097,1.0,1/8,0.56%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.898174520763731,1.4858102044776833,0.03225806451612903,0.8393718885548097,1.0,1/8,0.56%,IGF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8350408120030669,1.4838728095058704,0.08,0.8434792091101854,1.0,4/13,5.12%,IRS1;SOCS2;IL7R;STAT5A
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8350408120030669,1.4838728095058704,0.08,0.8434792091101854,1.0,4/13,5.12%,IRS1;SOCS2;IL7R;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.7376504853687984,1.4834742729524129,0.05660377358490566,0.8384061121490961,1.0,3/17,3.29%,SYK;IL4;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.9146849747306511,1.4828079962589744,0.018518518518518517,0.8357437637393311,1.0,2/7,2.18%,SASH3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.8064591703751854,1.4817883774256617,0.04081632653061224,0.8379454506611692,1.0,6/18,10.45%,F2;C3;MRAP2;KLK5;KLK14;PDE6H
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.8388632973672141,1.4813590469512798,0.07272727272727272,0.8335204801498524,1.0,3/12,8.60%,PNP;AMPD1;ADA
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.8206658842309225,1.480941973553914,0.03773584905660377,0.8319897498791023,1.0,4/13,7.84%,TIMELESS;SLFN11;GMNN;FBXO5
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.9290242228226783,1.4801555132782651,0.04,0.8323819233139794,1.0,2/9,3.18%,NPC1L1;INSIG1
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.8994487455412714,1.4781295767445355,0.0,0.843701174501276,1.0,3/10,3.29%,FGF10;TGFBR1;ZBTB1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6140206556134129,1.4760267883760552,0.021739130434782608,0.8591945365494655,1.0,48/129,24.16%,NRTN;GPRIN3;RUNX1;PBX3;NEDD4;EHD1;PRMT1;TENM3;NLGN1;CNTNAP2;LGI1;TENM1;UGDH;NPY;MANF;EPHA8;EPHA5;POU3F2;SLC44A4;HMGB1;LYN;GPM6A;BLK;PTPRM;MEF2C;PPP1R9A;GPM6B;HDGFL3;MYT1L;LRP12;RP1;CNTN4;L1CAM;FLRT3;ARL3;STMN4;RP1L1;CDK16;WNK1;RAPGEF2;MAP2;PLP1;TDP2;SH3GL2;TENM4;MICALL1;STX3;RYK
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.833896064935684,-1.4750288057760959,0.09302325581395349,0.7505374671325444,1.0,2/7,8.06%,CD24;CDH3
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.7192121664907577,1.4748328048032666,0.01694915254237288,0.862587534082336,1.0,12/33,13.66%,FGFR1;BRINP3;BMP2;ZEB1;ZC4H2;NEUROD2;PROX1;VWC2;TCF4;ADRA2C;CPNE1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8896370001701726,-1.4748270471853864,0.07142857142857142,0.7296228299247483,1.0,3/9,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8896370001701726,-1.4748270471853864,0.07142857142857142,0.7296228299247483,1.0,3/9,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8896370001701726,-1.4748270471853864,0.07142857142857142,0.7296228299247483,1.0,3/9,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8224117640937034,-1.4746302202063803,0.045454545454545456,0.7235520273286835,1.0,2/7,3.26%,PM20D1;TST
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.7975197939122387,1.4744062154921769,0.03333333333333333,0.8601147043074521,1.0,7/14,10.33%,FLT1;FGFR1;FGF2;ESR1;PDGFRA;BICD1;ABL2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.7092657677171577,1.473319844024617,0.05660377358490566,0.8619481067034759,1.0,6/36,10.40%,SULT2A1;IL4;IDH1;ABCA1;CYP27A1;FDX1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.8956657087623503,-1.4724326198978688,0.0,0.7298754708914986,1.0,3/8,6.25%,KCNE2;KCNE1;CAV1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.9549916279343862,1.4719535403462103,0.0,0.867447182161673,1.0,2/6,3.41%,SLC26A3;SLC26A6
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7413343986474548,1.4713269469196824,0.03508771929824561,0.8653106127474819,1.0,7/31,11.81%,IRGM;SIRT1;PYHIN1;FBXL3;SNCA;RNF139;GSN
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7572032833124226,1.4706785070129855,0.07017543859649122,0.8643527908632919,1.0,4/25,3.11%,DACH1;HGF;FGF2;MYC
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9517999480757648,1.4705298507568914,0.0,0.8585721468981381,1.0,1/6,1.55%,PIK3R6
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7384948873077244,1.4701629294362453,0.03389830508474576,0.8539095910835198,1.0,7/22,15.39%,CGNL1;NLGN1;PCLO;DSP;MARVELD3;TJP2;MPP4
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8361107047432872,-1.469467137414613,0.05454545454545454,0.7417300984493174,1.0,1/15,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7806107334026223,-1.4688348900825452,0.025,0.7382378210132389,1.0,1/22,0.70%,DDX11
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.966732590500079,-1.4686340530885067,0.0,0.7330095238850038,1.0,1/6,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.8751708213387263,-1.4685063187445,0.02564102564102564,0.7274678275243222,1.0,3/10,3.05%,CYP1A2;CYP2E1;CYP2A6
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.8049427047439173,-1.4681085446973954,0.14634146341463414,0.7237985612128923,1.0,2/6,6.50%,TIMP4;PTPN3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5346726272585436,-1.4669674376603352,0.0,0.7245784160958539,1.0,9/304,1.96%,CD44;NTRK1;ALB;APIP;NUPR1;TNFSF18;TEK;MPO;HMGN5
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.6889688125580643,1.4662927023974222,0.03508771929824561,0.8828360677462406,1.0,10/46,6.73%,CPA1;ACE2;TMPRSS2;MOGAT2;APOBEC1;CLDN2;ANPEP;CASR;PRSS3;MUC13
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.8543585569396484,1.465780475898324,0.05084745762711865,0.8800581697394569,1.0,2/10,4.93%,IRGM;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.8010628278532639,1.4649839133603162,0.03076923076923077,0.8822053757140863,1.0,2/13,0.72%,VEGFC;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.8410979170807276,1.4644667280496015,0.02040816326530612,0.8808606010473231,1.0,2/9,3.54%,SIRT1;KAT2B
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6404143576126207,1.4634075141567144,0.018518518518518517,0.8843383783084013,1.0,11/57,14.47%,VEGFC;FLT1;DOCK1;MAPKAPK2;MAPKAPK3;ITGAV;PIK3CA;HSPB1;NCK2;PXN;BCAR1
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.8346851096249748,1.4632749001791472,0.07272727272727272,0.8786243727441485,1.0,1/9,0.45%,F2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5773298084806965,-1.4624023511336477,0.0,0.7521912384490387,1.0,11/118,6.44%,CD44;HAPLN3;INHA;RFLNB;ACAN;PHEX;AHSG;COL1A1;ARSL;XYLT1;COL11A2
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6399802907206772,1.4604450467836922,0.037037037037037035,0.8999991105661217,1.0,28/67,21.17%,ANTXR2;GSTM2;STARD4;NFIL3;LDLR;PPARG;SCD;CBS;ANXA5;ACSS2;FDFT1;TP53INP1;HMGCS1;ALCAM;PLAUR;MVD;ETHE1;FASN;PLSCR1;SC5D;ERRFI1;CTNNB1;SQLE;STX5;DHCR7;LGMN;ABCA2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6355606267106041,1.4604115503933852,0.046153846153846156,0.8933908152151421,1.0,18/83,6.02%,VEGFC;GATA4;FLT1;SEMA5A;PIK3R6;RRAS;RUNX1;RAPGEF3;SIRT1;ITGB8;ITGAX;FGF2;HIF1A;TMIGD2;CD40;SP1;ANXA3;APELA
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.8231152286434569,-1.4599487250780598,0.05,0.7642797985361776,1.0,2/10,7.75%,NPTX2;BEGAIN
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.8883043166965243,-1.4595333734443587,0.03773584905660377,0.7598864710569346,1.0,2/7,6.08%,KCNE2;KCNE1
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.9233060172771891,-1.4580108866082724,0.05454545454545454,0.7647359481134985,1.0,1/5,0.60%,ANXA8
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8158794933660652,1.4564746590900433,0.016666666666666666,0.9277941401468788,1.0,5/11,13.10%,FGFR1;FGF2;SP1;HMGB1;SIRT6
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.9162321959237663,-1.4560584731329562,0.025,0.7732359667973179,1.0,1/5,7.12%,PRKD2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.776947867142796,-1.4548124169013803,0.044444444444444446,0.7758399001231984,1.0,3/27,4.04%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7353824174038633,-1.4537590666013305,0.10256410256410256,0.7770059504293417,1.0,4/12,4.88%,RTP1;RTP5;TAS2R5;TAS2R8
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.9209751266734177,-1.4534638327337008,0.047619047619047616,0.7721902488263226,1.0,2/5,4.63%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6870658685331396,1.4528420494564398,0.017857142857142856,0.9578027319158594,1.0,10/41,13.71%,LAMA4;ALDH1A1;RBPJ;MAP2K6;NOVA1;IL15;ARRDC3;IL18R1;LNPEP;NR1H3
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.740189392675934,-1.4519150604307764,0.07894736842105263,0.7762917980074107,1.0,4/10,4.88%,RTP1;RTP5;TAS2R5;TAS2R8
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.7829193660272582,-1.451208221740728,0.06666666666666667,0.7752035133459473,1.0,2/10,1.16%,IL10RB;NUPR1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8906149010605936,1.451090537313985,0.0,0.9680045154956486,1.0,3/9,5.54%,PPP1R3A;PPP1R3B;PPP1R3D
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.7821775263460804,-1.450148811125746,0.10638297872340426,0.7765804050595126,1.0,3/12,9.11%,KCNE2;CAV1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.6643787631016026,1.4494009532604042,0.0,0.9781432880299321,1.0,6/55,8.20%,ESPL1;FGF10;CDC25A;DLGAP5;FBXO5;UBE2E2
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.8633264804828628,1.4485169548084351,0.031746031746031744,0.9805812620692709,1.0,3/9,11.20%,MME;RELA;HYAL3
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6464090629944793,1.4484189898122057,0.03333333333333333,0.9746700189196786,1.0,19/64,16.89%,GABRR1;SLC12A7;SLC26A7;GABRE;GABRR2;SLC12A1;SLC26A6;SLC1A3;SLC12A3;GLRA1;GABRG3;SLC4A1;GLRB;GABRA5;PACC1;GABRG1;GABRB2;ANO6;ANO5
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.7873159603252012,-1.4477619600939093,0.06818181818181818,0.786305756882885,1.0,1/16,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.9098348922480669,1.4471290345507468,0.037037037037037035,0.9806334631736964,1.0,3/8,3.00%,LGALS9;IDO1;CCL5
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.9083365056565417,1.446489438478219,0.0,0.980568990230687,1.0,2/6,5.09%,SPR;GCH1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5756937616088951,1.4457259608793773,0.03333333333333333,0.9817561101454924,1.0,22/99,18.33%,IRGM;CDKN2C;CCNG1;CCNA2;CDC25A;SIRT1;KSR1;SLC8A1;CNPPD1;TELO2;SNCA;EZH2;SERTAD1;CDC25C;CCND3;CDK12;CCNB3;LRP6;PPEF2;CCNH;HMGA2;MNAT1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7971333812534738,-1.445695161882684,0.14285714285714285,0.7947272993854567,1.0,3/14,1.58%,SELP;SELE;SELL
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8385398872577771,1.445368886217832,0.0,0.9789353129161004,1.0,4/10,9.53%,SULT2A1;ALDH1A1;ACSS2;ALDH1B1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7765465074197193,1.4453430419498903,0.07692307692307693,0.9726339126905132,1.0,2/20,1.59%,IGF1;IRS1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5742941583291274,1.4452059207493837,0.057692307692307696,0.9667727950638078,1.0,22/85,12.65%,VEGFC;FBLIM1;ROR1;HAS2;EFNA5;GNG12;TENM3;CSRP2;IL17RD;WWTR1;ZNF462;ADGRL2;P3H2;PTPN14;CNN3;GPR161;TNC;EDNRA;SERTAD4;CDR2L;EFNB2;NOTCH3
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.8499921667599392,1.44514891006519,0.12280701754385964,0.9608218488289362,1.0,1/8,2.85%,SHMT2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7356218004512401,1.4444624895639948,0.09803921568627451,0.9605559714264192,1.0,8/28,13.65%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;IDI2;MVD;ACAA2
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.925989237045057,1.4442452535792007,0.0,0.9565293226582539,1.0,1/6,1.04%,DRD5
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.9087628181602956,-1.4404527041914215,0.05263157894736842,0.8261619343655546,1.0,2/6,3.82%,IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8363072069106214,1.4402161147735297,0.03571428571428571,0.9928295009638707,1.0,2/12,0.77%,SYK;LGALS9
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.9194107174148716,-1.440032246567099,0.08,0.8222267626852167,1.0,2/5,4.98%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7718366585589836,1.4398641183367429,0.06382978723404255,0.9895627139330712,1.0,6/26,7.63%,MITF;C3;SIRT1;CCL5;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.8687711708384085,1.4398248044824062,0.0196078431372549,0.9831570786714067,1.0,1/8,1.00%,TIMELESS
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6698097150655412,1.4387686346612074,0.02,0.9868247700831972,1.0,7/30,9.13%,SCGN;MAFB;LMO2;DPP4;ELP4;FOXO1;PAX6
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7228682666137788,1.438437428225826,0.0,0.9835828536086884,1.0,6/25,12.78%,GATA4;SIRT1;PYCR1;HTRA2;FBXO7;HSPB1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.7919776968246292,-1.438352038900138,0.05,0.8268673630882905,1.0,2/18,1.09%,TERT;GINS3
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.61420733804595,1.438209292768847,0.046153846153846156,0.9795638603163797,1.0,18/95,6.02%,VEGFC;GATA4;FLT1;SEMA5A;PIK3R6;RRAS;RUNX1;RAPGEF3;SIRT1;ITGB8;ITGAX;FGF2;HIF1A;TMIGD2;CD40;SP1;ANXA3;APELA
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8786186111138189,1.4377858124823923,0.046511627906976744,0.9769849544734428,1.0,1/8,1.86%,LYPD1
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),0.9318213508579655,1.4372727498113536,0.016666666666666666,0.9756553460615793,1.0,2/5,6.00%,GATA4;NPY
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.842554307230658,-1.4355989494610708,0.018518518518518517,0.8416832294444687,1.0,1/8,0.26%,NTRK1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7825794136753652,-1.4350866512645006,0.10416666666666667,0.8388162676381956,1.0,2/18,0.40%,ACTC1;MYH7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.5879129780705853,1.4345259695919823,0.0,0.9979979267565803,1.0,12/87,12.72%,F2;CSTA;KNG1;LIN28A;PATL2;SAMD4A;SYNCRIP;TM4SF20;TOB1;RNF139;RIDA;DNAJC1
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5558388033490964,-1.4335028605879931,0.0,0.8426434337027768,1.0,4/99,2.59%,CD44;H1-3;CD86;RNF39
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7612169634359147,-1.4334352715754621,0.08695652173913043,0.8366858626606379,1.0,5/15,10.28%,TERF2IP;SLX4;ERCC1;RTEL1;PARP1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.884989796528721,1.432151327075471,0.015873015873015872,1.0,1.0,1/7,0.56%,IGF1
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7388957636263224,-1.4306932401377943,0.05555555555555555,0.8504019087081075,1.0,4/11,4.88%,RTP1;RTP5;TAS2R5;TAS2R8
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.8520088917988361,1.4305415643359065,0.03225806451612903,1.0,1.0,3/11,5.54%,PPP1R3A;PPP1R3B;PPP1R3D
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7846916687207997,-1.4305086985622635,0.14285714285714285,0.8448682843233335,1.0,2/10,4.31%,DNASE1L1;REXO4
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.9341277193156109,1.4294783581258614,0.0,1.0,1.0,1/5,0.77%,LGALS9
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5874498115934064,1.4291744387976628,0.0,1.0,1.0,25/123,16.22%,IRGM;RIT2;URI1;SOCS2;GFAP;NEDD4;CD22;MLLT3;ZFYVE16;HIP1;NRG3;CHPT1;ABL2;LATS1;SNCAIP;CDK11A;PAK5;STON2;IRAK3;RAB33B;HSPA8;BCAR1;PICALM;RAP1A;SGK1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6548400258280829,-1.4290733607769976,0.05660377358490566,0.8486435289376993,1.0,3/60,0.43%,UGT2B15;SLC28A2;RFX6
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5890261555125519,1.4289725250417165,0.018867924528301886,1.0,1.0,18/79,12.33%,IRGM;SIRT1;IL4;TFEB;RNF152;MID2;STING1;FOXO1;TICAM1;HMGB1;GPSM1;TP53INP1;FOXO3;GNAI3;TRIM65;EPM2A;FBXO7;BNIP3L
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7705295825236935,1.4285856193717728,0.09259259259259259,1.0,1.0,7/15,18.51%,ITGA8;ITGA2;SNAI1;SMAD2;CRB2;HMGA2;MESP1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.8984112409462737,1.4284974972744375,0.06,1.0,1.0,2/7,2.98%,SYK;IL4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8358406313031332,-1.4281587814662617,0.046511627906976744,0.8489424206039423,1.0,2/10,11.10%,SCN5A;SCN3B
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7722642607043374,-1.428121371259495,0.07894736842105263,0.8429425256999913,1.0,5/20,7.05%,TEKT3;DNAH17;TEKT5;DRC1;RSPH9
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6919621206909623,1.4278475538883335,0.06451612903225806,1.0,1.0,3/22,9.19%,CGNL1;TMEFF2;DLC1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.9009833908717334,1.4276733470655483,0.016129032258064516,1.0,1.0,1/7,0.57%,SYK
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8766050128783265,-1.427298023790417,0.044444444444444446,0.842790580430126,1.0,1/8,0.03%,CYP1A2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5176804070688793,-1.426394711379797,0.0,0.8417781323663165,1.0,4/166,2.25%,CD44;CALB2;PTGES;SYT12
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.7302814327017864,1.4259658113930762,0.0392156862745098,1.0,1.0,4/24,8.90%,LDLR;NPC2;MTTP;SLC44A4
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.846708695738049,-1.4255680652527085,0.125,0.8423863421010858,1.0,4/7,10.74%,DNAAF1;DRC1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7678996575004517,1.4242689153448826,0.017857142857142856,1.0,1.0,2/18,3.66%,ATP6V0D2;TCIRG1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5938352598472717,-1.4239526719621702,0.043478260869565216,0.8465457132071483,1.0,10/90,5.18%,CD44;GAB3;ICAM3;CGA;GYPB;MPO;STK10;RAC2;RAB44;BTK
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.7918852216019019,-1.4236381827093103,0.08163265306122448,0.8423103201938715,1.0,1/18,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.8114052689451023,1.422610849495367,0.09433962264150944,1.0,1.0,2/11,2.98%,SYK;IL4
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5632378347535387,-1.422322625178777,0.02631578947368421,0.8452582423724311,1.0,7/118,3.58%,CD44;SELP;MPL;TEK;HMGB3;TIE1;RNASE1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6174932486211522,1.421969543624174,0.0425531914893617,1.0,1.0,11/101,4.43%,IGF1;CCNA2;RRAS;RAB38;RIT2;FGF2;RIN2;CDKN2A;KSR1;RRAD;ARHGAP31
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.8350300493663705,-1.4219687783549777,0.10204081632653061,0.8414565254680094,1.0,1/8,2.14%,COL5A1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8077480392721172,-1.4215935044680763,0.044444444444444446,0.8384831469752786,1.0,4/10,7.93%,CGA;DUOX1;TG;CPQ
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.7687304565015692,1.4211026633154766,0.0967741935483871,1.0,1.0,3/16,18.08%,COX19;BCS1L;SCO2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7942170213520094,1.4210683737614318,0.06,1.0,1.0,6/10,14.46%,LRP4;NLGN1;PTPRD;NLGN4X;CEL;PTEN
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6839483794760298,1.4178855245320554,0.07936507936507936,1.0,1.0,9/31,15.66%,IGF1;IRS1;PIK3R5;NYAP2;PIK3C2B;PIK3CA;PTEN;IGF1R;PIK3CD
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.8296375695420999,-1.4177612564101318,0.09090909090909091,0.8608760542952828,1.0,3/7,8.40%,COL4A2;COL1A1;UBASH3B
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.9399332736866804,1.4175908265467296,0.03389830508474576,1.0,1.0,1/6,1.73%,RAB38
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.9399332736866804,1.4175908265467296,0.03389830508474576,1.0,1.0,1/6,1.73%,RAB38
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.6362626536166829,-1.4174492852139577,0.047619047619047616,0.8577066496290757,1.0,5/74,4.04%,CYP1A2;ACOT1;AWAT1;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.7669128047074318,1.4172109335958212,0.12903225806451613,1.0,1.0,3/12,5.12%,ADRA1A;CD40;ADGRV1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.7588854307933316,1.4165316579630667,0.08333333333333333,1.0,1.0,3/16,5.72%,SLC26A6;SLC1A3;ABCC2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7642399922078502,1.416214116375724,0.07692307692307693,1.0,1.0,2/12,5.19%,GATA4;BMP2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5225434035276981,-1.4160841153114572,0.023809523809523808,0.8610013662519478,1.0,4/164,3.26%,CD44;PTGES;ASS1;TST
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.717153915922475,1.4158222208253728,0.09615384615384616,1.0,1.0,8/29,13.65%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;IDI2;MVD;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8054421040353815,1.41533425170208,0.05555555555555555,1.0,1.0,6/16,8.89%,F2;RUNX1;WNT4;F2R;VSIR;HDAC2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5764890309351784,-1.4152067437249043,0.02631578947368421,0.8611882342700844,1.0,10/69,8.53%,LRP10;SIGIRR;PRKCD;STXBP2;FOXO4;ST6GALNAC2;PRKD2;PSD4;ARRDC2;B3GALT4
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.8089440038943898,1.4148565359292582,0.057692307692307696,1.0,1.0,4/12,13.55%,IRGM;FYCO1;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7336049051758091,1.4148541879436318,0.07272727272727272,1.0,1.0,5/19,9.97%,DRD5;GRM3;ADGRV1;DRD3;GNAI3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6306032146872654,1.414675573369659,0.04081632653061224,1.0,1.0,15/79,8.35%,VEGFC;MRGPRF;ACTG2;CXCL12;LAMA4;ITGA8;RSPO3;GDF6;ADGRL4;MSRB3;COL6A2;POSTN;BGN;PDGFRA;BMPER
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.9805553822130666,1.41395482583759,0.0,1.0,1.0,1/6,0.92%,FGF10
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.8785448702197263,1.4137832337212073,0.08333333333333333,1.0,1.0,1/6,3.30%,HAS2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7478226581018728,-1.4133448366683132,0.0784313725490196,0.8691007633414577,1.0,4/18,8.71%,RBM4;EIF2S2;EIF2S3;EIF2S3B
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.8330484900309157,1.4133276643240502,0.01639344262295082,1.0,1.0,3/11,6.03%,F2;KLKB1;F12
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.7137619948599571,1.4132248171863127,0.04838709677419355,1.0,1.0,3/27,3.34%,ESPL1;NDC80;NDE1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6436734170463722,1.4122180328521505,0.0625,1.0,1.0,9/47,7.00%,GABRR1;SLC12A7;GABRE;GABRR2;SLC12A1;SLC1A3;SLC12A3;GLRA1;GABRG3
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.7928287615473375,-1.4120239291784291,0.07142857142857142,0.8716564861590737,1.0,1/13,0.26%,NTRK1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8893717458420184,-1.4112155016533132,0.075,0.8712265294186253,1.0,2/5,6.90%,COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.700591753989275,1.410696690440769,0.09259259259259259,1.0,1.0,12/32,20.06%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;IDI2;MVD;ACAA2;SC5D;SQLE;FAXDC2;DHCR7
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6161961226986505,-1.4105745426535903,0.022727272727272728,0.8700206541933363,1.0,10/69,6.52%,MS4A8;DUSP4;EHF;CAPN8;CLDN4;TMEM184A;FAM3D;SPDEF;C6ORF132;MUC5B
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8549286287402531,1.4104926708894812,0.034482758620689655,1.0,1.0,3/11,9.64%,GAS2L3;EPS8;GAS2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5575622295455523,-1.4094257279419167,0.0,0.8730529588843141,1.0,2/137,0.26%,CD44;NTRK1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7907942449956751,1.4091319316273554,0.09836065573770492,1.0,1.0,1/10,0.18%,STK26
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.7276926097133188,1.4089049960686075,0.038461538461538464,1.0,1.0,5/22,4.60%,SLC12A7;SLC12A1;CYP4F12;SCNN1B;SLC12A3
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6389631973507249,1.4087987993733484,0.05454545454545454,1.0,1.0,12/50,14.16%,SYK;LGALS9;SSC5D;F2R;RELA;TLR2;C5AR2;HMGB1;CD74;F3;BCL3;CD244
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.963631245528258,-1.4077534003750298,0.0,0.8669724474811701,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.963631245528258,-1.4077534003750298,0.0,0.8669724474811701,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.963631245528258,-1.4077534003750298,0.0,0.8669724474811701,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8711673268532839,1.4071013551711673,0.061224489795918366,1.0,1.0,3/8,9.04%,CXCL12;CALCR;RAMP3
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),0.9174300906269046,1.406865221767625,0.03571428571428571,1.0,1.0,1/5,0.19%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.7590167007191845,1.406584802592169,0.0847457627118644,1.0,1.0,2/12,4.81%,BOK;AGR2
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.7525992829553034,1.4065129358045076,0.0967741935483871,1.0,1.0,4/18,18.08%,COX19;BCS1L;COX10;SCO2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.7218950968508678,1.4063228740226166,0.10909090909090909,1.0,1.0,8/23,15.23%,ACSM2A;SIRT1;RORA;MLXIPL;NR1H4;NR1H3;ANGPTL4;DGAT2
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.9061316967629697,1.4055638215831037,0.03636363636363636,1.0,1.0,1/6,0.63%,SMYD1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7738526289526272,-1.405217387837779,0.06,0.8739139732962389,1.0,7/17,13.84%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;STMN1;FLG2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7738526289526272,-1.405217387837779,0.06,0.8739139732962389,1.0,7/17,13.84%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;STMN1;FLG2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.836424249615893,1.4048687235797768,0.038461538461538464,1.0,1.0,1/5,2.28%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.9581312582163933,1.404449774556679,0.04,1.0,1.0,1/5,1.04%,DRD5
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8300921609180462,1.4041372251859832,0.05,1.0,1.0,6/9,14.38%,NPC1L1;LDLR;ABCG8;ABCG5;CEL;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.8281754764897784,-1.40373189165142,0.13333333333333333,0.8780179412904208,1.0,4/6,13.02%,NLRP3;CD86;RARA;IL18
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7103207686316377,1.403458551002364,0.034482758620689655,1.0,1.0,3/23,2.74%,SULT2A1;ENPP1;SULT6B1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.7882923635566623,1.4033465336595965,0.057692307692307696,1.0,1.0,6/11,17.28%,GREM2;BMP2;DAND5;LTBP1;GREM1;FBN1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.6446770930031007,1.4030924730896692,0.07692307692307693,1.0,1.0,11/70,12.06%,GATA4;IGF1;HGF;TGFBR1;IL4;URI1;RELA;ITGAV;PELI3;PLAUR;NR4A2
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.9180014629630708,-1.402578821561753,0.14285714285714285,0.8805859126512726,1.0,1/5,4.04%,ALOX5
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.69646330449771,1.4025654066552564,0.07462686567164178,1.0,1.0,1/24,0.07%,MT4
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6490786010847988,1.4020940954881076,0.05970149253731343,1.0,1.0,3/25,9.19%,CGNL1;TMEFF2;DLC1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6198314921674333,1.401787407760721,0.05172413793103448,1.0,1.0,20/86,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;CPED1;ITGA11;PRRX1;SSC5D;PRKG1;ADGRL4;ANGPT1;CCDC80;MSRB3;COL6A2;POSTN;BGN;CYBRD1;PDGFRA;CNRIP1;OLFML3
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7905951774602498,1.4015987705550843,0.038461538461538464,1.0,1.0,3/11,5.19%,TGFBR1;GDF6;BMP2
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.884914530242798,1.399734097811375,0.07547169811320754,1.0,1.0,1/5,2.25%,TSPAN12
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8102855220052344,-1.3996028262300564,0.11764705882352941,0.8956992232148988,1.0,2/10,1.49%,DDX11;KDM4D
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.739758970265767,1.3995623102383739,0.03125,1.0,1.0,7/19,18.79%,CBLB;RGPD4;RGPD2;RGPD3;RGPD5;KPNA4;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8139579666230345,-1.3989966564050516,0.06,0.8947357533785097,1.0,3/12,4.04%,SELP;SELE;ALOX5
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.6286873839662142,1.3989550688862742,0.06779661016949153,1.0,1.0,5/67,6.76%,SGO1;ESPL1;NDC80;NDE1;EPS8
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.8662842403404707,1.3989485241733257,0.05,1.0,1.0,2/8,2.26%,IGF1;LMOD3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5724153132422004,-1.3987606432149584,0.06976744186046512,0.8908270359377538,1.0,7/116,4.85%,CYP1A2;AMACR;ACOT1;LDHC;PER2;SCPEP1;PDHX
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.6712260418514256,1.3986025759769742,0.06382978723404255,1.0,1.0,7/34,9.04%,SYK;LGALS9;CD40;IL23R;PLCG2;TLR2;HMGB1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8684128051976943,1.3980319537284314,0.03571428571428571,1.0,1.0,2/7,9.42%,ACE2;SNCA
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8299434944364917,1.3966292104789924,0.06896551724137931,1.0,1.0,6/10,14.38%,NPC1L1;LDLR;ABCG8;ABCG5;CEL;AKR1C1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.850366501729459,1.3962618590120726,0.1111111111111111,1.0,1.0,2/8,2.91%,ITGA8;ITGA2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.733389273025156,1.395976480981491,0.037037037037037035,1.0,1.0,1/21,0.07%,MT4
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5446697062612229,1.3956491210104147,0.04081632653061224,1.0,1.0,33/157,17.86%,NRTN;GPRIN3;NEDD4;EHD1;PRMT1;NLGN1;NYAP2;CNTNAP2;LGI1;ADGRV1;TNIK;NPY;NEFH;WHRN;MANF;EPHA8;HMGB1;LYN;GPM6A;BLK;PTPRM;PLXNB1;PPP1R9A;GPM6B;PTEN;HDGFL3;LRP12;GRM7;SGK1;DBN1;VASH2;CNTN4;L1CAM
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.6942695643708044,1.3951935295786038,0.1016949152542373,1.0,1.0,4/38,3.00%,VEGFC;CXCL12;LGALS9;CCL5
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5474813052185677,-1.3948266684471269,0.02702702702702703,0.9117442531514505,1.0,14/105,10.21%,TERT;DDX11;PRKCD;GOLGA2;CAV1;DAB2;TTBK1;CLDN5;PPP1CA;FLOT1;IFIT2;LRPAP1;GTF2F1;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.4867207919946753,-1.3946452368022866,0.0,0.9076439954555133,1.0,20/381,6.49%,CD44;NTRK1;ALB;APIP;NUPR1;TNFSF18;TEK;MPO;HMGN5;PRKCD;SFRP1;IL31RA;CRLF1;BCL2L2;NIBAN2;FOXQ1;PLK3;CAV1;CLEC5A;RNF213
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5631077898454786,-1.3943276328679621,0.0425531914893617,0.9040406418713449,1.0,12/76,10.21%,DDX11;PRKCD;GOLGA2;CAV1;JUN;DAB2;TTBK1;PPP1CA;IFIT2;LRPAP1;GTF2F1;ZFPM1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8096161726673321,1.394321092319351,0.11538461538461539,1.0,1.0,5/9,11.49%,TGFBR1;INSIG1;RORA;RORC;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5271853567580005,1.3941159923960007,0.04838709677419355,1.0,1.0,33/220,8.74%,VEGFC;IRGM;F2;IGF1;FLT1;FGF10;C3;HGF;EPHA7;FGFR1;SIRT1;FGF2;FGFR3;CCL5;ERBB4;ROR1;HIF1A;ANGPT1;EFNA5;CD40;BMP2;TNIK;PELI2;ACVR2A;FLT3;ZBTB20;FAM20A;EPHA8;PDGFRA;EPHA5;EPHB4;EPHA3;HDAC3
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.6876499753411922,1.3938016767001498,0.057692307692307696,1.0,1.0,3/37,7.50%,TNFSF14;CD40;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7703889373366266,-1.393561155275164,0.043478260869565216,0.8985090990266281,1.0,1/16,0.27%,TERT
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7703889373366266,-1.393561155275164,0.043478260869565216,0.8985090990266281,1.0,1/16,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.7990693339583315,1.393435250253259,0.06,1.0,1.0,5/15,8.89%,F2;RUNX1;WNT4;F2R;HDAC2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7519920743423907,1.3928236631488966,0.10638297872340426,1.0,1.0,1/17,0.72%,CXCL12
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.9028860042820652,1.3925681478766294,0.017543859649122806,1.0,1.0,2/6,5.09%,STK26;GCH1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.877323726606362,1.3925206112277781,0.09433962264150944,1.0,1.0,1/7,3.00%,CCL5
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.6554540363919346,1.3924979356169538,0.10909090909090909,1.0,1.0,13/44,13.66%,FGFR1;SIRT1;FGF2;HIF1A;ANGPT1;PPARG;CD40;STAT5A;SP1;HMGB1;NUS1;HSPB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8028076155916617,1.392007014210527,0.10344827586206896,1.0,1.0,3/9,4.85%,F2;HS3ST5;F2R
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.7477637985034207,1.3919034567125712,0.11320754716981132,1.0,1.0,1/14,0.56%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7696094457355844,1.3918787716678114,0.0847457627118644,1.0,1.0,6/13,13.66%,IGF1;FGF2;ERBB4;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.8689604816269131,1.3908964521634357,0.02,1.0,1.0,3/9,5.12%,SYK;IL2RA;STAT5A
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.8689604816269131,1.3908964521634357,0.02,1.0,1.0,3/9,5.12%,SYK;IL2RA;STAT5A
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.8834250499516658,1.3903654056583117,0.019230769230769232,1.0,1.0,1/7,0.19%,SGO1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.6494759293807382,1.3901982447854544,0.13043478260869565,1.0,1.0,7/33,5.36%,F2;C6;CFH;C3;CPN1;C9;CD59
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5757993159221407,-1.3896691847838352,0.020833333333333332,0.9204602426539722,1.0,11/63,10.21%,DDX11;PRKCD;GOLGA2;CAV1;DAB2;TTBK1;PPP1CA;IFIT2;LRPAP1;GTF2F1;ZFPM1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.7369949407591475,1.3895180644039022,0.037037037037037035,1.0,1.0,1/20,0.07%,MT4
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7786986315250956,1.3893313793372621,0.03125,1.0,1.0,3/13,10.80%,STK26;TNIK;RAPGEF6
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.728651589193832,1.3884557115607228,0.09090909090909091,1.0,1.0,8/20,19.42%,THRSP;NPC2;PRKAB2;ABCD3;ABCD2;ACACB;ACACA;ABCD4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.847649602028008,1.3884383727864882,0.08928571428571429,1.0,1.0,3/7,5.12%,ADRA1A;CD40;ADGRV1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7406621769570917,1.388164101774091,0.11320754716981132,1.0,1.0,2/16,3.23%,CXCL12;SNAI1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.8212207729756928,1.3874955665579451,0.11764705882352941,1.0,1.0,3/7,10.84%,CKMT1A;GAMT;CKM
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6590061457694695,1.3862100013374188,0.10204081632653061,1.0,1.0,8/38,7.84%,IGF1;HGF;WNT4;BMP2;ACVR2A;WWTR1;CCN4;FBXO5
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.8673612923778272,1.3859425837244999,0.05555555555555555,1.0,1.0,1/6,3.32%,PADI2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8901900017238046,1.3859397425965911,0.07246376811594203,1.0,1.0,2/7,3.81%,IGF1;PPARG
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.710486117328269,1.385618635261195,0.08064516129032258,1.0,1.0,1/22,0.07%,MT4
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.6492229156369548,1.3855545543472285,0.05660377358490566,1.0,1.0,11/43,11.84%,LGALS9;CCL5;SLC26A6;CD40;GCH1;IL23R;SYNCRIP;IRF8;TLR2;SNCA;CD74
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.636028456961912,1.3848961793822694,0.078125,1.0,1.0,16/40,22.32%,SLC26A7;ENPP1;SLC26A6;GLRA1;SLC4A1;SLC34A2;RACGAP1;PACC1;SLC26A4;ANO6;ANO5;SLC5A5;CLCN2;ENPP3;BEST1;SLC25A30
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6850403599681678,1.3847652475451542,0.15217391304347827,1.0,1.0,5/26,4.25%,CRISP1;ASB17;TEX101;PRNT;GCNA
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7715913177864068,1.3843953131623215,0.0,1.0,1.0,3/15,13.65%,BOK;RNF185;RNFT1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6603297252902208,1.3839967931571493,0.06666666666666667,1.0,1.0,6/35,11.22%,ZDHHC12;KAT2B;GLUL;ZDHHC22;FOXO1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7940535568740706,1.383949171045675,0.07407407407407407,1.0,1.0,2/11,3.59%,CTDNEP1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.845536015553648,1.3838572075619975,0.1346153846153846,1.0,1.0,2/6,6.04%,CXCL12;HCLS1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8099331902475393,1.383748393385447,0.0,1.0,1.0,4/16,7.49%,FGF10;SEMA5A;ANGPT1;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5587952640368778,-1.3827658199477004,0.0,0.9610664426418548,1.0,8/99,4.52%,CD44;TNFSF18;IL11;ENPP2;IL31RA;TEC;IL6R;CRLF1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5599374309538365,1.3825748106125286,0.07272727272727272,1.0,1.0,24/124,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;SEMA5A;COL9A1;PRRX1;MATN1;PBX3;PRG4;ADGRL4;CHODL;HAS2;CCDC80;LTBP2;COL6A2;BMP2;CSPG4;IL10RA;SOX6;POSTN;BGN;PDGFRA;OLFML3
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5765570270478617,1.3825566079719076,0.07272727272727272,1.0,1.0,40/115,19.01%,CXXC4;PDZRN4;UNC5C;ESRRG;ERBB4;PTGFR;SCGN;PCLO;PLCXD3;PCDH17;PLPPR1;NRXN1;ADGRL2;LIFR;PTPRD;PAX6;NOVA1;STOX2;FGF12;FGF14;PROX1;ANK2;MAGI1;GUCY1A2;PTPRT;PAK5;TMEM196;NOL4;PPP1R9A;CNTN1;SEMA3E;CNTN3;SEMA6D;FRZB;CPE;MAPK10;CNTN4;PXK;HMGCLL1;FLRT3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8918288802477942,1.3824643433677057,0.0,1.0,1.0,1/5,2.12%,TGFBR1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.7597786806110564,-1.3821931683302833,0.125,0.9597654966691594,1.0,3/15,1.58%,SELP;SELE;SELL
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8862393674731459,1.3821812079058622,0.03508771929824561,1.0,1.0,4/8,9.04%,LGALS9;RUNX1;VSIR;HMGB1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7426166029651107,1.3821014284423998,0.07547169811320754,0.9983973420138106,1.0,2/17,3.81%,SLC5A8;PPARG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6402846404060106,1.3820575977167242,0.09090909090909091,0.9950273503156536,1.0,18/59,13.10%,VEGFC;SEMA5A;FGFR1;TGFBR1;SIRT1;FGF2;HIF1A;STAT5A;BMP2;NRARP;SP1;APELA;HMGB1;AGGF1;PROX1;EGFL7;F3;SIRT6
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5596670144281457,1.3817098498945612,0.034482758620689655,0.9944102713525432,1.0,33/128,17.94%,LRRC3B;LSAMP;GRM3;LRRC4C;GRIN3A;GFAP;CDH20;CADM2;SLC1A3;ZEB2;HEPACAM;NTSR2;SEPTIN4;PMP2;NRXN1;SYNPR;ACSBG1;MAGI2;GRM5;CTNNA2;LRRTM3;ADGRB3;ATP1A2;GJB6;NPAS3;SLC39A12;GPM6B;BAALC;GABRG1;DLG2;RFTN2;MAPK10;CNTN2
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.932835566447574,1.3814712475749746,0.024390243902439025,0.9931310217037446,1.0,1/5,0.19%,SGO1
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.868764508097011,1.3811588096389291,0.03636363636363636,0.9918617661928271,1.0,1/7,0.45%,F2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6338116557007363,1.3810899358334523,0.06666666666666667,0.9885696559834389,1.0,14/36,20.17%,GRM3;GRIN3A;GRIN3B;GRM8;GRIK2;GRM5;GRIK3;GRM4;GRM7;GRM1;GRIK1;PLCB1;GRID2;FMR1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7454707726881902,1.3805573978587384,0.09259259259259259,0.9887406077697789,1.0,3/18,6.51%,F2;PPARG;ZBTB20
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.8199793901123876,1.3803996002617587,0.10344827586206896,0.9868462962653862,1.0,1/12,0.69%,AASS
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.7110136144450592,1.3802620696975998,0.08928571428571429,0.9841254634511418,1.0,10/28,9.04%,IGF1;LGALS9;ICOSLG;IDO1;TMIGD2;BTN2A2;IL23R;SCRIB;CLC;HMGB1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5440360305927873,1.3794510350500704,0.07272727272727272,0.9865457987880325,1.0,18/103,11.07%,MXRA5;CXCL12;LAMA4;PRRX1;PRKG1;LRP4;TMEM100;POSTN;BGN;PDGFRA;ADGRL2;LIFR;EFS;ANK2;MAGI1;GUCY1A2;GFRA1;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6099379058500953,1.3793649306589655,0.1016949152542373,0.9838932533146438,1.0,19/44,17.43%,SMAD6;GREM2;VWC2L;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;DAND5;SMAD1;VWC2;BMPR1A;GREM1;SMAD4;SPART;LRP2;FBN1;SMAD5
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.8961846338496567,1.378835597596787,0.03508771929824561,0.985556956013851,1.0,1/6,0.77%,LGALS9
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.8189308981513284,1.3786100873034453,0.06557377049180328,0.9838026196976195,1.0,5/11,11.81%,LGALS9;ST18;HTRA2;PLAUR;GSN
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7736768699159317,1.3783579091024587,0.07017543859649122,0.9826575182312406,1.0,4/12,7.76%,ZDHHC12;NLGN1;PCLO;NRXN1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5802842654100794,1.378211177000279,0.038461538461538464,0.9805162120978285,1.0,13/86,11.56%,MT4;CXCL12;VAPB;DRD5;CCL5;CD40;CASR;SLC8A1;SLC39A8;SLC24A2;DRD3;ANK2;HTR2C
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.8330234367258843,1.3780949459559493,0.09230769230769231,0.9780724294508526,1.0,1/6,2.18%,SIRT1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6713808048276647,1.3777530238055364,0.15789473684210525,0.9774148529718967,1.0,8/41,6.93%,HGF;FGFR1;TGFBR1;SNAI1;HIF1A;WNT4;BMP2;RBPJ
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.8854839147605398,1.3775788063006473,0.034482758620689655,0.9753169170379624,1.0,3/6,4.74%,ADRA1A;ZDHHC12;NLGN1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.806999919759695,1.3774516474999436,0.0625,0.9731445278872553,1.0,3/12,8.68%,STARD4;NPC2;ABCA1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6660789060720348,1.3774032340765499,0.04,0.9698225728809924,1.0,5/27,3.29%,TNFRSF18;IL2RA;RUNX1;IL4;ZBTB1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.6951613573587945,-1.3768772277657144,0.11904761904761904,0.9925083105972269,1.0,1/18,0.26%,NTRK1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6693345565814549,1.3765965375776492,0.07272727272727272,0.9724209405813244,1.0,12/31,20.20%,C3;SMOC1;PBX3;PAX6;FREM2;SLC39A5;ATF6;HIPK1;ABCB5;SCO2;ADAMTS18;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8832207721788524,-1.3765603852422421,0.044444444444444446,0.9887682310563564,1.0,3/6,7.55%,TAFA3;NUPR1;TTBK1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.7978115427180146,1.3764300031585017,0.14583333333333334,0.9708615613444896,1.0,3/9,8.15%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.6344476971898967,1.376386436418356,0.08196721311475409,0.9678946890862196,1.0,9/45,5.84%,PNP;IGF1;SYK;ICOSLG;IL4;CCL5;TMIGD2;IL23R;CCDC88B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7074167519023921,-1.376356609951745,0.023255813953488372,0.9841779232344705,1.0,2/21,3.17%,TEK;SFRP1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.658042324920259,1.3759964421241668,0.05454545454545454,0.9671141464069868,1.0,10/45,12.72%,F2;CSTA;KNG1;TM4SF20;HDAC2;SPOP;RNF139;SPOPL;PLAUR;DNAJC1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.9056935483898266,-1.3759528181553735,0.09302325581395349,0.9809953139654225,1.0,2/5,3.17%,INHA;SFRP1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.9711920236461675,1.3755847450271093,0.0,0.9672636494144342,1.0,1/5,0.73%,ACE2
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9075158475157963,-1.3754245591219763,0.11363636363636363,0.9786069009809156,1.0,2/5,3.01%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8203520083624964,1.3753243303505556,0.10909090909090909,0.9657015470292811,1.0,2/8,3.71%,CHRM2;HRH3
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.6191749103482096,1.3752188702307127,0.017543859649122806,0.9631892416240089,1.0,20/90,14.53%,STK26;DACH1;MITF;TMEFF2;CCDC125;NAV3;DLC1;TP53INP1;FOXO3;TMIGD3;ARID2;MAGI2;PTPRT;SINHCAF;KANK1;CD74;PTPRK;FRMD5;PTEN;MAPK15
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.7817394217317376,1.3749009393982532,0.1206896551724138,0.9629157524944567,1.0,7/14,13.66%,TGFBR1;RUNX1;FGF2;ERBB4;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5875651477485617,1.3748185395500556,0.05172413793103448,0.9601276133890307,1.0,13/108,8.71%,IGF1;HGF;IRS1;SIRT1;PRR16;FGF2;IL4;MYC;PRMT1;SAMD4A;EIF3E;TLR2;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8761957083255826,1.3744835038857295,0.0,0.9563770187340814,1.0,4/10,7.91%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8761957083255826,1.3744835038857295,0.0,0.9563770187340814,1.0,4/10,7.91%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.9198393283006913,1.3739001085203402,0.034482758620689655,0.9580203757816858,1.0,1/6,0.56%,PNP
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.62007138732437,1.373252558733437,0.0,0.9599516100380688,1.0,8/49,14.46%,LRRC4C;LRP4;CHODL;CDH2;ROBO2;PLXNB1;PLXNB2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8951833511008112,1.3724973631132968,0.01818181818181818,0.9626792331199109,1.0,2/8,2.89%,FGFR1;FGFR3
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.8318481622291364,1.3719277552564,0.08620689655172414,0.9611351014054789,1.0,2/5,11.22%,ENPP1;SLC52A1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.8318481622291364,1.3719277552564,0.08620689655172414,0.9611351014054789,1.0,2/5,11.22%,ENPP1;SLC52A1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.8398096859901489,1.3716007998372644,0.08,0.9604554467912082,1.0,3/10,7.49%,LGALS9;BTN2A2;SCRIB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.5212706298171752,1.370403918881195,0.0,0.9673474217441705,1.0,72/348,16.31%,STK26;FAM83H;DACH1;MITF;IGF1;CXCL12;FLT1;FERMT3;FGF10;SEMA5A;HGF;TGFBR1;ITGAX;FGF2;IL4;CCL5;ERBB4;SNAI1;HAS2;PRR5L;TMEFF2;ABI3;F2R;BMP2;SEMA6C;TCAF2;PDGFRA;NAV3;RHOD;FER;VSIR;PDGFC;DLC1;TP53INP1;FOXO3;TMIGD3;ARID2;FGF17;MAGI2;PTPRT;SINHCAF;CTNNA2;FAM89B;KANK1;CORO1C;FGF5;CD74;CASS4;PTPRK;CARMIL1;AMOTL1;WASHC1;F3;PLXNB1;LGR6;NTNG2;FRMD5;PLXNB2;PTEN;BCAR1;MAPK15;MGAT5;PPP3CA;IGF1R;SEMA3E;CPNE3;KIT;CSF1;PIK3CD;SGK1;RET;SEMA6D
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5803409823972019,-1.3703847641837383,0.0851063829787234,1.0,1.0,10/64,13.35%,H1-3;H1-4;H1-2;RNF8;SMARCD1;CTCF;CHAF1A;DAXX;SMARCA5;H2BC15
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5612477773382771,1.3702105014658823,0.07017543859649122,0.9656874816965482,1.0,15/79,17.04%,CDKN2C;CCNG1;CCNA2;CDC25A;CDKN2A;CNPPD1;LATS1;PROX1;PTEN;SERTAD1;CDC25C;CCND3;CCNB3;NR2F2;CCNH
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8880678219296622,1.3701150433374158,0.0784313725490196,0.9631622095387199,1.0,4/7,5.71%,IGF1;SIRT1;CDKN2A;DIPK2A
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.8268878927788271,1.3699231125593576,0.07272727272727272,0.9619856441982293,1.0,1/10,0.92%,FGF10
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.6727234969118137,1.3692745272021172,0.09803921568627451,0.9640098822227675,1.0,10/40,16.31%,NRTN;SEMA5A;NRG1;ERBB4;CDH2;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6830727534521245,1.369116001664822,0.10344827586206896,0.9620119667259165,1.0,8/21,17.07%,TMTC2;DPY19L1;DPY19L3;SDF2L1;POMT2;FKRP;CRPPA;TMTC3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6465354625660824,1.3689599533793837,0.07692307692307693,0.9603570640852708,1.0,17/60,18.51%,FGFR1;BRINP3;NLGN1;BMP2;ZEB1;MOSMO;ZC4H2;NEUROD2;BIN1;VWC2;TCF4;ADRA2C;CPNE1;MEF2C;NREP;CNTN4;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8597912058978526,1.3680430989616448,0.07272727272727272,0.964787903318395,1.0,3/6,11.81%,PLEKHH2;PIK3CA;GSN
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6759021915259579,1.3671834850121423,0.10909090909090909,0.9690661868644445,1.0,3/18,5.19%,GATA4;SMAD6;BMP2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.6781232526983542,1.3670481999937993,0.14035087719298245,0.9669150461211251,1.0,6/27,11.07%,LGR5;DRD5;CALCR;RXFP2;TMIGD3;EDNRA
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7897986107088057,1.3666855862612308,0.01694915254237288,0.9666473896942284,1.0,4/12,8.68%,SYK;LDLR;PPARG;ABCA1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7072605106873935,1.3666589881859252,0.06896551724137931,0.9635467229305643,1.0,5/26,6.39%,GATA4;CLMP;AGR2;NPY;PCSK5
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6177133777659664,-1.3665489718700963,0.1111111111111111,1.0,1.0,2/29,1.97%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.8852547984621547,1.3659068211775047,0.08,0.966359587337948,1.0,1/5,5.38%,IDH1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.6503316567454708,1.3657095526972112,0.07407407407407407,0.9648091050226968,1.0,9/37,14.16%,SYK;LGALS9;F2R;RELA;TLR2;HMGB1;CD74;F3;CD244
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6977795743107921,1.365698302862967,0.07017543859649122,0.961785300982336,1.0,2/19,3.81%,IRGM;PPARG
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.9181912448502322,1.3656328054129645,0.017857142857142856,0.9589412472343242,1.0,1/5,0.77%,LGALS9
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.90626447813377,-1.365609535941712,0.045454545454545456,1.0,1.0,2/5,4.45%,SLCO2A1;ABCC4
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7827916200002922,1.3653234270300934,0.058823529411764705,0.9585456670587547,1.0,4/12,11.07%,ADRA1A;SLC8A1;MYH11;EDNRA
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7408070762714258,1.3652489328520758,0.1346153846153846,0.9559690069794019,1.0,4/10,15.79%,THRSP;PRKAB2;ACACB;ACACA
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.6585062698576258,1.3651356332141635,0.041666666666666664,0.9536070013663371,1.0,5/30,5.40%,GATA4;SMAD6;SNAI1;BMP2;ROBO2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.729677099435015,1.3651221049773115,0.12,0.9505897651294227,1.0,7/19,13.79%,SLC12A1;CYP4F12;SCNN1B;SLC12A3;SLC8A1;ATP1A2;ATP12A
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5841655981034785,1.3650194114594698,0.05172413793103448,0.9483390912104447,1.0,16/91,11.40%,IRGM;FLT1;PIK3R6;FGFR1;SIRT1;FGF2;CD40;PIK3R5;TENM1;DIPK2A;FLT3;PDGFC;TELO2;SNCA;PROX1;EZH2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6853383470420015,1.3646820762976166,0.1,0.947748947601687,1.0,7/25,18.48%,FGF10;ANGPT1;ANK2;PTPRK;PTPRU;GGA1;CTNNB1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.8019172359335534,-1.3642754024447936,0.17073170731707318,1.0,1.0,2/5,17.53%,SSU72;CTDP1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.8358860503560316,1.3641526077869839,0.08333333333333333,0.9484517340693374,1.0,2/7,12.88%,PEX12;ZFAND6
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8449358191713502,1.3639300604848186,0.11320754716981132,0.9472419805925832,1.0,1/6,2.18%,SIRT1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.7773264727742485,-1.3638001951489256,0.04081632653061224,1.0,1.0,1/8,0.27%,TERT
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.8801855780905232,1.3637351209433513,0.07407407407407407,0.9460011420894882,1.0,2/6,8.68%,F2R;ABCA1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8376633058310371,-1.3635656873980184,0.10526315789473684,1.0,1.0,1/6,1.09%,GINS3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8376633058310371,-1.3635656873980184,0.10526315789473684,1.0,1.0,1/6,1.09%,GINS3
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.6043687957719676,1.3627378849780116,0.031746031746031744,0.9509588415123197,1.0,4/59,3.96%,VAPB;NR5A2;CCL5;MDFIC
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7283710735728016,1.362666544921555,0.1346153846153846,0.9484027481817413,1.0,2/15,3.59%,CTDNEP1;LDLR
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.549196292482865,1.3625895000295951,0.03333333333333333,0.9458243860741464,1.0,31/127,17.09%,NXPH1;LRRC3B;RIT2;NGB;GRM3;KCNC2;GFAP;CDH20;CADM2;SLC17A6;RAB3C;NRXN1;SYNPR;OLFM3;GRM5;CTNNA2;LRRTM3;ADGRB3;NR4A2;PAK5;TMEM196;KCND2;EMX1;GRIN2D;KCNB2;GABRG1;SEZ6L;CALB1;FEZF2;GRM1;KCNQ3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7901553515747568,1.3618768204788494,0.058823529411764705,0.949087736882524,1.0,7/10,15.66%,LGALS9;SIRT1;CDKN2A;LYN;BLK;MEF2C;PIK3CD
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.6766252439791107,1.361730086302552,0.08064516129032258,0.9474785563487436,1.0,8/28,11.36%,SLC26A7;SLC26A6;CA13;SLC39A8;SLC4A1;SLC4A7;CYB5R4;CA2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5768769684169466,-1.3615983574728572,0.09523809523809523,1.0,1.0,10/75,9.27%,LRP10;UMODL1;TMEM184A;UPK1A;PRKCD;STXBP2;PRKD2;PSD4;ABHD11;TRPV1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.7446881785301894,1.3614187189619744,0.07547169811320754,0.9468315901285248,1.0,5/17,8.89%,F2;RUNX1;WNT4;F2R;HDAC2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7436583433292052,1.3612111100871802,0.046153846153846156,0.9457710414403641,1.0,8/15,17.94%,EMB;CNTN6;MYPN;DSCAML1;DSCAM;ROBO3;CNTN4;CNTN2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8881851348995281,1.361123682235446,0.08196721311475409,0.9434681255585307,1.0,1/6,0.38%,MITF
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.7157669272115833,1.3611203298692305,0.11320754716981132,0.9405381003238767,1.0,8/18,16.13%,CXCL12;CCL5;MOSPD2;HMGB1;LYN;PLA2G7;GREM1;ANO6
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.7713192849262636,-1.360771645286553,0.10416666666666667,1.0,1.0,4/11,5.21%,DRD4;NMUR2;ABCC4;DRD2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7407520805076332,1.3600741537856387,0.10714285714285714,0.9454121863323385,1.0,7/14,16.56%,GRM3;GRM8;GRM5;GRIK3;GRM4;GRM7;GRM1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.7343691263485713,1.3598533819670662,0.14545454545454545,0.9442566198600847,1.0,5/19,14.66%,AUP1;RNF185;KLHL15;POMT2;RNF5
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7912509403616795,1.359455609298136,0.11764705882352941,0.9443791494484097,1.0,1/10,1.50%,SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5978110894322545,-1.3589622202444507,0.05405405405405406,1.0,1.0,12/65,8.06%,EPN1;TEK;COL4A2;ALOX5;ADAMTS1;NIBAN2;FOXO4;ANGPT4;SPARC;NAXE;CLDN5;SARS1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6582617456789528,1.3588499854486886,0.06,0.9467742289536744,1.0,14/42,17.27%,NPC1L1;STARD4;LDLR;NPC2;ABCG8;ABCA1;LIPG;ABCG5;CEL;MSR1;AKR1C1;SOAT1;ABCA8;STAR
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.920683809170211,1.3587037978790677,0.034482758620689655,0.9454021791040669,1.0,2/6,6.00%,GATA4;NPY
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8629585650575423,-1.3576510795812988,0.08333333333333333,1.0,1.0,3/5,10.49%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7969613841427348,-1.357368781396742,0.13725490196078433,1.0,1.0,4/12,14.49%,KCNE2;KCNE1;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5778585267324169,1.3569198566909475,0.057692307692307696,0.9554097755977232,1.0,11/81,9.04%,IGF1;SYK;LGALS9;FZD5;IL4;MAPKAPK2;PLCG2;TLR2;C5AR2;VSIR;HMGB1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6284190524051951,1.356807428411511,0.07142857142857142,0.9535028347763174,1.0,8/38,14.26%,IGF1;PYHIN1;PPARG;HMGB1;PLAUR;CPNE1;BCL3;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.8726954997160818,1.3563825204702786,0.06,0.9535586735068966,1.0,5/8,10.58%,SNAI1;WNT4;BMP2;DKKL1;PROX1
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.9160809593153076,1.3559798751863605,0.0,0.951254155288916,1.0,2/8,1.33%,ACE2;MME
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.9160809593153076,1.3559798751863605,0.0,0.951254155288916,1.0,2/8,1.33%,ACE2;MME
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7612781161532051,-1.3558448866858681,0.057692307692307696,1.0,1.0,1/15,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.705074831980807,-1.355725722434602,0.10526315789473684,1.0,1.0,2/13,3.96%,NTRK1;TEC
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.8486987005163855,-1.3557044582733457,0.16,1.0,1.0,3/5,9.11%,KCNE2;KCNE1;KCNQ1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.5418747524885955,1.3553336010269668,0.05660377358490566,0.953067468292216,1.0,29/96,20.03%,TMPRSS2;INSIG1;HERC3;SCD;STEAP4;UBE2J1;FKBP5;PDLIM5;ITGAV;ELOVL5;LIFR;TSC22D1;UAP1;HMGCS1;GNAI3;INPP4B;LMAN1;MYL12A;CCND3;ZBTB10;GUCY1A1;SGK1;ANKH;ELL2;KRT8;SAT1;SMS;DNAJB9;SELENOP
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7274310249968821,1.3551323925982566,0.16666666666666666,0.9520327034467818,1.0,5/17,9.44%,IL4;CD22;SAMSN1;ZFP36L2;BANK1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6639405931688007,1.3550530859863041,0.061224489795918366,0.9497710712668613,1.0,11/51,6.39%,FGF10;ITGA8;MME;TGFBR1;LRP4;GDF6;HAS2;WNT4;ROBO2;KANK2;PCSK5
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7538150576669524,1.35492612568344,0.07142857142857142,0.9477036916623921,1.0,3/16,9.04%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6890643550767406,1.3549038196401695,0.04838709677419355,0.9450717685446751,1.0,8/28,10.13%,ABHD3;SLC44A5;LPIN3;ACHE;PCYT1B;SLC44A4;CHPT1;CEPT1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.8042825828841715,-1.3548707693146267,0.14285714285714285,1.0,1.0,4/7,13.02%,NLRP3;CD86;RARA;IL18
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.7831077020014328,1.3546359541499053,0.08196721311475409,0.944719899920245,1.0,2/11,9.26%,PCBP3;NOVA1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7309136703367679,1.354231710070139,0.11475409836065574,0.9448360026817363,1.0,4/16,10.94%,GRIN3B;CASR;ANK2;EPB41
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7566125532332262,1.3541199176641192,0.046875,0.942807460097864,1.0,3/14,10.80%,STK26;TNIK;RAPGEF6
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.8128726922125521,1.3538551695864023,0.03389830508474576,0.9424296993740843,1.0,5/11,9.11%,TMPRSS2;MYRF;F12;HJV;HTRA2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8304891851585143,1.3535268879486113,0.08771929824561403,0.9425514801831242,1.0,1/11,0.92%,VAPB
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8883379947854313,-1.3531178961634402,0.15555555555555556,1.0,1.0,1/5,3.78%,OAS3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7880846441221551,1.3529267085251389,0.07692307692307693,0.9449040219568218,1.0,5/14,16.45%,SOCS2;STAT5A;LYN;PXN;PRLR
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.8285440390033911,1.3525754203269649,0.06896551724137931,0.9456536117175167,1.0,2/9,3.28%,GRIN3A;GRIN3B
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.8199642812302715,-1.352543071412587,0.1346153846153846,1.0,1.0,2/7,1.49%,DDX11;KDM4D
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5631683410286668,1.3510275236718563,0.05,0.9555547147305241,1.0,21/118,12.42%,STK26;DACH1;MITF;FGF2;IL4;TMEFF2;NAV3;DLC1;MARVELD3;TP53INP1;FOXO3;TMIGD3;ARID2;MAGI2;PTPRT;SINHCAF;KANK1;CORO1C;CD74;PTPRK;BMPR1A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6395596653985879,1.3508954839731706,0.15517241379310345,0.9542677445964196,1.0,17/42,17.37%,TSHZ3;GRM3;NLGN1;CDH2;SYT1;NRXN1;GRM8;DRD3;GRM5;ATP1A2;MEF2C;GRIK3;GRM4;GRM7;GRM1;GRIK1;DGKZ
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6139767748476991,-1.3507429874414323,0.06666666666666667,1.0,1.0,3/39,6.50%,EPN1;MVP;PTPN3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5923705122023428,1.3503261397311248,0.08620689655172414,0.9559992133018707,1.0,9/48,11.80%,FGF10;IL4;HIF1A;DOCK1;GLUL;PLCG2;BMPER;MARVELD3;CORO1C
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7090702022447423,-1.3500348674720206,0.10638297872340426,1.0,1.0,5/19,9.11%,KCNE2;SCN5A;KCNA5;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.7375051040228263,1.3500266519079471,0.05172413793103448,0.9554864100817327,1.0,5/26,6.39%,GATA4;TGFBR1;HES6;BMP2;PCSK5
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7623622714926853,1.3498364084901533,0.09803921568627451,0.9542106984434768,1.0,7/11,17.94%,LRP4;NLGN1;PTPRD;NLGN4X;CEL;PTEN;CNTN2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.7397221167266744,1.3496256783779843,0.13333333333333333,0.9531505472179824,1.0,3/13,5.60%,FGF10;NRG1;OPRK1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.655665882960153,-1.3488077352921717,0.1,1.0,1.0,4/36,2.56%,H1-3;H1-4;TERF2IP;H1-2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8684646889251004,1.3487784003321754,0.047619047619047616,0.956007691960761,1.0,1/7,1.43%,SLC12A7
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.720803469562665,1.3486363158056334,0.16071428571428573,0.9546378283123933,1.0,5/14,13.71%,PPARG;EHD1;ABCA1;MSR1;NR1H3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.6219966835292179,-1.3485860070124907,0.10416666666666667,1.0,1.0,5/34,11.30%,DUSP4;DUSP6;PGP;UBASH3B;DUSP9
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.7289118238865594,-1.3481026289053972,0.2,1.0,1.0,2/14,3.31%,PLAAT4;ETV4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.715074654472369,1.3474826727429199,0.1206896551724138,0.9612948335974834,1.0,2/19,4.90%,BOK;SYVN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7735110730441574,-1.3474577386322495,0.15217391304347827,1.0,1.0,4/12,16.34%,TAFA3;TTBK1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7742551185005458,1.3472919517757387,0.10714285714285714,0.9597118565719124,1.0,1/12,0.74%,CTDNEP1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6142948591083693,-1.3470101904204332,0.13953488372093023,1.0,1.0,3/29,4.04%,EPN1;FGF1;ALOX5
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.8090864333068358,1.3467517242049913,0.09836065573770492,0.9612178563686004,1.0,2/11,4.34%,RUNX1;MAFB
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.8222126922745057,1.34626024475867,0.11475409836065574,0.9620328606496698,1.0,3/10,10.53%,SEMA5A;PLEKHH2;PIK3CA
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8124170915011244,1.34594256290137,0.1111111111111111,0.9614139908217965,1.0,2/8,10.53%,DAPK2;PIK3CA
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.8843593266806409,1.3458568608702381,0.09615384615384616,0.9596447513093201,1.0,3/5,10.95%,ITGB8;ITGAV;LTBP1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.6765392432731373,1.3458134522118832,0.09259259259259259,0.9574454279986445,1.0,7/28,13.58%,GATA4;TGFBR1;ROBO2;DAND5;PROX1;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.7838409114623845,1.3453451905396823,0.08928571428571429,0.9590043018786285,1.0,6/14,17.27%,STARD4;LDLR;NPC2;ABCA1;LRP6;STAR
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.747553839565514,1.3453028833438894,0.13114754098360656,0.9566506669199206,1.0,7/12,14.24%,SYK;LGALS9;IL4;FER;LYN;BLK;ADGRE2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.8022893037971601,1.3449438489098253,0.14285714285714285,0.9566928739612119,1.0,1/7,2.12%,TGFBR1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6453159034700883,1.34494209850296,0.04838709677419355,0.9540573564020901,1.0,10/54,8.03%,GATA4;IGF1;FGF10;TGFBR1;NRG1;FGF2;MYOF;PDGFRA;HPSE;DSP
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7914312890835837,-1.3449094762169276,0.09523809523809523,1.0,1.0,1/15,0.47%,AMACR
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.838182721399537,1.3447673027140286,0.15151515151515152,0.9522039838970346,1.0,2/7,3.81%,CDKN2A;PPARG
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.6770820162406374,-1.3440390366713637,0.13333333333333333,1.0,1.0,9/22,13.66%,OR2M4;OR51M1;SLC24A4;DRD2;GNAL;OR52A1;SYT10;OR9Q1;OR9G4
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7868310422848636,1.343653320263923,0.03225806451612903,0.9587819378445568,1.0,5/11,12.17%,SLC1A3;GLUL;SLC22A3;SLC29A2;ATP1A2
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7358559341671711,1.3436205960475005,0.0784313725490196,0.956461063920897,1.0,4/15,8.15%,HPD;IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.7576818360751325,1.3436192115561234,0.11538461538461539,0.953854902983783,1.0,3/12,9.11%,IRGM;PYHIN1;HTRA2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6100330123541093,-1.3435656836167695,0.1346153846153846,1.0,1.0,2/42,1.97%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6181694334150952,-1.3429224482403286,0.15384615384615385,1.0,1.0,2/28,1.97%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8724265647445307,1.34115483459924,0.1346153846153846,0.9713023515093542,1.0,2/6,3.60%,FGF2;ANGPT1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.768460708552487,1.3404341535165007,0.09259259259259259,0.9741026292362303,1.0,4/16,13.66%,IGF1;SIX4;ADGRB3;MEF2C
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7482895894968502,1.3403401796484247,0.05555555555555555,0.9723893123073583,1.0,5/13,12.17%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7879682770275666,1.3402813759589742,0.1,0.9700957864035201,1.0,4/11,11.69%,VEGFC;GAB1;PIK3CA;NUS1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7612726676914825,-1.3401360981145944,0.0975609756097561,1.0,1.0,3/15,5.00%,TERT;TERF2IP;TPP1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6279483918797978,1.3400226070262204,0.07407407407407407,0.969414878622065,1.0,11/41,12.78%,FGFR1;SIRT1;FGF2;HIF1A;ANGPT1;CD40;STAT5A;SP1;HMGB1;NUS1;HSPB1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6716012412623706,-1.3399115016119847,0.10638297872340426,1.0,1.0,6/38,7.29%,H1-3;H1-4;H1-2;ERN2;INCENP;NCAPD3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.7196593786972054,1.3396974951541247,0.1568627450980392,0.9693239064415029,1.0,4/17,4.32%,ZBTB7B;NRG1;ERBB4;WNT4
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8327685674430909,1.3396240887071436,0.15254237288135594,0.9675117539771144,1.0,5/8,14.47%,EFS;MCU;GSN;CASS4;BCAR1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.8552765522526158,1.3395260440377041,0.14545454545454545,0.9630439561478883,1.0,2/6,3.59%,STARD4;LDLR
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.8552765522526158,1.3395260440377041,0.14545454545454545,0.9630439561478883,1.0,2/6,3.59%,STARD4;LDLR
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6841856577983245,-1.3392502920086116,0.1320754716981132,1.0,1.0,4/28,1.82%,P2RY10;KLRC1;SELL;SIRPG
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.6522718087237096,1.339022914359626,0.16,0.9645821373389802,1.0,7/25,13.62%,HPD;IDO1;IDO2;CBS;TDO2;HSD17B10;FAH
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6436974006779599,1.3384332246807968,0.0392156862745098,0.9672692390717602,1.0,10/33,18.79%,LRRC4C;NLGN1;NRG3;NLGN4X;GRIK2;CEL;GRIK3;GRIK1;PXK;GRID2
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.8103901684505157,1.3374513553754266,0.09615384615384616,0.9720578387718889,1.0,3/10,2.63%,MITF;LRMDA;ENPP1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.8295066430596357,1.3371834271742589,0.1206896551724138,0.9714180739643329,1.0,3/10,9.42%,FGFR1;FGFR3;SNCA
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8382466436884543,-1.3369651546429313,0.15217391304347827,1.0,1.0,2/6,8.30%,RFTN1;FLOT1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.4949611023240391,1.3368934023954206,0.0196078431372549,0.9707178925930454,1.0,41/138,20.61%,IRS1;RUNX1;MYC;INSIG1;PTGFR;HAS2;LDLR;PPARG;ADD3;MMP16;ACVR2A;PDLIM5;ADGRL2;PHF3;DLC1;ATXN1;AGGF1;SPOP;INPP4B;MAGI2;LTBP1;BMPR1A;NR1D2;F3;PTPRM;PTEN;IGF1R;COL11A1;KIT;PIK3CD;NEK7;DYRK1A;NOTCH2;VAV2;ADORA2B;PIK3R3;BCKDHB;TOGARAM1;CITED2;RASA2;SFMBT1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4883272372815823,1.3364984922921033,0.017543859649122806,0.9718978118878442,1.0,50/378,11.84%,MITF;ACTG2;RBM20;IGF1;LGALS9;IL26;NOX5;FGF10;CALCR;TGFBR1;ITGB8;ZBTB7B;ITGAX;PRR16;FGF2;IL4;MYC;CTCFL;HIF1A;RAB27A;KAT2B;ANGPT1;TMIGD2;MYCN;SF3B1;AGR2;LIN28A;SAMD4A;BMP2;EIF3E;SP1;CCDC88B;ZNF804A;RBPJ;MOV10;PLCG2;TICAM1;TLR2;VSIR;RAMP3;PAX6;ITK;IL15;SMAD1;RIMS2;ANK2;FGF17;GSN;FGF5;CD74
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7127172389242628,1.3361648799277055,0.12307692307692308,0.9719296158674209,1.0,6/15,16.75%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.8267201969828282,1.336117100455258,0.0847457627118644,0.9697465708317813,1.0,2/8,12.88%,PEX12;ZFAND6
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.876265658623292,1.335627930098369,0.09090909090909091,0.9712038242711563,1.0,1/6,3.75%,KLKB1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.7210438904030216,1.3349333935045145,0.11764705882352941,0.9744790426447933,1.0,3/13,8.64%,EGLN3;PLOD2;P3H2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5657981112858262,1.3346848518989711,0.07407407407407407,0.973687628092504,1.0,46/133,18.74%,IL26;FGF10;CALCR;SEMA5A;HGF;IRS1;FGFR1;TGFBR1;NRG1;FGF2;FGFR3;ERBB4;ANGPT1;PIK3R5;LIN28A;HCLS1;FLT3;HIP1;ESR1;PDGFRA;HPSE;GAB1;NRG2;RAMP3;PIK3CA;FGF17;FGF5;CASS4;F3;LCK;CPNE1;KLB;IGF1R;CD80;KIT;PIK3CD;RET;MFHAS1;RICTOR;IAPP;LRP2;RHOG;GAB2;AXL;MYDGF;AKR1C3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.5713038613658701,1.334388784289244,0.15254237288135594,0.9731507903203471,1.0,17/86,14.76%,SYK;RIT2;CD22;SEPTIN4;ZFYVE16;HIP1;RALA;SYT1;RAB3C;ITGAV;ABL2;RNF139;RIMS2;STON2;HAP1;RAB33B;PICALM
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7269118829362439,1.334346932336592,0.09433962264150944,0.9709614340521288,1.0,3/17,6.06%,SOX5;BMP2;SOX6
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.8940823840691356,1.3342068905158213,0.10869565217391304,0.9694063370569959,1.0,2/5,6.68%,IRGM;RELA
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.7861197176507323,1.3340182301086752,0.0425531914893617,0.9679524102781935,1.0,6/15,13.58%,LGALS9;ITGB8;HIF1A;ITGAV;LTBP1;SMAD4
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6482325081028031,1.3337789541487322,0.11864406779661017,0.9676836223287143,1.0,8/32,14.76%,IGF1;SP1;RELA;BIN1;LRRTM3;HAP1;RTN1;PICALM
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6752080442405886,-1.3334812865116408,0.10416666666666667,1.0,1.0,3/31,2.28%,ACTC1;MYH7;SCN5A
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.7747160080425808,1.333424929124263,0.061224489795918366,0.9679417367183466,1.0,1/9,2.86%,DLGAP5
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.8077915385723294,-1.333387550173242,0.1282051282051282,1.0,1.0,3/10,10.74%,DNAAF1;CFAP73;CCDC40
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.8050837925996167,-1.3332540430759297,0.15,1.0,1.0,1/9,0.27%,ALB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.8050837925996167,-1.3332540430759297,0.15,1.0,1.0,1/9,0.27%,ALB
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.724384677543274,1.3331341405219321,0.07547169811320754,0.9675509989431451,1.0,3/19,8.71%,IGF1;PLCG2;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6725272398125222,1.3327212797251529,0.10909090909090909,0.9677158703809071,1.0,5/24,11.46%,IGF1;PYHIN1;PPARG;HMGB1;PLAUR
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.7222696924248733,1.3325420204860274,0.1346153846153846,0.9665300068903796,1.0,5/16,6.93%,TGFBR1;SNAI1;HAS2;BMP2;RBPJ
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5727965790730529,1.3325195111725587,0.1,0.9643096387153118,1.0,19/93,9.19%,MXRA5;MRGPRF;CXCL12;LAMA4;ITGA8;ITGA11;PRRX1;SSC5D;PRKG1;ADGRL4;CCDC80;MSRB3;POSTN;ABI3BP;BGN;PDGFRA;MYH11;OLFML3;DLC1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7476068080250644,1.3324798996062206,0.125,0.9621614790245322,1.0,3/16,5.30%,PNP;SYK;IL23R
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6016723469327883,1.3320660392701433,0.14545454545454545,0.962703592258153,1.0,15/49,21.15%,REP15;SYK;NEDD4;RAB31;RAMP3;SNCA;PICALM;MVB12A;DNM3;CALCRL;MX2;CD81;ARRB2;LGMN;SMURF1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8609829648403202,1.3319662791521445,0.06,0.9609346620879207,1.0,3/7,12.07%,WNT4;BMP2;H6PD
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6271397605772958,1.3315063766548747,0.06521739130434782,0.9622648544128789,1.0,11/27,24.12%,CD40;TICAM1;UBE2D3;TNIP3;TANK;IRF3;UBE2D1;BIRC3;FADD;IKBKB;IKBKE
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.8790193666303656,1.331288699482468,0.09836065573770492,0.9610800284266123,1.0,2/6,11.20%,MME;HYAL3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7166784390357591,1.3311723299318303,0.07246376811594203,0.9595694687673699,1.0,3/13,4.74%,ADRA1A;ZDHHC12;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.8489505763530689,1.3304070712468292,0.07547169811320754,0.9628478477983626,1.0,4/8,11.81%,LGALS9;ST18;HTRA2;GSN
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.7849202334083075,1.3301626829756528,0.12727272727272726,0.9621503240534462,1.0,1/9,2.18%,SIRT1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6559907846587858,1.3299268546535588,0.10204081632653061,0.9611569969723386,1.0,4/26,5.40%,GATA4;SMAD6;SNAI1;ROBO2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8351747480167092,-1.3295814060391744,0.07142857142857142,1.0,1.0,3/8,5.41%,SIGIRR;IL6R;AHSG
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.765116445069024,1.3291481144140618,0.09523809523809523,0.9647058146684063,1.0,3/11,10.64%,SYT1;UNC13B;RIMS2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8201403342510933,1.3289875016170387,0.07272727272727272,0.963830202401859,1.0,3/7,9.04%,ZBTB1;CLC;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7680735142714142,1.32830942853926,0.14035087719298245,0.9665828148021356,1.0,4/14,14.46%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.78404299441614,-1.328307757205479,0.13333333333333333,1.0,1.0,5/10,15.25%,PLAAT4;ETV4;PRKCH;VDR;MED1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6616504599574432,1.3282444315245758,0.11666666666666667,0.9645808797474478,1.0,7/21,11.59%,ARHGAP24;ABI3;NLGN1;EPS8L2;EPS8;DEF8;KANK1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6937717900733198,1.3279650684829427,0.16666666666666666,0.9644509603681977,1.0,4/24,10.93%,IRGM;RELA;MAP2K6;TAB2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6371771545942004,1.3277643337296199,0.19047619047619047,0.9640857664189763,1.0,4/38,3.50%,F2;SYK;ACE2;RAB27A
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8510819159004133,1.3272516294073,0.19047619047619047,0.965016678224296,1.0,1/6,8.68%,CLC
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.755613928445922,-1.3271481348422423,0.06818181818181818,1.0,1.0,4/15,9.11%,KCNE2;SCN5A;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5900743120195149,1.3269984217666326,0.10344827586206896,0.9645638449259136,1.0,4/93,2.86%,SGO1;ESPL1;NDC80;DLGAP5
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.8200654018921677,-1.3269423747991798,0.18604651162790697,1.0,1.0,1/5,4.63%,WNT7A
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.8200654018921677,-1.3269423747991798,0.18604651162790697,1.0,1.0,1/5,4.63%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.8044951204718178,1.3264199338155258,0.08928571428571429,0.9659867932161833,1.0,1/10,1.50%,SEMA5A
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6525682542229208,1.3262162066020111,0.13793103448275862,0.9654753957620513,1.0,8/44,6.93%,HGF;FGFR1;TGFBR1;SNAI1;HIF1A;WNT4;BMP2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.8126980191096523,1.3260271210735366,0.14285714285714285,0.9645585669221433,1.0,1/6,4.85%,F2R
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.7065111316176321,1.3258418829516792,0.07547169811320754,0.9634426706570953,1.0,1/16,0.56%,PNP
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5749805184995417,1.3258064608581406,0.04081632653061224,0.9614042444306704,1.0,17/53,23.53%,FAIM;TIFA;RELA;TICAM1;TLR2;TAB2;ZNF675;BCL3;TANK;TAB3;TBKBP1;TAB1;BIRC3;ERC1;IKBKB;RIPK2;IRAK1BP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7526499949588638,1.3254128560630074,0.18461538461538463,0.9623549520920602,1.0,5/10,13.66%,FGF2;ERBB4;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8072988594070725,1.3251468383162461,0.12727272727272726,0.9616273928013678,1.0,2/7,3.02%,ZBTB7B;ERBB4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.754913503110791,1.324967681982709,0.1509433962264151,0.9586603640195855,1.0,2/10,4.88%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.754913503110791,1.324967681982709,0.1509433962264151,0.9586603640195855,1.0,2/10,4.88%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.7297838281353315,1.3247311879891472,0.10714285714285714,0.9579753197905507,1.0,2/14,2.82%,IGF1;NRG1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7654691326376556,1.3237949939942648,0.14035087719298245,0.9616671825704679,1.0,1/8,0.56%,PNP
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.8027600690692105,1.3235945813805639,0.043478260869565216,0.9609497771905148,1.0,6/13,14.38%,ABHD3;CYP4Z1;ACADM;OLAH;GLYATL2;OXSM
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7561921262395596,1.3233629381590966,0.05454545454545454,0.9604633502001325,1.0,5/12,12.17%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.7242252332601953,1.32335973164485,0.08,0.9583044343365691,1.0,4/17,9.11%,IRGM;PYHIN1;XAF1;HTRA2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.6161077451188984,1.323313816724678,0.08771929824561403,0.9564387796238463,1.0,11/43,23.32%,ACD;MYC;PARM1;GREM1;MAPK15;TERF1;NEK7;CTNNB1;POT1;TP53;MAPK3
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.8297193588894625,-1.3232654392989935,0.1891891891891892,1.0,1.0,1/5,4.04%,ALOX5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7110544134745362,1.3232491900435237,0.11864406779661017,0.9545818023749035,1.0,2/13,3.54%,AANAT;KAT2B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6108256351683718,-1.3231897397020898,0.1,1.0,1.0,9/49,16.32%,DDX11;RECQL5;RTEL1;XPC;PARP1;GTF2H2;SUPV3L1;RAD50;MCM2
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.7036740202705499,-1.3229149453567353,0.2894736842105263,1.0,1.0,1/10,1.54%,INHA
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6928837247904119,1.3220852504125349,0.04081632653061224,0.9605415774448444,1.0,5/22,13.34%,MYC;MRAP2;COQ10A;LEPR;SLC25A13
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.6038392652511722,1.322040113343334,0.07407407407407407,0.9587680689858828,1.0,8/57,9.84%,IGF1;FGFR1;TGFBR1;IL4;RELA;TNFRSF10A;ITGAV;PELI3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6778243787506477,1.321857118158532,0.16,0.9579567247386109,1.0,6/20,16.75%,ADRA1A;SLC8A1;JPH1;GRIN2D;TRPM2;RYR2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.8391032327980811,1.321812470701399,0.12962962962962962,0.9560013914599161,1.0,3/6,9.25%,HS3ST5;HS3ST3B1;HS2ST1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.8256364471300167,1.3216996347900976,0.11320754716981132,0.9546415574702389,1.0,2/6,9.71%,CYP4F12;CYP4F3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.8592768643623864,1.321015704905791,0.07272727272727272,0.9581921932578269,1.0,2/7,10.53%,CXCL12;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6721608753558952,1.3209204060580382,0.13114754098360656,0.956527756394007,1.0,6/18,16.75%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7730075677595042,1.3205058286464175,0.10638297872340426,0.9573950519771661,1.0,6/14,17.89%,SIRT1;SNAI1;HP1BP3;SETD7;LOXL2;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.8320770753777513,1.3202009522585576,0.10606060606060606,0.9573451367227133,1.0,2/5,3.71%,GABRE;HRH3
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.9022216921359392,-1.320177595135755,0.06521739130434782,1.0,1.0,3/5,8.96%,SLX4;ERCC1;RTEL1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6721018785720995,1.320108214224862,0.08928571428571429,0.9560529246991322,1.0,8/29,12.78%,VEGFC;FLT1;RELA;MAPKAPK2;GAB1;PIK3CA;NUS1;HSPB1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.8228875131542264,-1.3198286906064485,0.08163265306122448,1.0,1.0,2/7,7.34%,UMODL1;UMOD
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.631838547576055,1.319683134725308,0.10526315789473684,0.9575765736376326,1.0,6/39,12.52%,F2;GSTM2;F2R;SNCA;ANK2;JPH1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.83603556678869,-1.3196277638018898,0.1956521739130435,1.0,1.0,1/6,5.58%,KMT2B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5798609668852706,1.3195113317265437,0.12903225806451613,0.9565370653898825,1.0,6/34,11.89%,UTRN;NEDD4;TCAF2;FGF12;ANK2;SCN2B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.6303607478455225,1.3192843972660715,0.058823529411764705,0.955803921337792,1.0,6/34,12.72%,F2;CSTA;KNG1;TM4SF20;NLRP7;DNAJC1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6522911264771306,-1.3190438426989983,0.14285714285714285,1.0,1.0,11/45,10.74%,TEKT3;CFAP61;DNAH17;DNAAF1;TEKT5;CFAP73;RSPH9;DNHD1;DNAH11;ZBBX;CCDC40
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.7834679203802514,1.3187577111296438,0.12962962962962962,0.9577556423026876,1.0,1/8,0.38%,GATA4
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8550109230387006,-1.3184197808100528,0.058823529411764705,1.0,1.0,1/5,2.03%,CD24
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8550109230387006,-1.3184197808100528,0.058823529411764705,1.0,1.0,1/5,2.03%,CD24
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.7752062286632923,-1.3177932556340266,0.1276595744680851,1.0,1.0,1/10,0.91%,HK2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.5924327146816395,1.3177276184551494,0.1016949152542373,0.9631385670946874,1.0,12/66,13.35%,MME;GSTM2;GSTT2;ANPEP;CPN1;TRHDE;NAALADL1;PCSK5;HPGDS;LNPEP;BACE2;ETHE1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5854406262518279,-1.317686365411747,0.13333333333333333,1.0,1.0,4/40,5.63%,ANXA8;AHSG;TIMP4;SERPINI2
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8699517901234995,1.3176136946852568,0.09375,0.9617145484360788,1.0,1/6,0.36%,DACH1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.7418749108600043,1.3175180174470573,0.14285714285714285,0.9601066465468859,1.0,2/11,13.58%,RAPGEF3;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.85466309987944,1.3174960699152918,0.11538461538461539,0.9581262627849287,1.0,2/5,6.04%,RUNX1;HCLS1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.5614283748757516,1.3173945429149487,0.0625,0.9566417474663883,1.0,17/64,25.20%,SIRT1;LIN28A;HDAC3;TELO2;PIK3CA;EPM2A;RRAGC;RICTOR;PRKAA1;MLST8;RRAGD;DEPTOR;GSK3A;HTR6;GAS6;DYRK3;GPAT3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.7202517867841192,1.317063276841281,0.125,0.9563787420135421,1.0,3/19,6.55%,IGF1;CCL5;CCN4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7946091891982124,1.316174580854807,0.06521739130434782,0.9602384447674636,1.0,5/9,19.34%,POGLUT2;GALNT3;POGLUT3;GALNT1;GALNT16
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6526980265787745,1.3161434524022089,0.09259259259259259,0.9582752949365401,1.0,12/31,17.42%,CLSTN2;CDKN2AIP;LGI1;SYT1;SCRIB;RAMP3;SNCA;GRIK2;RIMS2;VAMP3;CD80;RAB29
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7454578781815746,1.3144598637957745,0.1111111111111111,0.9680944631337277,1.0,6/20,9.42%,CCL5;MRAP2;BICD1;KLK14;ADA;SNCA
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7626868568393342,1.3142913408581527,0.14285714285714285,0.9669789831874794,1.0,4/15,12.90%,CGNL1;SCRIB;DSP;TJP2
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.8173075801107206,1.3142547822402704,0.09836065573770492,0.9651474696468076,1.0,3/6,13.41%,GREM2;BMP2;GREM1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5561294448482775,-1.3140800861480768,0.09302325581395349,1.0,1.0,4/77,5.00%,SLC28A2;SLC6A6;ABCC4;SLC22A8
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.8525282421218929,1.3138738054120305,0.16363636363636364,0.9658017701533446,1.0,2/5,9.37%,ZBTB7B;ITK
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.8475351103345459,-1.3137718278870911,0.1836734693877551,1.0,1.0,1/7,0.70%,DDX11
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.6621197414584734,1.3137618180413175,0.15254237288135594,0.9644593690933853,1.0,8/29,15.22%,NRG1;ERBB4;GAB1;NRG2;ERBIN;PIK3CA;SOS1;CPNE3
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8981233714894606,1.3136292915840921,0.08,0.9634146211432549,1.0,1/6,2.21%,UHRF2
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.9146917489906751,1.3132606558020472,0.07017543859649122,0.9639890144305956,1.0,1/5,0.92%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7311144994899067,-1.3131866057053518,0.1,1.0,1.0,2/16,3.17%,TEK;SFRP1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5664720243576371,1.313064508227085,0.047619047619047616,0.9631082981581893,1.0,15/104,8.79%,SLC5A8;SLC26A3;SLC12A7;SLC26A7;SLC5A12;SLC12A1;SLC26A6;SLC1A3;SLC12A3;SLC17A6;GLRA1;SLC15A1;SLC8A1;SLC24A2;SLC4A1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.7533347842853393,1.3127013578935727,0.16071428571428573,0.9640498177344394,1.0,2/10,5.51%,TBC1D8B;MYO1E
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6998780677509033,1.3125966230361954,0.12727272727272726,0.9628046273201807,1.0,4/18,5.49%,FGF10;GDF6;ROBO2;SIX4
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.7897267222367417,1.3125820076659716,0.1896551724137931,0.9608038556857852,1.0,4/11,14.66%,AUP1;RNF185;POMT2;RNF5
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4838167582434864,1.31250277774632,0.034482758620689655,0.959440110835935,1.0,60/441,9.10%,TNFSF14;IGF1;FLT1;LGALS9;IL26;FGF10;ADRA1A;CALCR;SEMA5A;HGF;IRS1;TNFRSF19;RIT2;FGFR1;TGFBR1;SIRT1;BOK;NRG1;FGF2;FGFR3;CCL5;ERBB4;ROR1;ANGPT1;NEDD4;KSR1;CD40;PIK3R5;CANT1;NLGN1;LIN28A;F2R;ADGRV1;SLC35B2;BMP2;TIFA;MID2;PELI2;HCLS1;FLT3;SEPTIN4;HIP1;RELA;EPHA8;ESR1;PELI1;PDGFRA;PLCG2;HPSE;ITGAV;GAB1;TICAM1;TLR2;NRG2;HDAC3;PPM1A;NEUROD2;RAMP3;HMGB1;PDGFC
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.811728111380599,1.3124616749337077,0.14754098360655737,0.95753356161089,1.0,1/7,3.54%,KAT2B
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.6350561059312111,1.312317164066122,0.14814814814814814,0.9562609007618329,1.0,8/31,16.99%,LGALS9;GDF6;PRMT1;BMP2;RELL1;GADD45G;MFHAS1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8459100145862344,1.3122205071530584,0.1111111111111111,0.9549936902804377,1.0,2/7,5.71%,IGF1;DIPK2A
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.8749604654794737,1.312155370116328,0.06,0.9533684600088417,1.0,3/5,8.15%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.8913114506644351,1.3120700903603668,0.1320754716981132,0.951983299123873,1.0,2/5,5.66%,NPC1L1;MTTP
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.647398700497034,1.3118275417195613,0.14754098360655737,0.9518447937522884,1.0,4/30,3.41%,SLC26A3;RAPGEF3;AANAT;SLC26A6
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.7929037289867271,-1.3117481459379263,0.14285714285714285,1.0,1.0,2/6,16.72%,DBH;LRTOMT
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6066205875211697,-1.3114962101644927,0.045454545454545456,1.0,1.0,3/33,7.06%,RFX6;HLA-DRB1;NNAT
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5287488375935476,-1.3112175881760417,0.046511627906976744,1.0,1.0,7/116,3.79%,MS4A8;EHF;RFX6;TMEM179;NPTX2;IGSF21;MAPK4
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.768524018720249,1.3111034914276978,0.12903225806451613,0.9544410734163032,1.0,7/11,17.02%,PLA2G10;CD74;LYN;LCK;GPR137B;MFHAS1;PLSCR1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.7052547221277311,1.310917676750921,0.12244897959183673,0.9537059355699067,1.0,6/12,22.99%,SMAD6;ROBO2;NOTCH2;BMP4;JAG1;HEY2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7135853124308448,1.3107116292423673,0.15,0.9528197946674907,1.0,2/14,7.26%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6994851595193791,1.31051138257274,0.12962962962962962,0.9523218585852854,1.0,9/22,17.72%,ACVR2A;RBPJ;ELAPOR2;SMAD2;BMPR1A;SMAD4;CRB2;FBXL15;BMP4
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5641430010207281,1.3104966279394368,0.1206896551724138,0.9504704330328744,1.0,18/63,15.74%,SIRT1;INSIG1;LDLR;EHD1;NPC2;RORA;MTTP;ABCG8;ABCA1;CYP39A1;PLA2G10;LIPG;CYP7B1;ABCG5;NR1H3;AKR1C1;DGAT2;SOAT1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.810512858960829,1.3100157427323353,0.16666666666666666,0.9518427301613374,1.0,1/6,3.29%,ZBTB1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6977419920604984,-1.3099823929234744,0.1702127659574468,1.0,1.0,4/15,10.33%,RFTN1;NAXE;FLOT1;MYADM
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7931081109004994,1.30997388629151,0.10344827586206896,0.9499746020079419,1.0,3/9,8.41%,BOK;AGR2;PPP1R15B
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8045915870250787,1.3099719488711687,0.10714285714285714,0.9479872074430717,1.0,1/6,3.11%,MYC
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.7959938060596725,1.309914230280725,0.15384615384615385,0.94643929060785,1.0,1/8,0.38%,GATA4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7880421146876363,1.309783267937987,0.22413793103448276,0.9453787261006259,1.0,1/7,3.40%,HIF1A
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7793849653000764,1.309742520159741,0.125,0.9436153461328217,1.0,5/12,14.20%,AK3;EFL1;GNAI3;RAB23;ENTPD7
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6463453010852137,1.3096963162883661,0.1896551724137931,0.9419853113121694,1.0,12/25,24.24%,SCD;ELOVL5;SCD5;SLC25A1;ACSBG1;FASN;ACACA;TECR;ACSL4;ACSL5;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7726606374446048,1.309497292031455,0.1509433962264151,0.9413933178947748,1.0,2/13,2.18%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6468175146715252,1.3094684202272797,0.09615384615384616,0.9396240007945549,1.0,8/28,17.93%,DUSP29;RORA;SGCZ;MEGF10;TBX18;MEF2C;DMD;TMEM204
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6611695269207651,1.3094488799223498,0.11363636363636363,0.9378369301149581,1.0,8/33,16.31%,NRTN;SEMA5A;ERBB4;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8161354478126713,-1.308971422065546,0.09523809523809523,1.0,1.0,3/6,10.55%,CAV1;FLOT1;CAV2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6649087750006989,1.3088502531868165,0.1509433962264151,0.940031925799344,1.0,8/24,7.86%,F2;FLT1;IRS1;FGF2;FGFR3;FLT3;EPHA8;PDGFRA
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7283991009968859,1.3088071803618815,0.05357142857142857,0.9384259846017652,1.0,4/17,11.26%,MYC;MRAP2;PHKA1;LEPR
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7427860405932674,1.3088029037945748,0.12903225806451613,0.936552772011181,1.0,2/9,7.38%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5594477705124998,1.3086718936329766,0.16363636363636364,0.9357555483647888,1.0,9/47,10.37%,PLCH1;FGF2;ITPKB;NUDT4B;PLCG2;INPP1;NUDT4;IP6K3;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.7038864710497279,1.3082295103243045,0.09090909090909091,0.9367715496607881,1.0,2/12,7.15%,ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5287057980527718,1.3079924011307738,0.07407407407407407,0.9366204620526855,1.0,32/118,19.16%,FZD5;LRRC4C;LRP4;NEDD4;NLGN1;CDH2;F2R;SDK1;CACNB4;PPFIBP1;ACHE;NRXN1;UNC13B;ZC4H2;PTPRD;SNCA;NLGN4X;DSCAM;GRM5;GPC4;GPM6A;PTEN;LRFN5;SEMA3E;PPFIA3;DNM3;RAB29;L1CAM;CNTN2;PDZRN3;FLRT3;GPHN
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6053705480616585,-1.307960693808688,0.11904761904761904,1.0,1.0,1/38,0.27%,TERT
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.8229239326580968,1.3079044600239356,0.14285714285714285,0.9353587886037104,1.0,1/5,2.98%,IL4
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.7757791528264744,1.307546287012526,0.10714285714285714,0.9360736931725149,1.0,1/9,8.32%,BICD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.7082387246160698,1.3075089740801367,0.08620689655172414,0.9343263673182992,1.0,4/15,17.56%,SIRT1;HTRA2;HSPB1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8056473976526239,1.3073608937559584,0.16071428571428573,0.9333469553587445,1.0,2/5,16.53%,CEP120;CCP110
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8445754519305508,1.307043498043194,0.13114754098360656,0.9335962023383757,1.0,3/6,11.59%,ARHGAP24;ABI3;KANK1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.49838450880008833,1.3070007573684286,0.05357142857142857,0.9321088577122895,1.0,50/237,16.31%,FAM83H;IGF1;CXCL12;FLT1;FERMT3;FGF10;SEMA5A;HGF;TNFRSF18;TGFBR1;ITGAX;IL4;CCL5;SNAI1;HAS2;HIF1A;DOCK1;F2R;BMP2;APELA;CCN4;SEMA6C;TCAF2;FBXO5;PDGFRA;PLCG2;GAB1;RHOD;FER;VSIR;PDGFC;FAM89B;CASS4;CARMIL1;WASHC1;F3;LGR6;FERMT1;BCAR1;MGAT5;PPP3CA;IGF1R;SEMA3E;CPNE3;KIT;CSF1;PIK3CD;ACVR1B;RET;SEMA6D
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.7437892416876477,1.3067120103151162,0.2037037037037037,0.9322864023688123,1.0,1/10,2.36%,NDC80
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6571967002582415,1.3066712234523714,0.09836065573770492,0.9305398276165537,1.0,2/27,1.52%,IGF1;HGF
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.5202361970076317,1.3065067575146936,0.05084745762711865,0.9299422564619484,1.0,20/125,13.23%,IRGM;IGF1;IRS1;HIF1A;PRR5L;TFEB;RNF152;MID2;ZBTB20;MOV10;FOXO1;TICAM1;HMGB1;SNCA;TP53INP1;FOXO3;TRIM65;ZC3HAV1;MLXIPL;ABCD2
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8924355555550051,1.3062832700687148,0.07692307692307693,0.9298563153801461,1.0,1/5,3.99%,TOX
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7267807140751115,1.3061381135392722,0.18181818181818182,0.9291898822612987,1.0,8/14,18.48%,CDH2;SLC8A1;PIK3CA;NPPA;GSN;DMD;RYR2;CTNNB1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7207813829208964,1.3058848948835424,0.1320754716981132,0.9289125521035073,1.0,5/14,13.44%,IRS1;SCD;FOXO1;FOXO3;NR1H4
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8425599940744006,-1.3051623336223732,0.1,1.0,1.0,2/6,9.84%,CLDN4;DDRGK1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.70894943386346,-1.3048904293861296,0.12195121951219512,1.0,1.0,5/16,11.10%,KCNE2;SCN5A;KCNE1;KCNQ1;SCN3B
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7351321104101933,1.3048429036576021,0.16666666666666666,0.9336261396865346,1.0,4/8,19.01%,BMI1;RNF2;PCGF5;PCGF1
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.8306348575157012,-1.3042477707037232,0.13953488372093023,1.0,1.0,3/5,15.04%,SFRP1;CYP24A1;VDR
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.8842615162581444,1.3041668024060789,0.05263157894736842,0.9360836968663699,1.0,2/5,5.93%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6748477423594904,1.3040455132313364,0.1509433962264151,0.9351461136068259,1.0,2/21,7.26%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5548016145611862,-1.3038682354083444,0.07142857142857142,1.0,1.0,4/79,5.00%,SLC28A2;SLC6A6;ABCC4;SLC22A8
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5607939017695571,-1.3037693589945616,0.14634146341463414,1.0,1.0,8/61,6.35%,CYP1A2;ABCA4;SCPEP1;GPC2;AGRN;RBP2;GPC1;GPC3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7140065000341571,1.3036082059174467,0.19642857142857142,0.9362969891712952,1.0,5/12,22.93%,PRR5L;MOV10;ZC3HAV1;CNOT8;PNPT1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.829857166866382,-1.303562113709166,0.1590909090909091,1.0,1.0,3/6,10.74%,DNAAF1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.610406058736137,1.303539587584322,0.13114754098360656,0.9348126187260272,1.0,21/62,20.72%,GABRR1;SLC12A7;GABRE;GABRR2;SLC12A1;SLC1A3;SLC12A3;GLRA1;GABRG3;SLC37A4;GLRB;GABRA5;GABRG1;GABRB2;ANO6;ANO5;SLC5A5;SLC12A9;GABRA4;SLC12A4;GABRB1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.8375468003395365,1.3034876212010733,0.1111111111111111,0.9333340807775972,1.0,2/5,12.83%,SEC22B;TAP1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6399640634002647,1.303421268671432,0.18,0.9318851628215108,1.0,7/28,12.52%,ADRA1A;SLC35G1;SLC8A1;SMDT1;MCUB;MCU;JPH1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7839789768702232,-1.3029473750895118,0.20408163265306123,1.0,1.0,2/7,6.56%,SLC6A6;OLFM4
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.8848123342135045,1.3027766590363021,0.07017543859649122,0.9341746200259955,1.0,3/6,8.85%,LGALS9;ZBTB7B;VSIR
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.6860165169126864,1.3027217481745403,0.09230769230769231,0.9326585339762934,1.0,5/24,7.91%,F2;KNG1;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7396862746481417,1.3024570226579681,0.2,0.9326640383063053,1.0,1/11,1.18%,KLRD1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6410249422554668,1.3023710752309061,0.08928571428571429,0.9312986088227687,1.0,15/29,28.66%,PPARG;THRSP;PRKAB2;ABCD3;ABCD2;ACACB;ACACA;SPX;ABCD4;SLC27A6;ACSL1;CPT2;SLC27A1;APOE;MID1IP1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.8475806308624068,1.3022735068781037,0.09259259259259259,0.930103615650602,1.0,1/6,2.18%,SIRT1
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.8021387285604624,-1.301795325924599,0.14285714285714285,1.0,1.0,3/5,19.62%,CAV1;CAV2;CAV3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6847999409248455,1.3016227491099097,0.1320754716981132,0.932374340803049,1.0,6/28,12.14%,SYK;FERMT3;EPHA8;DPP4;ADA;LYN
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5751179959686765,1.3008957235786405,0.09615384615384616,0.9356702493953843,1.0,23/61,17.72%,SMAD6;VWC2L;PPARG;BMP2;CRIM1;ACVR2A;RBPJ;ELAPOR2;BMPER;UBE2D3;DAND5;SMAD1;VWC2;SMAD2;BMPR1A;GREM1;SMAD4;CRB2;SPART;LRP2;FBXL15;SMAD5;BMP4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7140887285302219,1.3008665246708215,0.12962962962962962,0.9340046595725942,1.0,1/16,0.56%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7084720279568796,-1.3007664748650398,0.20930232558139536,1.0,1.0,1/14,1.49%,KDM4D
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.7895122902882975,1.300669369670966,0.12727272727272726,0.933281836585217,1.0,1/8,6.32%,SAMD9
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.6951646459655264,1.3001439826591101,0.16,0.9345710712575168,1.0,6/19,13.38%,NPC1L1;LDLR;NPC2;ABCG8;ABCG5;MSR1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.5269613720984885,1.2996886695905718,0.08333333333333333,0.9358786757011291,1.0,18/153,7.36%,MXRA5;PCOLCE2;MRGPRF;CXCL12;LAMA4;SMAD6;SMOC1;TMTC2;STAB1;ADGRL4;GNG12;LTBP2;DOCK1;PLSCR4;POSTN;WWTR1;FAM114A1;BGN
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.7790236139318125,1.299582151551049,0.14754098360655737,0.9349469492100135,1.0,2/8,15.76%,DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6243820064203414,1.2994774551537627,0.16176470588235295,0.9337400296225348,1.0,6/38,7.25%,IRS1;SIRT1;ZBTB7B;ENPP1;VWA2;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7019208025007897,-1.2992795143998286,0.10416666666666667,1.0,1.0,6/16,12.37%,SIGIRR;TRIM5;BMP6;LY86;TRIB1;LY96
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.747569178656298,1.2988920433481772,0.15789473684210525,0.9360618888696418,1.0,6/14,17.87%,AK3;EFL1;GNAI3;RAB23;ENTPD7;IMPDH1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7672998299340947,-1.2987925502807054,0.20454545454545456,1.0,1.0,3/10,6.56%,BST1;RAC2;OLFM4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6396310995077862,1.2984646277412353,0.12962962962962962,0.9368938673335333,1.0,7/27,14.86%,CDKN2C;CDKN2A;KANK2;SLFN11;CDK4;PTEN;CDK2AP2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.6844266978556033,-1.2983827731467446,0.21951219512195122,1.0,1.0,2/14,1.95%,SELP;CXCL13
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6739263222159813,1.298200009675428,0.10344827586206896,0.9364985314867027,1.0,8/17,18.51%,NRG1;BMP2;SLC8A1;MYH11;MEF2C;VEGFA;ALPK3;MESP1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7934611016922253,1.2979122797029365,0.24489795918367346,0.9366349232228995,1.0,2/8,6.49%,UGDH;MAT2A
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7015453690335911,1.2977575525068148,0.17543859649122806,0.9358043910352274,1.0,8/21,13.66%,IGF1;SMYD1;LMOD3;NRG1;PROX1;EFNB2;GREM1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7770736393553122,1.297499410804948,0.1568627450980392,0.9356430186776638,1.0,4/10,13.66%,GATA4;EFNB2;GREM1;MEF2C
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.7301005819346789,1.2974189806187477,0.1746031746031746,0.934290266120857,1.0,4/13,14.96%,SLC26A7;SLC26A6;RACGAP1;SLC26A4
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.8038937156585844,-1.2971632017351933,0.13333333333333333,1.0,1.0,2/7,0.50%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.8038937156585844,-1.2971632017351933,0.13333333333333333,1.0,1.0,2/7,0.50%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.8446043962185905,-1.2968362647736011,0.08695652173913043,1.0,1.0,1/5,5.84%,POLR3H
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.694006707419921,-1.2964033503992205,0.2,1.0,1.0,3/21,6.75%,CLDN4;DUOX1;CLDN1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5856419983711839,-1.296206243447424,0.13043478260869565,1.0,1.0,11/57,6.59%,MS4A8;EHF;CAPN8;CLDN4;GPR39;PGC;TMEM184A;FAM3D;FOXQ1;XDH;LAMB3
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.7963040249969596,1.2960357752646317,0.16071428571428573,0.9418428116097548,1.0,3/9,14.71%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5646774271921312,1.2957284000627738,0.125,0.9423789362872412,1.0,18/62,15.74%,SIRT1;INSIG1;LDLR;EHD1;NPC2;RORA;MTTP;ABCG8;ABCA1;CYP39A1;PLA2G10;LIPG;CYP7B1;ABCG5;NR1H3;AKR1C1;DGAT2;SOAT1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6464731205116279,1.2952546139078631,0.13725490196078433,0.9435284830960605,1.0,11/32,26.70%,ACD;MYC;PARM1;GREM1;MAPK15;NEK7;CTNNB1;POT1;MAPK3;NAF1;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7574897472248346,1.29525292342943,0.13846153846153847,0.9400239824493432,1.0,1/10,1.96%,GSTM2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7574897472248346,1.29525292342943,0.13846153846153847,0.9400239824493432,1.0,1/10,1.96%,GSTM2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6825884816681592,1.2948467827865828,0.2,0.9409221598388148,1.0,7/27,11.73%,RUNX1;KANK2;ESR1;FOXH1;LATS1;UBA5;KCTD6
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7299332233757797,1.2947946748263843,0.16326530612244897,0.9395093379452137,1.0,5/11,21.66%,PDGFRA;PIK3CA;ERRFI1;NOTCH4;BMPR2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6602499154610068,1.294774337531237,0.13114754098360656,0.9378082020761646,1.0,6/21,17.72%,RUNX1;MAFF;KLF7;CTSV;ERRFI1;BMP4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.8207760573671085,1.2947274322001896,0.1568627450980392,0.9363387795164317,1.0,2/8,9.04%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.6405492685583303,1.2947152031829716,0.16071428571428573,0.9346498155550989,1.0,5/31,11.40%,SMYD1;SMYD2;WDR5B;PAXIP1;EZH2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.7753150028076841,1.2946930166763235,0.16981132075471697,0.9312457539486163,1.0,2/6,8.61%,RELA;TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.7753150028076841,1.2946930166763235,0.16981132075471697,0.9312457539486163,1.0,2/6,8.61%,RELA;TLR2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8793985161854908,1.294486425393413,0.12727272727272726,0.9308731967809403,1.0,3/6,8.20%,NOX5;CYBRD1;SLC39A8
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.8468034027291734,-1.2944398551291136,0.12962962962962962,1.0,1.0,3/5,12.62%,SLC6A6;SLC6A11;SLC6A12
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.8517766908276699,1.294245650804333,0.125,0.9307476716656855,1.0,1/6,3.40%,HIF1A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.7160002386125589,1.2941080742497502,0.17307692307692307,0.9298200965010548,1.0,3/13,9.05%,GRIN3A;GLRA1;DRD3
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5373879853450465,1.2938754285151923,0.07407407407407407,0.9293186906296437,1.0,19/121,7.86%,MXRA5;CGNL1;DACH1;IGF1;CXCL12;C3;RIN2;ADGRL4;SLC12A1;CDH6;CD40;SLC12A3;DOCK1;PLSCR4;POSTN;RNF182;FAM114A1;BGN;PDGFRA
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.8212030373183726,-1.293709735277936,0.23809523809523808,1.0,1.0,1/5,3.71%,SLX4
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5475494930107325,1.293691923666557,0.09259259259259259,0.9288413285094959,1.0,18/59,24.62%,LGALS9;MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;ARHGEF6;IRAK1;MAPK10;ADORA2B;TAB3;TAB1;IKBKB;MAPK3;RIPK2;GPS1;MAP3K8;MAP4K3
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6988576718725934,-1.2936079485890772,0.1282051282051282,1.0,1.0,4/15,8.02%,TIE1;BTK;HCK;HES7
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7654482806225217,1.293523880107392,0.14285714285714285,0.9282991988047593,1.0,4/6,17.02%,PLSCR2;PLSCR4;ANO6;PLSCR1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6714730718848037,1.2935027549512388,0.16363636363636364,0.9268296031821341,1.0,4/14,20.15%,LIN28A;MRPL44;PRKRA;AGO3
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.826299248411536,1.2933043415140233,0.21153846153846154,0.9263814597783613,1.0,3/5,17.28%,DAND5;LTBP1;FBN1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.9010430263852987,1.2932849303952283,0.06382978723404255,0.9247222359315735,1.0,3/5,9.04%,RUNX1;ZBTB7B;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.7783578269692271,1.29303183389705,0.19642857142857142,0.9247417287202344,1.0,3/7,13.55%,IRAK3;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.7227785003031186,1.2926513568463582,0.10909090909090909,0.925354326861116,1.0,3/15,6.55%,IGF1;CCL5;CCN4
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.6880060231166775,1.2925161470261075,0.125,0.9247366435446165,1.0,7/29,13.44%,IGF1;LGALS9;IL4;C5AR2;VSIR;IRAK3;NR1H4
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7666053990261306,1.2921306777426473,0.16326530612244897,0.9253470432871085,1.0,3/10,5.94%,PHGDH;SHMT2;CBS
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.7396374030006124,1.291977498064247,0.125,0.923267699956285,1.0,4/12,17.52%,STAT5A;IL15;IL2RB;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.7396374030006124,1.291977498064247,0.125,0.923267699956285,1.0,4/12,17.52%,STAT5A;IL15;IL2RB;PLCB1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6417556621794018,1.2919196710339027,0.13725490196078433,0.9219832328297893,1.0,3/21,10.39%,MITF;MED17;PAXIP1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.6304303261211094,1.2916757501914562,0.14035087719298245,0.9216379089998625,1.0,15/32,27.94%,RAB31;GGA1;GOLPH3L;MACF1;GORASP2;BLZF1;AFDN;VAMP4;GCC2;TRARG1;GOLGA4;ARFRP1;RILPL2;RAB34;SPTBN1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6678760714957283,1.2916329317206086,0.1509433962264151,0.9202307704519731,1.0,5/18,19.50%,SMYD1;HDAC3;PIEZO1;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7967224852110923,1.2915908930439572,0.18181818181818182,0.9189369293694802,1.0,3/12,8.71%,IGF1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.8358099191223356,-1.2915574450495328,0.1276595744680851,1.0,1.0,1/8,0.27%,TERT
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4853770863440951,1.29081822681614,0.05172413793103448,0.9223171054489216,1.0,22/194,9.19%,TNFSF14;ESPL1;NOX5;ADRA1A;TNFRSF19;EGLN3;IL2RA;PAWR;BOK;GDF6;MYC;DUX4;EFNA5;DAPK2;DCC;RNF152;SEPTIN4;HIP1;TNFRSF10A;FOXO1;TLR2;DLC1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6333855054251657,1.2906521925709886,0.17543859649122806,0.921628373980499,1.0,13/29,24.72%,SCRIB;ERBIN;LIN7A;SYNE4;ANK1;CRB2;LRRC7;DLG2;RAP2A;PARD3;DLG3;CRB1;DLG1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7689622223107909,-1.29064402594729,0.23255813953488372,1.0,1.0,1/6,2.41%,BUD23
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.8555550060005098,-1.2905850501328224,0.13953488372093023,1.0,1.0,3/5,8.30%,RFTN1;CAV1;FLOT1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.706780729823758,1.2904896887934043,0.16666666666666666,0.9210928717750647,1.0,7/16,17.83%,NCAM2;NLGN1;NRXN1;NLGN4X;CEL;RET;CNTN4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7454273156375859,-1.2896468083733417,0.15217391304347827,1.0,1.0,3/8,5.21%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7454273156375859,-1.2896468083733417,0.15217391304347827,1.0,1.0,3/8,5.21%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7218626793677538,1.2894914427596826,0.1276595744680851,0.925590936172857,1.0,8/23,14.09%,IGF1;MYC;BMI1;PDGFRA;PDGFC;CD74;LIG4;CDK4
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5243924781671861,1.2894569875081956,0.11864406779661017,0.9242346598944218,1.0,32/111,18.56%,LRRC3B;SLC35F1;LRRC4C;LRP4;GFAP;SLC1A3;NLGN1;TMEM200C;PCDH17;OLIG2;MEGF10;PTPRD;PAX6;NOVA1;EFS;ANK2;GUCY1A2;ADGRB3;ATP1A2;NOTCH3;NPAS3;GPM6B;ZNF536;MAGEL2;RUNX1T1;SEMA6D;CPE;FAT3;MAPK10;CNTN2;GPRC5B;PDZRN3
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.5876394952014707,1.2894213399748249,0.037037037037037035,0.9228617406395462,1.0,16/54,20.06%,SULT2A1;IL4;INSIG1;MSMO1;ABCA1;CYP39A1;CYP27A1;FDX1;CYP7B1;SOAT1;SC5D;FDXR;CYP4V2;SQLE;FAXDC2;DHCR7
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.7465451074641865,1.289204837980912,0.21568627450980393,0.92277701337483,1.0,1/8,4.67%,DCC
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.5233479075958587,1.2887631376863096,0.07272727272727272,0.9241444998676124,1.0,21/109,14.87%,CXCL12;SIPA1;SEMA5A;TNFRSF18;EPHA7;CCL5;ANGPT1;EFNA5;KNG1;EPHA8;ITGAV;RHOD;ADAMDEC1;ABL2;DSCAM;ZDHHC2;LYN;PLXNB1;FRMD5;PLXNB2;PPP3CA
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5516525418214023,1.2887574352199096,0.09433962264150944,0.9225445079734557,1.0,14/57,23.09%,MITF;CDKN2A;RELA;MED17;MOV10;CDK4;PTEN;CTNNB1;AGO3;MED30;MED25;TP53;TRIM28;CDK8
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.8081135828167045,1.2884385038272723,0.18181818181818182,0.9230990889756578,1.0,3/8,13.95%,F2;DRD3;TMEM98
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.6971041976825029,1.2881646189219391,0.1509433962264151,0.9230994981471586,1.0,8/15,23.39%,SMAD6;ROBO2;NOTCH2;BMP4;JAG1;BMPR2;HEY2;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7899520620370468,1.2879784330751236,0.2549019607843137,0.9224638262989504,1.0,2/12,3.81%,IRS1;PPARG
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.8049034029322174,-1.2877434376201362,0.14583333333333334,1.0,1.0,2/7,4.50%,ASS1;ARG2
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.8535570382521608,1.2875207786371736,0.22916666666666666,0.9237987807959376,1.0,2/5,8.68%,IL2RA;CLC
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.6575694620432696,1.2874619573601473,0.18181818181818182,0.9225513656004174,1.0,3/15,6.50%,SIRT1;RORA;RORC
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7015472007780956,1.2872518120499528,0.1320754716981132,0.9224894461713871,1.0,6/18,14.85%,GPR33;C5AR2;LYN;BLK;BCAR1;SH2B2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.7502549744194095,1.287069295468034,0.13559322033898305,0.9219224053456462,1.0,6/13,15.78%,TGFBR1;GDF6;ACVR2A;HJV;SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6886913183260019,1.2870679233131457,0.15789473684210525,0.9203694223613054,1.0,4/12,16.41%,CEP135;KIAA0586;CEP120;OOEP
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.73432351190855,1.2870399148401632,0.2391304347826087,0.919052616040437,1.0,4/13,6.50%,MLC1;INSIG1;RORA;RORC
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8322702572444044,1.286785112279909,0.13333333333333333,0.9189971559687792,1.0,2/6,9.04%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.6504732877083853,-1.2866478589078958,0.17391304347826086,1.0,1.0,1/20,0.26%,NTRK1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.48385403103423036,1.2866285941731412,0.06779661016949153,0.9182727442169087,1.0,50/186,17.94%,CXCL12;NRTN;SEMA5A;UNC5C;EMB;EPHA7;EFNA5;SPTBN5;DCC;LGI1;ROBO2;ARTN;SEMA6C;UNC5D;EPHA8;NRXN1;CNTN6;EPHA5;GAB1;EPHB4;EPHA3;MYPN;PLA2G10;ALCAM;EFNA2;DSCAML1;PIK3CA;DSCAM;GFRA1;EFNB2;RANBP9;NOTCH3;PTPRM;PLXNB1;LGR6;PLXNB2;SOS1;ROBO3;SEMA3E;KLF7;PIK3CD;RET;SEMA6D;VEGFA;RHOG;GAB2;NOTCH2;CNTN4;L1CAM;CNTN2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5818088930539704,-1.2862872110476717,0.14634146341463414,1.0,1.0,3/46,2.56%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.7970194711047743,1.2862864117749442,0.2,0.9187198093629954,1.0,1/5,1.36%,HPD
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.6243815587218196,1.2861197227193821,0.14,0.9180400363941544,1.0,8/29,17.27%,C3;THRSP;ADIPOR2;ZBTB20;PRKAB2;MLXIPL;CREB1;STAR
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.6255230170926721,1.2860232361503128,0.09803921568627451,0.9170713453827807,1.0,5/22,11.49%,TGFBR1;GRIN3A;GLRA1;DRD3;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7735749728995333,1.2859889231396564,0.1836734693877551,0.9157529147793573,1.0,4/9,13.71%,PPARG;ITGAV;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7266871145513819,1.2857277714194062,0.1724137931034483,0.9155170628645357,1.0,3/11,10.61%,TTLL2;TTLL9;TPGS1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7426919780862037,1.2856732521818877,0.1774193548387097,0.9143092570391649,1.0,2/11,13.41%,TGFBR1;GREM1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.54342101729391,1.2856171226737987,0.0392156862745098,0.9129609270135599,1.0,23/92,19.89%,FBLIM1;CDH7;FZD5;CDH20;CDH6;NLGN1;CDH2;SDK1;CDH12;ACHE;NRXN1;DSCAM;GPM6A;PTEN;CDHR3;CDH10;GJC1;DNM3;CDH8;RAB29;PKP4;FLRT3;FARP1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.8186007660606112,1.2856127918240137,0.17857142857142858,0.9114109084617542,1.0,1/7,0.77%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.7301239269639286,-1.2855685147084652,0.1951219512195122,1.0,1.0,2/9,14.56%,PRKCD;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.7301239269639286,-1.2855685147084652,0.1951219512195122,1.0,1.0,2/9,14.56%,PRKCD;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5515866419596864,1.2847577912445824,0.10909090909090909,0.9150552599558569,1.0,10/80,12.49%,IL26;MAP3K11;TNFRSF19;GDF6;PRMT1;BMP2;RELL1;HMGB1;MAP4K2;GADD45G
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.883704671910994,1.2846956573319597,0.061224489795918366,0.9139180808425085,1.0,1/5,2.29%,BOK
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.7118425475491397,1.284666574439506,0.14035087719298245,0.9124563889505336,1.0,4/17,13.38%,C3;EHD1;PLA2G10;MSR1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5583800824836218,1.2846553992505994,0.10344827586206896,0.9110406019897231,1.0,8/58,12.78%,CXCL12;SIRT1;URI1;SNAI1;SYVN1;HTRA2;PLAUR;HSPB1
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.8502330537439129,-1.2846304200550032,0.20833333333333334,1.0,1.0,2/5,8.32%,SFRP1;EGR1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.7905282526583444,1.28459892505571,0.13793103448275862,0.9098545656957536,1.0,1/7,1.31%,SMAD6
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.814080380336149,1.2845438967820395,0.1206896551724138,0.9085295852525398,1.0,1/8,2.18%,SIRT1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5506461684335633,1.2843755860548136,0.11666666666666667,0.9079428905274914,1.0,7/67,4.83%,SYK;FERMT3;ITGA10;ITGA11;ITGB8;ITGA2;DOCK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.617256928058852,1.2841053691916644,0.09302325581395349,0.9082128732526618,1.0,10/26,24.12%,CD40;TICAM1;UBE2D3;TANK;IRF3;UBE2D1;BIRC3;FADD;IKBKB;IKBKE
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5668487480428441,-1.2838210852536367,0.13043478260869565,1.0,1.0,6/37,9.11%,KCNMB2;KCNJ16;KCNN3;KCNE1;KCNN2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7459167232469599,1.2837189884387883,0.11764705882352941,0.9093352357150896,1.0,1/12,1.04%,DRD5
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.7940468490812025,1.2835438086405546,0.13114754098360656,0.9085878756680479,1.0,2/7,8.85%,LGALS9;VSIR
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7204924339074417,1.2834848871858986,0.2,0.9074177876142209,1.0,2/8,12.39%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.7324875264562842,1.2834311595513612,0.15,0.9063122378910139,1.0,3/11,12.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7637484357808036,1.2833377900007474,0.15384615384615385,0.9051901798276875,1.0,5/9,21.75%,DNAJB2;SACS;SNCAIP;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.8084276377945062,1.2830766869468542,0.14893617021276595,0.9052807110314045,1.0,2/7,2.28%,RENBP;ALDH1A1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.7755127018312018,-1.2826600307780822,0.19148936170212766,1.0,1.0,1/6,3.17%,SFRP1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6173405528125323,1.2825447043395561,0.1016949152542373,0.9068795252690095,1.0,9/37,9.42%,SLC12A7;TMTC2;SLC12A1;CYP4F12;SCNN1B;SLC12A3;SLC8A1;FAM20A;SNCA
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.735752640784239,-1.2823622378330137,0.25925925925925924,1.0,1.0,3/10,8.71%,EIF2S2;EIF2S3;EIF2S3B
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.6741586534673261,-1.2822324799465354,0.1590909090909091,1.0,1.0,8/17,13.66%,OR2M4;OR51M1;SLC24A4;DRD2;OR52A1;SYT10;OR9Q1;OR9G4
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7357970561947486,-1.2813781832582987,0.2222222222222222,1.0,1.0,4/7,14.16%,NOXA1;RAC2;JCHAIN;RAC1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.8128937303069563,1.281278636832742,0.14814814814814814,0.9134933517729129,1.0,1/6,3.24%,AMPD1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.7672760708400994,1.281134360492247,0.16326530612244897,0.9127678110731808,1.0,2/13,5.12%,IGF1;STAT5A
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.6873541428342566,1.2811253397303661,0.14285714285714285,0.9113641501010531,1.0,5/18,14.10%,ACSM2A;RORA;MLXIPL;NR1H3;ANGPTL4
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5851481957914895,1.281002876141863,0.08064516129032258,0.9106045338136151,1.0,11/72,8.51%,IRS1;SIRT1;ZBTB7B;ENPP1;INSIG1;KAT2B;PPARG;RAB31;LPIN3;FOXO1;FER
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.6098094555817934,1.2808917689133894,0.11764705882352941,0.9096678685126955,1.0,2/40,0.77%,TNFSF14;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5135712466786094,1.2801600544989669,0.06451612903225806,0.9127972587053231,1.0,21/150,9.42%,IGF1;CTDNEP1;HGF;IRS1;STARD4;SIRT1;PRR16;FGF2;CCL5;MYC;HIF1A;LDLR;ZEB2;PRMT1;SAMD4A;EIF3E;SP1;AGXT2;ELOVL5;DYRK2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5764926728865613,1.2798085615274548,0.14285714285714285,0.9130928782783927,1.0,7/46,11.84%,SYK;LGALS9;F2R;PLCG2;TLR2;HMGB1;CD74
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.543310431772615,1.2798078793525518,0.125,0.9116008964511404,1.0,13/78,5.73%,PPP1R3A;SMYD1;ADRA1A;FAM110D;COL9A1;PREX2;HIF3A;SLC35F1;CADM2;LRP1B;KBTBD12;ASB15;NMRK2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8057766335356323,1.2795747593761226,0.13559322033898305,0.9113822060698072,1.0,1/6,5.52%,SLC38A3
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.44367098692916357,-1.279489475323939,0.02631578947368421,1.0,1.0,24/391,7.93%,CD44;TBC1D10C;SELL;DNASE1L1;HGSNAT;MPO;BST1;CD53;PRKCD;STK10;CRACR2A;ALOX5;STXBP2;LILRB3;RAB44;AHSG;MVP;AGA;CLEC5A;OLFM4;SLC11A1;DOCK2;SVIP;BRI3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7341635597719254,1.2792118764543365,0.15789473684210525,0.9121733569114027,1.0,3/15,12.95%,KCNC2;MAT2A;TMEM120A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5427593034132153,1.2790723836511142,0.17391304347826086,0.9117371455514038,1.0,17/130,10.80%,IGF1;CCNA2;RRAS;RIT2;RAPGEF3;FGF2;CDKN2A;KSR1;EPS8L2;EPS8;RALA;ARHGAP5;RHOD;ROPN1B;SHOC2;SGSM3;RAPGEF6
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5129640844214677,1.2788318776368146,0.13114754098360656,0.911657357221097,1.0,21/120,9.26%,SASH3;SYK;LGALS9;EGLN3;TGFBR1;CSF3R;STAB1;ITGAX;CCL5;PPARG;LAIR1;PIK3R5;SAMSN1;IL10RA;RBPJ;FGL2;SIGLEC1;MARCHF1;HPGDS;TLR2;CYP27A1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.7616527561982627,1.2788249820253899,0.15517241379310345,0.9102585551523326,1.0,3/12,5.19%,GATA4;TGFBR1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.7824324246384136,1.2787730397437687,0.1724137931034483,0.9091395027387692,1.0,3/6,16.99%,APELA;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5536137698467041,1.2787377789086523,0.07692307692307693,0.9078474228987793,1.0,14/74,11.56%,CXCL12;VAPB;DRD5;TMTC2;CCL5;CD40;CASR;SLC8A1;FAM20A;SLC24A2;DRD3;SNCA;ANK2;HTR2C
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6145686285892468,1.2781791023548577,0.09259259259259259,0.9096751725284935,1.0,4/29,5.19%,SMAD6;PPARG;RORB;CRIM1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.7870275604954601,1.2780126773537253,0.23214285714285715,0.9092863262134862,1.0,3/11,8.73%,RPP25;RPP25L;RPP40
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7555904053537862,1.2779438014928555,0.2037037037037037,0.9081565009999143,1.0,1/11,0.92%,FGF10
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7952207102772071,1.2777974965295902,0.14285714285714285,0.9075958317031628,1.0,1/7,1.30%,MOGAT2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.7641489022198132,1.2775756802934444,0.14285714285714285,0.9077378702040618,1.0,2/9,9.70%,C3;PLA2G10
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6370319707222882,1.2770358401271888,0.16071428571428573,0.9095317345287325,1.0,9/27,13.56%,LGALS9;TMPRSS2;HS3ST5;MID2;PTX3;NECTIN2;GSN;CD74;TRIM26
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8269667777292298,1.2768139880714156,0.11538461538461539,0.9094761513334482,1.0,2/6,9.99%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6826529032282486,1.276732835403506,0.1346153846153846,0.9085487990113136,1.0,7/30,13.44%,IGF1;LGALS9;IL4;C5AR2;VSIR;IRAK3;NR1H4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6398618643162519,1.2764970137579827,0.16363636363636364,0.9085723409477193,1.0,9/29,14.64%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;B4GALNT2;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.8571753770494013,1.276242554984512,0.10909090909090909,0.9086537529584052,1.0,1/6,2.57%,PLOD2
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.8697909979394619,1.2761519601286273,0.08928571428571429,0.9078671122183818,1.0,2/5,9.91%,IL4;H2BC21
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7629050710434322,1.27573374447846,0.15517241379310345,0.9091431167124355,1.0,2/8,8.26%,HIF1A;TICAM1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7104720872730348,-1.2756234300635876,0.21428571428571427,1.0,1.0,5/11,18.39%,AQP7;AQP8;UPK3A;AQP1;SLC5A1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.7558951497043124,1.275609302095705,0.11320754716981132,0.9083581910321052,1.0,2/9,5.51%,TBC1D8B;MYO1E
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7679234262433462,-1.2752436769210258,0.24444444444444444,1.0,1.0,2/8,8.32%,CLU;EGR1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.645355395161321,1.2752378630493522,0.21428571428571427,0.9096101951975648,1.0,6/34,8.04%,MLC1;NEDD4;EHD1;PRR5L;TENM1;PCM1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7549870792765107,1.27491628039278,0.16666666666666666,0.9099001173153144,1.0,3/9,8.83%,ADGRV1;WHRN;SLC4A7
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5339681802155458,1.2749073438580232,0.12727272727272726,0.908524601162999,1.0,16/59,23.09%,CDKN2A;RELA;MED17;MOV10;PAXIP1;CDK4;PTEN;ATF7IP;CTNNB1;AGO3;MED30;MED25;TP53;TRIM28;HEY2;CDK8
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.48686958691598187,1.2744908854140482,0.09259259259259259,0.9098468475582794,1.0,45/178,22.89%,SIPA1;CDKN2C;TGFBR1;SIRT1;ENPP1;URI1;SOCS2;CDKN2A;CDKN2AIP;LGI1;NAIF1;NRG3;DNAJB2;SLC44A4;CHPT1;EXOSC4;SERTAD2;CDK11A;PAK5;GNG4;FBP1;RAB33B;PML;SMAD4;BCAR1;ZNF639;DACT3;ACVR1B;SGK1;DERL2;FRZB;BAP1;RPS6KA1;SMARCA2;DCBLD2;SLC25A33;ADAM10;BMPR2;ADNP2;ST7L;HSPA1A;TP53;BRAT1;NCBP1;ADAM15
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8316359098259783,1.2744470380222601,0.18032786885245902,0.9087427473947214,1.0,1/7,0.56%,PNP
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.769062443177577,1.2742125840836862,0.2,0.9088608288816667,1.0,1/7,0.92%,FGF10
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6449341945146145,-1.274199955732052,0.1111111111111111,1.0,1.0,2/18,7.75%,NPTX2;BEGAIN
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.8317650864747629,-1.2741388014575545,0.12,1.0,1.0,1/6,2.29%,IL11
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5330749614039055,1.274122644262647,0.1206896551724138,0.9079898799878799,1.0,25/78,20.81%,PPARG;THRSP;SCD;NPC2;RORA;SP1;RORC;FDFT1;HDAC3;HMGCS1;SMARCD3;NCOA2;TBL1X;MVD;NR1D2;ACACB;FASN;ACACA;CHD9;SC5D;SQLE;CCDC3;DHCR7;IRS2;PLPP1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.6594864480407321,1.2736256112881807,0.18181818181818182,0.9098741878543231,1.0,6/24,16.50%,CXCL12;PLEKHG2;HCLS1;LATS1;FCHSD2;DBN1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8242886272959205,1.2736137687285884,0.15384615384615385,0.9085494942710742,1.0,2/7,0.77%,CXCL12;LGALS9
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5167647189320707,1.273236089171886,0.07017543859649122,0.9093862478681641,1.0,23/157,6.02%,VEGFC;GATA4;FLT1;SEMA5A;PIK3R6;RRAS;RUNX1;RAPGEF3;SIRT1;ITGB8;TSPAN12;STAB1;ITGAX;FGF2;HIF1A;TMIGD2;PPARG;CD40;CCN6;SP1;ANXA3;GLUL;APELA
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.6992063188017855,1.2730584964502438,0.2,0.9087655274956328,1.0,5/17,17.56%,SIRT1;HIF1A;HTRA2;HSPB1;NFE2L2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7237166441095508,-1.2729504180225042,0.2,1.0,1.0,1/12,0.24%,ACTC1
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.5465721105877226,1.2726406772581793,0.13559322033898305,0.9099955139867387,1.0,10/66,6.04%,SASH3;PIK3R6;CSF3R;SELPLG;ITGAX;CCL5;LAIR1;PIK3R5;IL10RA;HCLS1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.6436367590694811,-1.2726403398594497,0.08,1.0,1.0,6/26,6.20%,H1-3;H1-4;TERF2IP;H1-2;NIBAN2;ERCC1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7552951913305326,1.2725115852432536,0.109375,0.9093381020393697,1.0,2/12,8.58%,SEMA5A;EPHA3
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.44494168139476437,-1.2724335526609425,0.027777777777777776,1.0,1.0,24/386,7.93%,CD44;TBC1D10C;SELL;DNASE1L1;HGSNAT;MPO;BST1;CD53;PRKCD;STK10;CRACR2A;ALOX5;STXBP2;LILRB3;RAB44;AHSG;MVP;AGA;CLEC5A;OLFM4;SLC11A1;DOCK2;SVIP;BRI3
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7493975336331881,1.272290750377206,0.19298245614035087,0.9088707922992424,1.0,3/7,14.46%,GRIN3A;NLGN1;PTEN
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.6267954078996396,1.2722227889644335,0.20833333333333334,0.9078603761197462,1.0,6/33,11.36%,SLC26A3;SLC26A6;SLC4A1;SLC4A7;SLC9A2;CA2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7562936863172932,1.2721905766807642,0.1111111111111111,0.9065905975167659,1.0,1/10,2.63%,ENPP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6750014889650362,1.271773871000859,0.22,0.9077395801815697,1.0,6/13,18.51%,SIRT1;PLCG2;TICAM1;CD74;KIT;GPRC5B
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.7599602209748344,1.2716155044984132,0.05357142857142857,0.9071654597331784,1.0,6/15,16.13%,F2;F2R;F12;HPSE;F3;ANO6
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.7023234150704413,-1.2715996798867153,0.15555555555555556,1.0,1.0,1/12,3.60%,AGBL1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6457566659901465,1.2708717130053244,0.16,0.9103628761833461,1.0,4/17,27.79%,PRDX6;PNPLA6;GPCPD1;PLA2G4E
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.7426903532178477,1.2708689262314259,0.17307692307692307,0.9089666141033103,1.0,2/10,1.36%,TYR;HPD
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.8008404404542823,1.2706900227154252,0.15384615384615385,0.9087653538867567,1.0,1/8,3.18%,INSIG1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.5174522110954848,1.2706353518082825,0.08928571428571429,0.9076730305982044,1.0,15/125,10.88%,FAM83H;CTDNEP1;TULP3;EHD1;SIX4;TULP1;CNTLN;TOR1B;AUP1;BANP;BICD1;ROPN1B;WASHC2A;ANK2;BBS9
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6024877358909712,1.2704862152397705,0.15517241379310345,0.9073074253773046,1.0,10/39,6.74%,PCDH15;MME;PNOC;TRPV2;NTSR2;ADGRV1;PENK;OPRK1;SCN10A;WHRN
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.8380219008127957,-1.2699848484995988,0.2619047619047619,1.0,1.0,2/6,6.53%,OAS3;ADCYAP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5893682267616207,1.2699113389303232,0.15217391304347827,0.9090912548415414,1.0,6/42,11.70%,PRR5L;ZFP36L2;MOV10;TOB1;RIDA;ZC3HAV1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8069333124571823,1.269867004920246,0.1111111111111111,0.9079294560402301,1.0,3/8,10.56%,IL4;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.5877247074202887,1.2696015895264863,0.08333333333333333,0.9078420836357374,1.0,5/59,8.32%,F2;NDC80;PYHIN1;WWTR1;BICD1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6798299459247774,1.269557153219213,0.1724137931034483,0.9066488349534122,1.0,5/23,14.66%,AUP1;RNF185;KLHL15;POMT2;RNF5
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.855424010389052,1.26951395248025,0.21311475409836064,0.9056800952707004,1.0,3/5,8.35%,SEMA5A;NRARP;BMPER
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5948056542296071,1.2694407894445228,0.1346153846153846,0.9048613259979009,1.0,3/30,10.60%,HELB;RPP40;RRS1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.796996913542964,1.2693380274635293,0.18181818181818182,0.904045030348282,1.0,3/11,8.71%,IGF1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.7643188078524612,1.2689619092013933,0.15384615384615385,0.9048437500361497,1.0,6/11,16.13%,CXCL12;CCL5;MOSPD2;HMGB1;PLA2G7;ANO6
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.5621931515336984,-1.2686113089171993,0.14893617021276595,1.0,1.0,9/70,3.01%,MS4A8;EHF;DUOXA1;CAPN8;CYP2B7P;SFTPA2;DUOX1;ALS2CL;CYP2E1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.7557924951719452,1.2684873045114986,0.18181818181818182,0.9058230326195107,1.0,2/13,3.41%,NPC1L1;SLC26A6
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5056469480601701,-1.2684197280509422,0.05405405405405406,1.0,1.0,23/180,7.34%,CD44;COL24A1;COL23A1;ICAM3;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;ACAN;COL6A3;AGRN;MATN4;ADAMTS1;COL1A1;TGFBI;ITGA9;COL11A2;COL28A1;LAMB3;MFAP5;LAMB1;SPARC
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6491288988850995,1.2683172497169923,0.19298245614035087,0.9053743604049207,1.0,9/25,20.68%,SIRT1;AANAT;KAT2B;FOXO1;ESCO1;KAT6A;NAA16;GTF2B;NAA11
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.560609424808816,1.2679934050224857,0.17857142857142858,0.9057114382097868,1.0,16/85,8.51%,MXRA5;ACTG2;SMIM3;MME;FBLIM1;GNG12;LTBP2;LRIG3;POSTN;MYOF;WWTR1;FAM114A1;DSP;MYH11;RHOD;SDC4
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6179687450786586,-1.2679436996581341,0.21153846153846154,1.0,1.0,1/24,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.568593856080158,-1.2676208414558683,0.1276595744680851,1.0,1.0,8/42,10.17%,IRF4;IFI27;OAS3;OAS1;EGR1;IFIT2;IFIT3;IRF5
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.568593856080158,-1.2676208414558683,0.1276595744680851,1.0,1.0,8/42,10.17%,IRF4;IFI27;OAS3;OAS1;EGR1;IFIT2;IFIT3;IRF5
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.8245826533715057,-1.2674604293410972,0.20634920634920634,1.0,1.0,2/5,4.98%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.6647099001888015,1.2672396087912055,0.16981132075471697,0.9082332540479237,1.0,2/21,0.93%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6354105226537994,1.2667665810752218,0.1896551724137931,0.909365284307093,1.0,4/19,14.57%,CDC25A;FBXO5;CDK4;CDC25C
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.79362439618955,1.2666635372300379,0.19117647058823528,0.9086597582126733,1.0,4/5,19.86%,LDLR;LRP2;RNF128;CD81
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8377539634743756,-1.26656341135296,0.15217391304347827,1.0,1.0,2/6,10.65%,APIP;BHMT2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.7754114319821209,1.266543409893146,0.1276595744680851,0.908155801333732,1.0,4/6,15.66%,SIRT1;CDKN2A;MEF2C;PIK3CD
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.7615054926218446,1.2665119468175716,0.19117647058823528,0.9057422214535328,1.0,3/10,4.60%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.7615054926218446,1.2665119468175716,0.19117647058823528,0.9057422214535328,1.0,3/10,4.60%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6635753693255987,-1.266499552794244,0.2222222222222222,1.0,1.0,1/18,1.06%,NLRP1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.73921531742296,1.266485264526616,0.18,0.9045408109633889,1.0,2/8,10.60%,RPP40;RRS1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6488186284304428,1.2662561403840675,0.1875,0.9048390737632196,1.0,7/18,18.79%,SLC17A6;UNC13B;GRIK2;GRIK3;CDH8;GRIK1;GRID2
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6424647210413807,1.2661480896149684,0.1346153846153846,0.9041825219021435,1.0,7/25,22.32%,LRP4;DCC;PTEN;KIAA0319;DIP2B;MCF2;MAP2
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7623456699762573,1.2656509767257738,0.22641509433962265,0.9052891754895289,1.0,4/9,17.88%,SIRT1;MLXIPL;DGAT2;PRKAA1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6295062284920399,1.2656433148392017,0.15254237288135594,0.9039699139602954,1.0,5/21,12.34%,HAS2;FUT9;HS2ST1;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6920799871633135,-1.2654581350680445,0.26666666666666666,1.0,1.0,4/14,9.13%,DUOX1;VGF;RFC3;KCNJ11
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.685530348856129,1.2652862776648797,0.16666666666666666,0.9048765070441191,1.0,5/17,16.54%,SHMT2;MTHFD2L;MTHFD2;SLC19A1;PM20D2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.505983442889439,1.265121613825814,0.0625,0.9045995137961929,1.0,27/112,18.01%,NRTN;GPRIN3;NEDD4;EHD1;PRMT1;NLGN1;CNTNAP2;LGI1;TTC29;NPY;MANF;EPHA8;ROPN1B;HMGB1;CARMIL1;LYN;GPM6A;BLK;PTPRM;PPP1R9A;GPM6B;HDGFL3;LRP12;MNS1;CNTN4;L1CAM;FAM161B
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7246479638406704,1.2650406628141821,0.171875,0.9036086811049757,1.0,3/11,16.94%,SIRT1;ZNF274;MYB
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6581657443377942,1.2649475321125938,0.1509433962264151,0.9029418804680208,1.0,6/15,15.01%,BMP2;PPP1R15B;ITGA1;MAGI2;MEF2C;MTMR9
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.7526757288577445,1.2649012962181283,0.19148936170212766,0.9018138723180411,1.0,1/9,1.47%,GREM2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7604167023806593,1.2648904938792374,0.17307692307692307,0.9006180157573825,1.0,3/9,18.58%,SIRT1;LEPR;GCK
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.792463731695187,-1.264639526999419,0.24444444444444444,1.0,1.0,1/7,0.60%,ANXA8
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7329986019433881,1.2642715002302412,0.20967741935483872,0.9028536970788902,1.0,2/8,1.06%,ESPL1;TOP2A
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5708593737895445,1.2639979633236562,0.14814814814814814,0.9031141613133041,1.0,4/52,1.76%,CDKN2C;CCNG1;CCNA2;CDC25A
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7474075006199296,-1.2638807187688548,0.16279069767441862,1.0,1.0,1/7,3.53%,CD200R1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.7030652587706282,1.2635873631830652,0.19672131147540983,0.9042770806521595,1.0,4/17,12.44%,IGF1;BIN1;HAP1;RTN1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.6504178831695373,1.2631658782595732,0.17857142857142858,0.9051890341664812,1.0,2/18,6.49%,CALCR;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5512324701074099,1.262582526167072,0.14545454545454545,0.9071225357396332,1.0,10/62,14.86%,FGF10;CDKN2C;CDKN2A;KANK2;SLFN11;UBE2E2;CDK4;PTEN;CCND3;CDK2AP2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.8246391649923858,1.262280498231885,0.12962962962962962,0.9074281910698333,1.0,1/7,2.73%,THEM5
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6375917593323533,1.2622678907150766,0.18032786885245902,0.9061659000111743,1.0,9/24,19.68%,MME;LMOD3;FAIM;LIG4;LRP2;SPEN;BMP4;NUMB;RGS14
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.7526610521340982,1.2616799031708137,0.19298245614035087,0.906742212259839,1.0,2/9,0.93%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.7526610521340982,1.2616799031708137,0.19298245614035087,0.906742212259839,1.0,2/9,0.93%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6675400566799369,1.2615332631570206,0.2413793103448276,0.9062226858481011,1.0,2/25,2.56%,DACH1;ACD
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6919703688192835,1.2607845333970251,0.1016949152542373,0.9094684330609555,1.0,4/13,17.72%,PPARG;RELA;NFATC3;BMP4
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.6597326057843033,-1.2607331621809372,0.2,1.0,1.0,4/12,7.55%,DRD4;PAH;DRD2;DBH
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.6840325374988241,1.259771161538814,0.0967741935483871,0.9141732228669541,1.0,3/20,6.06%,PRDM8;MYRF;SOX6
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7195054200986407,1.2595613989015761,0.19642857142857142,0.9141514723954173,1.0,3/11,21.43%,CD59;CD55;C4BPB
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7608693425163355,1.259558296464482,0.24489795918367346,0.9128399207850939,1.0,3/12,10.33%,TGFBR1;PDGFRA;DSCAML1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.4926831672862047,1.2595541537823398,0.125,0.9115843440512972,1.0,45/195,20.70%,ESPL1;TOP2A;MAP3K11;NDC80;SAC3D1;DLGAP5;FGD4;LLGL1;PLEKHG2;MYO1E;PDLIM5;ARHGAP5;FBXO5;PCM1;LATS1;BIN1;RAPGEF6;EPB41;CNTROB;GSN;RASAL2;RANBP9;NCK2;RACGAP1;PXN;CNTRL;BCAR1;SOS1;ANLN;LMNB1;PCGF5;RICTOR;DOCK4;DST;NOTCH2;KPTN;CD2AP;WASL;STK38L;MID1;FARP1;SUN2;RASA2;SMC3;CCNB2
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7910293956324703,1.2594991737797092,0.16981132075471697,0.9105409283988277,1.0,2/5,14.00%,ABCC2;SLC19A1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6590972182547549,1.2593874830120328,0.20833333333333334,0.9100211705138656,1.0,6/19,17.72%,SMAD6;ROBO2;BMPR1A;SMAD4;LRP2;BMP4
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7103582620956732,1.2590898168025462,0.22413793103448276,0.9101094849865525,1.0,1/12,2.18%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.8053304370014897,1.2590484171749716,0.20754716981132076,0.9090726293141717,1.0,1/6,8.32%,BICD1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.8500334966159098,1.2586044559638812,0.2,0.9101989510758414,1.0,2/5,5.71%,IGF1;DIPK2A
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5572006407357732,-1.2584194143499696,0.18181818181818182,1.0,1.0,1/65,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.6644534035878175,1.2583699603014065,0.16129032258064516,0.9104074375903017,1.0,1/13,3.40%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.8353644814988583,1.2583362547578947,0.23529411764705882,0.9093228730580887,1.0,1/5,2.53%,CD99
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.810146717392653,1.2580479301846255,0.14583333333333334,0.9098245524172522,1.0,1/7,1.26%,TEX101
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7614534254539789,1.257993224590915,0.2,0.9088126165908821,1.0,4/8,21.75%,DNAJB2;SACS;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5600617318853706,-1.257814419045064,0.15384615384615385,1.0,1.0,4/47,8.41%,LDHC;HK2;PDHX;ENO2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4898027734187092,1.2575542088235403,0.1320754716981132,0.9096911145123515,1.0,26/94,20.84%,RBM20;TGFBR1;ERBB4;KAT2B;BMP2;APELA;PCSK5;PDLIM5;FGF12;PIK3CA;TAB2;MEF2C;PTEN;BCOR;CRB2;NXN;ALPK3;FBN1;KDM6A;NOTCH4;DVL2;FLRT3;HDAC9;CITED2;PDLIM7;SHH
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5434249681696174,1.2570052945451164,0.16071428571428573,0.9118351665929666,1.0,18/57,20.27%,BLNK;IL4;NFIL3;TOX;CHD7;FLT3;LY6D;PLCG2;RAG2;KLF6;LEPR;LCK;KIT;PIK3CD;AXL;HDAC9;DNAJB9;RAG1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7110496905114208,1.2567079292618009,0.21875,0.9122107010896515,1.0,2/9,8.50%,ANTXR2;SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8105891210919445,-1.256699691027444,0.25925925925925924,1.0,1.0,2/5,8.32%,CLU;EGR1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6488880150471008,1.2566780021721393,0.18867924528301888,0.911047315914263,1.0,7/22,5.55%,F2;IL26;IL4;CCL5;ERBB4;F2R;IL10RA
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.8114491639257382,-1.2564531523637366,0.19047619047619047,1.0,1.0,1/5,4.04%,ALOX5
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7967459599786358,-1.25628815223647,0.25,1.0,1.0,1/8,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8424930108697207,1.2560645498071425,0.15555555555555556,0.9134705065984289,1.0,1/6,0.94%,ADRA1A
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.8455216788994406,1.2560423350230205,0.17543859649122806,0.912308617867419,1.0,1/5,1.73%,RAB38
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6542817625276753,1.256016766245337,0.15789473684210525,0.911252077173737,1.0,3/19,9.08%,RENBP;UGDH;UAP1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.7067562284812157,1.2554128548438137,0.1896551724137931,0.9131890445028461,1.0,5/12,22.05%,SIRT1;PXK;VCPKMT;PPIF;TP53
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.8530728057839485,1.2552765059506608,0.16,0.9128129471928034,1.0,2/5,9.04%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7469960920785008,1.2552285213515355,0.1568627450980392,0.9104902628866652,1.0,3/8,15.44%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7469960920785008,1.2552285213515355,0.1568627450980392,0.9104902628866652,1.0,3/8,15.44%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5280861521198992,1.254953803826795,0.0784313725490196,0.9107277892215272,1.0,11/82,12.44%,IGF1;LIN28A;PATL2;SAMD4A;SYNCRIP;TOB1;RNF139;BIN1;RIDA;HAP1;RTN1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8367461539740882,1.2548048724948175,0.203125,0.9103909473072042,1.0,1/5,0.07%,VEGFC
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.7799421841442928,1.2547184882972058,0.14285714285714285,0.9095832292739837,1.0,1/8,2.63%,ENPP1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8430778764374741,-1.2546287021538352,0.15,1.0,1.0,2/6,7.55%,SELP;TTBK1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4993796850811691,-1.2544147423568142,0.08695652173913043,1.0,1.0,3/122,1.35%,CD44;NTRK1;TEK
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.8114784229212055,1.254310989256889,0.1896551724137931,0.9107465119322764,1.0,2/7,4.07%,C3;RAB31
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7441997605843884,1.2542259487477008,0.16,0.9100581627964692,1.0,1/8,3.61%,NEDD4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.540491984279147,1.2537392892574055,0.13793103448275862,0.91153640648367,1.0,20/66,21.80%,ABHD3;ACADS;LPIN3;BDH2;PECR;ECI1;ACADM;GLYATL2;CEL;ABCD3;ABCD2;HSD17B10;ACAA2;ECHDC1;AIG1;AUH;PEX2;ABCD4;ACOX1;ECI2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6747546277994961,1.2537286062156467,0.19298245614035087,0.9103796593315411,1.0,6/23,12.31%,AGR2;HIP1;RBPJ;PDE6H;PLAUR;HAP1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.735389108512252,1.2535617658156453,0.22033898305084745,0.9099456748003939,1.0,3/11,11.94%,SEMA5A;CRACD;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.48414792216679803,1.2534138078192352,0.08064516129032258,0.9095630180954605,1.0,37/203,13.66%,IGF1;SMYD1;HGF;RRAS;FGFR1;TGFBR1;SOX5;RIN2;GDF6;SNAI1;TMEM100;PPARG;BRINP3;WNT4;CDH2;BMP2;ACVR2A;SOX6;WWTR1;CCN4;ZEB1;FBXO5;ZC4H2;NEUROD2;PLA2G10;VWC2;CTNNA2;EZH2;SMAD2;TCF4;BMPR1A;ADRA2C;MSR1;CPNE1;SMAD4;MEDAG;MEF2C
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6621819002643261,-1.2533033877258402,0.1836734693877551,1.0,1.0,3/16,9.10%,WTIP;NEK8;WWC1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5770097414096804,1.2532775570280374,0.17307692307692307,0.9089644640702407,1.0,16/54,19.03%,SMAD6;GDF6;TMEM100;BMP2;ACVR2A;ZFYVE16;HJV;SMAD1;SMAD2;BMPR1A;SMAD4;SLC39A5;GDF9;SMAD5;BMP4;BMP8B
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7749862105017432,1.2532455258223303,0.23333333333333334,0.9066239341437264,1.0,1/6,2.63%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7749862105017432,1.2532455258223303,0.23333333333333334,0.9066239341437264,1.0,1/6,2.63%,ENPP1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.7695421071135011,1.2532063742019754,0.27586206896551724,0.9057326996567516,1.0,1/7,8.46%,CHCHD4
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.4974096019663183,-1.2530727976148257,0.07692307692307693,1.0,1.0,23/180,7.34%,CD44;COL24A1;COL23A1;ICAM3;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;ACAN;COL6A3;AGRN;MATN4;ADAMTS1;COL1A1;TGFBI;ITGA9;COL11A2;COL28A1;LAMB3;MFAP5;LAMB1;SPARC
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6261555644239458,1.2529800024446671,0.18181818181818182,0.905756743967431,1.0,9/30,14.64%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;B4GALNT2;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.8105475824517967,1.2529344527599917,0.24444444444444444,0.9048028262312843,1.0,1/10,2.53%,CD99
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6973455393501324,1.2526973611236496,0.22641509433962265,0.9050929028416606,1.0,5/14,15.67%,ADRA1A;DRD5;DRD3;ADRA2C;ADRB1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.69707770076264,1.2522391371105073,0.23809523809523808,0.9061260138135399,1.0,5/10,21.85%,RAPGEF3;SGSM3;RAP1A;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.8224723176157898,1.2522288123551408,0.1746031746031746,0.9049278782518322,1.0,3/6,10.56%,IL23R;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6600148545954505,1.2521259035405992,0.2545454545454545,0.9044583146844942,1.0,6/17,17.07%,TMTC2;SDF2L1;POMT2;FKRP;CRPPA;TMTC3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.7301026880241257,-1.2517621425604761,0.23684210526315788,1.0,1.0,2/6,16.91%,FOXO4;FGFR2
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6137584792485152,-1.2516717286438312,0.1956521739130435,1.0,1.0,1/16,0.39%,SELP
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5517227902580482,1.2515778507352533,0.04838709677419355,0.9062453481284134,1.0,6/65,3.61%,MME;CDC25A;SIRT1;MYC;ZBTB1;NEDD4
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.8666110463639021,1.2514842003241546,0.19607843137254902,0.9055944331877008,1.0,1/5,1.35%,C3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7496426199202685,1.2509693055546556,0.16666666666666666,0.9073094305962355,1.0,3/10,16.45%,STAT5A;LYN;PRLR
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5291548977706448,-1.250888021008094,0.18518518518518517,1.0,1.0,23/102,15.61%,MS4A8;CFAP61;PVALB;AK8;VWA3A;DNAAF1;RGS22;DRC1;TMEM107;AK7;S100B;ZBBX;CCDC40;ANGPTL2;GAS2L2;CFAP221;RSPH1;CFAP52;DRC7;APOBEC4;DNAH2;RIIAD1;RSPH4A
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.687479468053107,1.2508629259209478,0.19230769230769232,0.9066916276498691,1.0,5/17,15.67%,ADRA1A;DRD5;DRD3;ADRA2C;ADRB1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8402910503574542,1.2505890595369147,0.17777777777777778,0.9071725129234242,1.0,3/6,11.36%,NGB;MYC;CA2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7129498567892474,1.250237529171066,0.16071428571428573,0.9077011580759131,1.0,1/16,0.81%,IL26
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.6320031631141098,-1.2495138793274219,0.15,1.0,1.0,3/20,7.67%,DUSP4;DUSP6;PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5873833130781568,1.2493475967113978,0.11764705882352941,0.9116085809041438,1.0,9/54,5.84%,SASH3;PNP;FGF10;TNFSF13B;IL4;CCL5;CD40;IL23R;CCDC88B
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6696911083712557,1.2491233626942442,0.2549019607843137,0.9114938582096246,1.0,1/17,3.50%,RAB27A
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4683811961419765,1.248823948177395,0.10526315789473684,0.9119657277034825,1.0,36/210,15.70%,ATP6V0D2;IRGM;DEPP1;HGF;BOK;FZD5;GFAP;NEDD4;DAPK2;TFEB;RNF152;MID2;IL10RA;PIP4K2A;PRKAB2;FOXO1;TICAM1;HMGB1;HTRA2;TP53INP1;FOXO3;ATG101;KEAP1;ABL2;TRIM65;TAB2;LEPR;WASHC1;HSPB1;RRAGC;MAPK8;MAPK15;ATP6V0B;MTMR9;MTMR3;GPR137B
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5031295775671,1.2488002275019674,0.08196721311475409,0.9109563205212535,1.0,16/112,9.77%,ACE2;LGALS9;IL26;NOX5;ICOSLG;TMIGD2;BTN2A2;CCDC88B;STING1;CCN4;MAPKAPK2;IRF8;RPS6KA4;C5AR2;ITK;IL15
prerank,MSigDB_Hallmark_2020__Coagulation,0.5125858320703576,1.2481964206209526,0.1206896551724138,0.9132954929850448,1.0,21/98,15.23%,F2;PROZ;CFH;C3;RAPGEF3;ITGA2;GNG12;KLKB1;CPN1;C9;F12;DPP4;MMP15;TF;GSN;F3;SH2B2;HTRA1;MAFF;CSRP1;KLF7
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.765606555786655,1.247866358291338,0.1320754716981132,0.9138279489108605,1.0,5/8,21.66%,SNAI1;SMAD2;CRB2;MESP1;BMPR2
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8119693932474996,1.2477925926630857,0.16363636363636364,0.9130630787997175,1.0,1/7,0.92%,FGF10
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.5550171045846316,1.2472630269099758,0.14583333333333334,0.9145812388992118,1.0,6/60,3.70%,CDKN2C;CCNA2;MAP3K11;CDC25A;MYC;CDKN2A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6996435403002734,1.2470814599604951,0.19672131147540983,0.9142374506702372,1.0,5/14,23.61%,DNASE2B;HMGB1;ENDOG;CASP3;CECR2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5793698630908801,1.2465837238696085,0.14285714285714285,0.9159113617789135,1.0,7/54,6.93%,DLGAP5;MYC;SNAI1;KAT2B;BMP2;NRARP;RBPJ
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.7129456715352251,-1.246521091489559,0.2558139534883721,1.0,1.0,1/8,0.43%,RFX6
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.503076992058504,1.2464717057011596,0.16071428571428573,0.9151477861871028,1.0,21/91,13.58%,SMAD6;VWC2L;TGFBR1;SIRT1;PPARG;BMP2;CRIM1;IL17RD;ACVR2A;BMPER;PPM1A;UBE2D3;DAND5;SMAD1;MAGI2;VWC2;FAM89B;SMAD2;BMPR1A;GREM1;SMAD4
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5411553004255256,-1.2460736268186607,0.19148936170212766,1.0,1.0,8/58,4.20%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3;CD53;CYTH4;IL6R
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7453817007847505,-1.2455820525875907,0.14893617021276595,1.0,1.0,2/7,15.60%,ERCC1;RAD50
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6051783618160498,1.2455646223075605,0.25,0.9190205996923865,1.0,12/42,12.47%,SYK;FLT1;TGFBR1;ITGB8;HAS2;CDH2;APELA;RBPJ;AGGF1;PROX1;EFNB2;EGFL7
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.587260663797976,1.2455595932328545,0.13559322033898305,0.9178210342433203,1.0,7/33,14.93%,SIRT1;RORA;ESR1;PPM1A;NR1H4;TNIP3;TANK
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6987517855094902,1.245544477946643,0.22807017543859648,0.9166727851634656,1.0,2/10,6.74%,ADGRV1;WHRN
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.7374084471873518,-1.245358813902664,0.24489795918367346,1.0,1.0,2/9,2.27%,TERT;DND1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.7984653828591224,1.245273325929155,0.1864406779661017,0.9170662406181764,1.0,2/8,9.42%,DRD5;SNCA
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.46928765691394897,1.2450041605763964,0.08620689655172414,0.9173306053317857,1.0,50/264,15.51%,IGF1;LGALS9;NRTN;FGF10;HGF;IRS1;IL2RA;RIT2;FGFR1;NRG1;FGF2;FGFR3;CCL5;ERBB4;MYC;ANGPT1;KSR1;SPTBN5;IL17RD;TNIK;ARTN;ABHD17B;FLT3;ZFP36L2;MAPKAPK2;CSF2RA;PDGFRA;ITGAV;NRG2;PPP1CC;SHOC2;PIK3CA;FGF17;GFRA1;PSMD13;FGF5;RASAL2;RANBP9;ABHD17C;MEF2C;MAPK8;KLB;RGL2;SOS1;PSMA1;PSME4;IL2RB;LYPLA1;KIT;LRRC7
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6728581167896849,1.2449892902759747,0.22916666666666666,0.9162035197997593,1.0,8/19,18.00%,NFIL3;TOX;ULBP2;IL21R;ELF4;CD244;PIK3CD;AXL
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6692305181001482,-1.2449512418359785,0.22448979591836735,1.0,1.0,8/23,14.49%,KCNE2;KCNA5;KCNE1;SLC11A1;KCNQ1;ATP4A;SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6451549083462125,1.2446452890300623,0.19642857142857142,0.9166439348597192,1.0,7/20,15.98%,CYP4F12;LPIN3;AGXT2;CYP4F3;CEL;FAH;LDHD
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.5628324370790769,1.244466886164575,0.1276595744680851,0.9163976137009802,1.0,14/89,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;PRRX1;PRKG1;ADGRL4;GFAP;CCDC80;PLSCR4;POSTN;BGN;PDGFRA;OLFML3
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5763660216791179,1.2440492991195427,0.17857142857142858,0.9175849930142835,1.0,9/58,6.27%,FLT1;MAP3K11;PIK3R6;FGFR1;FGF2;CD40;PIK3R5;TENM1;FLT3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7319589285516859,1.2440285580851524,0.2033898305084746,0.9165588874241886,1.0,4/9,18.58%,SIRT1;LEPR;LRP2;GCK
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8594934310380545,1.2437104471197384,0.2,0.9172823967791889,1.0,3/5,11.46%,ABHD3;ACADM;GLYATL2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.572332306607908,1.2436078916154805,0.14814814814814814,0.9165448538144014,1.0,5/42,4.24%,SASH3;SYK;TNFSF13B;IL4;CD40
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8012569613389934,1.2435404398323742,0.25396825396825395,0.9156349963303804,1.0,1/5,3.77%,AK3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6092249047377414,1.2434405763927405,0.2,0.9149015191030646,1.0,7/22,7.86%,FLT1;IRS1;FGF2;FGFR3;FLT3;EPHA8;PDGFRA
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.6618182733254976,-1.2432920048240799,0.16129032258064516,1.0,1.0,2/16,5.21%,TAFA3;DRD2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5309255067041033,1.242828253392036,0.09615384615384616,0.9167609192060256,1.0,18/96,12.87%,SYK;LGALS9;EGLN3;SIRT1;BOK;MYC;PPARG;F2R;HIP1;TNFRSF10A;ST18;HMGB1;HTRA2;DLC1;SNCA;GSN;F3;LCK
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5112945972257378,1.2422922038222808,0.11864406779661017,0.918505043151072,1.0,18/124,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;PRRX1;ADGRL4;ANGPT1;ANPEP;GNB4;STEAP4;COL6A2;LHFPL6;CSPG4;PLSCR4;POSTN;BGN;PDGFRA;OLFML3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6378402457451405,1.2422919146154994,0.2222222222222222,0.9173137266229902,1.0,4/34,3.81%,IGF1;PRKG1;FGF2;PPARG
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7736577755129274,1.2420718682029392,0.15789473684210525,0.917589056223797,1.0,1/6,2.18%,SIRT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6988606643782996,1.2417988517258491,0.26785714285714285,0.9177379387084483,1.0,6/12,21.98%,RENBP;UAP1;B4GALNT2;GNPDA2;GFPT1;GNPNAT1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.629894777416296,1.241798386965218,0.12903225806451613,0.9165679273150243,1.0,11/38,23.50%,LIN28A;HDAC3;TELO2;PIK3CA;RRAGC;GPR137B;RICTOR;MLST8;RRAGD;HTR6;GAS6
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.49586678470461465,1.2415327989024927,0.17543859649122806,0.9167020668883737,1.0,40/188,16.31%,FAM83H;IGF1;CXCL12;FLT1;FERMT3;SEMA5A;HGF;TGFBR1;ITGAX;IL4;CCL5;SNAI1;HAS2;F2R;BMP2;SEMA6C;CAVIN1;TCAF2;PDGFRA;RHOD;FER;VSIR;PDGFC;FAM89B;CASS4;CARMIL1;WASHC1;F3;LGR6;BCAR1;MGAT5;PPP3CA;IGF1R;SEMA3E;CPNE3;KIT;CSF1;PIK3CD;RET;SEMA6D
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.49612390703439274,-1.2411669834942753,0.15555555555555556,1.0,1.0,10/134,5.46%,CD44;TEK;COL4A2;COL5A1;COL4A1;BOC;CRYM;HEPH;SPC25;COL1A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.6300809091816544,1.241043611590789,0.20754716981132076,0.9180726912768292,1.0,1/22,0.56%,IGF1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.6011206599290562,1.240969162178308,0.17857142857142858,0.9173289366748689,1.0,10/40,11.36%,ITGA8;MME;TGFBR1;LRP4;HAS2;WNT4;PCSK5;C1GALT1;PROX1;TBX18
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7190951683488369,1.2408791032443895,0.3050847457627119,0.9166807890528492,1.0,2/10,2.44%,LGALS9;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7160826666009067,1.2407649803801344,0.21212121212121213,0.9162370507476751,1.0,3/13,2.87%,SEMA5A;FGFR1;FGF2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.8556291899667047,1.24074340123089,0.1935483870967742,0.9151402668377315,1.0,1/6,4.32%,WNT4
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.690435630428828,1.240693839812002,0.16981132075471697,0.9142951852209934,1.0,4/18,14.00%,SHMT2;MTHFD2L;MTHFD2;SLC19A1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.8051316344516222,1.2403167670266115,0.14285714285714285,0.9150990766276027,1.0,2/7,9.36%,ENPP1;SLC34A2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.5638797927855,1.2402929156606337,0.17543859649122806,0.9140234644239787,1.0,8/44,10.09%,C3;IL4;RAB31;NLGN1;HIP1;BICD1;SNCA;TF
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6124857875898478,1.2402813912924864,0.10344827586206896,0.9128886108219031,1.0,4/24,10.10%,BMI1;FBXO5;DCUN1D1;ARRDC3
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7852332100037526,1.2402752165385509,0.17857142857142858,0.9117566485665844,1.0,2/8,4.07%,C3;RAB31
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7089605256610344,1.2401535911915134,0.19298245614035087,0.9111994717716337,1.0,1/14,0.74%,CTDNEP1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.8240561896815684,1.240142100318732,0.19298245614035087,0.9101034069800475,1.0,1/5,6.59%,HIP1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.7488128219100234,1.240085127754299,0.12280701754385964,0.909364730379001,1.0,3/10,12.87%,CCL5;PAG1;LCK
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.667414640350764,-1.2398704406546652,0.17777777777777778,1.0,1.0,3/15,16.27%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.7785144463019928,1.2397747616669774,0.18518518518518517,0.9094748230607311,1.0,1/7,2.12%,TGFBR1
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.8177660198071118,1.2397746223773662,0.14285714285714285,0.9083235891074898,1.0,3/6,10.14%,FHIT;NUDT4B;NUDT4
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5318377900939193,1.2397263855636034,0.16363636363636364,0.907374935470917,1.0,20/104,8.61%,MXRA5;MRGPRF;CXCL12;LAMA4;CFH;MME;PRRX1;SSC5D;ADGRL4;CCDC80;LTBP2;COL6A2;POSTN;ABI3BP;BGN;CYBRD1;PDGFRA;ITGAV;OLFML3;TLR2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6925148698480122,-1.2396238771976837,0.20408163265306123,1.0,1.0,2/15,2.38%,MYH7;STAC
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.5387094182661284,1.2395986217595618,0.16666666666666666,0.9069809101606239,1.0,12/95,5.38%,VEGFC;IGF1;FGF10;SEMA5A;TGFBR1;SIRT1;FGF2;MYC;HIF1A;STAT5A;BMP2;NRARP
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7306001362667587,1.2395734544911348,0.20408163265306123,0.9060363422569894,1.0,4/11,16.99%,RORB;TULP1;DSCAM;VEGFA
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.7218011151867078,1.239333820304115,0.18181818181818182,0.9060581266308144,1.0,2/13,1.36%,TOP2A;MSH4
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7161034827149756,1.2393130485113977,0.19298245614035087,0.9051018138204361,1.0,6/11,22.82%,BOK;DLC1;TP53BP2;PTGIS;TP53;FAP
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6955135525867592,-1.2393093284512657,0.21739130434782608,1.0,1.0,1/11,1.54%,INHA
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.5077398441044684,1.2391278930580925,0.11320754716981132,0.9049110394969144,1.0,49/173,17.19%,GATA4;IL26;FGF10;CALCR;SEMA5A;HGF;IRS1;RRAS;FGFR1;TGFBR1;SIRT1;NRG1;FGF2;FGFR3;ERBB4;ANGPT1;PIK3R5;LIN28A;HCLS1;FLT3;HIP1;ESR1;PDGFRA;HPSE;GAB1;NRG2;RAMP3;DRD3;BANK1;PIK3CA;FGF17;MAGI2;FGF5;CASS4;F3;LCK;CPNE1;PTEN;KLB;IGF1R;CD80;KIT;PIK3CD;RET;MFHAS1;RICTOR;IAPP;LRP2;RHOG
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.6136388930750523,1.2390361087138126,0.1875,0.9043701419413793,1.0,10/28,23.50%,IRGM;HIF1A;CD74;CPNE1;CSF1;AXL;HSPA1A;FADD;EDN1;GAS6
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.7526898465784561,1.2388982709781893,0.22580645161290322,0.9038001510960125,1.0,2/10,7.89%,SYK;PLCG2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6051798398825493,1.2387930884708986,0.23214285714285715,0.9032163816042031,1.0,12/41,18.08%,SMOC1;PBX3;MAFB;SIX4;CHD7;PAX6;FREM2;SLC39A5;ATF6;HIPK1;ABCB5;SCO2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6381431120093679,1.2383059999724289,0.15384615384615385,0.9045779307678581,1.0,7/19,16.99%,GDF6;PRMT1;BMP2;RELL1;GADD45G;MFHAS1;VEGFA
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6610472914537657,-1.2382836259974903,0.18181818181818182,1.0,1.0,3/16,16.27%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.7895955606331325,1.2382543166749105,0.18518518518518517,0.9036002944023346,1.0,1/9,0.77%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7056825535823648,1.2382297122870045,0.20967741935483872,0.9026099475038094,1.0,6/13,23.52%,KLRD1;NECTIN2;CADM1;HLA-E;HLA-F;CD160
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.6819309289344455,-1.2382130495797072,0.2558139534883721,1.0,1.0,5/10,17.13%,PDXDC1;ENPP2;CYP1B1;FUCA1;SMPDL3B
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.6926265274403229,-1.2379370148672229,0.25,1.0,1.0,1/8,3.06%,STK10
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7920454385257947,-1.2378941905579632,0.2,1.0,1.0,2/9,2.05%,PALM3;SIGIRR
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.8007445282742832,1.237811514858769,0.16363636363636364,0.9037099608558051,1.0,1/8,2.18%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.6610146337719129,-1.237713325254476,0.16216216216216217,1.0,1.0,3/21,5.21%,DRD4;RHBDF1;DRD2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7104405471887265,-1.2373604863587655,0.24444444444444444,1.0,1.0,3/14,9.25%,ACTC1;NEB;MYLK3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4310735269235962,-1.2370621163551037,0.027777777777777776,1.0,1.0,24/388,7.93%,CD44;TBC1D10C;SELL;DNASE1L1;HGSNAT;MPO;BST1;CD53;PRKCD;STK10;CRACR2A;ALOX5;STXBP2;LILRB3;RAB44;AHSG;MVP;AGA;CLEC5A;OLFM4;SLC11A1;DOCK2;SVIP;BRI3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.8062384992478163,1.2367436677973436,0.25,0.9071796406809797,1.0,3/6,7.68%,GRIP1;SCRIB;GRIP2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6816719013517263,1.2366408698520404,0.2413793103448276,0.9066111162172005,1.0,8/12,23.50%,ZBTB1;IL23R;TICAM1;AXL;HLA-E;HLA-F;IL23A;GAS6
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.7313160814575961,1.2366265339754137,0.24561403508771928,0.905561655280196,1.0,1/6,14.93%,TANK
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.7831074927431059,-1.2365081504622455,0.34545454545454546,1.0,1.0,2/5,14.87%,CEACAM1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.6718278271627145,1.2362165124779152,0.22807017543859648,0.906486957252556,1.0,9/14,19.87%,GPR55;IL4;MAFB;ZNF675;LRRC17;GPR137B;FBN1;FSTL3;TMEM178A
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.6561914155525764,-1.2360097619251607,0.24,1.0,1.0,7/26,15.60%,DDX11;HMGB3;RECQL5;RTEL1;SUPV3L1;ZRANB3;RAD50
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.8429981694597697,1.2359940625197068,0.1836734693877551,0.9065829866817803,1.0,1/5,4.51%,DMC1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6812722299654789,1.2358390009638682,0.22580645161290322,0.9061681852758968,1.0,5/19,14.76%,IGF1;BIN1;HAP1;RTN1;PICALM
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.746760933103936,1.2358233554135798,0.15555555555555556,0.9051094547765357,1.0,3/11,8.15%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6091561348475677,1.2355739573719164,0.1836734693877551,0.9051918470836762,1.0,4/24,14.82%,PLEKHH2;NAV3;PIK3CA;HDGFL3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.5264321410244863,1.2355449197490938,0.11864406779661017,0.904241660476654,1.0,14/81,8.38%,MXRA5;MRGPRF;ACTG2;CXCL12;SEMA5A;FBLIM1;ADGRL4;NYNRIN;POSTN;FAM114A1;BGN;PDGFRA;MYH11;OLFML3
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7500208444393455,1.2354500907276587,0.2,0.9036225698322121,1.0,3/9,12.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.8069287762283508,1.2354080112387804,0.26785714285714285,0.9027064961132272,1.0,2/5,13.44%,SIRT1;NR1H4
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5337833649638133,1.2353047346701382,0.20754716981132076,0.9020013669711928,1.0,8/52,13.52%,VAPB;NR5A2;CCL5;PROX1;FKBP6;ZC3HAV1;OASL;TMEM39A
prerank,PanglaoDB_Augmented_2021__Microglia,0.5440302643938243,1.2350568522146663,0.10204081632653061,0.9021763951208084,1.0,18/94,8.38%,SASH3;LGALS9;TGFBR1;CSF3R;ITGAX;TCIRG1;LAIR1;PTGS1;CD40;MAFB;PIK3R5;IL10RA;STING1;IL21R;FGL2;SIGLEC1;HPGDS;OLFML3
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6823446785850897,1.2350091728212016,0.1746031746031746,0.9013844185345713,1.0,4/15,10.19%,FGF2;ITPKB;CYP27A1;IP6K3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.7770403528716732,1.2349384269923498,0.2641509433962264,0.9006686394473126,1.0,2/7,3.00%,CXCL12;CCL5
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6420951137134058,1.2348200133672573,0.2033898305084746,0.9001326173814881,1.0,7/24,8.54%,LRP4;NEDD4;F2R;CACNB4;PPFIBP1;UNC13B;ZC4H2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7198132206552925,1.2342001702055545,0.21052631578947367,0.9027240787375927,1.0,6/13,20.85%,FGFR1;NR5A2;STOX2;RICTOR;RAI2;SCEL
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.8533975027847288,1.2337918138404824,0.22033898305084745,0.9037406440355531,1.0,1/5,0.92%,FGF10
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.7613143351930796,1.2335859826653366,0.21568627450980393,0.9037201393280634,1.0,2/5,9.04%,C3;HMGB1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.7243164981399479,-1.2335298413616225,0.24390243902439024,1.0,1.0,3/7,25.55%,POLQ;POLL;PMS2
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7645103143859778,1.2331054510070352,0.22413793103448276,0.9053973136390724,1.0,2/7,8.85%,PATL2;DCP1B
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7492762787162022,1.2329613719798043,0.24528301886792453,0.9053453600231055,1.0,4/13,13.48%,RPP25;RPP25L;RPP40;HSD17B10
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5088930509997728,1.2329102471859918,0.14545454545454545,0.9045424958339463,1.0,27/91,17.42%,TMTC2;C1GALT1C1;PLOD2;GALNT8;POGLUT2;GALNT7;MUC20;MUC13;GALNT12;TET2;GALNT5;GALNT3;C1GALT1;POGLUT3;MUC17;GXYLT1;GALNT1;SLC35C1;SDF2L1;MUC7;B3GLCT;POMT2;FKRP;B3GALNT2;CRPPA;TMTC3;POMK
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5178325281205426,-1.2328228130498924,0.1276595744680851,1.0,1.0,5/50,9.84%,NUPR1;KCNE2;RHBDF1;LAMP3;DDRGK1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5805974895696544,1.2322229521344594,0.16923076923076924,0.9067420847305502,1.0,11/38,11.22%,FERMT3;EPHA7;EFNA5;TENM3;DPP4;FUT9;MEGF10;ADA;B4GALNT2;MAGI1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.7931863206862666,-1.232107511307087,0.2826086956521739,1.0,1.0,1/5,3.95%,SLC6A6
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.8076509949228187,-1.2320396342345048,0.20408163265306123,1.0,1.0,1/5,0.40%,MYH7
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.7526828232790707,-1.2320052938368724,0.2727272727272727,1.0,1.0,4/7,11.10%,SCN5A;CACNA1G;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6361047814081422,1.2319959726912533,0.16666666666666666,0.9067474558673642,1.0,6/23,10.64%,CLSTN2;CDKN2AIP;LGI1;SYT1;GRIK2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.8248178771605871,1.2318886721736806,0.22033898305084745,0.9061805728616553,1.0,1/5,6.03%,F12
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.7863399770981014,1.2315933499700922,0.15384615384615385,0.9057095920393454,1.0,2/6,13.71%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.7863399770981014,1.2315933499700922,0.15384615384615385,0.9057095920393454,1.0,2/6,13.71%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.548055476315294,1.2314834642191985,0.1896551724137931,0.9050144255571744,1.0,5/61,5.91%,MITF;RBM20;PCBP3;HNRNPH1;AFF2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7018410375420578,1.230891660614596,0.2,0.9067011063409821,1.0,7/15,23.52%,KLRD1;NECTIN2;CADM1;HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7009462668781625,1.2308624136815245,0.23529411764705882,0.9057876469604768,1.0,7/11,15.43%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;SERTAD1;ARID1B
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5100701508881295,1.2305848594098832,0.14814814814814814,0.906260270718585,1.0,12/82,12.17%,CXCL12;VAPB;DRD5;CCL5;CD40;CASR;SLC8A1;SLC24A2;DRD3;ANK2;HTR2C;ATP1A2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6273471239305495,1.2302071317227978,0.2542372881355932,0.9074156051375385,1.0,3/22,4.90%,PNP;REXO2;FHIT
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6671275126220717,-1.2301384417071788,0.21621621621621623,1.0,1.0,2/22,5.90%,GFRA3;GPC1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7830213644219185,1.2300650232561003,0.20967741935483872,0.906955074710973,1.0,4/7,18.22%,ADIPOR2;HPSE;VEGFA;CD34
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.7538568846904193,-1.2299783826473505,0.30612244897959184,1.0,1.0,3/6,9.11%,SCN5A;KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.8516645355100341,1.229881036781356,0.18518518518518517,0.906800461351335,1.0,3/5,9.04%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.7188906278821603,1.2298454868115827,0.23529411764705882,0.905877835886932,1.0,5/10,13.66%,BMP2;SOX6;EFNB2;GREM1;MEF2C
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.7476105678169213,1.2298120136040918,0.23809523809523808,0.903836689803376,1.0,2/5,12.40%,ZFP36L2;NPR2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.7476105678169213,1.2298120136040918,0.23809523809523808,0.903836689803376,1.0,2/5,12.40%,ZFP36L2;NPR2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.820073258371883,1.2294855679679186,0.234375,0.904177685153714,1.0,1/5,3.54%,KAT2B
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7925730252688957,-1.2294290039670122,0.225,1.0,1.0,2/6,16.74%,LDB1;NUP133
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.7644676114592569,-1.2294072852789555,0.20930232558139536,1.0,1.0,4/7,17.82%,TIE1;SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7482610065961167,1.2293739779124058,0.26785714285714285,0.9036809952757805,1.0,5/9,19.50%,HDAC3;HDAC2;SMARCAD1;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8281270160646805,-1.2292864973150324,0.275,1.0,1.0,2/5,9.69%,CIITA;TAF7
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6667454031420791,-1.2292043501977252,0.2608695652173913,1.0,1.0,4/14,12.54%,ENTPD2;AK8;AK7;ENTPD5
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8568801279863644,1.2291761928648568,0.23214285714285715,0.9035457779775793,1.0,1/5,3.01%,SLC7A2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.7723025469711339,1.2284481293332041,0.25806451612903225,0.9063186089194987,1.0,2/6,6.76%,CXCL12;EPS8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.8234886267164698,-1.2284460813714935,0.20454545454545456,1.0,1.0,1/5,1.55%,MRLN
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.7683835239130221,-1.2282651670074816,0.30612244897959184,1.0,1.0,1/5,5.70%,TICRR
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.8657249479781588,1.2282464763016063,0.14814814814814814,0.9061374572548571,1.0,3/6,10.58%,SIX4;CHD7;PROX1
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.816456592732409,1.2281533159826037,0.21739130434782608,0.9054253893443414,1.0,2/5,15.00%,POU3F2;MYT1L
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.7295172795957761,1.2280894330674423,0.23636363636363636,0.9045715657476834,1.0,4/9,21.66%,FGFR3;MEF2C;BMP4;BMPR2
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.8215892900789024,1.2276562575850611,0.2916666666666667,0.9057111800693781,1.0,1/5,0.77%,LGALS9
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.678893393254916,1.227647564657922,0.24561403508771928,0.9046586923663498,1.0,3/15,7.76%,TSHZ3;NLGN1;NRXN1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8069405955178398,1.2273659551279315,0.24074074074074073,0.9046806622989472,1.0,1/6,2.13%,RUNX1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.46204006097331035,1.2272176718396983,0.09375,0.904445607433148,1.0,38/168,17.59%,DACH1;PLEKHH2;ARHGAP24;PLOD2;GNG12;NPHS2;MAFB;DOCK1;LRIG3;BCAM;MYO1E;PLSCR4;WWTR1;ARHGEF17;DPP4;UNC13B;ADGRL2;LIFR;TOB1;PRICKLE2;MAGI1;MAGI2;EDNRA;KANK1;RASAL2;QKI;BCAR1;SEMA3E;HTRA1;FZD4;CD80;CRB2;EMC2;LOXL2;NR2F2;VEGFA;CPE;DST
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.781286812176302,1.226915554278473,0.3269230769230769,0.9046959283848081,1.0,2/5,14.88%,ROBO2;ROBO3
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7425231032260153,1.2268590665992003,0.2033898305084746,0.9038774513801036,1.0,4/9,20.26%,APELA;RYR2;MESP1;CITED2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5916286803201517,1.2266418381320996,0.11764705882352941,0.9040567207078268,1.0,6/31,5.55%,F2;IL26;CCL5;ERBB4;F2R;IL10RA
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.4902523089643853,1.2259916738477532,0.1724137931034483,0.906082805342134,1.0,27/137,13.66%,MXRA5;MRGPRF;CXCL12;LAMA4;ITGA8;PAWR;PRRX1;ADGRL4;CCDC80;LTBP2;CRIM1;PLSCR4;POSTN;ABI3BP;FAM114A1;BGN;PDGFRA;OLFML3;DLC1;EDNRA;TBX18;HMCN1;NCOA2;NR4A2;PML;MEDAG;MEF2C
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.665087907986192,-1.2258801614140398,0.2,1.0,1.0,1/20,1.26%,MTFR2
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.8007869279247463,1.2256219648496336,0.14545454545454545,0.9068126024678921,1.0,3/5,13.58%,BMP2;SOX6;SMAD4
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.7872342921269224,1.2254423471456193,0.25862068965517243,0.9054492903065593,1.0,2/5,11.98%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.7872342921269224,1.2254423471456193,0.25862068965517243,0.9054492903065593,1.0,2/5,11.98%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7645518736099431,1.2248794706682034,0.19298245614035087,0.9069834459596329,1.0,1/8,0.73%,ACE2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7873457433392577,1.224761020313441,0.19642857142857142,0.9066210313593527,1.0,4/5,21.17%,ENPP1;SMPDL3A;DCTPP1;ENPP3
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7729712242066955,-1.2245953528745606,0.3111111111111111,1.0,1.0,2/5,10.12%,RFX4;DLL4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5553547039668943,1.2243245191137972,0.14893617021276595,0.907585843388393,1.0,6/50,9.04%,SYK;LGALS9;FZD5;PLCG2;TLR2;HMGB1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.5984045883398804,1.2241220370674912,0.18181818181818182,0.9072799472481654,1.0,4/27,9.42%,SYK;IL4;PLCG2;SNCA
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.7867446863107672,1.2238234796390866,0.22641509433962265,0.907932048750774,1.0,2/5,20.15%,MOV10;AGO3
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.7846313868972082,1.2233695444531183,0.14285714285714285,0.9091029155824724,1.0,1/6,13.48%,HSD17B10
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6692340495183529,1.222926529021273,0.203125,0.9100042159200299,1.0,4/17,11.73%,NPC2;SLC29A2;PLA2G10;SLC15A2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5611009909938749,1.2229102542170551,0.16363636363636364,0.9091217508235634,1.0,15/63,17.32%,DERL3;OSTC;UBE2J1;GAL3ST1;ALG6;SLC39A8;MGAT2;MAGT1;B4GALNT2;LMAN1;FUT8;MGAT5;ALG9;MGAT4A;MGAT4C
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5670369276603763,1.2229079502851088,0.07272727272727272,0.9081011931414101,1.0,8/69,12.57%,SYK;CBLB;RGPD4;RGPD2;RGPD3;NXT1;RGPD5;RANBP17
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.7328605291541842,-1.2228725084261223,0.22641509433962265,1.0,1.0,6/8,23.64%,DARS2;SARS2;GARS1;WARS2;AARS2;TARS2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6606327583116878,-1.222301740733556,0.2564102564102564,1.0,1.0,5/15,20.19%,ZWILCH;SPDL1;CTCF;TTK;CDK1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.853826857035713,1.2222741752332316,0.1323529411764706,0.9097843466500916,1.0,2/5,11.56%,SLC26A6;SLC2A5
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.8286734018093169,1.222092917531705,0.26229508196721313,0.9096042098326544,1.0,2/5,7.99%,SIX4;MEGF10
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.7204447745391422,1.222019340837863,0.2553191489361702,0.9088379778718891,1.0,5/11,20.03%,PHGDH;CBS;SRR;PSPH;CTH
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7411955039784665,-1.2218589213593674,0.30434782608695654,1.0,1.0,4/6,20.62%,BMP6;LY86;LY96;PRKCA
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.5314909720318612,-1.221714520324437,0.18604651162790697,1.0,1.0,16/70,9.74%,SELL;MPO;CD24;BST1;NLRP3;CYTH4;OAS3;ARG2;LILRB3;DOCK8;PRAM1;SLC11A1;HCK;MEFV;LY86;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6078866682460062,-1.2214756372237352,0.23333333333333334,1.0,1.0,4/25,6.25%,PRKCD;SFRP1;MVP;CAV1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7553716331590037,1.2212220761137131,0.2857142857142857,0.9116722114393604,1.0,2/7,11.61%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.665536871037692,-1.2211975049597539,0.2,1.0,1.0,1/11,4.04%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.6683742612488627,-1.2211635876436782,0.275,1.0,1.0,2/7,10.69%,ADCK1;VAT1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.455463171010156,1.22114653217095,0.07692307692307693,0.9110307576254987,1.0,63/341,13.17%,IRGM;SYK;CXCL12;LGALS9;IL26;MME;GREM2;HGF;IL2RA;SIRT1;CSF3R;SELPLG;ITGAX;FGF2;IL4;CCL5;MYC;HAS2;HIF1A;SLC26A6;SOCS2;PYHIN1;CD40;STAT5A;PTPN20;IL23R;SYNCRIP;RORA;IL10RA;HCLS1;FLT3;ZFP36L2;RORC;RELA;ZEB1;IRF8;CSF2RA;FOXO1;FER;LIFR;TLR2;HTRA2;SOCS6;FOXO3;NLRP7;PTPN14;FOXH1;ERBIN;ABL2;PIK3CA;ST3GAL6;IL18R1;ZNF675;PTPRT;HYAL3;LEPR;RO60;NPR2;F3;LCK;ZFAND6;IRAK3;RHOU
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6791432969264781,1.2211224323969971,0.21428571428571427,0.9101124429910881,1.0,2/17,5.40%,TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6229622145682892,1.2210390687510115,0.25925925925925924,0.9095298440477863,1.0,8/15,22.99%,SNAI1;BMP2;RBPJ;BMPR1A;NOTCH2;BMP4;JAG1;HEY2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.768222396707116,-1.220716791636716,0.23255813953488372,1.0,1.0,2/5,11.10%,SCN5A;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7932789231244874,1.2206737931824023,0.22033898305084745,0.910253739386234,1.0,3/7,6.50%,NLGN1;RORA;RORC
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7865066595142461,1.220534413552089,0.3018867924528302,0.909866473301686,1.0,2/7,13.80%,SOCS2;PXN
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8133918931744334,1.220281481311803,0.30357142857142855,0.9098818286742882,1.0,2/5,4.83%,ACE2;CNTNAP2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5530140601313156,-1.2201575656070012,0.14285714285714285,1.0,1.0,3/64,4.04%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.679075858275559,1.2197332494049054,0.20689655172413793,0.9118205291457797,1.0,2/9,13.94%,FBXO5;BAG2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.6989717767880386,1.2197018046290953,0.28888888888888886,0.9109352274313725,1.0,2/8,3.40%,PADI2;HIF1A
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7382465635279447,1.2196870797911423,0.20689655172413793,0.9099691028558728,1.0,2/7,8.13%,ERBB4;LHX6
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.8022773720144369,1.2195708594199302,0.18518518518518517,0.9085117594125796,1.0,1/5,3.99%,TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.8022773720144369,1.2195708594199302,0.18518518518518517,0.9085117594125796,1.0,1/5,3.99%,TOX
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5101943510012754,1.2195380014654975,0.15789473684210525,0.9076342153160554,1.0,32/111,20.96%,MT4;SYT15;ITPKB;NLGN1;GLRA1;ADGRV1;SYT1;SYT6;PLCG2;NEUROD2;SNCA;CPNE4;TF;SLC25A24;FBP1;CPNE1;MEF2C;CPNE7;MAPK8;CPNE3;TRPM2;DLG2;SLFN14;PRKAA1;AKR1C3;SYT17;ALOX5AP;MT1M;DPEP1;PPIF;CRHBP;LGMN
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5792627317956845,1.2193121155525448,0.13725490196078433,0.9076519742750577,1.0,8/37,15.20%,FERMT3;CD99;PDGFRA;MEGF10;MYL12A;HSPB1;TJP2;CSRP1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.6158963868149624,1.2192739910851917,0.2545454545454545,0.9068460239348299,1.0,3/22,6.51%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.7376541094709145,1.2189592520691168,0.2978723404255319,0.9065270804141101,1.0,1/7,6.15%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.7376541094709145,1.2189592520691168,0.2978723404255319,0.9065270804141101,1.0,1/7,6.15%,THOC6
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6036987926221697,1.2188294735452907,0.22641509433962265,0.9060534742514069,1.0,8/32,19.17%,SEMA5A;LLPH;ALCAM;AUTS2;CPNE1;CTNNB1;FLRT3;FLRT1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.7402107789138932,-1.2188009268869808,0.2894736842105263,1.0,1.0,2/6,6.34%,OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7003957605662783,1.2187734492191686,0.27586206896551724,0.9053622767379186,1.0,5/9,14.24%,SYK;FER;LYN;BLK;ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4788407557585112,1.2183252477467708,0.08620689655172414,0.9066246821271156,1.0,27/182,12.37%,VEGFC;IRGM;F2;FGF10;C3;HGF;RAPGEF3;SIRT1;FGF2;ERBB4;ANGPT1;EFNA5;CD40;BMP2;TNIK;PELI2;ACVR2A;FAM20A;HDAC3;DLC1;FGF17;LEPR;PLAUR;FGF5;CD74;LYN;AKTIP
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6988389706501217,1.2182350433043911,0.17647058823529413,0.9060434780465542,1.0,4/14,13.71%,PPARG;ITGAV;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.524786106726506,1.217915067615439,0.2,0.9064169834077476,1.0,17/77,13.73%,SLC5A8;SCN7A;SLC5A12;SLC12A1;SCNN1B;ASIC1;SLC12A3;SCN10A;SLC8A1;SLC6A16;SLC24A2;SCN3A;SCN2B;ATP1A2;HCN1;SLC5A4;SCN9A
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6979591109070732,1.2176283740718614,0.20408163265306123,0.9067624425750784,1.0,3/10,12.42%,BMP2;SMAD2;BMPR1A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7518151473742315,1.217443447205921,0.22,0.9066043129664884,1.0,1/9,1.61%,UNC5C
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.7608835598788309,1.2173135742780257,0.3508771929824561,0.906392238976249,1.0,2/8,9.33%,MME;OPN1SW
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6425246916604572,1.217294648637465,0.22033898305084745,0.9054348776389913,1.0,5/21,7.91%,GATA4;C3;HIF1A;RORA;HPSE
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7534176265234774,1.217263520854023,0.2545454545454545,0.9045609159047041,1.0,4/7,23.50%,PYHIN1;RO60;AXL;GAS6
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.7562788102982234,1.2170712782997788,0.24444444444444444,0.9045953494674746,1.0,3/8,9.53%,ALDH1A1;ACSS2;ALDH1B1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5242413769379902,1.216914280968713,0.18181818181818182,0.9044675379696155,1.0,15/82,13.38%,GPR55;CLIC6;C3;ALDH1A1;ADAM28;TEX26;SLC8A1;FAM20A;FGL2;ABCA1;CYP27A1;ST3GAL6;CD74;IRAK3;MSR1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.4570793938031993,-1.2168929552944843,0.09302325581395349,1.0,1.0,5/180,1.35%,CD44;NTRK1;DUSP4;APIP;TEK
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5749148120906202,-1.216872165545913,0.19148936170212766,1.0,1.0,2/33,1.71%,DNASE1L1;ENTPD2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6584421851278366,1.2166836943109702,0.22033898305084745,0.9047449811705854,1.0,8/16,18.00%,LGALS9;IL4;FLT3;IRF8;LYN;BLK;TRPM2;AXL
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6682972913556404,1.2165528201343716,0.2413793103448276,0.9042262501450247,1.0,8/17,25.55%,PDE4DIP;RAB33B;STX5;STX18;CAMSAP2;USP6NL;MAPK3;AKAP9
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6310745523846991,1.2163254753691377,0.23076923076923078,0.9043147783999257,1.0,3/19,4.96%,CHRM2;LYPD1;RGS10
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.7612914514415912,1.2163125053107853,0.30434782608695654,0.9034209557899443,1.0,1/6,2.98%,IL4
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7276353658703556,-1.216033309243939,0.22727272727272727,1.0,1.0,2/11,6.93%,SPTLC3;DEGS2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6029000889993028,-1.2158231552672782,0.24444444444444444,1.0,1.0,7/29,11.10%,KCNE2;SCN5A;CACNA1G;KCNA5;KCNE1;KCNQ1;SCN3B
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.716786802220053,-1.215238695320595,0.2127659574468085,1.0,1.0,2/8,25.07%,MAN2B1;MAN2B2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7881902328791277,-1.21522988821112,0.3333333333333333,1.0,1.0,1/6,9.74%,CEACAM1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6143634058904295,-1.2151585767198783,0.19444444444444445,1.0,1.0,7/25,15.22%,RPF2;DDX18;LAS1L;FTSJ3;NSA2;RRP15;NHP2
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.7216213258746238,-1.2148228736174926,0.3333333333333333,1.0,1.0,2/5,6.34%,OAS3;OAS1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.7745641060333829,1.2145688868906293,0.26785714285714285,0.9103239001713996,1.0,1/6,4.82%,LIN28A
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7587321400659637,1.214355058595092,0.29411764705882354,0.910700734956215,1.0,2/6,12.42%,SMAD6;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7708132292031019,1.2142534912202487,0.18032786885245902,0.9102185218798123,1.0,2/8,4.74%,INSL5;NLGN1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5737194066111747,-1.214139184873808,0.20454545454545456,1.0,1.0,4/26,8.52%,RNF8;LDB1;RECQL5;BTBD18
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6087750629318714,1.2141366719642528,0.18333333333333332,0.9097775566388537,1.0,5/21,13.66%,GRIN3A;LLPH;NLGN1;FOXO6;MEF2C
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.6923809770315752,1.2141142105298772,0.3333333333333333,0.9088291193306538,1.0,1/12,0.56%,PNP
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5822898533504492,1.2140663744878237,0.22,0.9080030571120046,1.0,3/40,6.68%,STK26;SIRT1;RELA
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.7843721232322916,1.2140014653860496,0.2542372881355932,0.9072589145039348,1.0,2/6,20.17%,EIF3E;FMR1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5099474151709896,-1.2138316499490975,0.175,1.0,1.0,4/53,8.30%,TERT;CAV1;CLDN5;FLOT1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.5656244489621495,1.2137252323695726,0.19607843137254902,0.9075299435976106,1.0,7/40,9.42%,SYK;NEDD4;SAG;RAB31;RAMP3;DRD3;SNCA
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6599928719233125,1.2137229561695373,0.24561403508771928,0.9065614877826972,1.0,7/20,5.55%,F2;IL26;CCL5;ERBB4;IL7R;F2R;IL10RA
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7661333948527237,1.2136315939560829,0.21818181818181817,0.906074198713425,1.0,4/8,12.42%,TGFBR1;NRG1;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.6254258413617537,1.2134728899227536,0.21666666666666667,0.9058671132571763,1.0,3/21,11.80%,FGF2;PRR5L;CORO1C
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.742122145484851,-1.2131090722759958,0.2926829268292683,1.0,1.0,5/8,16.76%,CXCL13;NR4A1;CCN3;CORO1B;EGR3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6780115529773726,1.2130112137384335,0.19672131147540983,0.9070944749619481,1.0,5/13,16.99%,RORB;TULP1;CRB2;RP1;VEGFA
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.8450604379948671,1.2129292180854225,0.1956521739130435,0.9065020941005815,1.0,2/5,12.74%,HS3ST5;TPST2
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.8246510550511779,1.2127800545484269,0.16981132075471697,0.9064012096504053,1.0,1/5,4.93%,FYCO1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6374217411932884,1.2125868609165136,0.16981132075471697,0.9063667166706998,1.0,9/18,15.41%,LRP4;NLGN1;PCLO;PTPRD;NLGN4X;LRRTM3;CEL;PTEN;FZD1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6902723202513005,1.2124211264428773,0.2727272727272727,0.906173659538197,1.0,4/10,26.96%,LYN;GREM1;MAPK3;RNF13
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7389564970807239,1.2116624954239401,0.3541666666666667,0.9090579188409971,1.0,1/7,2.57%,PLOD2
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.7568361758433688,1.211252273050323,0.2692307692307692,0.9100495693414428,1.0,2/5,11.84%,SIRT1;CD74
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.8367865754632299,-1.2111844166254624,0.27906976744186046,1.0,1.0,2/6,1.92%,GUCY2C;GUCA1B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.8363157019234189,1.2111601563132999,0.2033898305084746,0.9093787768418969,1.0,2/5,15.59%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.7960816640983541,1.210858533170548,0.23076923076923078,0.9099598890052348,1.0,1/5,7.78%,TCAF2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.5261562510903027,1.2107924787395403,0.125,0.9092380519002149,1.0,12/85,12.33%,CALCR;FGF2;CCL5;DCC;AGR2;CCN6;SLFN11;CCN4;RAMP3;SNCA;SLC25A24;BNIP3L
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7481346806177837,1.2105051345552202,0.23214285714285715,0.9096735837159131,1.0,3/7,12.34%,HS2ST1;EXT1;CSGALNACT1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5078135513224684,1.2104521943020319,0.1346153846153846,0.9089142548386516,1.0,30/109,20.43%,CGNL1;CLIC6;FGFR3;CLDN2;BCAM;ARHGEF17;UNC13B;ADGRL2;NEO1;MMP15;PRICKLE2;EFS;MAGI1;HTR2C;NOTCH3;PLXNB1;TMEM98;BCAR1;PRLR;PTPRU;FRZB;CPE;COBL;GPRC5B;PDZRN3;RNF128;FLRT3;TMEM178A;FARP1;MPDZ
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.7730198432216774,1.210069745818071,0.27419354838709675,0.9101355471131748,1.0,2/7,0.77%,SYK;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7473165179085832,1.210038550131524,0.22807017543859648,0.9092464396716611,1.0,3/8,13.71%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.6185545910623226,1.2099282036122354,0.18181818181818182,0.9087646529416991,1.0,6/22,16.75%,MYBPH;SCN10A;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.7801539137633933,1.2099121960301513,0.23636363636363636,0.9078919952090594,1.0,1/5,11.48%,COL22A1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.7473268078778286,1.2098430089103385,0.25,0.9063087241523379,1.0,3/10,8.15%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.7473268078778286,1.2098430089103385,0.25,0.9063087241523379,1.0,3/10,8.15%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4198593225045671,1.2096160396829938,0.043478260869565216,0.9063920789346672,1.0,79/381,18.00%,NRTN;CHRM2;SEMA5A;LSAMP;TGFBR1;FZD5;NRG1;FGF2;ERBB4;EFNA5;IL1RAPL2;ZEB2;POU6F2;NLGN1;CDH2;LGI1;ADGRV1;TENM1;CRIM1;ROBO2;CHD7;ARTN;SOX6;SDK1;THOC6;WWTR1;VCAN;NHLH2;ACTL6A;ST8SIA4;ACHE;NRXN1;CNTN6;NAV3;POU3F2;ZC4H2;NEUROD2;PDGFC;PAX6;FGF12;ATXN1;SCD5;SNTG2;DSCAML1;PROX1;FGF17;DSCAM;GFRA1;NPAS1;GSN;FGF5;GPM6A;HAP1;LIG4;EMX1;ADGRG6;MEF2C;DPF3;GLRB;GPM6B;DPF1;PTEN;ADORA1;MYT1L;TRPC5;ACVR1B;APBA1;DYRK1A;MOBP;DNM3;VEGFA;GRIK1;RAB29;ROGDI;NOTCH2;CNTN4;L1CAM;PCDHA1;AXL
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7114405586134975,1.2095409417970733,0.23076923076923078,0.9058769045535188,1.0,3/9,16.45%,INSL5;LEPR;UCN
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.5445401899402649,1.2092502284780688,0.1206896551724138,0.90632436679637,1.0,12/76,14.92%,MT4;MYC;COX19;CYBRD1;HJV;SLC39A8;ANKRD9;TF;LCK;SMAD4;SLC39A12;SLC39A5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.7286932408064921,-1.2091265297106766,0.26666666666666666,1.0,1.0,8/14,16.91%,MYH7;DSG2;ADAMTS9;HOPX;TGFB1;ID2;TGFBR3;FGFR2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5359731318697433,1.2091081161220754,0.16666666666666666,0.9061738007768179,1.0,10/67,16.65%,CGNL1;TGFBR1;RAPGEF3;TMEFF2;DLC1;CARMIL1;PPM1E;PXN;SORBS3;PHLDB2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.695020448272009,1.209019158369265,0.2786885245901639,0.9056345768342015,1.0,2/10,8.85%,PATL2;DCP1B
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.756617916715729,-1.2088715485766297,0.2765957446808511,1.0,1.0,1/7,4.06%,SENP3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),0.7905670046641531,1.20846180537588,0.19642857142857142,0.9072854166031045,1.0,2/5,10.95%,IL4;NECTIN2
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.7807036796882455,1.2084074807165615,0.328125,0.9065520819353379,1.0,1/5,3.23%,SNAI1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.7171947687668969,1.2082638961056726,0.23809523809523808,0.9063889897761483,1.0,3/9,20.13%,ADRB1;CPS1;F2RL1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.7683873922808527,1.208178474153228,0.2413793103448276,0.9060325813378338,1.0,4/7,21.74%,ABCD3;ABCD2;ABCD4;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7595995733834737,1.2081739201469974,0.26666666666666666,0.9050836604661358,1.0,2/7,2.98%,SIRT1;IL4
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7082757902988472,1.2080567598858643,0.28846153846153844,0.9045490234630384,1.0,3/12,9.08%,RENBP;NANP;UAP1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.8539100469498725,-1.2079033436570845,0.25,1.0,1.0,2/5,12.57%,CLDN5;F11R
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.8539100469498725,-1.2079033436570845,0.25,1.0,1.0,2/5,12.57%,CLDN5;F11R
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.81736630067122,1.2076378767270175,0.2807017543859649,0.9053411117294703,1.0,3/5,15.75%,KANK2;KANK1;ANLN
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6581907349843261,1.2075851141352127,0.16923076923076924,0.9046402030440072,1.0,4/20,7.94%,BOK;IL4;DCC;ITGAV
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.8112367154865141,-1.2075287992459163,0.2926829268292683,1.0,1.0,1/5,4.59%,ATG14
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.756296179869573,-1.2073672447385162,0.37254901960784315,1.0,1.0,2/5,8.30%,CAV1;FLOT1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7014455993445637,-1.2072507990050934,0.24444444444444444,1.0,1.0,2/9,6.90%,IRF4;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7605309025495862,1.2070351951944438,0.1875,0.9061625497620157,1.0,5/8,22.68%,IL23R;NFKBIZ;NFKBID;CARD9;IL23A
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7307425302417997,1.206970326737937,0.24074074074074073,0.9055263992395199,1.0,1/7,4.65%,SLC35G1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7766196038248407,1.206933195771877,0.29508196721311475,0.9047890665856512,1.0,4/6,21.17%,LYN;BLK;GREM1;ENPP3
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.6869757854500007,-1.2065287598420342,0.23076923076923078,1.0,1.0,2/6,12.85%,ASS1;MAPK7
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7004012632179231,1.2065138894593026,0.30357142857142855,0.9058071650513615,1.0,5/8,14.24%,SYK;FER;LYN;BLK;ADGRE2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.707477996571396,1.2059891979134176,0.30357142857142855,0.9073730276977006,1.0,2/10,8.64%,GPR33;C5AR2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.5849368540913061,1.2059343142112038,0.19642857142857142,0.9066233041387897,1.0,5/30,13.23%,F2;HIF1A;TICAM1;NLRP7;ABCD2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6634723276451652,1.205772084534425,0.21568627450980393,0.9064366695881194,1.0,11/27,17.23%,IGF1;SGCZ;MYOF;SLC8A1;MEGF10;MYH11;ANK2;BIN1;DMD;VEGFA;ALPK3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8115479279822914,1.2054071691926567,0.2037037037037037,0.907155555292626,1.0,2/5,10.57%,LLPH;AUTS2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.6567570938611327,-1.2053565122895178,0.1875,1.0,1.0,1/17,0.94%,GUCY2C
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6343551361740667,1.2051711502945461,0.2830188679245283,0.906642406592138,1.0,3/19,6.51%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6343551361740667,1.2051711502945461,0.2830188679245283,0.906642406592138,1.0,3/19,6.51%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.7990845263499364,1.2044727170051266,0.2727272727272727,0.9086042330762681,1.0,1/7,3.30%,HAS2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.762872956508346,-1.204411584174745,0.3,1.0,1.0,2/5,13.37%,PRKCD;PRKCH
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.49429701370385326,1.2043315955596428,0.08928571428571429,0.9083657236698219,1.0,23/123,12.16%,NXPH1;LRRC3B;LSAMP;RIT2;GRM3;LRRC4C;NEGR1;KCNC2;GFAP;CADM2;PENK;NPY;RAB3C;NRXN1;SYNPR;OLFM3;ATXN1;GRM5;LRRTM3;ADGRB3;SCN2B;PAK5;TMEM196
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.48534730025291795,-1.2036817950715628,0.17142857142857143,1.0,1.0,8/82,10.29%,NTRK1;PM20D1;CD200R1;CRLF1;FOXQ1;WFS1;NRBP2;TYRO3
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7810893291025373,-1.203340912331093,0.24390243902439024,1.0,1.0,2/5,12.16%,TRAIP;TEX264
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7388949465464727,1.203137245109855,0.2553191489361702,0.9109562188719882,1.0,3/8,16.64%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7388949465464727,1.203137245109855,0.2553191489361702,0.9109562188719882,1.0,3/8,16.64%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7388949465464727,1.203137245109855,0.2553191489361702,0.9109562188719882,1.0,3/8,16.64%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4493641152061915,1.2030886516212864,0.08064516129032258,0.9102737790231777,1.0,67/354,15.01%,VEGFC;ATP6V0D2;IGF1;SYK;FLT1;FGF10;HGF;IRS1;EPHA7;FGFR1;BLNK;IRS4;NRG1;FGF2;FGFR3;ERBB4;ROR1;SOCS2;ANGPT1;EFNA5;TCIRG1;HNRNPH1;DOCK1;MUC20;FLT3;MAPKAPK2;EPHA8;MAPKAPK3;PDGFRA;ITGAV;EPHA5;FOXO1;GAB1;EPHB4;FER;EPHA3;GALNT3;PDGFC;FRK;CLNK;EFNA2;MTSS1;SHOC2;PIK3CA;EFS;FGF17;PTPRT;NUS1;FGF5;CASS4;LYN;MPZL1;EFNB2;HAP1;ATP6V0A4;LCK;NCK2;BLK;PXN;TIAL1;FLRT2;KLB;BCAR1;SOS1;SH2B2;IGF1R;ATP6V0B
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.7688807579003007,-1.2029477391467194,0.30434782608695654,1.0,1.0,2/5,4.98%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5592440499021352,1.2026668746916305,0.2222222222222222,0.9112597890141583,1.0,14/38,24.62%,MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;ARHGEF6;IRAK1;MAPK10;ADORA2B;TAB3;TAB1;RIPK2;GPS1;MAP4K3
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.7004021431617925,1.2026227907912126,0.2553191489361702,0.9105784512521136,1.0,3/9,20.89%,NXF5;HNRNPA2B1;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6708597479484504,1.2025560133681998,0.23076923076923078,0.9099489383410208,1.0,4/13,9.97%,GRM3;ADGRV1;DRD3;GNAI3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7638577130230766,-1.2025326174781892,0.24489795918367346,1.0,1.0,2/6,8.89%,CCBE1;ADAMTS3
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6460330822405388,1.2017495070796478,0.22580645161290322,0.9122415548722468,1.0,1/14,1.00%,TIMELESS
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6166940532332841,1.2017041569098308,0.16,0.9114984331003019,1.0,6/23,16.99%,SEMA5A;SEMA6C;DSCAM;SEMA3E;SEMA6D;VEGFA
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.7653123388928686,-1.2016234336087352,0.36585365853658536,1.0,1.0,1/5,3.60%,AGBL1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.41879624939920074,1.2012019421965552,0.06349206349206349,0.9129429361040091,1.0,92/604,13.47%,VEGFC;IGF1;ACE2;FLT1;FGF10;ADRA1A;TIMELESS;CDKN2C;SMAD6;IRS1;EGLN3;GNRH1;FGFR1;TGFBR1;RUNX1;SIRT1;BOK;ITGAX;NRG1;FGF2;FGFR3;IL4;ERBB4;MYC;DUX4;PTGFR;HAS2;KAT2B;TCIRG1;IL7R;CDKN2A;KSR1;PRMT1;F2R;CCN6;STAT5A;TENM1;BMP2;SSTR3;SIX4;KANK2;HCLS1;SMYD2;FLT3;WWTR1;RELA;ST18;DPP4;DNAJB2;FBXO5;PDGFRA;ITGAV;POU3F2;FER;LIFR;P3H2;HDAC2;CDCA7L;PDGFC;DLC1;FRK;CBFA2T3;TOB1;TP53INP1;IL15;TMIGD3;PTPN14;ITGA1;PROX1;RNF139;ARID2;FGF17;MAGI2;TMEM115;CTBP2;SINHCAF;EZH2;RPS6KA2;FGF5;PTPRK;LYN;EFNB2;TRAPPC14;MVD;BMPR1A;CNOT6L;HP1BP3;NCK2;MLXIPL;RAB33B;GREM1;PML
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6614159308413604,-1.2011720995939914,0.3170731707317073,1.0,1.0,2/9,13.39%,DRD2;SHANK1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.6835097232133946,1.201083480384067,0.2727272727272727,0.9126524519244736,1.0,5/13,22.32%,NPY;LHX6;PTEN;RAPGEF2;MAP2
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.6362051195747722,1.2005753537927955,0.2641509433962264,0.9131504188665729,1.0,8/17,27.96%,PRSS3;TCN2;ABCD4;TCN1;LMBRD1;CBLIF;MTR;MMAB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.6362051195747722,1.2005753537927955,0.2641509433962264,0.9131504188665729,1.0,8/17,27.96%,PRSS3;TCN2;ABCD4;TCN1;LMBRD1;CBLIF;MTR;MMAB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7835641728806328,1.200570963370232,0.23333333333333334,0.9122350201245853,1.0,4/5,17.56%,HIF1A;RBPJ;VEGFA;NFE2L2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6876799868338658,1.2000106189427244,0.2777777777777778,0.9137838266053936,1.0,5/11,21.98%,RENBP;UAP1;GNPDA2;GFPT1;GNPNAT1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6348387093943757,-1.199985091314105,0.22641509433962265,1.0,1.0,1/15,0.27%,TERT
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.781847486534804,1.199932548674514,0.2727272727272727,0.9132941909430452,1.0,1/6,1.96%,GSTM2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.5086250371964854,1.1998779187323658,0.1346153846153846,0.9125935123935845,1.0,11/93,10.91%,SYK;TGFBR1;RUNX1;RAPGEF3;NRG1;LRP4;NRXN1;NEUROD2;SNCA;FRMPD4;LMAN1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.503576265951579,1.1995015129321196,0.1111111111111111,0.9134269293738626,1.0,27/100,22.93%,SIPA1;CDKN2C;SIRT1;ENPP1;FGFR3;CDKN2A;CDKN2AIP;NAIF1;DNAJB2;SERTAD2;GNG4;FBP1;PML;SMAD4;DACT3;ACVR1B;FRZB;NOTCH2;SMARCA2;MT1M;DCBLD2;BMPR2;ST7L;HSPA1A;TP53;ADAM15;PNPT1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.6707935289125218,1.199473453230236,0.2222222222222222,0.9127026549005001,1.0,5/16,14.15%,MYC;ARID2;SMARCD3;SMARCD2;ARID1A
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5785931786599999,1.1994245549412264,0.26666666666666666,0.9120047333333229,1.0,1/35,0.83%,CDC14A
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.7166996600385225,-1.1992923314530877,0.2916666666666667,1.0,1.0,1/8,4.59%,ATG14
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.7455285030652987,1.1991268911719852,0.2535211267605634,0.9123889889649087,1.0,2/11,8.03%,ASF1B;ASF1A
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7731788804041951,-1.1989782495617582,0.3111111111111111,1.0,1.0,1/6,6.81%,ST6GALNAC2
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.7834832200873184,1.1987354228916922,0.23076923076923078,0.9135170430649701,1.0,2/5,18.27%,SLC30A2;SLC30A4
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.7522116963392824,-1.1987142630152847,0.3111111111111111,1.0,1.0,1/7,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7386890430052356,-1.1986529763633351,0.26666666666666666,1.0,1.0,5/9,25.06%,MAP1LC3B2;BECN1;GABARAPL1;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7386890430052356,-1.1986529763633351,0.26666666666666666,1.0,1.0,5/9,25.06%,MAP1LC3B2;BECN1;GABARAPL1;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.7080555161468354,-1.198647836947108,0.30434782608695654,1.0,1.0,2/8,1.35%,NUPR1;TEK
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4925095824482747,1.1985456312406302,0.1568627450980392,0.9134526771168261,1.0,17/115,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;FGF10;HGF;PRRX1;ADGRL4;GFAP;PPARG;COL6A2;PLSCR4;POSTN;SLC8A1;BGN;PDGFRA;OLFML3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5849171514845733,1.1984724805758664,0.22916666666666666,0.9128930654234862,1.0,7/31,16.31%,UNC5C;EPHA7;SEMA6C;ITGAV;LGR6;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.6546917153976249,-1.1981780182054456,0.2708333333333333,1.0,1.0,2/16,6.34%,OAS3;OAS1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.7623674381544778,1.1981503298927112,0.26,0.9126300444415322,1.0,1/9,0.73%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.7623674381544778,1.1981503298927112,0.26,0.9126300444415322,1.0,1/9,0.73%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7412579398334214,1.1979460632435504,0.22,0.9124927615637399,1.0,5/9,17.42%,SCRIB;RAMP3;SNCA;VAMP3;RAB29
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.810890477598516,1.1978151619375268,0.25,0.9120967406571053,1.0,4/5,17.57%,CALCR;RAMP3;IAPP;CALCRL
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.7340512053959125,1.197711778105166,0.265625,0.9116645581695565,1.0,2/7,6.93%,SNAI1;RBPJ
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.5050491729965978,1.197656719773852,0.12962962962962962,0.9109747595126151,1.0,25/101,23.41%,MITF;MATN1;CD40;LLGL1;TEAD2;SLC7A9;LIN7A;MAGI1;CD74;RANBP9;PML;PICALM;CLDN14;VAMP3;IL2RB;CD247;MNAT1;CD2AP;WASL;GPAA1;PARD3;TP53;IL1RAP;WIPF1;SKAP2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.6425150851949988,1.197556009732858,0.2641509433962264,0.910618367579023,1.0,5/11,26.05%,BMP2;BMPR1A;BMP4;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.8448248867582536,1.197509306779354,0.21818181818181817,0.9100047271719246,1.0,3/5,15.23%,SIRT1;NR1H4;DGAT2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8226389559368181,1.1974841051243172,0.2,0.90925733621799,1.0,3/6,14.38%,ABHD3;OLAH;OXSM
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.7924463914084228,1.1974523255214269,0.2727272727272727,0.9085359725317695,1.0,5/7,17.27%,STARD4;SIRT1;PROX1;NR1H4;STAR
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7441956546397154,1.197333816731522,0.2037037037037037,0.9082447116019144,1.0,3/9,13.44%,PRDM14;PRMT1;NR1H4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5103040972040476,-1.197258939466838,0.17391304347826086,1.0,1.0,9/91,6.59%,LRP10;EHF;RAC2;OAS3;FAM3D;MVP;IER3;OAS1;LAMB3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5742010381476967,1.1971470959029697,0.18333333333333332,0.9081742630440934,1.0,4/38,6.55%,IGF1;CCL5;PPARG;CCN4
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5517072854588227,1.1971127369027794,0.2,0.9074194987579107,1.0,9/43,17.85%,ACE2;SLC8A1;ANK2;NPPA;ATP1A2;NPR2;CORIN;RYR2;ASPH
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.6752198393692196,-1.1968786522903592,0.3023255813953488,1.0,1.0,3/9,5.21%,DRD4;CBARP;DRD2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7230724251800659,1.1968473841878617,0.2,0.9073988618490878,1.0,3/10,5.62%,DERL3;INSIG1;UBE2J1
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8428394261909768,1.1965675991135858,0.2682926829268293,0.9078295891181325,1.0,1/5,1.35%,C3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.5629553838108621,1.1965613465391691,0.2631578947368421,0.9069190278451956,1.0,2/45,3.07%,ESPL1;SNX18
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7273265420516684,1.1965339987762553,0.234375,0.9061685464170726,1.0,2/10,5.57%,ITGAX;MYRF
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.602598186387617,1.1964102442473217,0.20754716981132076,0.9057235994912668,1.0,2/34,1.52%,IGF1;HGF
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7793269945698122,1.196350151996493,0.2909090909090909,0.9042173865102238,1.0,4/8,15.34%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7793269945698122,1.196350151996493,0.2909090909090909,0.9042173865102238,1.0,4/8,15.34%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7534612957209583,1.1963494411486872,0.2830188679245283,0.9033149739488364,1.0,2/6,6.06%,BMP2;SOX6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.7523853991438185,1.196202557466736,0.3389830508474576,0.9030805638161943,1.0,1/6,11.80%,CORO1C
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7453836852946585,1.1958964432491002,0.2037037037037037,0.90343955578513,1.0,4/6,16.22%,FGF10;OPRK1;EPB41;SGK1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.7410077540438499,1.1958340091171271,0.21818181818181817,0.9027823844897884,1.0,3/9,19.18%,ODC1;SLC22A3;SMS
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4687187179996822,1.195749282876733,0.1111111111111111,0.9022593629606223,1.0,58/182,24.29%,LGALS9;TNFRSF19;SIRT1;ROR1;CD40;CANT1;F2R;SLC35B2;TIFA;MID2;RORA;PELI2;RELA;ESR1;PELI1;PLCG2;TICAM1;PPM1A;TAB2;CD74;HSPB1;ZFAND6;TSPAN6;CPNE1;NR1H4;TNIP3;TANK;EEF1D;IRAK1;CARD16;TRIM52;TAB3;GPRC5B;ZDHHC17;TNFRSF10B;F2RL1;LGALS1;NDFIP2;TFG;RIOK3;BIRC3;SLC20A1;ZDHHC13;C18ORF32;ATP2C1;GPR89A;FADD;CARD9;PIM2;IKBKB;ANKRD17;RIPK2;TRIM68;CASP10;MIER1;IKBKE;WLS;TRAF5
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7998759851899618,1.1957171239954716,0.3114754098360656,0.9015443455227024,1.0,3/6,19.50%,NRG1;MESP1;HDAC9
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5844536372808511,1.1955940677093542,0.2037037037037037,0.9011320642354116,1.0,11/34,17.72%,WNT4;ADGRV1;BMP2;ACVR2A;SLC8A1;FBXO5;BMPR1A;MEF2C;GPM6B;ANO6;BMP4
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6233587793454337,1.195528640007854,0.25,0.9004677443340569,1.0,5/28,5.49%,IGF1;FGFR3;AGR2;STAT5A;SIX4
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5899343913991897,1.1952974446130509,0.24528301886792453,0.9005745851579464,1.0,6/30,11.78%,RUNX1;ESR1;LATS1;UBA5;KCTD6;NCOA2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.7705393917718325,1.1952031945584698,0.2923076923076923,0.9000323001931531,1.0,1/6,2.87%,FGF2
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.6236612664100086,1.1949722035375983,0.24528301886792453,0.9001273550904565,1.0,1/18,3.00%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7066062773354091,1.194932533500148,0.2708333333333333,0.8994066841404923,1.0,2/9,4.85%,ADRA1A;F2R
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.6348135128352309,1.1948633330528862,0.24561403508771928,0.8987113973939764,1.0,6/21,16.75%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.6120790415914834,1.1942091996908841,0.25925925925925924,0.9008423007364281,1.0,4/16,12.65%,DLGAP5;KAT2B;RBPJ;NOTCH3
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6889901174854746,-1.1938468637476032,0.17391304347826086,1.0,1.0,2/12,9.10%,WTIP;WWC1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6769884248736541,1.1937719735397194,0.21052631578947367,0.9016775674764133,1.0,3/15,13.23%,F2;NLRP7;ABCD2
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.6850633506315978,-1.193580339559323,0.34,1.0,1.0,2/10,6.90%,TNFSF18;SLC11A1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.47558274309535814,1.1933262903221002,0.1694915254237288,0.9027023282082307,1.0,21/122,12.17%,LHFPL3;PCDH15;NXPH1;LRRC3B;C1QL1;SLC35F1;LRRC4C;GFAP;TMEM100;OLIG1;CSPG4;OLIG2;PMP2;VCAN;PDGFRA;MEGF10;GPR17;ANK2;LRRTM3;ADGRB3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.6886641425150446,1.193176506243233,0.21739130434782608,0.9024123023552927,1.0,1/13,2.44%,ZBTB7B
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.7540510897823858,1.1931289957328604,0.23529411764705882,0.9018128583733543,1.0,1/7,5.09%,GCH1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.7863151630431365,1.192943972428661,0.2391304347826087,0.9008554778216801,1.0,1/6,5.12%,STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.7863151630431365,1.192943972428661,0.2391304347826087,0.9008554778216801,1.0,1/6,5.12%,STAT5A
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6279900041087013,-1.1926980512933796,0.2708333333333333,1.0,1.0,2/15,3.23%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.713906560707798,1.1925956989762314,0.2916666666666667,0.901804703881096,1.0,3/7,11.84%,SIRT1;PLCG2;CD74
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5578568420628601,-1.1923595579521344,0.2,1.0,1.0,1/30,0.27%,TERT
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.80662092408838,1.1923569460686134,0.2962962962962963,0.9021107716386262,1.0,1/5,3.40%,HIF1A
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6743556677395233,-1.1923405035156533,0.2857142857142857,1.0,1.0,5/12,9.32%,NUPR1;ALOX5;MBTPS2;CLU;WFS1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7388283810528624,1.1923277926651255,0.25,0.9013247190897472,1.0,2/9,10.48%,ACADS;ACADM
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.6422000162177541,1.1919977154346388,0.2,0.9021758867286432,1.0,2/14,10.39%,IL4;PAXIP1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.7788748750351917,1.1916422371613147,0.25,0.9028477764550119,1.0,2/8,9.91%,IL4;H2BC21
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7411848058945806,1.1915640419027036,0.30357142857142855,0.9023590453840189,1.0,3/10,10.72%,F2;BMP2;BIN1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.6986703826975025,1.1914984221979559,0.3333333333333333,0.9017176284176599,1.0,2/10,11.62%,HIF1A;FBXO7
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.46092014545199833,1.1914689907637621,0.1509433962264151,0.9009357774294859,1.0,32/175,13.56%,IRGM;SYK;ZDHHC11;KLRD1;C3;PPP1R14B;SHMT2;IL4;PPARG;CD40;GCH1;TIFA;IL23R;MID2;F12;STING1;RELA;PLCG2;FER;TLR2;PTX3;HMGB1;FRK;SNCA;H2BC21;MSRB1;CD74;LYN;LCK;BLK;PML;TRIM26
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.5531664297695378,1.1913427565103667,0.19672131147540983,0.9006272550917102,1.0,6/55,8.10%,IGF1;PRR5L;TENM1;ACHE;PCM1;UNC13B
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6940221304506269,1.1909354793666982,0.2545454545454545,0.9014859295961377,1.0,6/8,30.26%,MAPKAPK2;CX3CR1;CD274;FOXP1;SIRPA;CD47
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6749989599192682,-1.1909173373713922,0.2903225806451613,1.0,1.0,2/12,5.61%,RNF8;RECQL5
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.7820377282801693,-1.1905849427654203,0.29545454545454547,1.0,1.0,2/5,12.89%,DUOX1;CYBA
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.572048605649679,-1.190443113054341,0.20454545454545456,1.0,1.0,4/31,1.82%,P2RY10;SPON2;ICAM3;SIRPG
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.8047693008939169,1.1902980585169645,0.29411764705882354,0.9033200494760046,1.0,2/5,10.57%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.680861117694288,1.1902721233368663,0.25396825396825395,0.9025043917330382,1.0,7/18,18.48%,CTCFL;PAXIP1;AUTS2;SMAD4;BCOR;MYB;CTNNB1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7847070896311124,1.190181185450261,0.21428571428571427,0.9021367977067284,1.0,2/8,4.07%,C3;RAB31
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7219936195069534,-1.190068892666563,0.3404255319148936,1.0,1.0,2/6,8.30%,CAV1;FLOT1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.7801938800949899,-1.1900401398298668,0.23255813953488372,1.0,1.0,2/5,3.48%,NOXA1;RAC2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.48186171894470603,1.1898026314426697,0.11864406779661017,0.9029437420455267,1.0,25/147,9.99%,MXRA5;MRGPRF;ACTG2;CXCL12;LAMA4;ITGA8;SMOC1;PRRX1;PRKG1;ADGRL4;KAT2B;ANGPT1;RRAD;CCDC80;MSRB3;PLSCR4;POSTN;ZBTB44;BGN;PDGFRA;MYH11;OLFML3;ADAMDEC1;PDE4DIP;ITGA1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.6989373007599868,1.189684553041136,0.2982456140350877,0.9025177988268892,1.0,2/9,7.17%,ASIC1;GNAT3
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6041543922667524,-1.1896183895606398,0.2826086956521739,1.0,1.0,2/19,2.04%,TAFA3;SHCBP1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.6855087767189225,-1.189527960740773,0.3023255813953488,1.0,1.0,2/13,7.76%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6299521555550289,-1.1894443580066503,0.24528301886792453,1.0,1.0,2/14,2.27%,ZC3H12D;DND1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6826926744742621,1.189427279145273,0.2807017543859649,0.9027487530215057,1.0,5/14,12.34%,CSPG4;VCAN;BGN;DSEL;CSGALNACT1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4553807947816343,1.189285773206195,0.11290322580645161,0.9024993836741944,1.0,50/223,17.94%,CXCL12;NRTN;SEMA5A;UNC5C;EMB;EPHA7;EFNA5;LLGL1;SPTBN5;DCC;LGI1;ROBO2;ARTN;NEFH;SEMA6C;UNC5D;EPHA8;NRXN1;CNTN6;EPHA5;GAB1;EPHB4;EPHA3;MYPN;PLA2G10;EFNA2;DSCAML1;PIK3CA;AUTS2;DSCAM;GFRA1;CTNNA2;EFNB2;RANBP9;NOTCH3;LGR6;NTNG2;PTEN;SOS1;ROBO3;SEMA3E;KLF7;PIK3CD;RET;SEMA6D;GAB2;NOTCH2;CNTN4;L1CAM;CNTN2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5601878653947612,1.1892852467632584,0.17391304347826086,0.9016307605907734,1.0,12/32,23.55%,KLKB1;HGFAC;F12;PRSS3;VSIR;ASPH;PERP;CD5L;LGMN;FADD;RIPK2;BAD
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.7030215289870018,1.1891352704563034,0.2708333333333333,0.9014764005633774,1.0,2/10,7.86%,TGFBR1;PDGFRA
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.7578890949743504,1.1883044732328771,0.2222222222222222,0.904018251377357,1.0,1/5,8.82%,ZNF274
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.5627773059713457,-1.1880787208159271,0.2222222222222222,1.0,1.0,2/25,3.82%,RFX6;HLA-DRB1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6751020824932917,1.188057655417525,0.2830188679245283,0.9043049544946877,1.0,1/10,3.29%,ZBTB1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5881479047548476,1.1875349441387948,0.22448979591836735,0.9056743946898814,1.0,8/31,13.80%,SIRT1;BOK;FHIT;ZNF385B;DYRK2;TP53BP2;PML;BCL3
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.6919684992545266,1.187420293806574,0.21818181818181817,0.9054236561609756,1.0,1/11,5.19%,BMP2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.4661962993786921,1.1873546194348163,0.14814814814814814,0.9048478708488201,1.0,31/168,15.90%,LAMA4;HS3ST5;SMAD6;ALDH1A1;IL4;LRP4;F2R;BMP2;BTN2A2;IL17RD;RBPJ;TNNT1;MAP2K6;ELAPOR2;ZNF706;RPS6KA4;NOVA1;MARVELD3;IL15;ARRDC3;IL18R1;TBX18;LNPEP;CORO1C;NR1H4;MEF2C;NR1H3;PTEN;KLF7;VASN;TRPV3
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.6839570360052164,-1.1872824416908843,0.2631578947368421,1.0,1.0,2/9,10.68%,TICRR;CDC6
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5835722843240483,1.1868587871030776,0.1896551724137931,0.9059224934131361,1.0,6/27,8.13%,SIRT1;ENPP1;RORA;WWTR1;ZFP36L2;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5284550198611571,1.186790245652078,0.21818181818181817,0.9054169539983657,1.0,21/66,17.43%,SMAD6;VWC2L;FGF2;IL4;NEDD4;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;DAND5;SMAD1;VWC2;BMPR1A;GREM1;SMAD4;SPRY3;SPART;LRP2;SMAD5
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7539019203514783,1.1865874486986194,0.2903225806451613,0.9053297155434903,1.0,2/7,17.73%,BCL3;CARD16
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7680508429103742,1.1863860272526754,0.23214285714285715,0.9054742758311095,1.0,1/6,4.93%,FYCO1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.7200670268136159,1.186048323589834,0.27450980392156865,0.906069813801738,1.0,2/9,4.85%,TMEM100;F2R
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5056308090953326,1.185971242264713,0.16666666666666666,0.9055313795027389,1.0,19/83,13.00%,ADRA1A;LGR5;DRD5;CALCR;ADGRL4;PTGFR;RXFP2;GPHB5;ADGRG4;ADGRL2;ABCA1;GPR12;GPR26;RAMP3;DRD3;GPR161;ADGRB3;ADGRG6;ADRA2C
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.6754666150478046,1.1858803656070698,0.1774193548387097,0.9050863575898469,1.0,2/16,5.57%,PRDM8;MYRF
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5018613074541944,1.1858131919198693,0.15254237288135594,0.9044921917845021,1.0,27/87,23.85%,IGF1;TGFBR1;CDKN2AIP;LGI1;SYT1;SLC44A4;RIMS2;EXOSC4;ZNF639;DBN1;DERL2;L1CAM;CDKL5;RPS6KA1;SYT17;MACF1;SLC25A33;ADAM10;SMURF1;ADNP2;CPNE9;BRAT1;GOLGA4;NCBP1;EDN1;H3-3A;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.7789302160960605,1.1856941251288566,0.2711864406779661,0.9040720536210796,1.0,2/5,12.90%,ANGPT1;TJP2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5930705240882242,1.185633506899094,0.18333333333333332,0.9035605858981687,1.0,7/26,12.90%,MOB1A;WWTR1;TEAD2;LATS1;SAV1;AMOTL1;TJP2
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.7825723712081489,1.1853247079193157,0.3275862068965517,0.9040279990013044,1.0,3/6,17.72%,FGFR3;MEF2C;BMP4
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5905953433018525,1.1853049812987917,0.3114754098360656,0.9032531795522857,1.0,9/20,23.21%,SP1;RELA;LRRTM3;LYN;RANBP9;PICALM;CASP3;ABCA2;GSK3A
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.5422637529432001,1.1850961318304563,0.22413793103448276,0.9032491925155418,1.0,7/49,5.84%,PNP;LGALS9;IL4;CCL5;ZBTB1;IL23R;CCDC88B
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6085328946583488,1.1850930011116858,0.21875,0.902430682759243,1.0,3/28,8.78%,RBM20;PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.7955103887531019,-1.184642047612205,0.3,1.0,1.0,1/5,2.94%,FGF1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.4706457341481984,1.1844613335443557,0.2037037037037037,0.9038257741518051,1.0,21/161,17.76%,IRGM;SWSAP1;IGF1;PYHIN1;SYVN1;HIP1;TELO2;ANK2;TBL1X;CHEK2;ZNF207;BAG2;PTEN;ATF7IP;MTMR9;PRKRA;CREB1;MARCHF7;CCNH;NAA16;GTSE1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.5953105683484966,1.1844361935258798,0.27586206896551724,0.9030884182873674,1.0,1/25,0.38%,GATA4
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7185310124318939,-1.1843536487241884,0.23684210526315788,1.0,1.0,4/7,17.25%,OVGP1;CHI3L1;AMDHD2;CHIT1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.5730202708276473,1.1842257757143149,0.2222222222222222,0.9032333194540044,1.0,10/51,12.42%,SMAD6;TGFBR1;RAB31;LTBP2;BMP2;WWTR1;PPM1A;UBE2D3;SMAD1;BMPR1A
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4964260754138684,1.1842024571079357,0.1875,0.9024750500674877,1.0,40/163,16.66%,DACH1;EPHA7;PNOC;NRG1;SLC35F1;EDIL3;CLSTN2;CADM2;ISOC1;NLGN1;SLC17A6;CNTNAP2;TMEM200C;KCNH7;RALGPS2;NHLH2;SYT1;ZDHHC22;ELAVL2;ACHE;FUT9;MEGF10;CNRIP1;LINGO2;OLFM3;NOVA1;FAM171B;SMAD1;ANK2;ADGRB3;LZTFL1;PAK5;NOL4;MAPK8;GPM6B;ZNF536;TMEM170B;NBEA;RIMS4;DNM3
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6134981597253983,1.184158511838191,0.30357142857142855,0.9017867160756731,1.0,6/22,16.65%,ROBO2;TLR2;DLC1;CORO1C;PTEN;PHLDB2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6378619694377358,-1.184123361891436,0.2564102564102564,1.0,1.0,3/14,8.49%,RPF2;DDX18;FTSJ3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4828101510015338,1.1840706997470307,0.18181818181818182,0.9012479738496446,1.0,18/114,11.56%,F2;CXCL12;VAPB;DRD5;CCL5;CD40;SCGN;SLC35G1;TRPC4;CASR;SLC8A1;SMDT1;MCUB;SLC24A2;DRD3;ANK2;MCU;HTR2C
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5880444049095114,1.1839810436679712,0.2857142857142857,0.9009837685553348,1.0,7/27,13.80%,BOK;FHIT;ZNF385B;PAXIP1;TP53BP2;GREM1;BCL3
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6922038667163135,1.1836444156780386,0.23636363636363636,0.9015967991240628,1.0,4/6,29.35%,FOXO1;DNAJC3;EIF2AK3;NFKBIA
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.6569356498211787,-1.1833574253983161,0.30434782608695654,1.0,1.0,1/17,0.27%,TERT
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.7465615716108869,-1.1833053030427343,0.36585365853658536,1.0,1.0,2/5,17.80%,AQP7;AQP1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7763293799701568,1.1831408849394776,0.3018867924528302,0.9028684653766541,1.0,1/5,8.51%,SDC4
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5823554259118592,1.1827725890222722,0.25925925925925924,0.9035922353691654,1.0,14/34,21.23%,SOCS2;ITPKB;PIP4K2A;PIK3C2B;SOCS6;SMG1;IP6K3;PIK3CA;EFR3A;PI4K2B;PIK3CD;PIK3R3;SOCS7;IP6K1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7648198243749015,1.182685432825902,0.2608695652173913,0.9031792207263317,1.0,2/5,13.55%,TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7317784925272225,1.1823987184056424,0.3333333333333333,0.9037311932414296,1.0,2/5,20.09%,OPRK1;OPRL1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5574511764330657,1.1823420875151338,0.25,0.903262153850855,1.0,5/47,4.32%,FGF10;TGFBR1;NRG1;ZBTB1;WNT4
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6123090599029976,1.1821370685090054,0.21052631578947367,0.9034167302009045,1.0,2/17,3.00%,IGF1;CCL5
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6659057394444252,1.18193870234583,0.3333333333333333,0.9033560901296612,1.0,1/12,0.56%,PNP
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7757469470277587,1.181640784753842,0.38095238095238093,0.9038832412495402,1.0,2/6,16.03%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5114514299929507,1.181445818185074,0.18867924528301888,0.9038335713356317,1.0,16/84,10.99%,BOK;SHMT2;ZBTB1;KCNC2;EHD1;PRMT1;C9;TIFA;UGDH;STING1;MAT2A;VSTM5;SNCA;RS1;WDCP;MCU
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5495888666489129,1.1813788539931904,0.21212121212121213,0.9033214923332327,1.0,16/55,20.25%,IGF1;ACHE;UNC13B;TLR2;MCU;BLK;MYRIP;MYOM1;CAPN10;GCK;CD2AP;GOLPH3L;PTPN23;ACSL4;F2RL1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6234296766443567,-1.1813405970036914,0.2391304347826087,1.0,1.0,1/15,0.27%,TERT
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.5249412089644014,1.181281234234248,0.2,0.9028779837196973,1.0,10/67,12.89%,SYK;LGALS9;F2R;MAPKAPK2;PLCG2;TLR2;C5AR2;HMGB1;CD74;IRAK3
prerank,MSigDB_Hallmark_2020__Apical Surface,0.6058915672882765,1.181100208130292,0.24242424242424243,0.9027843451185582,1.0,13/37,21.14%,EFNA5;ADIPOR2;EPHB4;PLAUR;LYN;ATP6V0A4;HSPB1;IL2RB;SCUBE1;GAS1;ATP8B1;DCBLD2;ADAM10
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6946962851551235,1.1810291645376803,0.2698412698412698,0.9022521616928515,1.0,3/11,10.19%,FGF2;ITPKB;IP6K3
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5672965831209653,1.1807562423590368,0.2833333333333333,0.9026762591031396,1.0,8/45,8.39%,VEGFC;SEMA5A;RSPO3;FGF2;ANGPT1;NRARP;BMPER;EPHB4
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7580764024773878,1.1807257555970971,0.26153846153846155,0.9019542766104227,1.0,2/6,7.38%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7921412076806481,1.1805348356527623,0.3125,0.9019627989910924,1.0,3/6,20.72%,SNCA;NDFIP2;PPIF
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.705631464737411,-1.1804588594326944,0.325,1.0,1.0,2/11,7.76%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7665737316938968,1.1801055672597154,0.30612244897959184,0.9028230889827515,1.0,3/9,13.05%,NEDD4;ATP1A2;HECW2
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7732926891247375,1.180044757896983,0.34615384615384615,0.9022933223065972,1.0,1/5,4.67%,DCC
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5565772831478248,1.1799863491911098,0.16666666666666666,0.9017533442245073,1.0,10/38,16.54%,LDLR;ODC1;SPOP;SPOPL;ZDHHC2;CHMP6;PLAUR;CHEK2;MAPK8;PM20D2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.6917502476913479,1.1798660393405827,0.26785714285714285,0.901449071276115,1.0,3/12,2.68%,CXXC4;SMAD6;FZD5
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7003375896282762,-1.179333582925611,0.32142857142857145,1.0,1.0,2/7,6.54%,SFRP1;CYP24A1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.48584816450656604,1.179007473262202,0.14545454545454545,0.9041156388779581,1.0,28/103,23.21%,SIPA1;CDKN2C;SIRT1;ENPP1;CDKN2A;DCC;CDKN2AIP;NAIF1;DNAJB2;SERTAD2;GNG4;FBP1;PML;SMAD4;DACT3;ACVR1B;KIAA0319;FRZB;DIP2B;SMARCA2;DCBLD2;BMPR2;ST7L;HSPA1A;TP53;MAP2;ADAM15;GSK3A
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7249303434021206,-1.1789516576521275,0.30434782608695654,1.0,1.0,1/6,4.50%,ARG2
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7467771713146902,-1.178903843492242,0.3142857142857143,1.0,1.0,1/6,6.08%,KCNE1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.649725587941043,1.178812901174018,0.3137254901960784,0.9040886609306693,1.0,4/11,11.43%,NLGN1;EPS8L2;EPS8;DEF8
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.6239709477588515,1.1785420025467772,0.3103448275862069,0.9042512141753682,1.0,1/16,1.14%,CSTA
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.7876103301057497,1.1785138216086875,0.2653061224489796,0.9035560154844469,1.0,1/5,1.60%,ICOSLG
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6659334897990138,1.1779402820878417,0.29411764705882354,0.9053653428393212,1.0,1/11,2.68%,MLC1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.7755809802662821,1.1779055824332094,0.2641509433962264,0.9047259738553621,1.0,1/6,0.57%,SYK
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5997414082416687,1.1778953287137957,0.24193548387096775,0.903932300534283,1.0,10/22,24.24%,THEM5;ELOVL5;ACSBG1;DGAT2;FAR2;TECR;ACSL4;ACSL5;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.538401559921969,-1.1778108462855754,0.2765957446808511,1.0,1.0,12/61,12.55%,SELE;NLRP1;BST1;PTGES;IL1RL2;ALOX5;AHSG;HCK;DHX58;TMSB4X;AKNA;WNT5A
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6990857920778873,1.1776790358346945,0.25862068965517243,0.9040165887130317,1.0,2/12,5.19%,IGF1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6935851913338604,1.177625775497467,0.28,0.9034467102238429,1.0,2/10,4.82%,MYCN;LIN28A
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.47770486413385793,1.176363940095903,0.10344827586206896,0.9078061829153656,1.0,23/119,11.46%,MXRA5;GATA4;MRGPRF;IGF1;CXCL12;ALDH1A1;ESRRG;NR5A2;ADGRL4;MAFB;PLSCR4;POSTN;FAM114A1;BGN;PDGFRA;OLFML3;SLC22A3;LIFR;PRICKLE2;EFS;ACSBG1;EDNRA;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6357557211367741,1.1762357512586459,0.2549019607843137,0.907532639952708,1.0,2/16,5.19%,RUNX1;BMP2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.43297796497722496,-1.1757130782496912,0.12121212121212122,1.0,1.0,23/190,7.34%,CD44;MGP;SPON2;TEK;COL4A2;ENTPD2;COL5A1;TNXB;PRKCD;COL4A1;NR4A1;INMT;OAF;FBLN2;COL6A3;COL1A1;PCSK6;ERCC1;PTCH1;MFAP5;DAB2;LAMB1;SPARC
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7757643799015576,1.1755027109846088,0.3508771929824561,0.9095810827294288,1.0,1/6,5.12%,STAT5A
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5971574823132819,1.1752531327089077,0.265625,0.909770299070809,1.0,3/25,6.08%,SMYD1;METTL21C;SMYD2
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.432095561290818,-1.1751537742774467,0.1794871794871795,1.0,1.0,23/251,7.34%,CD44;COL24A1;COL23A1;ICAM3;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;ACAN;COL6A3;AGRN;MATN4;ADAMTS1;COL1A1;TGFBI;ITGA9;COL11A2;COL28A1;LAMB3;MFAP5;LAMB1;SPARC
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6721354057934261,1.1748281244557792,0.2545454545454545,0.9100264308277705,1.0,4/11,9.97%,GRM3;ADGRV1;DRD3;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6721354057934261,1.1748281244557792,0.2545454545454545,0.9100264308277705,1.0,4/11,9.97%,GRM3;ADGRV1;DRD3;GNAI3
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.49881593799699053,-1.1747428077888897,0.1891891891891892,1.0,1.0,10/92,11.68%,ANKK1;FBXO43;SFRP1;PLK3;ENTR1;PLK4;IHO1;CAV2;BUB1;KIF20B
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5540834349192548,1.1747312172393403,0.2153846153846154,0.9096089249497206,1.0,8/51,14.26%,STK26;SIRT1;HIF1A;PDGFRA;FER;PTPRK;PXN;MAPK8
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.6210475800869337,1.1745780563160213,0.3333333333333333,0.909555328472306,1.0,2/12,2.86%,NDC80;DLGAP5
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5396270707799852,1.1745509790118003,0.19696969696969696,0.9088641376251637,1.0,9/45,17.39%,PBX3;APELA;PCSK5;TEAD2;RBPJ;BMPR1A;RARB;KIT;COBL
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5763230792276236,1.1742521685103346,0.21568627450980393,0.9094374415379707,1.0,7/30,14.86%,CDKN2C;CDKN2A;KANK2;SLFN11;CDK4;PTEN;CDK2AP2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6647419707075206,-1.1739786675023778,0.2857142857142857,1.0,1.0,2/12,10.28%,PARP2;PARP1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.6834923041015233,-1.1738798983302199,0.3076923076923077,1.0,1.0,4/11,20.19%,ZWILCH;SPDL1;TTK;CDK1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7453575093271807,1.1738666757545428,0.3220338983050847,0.9103499289361642,1.0,2/6,16.73%,PRR5L;RICTOR
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.5865664580998464,1.1737016444275779,0.21428571428571427,0.9102191028021924,1.0,1/20,2.18%,SIRT1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.5499655427394179,1.1735926589688341,0.24,0.9098146370354971,1.0,3/35,9.22%,HELB;RIOK2;TSR3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6434103284054611,1.1735735780928693,0.3125,0.9090934905893255,1.0,6/14,23.55%,ASPH;PERP;LGMN;FADD;RIPK2;BAD
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6715779825312873,1.173381162321972,0.29310344827586204,0.9090953722493493,1.0,1/15,0.56%,PNP
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5430572196519707,-1.1733427712417062,0.2765957446808511,1.0,1.0,5/57,8.65%,TRMO;BUD23;CMTR1;FTSJ3;METTL6
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.6930710753486335,-1.173340047206431,0.3111111111111111,1.0,1.0,2/8,6.56%,BST1;OLFM4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6175887468895292,1.1723520404947043,0.26785714285714285,0.9122874871239379,1.0,5/22,7.91%,GATA4;C3;HIF1A;RORA;HPSE
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.7451220724811429,1.172168599270125,0.3111111111111111,0.9122428330780783,1.0,3/5,18.74%,RPS6KA4;HMGA2;RPS6KA5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5853505117475918,-1.17196356537633,0.23255813953488372,1.0,1.0,8/23,23.32%,XPC;PARP1;COPS7A;COPS7B;COPS6;COPS3;COPS5;COPS8
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6996214247281652,1.1719633238085139,0.32142857142857145,0.9125690582017301,1.0,3/9,14.76%,BIN1;LYN;PICALM
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.691473597751836,1.1718620468927883,0.36666666666666664,0.9122627259964569,1.0,2/9,6.02%,FGF2;APELA
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.72428351253044,1.1716901764031713,0.30357142857142855,0.9121964415589022,1.0,1/7,0.38%,GATA4
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6911379089264091,1.1715699659540975,0.34545454545454546,0.9118909914315642,1.0,1/10,3.81%,PPARG
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.6619753067928867,-1.1715227625554798,0.3181818181818182,1.0,1.0,4/13,20.19%,ZWILCH;SPDL1;TTK;CDK1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6269226895375379,1.17143689559077,0.27692307692307694,0.9116186882280627,1.0,5/15,9.13%,ROBO2;ELAPOR2;PCM1;TLR2;PAX6
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.5664918785181048,1.1714148973841336,0.1896551724137931,0.9108800154426834,1.0,12/42,24.03%,NRG1;ITGAV;EPHA3;TLR2;SNCA;NR1H3;PTEN;PLSCR1;PXK;NDFIP2;MCTP1;ABCA7
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5949641775358706,1.1713399230128205,0.21428571428571427,0.9104355422920591,1.0,4/46,8.13%,LGALS9;IL26;MYC;FOXO1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6854937195927997,1.1713364118239615,0.32075471698113206,0.909634216313385,1.0,3/11,5.19%,FGF2;MYC;BMP2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6209481617252015,1.171322538462346,0.3148148148148148,0.9089425996519488,1.0,4/16,18.18%,SLC8A1;SLC9A2;SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7181703929190175,1.1711739980715714,0.31666666666666665,0.9086524973989374,1.0,2/12,4.75%,NRG1;CDH2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.49185320754728806,1.1700283758402246,0.21153846153846154,0.912589162229608,1.0,29/113,21.66%,SMAD6;TGFBR1;SIRT1;GDF6;TMEM100;LTBP2;BMP2;ACVR2A;ZFYVE16;HJV;FOXH1;SMAD1;CGN;SMAD2;PTPRK;BMPR1A;SMAD4;PXN;SLC39A5;ACVR1B;GDF9;SMAD5;BMP4;BMP8B;TGFBR3L;ARRB2;SMURF1;PARD3;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6277880377709999,1.1698845330728327,0.3103448275862069,0.9122855351070236,1.0,3/18,13.05%,NEDD4;TCAF2;HECW2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.473321907773625,1.1697845474809445,0.15789473684210525,0.9120148161681336,1.0,25/121,12.78%,MITF;LAMA4;TYR;RAB38;PRRX1;ENPP1;GNG12;PPARG;CCDC80;BMI1;DOCK1;CSPG4;POSTN;WWTR1;FAM114A1;EPS8;PPFIBP1;ITGAV;PTPN14;PRICKLE2;TNC;HMCN1;PMEL;RASAL2;HSPB1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.7910452970305025,-1.1695945927779392,0.37777777777777777,1.0,1.0,1/5,3.96%,CRACR2A
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.6851836676773257,-1.169504652196696,0.3181818181818182,1.0,1.0,1/7,3.17%,SFRP1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6850867766112062,1.1694888861387571,0.21153846153846154,0.9124452811252245,1.0,6/10,27.74%,FOXO3;SLC25A33;TFB1M;MTERF2;TFB2M;MTERF1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.756633117504736,1.1691741019116457,0.34545454545454546,0.9131980977454678,1.0,2/5,21.90%,PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5836995463855932,-1.1691613013464746,0.2765957446808511,1.0,1.0,4/27,12.55%,OAS3;OAS1;CDC37;WNT5A
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.48892116293658827,1.1691105726610937,0.1694915254237288,0.9125721782996099,1.0,25/119,19.39%,SLC7A11;RAB38;SLC38A4;SLC7A2;LRP1B;SLC38A3;ABCC2;TCN2;SLC22A3;SLC44A4;RAMP3;SLC7A9;ARRDC3;SLC52A1;SLC25A48;SLC15A2;TOM1;SLC3A2;LMAN2L;LRP2;SLC22A5;CALCRL;SLC18A2;SLC7A14;SLC36A1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.6538529787682145,1.1690602847971718,0.2807017543859649,0.9119366152419761,1.0,5/13,24.58%,ELP4;CTU1;MTO1;DPH3;TRMT9B
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.7238011931810757,1.1688091455010512,0.2553191489361702,0.9121830141493108,1.0,2/9,5.19%,NRG1;BMP2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6819443811198985,-1.168782668603322,0.24390243902439024,1.0,1.0,1/9,0.61%,TRIM56
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6920938429411199,-1.1686223181694702,0.30952380952380953,1.0,1.0,3/10,9.20%,SLX4;ERCC1;EXO1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6920938429411199,-1.1686223181694702,0.30952380952380953,1.0,1.0,3/10,9.20%,SLX4;ERCC1;EXO1
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6920938429411199,-1.1686223181694702,0.30952380952380953,1.0,1.0,3/10,9.20%,SLX4;ERCC1;EXO1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.6739263329823674,1.1685794624308041,0.3050847457627119,0.9123323857778474,1.0,1/13,1.15%,CPSF4L
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.7463948175981214,1.16855978830526,0.30612244897959184,0.9115914875743276,1.0,1/5,3.89%,ASIC1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7224520515521673,1.1684951734921318,0.32142857142857145,0.911034025737456,1.0,2/11,6.03%,RUNX1;F12
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.7632573247911396,1.168445738113368,0.3333333333333333,0.9104133217882351,1.0,1/5,3.81%,PPARG
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5407316477030231,1.1684340635704307,0.16129032258064516,0.9096653748509143,1.0,9/48,9.89%,GSTM2;CYP4F12;PTGS1;SCD;CYP4Z1;ELOVL5;PLA2G10;CYP4F3;SCD5
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.48969216336773813,1.168263167928984,0.23333333333333334,0.9095384876017013,1.0,27/101,18.79%,GRM3;LRRC4C;CLSTN2;NLGN1;CDH2;LGI1;MCTP2;NRG3;SYT1;GRM8;NLGN4X;GRIK2;RIMS2;GRM5;CEL;SNCAIP;ATP1A2;MEF2C;GRIK3;GRM4;PTEN;GRM7;GRM1;GRIK1;DGKZ;PXK;GRID2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.622832335175348,1.1681904275689323,0.2631578947368421,0.909070196071426,1.0,5/27,12.31%,AGR2;HIP1;PDE6H;PLAUR;HAP1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6037531817937509,1.1677688093960847,0.3148148148148148,0.9098933708511245,1.0,4/19,16.31%,SEMA5A;SEMA6C;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6532134914635358,1.1677517623865574,0.3333333333333333,0.9091911328782597,1.0,7/18,17.72%,ITGAX;FGF2;SIX4;SIRT6;PIK3CD;VEGFA;BMP4
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6227069687073928,1.1676389210779956,0.2542372881355932,0.9089266849177329,1.0,6/23,11.73%,KCTD21;TULP3;ENPP1;MOSMO;GPR161;KCTD6
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6702558007589028,1.1675247989925226,0.2692307692307692,0.9086095077933962,1.0,9/11,27.99%,B4GALNT2;CSGALNACT1;FUT8;GFUS;GFPT1;EXTL2;GMDS;GALT;UGP2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.7485106382978723,-1.1673700465947467,0.3584905660377358,1.0,1.0,5/5,25.17%,P2RY12;CD9;P2RX4;TGFB2;AZU1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5415421658440631,1.1671780012575022,0.25,0.9091963635396701,1.0,20/51,17.94%,EMB;TENM3;CDH2;ROBO2;SDK1;CNTN6;MYPN;DSCAML1;DSCAM;NECTIN2;PTPRT;HMCN1;CADM1;IGSF11;PTPRM;PLXNB2;ROBO3;CNTN4;L1CAM;CNTN2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.585015066199455,1.1671587895406363,0.20754716981132076,0.9085184299370845,1.0,6/24,25.17%,FKBP5;P3H2;PPIL6;PPIF;CWC27;NKTR
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.44324500518503457,1.1670971823570264,0.09615384615384616,0.9080114498632142,1.0,35/230,12.78%,VEGFC;IRGM;F2;FGF10;C3;HGF;EPHA7;SIRT1;FGF2;ERBB4;ANGPT1;EFNA5;CD40;PRR5L;BMP2;TNIK;PELI2;ACVR2A;WWTR1;FAM20A;BMPER;PPP1R15B;FER;HDAC3;ROPN1B;FGF17;GRM5;LEPR;PLAUR;CORO1C;FGF5;CD74;LYN;AKTIP;HSPB1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.7655288040721513,1.167073652643787,0.2542372881355932,0.9072933280408103,1.0,2/5,18.34%,CLC;TNFRSF21
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.7211522742566594,1.1668879421855867,0.3333333333333333,0.907211983424636,1.0,3/9,10.64%,GATA4;DAND5;ANK2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.595597421041361,-1.1667384909226362,0.2826086956521739,1.0,1.0,1/29,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.4761530608181334,1.1667082352966467,0.1864406779661017,0.9071413633811367,1.0,37/153,20.87%,PLD6;FGFR1;RAPGEF3;SOX5;SIRT1;LLPH;NLGN1;AGR2;BMP2;GRIP1;APELA;SOX6;RALA;NRXN1;FBXO5;ELAPOR2;NEUROD2;PAXIP1;MCU;CORO1C;BMPR1A;FOXO6;FZD4;ACVR1B;NCOA3;PHLDB2;VEGFA;COBL;PLCB1;BMP4;RPS6KA1;DVL2;PPP1R13L;MFF;FMR1;SHH;KMT5B
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7079881257543297,1.1666169510631068,0.30357142857142855,0.9067536568573383,1.0,4/11,9.33%,CSPG4;VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7079036275109438,-1.1665790152171247,0.2571428571428571,1.0,1.0,4/8,16.39%,XDH;DCN;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7184236479909571,1.1663497432064551,0.25806451612903225,0.9071695229840809,1.0,2/8,11.61%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5905968557703006,-1.1662618756234795,0.2857142857142857,1.0,1.0,6/18,19.90%,SFRP1;PDCL;TXNDC15;DCDC2;EVC;TTC23
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7891200427095825,1.1660996680220417,0.3148148148148148,0.9076057770414429,1.0,1/5,3.07%,LHFPL2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.6840672334447337,-1.1660922137853516,0.3541666666666667,1.0,1.0,1/12,0.91%,HK2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6529946594676573,-1.1657714413806244,0.3157894736842105,1.0,1.0,8/18,25.40%,SPRED2;SPRED3;SPRED1;EIF5A;MSX1;RPS20;RPL37;HIC1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5120844064841303,-1.1656934151713814,0.3,1.0,1.0,6/61,9.74%,EPN1;RHBDF1;MVP;PTPN3;WDR54;CEACAM1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.6165183100133469,-1.1656850305481463,0.21052631578947367,1.0,1.0,1/16,3.08%,EML3
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.7636575984824489,1.165616767422469,0.26666666666666666,0.9086424020564356,1.0,1/6,3.59%,LDLR
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.6600197277021546,1.1655004702362335,0.3064516129032258,0.9084338671118152,1.0,3/11,7.80%,CARNS1;UGDH;NANP
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.6434348697353978,1.1647520145169032,0.21428571428571427,0.9113103488812357,1.0,7/18,23.13%,IGF1;DRD3;OOEP;PHIP;EDN1;DMRT1;LRP5
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5491598036736651,-1.1644906161802104,0.22641509433962265,1.0,1.0,6/39,10.17%,TRIM56;OAS3;OAS1;FLOT1;DHX58;IRF5
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6492131144242763,1.16444692308677,0.2,0.9116678759398833,1.0,3/15,7.63%,PPARG;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.44194398623491976,1.1640624437686762,0.11320754716981132,0.9125607750365919,1.0,41/290,11.84%,MITF;ACTG2;IGF1;LGALS9;FGF10;CALCR;TGFBR1;ITGB8;ZBTB7B;ITGAX;FGF2;IL4;MYC;CTCFL;HIF1A;RAB27A;ANGPT1;MYCN;AGR2;BMP2;SP1;ZNF804A;RBPJ;SCRIB;MOV10;PLCG2;TICAM1;TLR2;VSIR;RAMP3;PAX6;SNCA;RESF1;SMAD1;RIMS2;ANK2;FGF17;MAGI2;GSN;FGF5;CD74
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6317256552321748,-1.1639862154281053,0.3,1.0,1.0,1/9,4.20%,RNF8
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5199415528621315,1.1639615548370734,0.1935483870967742,0.9121710652634722,1.0,10/75,5.38%,VEGFC;SEMA5A;TGFBR1;SIRT1;FGF2;HIF1A;ANGPT1;STAT5A;BMP2;NRARP
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.4863576759416741,1.16388173368571,0.18333333333333332,0.9116876053502498,1.0,29/93,17.74%,LAMA4;FGF2;TENM3;CSRP2;IL17RD;ALDH7A1;WWTR1;ZNF462;PPFIBP1;ADGRL2;LIFR;PTPN14;GPR161;ANK2;MAGI1;GUCY1A2;EDNRA;BMPR1A;AMOTL1;FIGN;PYGO1;FLRT2;RBMS3;PCDH18;RUNX1T1;GJC1;SEMA6D;FBN1;DIXDC1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7383851478545713,1.1635998413061492,0.3269230769230769,0.9122008092322552,1.0,2/7,16.82%,SPSB4;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6502675845839356,1.1633501387845062,0.3148148148148148,0.912514134069836,1.0,2/16,9.42%,AASS;SNCA
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.7354847600525956,-1.1632799720676308,0.391304347826087,1.0,1.0,3/5,11.10%,SCN5A;CACNA1G;SCN3B
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6945634157674133,1.163279825111779,0.3090909090909091,0.9120002348373529,1.0,1/9,3.81%,PPARG
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.5687468482516507,1.1632365501792903,0.2641509433962264,0.9113722112298983,1.0,6/31,12.52%,IRS1;SIRT1;RORA;RORC;ZNF692;FBP1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.5243714349970627,1.1631639811670405,0.2127659574468085,0.9108079458067988,1.0,14/65,14.38%,SULT2A1;ACSM2A;ENPP1;THEM5;SULT6B1;AMPD1;AK3;EFL1;GNAI3;RAB23;TPST2;GLYAT;ENTPD7;OXSM
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.6849640556141319,1.1631028598557158,0.288135593220339,0.9102029003579715,1.0,8/11,24.16%,MANF;NR4A2;LRP6;VEGFA;CTNNB1;SHH;WNT2;RYK
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.7763317289374064,1.1630585122203427,0.4074074074074074,0.9095467514670033,1.0,1/5,6.61%,NEFH
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6779151642662664,1.1627990693861376,0.29508196721311475,0.9098919986625043,1.0,1/9,0.56%,IGF1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6282471816524754,1.1625915537318752,0.2413793103448276,0.9100596747031099,1.0,6/18,16.26%,NPC2;ABCG8;ABCA1;ABCG5;SOAT1;ABCA8
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6539249084569168,1.1625586421603542,0.32608695652173914,0.9094469403268002,1.0,4/12,12.89%,SIRT1;PLCG2;CD74;IRAK3
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.767101740461932,1.16247507271983,0.26666666666666666,0.9091470366388592,1.0,2/6,11.61%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.739310167424042,1.1622751300978345,0.3157894736842105,0.9090345551483079,1.0,3/6,24.72%,NPPA;ANO6;DLG1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5697000470103495,1.1621806286663805,0.20754716981132076,0.9086732658680223,1.0,8/32,14.44%,ARHGAP24;LZTR1;CCDC125;DLC1;ABL2;KANK1;FBP1;SPRY3
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.7712191049658951,1.1620267391321488,0.3,0.9085406482796513,1.0,3/5,22.53%,EIF3E;FMR1;NCBP1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6980643143755962,1.161942896944579,0.2857142857142857,0.9073964697372118,1.0,3/12,5.91%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6980643143755962,1.161942896944579,0.2857142857142857,0.9073964697372118,1.0,3/12,5.91%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.595486331855055,1.1617422221600453,0.25757575757575757,0.9074617312404701,1.0,5/21,18.53%,SAMD4A;CNOT6L;CNOT4;CNOT8;CNOT2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.7981072796442257,-1.161699570792225,0.25,1.0,1.0,1/5,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5026502344693943,1.16158591336144,0.17307692307692307,0.9073099331798069,1.0,13/82,9.11%,TMPRSS2;MME;KLKB1;CPN1;MMP16;HGFAC;MYRF;F12;PRSS3;PCSK5;HJV;VSIR;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7843759758580883,-1.161313415080847,0.3023255813953488,1.0,1.0,1/7,3.17%,SFRP1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5086541473231212,1.1610967639581917,0.15555555555555556,0.9085312333200792,1.0,10/69,12.79%,ACE2;SCN10A;APELA;SLC8A1;TMIGD3;ANK2;NPPA;ATP1A2;NPR2;CORIN
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.6886903291600835,1.1610073527070897,0.2692307692307692,0.9081106381192502,1.0,4/7,26.07%,RP1;ARL3;RP1L1;NKD1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6380355419965305,1.1606304588232597,0.25862068965517243,0.9088551758894259,1.0,4/15,18.51%,NRG1;BMP2;MEF2C;MESP1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.44467641221769955,1.1605816512283234,0.15517241379310345,0.9082599893364449,1.0,34/183,20.09%,ESPL1;CDKN2C;TOP2A;CCNA2;CDC25A;NDC80;MYC;HIF1A;EFNA5;SYNCRIP;ODC1;FBXO5;EZH2;E2F4;RASAL2;HNRNPD;PML;RACGAP1;BCL3;CDK4;HSPA8;XPO1;H2AZ2;DMD;LMNB1;NOTCH2;MNAT1;FOXN3;RPS6KA5;DTYMK;SQLE;G3BP1;H2AX;UCK2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5821253789090463,1.160572463834385,0.32653061224489793,0.9075732264001622,1.0,10/37,6.27%,IGF1;TNFRSF18;FGFR3;IL4;CCL5;ERBB4;CD40;IL23R;HCLS1;FLT3
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7111456880826394,1.1605625202658956,0.2807017543859649,0.9068465117253681,1.0,2/7,8.68%,RIT2;ABCA1
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.8222376469499415,1.160542885173316,0.25862068965517243,0.9061518349118964,1.0,1/5,8.79%,SLC4A1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6307843807329325,1.1601473307723313,0.25,0.9062013377310703,1.0,2/14,9.44%,ZFP36L2;TOB1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6307843807329325,1.1601473307723313,0.25,0.9062013377310703,1.0,2/14,9.44%,ZFP36L2;TOB1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.585964440566267,1.159978033155503,0.2835820895522388,0.9061133449784223,1.0,10/22,26.05%,TGFBR1;BMPR1A;VEGFA;LRP2;BMP4;JAG1;BMPR2;HEY2;SMAD7;NOTCH1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6127689951263781,1.1597855625934674,0.2807017543859649,0.9059231490105444,1.0,7/23,23.32%,DRD5;SNCA;PDE4B;RYR2;GABPA;ABL1;MAPK3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.7461851243360195,1.1597379162135315,0.34,0.9053651180803729,1.0,3/7,7.68%,GRIP1;SCRIB;GRIP2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.7371946860880626,-1.159656718922556,0.3076923076923077,1.0,1.0,1/6,9.71%,DHX58
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.6397762868141871,-1.1596477053465806,0.27906976744186046,1.0,1.0,3/14,12.43%,KCNE2;KCNE1;KCNS1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.5643652738954117,1.1595568206769793,0.25396825396825395,0.9052678327101558,1.0,3/30,8.47%,PAWR;EPS8;RHOD
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.7541843451998305,1.1595407203437442,0.2807017543859649,0.9045581501624932,1.0,2/5,13.00%,HRH3;ADRA2C
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5377802058240241,1.1590391417610555,0.2857142857142857,0.9061346324255143,1.0,12/39,19.68%,MME;FAIM;CLSTN2;NLGN1;NRXN1;PTPRD;LIG4;LRP2;SPEN;GRID2;NUMB;RGS14
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5697648091067931,1.1589273375740634,0.30357142857142855,0.9049923425533329,1.0,4/23,11.22%,ZDHHC11;ZDHHC12;ZDHHC22;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5697648091067931,1.1589273375740634,0.30357142857142855,0.9049923425533329,1.0,4/23,11.22%,ZDHHC11;ZDHHC12;ZDHHC22;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.756912291937057,1.1586432614048192,0.3584905660377358,0.905160330489259,1.0,3/8,3.66%,RRAS;RIN2;TMEM100
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6189686958743132,1.1586290716261392,0.2909090909090909,0.9044638739124398,1.0,9/23,19.17%,SIRT1;ABHD17B;HDAC3;SIRT6;ABHD17C;ABHD10;LYPLA1;SIRT7;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.7474188654413798,-1.158512261299471,0.3181818181818182,1.0,1.0,3/5,19.79%,CD200R1;APOD;RIPOR2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.7814539956901783,1.1584928707550841,0.3469387755102041,0.9042155395779954,1.0,1/5,1.95%,FLI1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5670836932295285,1.1584578378721329,0.24193548387096775,0.9036123827387282,1.0,12/35,18.14%,ZEB2;KANK2;PRSS3;DPP4;PIK3CA;KANK1;PXN;FERMT1;KIT;ANLN;LOXL2;PKN2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5327420206693044,1.1583031579758545,0.2641509433962264,0.9033753149151696,1.0,5/52,5.30%,SASH3;LGALS9;SIRT1;CCL5;IL23R
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.48658344476219634,1.1582960719779314,0.14583333333333334,0.9026522724178216,1.0,19/117,8.51%,MXRA5;MRGPRF;CXCL12;FRAS1;ADGRL4;HAS2;GNG12;CCDC80;DOCK1;LRIG3;PLSCR4;POSTN;WWTR1;FAM114A1;BGN;DPP4;DSP;RHOD;SDC4
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7131666986692585,1.15802224575503,0.3,0.9030036072754897,1.0,6/11,26.23%,BACE2;SOAT1;ABCA2;ITM2B;ABCA7;NECAB3
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.7103641411713575,1.1579606891303198,0.34,0.9024742792464205,1.0,1/8,2.98%,IL4
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.7338649049136805,1.157822686580144,0.4107142857142857,0.9021783026488157,1.0,2/5,22.23%,UBE2E2;UBE2E1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7031645539249342,1.1575131615488274,0.32142857142857145,0.9026402445616606,1.0,3/6,28.42%,SMURF1;FNBP1L;HGS
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6181615224033369,1.157424525396403,0.2631578947368421,0.9023244405117994,1.0,5/20,13.79%,SLC12A7;SLC12A1;SLC12A3;ATP1A2;ATP12A
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.532616630822094,1.157359922996173,0.2542372881355932,0.9018680090140733,1.0,5/51,11.75%,IRGM;STING1;TP53INP1;ATG101;RAB23
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.6926348565967057,1.157269154342185,0.26666666666666666,0.9014929256295995,1.0,5/10,18.59%,NRG1;CD74;NR1H3;VAMP3;SPX
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.7556328565635869,-1.1571089229546627,0.32653061224489793,1.0,1.0,1/5,1.35%,TEK
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5898838720106325,1.1568190256223603,0.23636363636363636,0.9023967887504765,1.0,2/20,3.70%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5742978264118034,1.1562300996069892,0.32142857142857145,0.9040333323748614,1.0,4/24,4.24%,SASH3;TNFSF13B;IL4;CD40
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.662266333674577,1.1557990568729073,0.23214285714285715,0.9049737946254376,1.0,4/11,29.36%,ZNF675;NPPA;HIPK3;PDCD4
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.45475395923164663,1.1557748409811541,0.23076923076923078,0.9042961665649112,1.0,20/171,8.54%,SEMA5A;RSPO3;FRMPD1;RUNX1;SIRT1;TULP3;TSPAN12;RFNG;SOCS2;MDFIC;VWA2;LLGL1;CDKN2AIP;RORA;WWTR1;KCTD8;ESR1;GPHB5;DHRS3;LIFR
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.4462707094458931,1.1557159130021304,0.16981132075471697,0.9037300129703656,1.0,29/183,15.38%,LAMA4;CDKN2C;C3;ANGPT1;PPARG;ADIPOR2;STAT5A;IDH1;STOM;ACADS;JAGN1;CAVIN1;PPP1R15B;LIFR;ABCA1;HIBCH;TOB1;SLC25A1;ACADM;MTARC2;FAH;ACAA2;SLC19A1;ANGPTL4;REEP6;TANK;PGM1;FZD4;DNAJC15
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6892558742681203,-1.1556770450169502,0.32727272727272727,1.0,1.0,1/9,1.16%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.7150225914706716,1.1556189375979906,0.25,0.9033452261008686,1.0,3/9,4.66%,SIRT1;CDKN2A;ABI3
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.7354351146902054,1.1555697987133475,0.35185185185185186,0.9027407268895546,1.0,1/7,1.06%,TOP2A
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.6635747488777789,1.155519153661528,0.25,0.9022473061960365,1.0,2/13,4.16%,HS3ST5;KNG1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5774196659683062,1.155478213534577,0.2857142857142857,0.9017047013382345,1.0,10/43,6.27%,IGF1;TNFRSF18;FGFR3;IL4;CCL5;ERBB4;CD40;IL23R;HCLS1;FLT3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5280469874580964,-1.1553235719527561,0.23529411764705882,1.0,1.0,17/72,8.55%,EHF;DUOXA1;CAPN8;ETV5;PGC;SFTPA2;IFI27;RNASE1;INMT;CRLF1;FAM3D;NRN1;MS4A4A;LAMB3;C2;LAMP3;ADGRF5
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6152213146383301,1.1551860876588784,0.3392857142857143,0.9021820763076916,1.0,2/20,2.87%,IGF1;FGF2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6545571975124999,1.1551447919411812,0.2982456140350877,0.9015705368551613,1.0,5/11,23.44%,AANAT;METAP1D;NAA16;NAA11;NAA50
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.5062469646963973,1.1550186702619458,0.23214285714285715,0.901329063516132,1.0,5/58,7.89%,CWH43;ZDHHC12;GLUL;ZDHHC22;PIGQ
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.567606062288453,1.1548133245876204,0.27586206896551724,0.9014368126164953,1.0,6/44,7.32%,IGF1;ITGA11;UTRN;CHODL;SOX6;MKX
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.6568044184105223,-1.1547117101861106,0.3103448275862069,1.0,1.0,2/13,5.61%,RNF8;RECQL5
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7781685689237169,1.1544531204200374,0.33962264150943394,0.9015124793861172,1.0,1/5,7.15%,NAPEPLD
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7781685689237169,1.1544531204200374,0.33962264150943394,0.9015124793861172,1.0,1/5,7.15%,NAPEPLD
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7246281946805778,1.154125279302362,0.35185185185185186,0.9022063916849513,1.0,6/7,23.72%,ABCG8;PLA2G10;ABCG5;SHH;ABCA2;SREBF2
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.733045606630894,1.1539071184717635,0.32786885245901637,0.9024521451665141,1.0,1/6,12.23%,CADM1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5281734637366949,1.1538861979772597,0.25925925925925924,0.9017545506694771,1.0,7/43,18.16%,SIRT1;ZBTB1;PRIMPOL;PCLAF;REV1;POLD4;FAAP20
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.7185819341511112,1.153628585854022,0.3114754098360656,0.90203994236724,1.0,2/6,16.96%,PTPRD;PTPRU
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5984283282893282,1.1534365194497236,0.2545454545454545,0.9019582147903424,1.0,5/23,21.85%,RAPGEF3;COL22A1;RAP1A;F2RL1;RAPGEF2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7354071754969851,-1.1533887537788552,0.3404255319148936,1.0,1.0,4/5,22.23%,SF3A3;SF3A1;SLU7;SF3A2
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.7795128224950475,1.153320995351128,0.3050847457627119,0.9016389848258273,1.0,2/5,16.18%,HRH3;GRM7
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6530741550972049,-1.1531799431868384,0.3584905660377358,1.0,1.0,1/10,1.49%,KDM4D
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6057314154486011,1.1528952433534028,0.28846153846153844,0.9024184444394433,1.0,3/14,8.74%,BMP2;SOX6;HDAC3
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.717345372716445,-1.1528173005485305,0.3191489361702128,1.0,1.0,2/7,6.01%,GOLGA2;PLK3
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6619213236765319,-1.1528026442611363,0.3469387755102041,1.0,1.0,1/10,1.03%,FBXO43
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6770686423878729,1.1527978978918076,0.26666666666666666,0.9020795887547358,1.0,4/9,11.09%,SELPLG;RELA;ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6426412091022904,-1.1527369072430709,0.3111111111111111,1.0,1.0,3/13,22.02%,RCC1L;MPV17L2;UQCC2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.673845114938602,1.1526322308361907,0.30158730158730157,0.9020474813932134,1.0,5/10,19.63%,SMAD1;SMAD2;MRPL44;HNRNPA2B1;PUS10
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6631297205088017,1.152507403687508,0.30357142857142855,0.9018772558610546,1.0,5/14,17.42%,SCRIB;RAMP3;SNCA;VAMP3;RAB29
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.4243846630718185,1.1523377773007277,0.14285714285714285,0.9018946713474288,1.0,35/197,18.34%,CDKN2C;CCNG1;CCNA2;CDC25A;MYC;NDE1;CDKN2A;CEP70;EPS8;CEP152;PCM1;FBXL3;CDK14;BCAT1;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;PPP1R12B;CDK4;CNTRL;PHLDA1;CDC25C;CCND3;CCNB3;NEDD1;ACVR1B;CCP110;CCNH;FBXL15;PLCB1;TAF2;MNAT1;RCC1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.47580016292283395,1.1522732208750057,0.20588235294117646,0.90138983362903,1.0,22/129,18.55%,HEMGN;SMOC1;FGFR1;TGFBR1;RUNX1;MAFB;NLGN1;RORC;MEGF10;MOSMO;EPHA3;BIN1;SINHCAF;NR1D2;GREM1;NREP;CSF1;PHLDB2;TRPS1;ANP32B;RPS6KA1;NOTCH4
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.7598798643525442,1.1522345043804778,0.31666666666666665,0.9007775156458462,1.0,1/5,0.86%,NOX5
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.7363372245597933,1.1519841424118749,0.375,0.9010023635353954,1.0,2/6,11.36%,ADRA1A;NPPA
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5085201375420249,1.1519796705883008,0.26,0.9003127147629505,1.0,16/76,12.14%,CALCR;C3;FRMPD1;TULP3;CCL5;SAG;MRAP2;CNGA1;KCTD8;KLK5;KLK14;RAMP3;PDE6H;CAMKMT;PDE6A;GNG4
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.7705048198957651,1.1517707827364119,0.27450980392156865,0.900213467372434,1.0,2/6,12.30%,MYC;TCF4
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5833048213019599,-1.1516410092956026,0.19230769230769232,1.0,1.0,6/29,10.17%,TRIM56;OAS3;OAS1;FLOT1;DHX58;IRF5
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.6443642945573211,1.1516341508227663,0.32786885245901637,0.8999377372122976,1.0,7/10,26.05%,RBPJ;SMAD4;RYR2;CPE;HEY2;GSK3A;NOTCH1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.7851993863007015,1.1513673291905606,0.2641509433962264,0.8995737669442263,1.0,1/5,5.18%,SLC35B2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.7851993863007015,1.1513673291905606,0.2641509433962264,0.8995737669442263,1.0,1/5,5.18%,SLC35B2
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.6905413681805612,-1.1513232337126844,0.24444444444444444,1.0,1.0,1/8,1.71%,ENTPD2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5665158003770757,-1.1511272339812988,0.32075471698113206,1.0,1.0,2/25,2.28%,MYH7;SCN5A
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.7605974323536937,1.1510252605001292,0.3387096774193548,0.8993283516869862,1.0,2/5,10.48%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.7605974323536937,1.1510252605001292,0.3387096774193548,0.8993283516869862,1.0,2/5,10.48%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7092563743560647,1.15093214277348,0.2413793103448276,0.8989957985544411,1.0,5/9,22.79%,SIRT1;PRKAA1;KLF15;DIP2B;DIP2A
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.7402305717480963,1.1509151288744455,0.34375,0.8982926654691055,1.0,2/7,23.74%,TRPM7;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5265611762234423,1.150672797692822,0.21818181818181817,0.8984981865561523,1.0,5/57,7.42%,HGF;ACD;FGF2;MYC;PARM1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5738263315378132,1.1506511110086461,0.24528301886792453,0.8978453339516838,1.0,10/30,17.72%,WNT4;ADGRV1;BMP2;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6;BMP4
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.7515775739155801,-1.1505980498478476,0.3409090909090909,1.0,1.0,2/5,9.74%,CELA2A;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.7729188281081915,1.1505370402741888,0.31343283582089554,0.8974565807462244,1.0,1/5,3.81%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5864092634807517,1.1502217646952726,0.3559322033898305,0.8979445890185387,1.0,7/19,14.53%,SMAD6;ENPP1;LRP4;RBPJ;GREM1;MEF2C;BCOR
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.7874195734719833,1.150044709778127,0.31666666666666665,0.8979260078057782,1.0,2/5,0.77%,SYK;LGALS9
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5375530068974386,-1.1499981922620885,0.1956521739130435,1.0,1.0,7/51,2.73%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6309231705159556,1.149712430539813,0.2962962962962963,0.8984128597232092,1.0,5/11,11.72%,LRP4;NLGN1;NRXN1;NLGN4X;CEL
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5686286212358249,1.149040972784816,0.27450980392156865,0.9005207582987442,1.0,7/28,7.86%,FLT1;IRS1;FGF2;FGFR3;FLT3;EPHA8;PDGFRA
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5713988207559649,1.1488948476090948,0.2909090909090909,0.9003254961041851,1.0,10/26,23.63%,SLC26A7;SLC26A6;SLC35B2;SLC44A4;RACGAP1;SLC26A4;SLC36A1;SLC19A2;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.6949766165032725,-1.1487929491990194,0.3,1.0,1.0,2/6,13.37%,PRKCD;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.6602586106324682,1.1486434711914684,0.2653061224489796,0.9006056508402784,1.0,3/14,10.39%,IL4;CD40;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8044093969194118,1.1486297082577133,0.2692307692307692,0.8999262176903209,1.0,3/5,16.99%,SEMA5A;DSCAM;VEGFA
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.39027452263285006,1.148394884352134,0.08620689655172414,0.9001868829670877,1.0,133/857,15.78%,GATA4;MITF;ACTG2;RBM20;CRX;IGF1;ACE2;LGALS9;FGF10;CALCR;ICOSLG;PRDM14;TGFBR1;RUNX1;SIRT1;ITGB8;TULP3;ESRRG;ZBTB7B;NR5A2;ITGAX;PCBP3;FGF2;IL4;MYC;CTCFL;PRDM8;HIF1A;RAB27A;NFIL3;ANGPT1;POU6F2;WNT4;MAFB;MYCN;HNRNPH1;TFEB;RORB;SFMBT2;BMI1;AGR2;ZNF114;HES6;BMP2;BTN2A2;RORA;SP1;ABCC2;CHD7;AFF2;ZNF804A;HCLS1;SOX6;ZNF257;WWTR1;TEAD2;CCN4;ZNF462;RELA;SLC8A1;RBPJ;ESR1;NFKBIZ;HMG20B;ELAVL2;MOV10;PLCG2;NFIA;SLC39A8;TICAM1;RPS6KA4;TLR2;ZNF274;VSIR;RAMP3;RYBP;PAX6;NOVA1;SSBP2;TOB1;ATXN1;RAG2;SMAD1;YAF2;ZNF195;GPBP1L1;NFKBID;PROX1;RIMS2;ANK2;CIAO3;FGF17;ZNF675;FASTK;RO60;EZH2;NCOA2;GSN;FGF5;CD74;CDK11A;LYN;BMPR1A;NR1D2;F3;HNRNPD;HP1BP3;CHEK2;MLXIPL;SP3;MSR1;CPNE1;PML;DMTF1;TRIM26;MEF2C;MYOM1;CDK4;ZNF117;MAPK8;AFF1;ZNF536;PICALM;RBMS3;PRRX2;MAGED1;ZNF281;SPIN1;CSF1;PIK3CD;MLF1;ZNF212;ACVR1B
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.7658434727688908,1.1483748094458948,0.3157894736842105,0.8995572294629618,1.0,1/5,6.94%,EFL1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7212848858712047,1.1482003520668242,0.39622641509433965,0.8994891577237623,1.0,2/6,18.53%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5052605717366169,1.1481921095302274,0.25862068965517243,0.898803114959749,1.0,10/65,15.26%,SIPA1;SEMA5A;ANGPT1;KNG1;ADAMDEC1;B4GALNT2;DSCAM;PLXNB1;PLXNB2;FZD4
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.7096199552744653,1.1481220313505558,0.3728813559322034,0.898311158366899,1.0,2/9,9.89%,SCD;SCD5
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6066378849252325,-1.1480222535475497,0.2972972972972973,1.0,1.0,3/16,9.36%,TEK;HCK;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.6983277683266067,1.1479274859909951,0.23214285714285715,0.8983020906019088,1.0,3/10,4.66%,SIRT1;CDKN2A;ABI3
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6212850735383152,1.1478468839602258,0.3333333333333333,0.8978883876959188,1.0,3/15,16.72%,NXF1;DDX19B;NXF5
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.6756843860244579,1.1477747677053007,0.3050847457627119,0.8973886985173671,1.0,1/12,1.15%,CPSF4L
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.7887530245606755,1.1475516241788806,0.3137254901960784,0.8975439100132764,1.0,1/5,10.27%,ACP6
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.6108582259920922,1.1475372999864693,0.30303030303030304,0.8969011093260731,1.0,6/23,14.00%,SLC26A7;SLC26A6;SLC1A3;ABCC2;SLC25A13;SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5860672521818701,1.1474792425443683,0.288135593220339,0.8964418018287063,1.0,4/22,14.57%,CDC25A;FBXO5;CDK4;CDC25C
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.47165763994465376,1.147108815051035,0.22727272727272727,0.8972883386930843,1.0,26/111,18.71%,ATP6V0D2;IRS1;IRS4;ENPP1;INSIG1;KAT2B;TCIRG1;PPARG;RAB31;LPIN3;FOXO1;GAB1;FER;ATP6V0A4;BCAR1;SOS1;SH2B2;IGF1R;ATP6V0B;CPEB1;TBC1D4;CAPN10;PHIP;DENND4C;GCK;PIK3R3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.5422880487653882,-1.1470350072152464,0.2,1.0,1.0,4/25,13.44%,HK2;ENO2;GAPDHS;PFKFB1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.45987320230282036,1.1469457410481665,0.23809523809523808,0.8971842394301028,1.0,31/150,14.31%,NXPH1;LRRC3B;RIT2;PRKG1;GRM3;PCBP3;HRH3;CADM2;PDE1A;SLC17A6;CNTNAP2;PENK;ZDHHC22;RAB3C;NRXN1;SYNPR;SLC24A2;OLFM3;GPSM1;HIVEP2;GRM5;CTNNA2;LRRTM3;ADGRB3;PAK5;GNG4;TMEM196;HCN1;PPM1E;GRIK3;TSHZ1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.769898930005818,1.1469292909193092,0.36,0.8965437501571994,1.0,3/6,14.46%,ZDHHC12;NRXN1;PTEN
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6475793190864496,-1.146610528711211,0.3939393939393939,1.0,1.0,4/16,9.25%,SIGIRR;IL6R;AHSG;MYLK3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.5095378353251142,1.1465189110359302,0.2962962962962963,0.8973211889913885,1.0,10/67,16.03%,ESPL1;NOX5;SNX18;SEPTIN4;ROPN1B;SEPTIN14;DCTN3;RACGAP1;ANLN;SPIRE2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7194137158892371,1.1464827537651168,0.3269230769230769,0.8967963953652288,1.0,4/8,18.00%,NFIL3;TOX;PIK3CD;AXL
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7137279237026121,1.1458933673783178,0.3114754098360656,0.8984709307971895,1.0,4/8,23.32%,MAP2K6;CHEK2;ABL1;MAPK3
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4857652204241601,1.145824833814654,0.25,0.8980415703844179,1.0,28/72,31.92%,ZEB2;PDE4DIP;LMAN1;PLXNB1;RAB33B;MAPK15;SIRT7;MFF;STX5;CENPV;STX18;CAMSAP2;SAR1A;USP6NL;MAPK3;TBC1D25;SPATA4;MIEF2;AKAP9;EP300;PAK2;TMEM33;CLIC4;TJP1;MYO5A;CPLANE2;RHOT1;MUL1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.6251929682199706,1.1457897607849852,0.2708333333333333,0.8974697291529903,1.0,2/21,4.90%,PNP;FHIT
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6789146543229148,1.1456820901237057,0.2982456140350877,0.8971181182567466,1.0,3/8,24.63%,HSD17B10;MTO1;TRMT5
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7231206120368188,1.1455331846889145,0.38028169014084506,0.8969766907849392,1.0,2/6,13.61%,HAP1;CEP135
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5331555242249141,1.1454821721866353,0.2641509433962264,0.8965308048559191,1.0,6/59,3.99%,FGF10;HGF;SIRT1;FGF2;MYC;TOX
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.6620009516728478,1.1452278574277384,0.2777777777777778,0.8967896383212101,1.0,4/12,20.87%,RENBP;NPL;GNPDA2;PON1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6702498901427322,1.1451011923647594,0.375,0.8965062045578345,1.0,5/7,32.69%,CPEB1;FMR1;CPEB2;CPEB3;CPEB4
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7706931650545851,-1.145087536379147,0.3404255319148936,1.0,1.0,1/5,4.99%,RAB7B
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5543746663501259,1.1449773762854007,0.3090909090909091,0.8961567215576631,1.0,9/33,13.66%,SASH3;TNFSF13B;IL4;CD40;CD22;CD74;LYN;BLK;MEF2C
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.4669828231718139,-1.1449101296822006,0.18421052631578946,1.0,1.0,10/131,5.46%,CD44;TEK;COL4A2;COL5A1;NLRP3;COL4A1;SLC6A6;PHEX;COL6A3;COL1A1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4870391012667334,1.1448417285460017,0.2537313432835821,0.8958837166259191,1.0,17/92,13.68%,GSTM2;ANGPT1;SLC35B2;CSPG4;UGDH;CBS;CHSY3;VCAN;MAT2A;BGN;HPGDS;SLC35D2;DSEL;GGT5;ST3GAL6;CSGALNACT1;CHST6
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5555820982430477,1.144807175589993,0.25396825396825395,0.8953550674822379,1.0,5/31,11.22%,ZDHHC11;ZDHHC12;GLUL;ZDHHC22;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5817499450043038,1.144759489985406,0.3064516129032258,0.8947703829072752,1.0,5/33,8.85%,PNP;IL4;ZBTB1;IL23R;VSIR
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6891228906127985,1.1446792891093542,0.3387096774193548,0.894394934508083,1.0,2/8,11.36%,LRRC55;NPPA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.7345220757351082,-1.1445430400703764,0.38095238095238093,1.0,1.0,2/5,12.55%,WNT7A;WNT5A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6390045264229942,1.1444472705042659,0.36538461538461536,0.8947107919276427,1.0,7/13,27.74%,FOXO3;SLC25A33;TFB1M;PNPT1;MTERF2;TFB2M;MTERF1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.5059437569354476,1.1444190645041452,0.2857142857142857,0.8941185191885408,1.0,15/96,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;PRRX1;SSC5D;ADGRL4;CCDC80;LTBP2;COL6A2;CSPG4;POSTN;BGN;PDGFRA;OLFML3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6163137531762137,1.1443155510882594,0.25,0.8938389256967357,1.0,7/23,17.88%,SLC26A6;LIN28A;ZBTB20;UNC13B;SLC2A5;IGF1R;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6594203846219711,1.1443146426655382,0.375,0.8931444121569557,1.0,4/13,16.13%,C3;SLC26A6;CA2;ANO6
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.684168497672516,-1.1442850034430652,0.3333333333333333,1.0,1.0,3/11,10.66%,NLRP1;IRF5;NOD1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.45574775631952735,1.1440593374232795,0.24242424242424243,0.8933470689944445,1.0,16/115,10.67%,ASB17;TEX101;PRNT;C2ORF78;LRRC46;GCNA;DMC1;MEIG1;DKKL1;PDCL2;TEX15;GALNTL5;POTEA;GTSF1;UBE3D;FKBP6
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.7662372950684518,1.144008147904006,0.33962264150943394,0.8887620864787655,1.0,2/5,10.14%,NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),-0.6981480308553425,-1.1437816221943533,0.30612244897959184,1.0,1.0,3/5,16.91%,PAX2;PODXL;FGFR2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6595665598476292,1.1437643771941222,0.3148148148148148,0.8890137453779597,1.0,3/12,3.66%,RRAS;RIN2;TMEM100
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.666054420302018,-1.1435201116237568,0.3181818181818182,1.0,1.0,6/7,32.17%,PINK1;MFN2;TOMM7;PRKN;OPTN;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.8012830762937297,1.1434966253556924,0.3333333333333333,0.889311851681312,1.0,2/5,5.49%,FGF2;SIX4
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6221737176525199,1.1434890818206735,0.3472222222222222,0.8886454313336352,1.0,5/17,14.34%,ITGAX;MYRF;UNC13B;RIMS2;ATPSCKMT
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6772136189443458,-1.1433564741184394,0.36,1.0,1.0,2/7,16.12%,CAV1;CALM1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4869751752305549,1.1433111902398567,0.22641509433962265,0.8887282507523654,1.0,10/75,12.95%,EPHA7;EFNA5;EPHA8;EPHA5;EPHB4;EPHA3;EFNA2;LYN;EFNB2;NCK2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.634302081557343,1.1433014247601454,0.2711864406779661,0.8880539591134776,1.0,1/15,1.35%,C3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7288354537444879,1.1431130017380295,0.3392857142857143,0.8882024739009787,1.0,2/5,26.64%,TANK;OTUD4
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.7735872321365491,1.1430432731888336,0.27450980392156865,0.8877069131713826,1.0,2/6,18.09%,TSR3;RPUSD2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5155616854306094,1.1429492371837737,0.2909090909090909,0.8873799443719702,1.0,6/50,9.11%,SYK;SIRT1;MYC;F2R;HMGB1;HTRA2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.4605827137339733,1.1429315433030753,0.19402985074626866,0.8867739727594051,1.0,25/118,17.25%,TSPAN12;BOK;SLC7A2;GNG12;LRIG3;RORA;EPDR1;ARHGEF17;FKBP5;UNC13B;ADGRL2;GAMT;BCAT1;CLDN12;MMP15;MAGI1;KCTD3;CDR2L;PLXNB1;AOX1;BCAR1;PRLR;PTPRU;ERRFI1;CPE
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.6979736167752429,-1.1428471359749097,0.325,1.0,1.0,1/11,0.27%,TERT
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5348630324009769,1.1427935839086585,0.24193548387096775,0.8866157940301695,1.0,10/50,19.47%,GDAP1;IMMP2L;TIMM22;CHCHD4;FBXO7;DNAJC15;TIMM10;IMMP1L;AIP;MFF
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.7660187765401634,1.1427898357877733,0.3157894736842105,0.8859369151679718,1.0,3/5,22.56%,CCL5;BMP4;FADD
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.7319152502103072,1.1427119213391923,0.3076923076923077,0.8848609211126311,1.0,3/5,16.93%,RORB;CRB2;RP1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.7319152502103072,1.1427119213391923,0.3076923076923077,0.8848609211126311,1.0,3/5,16.93%,RORB;CRB2;RP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7427112172165944,1.142594790935059,0.35185185185185186,0.8846582810889511,1.0,3/6,24.03%,BACE2;ITM2B;ABCA7
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5693304549006877,1.142103119225812,0.2641509433962264,0.8859861831360908,1.0,4/39,4.49%,SYPL2;PADI2;GNB4;NDRG2
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.6216201870420769,1.141861995851504,0.29508196721311475,0.886153676465544,1.0,1/14,0.08%,TNFSF14
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6917530719580901,1.1417992055359434,0.3898305084745763,0.8857375344602758,1.0,6/10,26.80%,FZD5;RIPPLY2;MESP1;SHH;WLS;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.7509815398953139,1.1416495072315098,0.2857142857142857,0.8856181206578693,1.0,2/5,11.36%,ADRA1A;NPPA
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.6790708893881428,-1.1415958630336895,0.37777777777777777,1.0,1.0,1/6,4.04%,ALOX5
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7179264582902192,1.141384769946375,0.296875,0.8858409871255871,1.0,4/9,16.75%,GSTM2;SLC8A1;TRPM2;RYR2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7406787736812577,1.1411774396903736,0.3617021276595745,0.8859064537634138,1.0,3/7,20.25%,CCL5;NOC2L;IRS2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.5697544184340926,1.14115543163538,0.2711864406779661,0.8853255911100854,1.0,11/34,20.48%,SLC12A7;SLC1A3;IL10RA;GLUL;SLC29A2;ATP1A2;SLC19A1;LRP2;SLC36A1;SLC1A6;SLC12A4
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.6687952342060195,-1.14107488418483,0.32608695652173914,1.0,1.0,1/8,0.24%,ACTC1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.7832276454016136,1.1410043775659748,0.2692307692307692,0.8852253024701365,1.0,2/5,8.89%,SIRT1;HDAC2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6162946312828121,-1.1409130176994378,0.3023255813953488,1.0,1.0,5/19,17.36%,BUD23;FTSJ3;EMG1;MRM1;NSUN4
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6146432344018413,1.1408942019745367,0.3269230769230769,0.885042205404918,1.0,10/17,24.72%,SCRIB;ERBIN;CRB2;LRRC7;OOEP;DLG2;PARD3;DLG3;CRB1;DLG1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.612280175522329,1.1408244295875416,0.2903225806451613,0.884730433973781,1.0,3/19,4.41%,SASH3;IL4;CD22
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.6469573509487229,1.1407057610844313,0.38181818181818183,0.8845756008655489,1.0,5/12,12.96%,SYK;CCL5;PLAUR;LYN;BLK
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5620512101273101,1.1404598672645965,0.2727272727272727,0.8849728168701985,1.0,10/31,29.30%,ACD;MAPK15;NEK7;CTNNB1;POT1;MAPK3;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5729388158103016,1.14029556003002,0.2727272727272727,0.8849283141142357,1.0,9/32,12.64%,RAPGEF3;KSR1;EPHA5;PDE7A;NUDT4;RIMS2;NPPA;HTR2C;ADGRG6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.691843876748062,1.1397946454972057,0.3,0.8861786828272661,1.0,1/11,0.72%,CXCL12
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.587458277289406,1.1397445724581772,0.2727272727272727,0.8857112371788796,1.0,8/15,31.80%,CORO7;AP1AR;KLHL20;MON2;VPS13A;EPS15;GBF1;KIF16B
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5543751487249757,1.139740076440599,0.2698412698412698,0.8850519450151207,1.0,5/32,13.35%,GSTM2;GSTT2;HPGDS;GGT5;ETHE1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.7299402675627232,1.1397357770502279,0.375,0.8843936472588487,1.0,1/6,1.71%,EGLN3
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.7153812256878677,1.1396530123256319,0.3442622950819672,0.8840293121565777,1.0,2/8,19.14%,AUP1;SQLE
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.6344684703202463,1.1394895023984883,0.30357142857142855,0.884040611541006,1.0,7/11,31.56%,KEAP1;LATS1;DBN1;PKD1;NFKBIA;SUFU;PKD2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6838936285369733,1.139482613841011,0.32075471698113206,0.8833845607574525,1.0,3/10,14.49%,RENBP;NANP;NPL
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.5068386525037072,1.1394724589344492,0.18518518518518517,0.8827386311932715,1.0,12/77,5.99%,SEMA5A;RRAS;FGFR1;SIRT1;FGF2;RIN2;HIF1A;ANGPT1;CD40;STAT5A;SP1;ANXA3
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5114506272026004,1.1394622006223147,0.23636363636363636,0.8821028000357972,1.0,8/50,10.64%,TVP23B;LTBP2;MTTP;PCSK5;RAB3C;ABCA1;CYB5R4;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6223957954089604,1.1390346994127367,0.27586206896551724,0.8829637612017788,1.0,5/19,14.44%,CGNL1;LZTR1;FBP1;ARHGAP25;SPRY3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5323452762089729,1.1389297543768042,0.2,0.8826932798869452,1.0,5/35,8.68%,TVP23B;LTBP2;MTTP;RAB3C;ABCA1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.7210361278108182,-1.138385531570866,0.3695652173913043,1.0,1.0,2/6,4.63%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.6882567117757059,1.1382443468572476,0.2982456140350877,0.8844814508415684,1.0,1/9,6.39%,PCSK5
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5474875950237402,1.1381610526224728,0.30612244897959184,0.8841465346440395,1.0,7/34,5.36%,F2;C6;CFH;C3;CPN1;C9;CD59
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7335094251850617,-1.1380829022911196,0.34146341463414637,1.0,1.0,1/5,4.85%,PDHX
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5539686939787134,1.137775682044349,0.23076923076923078,0.8847032977966846,1.0,8/48,16.50%,NYAP2;CNTNAP2;TNIK;GPM6A;PLXNB1;SNX2;SGK1;DBN1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6135305975679516,1.1376033298424337,0.3442622950819672,0.8845504536929526,1.0,14/28,25.43%,TOX;NPY;MDGA2;ZC4H2;PROX1;NR4A2;LRP6;CTNNB1;GRID2;MAP2;WNT2;RYK;SPOCK1;CEND1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6367250510234183,1.1375420904023315,0.23636363636363636,0.8840255555982458,1.0,3/18,17.02%,PLOD2;GAMT;PLSCR1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.5283486328025077,1.1374452120296714,0.288135593220339,0.8836375406993302,1.0,12/37,16.75%,FGF2;TRPV2;F2R;SLC8A1;PLCG2;SLC24A2;HTR2C;LCK;GRIN2D;TRPV3;TRPM2;RYR2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6930519658113254,1.1372464476193078,0.4423076923076923,0.8837940953837715,1.0,2/7,8.13%,MYC;FOXO1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6504922070552479,1.1370398834903965,0.3793103448275862,0.8840681932846259,1.0,3/15,17.12%,SYVN1;AUP1;DERL2
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.7855043156442413,1.1368277589734663,0.41509433962264153,0.8839707098710735,1.0,1/5,0.76%,PCDH15
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6047621955573022,-1.1367569319733573,0.38,1.0,1.0,1/14,1.71%,ENTPD2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6513152236004982,1.1367219207334232,0.3137254901960784,0.8836653077697066,1.0,6/16,21.56%,PDGFRA;FER;PDGFC;BCAR1;RGS14;ABL1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.6557631609156338,1.1366270544206114,0.296875,0.883405557755538,1.0,2/11,13.65%,RNF185;RNFT1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.616831547851823,1.1361049847987414,0.3333333333333333,0.8845914424861747,1.0,1/12,4.99%,MLLT3
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6758556417817376,-1.1357786571272408,0.30434782608695654,1.0,1.0,3/14,9.11%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6865593198801779,1.1356506967805633,0.3333333333333333,0.8856853042068229,1.0,4/8,29.20%,PRIMPOL;POLG2;DNA2;POLG
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6247853812117445,1.1356047803245468,0.3157894736842105,0.8851540513327099,1.0,3/20,16.04%,LIN28A;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7240581263429033,1.1349215549947655,0.39622641509433965,0.8869939268843482,1.0,2/5,21.68%,SLC15A2;BIRC3
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.7612014419429948,-1.134788781432838,0.4090909090909091,1.0,1.0,2/5,14.58%,RRM2;RRM1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5697174477876612,-1.1344846321146482,0.25,1.0,1.0,15/33,24.41%,SMUG1;RFC3;PARP1;XRCC1;LIG1;RFC2;RPA3;RFC1;PNKP;LIG3;MBD4;POLL;PARG;APEX1;RPA2
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7299329014805505,-1.1339817298472172,0.32608695652173914,1.0,1.0,1/5,3.26%,TST
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5473566576737305,1.1335605410419256,0.3050847457627119,0.8909835133153788,1.0,16/59,22.90%,IGF1;RAB27A;BMP2;ACHE;UNC13B;SNCA;PLA2G10;MYOM1;RAB9A;RAB27B;CD2AP;STXBP5;GOLPH3L;CADPS2;EDN1;CADPS
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.6915438068162532,-1.1334009317345615,0.3684210526315789,1.0,1.0,2/7,10.15%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6464961595402834,1.1332464820157346,0.4107142857142857,0.8915474368958671,1.0,2/8,16.93%,RORB;RP1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.5844910388478002,1.1331268174294096,0.3076923076923077,0.8911932715737708,1.0,5/29,6.06%,RUNX1;SOX5;FGFR3;BMP2;SOX6
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5702208125122942,1.1331075344902752,0.2903225806451613,0.8906239653092808,1.0,9/28,21.32%,SLC7A2;SLC1A3;SLC38A3;SLC7A9;SLC25A13;SLC3A2;SLC36A1;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.4959307998328165,1.1330428241058346,0.24561403508771928,0.8902710060494393,1.0,6/28,12.84%,ADRA1A;SCN10A;SLC8A1;ANK2;NPPA;PDE4B
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6057605064301725,-1.1330240761741581,0.3,1.0,1.0,4/19,6.08%,KCNE2;SCN5A;CACNA1G;KCNE1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.645000830219075,1.132878878338506,0.3018867924528302,0.8902415875914146,1.0,4/14,14.80%,LRRC4C;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6261530599935197,1.132675056458486,0.35,0.8904363660646627,1.0,4/17,13.15%,ODC1;ZDHHC2;CHMP6;CHEK2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.449496184199152,1.132161415560185,0.22413793103448276,0.8916074458245428,1.0,25/187,11.61%,PNP;SLC7A11;CCNG1;EGLN3;CDC25A;STARD4;PLOD2;PHGDH;SHMT2;INSIG1;NFIL3;LDLR;ADD3;SCD;ADIPOR2;IDH1;FGL2;ELOVL5;UBE2D3;HMGCS1;BCAT1;CYB5B;MTHFD2L;PSMD13;GMPS
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.7502904873138124,1.13204411056567,0.3076923076923077,0.8913622373376593,1.0,4/6,23.39%,PLCG2;TICAM1;KIT;CAMK4
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.48187488566895165,1.131916307711926,0.23728813559322035,0.8912068533124528,1.0,19/72,17.33%,LHFPL3;PCDH15;CDC14A;ROR1;ADGRV1;ALDH7A1;EPS8L2;WHRN;CCDC50;USH2A;TBL1X;ATP6V0A4;TPRN;SLC26A4;COL11A1;GRM7;LRP2;MYO3A;TIMM10
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6453434877752177,1.1318832424863974,0.30357142857142855,0.890640469463057,1.0,1/9,1.31%,SMAD6
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.45421114234788207,1.1315619516438462,0.20689655172413793,0.8908253053668665,1.0,55/154,25.86%,SCN7A;FSTL5;LSAMP;LIX1;LRRC4C;EFNA5;CADM2;CYB561;TOX;PCLO;PCDH17;NRXN1;OLFM3;NOVA1;PIK3CA;ANK2;SCN3A;GUCY1A2;ZDHHC2;FBXO7;ADGRB3;PAK5;TMEM196;CNTN1;TSHZ1;ZNF536;RET;CPE;MAPK10;CNTN2;HMGCLL1;SLC7A14;TAFA1;STXBP5;TAC1;CSRNP3;STMN4;RBFOX1;GOLGA7B;ELAVL4;HIVEP3;MAP2;KCTD16;SNX21;ADGRL3;AKAP6;SCRT1;RGS7BP;PARVA;CLVS2;SNAP91;GAL;ASXL3;PPFIA2;DCLK1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5159120529107724,-1.1315045572684306,0.3181818181818182,1.0,1.0,7/46,7.46%,PM20D1;ASS1;PNPLA1;SPTLC3;ARG2;DEGS2;ALOXE3
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.7778652575035742,-1.1315012573781233,0.3333333333333333,1.0,1.0,2/6,8.26%,CD24;PAX2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.570236000177185,1.13132840965984,0.2962962962962963,0.8911884019114986,1.0,1/29,0.38%,GATA4
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.7605282507024866,-1.1313159511125035,0.3888888888888889,1.0,1.0,1/5,0.27%,TERT
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.48962403979767455,1.1312926283998326,0.29411764705882354,0.890676799504202,1.0,7/45,10.37%,PLCH1;ITPKB;PLCG2;INPP1;NUDT4;IP6K3;INPP4B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5159149095238962,1.1309811397743554,0.23214285714285715,0.8911196938438145,1.0,12/51,25.81%,PATL2;SAMD4A;DCP1B;EXOSC4;CNOT6L;CNOT4;CNOT8;CNOT2;EXOSC1;PAN3;PATL1;LSM2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.7375489296160422,1.13097848385738,0.3064516129032258,0.8904752872648956,1.0,1/7,10.09%,SFXN2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7166903881707645,1.130923038115685,0.38596491228070173,0.8899831325955222,1.0,2/7,11.46%,CCL5;PLAUR
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.6783233460178785,1.1308413813052265,0.34,0.8895895318291652,1.0,6/11,27.07%,IL7R;PTPRT;MGAT5;JAK2;DOT1L;PTPRC
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6444496095183732,-1.130808046996438,0.30612244897959184,1.0,1.0,1/17,1.02%,PLAAT4
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.7819540408930249,1.1303846109818787,0.30158730158730157,0.8905473966602339,1.0,2/5,13.66%,MTSS1;MEF2C
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6880154835791161,1.1301922836646334,0.39215686274509803,0.8906424103298249,1.0,3/10,12.96%,RUNX1;LYN;BLK
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5623569094238754,1.1301833134067973,0.3275862068965517,0.8900184548515674,1.0,8/27,17.52%,LHFPL2;GLRA1;APELA;PLA2G10;HYAL3;ACVR1B;VEGFA;PLCB1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5812985816861631,1.1300161713142471,0.32142857142857145,0.8899629603978719,1.0,2/21,5.84%,TUBA1C;CCDC88B
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5992681122774155,-1.1299327113025428,0.32558139534883723,1.0,1.0,4/15,13.91%,F7;IL6R;PTK2B;EDN3
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7084785732502232,1.1295797886581966,0.33962264150943394,0.8901178654938869,1.0,2/7,8.13%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7084785732502232,1.1295797886581966,0.33962264150943394,0.8901178654938869,1.0,2/7,8.13%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7281295450775919,1.1295495523565386,0.3559322033898305,0.8889459964631656,1.0,1/7,1.52%,HGF
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7281295450775919,1.1295495523565386,0.3559322033898305,0.8889459964631656,1.0,1/7,1.52%,HGF
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.7104970492698259,-1.1295044383192896,0.4222222222222222,1.0,1.0,3/6,23.86%,TGFB1;FGFR2;TGFB2
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7488302459316805,1.1292571677195715,0.31666666666666665,0.8892625841760066,1.0,2/6,17.03%,LDLR;LRP2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6843667433376001,1.1291654179879336,0.36538461538461536,0.8888547089297704,1.0,1/9,3.02%,ERBB4
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.6665046317700164,1.1290454380216974,0.4107142857142857,0.8886238839046378,1.0,2/11,4.41%,PADI2;PRMT1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5067416402013789,-1.128941359673134,0.3469387755102041,1.0,1.0,14/70,17.81%,UVSSA;ERCC1;RFC3;PRPF19;GTF2H2;XRCC1;COPS7A;LIG1;RFC2;RPA3;RFC1;COPS7B;COPS6;LIG3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5558742272097232,1.1288155324757956,0.25806451612903225,0.88879013584538,1.0,1/35,0.36%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7611630805592607,1.1287474932755845,0.3333333333333333,0.8884275410016539,1.0,2/5,21.82%,TENT4B;ELAVL4
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.629899601992719,-1.1285690249952431,0.32075471698113206,1.0,1.0,4/14,9.48%,P2RY11;KCNJ11;TRPV1;P2RY12
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5108390226844741,-1.1282021458187061,0.26666666666666666,1.0,1.0,6/57,2.72%,P2RY10;IRF4;PRDM1;CD24;KCNA3;CD53
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.45967426157823,1.1280844094335674,0.23728813559322035,0.8899758767903392,1.0,33/139,17.94%,SCN7A;LSAMP;CADM2;SLC17A6;NKAIN2;GDAP1;SCN10A;NEFH;VAMP1;PARM1;RAB3C;NRXN1;SYNPR;PTPRD;OLFM3;NOVA1;CLGN;ANK2;MAGI2;GRM5;ZDHHC2;LRRTM3;ADGRB3;PAK5;TMEM196;SCN9A;ZNF536;LRFN5;CPNE3;DLG2;DGKZ;MAPK10;CNTN2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.66578581323486,1.1280231539282182,0.2857142857142857,0.8895689617784384,1.0,6/7,33.30%,DDR2;MELTF;CLASP2;CLASP1;PDPN;CARMIL2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.74599070823295,1.1278948742654904,0.38461538461538464,0.8894175737678225,1.0,2/5,7.76%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7074929933884689,-1.127625433793729,0.37777777777777777,1.0,1.0,3/8,13.35%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7074929933884689,-1.127625433793729,0.37777777777777777,1.0,1.0,3/8,13.35%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.7167232563407715,-1.1275342383013516,0.34782608695652173,1.0,1.0,1/6,2.40%,DRD4
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6881309480920124,-1.1274357913981528,0.4230769230769231,1.0,1.0,1/6,1.06%,NLRP1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6680335374827058,1.127338007714892,0.3275862068965517,0.890794927398951,1.0,5/11,18.74%,IRS1;NR1H4;AKR1C1;DGAT2;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.766940840512236,1.1272190362022796,0.4090909090909091,0.8905550896834343,1.0,2/5,13.61%,HAP1;CEP135
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.734332090729898,1.1271232391373893,0.3541666666666667,0.8902015632407354,1.0,2/5,13.71%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6509222126123213,-1.1270608398753883,0.3333333333333333,1.0,1.0,3/8,17.92%,ALOX12B;AQP1;CYP4F2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.576971840132911,1.1270239006482587,0.3018867924528302,0.889918671729113,1.0,11/25,27.94%,RAB31;GGA1;GOLPH3L;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;ARFRP1;RAB34;SPTBN1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.42245644913902075,1.1268033638294177,0.12903225806451613,0.8902143005607592,1.0,51/211,17.09%,DRD5;GABRR1;CHRM2;SLC12A7;GABRE;RIT2;GABRR2;PNOC;GRM3;HTR1F;HRH3;SLC1A3;NLGN1;GLRA1;PENK;OPRK1;NPY;CACNB4;GABRG3;SYPL1;SYT1;NRXN1;UNC13B;NOVA1;SNCA;GPR176;NLGN4X;GRIK2;GRM5;HTR2C;RPS6KA2;CEL;SCN2B;HAP1;KCND2;HTR7;HCRTR1;UTS2;GLRB;GABRA5;GRM4;ZACN;GABRG1;GABRB2;APBA1;LRP6;GRM7;GRM1;DLG2;GRIK1;KCNQ3
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6374563822475184,1.126759503452442,0.39622641509433965,0.8896867243806568,1.0,6/12,20.31%,RORB;TULP1;RP1;VEGFA;ARL3;RP1L1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.6820808810548885,1.1267051291874788,0.32727272727272727,0.8892298811839573,1.0,4/8,13.95%,IL4;RORC;HMGB1;TMEM98
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.45365413594617676,1.1264430080928935,0.1864406779661017,0.8895778097459925,1.0,47/139,24.29%,LGALS9;TNFRSF19;ROR1;CD40;CANT1;F2R;SLC35B2;TIFA;MID2;PELI2;RELA;PELI1;TICAM1;PPM1A;TAB2;CD74;TSPAN6;EEF1D;IRAK1;CARD16;TRIM52;TAB3;GPRC5B;ZDHHC17;TNFRSF10B;F2RL1;LGALS1;NDFIP2;TFG;BIRC3;SLC20A1;ZDHHC13;C18ORF32;ATP2C1;GPR89A;FADD;CARD9;PIM2;IKBKB;ANKRD17;RIPK2;TRIM68;CASP10;MIER1;IKBKE;WLS;TRAF5
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.49741673420125415,-1.1264166939459967,0.2549019607843137,1.0,1.0,14/70,13.02%,ANXA8;CLDN4;TMEM184A;PTGES;C6ORF132;IER3;CYP24A1;LAMB3;ABCC3;ADAM19;PARP1;PHLDA2;MALL;IL18
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.7231446855560328,1.1258038842215612,0.36507936507936506,0.8911392766620502,1.0,4/6,25.59%,IL23R;CARD9;IL23A;SMAD7
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7020690608117267,1.1257637084167365,0.4230769230769231,0.8906300076435969,1.0,2/6,16.93%,RORB;RP1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.6142537510511242,1.1256949162137573,0.3333333333333333,0.89029590082328,1.0,11/22,19.87%,GPR55;IL4;MAFB;IL23R;ZNF675;LRRC17;CSF1;GPR137B;FBN1;FSTL3;TMEM178A
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.7586858787147955,1.125648232602624,0.3333333333333333,0.8897792521733184,1.0,1/5,8.90%,SLC44A4
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6764994491936062,1.1252041557480346,0.3050847457627119,0.8904216474543099,1.0,4/13,18.76%,FGD4;VSTM5;DNM3;ARHGEF4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.43720426112188143,1.1251252079432152,0.14814814814814814,0.8900448938429173,1.0,29/250,9.77%,GATA4;PNP;SYK;LGALS9;IL26;NOX5;C3;RUNX1;ZBTB7B;LY9;FZD5;IL4;HIF1A;TMIGD2;CD40;F2R;IL23R;RORA;CCDC88B;STING1;RELA;SCRIB;PLCG2;HPSE;TICAM1;TLR2;HMGB1;ITK;IL15
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.743673991373561,1.1250509909558732,0.39655172413793105,0.8896773761852977,1.0,1/6,3.01%,SLC7A2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.45880113797859434,1.1249740858536803,0.26785714285714285,0.8893277650196041,1.0,15/126,7.13%,PPP1R3A;GATA4;MITF;RBM20;SMYD1;SYPL2;PRKG1;FGF2;RRAD;PDE1A;ADIPOR2;MTTP;NMRK2;PDLIM5;ASB5
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.6195596024323564,1.1249389472112847,0.3148148148148148,0.8888397073200702,1.0,5/16,9.04%,IGF1;ICOSLG;TMIGD2;IL23R;HMGB1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.49766328350942574,1.1247528452873183,0.26,0.8892027852597055,1.0,16/87,11.00%,SLC26A3;LAMA4;MOGAT2;SEMA5A;LSAMP;SCGN;MTTP;FREM1;BGN;PDGFRA;ADGRG4;PTPRD;ITGA1;FGF14;PROX1;MUC17
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7605290757898524,1.1245045920654726,0.3469387755102041,0.8896260471290403,1.0,6/7,22.82%,BOK;DLC1;TP53BP2;PTGIS;TP53;FAP
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.5497094385960996,1.124458114254108,0.2777777777777778,0.8891734832752858,1.0,10/33,18.48%,TGFBR1;MYC;URI1;ACVR2A;HTRA2;BMPR1A;CPNE3;ACVR1B;LRP2;CTNNB1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5148538982285373,-1.1244444727306262,0.22,1.0,1.0,2/33,1.73%,TERT;NOSTRIN
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.519487545770578,1.1242183472408032,0.24489795918367346,0.8891545339173437,1.0,11/47,16.16%,RAB27A;SEPTIN4;RALA;SYT1;RAB3C;SNCA;RIMS2;CHMP6;HAP1;RAB9A;RAB27B
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.6821440474290839,-1.1240694450957291,0.35555555555555557,1.0,1.0,1/9,0.94%,GUCY2C
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.735536084583916,1.1239375530886426,0.2909090909090909,0.8895682725285132,1.0,3/8,24.03%,BACE2;ITM2B;ABCA7
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.5770948906301171,-1.1237217344819201,0.3333333333333333,1.0,1.0,2/19,10.44%,EPOP;ATXN7L3
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.711966518091181,1.1236910562308704,0.41818181818181815,0.8897825397932171,1.0,2/5,27.70%,NAA16;NAA30
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.46778857765733944,1.1232990734847628,0.23636363636363636,0.8905149568995792,1.0,19/78,11.99%,SULT2A1;ACSM2A;C6;SLC26A7;CYP4F12;OIT3;KNG1;SLC15A1;RORC;HSD17B2;AGXT2;ABCG8;SLC7A9;FRK;CYP3A4;CYP4F3;ABCG5;TMEM45B;SLC10A1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6545932444074262,1.1232295805097938,0.41818181818181815,0.8902187953720992,1.0,2/11,5.97%,HGF;MUC20
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.7969743037575113,1.1230558448979402,0.36363636363636365,0.8901387704412199,1.0,1/5,9.04%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6197509141974895,1.1227401187240524,0.3770491803278688,0.8907659051314376,1.0,3/12,3.88%,RAPGEF3;IL4;EHD1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5916016305300505,1.122678071559764,0.3508771929824561,0.8903495661951448,1.0,10/24,23.52%,FZD5;PLCG2;KIT;HLA-E;F2RL1;CD55;HLA-F;TNFSF4;RAET1G;CD160
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.6439469034093361,-1.122519713223134,0.391304347826087,1.0,1.0,2/11,6.01%,GOLGA2;PLK3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6907756202279117,1.1225172202701585,0.4,0.8902868393113004,1.0,2/9,13.05%,NEDD4;HECW2
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.4453725214074094,1.1223707201891784,0.23214285714285715,0.8900693258057827,1.0,21/150,9.26%,MXRA5;MRGPRF;CXCL12;C6;CFH;C3;RSPO3;ADGRL4;PPARG;LTBP2;STEAP4;COL6A2;PLSCR4;POSTN;FAM114A1;BGN;CAVIN1;PDGFRA;OLFML3;TLR2;CYP27A1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.40343871670228026,1.1222571192422959,0.16666666666666666,0.8898263258646075,1.0,100/459,21.66%,DACH1;TIMELESS;SIRT1;TSHZ3;ENPP1;NRG1;IL4;FOXP2;NFIL3;CDKN2A;PPARG;MDFIC;WNT4;RORB;SFMBT2;LIN28A;PATL2;SAMD4A;BMP2;SYNCRIP;SIX4;SLFN11;GMNN;RELA;RBPJ;ZEB1;FOXO1;ZNF706;HDAC3;HDAC2;CBFA2T3;TOB1;ATXN1;YAF2;PROX1;RNF139;TLE2;NPAS1;CTBP2;EZH2;SMAD2;RIDA;PTPRK;SPINDOC;NR1D2;PASD1;MBTD1;MLXIPL;SP3;PML;SMAD4;DPF3;BCL3;HSPA8;DPF1;BCOR;MAGEL2;ZNF639;ATF7IP;ZNF281;TERF1;PRICKLE1;RUNX1T1;CAPRIN1;ZBTB33;KAT6A;LOXL2;EPC1;POU2F1;NR2F2;MYB;DEAF1;SPEN;PLCB1;BMP4;HMGA2;CNOT8;BAP1;CTNNB1;MESP1;FOXN3;RPS6KA5;SMARCA2;HDAC1;ATP8B1;HDAC9;ZNF12;MTERF3;FMR1;CITED2;EED;PSPC1;SFMBT1;ZBTB4;KLF10;NR3C1;ID4;HEXIM2;NAB1;BMPR2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4693708665792594,1.1219569431235312,0.32653061224489793,0.8903999117924036,1.0,20/121,10.60%,LGR5;DRD5;CALCR;CHRM2;ADGRL4;PTGFR;HTR1F;OPRK1;RXFP2;GNAT3;GPHB5;GRM8;ADGRG4;ADGRL2;ABCA1;GPR12;GPR26;RAMP3;GNAI3;GPR161
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.6666218351968027,1.121910341187335,0.2727272727272727,0.8899080291149343,1.0,1/9,3.00%,CCL5
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.7732742924215695,-1.121523978175675,0.4444444444444444,1.0,1.0,1/5,6.81%,ST6GALNAC2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.640406685597136,1.1214818123597143,0.2692307692307692,0.8908496823403452,1.0,2/16,7.04%,MOGAT2;LPIN3
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6965953565984534,1.1213725641950387,0.36923076923076925,0.890555374651845,1.0,4/7,22.65%,PLCG2;FAM3A;CX3CR1;CARD9
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.48253281227453126,1.1211658328368614,0.30158730158730157,0.89056992235299,1.0,17/71,25.07%,RBM20;HNRNPH1;AFF2;KHDRBS2;FASTK;QKI;KHDRBS3;DYRK1A;PTBP2;RBM12B;BRDT;FUS;HSPA1A;RRP1B;MBNL2;SRSF3;HNRNPF
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.728183243824225,1.1210673544211118,0.3333333333333333,0.8903275971144929,1.0,3/7,15.23%,ELAPOR2;MAFF;KLF7
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.701022205667298,-1.1208828234659842,0.36,1.0,1.0,2/8,11.10%,TAF7;SPI1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5468616352558326,1.1207729307478842,0.3114754098360656,0.8908299606842581,1.0,4/39,9.05%,SLC7A11;SLC38A4;SLC38A3;SLC7A9
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5804188837939306,1.1207301280096287,0.26785714285714285,0.8903398522834766,1.0,5/19,11.72%,LRP4;NLGN1;NRXN1;NLGN4X;CEL
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7571855464677824,-1.1206162409963443,0.3617021276595745,1.0,1.0,1/5,4.04%,ALOX5
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.6863719980319776,1.120018433980673,0.375,0.8923622766218751,1.0,4/10,14.07%,SHMT2;GCAT;RIDA;GLYAT
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4800540633249453,1.1199975221892826,0.2641509433962264,0.8918290918330908,1.0,9/59,11.49%,SMAD6;TGFBR1;SIRT1;IL17RD;PPM1A;DAND5;LTBP1;FAM89B;SMAD2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5892807289301559,-1.1197817855995285,0.32608695652173914,1.0,1.0,13/25,23.81%,AFG3L2;APOO;SPG7;LETM1;DNAJC11;DMAC2L;ATP5F1E;ATP5ME;SAMM50;ATP5F1A;ATP5PB;ATP5MC3;ATP5F1B
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6938642383128762,1.119771873213808,0.32075471698113206,0.8919280006287552,1.0,4/8,25.07%,RAP1GDS1;MCU;MICU1;BCAP31
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.6677281558795398,1.1197263878948418,0.36538461538461536,0.8914214460197362,1.0,3/12,10.58%,GATA4;BMP2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7039819888419072,1.1196131148717237,0.38181818181818183,0.8911797131746488,1.0,2/7,18.59%,F2R;SPX
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.68852852273278,-1.1194745460970335,0.35555555555555557,1.0,1.0,1/5,3.17%,SFRP1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.5167207627427469,1.119409893747501,0.25,0.8914406303347422,1.0,15/58,17.72%,SMAD6;GDF6;TMEM100;BMP2;ACVR2A;ZFYVE16;HJV;SMAD1;SMAD2;BMPR1A;SMAD4;SLC39A5;GDF9;SMAD5;BMP4
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.7144555640870376,-1.1193811237535796,0.43243243243243246,1.0,1.0,1/7,0.94%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5615703359146482,1.1192654464623577,0.3148148148148148,0.8914204250852656,1.0,10/37,18.39%,F2;PYHIN1;GLUL;WWTR1;LATS1;MFHAS1;BMP4;GTSE1;LIMK2;BYSL
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.7066953503868052,1.119245212918361,0.39622641509433965,0.8909071417665066,1.0,2/11,9.33%,MME;OPN1SW
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.6533056482571888,1.1190287582311347,0.3275862068965517,0.8910062802805574,1.0,5/12,22.95%,ELOVL5;TECRL;TECR;ELOVL4;ELOVL6
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.47682962353528935,1.1189507298194907,0.22727272727272727,0.8906977625775931,1.0,6/73,15.04%,CDC20B;FBXO5;ANAPC16;PSMD13;PSMA1;PSME4
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.40937698781498966,1.1186710784388922,0.23076923076923078,0.891102333654005,1.0,95/486,17.99%,VEGFC;IGF1;CXCL12;FLT1;FGF10;CALCR;IRS1;TNFRSF18;FGFR1;TGFBR1;SIRT1;MLC1;ITGAX;NRG1;FGF2;FGFR3;IL4;CCL5;ERBB4;MYC;PTGFR;HAS2;RAB27A;TCIRG1;IL7R;PRMT1;CDKN2AIP;F2R;LGI1;MYRF;TULP1;HCLS1;SLFN11;FLT3;WWTR1;RELA;DPP4;FBXO5;PDGFRA;ITGAV;POU3F2;RHOD;FER;LIFR;TLR2;HDAC2;SLC44A4;CDCA7L;RAMP3;PDGFC;IL15;PROX1;FGF17;EXOSC4;SINHCAF;EZH2;FGF5;LYN;EFNB2;MVD;CNOT6L;SLC30A2;MLXIPL;GREM1;CDK4;FRMD5;MAPK8;NOXO1;SMC5;PTEN;SERTAD1;MAPK15;ZNF639;PPP3CA;IGF1R;ACACB;IL2RB;FASN;CSF1;ACACA;GDF9;LRP6;PRLR;RYR2;MARCHF7;VEGFA;DERL2;RHOG;CAPN10;PHIP;GAB2;BMP4;PRKAA1;HMGA2;CNOT8
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.6863527609319386,1.1186473191985056,0.37037037037037035,0.8905398364507492,1.0,3/8,17.39%,CLMP;KIT;COBL
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.7560646285156842,1.1183205477532494,0.36065573770491804,0.8911049250081533,1.0,2/5,13.41%,RBPJ;GREM1
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7592839225978891,1.1178156635184628,0.28,0.8922618659953614,1.0,2/5,8.60%,PNP;ADA
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.666887846190031,-1.1176695379726687,0.40425531914893614,1.0,1.0,6/10,22.13%,P2RY11;TRPV1;P2RY12;CIB2;P2RX4;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.45179446912563315,1.117665150204535,0.28846153846153844,0.8921227559572765,1.0,9/86,11.52%,LIN28A;PATL2;SAMD4A;SYNCRIP;EIF3E;C8ORF88;TOB1;RNF139;RIDA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6226248097035114,-1.117590178680869,0.32558139534883723,1.0,1.0,1/10,2.91%,PRKCD
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.6815711700182105,1.1175329974196055,0.35,0.8918992945051992,1.0,3/7,8.54%,SOX6;MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6754602204742786,-1.1172700689723434,0.3488372093023256,1.0,1.0,4/7,12.32%,GPX3;PRKCD;XRCC1;RNF112
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6277826395050744,1.117205791904569,0.35185185185185186,0.8925463520401409,1.0,2/12,8.95%,HGF;PYCR1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6560007146224159,-1.1169985953305572,0.39622641509433965,1.0,1.0,2/9,8.45%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6343797507929145,1.116919162164036,0.35714285714285715,0.8928125864173374,1.0,8/12,27.07%,ZFP36L2;RAG2;LIG4;RAG1;SHH;FADD;MR1;PTPRC
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6206007390665074,-1.1165943245059977,0.3695652173913043,1.0,1.0,4/16,15.18%,HLA-DRB1;IL18BP;IL18;BTN3A2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.46729289983454564,1.1165426200055437,0.24528301886792453,0.8932809363612048,1.0,29/120,16.11%,TGFBR1;RUNX1;FZD5;PBX3;WNT4;RORB;TENM3;OLIG1;TENM1;UGDH;OLIG2;MANF;FUT9;EPHA5;LHX6;POU3F2;NEUROD2;PTPRD;PAX6;INSM2;NLGN4X;USH2A;NR4A2;EMX1;MEF2C;MYT1L;FZD4;FZD1;LRP6
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.6871951355647066,-1.1164107205114249,0.37209302325581395,1.0,1.0,4/6,28.19%,SVIP;USP14;UBXN1;AQP11
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.6895423041459446,1.1163075932706572,0.3148148148148148,0.893394532836496,1.0,2/12,7.89%,SYK;PLCG2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.497102620443196,1.116052222036046,0.20754716981132076,0.8937775777538096,1.0,9/38,20.78%,CTCFL;METTL21C;PRMT1;EZH2;CAMKMT;ATPSCKMT;VCPKMT;NSD1;FAM98A
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.621750941316199,-1.1158316391604655,0.39622641509433965,1.0,1.0,1/9,1.76%,PRDM1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7665709932122746,1.1157776131588244,0.3541666666666667,0.8934146645579093,1.0,2/5,7.76%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7665709932122746,1.1157776131588244,0.3541666666666667,0.8934146645579093,1.0,2/5,7.76%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.6976351642707613,1.1157036496980954,0.30612244897959184,0.8929813538172905,1.0,7/10,28.44%,TBX18;MEF2C;BMP4;TMEM204;HEY2;MRTFA;MRTFB
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.429771157330884,-1.115600377079443,0.2222222222222222,1.0,1.0,18/175,7.34%,CD44;MGP;COL4A2;COL5A1;COL4A1;SFRP1;FZD8;CRLF1;FBLN2;COL6A3;COL1A1;TGFBI;GPC1;MFAP5;RGS4;JUN;DAB2;SPARC
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6151895643273215,-1.1155279294456335,0.35555555555555557,1.0,1.0,5/14,16.72%,DUOX1;VGF;KCNJ11;STAT1;RYR1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6388410542658708,1.1149904101775632,0.3582089552238806,0.8949599823010184,1.0,7/13,15.43%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;SERTAD1;ARID1B
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5024085359857987,-1.114964257222219,0.3181818181818182,1.0,1.0,7/60,2.73%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.6215321619541926,-1.1148743306973528,0.32558139534883723,1.0,1.0,7/15,14.49%,KCNE2;KCNA5;KCNE1;KCNN2;KCNQ1;KCNJ5;ATP1B1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5344960476285663,1.1148461237903267,0.36065573770491804,0.8948536494397868,1.0,8/31,14.96%,SLC26A3;SLC26A7;SLC17A6;SLC22A3;SLC4A1;SLC19A1;ABCC11;SLC26A4
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.549614507711362,1.114728878734585,0.30357142857142855,0.8946467801305872,1.0,5/43,6.87%,RBM20;MYCN;LIN28A;RELA;RIOK2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7486318519928028,1.1146609725349774,0.36,0.894280891121491,1.0,2/6,12.17%,TSHZ3;ATP1A2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4599585859759763,1.1144278439435962,0.24561403508771928,0.8945020160378447,1.0,22/94,17.10%,C1QL1;LRP4;GNG12;TENM3;CDH2;IL17RD;SIX4;ADGRL2;LIFR;CNN3;GPR161;MAGI1;SERTAD4;CDR2L;ADRA2C;FIGN;GLRB;BCAR1;FJX1;NR2F2;PTPRU;NXN
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.7191658378877299,-1.1143911828511595,0.35185185185185186,1.0,1.0,1/9,0.24%,ACTC1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.4161687653871337,1.1139299881931444,0.2631578947368421,0.8956438583711419,1.0,55/247,18.26%,IRGM;SLC26A3;DRD5;IRS1;RAPGEF3;INSIG1;AANAT;SLC26A6;KCNC2;BRINP3;RORB;NRIP1;GLRA1;RORA;RORC;RELA;ESR1;PDGFRA;FOXO1;TICAM1;FER;EPHA3;TLR2;RAMP3;HMGB1;HTRA2;NLRP7;ABL2;PTPRK;LYN;HCN1;PDE4B;RRAGC;NR1H4;MEF2C;NR1H3;PXN;STRA8;MAPK8;TNIP3;PTK7;FZD4;CD80;RAP1A;CPEB1;NCOA3;CREB1;RET;ZFAND1;SLC5A5;IRAK1;CARD16;NFKBIB;AXL;WNT8B
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5805429499728909,1.1137515694522584,0.3877551020408163,0.8957214982596344,1.0,3/24,10.57%,SEMA5A;ALCAM;AUTS2
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5353514373395428,1.1136817482708679,0.29310344827586204,0.8953725996691921,1.0,4/35,3.41%,SLC26A3;RAPGEF3;AANAT;SLC26A6
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6706493571149181,-1.1133947114978513,0.4411764705882353,1.0,1.0,3/8,25.74%,DCN;SRC;RACK1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.5580791957760156,1.1133431133751979,0.25,0.896160549871154,1.0,13/36,27.15%,FGF10;DNAJB2;RYR2;PLSCR1;DNAJB1;TOR1AIP2;POT1;ATP1B2;DNAJC9;HNRNPU;DNAJB11;DHX9;MYBPC3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.5231738117297624,1.1133361163476627,0.22807017543859648,0.8955696816998301,1.0,14/49,27.57%,ACD;MAPK15;TERF1;NEK7;TENT4B;CTNNB1;GNL3L;POT1;MAPK3;HNRNPU;NAF1;HMBOX1;HNRNPC;CCT3
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.6490384159293245,-1.1131363787096797,0.34210526315789475,1.0,1.0,3/8,12.55%,WNT7A;ARF1;WNT5A
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.6822814606668696,1.1130933379152346,0.28846153846153844,0.8958724519883726,1.0,2/6,11.10%,TCAF2;GRM5
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4824746785470241,1.112892576725157,0.30434782608695654,0.8959413300970038,1.0,11/95,13.80%,SYK;CTDNEP1;SIX4;TOR1B;BANP;NXT1;RRS1;TAF3;RANBP17;PML;BCL3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4961185421132851,1.1127340293854509,0.3157894736842105,0.8957851300152563,1.0,16/57,17.44%,FGF10;NPHS2;TNIK;RALA;GAB1;FER;AUTS2;EFS;MCU;GSN;CASS4;BCAR1;PTK7;KIT;RICTOR;CAPN10
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6143346270219254,1.1127283283685112,0.3728813559322034,0.8951794850462247,1.0,4/18,12.96%,RUNX1;CD22;LYN;BLK
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.7147791112036819,1.112706739826936,0.41818181818181815,0.8946329189342662,1.0,1/6,1.59%,RENBP
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.4736973548775395,1.112629251820818,0.19642857142857142,0.894428041433092,1.0,30/107,22.90%,NXPH1;LSAMP;RIT2;GRM3;KCNC2;SLC17A6;NRXN1;FUT9;SYNPR;OLFM3;MAGI2;GRM5;CTNNA2;LRRTM3;PAK5;TMEM196;NOL4;GABRG1;GRM1;DLG2;CNTN2;UNC79;CSRNP3;SLC1A6;STMN4;RBFOX1;TRPM3;AMER2;KCTD16;CADPS
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.6728056660319734,-1.1124615409449052,0.3888888888888889,1.0,1.0,3/7,8.84%,SFRP1;UBASH3B;CARTPT
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5048084945694659,1.112435196017865,0.3018867924528302,0.8944727421541835,1.0,17/64,19.68%,MME;FAIM;CHODL;ROBO2;PTPRD;SMARCD3;LIG4;PLXNB1;PLXNB2;CAPRIN1;VEGFA;LRP2;SPEN;CDKL5;CTNNB1;NUMB;RGS14
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6812758967228092,1.1124286557153542,0.3728813559322034,0.8938862586397891,1.0,3/7,10.90%,NPHS2;MYO1E;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6059684081633039,1.1122501983663942,0.38596491228070173,0.8938482825708314,1.0,5/14,23.50%,RAPGEF3;ANP32B;GTSE1;TP53;GAS6
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7603833576036079,1.1122167012529944,0.39655172413793105,0.8933874196909674,1.0,4/5,23.32%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.7010128142008321,-1.1121622674894955,0.3469387755102041,1.0,1.0,1/5,6.71%,PEX7
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.7010128142008321,-1.1121622674894955,0.3469387755102041,1.0,1.0,1/5,6.71%,PEX7
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.6170013028811288,1.1119094560153218,0.3269230769230769,0.8937973476341496,1.0,7/22,15.59%,PPARG;ITGAV;ABCA1;PLA2G10;MSR1;NR1H3;CSF1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.6912553857727932,-1.1118776249287547,0.39215686274509803,1.0,1.0,1/5,2.35%,CTNNA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.6912553857727932,-1.1118776249287547,0.39215686274509803,1.0,1.0,1/5,2.35%,CTNNA1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.6664002938414785,1.1116521957371885,0.3148148148148148,0.8941321822319526,1.0,3/8,12.55%,CHPT1;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4046769958364918,1.1112749277966083,0.23076923076923078,0.8948969109585828,1.0,53/302,22.24%,CDC20B;DERL3;SIRT1;SPSB2;NEDD4;SYVN1;UBE2J1;PELI1;AUP1;DNAJB2;RNF185;FBXO5;SPSB4;FBXL3;UBE2D3;ANKRD9;UBE3D;SPOP;KLHL15;SPOPL;ANAPC16;PSMD13;TBL1X;FBXL14;HECW2;KLHL42;PML;UBE2J2;RNF5;PSMA1;PSME4;UBE4A;FBXL2;RMND5A;DERL2;FBXL15;NFE2L2;UBE2U;CTNNB1;NHLRC3;DNAJB9;ARRB2;FBXL20;UBE2D1;SMURF1;UBE2A;HSPA5;FBXO17;TMUB2;STT3B;FEM1B;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.5983129718169512,1.1111597609783996,0.35294117647058826,0.8946185364840933,1.0,2/21,5.65%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5948317522017339,1.1111503807831957,0.32653061224489793,0.8940430112761404,1.0,7/18,19.42%,THRSP;PRKAB2;ABCD3;ABCD2;ACACB;ACACA;ABCD4
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7085053169799117,-1.111029927461779,0.44680851063829785,1.0,1.0,2/5,17.78%,GOLGA2;CHP1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.6033694901043898,1.110960577453221,0.39285714285714285,0.8940711820742345,1.0,5/18,12.45%,TGFBR1;BMP2;CHD7;LIG4;FUT8
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5268931576748143,1.1107267694447367,0.296875,0.8942148632943261,1.0,7/40,14.16%,LGALS9;FZD5;IL23R;SCRIB;IL18R1;PDE4B;CD244
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6655021030033443,1.1100547815469661,0.4307692307692308,0.8957192488391201,1.0,3/9,8.89%,SIRT1;IL4;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.5351467031909808,1.1099700677642867,0.32142857142857145,0.8953835647941446,1.0,5/34,4.84%,SIRT1;MYC;CDKN2A;ABI3;CDKN2AIP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.4514137654965921,1.109871486501956,0.30158730158730157,0.8951224661389149,1.0,23/108,21.23%,TNFRSF19;FGFR3;LRP4;GFAP;DOCK1;SLC38A3;ARHGEF17;LIFR;FAM43B;ALCAM;PLXNB1;SLC19A1;BCAR1;KAZN;PTPRU;CPE;TNFRSF21;GPRC5B;FARP1;MPDZ;DZIP1;GPR37;ID4
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.6980254323115582,1.1096165462654544,0.4807692307692308,0.895413205729349,1.0,2/6,26.11%,LIG4;ERCC8
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.6402965278630138,1.109610680214718,0.3709677419354839,0.8948480956381251,1.0,6/15,31.08%,TELO2;GPR137B;RRAGD;SIK3;PIP4P1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7293864791028649,1.1095552742850725,0.3548387096774194,0.8944399297309004,1.0,1/6,4.74%,NLGN1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.680390509450158,-1.1093485469647295,0.3170731707317073,1.0,1.0,1/13,0.24%,ACTC1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.615712374844043,1.1092233200027581,0.3958333333333333,0.8946976834098019,1.0,3/13,15.01%,APOBEC1;RESF1;ATF7IP
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.4697258060024402,1.1089667100641225,0.2542372881355932,0.8948976267179287,1.0,16/89,18.07%,TOP2A;SIRT1;NDC80;MYC;PADI2;RFWD3;HDAC3;HDAC2;LATS1;EZH2;LIG4;LRWD1;SETD7;PADI4;HMGA2;HMGN4
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6885204111380813,1.1087268999426192,0.39622641509433965,0.8951465199481177,1.0,4/8,25.19%,TLR2;EDN1;FCER2;JAK2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.7660948990393381,1.1086750562470133,0.4074074074074074,0.8946654742551534,1.0,1/5,0.77%,LGALS9
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5816814510337441,1.108660202177972,0.37037037037037035,0.8941195392363626,1.0,6/19,13.44%,ZBTB7B;LY9;IL23R;VSIR;IL15;NR1H4
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6721637858699115,1.1085850207598413,0.36585365853658536,0.8937462614912933,1.0,4/12,10.52%,ERBB4;WNT4;SCRIB;LATS1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6401760774063983,1.1085719707266415,0.39285714285714285,0.8932016807370152,1.0,3/12,8.32%,PCM1;CCDC120;BICD1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3982734986192812,1.1084852228909123,0.1935483870967742,0.8929358074176311,1.0,82/396,19.10%,GATA4;MITF;CRX;CCNA2;TGFBR1;TULP3;ESRRG;NR5A2;PRDM8;HIF1A;NFIL3;POU6F2;MAFB;TFEB;RORB;ZNF114;HES6;BMP2;RORA;SP1;CHD7;HCLS1;SOX6;ZNF257;WWTR1;GMNN;TEAD2;RELA;ESR1;ELAVL2;FBXO5;NFIA;SLC39A8;RPS6KA4;ZNF274;RYBP;SSBP2;FOXO3;ATXN1;YAF2;ZNF195;GPBP1L1;ZNF675;GRM5;EZH2;NCOA2;CDK11A;NR1D2;HNRNPD;HP1BP3;CHEK2;MLXIPL;SP3;PML;DMTF1;MEF2C;ZNF117;RBBP6;ZNF536;PRRX2;MAGED1;ZNF281;SPIN1;MLF1;ZNF212;ACVR1B;ESCO1;ZNF502;TAF5;MYB;ZNF280B;BNC2;HMGA2;ZNF263;FOXN3;RPS6KA5;SMARCA2;HCFC1;ZNF682;DVL2;PCGF1;METTL18
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.746826551318913,-1.1084511200636307,0.38636363636363635,1.0,1.0,2/7,10.74%,DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7325942029856433,1.1082337275336656,0.43636363636363634,0.8931196539082991,1.0,2/7,16.04%,LIN28A;TENT4B
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.675809553834001,1.108158665261314,0.2982456140350877,0.8927725457579229,1.0,2/9,5.62%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5643911286524865,1.1079353343567881,0.2909090909090909,0.8928909809706135,1.0,7/14,22.79%,SCD;SCD5;SLC25A1;FASN;ACACA;ACSS1;DIP2A
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.653855038540351,1.1074023840270628,0.39285714285714285,0.8940610937907945,1.0,2/10,5.09%,SPR;GCH1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6599977592123626,1.1073638592366049,0.425531914893617,0.8936162729926574,1.0,7/11,31.83%,KCNC2;GUCY1A1;APOE;DDAH2;CD36;DDAH1;GUCY1B1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6250319027718878,1.1072678728776075,0.38095238095238093,0.8933104767823008,1.0,2/13,10.60%,RPP40;RRS1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.5743786240431448,-1.1070736479107794,0.3409090909090909,1.0,1.0,1/21,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.698740464566097,1.1070356146813825,0.41379310344827586,0.8934200969969514,1.0,1/7,1.96%,GSTM2
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5835099724188273,1.1069562049576254,0.27586206896551724,0.8931798969914161,1.0,4/27,5.49%,GATA4;LHFPL2;WNT4;SIX4
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6803459683840097,1.10675169991391,0.41379310344827586,0.8933057109049017,1.0,2/9,8.64%,EGLN3;P3H2
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.7726772734559588,1.1066537932476588,0.423728813559322,0.8930577874140084,1.0,4/5,17.03%,TGFBR1;DSP;BMPR1A;LRP2
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.7518806047688718,1.1064144475423459,0.4426229508196721,0.8934107528620995,1.0,4/6,24.04%,LHFPL2;NR2F2;COL9A3;CYP19A1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.43880356635612,1.1063819605708172,0.3,0.8928873425342776,1.0,31/111,23.42%,CCL5;HAS2;HIF1A;CD40;PELI2;RELA;PELI1;ST18;RPS6KA4;PELI3;NLRP7;TAB2;HYAL3;PSMD13;IRAK3;PSMA1;TANK;PSME4;PLCB1;IRAK1;PTGIS;TAB3;RPS6KA5;TAB1;CCL25;PSMD4;IL1RAP;IKBKB;IL1R1;MAPK3;RIPK2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.7235800516744353,1.1061770430302649,0.40350877192982454,0.8929238629031478,1.0,4/8,20.10%,NECTIN2;LYN;PLSCR1;MILR1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.6342205556944411,1.106081642069595,0.375,0.8926201592126394,1.0,7/16,26.05%,DRD3;TMEM98;TNFRSF21;TNFRSF1B;TENM4;HES5;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.529528241357585,1.1059344802681406,0.32075471698113206,0.8924625525047765,1.0,10/34,17.72%,WNT4;ADGRV1;BMP2;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6;BMP4
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6637660396022059,1.1058033013479553,0.39285714285714285,0.8923698646883934,1.0,2/9,19.04%,PHKA1;GBE1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.5722989126140587,1.1056335511126887,0.3728813559322034,0.8923419661848642,1.0,3/28,4.36%,NDC80;NDE1;LLGL1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.4753952282644776,1.105608680432529,0.25925925925925924,0.8918213545595982,1.0,20/75,17.33%,LHFPL3;PCDH15;CDC14A;ROR1;ADGRV1;ALDH7A1;EPS8L2;WHRN;CCDC50;USH2A;TBL1X;ATP6V0A4;TPRN;SLC26A4;COL11A1;KIT;GRM7;LRP2;MYO3A;TIMM10
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6357852067001759,1.1055048762174378,0.47368421052631576,0.8915758999509399,1.0,3/13,16.07%,MME;BACE2;DYRK1A
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5631373457308517,1.1053133448411112,0.3389830508474576,0.8917583299901762,1.0,11/23,18.00%,IL4;PPARG;FLT3;LY6D;IRF8;LYN;BLK;TRPM2;VEGFA;BMP4;AXL
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5407015273822402,1.104864726840341,0.3050847457627119,0.8928111914304363,1.0,8/32,22.90%,RAB27A;SDC4;SNCA;RAB9A;RAB27B;STXBP5;CADPS2;CADPS
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6303161201025705,1.1045447823076964,0.3442622950819672,0.8934437213234852,1.0,1/12,2.44%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.6851267664793061,1.1044347255711748,0.35714285714285715,0.8932541999772913,1.0,3/6,18.34%,LYN;BLK;TNFRSF21
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4892313646553304,1.1043925024452173,0.32727272727272727,0.892807464853843,1.0,22/55,27.07%,ADIPOR2;ACADS;BDH2;PECR;ECI1;ACADM;ABCD3;ABCD2;HSD17B10;ACAA2;ECHDC1;AUH;PEX2;CYP4V2;ABCD4;ACOX1;ECI2;ADH4;PEX13;CPT2;ADIPOR1;ADH5
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6422790346770948,-1.1043379542170644,0.3170731707317073,1.0,1.0,1/12,2.05%,BST1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.41678707975729345,1.1043178324555856,0.2459016393442623,0.8924497659927563,1.0,64/366,14.53%,VEGFC;IGF1;FLT1;FGF10;IRS1;FGFR1;TGFBR1;SIRT1;ITGAX;NRG1;FGF2;FGFR3;IL4;CCL5;ERBB4;MYC;PTGFR;HAS2;TCIRG1;IL7R;TOX;PRMT1;BMI1;F2R;BMP2;HCLS1;FLT3;WWTR1;CCN4;RELA;RBPJ;DPP4;FBXO5;PDGFRA;HPSE;ITGAV;MEGF10;POU3F2;FER;LIFR;HDAC2;CDCA7L;PDGFC;IL15;PROX1;FGF17;SINHCAF;EZH2;FGF5;CD74;LYN;EFNB2;MVD;LIG4;BMPR1A;CNOT6L;SIRT6;MLXIPL;GREM1;MEF2C;CDK4;PTEN;SERTAD1;MAPK15
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.7290367321034664,-1.104260896050255,0.4339622641509434,1.0,1.0,1/8,1.02%,PLAAT4
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5876805363622275,-1.104155696534567,0.37209302325581395,1.0,1.0,2/14,7.80%,SLC5A10;SLC2A8
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6915058151682307,-1.1041378724603776,0.3958333333333333,1.0,1.0,3/6,24.35%,RAC1;PIK3CB;PIK3CG
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7256949801849355,1.1039559681898785,0.4074074074074074,0.8931130020939129,1.0,2/6,17.03%,NLGN1;LRP2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5007943130395874,1.103888364695953,0.2727272727272727,0.8927796635904449,1.0,14/48,17.72%,ENPP1;WNT4;ADGRV1;BMP2;ACVR2A;SLC8A1;BMPR1A;GREM1;MEF2C;GPM6B;BCOR;ANO6;ANKH;BMP4
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7212828399182367,1.103839568705285,0.4074074074074074,0.89237454476678,1.0,2/6,14.46%,NLGN4X;PTEN
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.40178465056679025,1.1034733662647243,0.22413793103448276,0.8930204787375907,1.0,103/421,18.86%,GATA4;MITF;IGF1;RFPL2;FLI1;TGFBR1;RUNX1;ESRRG;NR5A2;FGF2;IL4;ERBB4;GDF6;MYC;CTCFL;SNAI1;HIF1A;PYHIN1;NFIL3;PPARG;MDFIC;WNT4;MAFB;MYCN;TFEB;RORB;F2R;MLLT3;FANK1;BMP2;RORA;SIX4;MYRF;SP1;TEAD2;RORC;RELA;ESR1;MED17;ELF4;FOXO1;PPM1A;HDAC2;RYBP;PAX6;TP53INP1;ELK1;FOXO3;FOXH1;YAF2;KLF6;KDM3A;SMARCD3;SMAD2;CD74;TBL1X;TCF4;NR1D2;HNRNPD;CHEK2;MLXIPL;SP3;NPAS3;NR1H4;PML;SMAD4;CREB3L2;MEF2C;NR1H3;BCL3;ARID1A;PICALM;ATF7IP;ZNF281;FZD4;CD80;FZD1;ARID1B;SPIN1;ZXDC;CREB1;DYRK1A;LRP6;RET;KAT6A;EPC1;LBHD1;NR2F2;MYB;RHOG;DEAF1;SMAD5;PHIP;PLCB1;NAA16;BMP4;HMGA2;CTNNB1;MESP1;RPS6KA1;NOTCH4;SMARCA2;HCFC1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.4767929295703487,1.1034335971501048,0.23636363636363636,0.8925436101386719,1.0,24/88,26.07%,GFAP;NEDD4;SEC22B;ODC1;ASB5;BANP;FOXO1;ZDHHC2;CHMP6;IRAK3;HECW2;CHEK2;TIPARP;FMN2;STX5;SMURF1;C4BPB;GSK3A;FZR1;CTSA;EGFR;MDM4;BARD1;NKD1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.6582720316705539,1.1033136818304083,0.4117647058823529,0.8924357680831425,1.0,5/13,24.58%,ELP4;CTU1;MTO1;DPH3;TRMT9B
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5008405362390878,1.103293181833411,0.27692307692307694,0.8919359028355133,1.0,11/49,12.95%,SMAD6;SIRT1;GDF6;PPARG;MAFB;STEAP4;FOXO1;BBS9;CTBP2;NR4A2;TMEM120A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5539399674645853,1.1032858112815351,0.31666666666666665,0.8913647128009912,1.0,6/24,13.66%,NEDD4;ABHD17B;PDLIM5;CTNNA2;ABHD17C;MEF2C
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6677507773144596,1.1027707908879743,0.36363636363636365,0.8925926638353484,1.0,3/10,22.24%,PSMD13;PSMG2;PSMD4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5740398591053557,1.1027499565619137,0.33962264150943394,0.8920457558387385,1.0,7/19,22.46%,SIRT1;DYRK2;PML;BCL3;HIPK1;TP53;PHLDA3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6324472667186872,1.1022936466449342,0.36507936507936506,0.8928086701341926,1.0,7/15,19.78%,GRIP1;MOV10;NTNG2;SPRY3;FZD4;DVL2;MACF1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5650694694866972,1.102154398757544,0.3958333333333333,0.8925893995228923,1.0,3/29,6.63%,SEMA5A;ROBO2;SEMA6C
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49179399440140575,-1.1021061268400147,0.35555555555555557,1.0,1.0,6/43,9.11%,KCNMB2;KCNJ16;KCNN3;KCNE1;KCNN2;KCNQ1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6405917087974025,1.1019382987603494,0.37037037037037035,0.8929603345781929,1.0,3/6,25.30%,LHX6;HTR6;PEX13
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.5264191508222273,1.1016089509929088,0.2857142857142857,0.8935538489747676,1.0,5/33,5.48%,ATP6V0D2;RAB38;TCIRG1;RAB31;RAB39A
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6682373914375458,1.101376979837783,0.39705882352941174,0.8937405533065269,1.0,3/5,22.65%,PLCG2;CX3CR1;CARD9
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.6943386906380409,1.1011690592056642,0.42857142857142855,0.8938076700733623,1.0,2/5,20.84%,RPIA;RPE
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.47318985205667585,1.1010516140230664,0.3559322033898305,0.8935805121799408,1.0,18/97,13.29%,GATA4;SMAD6;TSPAN12;PLOD2;LRP4;GNG12;TENM3;DOCK1;LRIG3;WWTR1;ADGRL2;LIFR;MAGI1;EDNRA;TBX18;CDR2L;FIGN;TSPAN6
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6992245672370947,1.1010420912122079,0.36538461538461536,0.8930199280389435,1.0,3/10,14.16%,IRS1;SNCA;CD244
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.5892851622023056,1.100691785322202,0.38461538461538464,0.8937067511132545,1.0,6/24,18.48%,SIRT1;PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4706999868510018,1.1006374291913954,0.3469387755102041,0.8932341063919373,1.0,16/75,13.79%,SCN7A;SLC12A1;SCNN1B;ASIC1;SLC12A3;SCN10A;SLC8A1;SLC6A16;SLC24A2;SCN3A;SLC9A2;SCN2B;ATP1A2;HCN1;SCN9A;ATP12A
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.720087438655275,-1.100596618730452,0.35555555555555557,1.0,1.0,1/5,4.03%,CBARP
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7608192838056661,1.1002231235046829,0.36363636363636365,0.8939833349082101,1.0,2/5,17.94%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5241531625352424,1.1001081282838217,0.37037037037037035,0.8937964286296771,1.0,14/47,23.50%,SYK;PELI3;ZNF675;CPNE1;HIPK1;CARD16;CCDC3;F2RL1;NLRP2B;BIRC3;HSPA1A;FADD;IKBKB;GAS6
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7464489502828674,1.1000576299716536,0.4,0.8934592880152826,1.0,4/6,25.19%,FER;IL15;PTK6;JAK2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6458149657880516,1.09996886974039,0.3064516129032258,0.8932017340349026,1.0,4/11,23.46%,HIF1A;HAP1;ACTR10;TRAK2
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.7065996647974337,1.0998196537695182,0.40350877192982454,0.8931422549978296,1.0,2/6,20.71%,TBCE;TBCA
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5357137877831867,1.0996006564329235,0.3,0.8933674131014295,1.0,5/31,9.42%,ACE2;NEDD4;KCNJ3;SCN10A;SNCA
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6234427466888413,1.0994013849878301,0.40350877192982454,0.8933552994741079,1.0,3/17,17.12%,SYVN1;AUP1;DERL2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6693318106648904,-1.099170400347142,0.44680851063829785,1.0,1.0,4/7,28.33%,SCTR;AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.4735252278944232,1.0989138176240918,0.22413793103448276,0.8943615488960656,1.0,25/99,17.03%,MME;TGFBR1;CCL5;URI1;SOCS2;PTPN20;ROBO2;ACVR2A;HCLS1;STING1;FLT3;RAMP3;HTRA2;PTPN14;FOXH1;IL18R1;NCOA2;BMPR1A;NR1H4;MAPK8;CPNE3;ACVR1B;NCOA3;TIPARP;LRP2
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6769715071597342,1.098868436187078,0.3870967741935484,0.8938833521517033,1.0,3/9,21.18%,RNF139;GAS1;STX18
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5826461523278033,1.0986053842782513,0.4107142857142857,0.8942572393625068,1.0,6/23,17.12%,SYVN1;RNF185;RNF139;RNF5;MAN1A2;DERL2
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6935548024321896,1.0985286995452916,0.3333333333333333,0.8940712463473021,1.0,1/8,2.18%,SIRT1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.4706401551933017,1.098498871047533,0.3148148148148148,0.8935862937847828,1.0,13/105,8.38%,MXRA5;MRGPRF;CXCL12;LAMA4;PRRX1;ADGRL4;PLSCR4;POSTN;FAM114A1;BGN;PDGFRA;MYH11;OLFML3
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5658497998145285,1.0983733997138663,0.36363636363636365,0.8933852390410884,1.0,13/23,28.56%,TGFBR1;ROBO2;PROX1;BMPR1A;SMAD4;BMP4;CITED2;BMPR2;HEY2;SMAD7;NOTCH1;ZFPM2;SLIT2
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.7488948267527624,1.0982905270211292,0.42857142857142855,0.8930350379062734,1.0,1/7,2.09%,STARD4
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6281049377728983,-1.0981459139094687,0.45,1.0,1.0,6/10,23.32%,COPS7A;COPS7B;COPS6;COPS3;COPS5;COPS8
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7298800158453179,1.0981347638675087,0.4067796610169492,0.8923674072511246,1.0,2/7,6.92%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7298800158453179,1.0981347638675087,0.4067796610169492,0.8923674072511246,1.0,2/7,6.92%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.5909166130547393,1.0978803668381978,0.3384615384615385,0.8919760127028593,1.0,3/15,16.16%,RAB27A;MLPH;RAB27B
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.5909166130547393,1.0978803668381978,0.3384615384615385,0.8919760127028593,1.0,3/15,16.16%,RAB27A;MLPH;RAB27B
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4608956026650587,1.0978329840347,0.3333333333333333,0.8915337927226455,1.0,18/73,16.68%,CDH7;CDH20;CADM2;CDH6;CDH2;F2R;SDK1;CDH12;DSP;MARVELD3;NLGN4X;NECTIN2;CADM1;TJP2;CDHR3;CDH10;GJC1;CDH8
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5014253868350057,-1.0974188485682905,0.29411764705882354,1.0,1.0,9/67,10.17%,TRIM56;DDX41;OAS3;POLR3H;OAS1;POLR3E;FLOT1;DHX58;IRF5
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.7290406173393857,-1.097303054052741,0.40425531914893614,1.0,1.0,1/6,2.65%,ASS1
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7106582231535135,1.0972772844854919,0.3829787234042553,0.892901586414758,1.0,2/5,18.37%,SLC17A6;SLC18A2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6368487446592899,-1.0969952605385869,0.3673469387755102,1.0,1.0,1/10,6.90%,B3GALT5
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.40037317800461597,1.0969866632467575,0.1702127659574468,0.8932969403568841,1.0,85/384,21.31%,DACH1;TIMELESS;SIRT1;TSHZ3;NRG1;IL4;FOXP2;NFIL3;CDKN2A;PPARG;MDFIC;WNT4;RORB;SFMBT2;BMP2;SIX4;GMNN;RELA;RBPJ;ZEB1;FOXO1;ZNF706;HDAC3;HDAC2;CBFA2T3;ATXN1;YAF2;PROX1;TLE2;NPAS1;CTBP2;EZH2;SMAD2;PTPRK;SPINDOC;NR1D2;PASD1;MBTD1;MLXIPL;SP3;PML;SMAD4;DPF3;BCL3;HSPA8;DPF1;BCOR;MAGEL2;ZNF639;ATF7IP;ZNF281;PRICKLE1;RUNX1T1;ZBTB33;KAT6A;LOXL2;EPC1;POU2F1;NR2F2;MYB;DEAF1;SPEN;PLCB1;BMP4;HMGA2;BAP1;CTNNB1;MESP1;FOXN3;RPS6KA5;SMARCA2;HDAC1;ATP8B1;HDAC9;ZNF12;MTERF3;CITED2;EED;PSPC1;SFMBT1;ZBTB4;KLF10;NR3C1;ID4;HEXIM2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6028360892130391,-1.0968863122651962,0.42,1.0,1.0,1/9,1.16%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.6028360892130391,-1.0968863122651962,0.42,1.0,1.0,1/9,1.16%,NUPR1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.4893390985452994,1.096862267375691,0.31666666666666665,0.8930894140909249,1.0,7/48,12.14%,TGFBR1;NRG1;ERBB4;NRG2;ZSWIM5;ABL2;LYN
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.4614044994868148,1.0966846647698845,0.37254901960784315,0.8930854220448425,1.0,14/138,11.60%,TNFSF14;TNFRSF18;SIRT1;TNFSF13B;CCL5;HAS2;CD40;ZFP36L2;RELA;ST18;FOXO3;ERBIN;HYAL3;PSMD13
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.7162781214935661,1.0965413732917633,0.3684210526315789,0.8930501833770875,1.0,2/7,9.05%,DRD5;DRD3
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6109858647825184,1.0963312873997304,0.32727272727272727,0.893202380032016,1.0,9/22,16.11%,FGFR1;TGFBR1;FGFR3;PDGFRA;SPEF2;DSCAML1;RAB33B;WWOX;LRP6
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.6897709506636513,1.0963192679690583,0.38181818181818183,0.8926755286133634,1.0,2/6,13.38%,EHD1;MSR1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.45608312800366974,1.096157829227326,0.3,0.8926094293093063,1.0,32/128,19.50%,ESRRG;NR5A2;HNF4G;KAT2B;PPARG;RORB;RORA;WWTR1;TEAD2;RORC;RBPJ;ESR1;MED17;HDAC3;TAF3;NPPA;NR4A2;TBL1X;NR1D2;NOTCH3;NR1H4;NR1H3;RARB;TAF5;THRB;CCNH;TAF2;NOTCH2;MNAT1;NOTCH4;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5624643011549637,1.0960426536362313,0.37037037037037035,0.8924499000862165,1.0,11/18,38.39%,RIDA;DXO;YTHDF2;PUM1;MEX3D;YTHDF3;YTHDF1;CELF1;METTL16;ROCK1;GIGYF2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7139022584519452,-1.0959098908680833,0.3953488372093023,1.0,1.0,1/8,3.17%,SFRP1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.4452690470617897,-1.095557815912552,0.225,1.0,1.0,11/84,10.15%,TRIM56;NLRP1;APOBEC3H;IFI27;RNASE1;OAS3;TRIM5;OAS1;IFIT2;IFIT3;APOBEC3G
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.6019861062420976,1.0952372238905812,0.3584905660377358,0.8944867625005489,1.0,5/18,17.12%,SYVN1;RNF185;RNF139;RNF5;DERL2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5610556329042693,1.0950422728284765,0.31746031746031744,0.8944741102851613,1.0,3/23,12.31%,NDE1;FYCO1;HAP1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5499911951457019,1.0949863327310645,0.32727272727272727,0.8940570221249063,1.0,4/22,22.05%,MYC;LIG4;PRKAA1;TP53
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.5446765114617305,1.0949753274104546,0.39215686274509803,0.8935083275237995,1.0,10/34,11.07%,GPR55;FLT1;ADRA1A;FGFR1;FGF2;ESR1;PDGFRA;ITK;ABL2;EDNRA
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5994102866400057,1.0947638296986082,0.3709677419354839,0.8935973089108425,1.0,2/10,11.36%,BIN1;NPPA
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7022377726649349,-1.094750600061061,0.4523809523809524,1.0,1.0,1/6,3.66%,SLC19A3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.595468830836569,1.0945130768828217,0.4482758620689655,0.8940820904048131,1.0,5/12,25.77%,UBA5;UBA6;UBA3;SENP6;SAE1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6759921042571699,-1.094387270034699,0.425531914893617,1.0,1.0,1/9,6.90%,B3GALT5
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.7103691202740131,1.0938559967170522,0.4074074074074074,0.8955282520658375,1.0,4/5,27.57%,HMGB1;CD74;MBP;LPL
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.523628568037043,1.0938480334380687,0.3064516129032258,0.8950110316378367,1.0,8/35,22.23%,PEX12;UBE2D3;UBE3D;FANCL;MARCHF7;KLHL12;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6562602410350186,1.0937830425629338,0.3770491803278688,0.8946416860342136,1.0,5/15,19.06%,NRG1;CDH2;MEF2C;LRP6;KLHL12
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.5950694097888256,1.093763090981531,0.3584905660377358,0.8941024602819886,1.0,6/22,12.64%,RAPGEF3;KSR1;EPHA5;PDE7A;RIMS2;ADGRG6
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7163445493637652,1.0936748353531094,0.38095238095238093,0.8938192851145089,1.0,3/6,19.81%,PHGDH;SRR;PSPH
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.4818192984645275,-1.0932765122591237,0.3023255813953488,1.0,1.0,8/53,9.11%,KCNMB2;KCNE2;KCNJ16;KCNN3;KCNE1;CAV1;KCNN2;KCNQ1
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7579809914024627,1.0932404521148031,0.3269230769230769,0.8948124760724661,1.0,3/5,20.03%,CBS;ETHE1;CTH
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.596097676827442,1.0930622680616906,0.40350877192982454,0.894830618985317,1.0,2/15,3.00%,CXCL12;CCL5
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.45127130614207295,1.093054601238715,0.2413793103448276,0.8942926443265808,1.0,36/127,21.85%,SLC26A3;DRD5;RAPGEF3;CCL5;INSIG1;URI1;AANAT;SLC26A6;NRIP1;RORA;STING1;RORC;ESR1;RAMP3;CASP7;ATP1A2;HCN1;NR1H4;MEF2C;RAP1A;GABRB2;NCOA3;TRPM2;TIPARP;SLC5A5;CTNNB1;LCOR;RUVBL2;CASP3;GABRB1;CRHBP;RIOK3;JUP;NR3C1;SSTR1;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.36798454324788443,-1.0929351943534527,0.2222222222222222,1.0,1.0,27/602,7.32%,CD44;NTRK1;ALB;APIP;NUPR1;TNFSF18;TEK;MPO;HMGN5;SFRP1;OBSCN;RASGRF2;IL31RA;DUSP6;BCL2L2;SPDEF;OLFM1;NIBAN2;VAV3;PLK3;BEX2;CLEC5A;OLFM4;WNT10B;JUN;DAB2;ANGPT4
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.6981004470634327,1.0924997326699424,0.4,0.8955692307834279,1.0,1/7,2.26%,LMOD3
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6049072071404158,1.0920722279151402,0.39622641509433965,0.8964430823683845,1.0,2/18,5.65%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5159391598197053,1.0916163995372465,0.25925925925925924,0.8975856341460899,1.0,12/45,14.80%,IL1RAPL2;CLSTN2;NLGN1;ROBO2;PDLIM5;NRXN1;TLR2;PTPRD;SNCA;GPC4;MEF2C;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4922280699912023,1.0914837307864185,0.3137254901960784,0.8974632900353465,1.0,6/53,9.04%,SYK;LGALS9;FZD5;PLCG2;TLR2;HMGB1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6073552016794068,1.0913389775217601,0.2631578947368421,0.8972872075512403,1.0,1/11,0.57%,SYK
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5916350881946659,-1.0911959938496727,0.39285714285714285,1.0,1.0,1/15,1.54%,INHA
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.5499202518021757,-1.091092328182771,0.35135135135135137,1.0,1.0,10/36,11.10%,KCNE2;SCN5A;CACNA1G;KCNA5;KCNE1;CAV1;DSG2;KCNQ1;CTNNA3;SCN3B
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5816768724563525,1.0910257286747262,0.2857142857142857,0.8977038004441069,1.0,3/18,4.96%,CHRM2;HRH3;RGS10
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.401998220418685,1.0910129933267596,0.2542372881355932,0.8971663907481255,1.0,60/266,17.09%,DRD5;GABRR1;CHRM2;SLC12A7;GABRE;RIT2;GABRR2;PNOC;GRM3;HTR1F;HRH3;SLC1A3;NLGN1;SLC17A6;GLRA1;PENK;OPRK1;NPY;CACNB4;GABRG3;SYPL1;SYT1;NRXN1;UNC13B;NOVA1;SNCA;GPR176;NLGN4X;GRIK2;LIN7A;GRM5;HTR2C;RPS6KA2;CEL;SCN2B;HAP1;KCND2;HTR7;GRIN2D;HCRTR1;FCHSD2;UTS2;GLRB;GABRA5;GRIK3;HSPA8;GRM4;PTEN;ZACN;GABRG1;GABRB2;PPFIA3;APBA1;LRP6;GRM7;GRM1;DLG2;CDH8;GRIK1;KCNQ3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6055144079169282,-1.090991429628501,0.3409090909090909,1.0,1.0,1/14,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),0.7617994379586422,1.0908627300518088,0.41818181818181815,0.8965543853069062,1.0,4/5,23.52%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),0.7617994379586422,1.0908627300518088,0.41818181818181815,0.8965543853069062,1.0,4/5,23.52%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.6266847224427722,1.09083852105444,0.42857142857142855,0.8960340696631179,1.0,2/12,5.09%,SPR;GCH1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.4920329166695983,1.0908043410518315,0.3448275862068966,0.8955834400755623,1.0,15/52,25.07%,GDAP1;TIMM22;SLC25A24;MTX2;FBXO7;SLC25A13;BCS1L;TIMM10;SLC25A31;AIP;MFF;PPIF;BAD;MAIP1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6235759393580771,1.0904689373316696,0.40476190476190477,0.8960531863132285,1.0,4/16,11.59%,CCDC125;DLC1;ABL2;KANK1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.576970986094046,1.0903797852182544,0.3220338983050847,0.8958482401991105,1.0,5/25,9.77%,SOCS2;STAT5A;FER;SOCS6;IL15
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5234172261544383,1.0902043862135997,0.3235294117647059,0.8958732143736998,1.0,7/42,15.24%,SLC7A11;SLC38A4;SLC38A3;SLC7A9;SFXN2;SLC25A13;SLC3A2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6517716252688874,-1.0899004912786738,0.41025641025641024,1.0,1.0,4/10,16.39%,XDH;DCN;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.7289546817412761,1.0898194130578331,0.35,0.8966938173595477,1.0,1/5,5.49%,SIX4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4625109132116634,1.0895677907179437,0.2727272727272727,0.8969476008987944,1.0,21/85,12.34%,HS3ST5;HAS2;ANGPT1;HS3ST3B1;CSPG4;HS3ST1;HS3ST2;UGDH;CHSY3;VCAN;BGN;SDC4;SLC35D2;GALNT5;HS2ST1;DSEL;GPC5;ST3GAL6;GPC4;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6279382865230103,1.0894313583314377,0.4067796610169492,0.8967273259352891,1.0,1/12,3.81%,PPARG
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5065902178666043,1.0893412470068535,0.2727272727272727,0.8965302363335199,1.0,11/42,24.63%,FZD5;HTRA2;INF2;IAPP;SIRT7;MFF;GSK3A;SREBF2;MARCHF5;PID1;MIEF2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6155906062632012,1.0893110402748225,0.3387096774193548,0.8961197163383147,1.0,7/12,33.83%,SCRIB;SYNE4;RAP2A;ZDHHC7;MYO9A;OPHN1;RAB10
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6346715279338901,1.08928797260836,0.3684210526315789,0.8956258195181308,1.0,8/11,33.60%,RANBP9;PICALM;ABCA2;ABCA7;APOE;TMED10;FLOT2;PRNP
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.5744707732270733,1.0891591791535222,0.35384615384615387,0.8954907661376973,1.0,3/23,8.61%,PRDM8;MYRF;TLR2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.48359122120599335,-1.089141826385817,0.37735849056603776,1.0,1.0,4/50,2.56%,H1-3;H1-4;TERF2IP;H1-2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5417700740517252,1.0891256269509948,0.36507936507936506,0.8950512019728293,1.0,9/33,17.75%,UTRN;NEDD4;FGF12;FGF14;SCN2B;HECW2;NETO1;DMD;GLRX
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5629092075482616,1.0889210046861668,0.38596491228070173,0.8952287793270063,1.0,12/18,37.34%,EXOSC4;INTS6L;INTS6;INTS14;INTS8;EXOSC2;INTS2;EXOSC5;EXOSC8;EXOSC7;INTS1;INTS5
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6419927895622475,1.088898860880441,0.33962264150943394,0.8946986401294273,1.0,6/12,29.29%,RORC;PGRMC2;DGAT2;LRP5;ARID5B;SOX8
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6667903946560949,1.0886081045191676,0.40384615384615385,0.8949446401925657,1.0,2/8,18.62%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6204547160062801,1.0885220445923265,0.423728813559322,0.8945976925536419,1.0,7/18,27.20%,ACD;TERF1;TENT4B;GNL3L;POT1;HNRNPU;HNRNPC
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.44093800947384687,1.0884878356381107,0.2542372881355932,0.8941220941971594,1.0,37/115,20.43%,SCN7A;PRKG1;LRP4;EDIL3;PRDX6;TMEM200C;PENK;VCAN;MEGF10;ADGRL2;LIFR;PTPRD;STOX2;PRICKLE2;EFS;ANK2;GUCY1A2;GFRA1;EDNRA;PABPC5;MAGEL2;LRFN5;PCDH18;COL11A1;RUNX1T1;SEMA6D;FRZB;CPE;MAPK10;GPRC5B;PDZRN3;CCDC3;VAT1L;TMEM178A;CSRNP3;COL25A1;MPDZ
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.599154361462885,-1.088452852747142,0.38636363636363635,1.0,1.0,3/10,12.77%,APOBEC3H;APOBEC3G;MORC2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.4138593801814988,1.0882210734060473,0.21568627450980393,0.8945197625611783,1.0,31/137,15.59%,F2;KLRD1;ICOSLG;IL2RA;STAB1;IL4;CCL5;HIF1A;CDKN2A;CD40;F2R;ACVR2A;HCLS1;IRF8;ST8SIA4;ACHE;ELF4;TLR2;ITK;BCAT1;IL15;CD74;GALNT1;LYN;TAP1;LCK;BCL3;CCND3;IL2RB;CD80;CSF1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.6761868947801817,1.0882116314008177,0.38596491228070173,0.8939765531216248,1.0,3/7,20.84%,RPIA;DCXR;RPE
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.5337167249623862,-1.0880939265469654,0.27450980392156865,1.0,1.0,1/25,0.47%,AMACR
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.7168772294166414,-1.0877181964365574,0.4666666666666667,1.0,1.0,1/6,0.24%,ACTC1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5893115224426102,-1.0876860026774313,0.38095238095238093,1.0,1.0,4/24,10.48%,ERCC1;XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7219073207058609,1.0876387344472291,0.4262295081967213,0.895381821729391,1.0,3/5,25.19%,TLR2;FCER2;JAK2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.513953172525957,1.0876130411903806,0.4,0.8948917720162087,1.0,5/32,6.93%,SMAD6;ENPP1;LRP4;BMP2;RBPJ
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5356345292837399,1.0875524720921041,0.3684210526315789,0.8945310152268883,1.0,8/36,19.10%,IRGM;GFAP;LATS1;SNCAIP;HSPA8;RAP1A;HCFC1;METTL18
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4744522266175964,1.087182932932739,0.32,0.8951238765313225,1.0,6/96,7.53%,TNFSF14;TNFRSF18;TNFSF13B;CD40;RELA;ST18
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.6924507478678401,1.0868060260149923,0.4,0.8958067214821606,1.0,2/7,6.04%,RUNX1;HCLS1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.4970442705973201,1.086686543526135,0.3333333333333333,0.8956802868614039,1.0,10/49,16.31%,NRTN;SEMA5A;ERBB4;SEMA6C;CORO1C;AMOTL1;PHACTR4;SGPL1;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.7425381436750763,1.0866592310688483,0.46938775510204084,0.8952368788540166,1.0,1/5,9.42%,SNCA
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.6068098218341567,1.0865399378931626,0.45,0.8950204027857379,1.0,3/14,14.15%,PADI2;ESR1;ARID1A
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.7482376320018724,-1.086144415998028,0.42105263157894735,1.0,1.0,2/5,24.60%,SLF1;XRCC4
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4955547361195361,1.0861190186367786,0.29310344827586204,0.895761947336532,1.0,8/36,14.76%,LRP4;NLGN1;NRXN1;PTPRD;NLGN4X;CEL;PTEN;PICALM
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.6468325612937956,-1.0856816975249468,0.40540540540540543,1.0,1.0,3/8,10.49%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5831273068207173,1.0854953807365262,0.3508771929824561,0.8971657992622346,1.0,6/25,25.46%,FAIM;TNFRSF10A;TNFRSF10B;FADD;SERPINE1;ARHGEF2
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.5889826326423815,1.0853171626888414,0.3492063492063492,0.8972272140526883,1.0,3/20,13.08%,TSHZ3;SLC24A2;GRIN2D
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.5665383706738832,1.08523944467071,0.3225806451612903,0.8969498226234975,1.0,4/21,9.63%,LRAT;CYP4F12;RPE65;CYP3A4
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.5059787315611898,1.0852010197769069,0.36363636363636365,0.8964922305120145,1.0,15/61,23.74%,SLC7A2;SLC1A3;SLC39A8;SLC44A4;SFXN2;SLC25A1;SLC25A13;SLC19A1;SLC3A2;SLC1A6;SLC25A12;SLC25A30;SLC16A7;SLC25A14;SLC7A8
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7157124530216094,1.0851678763261792,0.4264705882352941,0.8960502407672516,1.0,3/6,10.72%,MYOF;ANK2;BIN1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5426798936728833,1.084833506756044,0.37254901960784315,0.8967207765443466,1.0,6/29,18.62%,SEMA5A;SEMA6C;SEMA3E;KIAA0319;SEMA6D;DIP2B
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.669765389264477,1.0847627995298945,0.4074074074074074,0.8964293664271635,1.0,1/9,2.18%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.6971341924565487,1.0846466341736485,0.4406779661016949,0.8957276341789265,1.0,2/7,11.75%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.6971341924565487,1.0846466341736485,0.4406779661016949,0.8957276341789265,1.0,2/7,11.75%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.5162250590530479,-1.0845930915266344,0.3783783783783784,1.0,1.0,12/50,17.85%,FANCG;SLX4;RNF8;ERCC1;FANCC;RAD51AP2;RAD51AP1;FAN1;NUCKS1;RPA3;FANCB;MUS81
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.716789750415811,1.0845785795438854,0.41935483870967744,0.8953924070670036,1.0,2/5,11.10%,GABRE;GRM5
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.63963771756219,1.0845129188837548,0.42105263157894735,0.8950426128859237,1.0,4/12,9.33%,CSPG4;VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),0.7219768341954125,1.0844090401773046,0.42592592592592593,0.8948429616452805,1.0,3/5,27.09%,CD80;TNFSF4;ANXA1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.5413036258371753,1.0843954412098264,0.36363636363636365,0.8943368358814534,1.0,5/23,11.55%,ANPEP;TRHDE;NAALADL1;GGT5;LNPEP
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6084909677840749,1.0843176837752888,0.38095238095238093,0.8940257189648169,1.0,7/19,18.53%,MYC;ZNF706;NCOA3;LOXL2;ZC3H13;HMGA2;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.58383574704912,1.0842616702445687,0.37037037037037035,0.8937149847258145,1.0,4/15,11.20%,IGF1;WEE2;ASTL;HYAL3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.5251091460375427,1.084188896966758,0.2962962962962963,0.8934120996501044,1.0,11/39,21.41%,TRPM8;SLC7A2;SLC44A4;SFXN2;ATP1A2;SLC3A2;TRPM2;SLC22A5;TRPM7;KCNJ8;TRPM3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7521700599818766,1.0841820470366466,0.49056603773584906,0.8928707833236597,1.0,2/5,12.34%,DSEL;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.5660506077711804,1.0838011687709899,0.36065573770491804,0.8934264610437525,1.0,1/20,2.85%,SHMT2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.6107390153568832,1.0837500163458995,0.3389830508474576,0.893012508714014,1.0,1/10,0.57%,SYK
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6762143966702577,-1.083712989803853,0.4375,1.0,1.0,1/7,3.78%,OAS3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5319944456421013,1.08351404037299,0.3770491803278688,0.8931204854575702,1.0,5/27,21.47%,SLC4A1;SLC4A7;SLC30A2;SLC30A4;WNK1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.49226990437247176,1.0834480920673908,0.375,0.8927667824181704,1.0,10/57,11.96%,CDC25A;MYC;ZBTB1;NEDD4;SAG;CNGA1;OPN1SW;RGR;PTPRK;PDE6A
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5576419981782964,1.0833889051316863,0.43859649122807015,0.8923911933074193,1.0,4/41,5.12%,IRS1;SIRT1;ZBTB7B;STAT5A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6742120592777038,1.0832379482628605,0.421875,0.892313471997253,1.0,2/8,8.51%,CDH2;FER
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5433178107269317,1.0828770071593672,0.33962264150943394,0.8928451594325818,1.0,16/34,28.17%,CSTA;DSP;HDAC2;USH2A;CTNNB1;AKR1C3;HDAC1;CASP3;SCEL;JAG1;CERS3;LORICRIN;ERCC3;ACER1;ANXA1;CLIC4
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5609461120062347,-1.082814592578923,0.2926829268292683,1.0,1.0,4/29,7.31%,DUSP4;COL4A2;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.5133511735665851,-1.082634962768979,0.34615384615384615,1.0,1.0,2/36,2.27%,ZC3H12D;DND1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.601224963432063,-1.0825643058488563,0.3695652173913043,1.0,1.0,2/8,5.21%,DRD4;DRD2
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.5951989693214418,1.0819256962735715,0.3709677419354839,0.8951237240331819,1.0,3/14,16.16%,RAB27A;MLPH;RAB27B
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.5951989693214418,1.0819256962735715,0.3709677419354839,0.8951237240331819,1.0,3/14,16.16%,RAB27A;MLPH;RAB27B
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5233210362061587,1.0818584295680935,0.3148148148148148,0.8948590981745151,1.0,3/33,3.66%,ATP6V0D2;REP15;TCIRG1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6462825026380914,1.0818066006763107,0.37735849056603776,0.89396041459452,1.0,1/5,20.87%,KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6462825026380914,1.0818066006763107,0.37735849056603776,0.89396041459452,1.0,1/5,20.87%,KMT5B
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.6051211522529257,1.0813473805168767,0.36363636363636365,0.8948593286859777,1.0,5/14,19.97%,LPIN3;CEPT1;SELENOI;ETNK1;ETNPPL
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.6165699424473894,1.08099553612133,0.42105263157894735,0.8953724010731136,1.0,2/11,2.18%,RAPGEF3;SIRT1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.6188539062999372,1.0807795339071467,0.4264705882352941,0.8955816754852608,1.0,5/13,23.63%,SLC34A2;SLC37A4;SLC20A1;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6944612790590463,1.0801883533370735,0.4230769230769231,0.8969509215046559,1.0,2/5,18.58%,PRIMPOL;SIRT7
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.42513327488517805,1.080168149258285,0.2962962962962963,0.8964795174198406,1.0,24/121,18.33%,CCNA2;CDC25A;NDE1;CEP70;CEP152;PCM1;FBXL3;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;PPP1R12B;CNTRL;PHLDA1;CDC25C;NEDD1;CCP110;CCNH;FBXL15;PLCB1;TAF2;MNAT1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.6005352079867442,1.0800863635413895,0.3333333333333333,0.8962596400026518,1.0,4/15,12.17%,ADRA1A;APELA;NPPA;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5804040593307723,1.079662163146023,0.32142857142857145,0.8972055189583666,1.0,3/21,3.70%,CDKN2C;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.6912013026956821,1.0796354887589703,0.47540983606557374,0.896705330367488,1.0,4/7,23.31%,ANGPT1;TJP2;VEGFA;SH3GL2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.6563011067913347,-1.0792750383243948,0.41025641025641024,1.0,1.0,2/5,8.84%,UBASH3B;CARTPT
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5530418830360351,-1.0792628377180222,0.4,1.0,1.0,5/24,11.30%,CD24;SPAAR;DUSP6;GFI1B;DUSP9
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5968793450029806,-1.079260393561142,0.40816326530612246,1.0,1.0,7/10,30.32%,MED1;G6PD;ALAS2;NCKAP1L;ALAS1;SH2B3;LYAR
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4055527666221109,1.078911472187104,0.24528301886792453,0.8984823270516058,1.0,58/264,21.16%,TOP2A;MAP3K11;PAWR;EPHA7;TGFBR1;SIRT1;BOK;DAPK2;FGD4;KNG1;PLEKHG2;FANK1;BMP2;DKKL1;SEPTIN4;ARHGEF17;SCRIB;TNFRSF10A;UNC13B;FOXO1;HMGB1;RYBP;HTRA2;DLC1;SNCA;UBE2Z;FOXO3;LATS1;BIN1;RPS6KA2;BNIP3L;GADD45G;TP53BP2;MAPK8;PHLDA1;SOS1;ANO6;RBM5;ATF6;IAPP;ARHGEF6;FRZB;BMP4;HMGA2;PTGIS;VAV2;CTNNB1;ARHGEF4;TNFRSF10B;ARHGEF16;CSRNP3;JMY;RHOB;CASP3;MELK;NLRP2B;GNA13;MCF2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.570668416324221,1.0787596048848953,0.3728813559322034,0.8984458464253234,1.0,4/21,12.86%,TOP2A;DNASE2B;HMGB1;ENDOG
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5125524686259434,-1.0785453891621928,0.3090909090909091,1.0,1.0,15/44,22.70%,SMUG1;RFC3;POLQ;PARP1;XRCC1;LIG1;RFC2;RPA3;RFC1;PNKP;LIG3;MBD4;POLL;PARG;APEX1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6841690917500836,1.0784814555232034,0.4909090909090909,0.8988362113064647,1.0,2/6,21.82%,TENT4B;ELAVL4
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.6283806051403642,1.078399217067588,0.38461538461538464,0.8985568723935312,1.0,2/13,3.77%,PNP;AK3
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6469099110594814,-1.0779669339667581,0.4186046511627907,1.0,1.0,2/6,14.71%,DNAAF1;AHI1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.6756399214399723,1.077950281216244,0.43103448275862066,0.8993215345368534,1.0,6/7,30.40%,PLSCR1;ITGAM;ITGB2;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.42286628327044123,1.0779327041666051,0.3090909090909091,0.89880719048985,1.0,24/122,18.33%,CCNA2;CDC25A;NDE1;CEP70;CEP152;PCM1;FBXL3;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;PPP1R12B;CNTRL;PHLDA1;CDC25C;NEDD1;CCP110;CCNH;FBXL15;PLCB1;TAF2;MNAT1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.6460080291471072,-1.0777835345386493,0.4418604651162791,1.0,1.0,2/8,8.54%,AK8;AK7
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.43892757322137343,1.077669762803631,0.2711864406779661,0.8991523484073785,1.0,16/63,21.56%,DEPP1;BOK;DAPK2;PIP4K2A;KEAP1;ABL2;HSPB1;RRAGC;MAPK15;MTMR3;GPR137B;FBXL2;VPS29;RRAGD;RMC1;ABL1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6686780068657547,1.077584003542259,0.43333333333333335,0.8988294747706291,1.0,4/10,21.32%,SLC1A3;SLC25A13;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.6484747022708051,1.077505836039625,0.4,0.8985436508310825,1.0,2/6,5.09%,SYK;GCH1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.4414793479008424,1.077382610454906,0.34375,0.8982801543996628,1.0,35/128,14.64%,NXPH1;LSAMP;EPHA7;SOX5;GRM3;SLC35F1;LRRC4C;CADM2;SLC17A6;PCLO;ROBO2;ZDHHC22;RAB3C;NRXN1;FUT9;LHX6;POU3F2;SYNPR;EPHA3;PAX6;OLFM3;NOVA1;HIVEP2;PROX1;ANK2;CTNNA2;LRRTM3;ADGRB3;PAK5;NOTCH3;NPAS3;NOL4;GRIK3;GPM6B;ZNF536
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3738389751457289,1.0771987910351717,0.19642857142857142,0.8983245482884317,1.0,87/446,18.54%,STK26;SYK;FLT1;CCNA2;MAP3K11;FGFR1;TGFBR1;PRKG1;FGFR3;ERG;ERBB4;GDF6;DAPK2;CDK18;STK33;ABI3;BMP2;TNIK;ACVR2A;FLT3;MEX3B;RIOK2;FAM20A;MAPKAPK2;EPHA8;MAPKAPK3;MAP2K6;PDGFRA;EPHB4;FER;RPS6KA4;EPHA3;PPP4R1;TLR2;DYRK2;CDK14;FRK;MAP3K9;SMG1;IP6K3;ABL2;LATS1;FASTK;SMAD2;RPS6KA2;MAP3K21;MAP4K2;CDK11A;PAK5;NIM1K;LYN;STRADA;BMPR1A;LCK;IRAK3;STK32B;BLK;CHEK2;VRK2;CDK4;MAPK8;MAPK15;CDK12;IGF1R;KIT;PIK3CD;ACVR1B;CREB1;NEK7;DYRK1A;CSNK1G3;SGK1;RET;MAP3K1;RICTOR;HIPK1;CCNH;MYO3A;IRAK1;MAPK10;BMP4;PRKAA1;PKN2;LIMK2;PXK;CDKL5;RPS6KA1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6173632689280604,1.0769687493478732,0.36666666666666664,0.8984201199203397,1.0,2/13,5.62%,DERL3;UBE2J1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.6608157697370811,1.076842993577215,0.36666666666666664,0.8982449458625413,1.0,5/11,15.47%,GABRE;GABRG3;GABRA5;GABRG1;GABRB2
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.7172517971380181,1.0766871405385474,0.4444444444444444,0.898113842243555,1.0,2/7,5.19%,WNT4;BMP2
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.6830525103834981,1.076193401524447,0.37735849056603776,0.8989910614114652,1.0,2/7,9.05%,DRD5;DRD3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5330030316273033,1.0761389794990641,0.375,0.8985530185156513,1.0,11/40,16.57%,LMOD3;TENM1;FER;CRACD;BIN1;GSN;CARMIL1;NCK2;FCHSD2;SPIRE2;LMOD2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6025299899552188,1.0759774776344928,0.38333333333333336,0.8985970885440907,1.0,8/14,19.50%,SIRT1;HDAC3;HDAC2;SIRT6;SMARCAD1;SIRT7;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.6817365226373391,1.0757801922087,0.40384615384615385,0.8986994447799311,1.0,3/6,13.07%,ROBO2;ALCAM;PTPRM
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5698585197272055,-1.075559469889619,0.32558139534883723,1.0,1.0,1/15,4.22%,CMTR1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6611572174949814,1.075063182641665,0.39622641509433965,0.9003394492757467,1.0,2/7,13.71%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6341197564396104,1.0749944158090592,0.43333333333333335,0.9000618886509653,1.0,2/10,17.33%,TIMM22;TIMM10
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.7046676621672561,-1.0749569279795084,0.45,1.0,1.0,1/6,1.85%,EIF5AL1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.49906770690073055,1.0746250382923281,0.3684210526315789,0.9007236878984641,1.0,5/53,11.75%,IRGM;STING1;TP53INP1;ATG101;RAB23
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.666279581931196,1.0745596775682567,0.36507936507936506,0.90043167975406,1.0,3/7,25.31%,MYRF;PLP1;HES5
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.6501875771213954,-1.0743468496729558,0.425531914893617,1.0,1.0,3/6,13.02%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.6501875771213954,-1.0743468496729558,0.425531914893617,1.0,1.0,3/6,13.02%,ALOX5;IL18BP;IL18
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.5146937674819968,1.074333490463536,0.4489795918367347,0.90059079636644,1.0,4/47,4.38%,HEMGN;FERMT3;PRSS57;GPSM3
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6892324968953236,-1.0740912202685582,0.46511627906976744,1.0,1.0,1/7,3.06%,RIN3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.6307356514525598,1.0740599690720725,0.4230769230769231,0.9010113065756593,1.0,2/12,3.00%,CXCL12;CCL5
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.602142597176443,1.0739435761621858,0.3793103448275862,0.9008939351858973,1.0,2/13,9.13%,IGF1;PAX6
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.5351146937354463,1.0738229174675666,0.34615384615384615,0.9006533258626872,1.0,5/36,11.04%,MYC;FOXO1;HDAC3;MARVELD3;ZNF675
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.4810592314256922,1.0736351496179741,0.32727272727272727,0.900782917344708,1.0,25/63,22.40%,SYT15;ITPKB;NLGN1;ADGRV1;SYT1;SYT6;PLCG2;NEUROD2;CPNE4;SLC25A24;CPNE1;MEF2C;CPNE7;CPNE3;TRPM2;PRKAA1;AKR1C3;SYT17;ALOX5AP;DPEP1;PPIF;CRHBP;LGMN;CPNE9;RYR3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3908717240346204,1.0736274731057658,0.2542372881355932,0.9002672040053584,1.0,74/359,19.01%,GATA4;MITF;CRX;TGFBR1;TULP3;ESRRG;NR5A2;PRDM8;HIF1A;NFIL3;POU6F2;MAFB;TFEB;RORB;ZNF114;HES6;BMP2;RORA;SP1;CHD7;HCLS1;SOX6;ZNF257;WWTR1;TEAD2;RELA;ESR1;ELAVL2;NFIA;SLC39A8;RPS6KA4;ZNF274;RYBP;SSBP2;ATXN1;YAF2;ZNF195;GPBP1L1;ZNF675;EZH2;NCOA2;CDK11A;NR1D2;HNRNPD;HP1BP3;CHEK2;MLXIPL;SP3;PML;DMTF1;MEF2C;ZNF117;ZNF536;PRRX2;MAGED1;ZNF281;SPIN1;MLF1;ZNF212;ACVR1B;ZNF502;TAF5;MYB;ZNF280B;BNC2;HMGA2;ZNF263;FOXN3;RPS6KA5;SMARCA2;HCFC1;ZNF682;DVL2;PCGF1
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),-0.685059453631813,-1.0734915010112107,0.38461538461538464,1.0,1.0,1/6,1.03%,FBXO43
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.6769151955121442,1.0734493834236134,0.4230769230769231,0.9002302463963426,1.0,3/7,5.36%,CFH;IL4;CD59
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6277851005457104,-1.073131338355598,0.3023255813953488,1.0,1.0,4/14,7.31%,PXDN;COL4A1;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.7546620921255442,-1.073102737993803,0.37735849056603776,1.0,1.0,1/5,2.94%,FGF1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.5936125554642827,-1.0727465818758424,0.37777777777777777,1.0,1.0,3/19,9.57%,NUPR1;FLOT1;CDC37
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5425659091952956,1.072567825999213,0.3559322033898305,0.9024233262940654,1.0,6/28,9.42%,SYT15;HRH3;SYT1;SYT6;DRD3;SNCA
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.7031747603908506,-1.0725113068530918,0.45098039215686275,1.0,1.0,2/5,16.18%,HTR1D;HTR2B
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.6614664990111861,1.0723679049603112,0.4126984126984127,0.9024719596530719,1.0,2/6,20.97%,ABCC11;SLC25A33
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.5958323051512129,1.0723490634622406,0.3709677419354839,0.9019709320586305,1.0,3/12,20.84%,RPIA;H6PD;RPE
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.6953815603065046,1.072265944725195,0.48333333333333334,0.9017234566724764,1.0,1/5,3.50%,RAB27A
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4514784731198802,1.0721229963058527,0.36,0.9015990668952072,1.0,12/80,8.90%,ACE2;TMPRSS2;LGR5;AP1M2;CAPN13;CYP4F12;ANPEP;VWA2;AGR2;SELENBP1;DSP;SLC44A4
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.6728736971962259,-1.0720870942079932,0.4583333333333333,1.0,1.0,3/6,12.78%,CAV1;FLOT1;APOA1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5152492737778246,1.0720386759470346,0.3673469387755102,0.9013376690940437,1.0,6/32,16.31%,SEMA5A;SEMA6C;PLXNB1;PLXNB2;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.40213136582108705,1.0719240357052586,0.32786885245901637,0.9011559406027282,1.0,45/238,20.31%,MITF;PAWR;MATN1;FBLIM1;ACD;HAS2;CD40;LLGL1;NLGN1;PCLO;TEAD2;NEFH;EPS8;SPAG16;RHOD;SLC7A9;NLGN4X;LIN7A;MAGI1;LRRTM3;GSN;CD74;RANBP9;RHOU;PML;SYCP2;GPM6B;PICALM;CLDN14;VAMP3;HORMAD1;IL2RB;FZD1;CD247;RP1;RHOG;NOC2L;MNAT1;CD2AP;ESPN;WASL;GPAA1;GORASP2;TOGARAM1;RP1L1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.5142117529772656,1.0717822482434605,0.35185185185185186,0.9009888481335964,1.0,7/36,10.50%,BLNK;IL4;SYVN1;FLT3;PLCG2;RAG2;KLF6
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6753562178426671,-1.071621555449557,0.4444444444444444,1.0,1.0,1/5,25.20%,ABHD12B
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.417309155199657,1.0707966502039017,0.21052631578947367,0.9037475427258318,1.0,17/151,8.87%,IGF1;LGALS9;RUNX1;SIRT1;ITGB8;FGF2;APOBEC1;HIF1A;LDLR;WNT4;MYCN;SFMBT2;BMP2;ABCC2;ESR1;MOV10;ANKRD13D
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.6009966345285934,1.070778471419504,0.45614035087719296,0.903276644408736,1.0,4/11,18.59%,TMEM100;F2R;ATPSCKMT;SPX
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.6333125967998491,-1.0707050994161715,0.44680851063829785,1.0,1.0,3/7,20.36%,CARTPT;KCNB1;VIP
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),0.7107245836910991,1.070637604890422,0.5172413793103449,0.9032453421394677,1.0,1/5,16.23%,RET
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6064540055216401,1.0703974035765467,0.42105263157894735,0.9034658349036396,1.0,3/14,7.43%,FGF2;TMEM100;VEZF1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5851679682625868,1.0701627953612796,0.36363636363636365,0.9037220108722279,1.0,2/16,3.23%,RUNX1;SNAI1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.42116575980047727,1.0697592798027755,0.23404255319148937,0.9043371127178,1.0,23/106,20.53%,PADI6;CCNA2;SIRT1;CTCFL;PADI2;PRMT1;RPS6KA4;HDAC2;EYA2;EZH2;TBL1X;CPA4;PADI4;KAT6A;UBE2U;SIRT7;RPS6KA5;HDAC1;HDAC9;SUPT3H;RUVBL2;MIER3;NSD1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6685102025050405,1.0696550430264355,0.4426229508196721,0.904132929748773,1.0,2/7,5.30%,ZBTB1;IL23R
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.604024374280834,1.0695933074427204,0.45614035087719296,0.9038356988195329,1.0,5/12,27.09%,ZFP36L2;AKR1C3;NR3C1;HNRNPU;ANXA1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.73446270244714,1.0692724143645382,0.42105263157894735,0.9043133790138342,1.0,3/6,21.32%,SLC25A13;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7160215881799821,-1.0692124130174114,0.38461538461538464,1.0,1.0,2/6,11.72%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.41123125969885826,1.069073989335562,0.2982456140350877,0.9043819410891424,1.0,44/258,12.49%,SYK;IL26;NOX5;ADRA1A;TRPM8;TGFBR1;SOX5;SIRT1;ESRRG;ZBTB7B;ITGAX;FGF2;IL4;SNAI1;TMIGD2;SCD;TRPV2;ADIPOR2;NLGN1;F2R;PLAC8;BMP2;SIX4;CCDC88B;APELA;SOX6;WWTR1;PRKAB2;ACHE;FBXO5;ABCA1;HDAC3;PDGFC;ITK;IL15;PAXIP1;KDM3A;LEPR;EZH2;SMAD2;CADM1;HAP1;BMPR1A;GADD45G
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6640188455759928,1.0689931958732328,0.4444444444444444,0.9041065792884649,1.0,4/8,20.95%,VAMP1;SNCA;VAMP3;VAMP4
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6489130670363684,1.068925490598798,0.4423076923076923,0.9037957461398852,1.0,2/8,25.90%,HEXB;NAGA
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.6609628949563652,1.068790540372413,0.3617021276595745,0.9036641530803842,1.0,3/8,25.46%,PELI1;BIRC3;ARHGEF2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4744280402459842,1.0686104983112736,0.36538461538461536,0.9036328253939826,1.0,13/65,14.94%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;PROX1;USH2A;MEGF9;MEF2C;PXN;NTNG2;VAMP3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.41732428342422917,1.0685881619610416,0.2830188679245283,0.9031870351686804,1.0,38/154,18.26%,IRGM;IRS1;INSIG1;URI1;BRINP3;RORB;NRIP1;RORA;RORC;RELA;ESR1;TICAM1;EPHA3;RAMP3;HMGB1;HTRA2;NLRP7;ABL2;LYN;ATP1A2;PDE4B;NR1H4;MEF2C;NR1H3;STRA8;MAPK8;TNIP3;PTK7;FZD4;CD80;NCOA3;CREB1;RET;IRAK1;CARD16;NFKBIB;AXL;WNT8B
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.7141914137780737,-1.0682989502793088,0.47368421052631576,1.0,1.0,1/5,4.29%,TNFRSF11A
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4524031113323512,1.0679841059055364,0.42592592592592593,0.9045416387531564,1.0,20/143,7.89%,IGF1;SYK;FLT1;FGF10;ADRA1A;RRAS;RIT2;EPHA7;FGFR1;FGF2;FGFR3;ROR1;KSR1;F2R;BMP2;TNIK;PELI2;FLT3;EPHA8;PLCG2
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.5979122336061682,1.0676939221727944,0.4807692307692308,0.904895310472217,1.0,2/15,2.68%,TGFBR1;MLC1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.5882928451799934,1.0676052688227409,0.3793103448275862,0.9046493148747194,1.0,1/16,2.29%,BOK
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.5800893987408762,-1.067465676546165,0.39215686274509803,1.0,1.0,1/11,1.71%,SLCO2A1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.5458428522837018,-1.0674381272223343,0.3541666666666667,1.0,1.0,2/16,4.63%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.625179170830855,1.0672185212550247,0.3695652173913043,0.9052021417264057,1.0,3/17,5.91%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.49013304691191695,-1.0670742089881764,0.3333333333333333,1.0,1.0,2/38,4.59%,MAP1LC3B2;ATG14
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.49691912881032935,1.0669600803301482,0.4107142857142857,0.9054550455856968,1.0,8/55,13.82%,RUNX1;KAT2B;MAFB;PRMT1;MOV10;LYN;MEF2C;CNOT4
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4484976635225256,1.0667326301748117,0.3673469387755102,0.9057005315505465,1.0,32/106,24.10%,TRPM8;MCOLN3;KCNC2;ZNF493;PMP2;CACNB4;GNAT3;ST18;NRXN1;SYNPR;SLC24A2;PROX1;CTNNA2;SCN2B;HCN1;GRM4;MYT1L;SEZ6L;MOBP;CNTN2;PCSK2;RPS6KA5;SLC7A14;XKR4;STMN4;NR3C1;AMER2;CADPS;ATP1B2;PDE1B;ASPA;HTR5A
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.49180266725339683,1.0667133713370403,0.3269230769230769,0.9052126546844887,1.0,5/29,5.87%,IGF1;B3GAT2;CANT1;HS3ST3B1;UGDH
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.7016054797026356,1.0665033894136784,0.3888888888888889,0.9053655252256811,1.0,2/5,25.07%,RAP1GDS1;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5518107929747612,1.0663316402212724,0.4,0.9054115832776647,1.0,8/26,25.19%,HIF1A;HDAC2;ADRA2C;GREM1;NCOA3;HDAC1;EDN1;JAK2
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.4577922571139255,1.0660870698995615,0.3,0.9056423109255859,1.0,22/102,13.44%,CGNL1;F2;C6;CALCR;MOGAT2;CLDN2;OIT3;OPRK1;MTTP;GHRLOS;AGXT2;SLC6A16;OLFML3;ABCG8;SLC7A9;CYP3A4;PROX1;COL22A1;ADAMTS6;GRAMD2A;CORIN;NR1H4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.40746807726599393,1.0658910260962242,0.27419354838709675,0.905851467085552,1.0,53/290,19.50%,PKNOX1;SOX5;PRRX1;ESRRG;ZBTB7B;NR5A2;HNF4G;ZBTB1;KAT2B;PPARG;RORB;MLLT3;RORA;SP1;WWTR1;TEAD2;RORC;RBPJ;ESR1;MED17;ELP4;HDAC3;TSC22D1;PAPOLA;TAF3;NPPA;PCF11;NR4A2;TBL1X;NR1D2;NOTCH3;NR1H4;NR1H3;ELOF1;INTS6;CDK12;RARB;TAF5;POU2F1;THRB;CCNH;TAF1A;DEAF1;ELL2;NELFB;TAF2;NOTCH2;EAF2;MNAT1;NOTCH4;INTS11;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.6108799148321001,1.065756354505699,0.39622641509433965,0.9056700742249405,1.0,5/6,24.93%,GLRA1;TMEM98;TNFRSF21;JAM2;EIF2AK3
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4936183508167511,1.0657185783147072,0.34,0.9052193855197198,1.0,11/45,14.94%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;USH2A;MEGF9;PXN;NTNG2;VAMP3
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.757929974704677,1.0654950490915598,0.45454545454545453,0.9053220998208474,1.0,3/5,17.03%,TGFBR1;VEGFA;LRP2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.42424448695341543,-1.065421909576537,0.3023255813953488,1.0,1.0,17/89,10.12%,RFX6;CAMK1G;KIF12;SLC22A8;KIRREL2;UMOD;TTBK1;SPRED2;ARNT2;NPAS4;CYS1;PAX2;UCHL1;WWC1;WFS1;SLC22A6;DLL4
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.6685242360204985,1.0654069707718097,0.44,0.9050988287238841,1.0,3/6,21.66%,NPPA;ADRB1;BMPR2
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6813165056882236,1.0653880480765052,0.4642857142857143,0.9046563407365044,1.0,5/8,30.62%,RELA;RPS6KA1;RGS14;DDIT3;RPS6KA3
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5624983951730677,-1.0651894053666202,0.3958333333333333,1.0,1.0,1/14,1.76%,PRDM1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5261056316838632,1.0651554171219615,0.31666666666666665,0.9048228855464641,1.0,11/38,20.32%,NEDD4;DCC;TNIK;ADGRB3;HECW2;KIAA0319;DBN1;CSMD3;COBL;CDKL5;RAP2A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5877207323014542,-1.064922149222115,0.4186046511627907,1.0,1.0,3/20,10.48%,XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.6867810814241172,-1.06470874058092,0.4,1.0,1.0,1/7,5.58%,KMT2B
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5053657523904729,1.0647051028847454,0.29310344827586204,0.9055973996506251,1.0,10/32,21.73%,TULP3;EHD1;TULP1;ROPN1B;BBS9;MAPK15;RAB29;ARL3;TTC21B;IFT140
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.43576273060250426,1.0646616250342789,0.32727272727272727,0.9052190018173003,1.0,34/120,20.84%,GATA4;RBM20;TGFBR1;ERBB4;KAT2B;BMP2;SGCZ;CHD7;APELA;PCSK5;PDLIM5;EPHB4;DLC1;FGF12;DAND5;SGCG;TAB2;MEF2C;FLRT2;PTEN;BCOR;VEGFA;SCUBE1;ALPK3;FBN1;BMP4;KDM6A;MESP1;DVL2;FLRT3;HDAC9;CITED2;PDLIM7;SHH
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.6630951330515364,1.0645989380165632,0.41509433962264153,0.9048904880752865,1.0,3/7,13.72%,LRAT;RPE65;BCO1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.45233779734176993,1.064343430910368,0.328125,0.9052188745110357,1.0,14/66,24.93%,VAPB;TOR1B;LMAN1;UBE2J2;MAPK15;REEP6;LMAN2L;SEC61A1;STX5;TOR1AIP2;STX18;TMCC1;BNIP1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5598800466063989,-1.0642794190387481,0.3541666666666667,1.0,1.0,1/21,0.27%,TERT
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6939230268224779,1.0639296157861482,0.4489795918367347,0.9060901328877841,1.0,2/7,18.62%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.6806964871112675,1.063806163208907,0.4117647058823529,0.905930912990759,1.0,2/5,17.69%,FBN1;NOTCH2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.559397391201248,1.0637388215852408,0.30612244897959184,0.9056450308409638,1.0,3/24,10.14%,PNP;NUDT4B;NUDT4
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.6930535242794456,-1.063733593773989,0.46153846153846156,1.0,1.0,2/5,7.14%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.6813213675737088,-1.0637142209252304,0.40476190476190477,1.0,1.0,4/5,28.33%,SCTR;AQP1;AQP11;AQP4
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.4940984212807918,1.0636022657171076,0.37735849056603776,0.9055355543545065,1.0,12/43,12.52%,SLC26A3;MOGAT2;APOBEC1;CYP4F12;AGR2;TM4SF20;MUC13;PPP1R14D;ADAMDEC1;MUC17;TMEM45B;FBP1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.6558565478675354,-1.0635691214838812,0.4166666666666667,1.0,1.0,1/9,1.09%,GINS3
prerank,MSigDB_Hallmark_2020__E2F Targets,0.41964894173420403,1.0635552646505322,0.30357142857142855,0.9051939214291314,1.0,20/189,14.09%,ESPL1;TIMELESS;CDKN2C;TOP2A;CDC25A;DLGAP5;MYC;CDKN2A;ASF1B;SYNCRIP;TK1;ASF1A;GINS1;MCM7;EZH2;MTHFD2;HNRNPD;CHEK2;RACGAP1;CDK4
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5871868294874725,1.0633767377943812,0.4032258064516129,0.9051059373705721,1.0,1/13,1.59%,RENBP
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.6774278705059051,-1.0633482341187332,0.4222222222222222,1.0,1.0,1/6,5.08%,PAH
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5474699914589389,1.063109204980271,0.41379310344827586,0.9053766229290455,1.0,7/27,21.85%,RAPGEF3;RAPGEF6;TJP2;RAP1A;F2RL1;AFDN;RAPGEF2
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5320128041237702,1.062948774214992,0.42857142857142855,0.9053167416740784,1.0,7/24,19.80%,PEX12;ABCD3;ABCD2;PEX2;ABCD4;MFF;PEX11A
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4574410036941638,-1.0629303846003435,0.3055555555555556,1.0,1.0,9/73,7.21%,ALB;EHF;CAPN8;CLDN4;CD24;KIF12;FAM3D;MUC5B;KCNN2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.5323759849117821,1.062861813625679,0.3333333333333333,0.9050883869380414,1.0,2/22,3.00%,SYK;CCL5
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6173708607481975,1.0624095760388361,0.4827586206896552,0.9060043206490307,1.0,2/14,10.57%,ARHGAP24;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5295641269969933,1.0622323894904642,0.38461538461538464,0.9060493982560842,1.0,6/30,17.52%,FGF10;PLCG2;UBE2E2;EZH2;CCND3;PLCB1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5112860561893856,-1.0619052697148281,0.37777777777777777,1.0,1.0,1/26,0.26%,NTRK1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7025532613615761,1.0618336993376811,0.4716981132075472,0.9069216576451287,1.0,1/5,17.02%,PLSCR1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.435736205758127,1.0617963705956168,0.2833333333333333,0.9064476796657419,1.0,14/114,12.88%,ZDHHC11;AP1M2;ZDHHC12;NLGN1;LTBP2;PEX12;GDAP1;ZDHHC22;TIMM22;RAB3IP;ZDHHC2;FBXO7;HAP1;ZFAND6
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6220983510330814,1.061741234124398,0.4117647058823529,0.906093288429485,1.0,2/9,3.24%,PNP;AMPD1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.4978438948490954,1.0615053770600233,0.288135593220339,0.9063341644739493,1.0,9/44,12.45%,FGFR1;TGFBR1;BMP2;SIX4;CHD7;PCSK5;PROX1;LIG4;FUT8
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5748886520429427,1.0613845458502846,0.37254901960784315,0.9061900760031586,1.0,5/19,25.17%,FKBP5;PPIL6;PPIF;CWC27;NKTR
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.6426670048325,1.0612233673189855,0.43333333333333335,0.9060950853564933,1.0,2/8,5.49%,WNT4;SIX4
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6411120965431699,-1.0611263921439673,0.4222222222222222,1.0,1.0,2/8,8.54%,AK8;AK7
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5472310222754466,1.060973431345655,0.37735849056603776,0.9063565036295572,1.0,8/28,20.15%,LIN28A;SMAD1;SMAD2;MRPL44;PRKRA;HNRNPA2B1;PUS10;AGO3
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.44489982268408906,1.0609720394076039,0.3103448275862069,0.9058425913402288,1.0,21/122,14.93%,NXPH1;PLEKHH2;SLC35F1;GFAP;SLC1A3;SLC17A6;TMEM200C;IFI44;ZDHHC22;MEGF10;POU3F2;STOX2;PAK5;NPAS3;DLL3;GRIK3;GPM6B;ZNF536;MGAT5;MAGEL2;IGF1R
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.4957131575865227,-1.0609711540655715,0.34146341463414637,1.0,1.0,4/35,13.44%,HK2;ENO2;GAPDHS;PFKFB1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.656463168465249,-1.060727153436159,0.4489795918367347,1.0,1.0,1/7,0.89%,TAFA3
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4373249406847834,1.060632615529914,0.3958333333333333,0.9063969405184048,1.0,9/79,10.52%,CDKN2C;CDC25A;MYC;CDKN2A;CDK18;FBXO5;CDK14;BCAT1;LATS1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6766301711529663,-1.0602997385337756,0.40816326530612246,1.0,1.0,2/5,25.78%,ATP6V0A2;ATP6AP1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5710381243399438,-1.060296885260442,0.3877551020408163,1.0,1.0,4/13,16.65%,PRPF19;USP4;SRSF10;PRPF6
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.5911638663025508,1.0601270169042603,0.3220338983050847,0.9073760816792116,1.0,5/12,33.55%,TIPARP;PARP8;PARP9;PARP12;PARP14
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.48865134897023654,1.0599948235225252,0.3559322033898305,0.9072388616730324,1.0,15/50,22.09%,ENGASE;HIF1A;ST6GALNAC3;ST8SIA4;HPSE;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A;ST8SIA1;FBXO17;B4GALT7;GAL3ST2;STT3B
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.5362936177526965,1.0599694058032978,0.3684210526315789,0.9067674195742454,1.0,1/28,0.38%,GATA4
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.6524708314714994,1.059840204524009,0.4375,0.9066724791229701,1.0,3/10,18.59%,RNLS;ATP1A2;SPX
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.5296153142299099,1.0598024777846786,0.42105263157894735,0.9062854005460201,1.0,10/26,15.66%,SYK;BLNK;PLCG2;ITK;LCK;BLK;MEF2C;BCAR1;SH2B2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.483767708064986,1.0594152611646526,0.42592592592592593,0.9067819581581622,1.0,5/33,9.04%,SYK;LGALS9;HIF1A;TLR2;HMGB1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.41644089435598136,1.0588327313146693,0.3191489361702128,0.9080216294693879,1.0,36/142,21.80%,ALDH1A1;OSTC;ADIPOR2;PRDX6;IDH1;UGDH;ACADS;GLUL;ODC1;TDO2;ELOVL5;ALDH9A1;ECI1;HIBCH;HMGCS1;ACADM;RAP1GDS1;CA2;CEL;HSD17B10;ACAA2;REEP6;FASN;CRYZ;AUH;SLC22A5;GPD2;SMS;BCKDHB;ACSL4;LGALS1;ACSL5;ACSS1;GRHPR;ACOX1;ECI2
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.6625539370608795,-1.0585528695332316,0.45098039215686275,1.0,1.0,2/7,0.71%,SELP;SELE
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.7046050174188819,1.058423036474257,0.43103448275862066,0.90875974789502,1.0,1/5,5.49%,SIX4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6199964234820035,-1.0583757085700591,0.4489795918367347,1.0,1.0,1/8,0.56%,DUOXA1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.6597341476537668,1.0583079374473152,0.42,0.908552862558466,1.0,1/7,3.59%,LDLR
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.4166871918100901,1.0582937313973402,0.2857142857142857,0.9080756163326702,1.0,21/128,11.81%,GATA4;CXCL12;C3;BOK;PADI2;MAFB;BCAM;MEIG1;PLSCR4;FAM114A1;ARHGEF17;EPS8;BGN;SELENBP1;OLFML3;SDC4;ABCG8;GAMT;TF;NECTIN2;GSN
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.4863148161155216,1.0582212018415513,0.41379310344827586,0.9077306690659043,1.0,9/54,14.76%,RIT2;CD22;ZFYVE16;HIP1;EPHA3;SNCA;ABL2;STON2;PICALM
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.4008755875683693,-1.0579021136600708,0.30434782608695654,1.0,1.0,17/141,8.86%,ACTC1;SLC29A3;MYH7;KCNE2;PLAG1;CAPN9;YBX2;C5;SNN;PDE6B;TG;CHRNG;STAG3;HTR1D;MEFV;MYO15A;THNSL2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7294882610771294,1.0577471998446641,0.4528301886792453,0.9087444881730165,1.0,2/5,18.48%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.4438585601845455,1.057595024297956,0.30357142857142855,0.9086212016069575,1.0,31/114,24.03%,LDLR;PPARG;SCD;SP1;ODC1;FDFT1;PRKAB2;HDAC3;HMGCS1;SMARCD3;PSMD13;NCOA2;TBL1X;MVD;NR1D2;PSMA1;ACACB;PSME4;FASN;ACACA;CHD9;SC5D;SQLE;DHCR7;IRS2;PLPP1;PSMD4;ELOVL6;SREBF2;IDI1;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.6514105901352537,1.0575864071517156,0.42592592592592593,0.9081311590309954,1.0,1/10,0.57%,SYK
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5485635799458011,-1.0574613359401186,0.38461538461538464,1.0,1.0,2/25,2.68%,P2RY10;PRAG1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.5741942824383257,-1.0574600260589555,0.4411764705882353,1.0,1.0,3/10,13.20%,CD200R1;P2RY12;PTK2B
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.6536050355199434,-1.057410340570119,0.46,1.0,1.0,1/8,3.01%,CYP2E1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.6354017607522624,-1.057375717590507,0.3902439024390244,1.0,1.0,2/10,10.28%,PARP2;PARP1
prerank,PanglaoDB_Augmented_2021__Platelets,0.4192528682942464,1.0572776167695133,0.2857142857142857,0.9084995851280094,1.0,17/136,7.86%,TNFSF14;SASH3;FERMT3;NOX5;PIK3R6;CSF3R;SELPLG;ITGAX;ITGA2;CCL5;ANGPT1;PTGS1;CD40;F2R;HCLS1;FGL2;CYP2U1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.7162594350368494,-1.0566390515093114,0.42857142857142855,1.0,1.0,1/5,11.25%,GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.7162594350368494,-1.0566390515093114,0.42857142857142855,1.0,1.0,1/5,11.25%,GAS2L2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.44962788468460985,1.056622404798669,0.38,0.9098425639260893,1.0,17/67,18.09%,ACSM2A;SCD;ACSS2;FDFT1;SCD5;LIPG;OLAH;IDI2;MVD;ABCD3;OXSM;ACACA;PRLR;FDXR;STAR;PRKAA1;ELOVL4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.536156044160018,1.0565878350259401,0.39622641509433965,0.9094632350523923,1.0,6/19,23.64%,CDKN2A;LATS1;PTEN;NR2F2;HEXIM2;INCA1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5521779314612077,1.056412015219955,0.37254901960784315,0.9095263748259047,1.0,2/14,3.00%,SYK;CCL5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.43126020972319073,-1.0560793052067234,0.26666666666666666,1.0,1.0,20/59,16.91%,NUPR1;SFRP1;ALOX5;XDH;ATOH8;CAV1;SPARC;WDR77;CEACAM1;CAV2;DAB2IP;CDKN1C;TGFB1;VDR;MED1;TGFBR3;SCG2;STAT1;SFRP2;FGFR2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6549635830983254,1.0560080099691658,0.43137254901960786,0.910210704677999,1.0,3/9,7.68%,GRIP1;SCRIB;GRIP2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6045017016468025,-1.0559853323682038,0.375,1.0,1.0,4/18,14.77%,ERCC1;PARP1;GTF2H2;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6045017016468025,-1.0559853323682038,0.375,1.0,1.0,4/18,14.77%,ERCC1;PARP1;GTF2H2;RPA3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.47118283198954425,1.0557482790821802,0.31666666666666665,0.9105424088686396,1.0,7/44,15.90%,CCNA2;SLFN11;GMNN;FBXO5;RBBP6;TERF1;ESCO1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5791037045724529,1.0555567398437373,0.3225806451612903,0.9106875695554569,1.0,7/14,29.58%,PAXIP1;NECTIN2;KMT5B;TNFSF4;SHLD2;SHLD1;C17ORF99
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.6481684180252252,-1.0554590233399002,0.4523809523809524,1.0,1.0,5/7,17.56%,CYP21A2;HSD11B1;CACNA1H;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.5343166191491366,1.0553555173526994,0.2909090909090909,0.9107154157982895,1.0,18/40,26.20%,IGF1;MYC;BMI1;PDGFRA;PDGFC;CD74;LIG4;CDK4;CTNNB1;PEX2;MED25;B4GALT7;TP53;GAS6;WNT2;CDK6;DDR2;DHX9
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5767533207282882,1.055330985252002,0.3793103448275862,0.9103162205758254,1.0,4/22,11.75%,INSIG1;MDFIC;LMAN1;RAB23
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.5271096935140546,1.0552525755769533,0.3870967741935484,0.9099863112414229,1.0,7/26,23.74%,SLC7A2;SLC1A3;SLC25A13;SLC3A2;SLC1A6;SLC25A12;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.6844514143802367,1.0552411352850561,0.43548387096774194,0.9095191864000565,1.0,2/5,20.84%,KIT;SHH
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.48656516442159703,1.0550846805055618,0.30612244897959184,0.9094995018883874,1.0,5/50,4.85%,IGF1;LGALS9;FZD5;PYHIN1;F2R
prerank,PanglaoDB_Augmented_2021__Interneurons,0.38920865321774023,1.0550428493245523,0.3283582089552239,0.9090675391850456,1.0,48/278,14.04%,TIMELESS;NXPH1;LYPD1;RIT2;PNOC;GRM3;PCBP3;SLC35F1;KCNC2;CADM2;RORB;PDE1A;SLC17A6;RGS10;VSX2;RORA;NPY;NXPH4;SYT1;PARM1;ZDHHC22;RAB3C;KCNQ5;DHRS3;NRXN1;LHX6;ADGRL2;SYNPR;RAMP3;PAX6;OLFM3;FGF12;HIVEP2;GRM5;CTNNA2;PCF11;OXR1;LRRTM3;ADGRB3;SCN2B;PAK5;GNG4;TMEM196;HAP1;GRIN2D;FCHSD2;NOL4;GABRA5
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3976780511344974,1.0549259203512171,0.32653061224489793,0.9088833052847264,1.0,59/272,21.14%,IGF1;LGALS9;RUNX1;SIRT1;ITGB8;FGF2;HIF1A;KAT2B;WNT4;MYCN;SFMBT2;BMI1;LIN28A;PATL2;SAMD4A;BMP2;BTN2A2;SYNCRIP;ABCC2;ZFP36L2;ESR1;MOV10;RPS6KA4;NUDT16L1;TOB1;RNF139;EZH2;RIDA;BMPR1A;MSR1;CPNE1;MEF2C;PICALM;RBMS3;ZNF281;CAPRIN1;EPC1;SLFN14;PTBP2;TIPARP;VEGFA;NOTCH2;BMP4;DXO;PRKAA1;CNOT8;CD34;RPS6KA5;HDAC1;HDAC9;CCDC3;AGO3;FMR1;CITED2;CENPV;EED;NDFIP2;LGMN;ADAM10
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3713072974619738,-1.0549023147832088,0.3111111111111111,1.0,1.0,22/436,4.61%,CD44;IRF4;IL10RB;TNFSF18;CXCL13;IL11;CD86;DUOX1;PRKCD;IL1RL2;IFI27;OAS3;HLA-DRB1;IL31RA;TEC;ALOX5;IL18BP;IL6R;TNFRSF11A;TRIM5;CRLF1;FOS
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6052310536688437,1.0546357952761911,0.45454545454545453,0.909317031432798,1.0,11/16,32.91%,FZD5;CLC;CD55;HLA-F;TNFSF4;TNFRSF1B;SMAD7;TRAF6;TRPM4;B2M;MAP3K7
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4770620708813882,-1.0546285852854769,0.4,1.0,1.0,2/44,0.70%,NTRK1;DDX11
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6792023893681614,1.0543456974194612,0.4339622641509434,0.9087514499177761,1.0,2/7,21.43%,CD55;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.6792023893681614,1.0543456974194612,0.4339622641509434,0.9087514499177761,1.0,2/7,21.43%,CD55;C4BPB
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6792023893681614,1.0543456974194612,0.4339622641509434,0.9087514499177761,1.0,2/7,21.43%,CD55;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5490272993376092,1.0543216480270712,0.38333333333333336,0.9082871277032725,1.0,6/21,21.47%,NEDD4;HRH3;SNCA;GPM6B;PXK;WNK1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.6648185685381183,-1.0538510323066395,0.43137254901960786,1.0,1.0,2/9,17.78%,TRPV1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.4709408923631338,1.0538354611161669,0.3673469387755102,0.9091990881954145,1.0,19/65,25.06%,CCL5;GPSM3;CCN4;NAPEPLD;NFKBIZ;TLR2;SNCA;IL15;PLA2G7;MEF2C;POLR3G;PLSCR1;GPRC5B;RIOK3;TNFSF4;IL23A;FPR2;SERPINE1;NINJ1
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.658987729115196,-1.0536033299997782,0.4146341463414634,1.0,1.0,2/5,12.37%,CRH;FFAR4
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.6589182734386232,-1.0534949690816051,0.3953488372093023,1.0,1.0,1/5,5.46%,COL1A1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6683940457064669,-1.0534689686618073,0.525,1.0,1.0,4/5,32.66%,BAIAP3;STX1B;PRKN;GPER1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.6042549428881286,-1.053147384634577,0.40425531914893614,1.0,1.0,1/11,3.36%,SPTLC3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.6042549428881286,-1.053147384634577,0.40425531914893614,1.0,1.0,1/11,3.36%,SPTLC3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6236019406570429,-1.053078031098476,0.34782608695652173,1.0,1.0,3/9,8.38%,SLCO2A1;ABCC4;ABCC3
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5719294905241913,1.0529684485842974,0.42,0.9112797849673606,1.0,6/11,32.11%,CRB2;PHLDB2;TENM4;PHLDB1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.6916087761700693,1.052875416250199,0.45,0.9110677880645806,1.0,2/5,11.32%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5430503043920385,1.0527596531684615,0.3584905660377358,0.9109926901481741,1.0,4/21,17.18%,CBLB;CHMP6;NCK2;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6245033316890447,1.0527237474649034,0.48214285714285715,0.9105830465915844,1.0,2/13,15.59%,CCL5;CSF1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.49325975869648897,-1.05263087726191,0.3829787234042553,1.0,1.0,8/39,5.60%,EHF;DUOXA1;ANXA8;MGP;NUPR1;IL1RL2;ADIRF;C6ORF132
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.47178543308082943,-1.0522550465584934,0.3958333333333333,1.0,1.0,7/44,15.67%,GPX3;MPO;PTPA;TXN;TXNRD2;PRDX1;CDKN2D
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5774249006856402,1.0522497726419915,0.3617021276595745,0.9115048062517307,1.0,3/26,5.57%,FGF10;CDH2;MYRF
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.44419673015859584,1.0516715973107948,0.3050847457627119,0.9127802496462923,1.0,16/104,15.01%,ATP6V0D2;SIRT1;IL4;NEDD4;STING1;PRKAB2;GPSM1;SMG1;ATG101;GNAI3;PIK3CA;EPM2A;BNIP3L;RRAGC;MAPK8;ATP6V0B
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.5919558240572905,-1.0515058363832668,0.38095238095238093,1.0,1.0,2/11,9.48%,CXCL13;P2RY12
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.5252672157424222,1.0514851490800365,0.42857142857142855,0.9128202600202651,1.0,4/24,10.64%,SYT15;SYT1;SYT6;RIMS2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6948539432005676,1.0514303586622085,0.43137254901960786,0.9119603600004891,1.0,2/6,18.62%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6948539432005676,1.0514303586622085,0.43137254901960786,0.9119603600004891,1.0,2/6,18.62%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5835699024230242,1.051413443315356,0.43333333333333335,0.9114834889870387,1.0,3/19,1.55%,LGALS9;KLRD1;PIK3R6
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5442009737996363,1.051409302068524,0.38181818181818183,0.9109867447269099,1.0,4/18,8.92%,RIT2;CD22;PLCG2;NEUROD2
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.554939224834171,1.0513499027873086,0.38596491228070173,0.9105857369924086,1.0,6/17,19.01%,BMI1;RYBP;BCOR;RNF2;PCGF5;PCGF1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.6008296178539757,1.0512284894623187,0.45454545454545453,0.9104365857807307,1.0,5/15,11.84%,IL4;DAPK2;MOSPD2;MCU;CD74
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.6870653523221526,1.0510594311749701,0.5,0.9103147653590007,1.0,4/6,24.24%,IRS2;ACSL5;AKT2;ACSL1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.6597173139162325,1.0509723167636535,0.45454545454545453,0.9100437622537396,1.0,2/5,24.71%,ZFAND1;DYRK3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.6681576652428094,-1.0509106269986177,0.5116279069767442,1.0,1.0,4/7,11.10%,SCN5A;KCNA5;KCNQ1;SCN3B
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.6482082351877916,1.0507661825025822,0.43137254901960786,0.910193634334692,1.0,4/5,35.14%,SIRT7;FBLL1;TRMT112;FBL
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5328698854513145,1.0506837072134239,0.42592592592592593,0.9099365605696272,1.0,10/19,17.72%,GATA4;SMAD1;NPPA;TBX18;BMPR1A;GJB6;SMAD4;SMAD5;NOTCH2;BMP4
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6593189896929348,1.0503449942452245,0.4489795918367347,0.9104251183546729,1.0,3/6,27.18%,GALK1;GALM;GALT
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5676782305121018,1.0503357893901515,0.4426229508196721,0.9099311791807833,1.0,2/17,19.14%,AUP1;SQLE
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6661263823998061,1.050292781789025,0.3584905660377358,0.9095731565987123,1.0,1/5,6.68%,RELA
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.6651171852587499,-1.0502400388459103,0.5121951219512195,1.0,1.0,2/7,4.98%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.6852376059878629,1.0501922258375658,0.5,0.9093575881198316,1.0,1/7,4.81%,AGR2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5620905798716489,1.0499787433383525,0.43333333333333335,0.9093383221577619,1.0,4/23,14.46%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5318433550642169,1.0499006884029614,0.46296296296296297,0.9090285258082592,1.0,5/22,19.78%,NEDD4;MVB12A;UBAP1;UBAP1L;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.5859130061911725,-1.0496871041983338,0.4186046511627907,1.0,1.0,1/14,0.70%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.6880936166593042,1.049270834935127,0.4576271186440678,0.9103128439443084,1.0,5/9,24.90%,IRS1;ABCD2;IRS2;AKT2;PPARA
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6831686207349271,1.0490114277424587,0.46153846153846156,0.9105495608209047,1.0,1/6,2.18%,SIRT1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.4184866149649801,-1.048710009459044,0.3333333333333333,1.0,1.0,10/86,5.18%,P2RY10;SP140;TBC1D10C;SELL;CD86;TRAF3IP3;CD53;CYTH4;ALOX5;BTK
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5221780475049302,-1.048695683023294,0.3333333333333333,1.0,1.0,6/23,14.98%,ABCA4;RFT1;ABCB1;ABCB4;ATP9B;ATP8B4
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.7149577383027905,1.0484957092017533,0.5,0.9116292352716485,1.0,2/5,18.79%,PROX1;GRID2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5257681360670052,1.0484591749152508,0.35714285714285715,0.9112514350765858,1.0,4/26,11.59%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6567914939333725,1.0484278565076384,0.4482758620689655,0.9104028075902261,1.0,3/9,23.32%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6567914939333725,1.0484278565076384,0.4482758620689655,0.9104028075902261,1.0,3/9,23.32%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.6704753734577372,1.0481917465864563,0.48,0.9106051648274758,1.0,3/8,9.77%,SYK;CCL5;IL15
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.6763525896705029,1.0481688105267244,0.49122807017543857,0.9101547704735219,1.0,2/7,17.72%,ELAPOR2;BMP4
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.6314090441988962,-1.0479756744426343,0.4375,1.0,1.0,4/8,15.21%,RGS8;DRD2;CAV2;VPS35
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.599524733259797,1.0477861936702553,0.43636363636363634,0.9108209531763654,1.0,5/10,21.17%,SLC8A1;MYH11;VEGFA;ALPK3;JAG1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6217783570299126,1.0477157609168228,0.4888888888888889,0.9105120502629669,1.0,4/13,10.90%,PPP1R15B;PPP1R14D;ITGA1;MAGI2
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.6873738325727381,1.0476500331928558,0.46551724137931033,0.910196772935875,1.0,1/7,0.41%,GPR55
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5387021832458693,-1.0475473576540149,0.37209302325581395,1.0,1.0,2/12,2.34%,NLRP3;CD86
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5516595623391523,1.047402256177149,0.44680851063829785,0.9104188216698446,1.0,6/18,12.34%,HS3ST5;HS3ST3B1;UGDH;HS2ST1;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6279372809526873,-1.0473181187999698,0.40476190476190477,1.0,1.0,1/13,0.27%,TERT
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.47565145028528044,1.0472782282081776,0.4262295081967213,0.9102246972675552,1.0,16/62,9.10%,IGF1;FLT1;HGF;FGFR1;SIRT1;FGF2;CCL5;ROR1;NEDD4;PIK3R5;F2R;HCLS1;FLT3;PDGFRA;GAB1;PDGFC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.4387944136314452,1.0471556156768294,0.3333333333333333,0.910131359317683,1.0,17/64,12.96%,SYK;FLT1;FGFR1;FGFR3;IL4;ERBB4;ABI3;FLT3;PDGFRA;FER;EPHA3;ITK;IL15;ABL2;LYN;LCK;BLK
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.6698361970404931,1.0471023076003017,0.48148148148148145,0.9097700797616142,1.0,2/8,7.86%,AGR2;PDGFRA
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6632259778518548,1.04674217967644,0.4230769230769231,0.9103200476730686,1.0,2/5,11.94%,CRACD;CARMIL1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5786543748261946,1.046278450875036,0.4406779661016949,0.9112710333674859,1.0,7/16,24.24%,ELOVL5;ACSBG1;TECR;ACSL4;ACSL5;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.6687884480106528,1.04620791227068,0.4406779661016949,0.9109833135508445,1.0,3/5,31.74%,PPP1R15B;ABCA7;NCK1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6797740967874556,1.0461956892100603,0.43902439024390244,0.9105354377379861,1.0,1/5,12.23%,TPRKB
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6892404631905547,1.0461013059268682,0.43103448275862066,0.9104288715410466,1.0,1/7,3.61%,NEDD4
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.47293878652585936,1.0459259892500659,0.3584905660377358,0.9104493237147298,1.0,5/60,8.77%,TNFSF14;LGALS9;RELA;TLR2;PPM1A
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6228369959694693,1.045692650714205,0.4827586206896552,0.9106099355696315,1.0,4/7,25.43%,BBIP1;RAB29;ARL3;ARL13B
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),0.7245166477227234,1.0456728241042694,0.3958333333333333,0.910156576923733,1.0,1/5,1.06%,TOP2A
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5059217137824942,-1.0455044661016926,0.36,1.0,1.0,1/29,0.47%,AMACR
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.38543399424427216,-1.0453834188180395,0.3333333333333333,1.0,1.0,12/306,4.59%,CD44;NTRK1;TEK;INHA;TERF2IP;IL11;FGF1;ENPP2;HLA-DRB1;TEC;IL6R;ATG14
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.6631257233608691,-1.0452123031655356,0.49056603773584906,1.0,1.0,4/8,16.18%,DRD2;HTR1D;EDN3;HTR2B
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.3906610719274883,-1.0451642631359204,0.3783783783783784,1.0,1.0,14/162,7.96%,ACTC1;MYH7;GPX3;PVALB;COL4A2;SPDEF;COL6A3;AGRN;COL1A1;FOXO4;SVIL;CHRNG;SPARC;CLU
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6567782904873672,1.0449249845856996,0.4098360655737705,0.9118308121639833,1.0,1/9,7.25%,PIP4K2A
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.45002214067010776,1.0449229839987597,0.34375,0.9113306306981774,1.0,18/85,15.24%,SLC7A11;SLC26A7;SLC38A4;SLC7A2;SLC26A6;SLC10A3;SLC38A3;ABCC2;SLC7A9;SLC10A5;SLC25A48;NCOA2;SLC10A1;NR1H4;SLC19A1;ABCC11;AKR1C1;SLC3A2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5375149654392348,1.044915361991689,0.4067796610169492,0.9108509797825507,1.0,3/27,6.50%,SIRT1;RORA;RORC
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.45164160871448333,1.0448494763491794,0.4032258064516129,0.9105316237636865,1.0,18/88,9.10%,IGF1;FLT1;HGF;FGFR1;SIRT1;FGF2;CCL5;ROR1;NEDD4;PIK3R5;F2R;DIPK2A;HCLS1;FLT3;PIP4K2A;PDGFRA;GAB1;PDGFC
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.6132456593873262,-1.0447174845355112,0.48,1.0,1.0,2/8,12.37%,CRYM;FFAR4
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.7058999673698148,-1.0440624624740231,0.5625,1.0,1.0,2/5,26.08%,GK5;GPAT2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.47978300312956335,-1.0440379835910427,0.37209302325581395,1.0,1.0,7/40,11.10%,SCN5A;DRD4;CRACR2A;DRD2;CAMK2A;WFS1;SCN3B
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7050099248039483,1.0439060855181697,0.46153846153846156,0.911363362194108,1.0,3/6,22.95%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7050099248039483,1.0439060855181697,0.46153846153846156,0.911363362194108,1.0,3/6,22.95%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7050099248039483,1.0439060855181697,0.46153846153846156,0.911363362194108,1.0,3/6,22.95%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7050099248039483,1.0439060855181697,0.46153846153846156,0.911363362194108,1.0,3/6,22.95%,ELOVL5;ELOVL4;ELOVL6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5527665999353975,-1.0438502918617578,0.40476190476190477,1.0,1.0,2/16,4.51%,ASS1;FGL1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4366338524552814,-1.043777431728724,0.35555555555555557,1.0,1.0,20/100,10.38%,SELE;NLRP1;GUCA1B;BST1;PTGES;IL1RL2;SPAAR;ALOX5;CNGB1;TRIM5;PDE6B;AHSG;CAV1;PPEF1;HCK;NMT1;P2RY12;DHX58;TMSB4X;GRK7
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.531029459034282,-1.043566778232949,0.425,1.0,1.0,3/34,3.75%,SELP;SELE;IGSF21
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.6325629391370503,1.0435490648990988,0.5,0.9119541230412851,1.0,4/6,20.84%,ARTN;RACGAP1;PLXNB2;SHH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6094572151899716,1.0434863148285825,0.36538461538461536,0.9116617519889134,1.0,5/12,13.44%,ZBTB7B;LY9;IL23R;IL15;NR1H4
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.6402894110136488,1.0434488344374746,0.46551724137931033,0.9107863350001476,1.0,1/7,21.29%,ATG2B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.6402894110136488,1.0434488344374746,0.46551724137931033,0.9107863350001476,1.0,1/7,21.29%,ATG2B
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.6477615986191707,-1.0434412665602448,0.42857142857142855,1.0,1.0,1/7,4.20%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5275332983818541,1.0430452292127776,0.4074074074074074,0.9112568830993613,1.0,7/32,12.74%,F2;KLKB1;KNG1;F12;PDGFRA;PLAUR;F3
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5735665146350767,1.0430074118223438,0.4915254237288136,0.9108794592740046,1.0,6/12,32.15%,PATL2;LSM14A;LIMD1;PATL1;RC3H1;LSM3
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.6204339117035209,1.0428915309815563,0.4642857142857143,0.9106877272859055,1.0,3/14,7.86%,F2;PRKG1;PDGFRA
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6731723934138851,-1.0427438341478763,0.55,1.0,1.0,1/5,10.95%,AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6731723934138851,-1.0427438341478763,0.55,1.0,1.0,1/5,10.95%,AR
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.4956276524773779,-1.042396369271882,0.3673469387755102,1.0,1.0,5/57,2.46%,MS4A8;EHF;DUOXA1;CYP2B7P;DUOX1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.528012191233381,-1.0422923337300516,0.35294117647058826,1.0,1.0,5/36,2.46%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7093044201243708,1.0422075987273416,0.5344827586206896,0.9120371648515297,1.0,3/5,23.50%,BCL11B;JAM2;GAS6
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5508404145342425,1.042063459229073,0.42857142857142855,0.9120697505158475,1.0,8/22,30.90%,PIK3CA;HSPA8;ABL1;MAP2;CAMSAP2;APOE;EFEMP2;MAP1B
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6573540987690161,1.042052273444938,0.4915254237288136,0.9116200355027275,1.0,3/11,10.09%,HIF1A;SNCA;TF
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6657273713409173,-1.0417797854670987,0.4222222222222222,1.0,1.0,2/9,21.39%,PGP;GK5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6520679202572279,1.0416324014772977,0.44642857142857145,0.9124583519399897,1.0,5/9,28.45%,ABCD2;SLC18A2;SLC30A10;PPARA;ABCB7
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4761911304734797,-1.0415781970800242,0.36585365853658536,1.0,1.0,2/42,1.30%,GUCY2C;ADSS1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5383277309347876,1.0415054076598438,0.43137254901960786,0.9124378621531026,1.0,1/17,0.56%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.5802168498205498,-1.0414532180928746,0.43243243243243246,1.0,1.0,6/12,14.72%,XDH;CAV1;SPRED2;SPRED3;SPRED1;MMP9
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5079701504767115,1.0414482182661646,0.4406779661016949,0.9121074007756896,1.0,9/34,22.61%,PADI2;NEDD4;ESR1;KDM3A;ARID1A;UBR5;PLPP1;NR3C1;TRIP4
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.709709875799406,1.041413378040247,0.48148148148148145,0.9117047856275623,1.0,3/5,22.40%,FBP1;SLFN14;RYR3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.34033881501955665,1.0413210777946516,0.2535211267605634,0.9114936724946454,1.0,353/1744,21.17%,DACH1;GATA4;MITF;ZSCAN4;CRX;IGF1;AASS;IL26;TPRX1;ZNF300;SMAD6;EBF1;PKNOX1;HGF;PRDM14;FLI1;HIF3A;RUNX1;SOX5;SIRT1;DUXA;PRRX1;ESRRG;ZBTB7B;TSHZ3;DMRT3;ZNF792;FZD5;NR5A2;DBX2;FGF2;PBX3;ERG;IL4;ZBTB40;HNF4G;MYC;DUX4;CTCFL;URI1;SNAI1;FOXP2;ZBTB1;HIF1A;NFIL3;KAT2B;CDKN2A;ZNF493;TSHZ2;PPARG;TOX;ZEB2;POU6F2;CD40;MAFB;MYCN;TFEB;RORB;NRIP1;BMI1;ZNF518A;PLAC8;VSX2;OLIG1;STAT5A;HES6;BMP2;RORA;SIX4;LMO2;SP1;ACVR2A;KANK2;HCLS1;SOX6;SMYD2;OLIG2;ZGLP1;STING1;ZNF582;WWTR1;TEAD2;RORC;ZBTB20;ZNF462;RELA;LMO1;LCORL;RBPJ;ZEB1;LPIN3;ZNF467;ZBTB2;IRF8;NHLH2;ESR1;MKX;ZNF283;ACTL6A;MED17;VEZF1;TET2;ST18;ZBTB26;MYPOP;HJV;MOV10;ZNF20;NFIA;ELF4;ELP4;BBX;FOXO1;LHX6;MED13L;POU3F2;ZNF595;RFXAP;RPS6KA4;TLR2;PTOV1;NCOA5;HDAC3;PPM1A;ZNF274;HDAC2;NEUROD2;ZNF230;HMGB1;UBE2D3;PAX6;ZNF669;FRK;SSBP2;INSM2;SNCA;GBX1;ELK1;ZSCAN23;FOXO3;ZSCAN20;ATXN1;ZNF41;TFCP2L1;ONECUT2;FOXH1;SMAD1;ZNF692;ZNF165;HIVEP2;ZNF543;VRTN;KLF6;AUTS2;PROX1;KDM3A;ZNF599;TAF3;ZNF426;ZNF675;RIPPLY2;NPAS1;CTBP2;SMARCD3;ZNF771;TBX18;EZH2;ZNF607;SMAD2;NCOA2;ZNF561;NR4A2;E2F4;TBL1X;TCF4;BMPR1A;ZBTB41;ONECUT3;ABRA;FBP1;NR1D2;PASD1;EMX1;ZNF239;FOXO6;NCK2;PLAGL1;ZNF292;SIRT6;MLXIPL;PHF21A;SP3;SMARCD2;ZNF202;ZNF347;NPAS3;GREM1;NR1H4;MYCL;ZNF704;DMTF1;SMAD4;SLTM;VGLL3;CREB3L2;MEF2C;NR1H3;DPF3;BCL11B;CDK4;ARID1A;ZNF442;STRA8;TIAL1;TSHZ1;DPF1;PTEN;BCOR;CDC5L;TNIP3;ZNF536;TFEC;ZNF639;HDGFL3;CDK12;PPP3CA;RNF2;ZNF175;PRRX2;MYT1L;RARB;ZNF281;MAFF;MXD4;KLF7;ETV3;ZNF584;WWOX;ARID1B;ZNF780B;KIT;ZXDC;ZBTB10;ZNF652;ZNF212;NCOA3;CREB1;LRP6;NFATC3;ZNF778;ZNF672;ZBTB33;PCGF5;KAT6A;LOXL2;EPC1;POU2F1;NR2F2;GABPB1;ATF6;ZNF311;THRB;MYB;VEGFA;TRPS1;PLSCR1;CCNH;ZFP30;DEAF1;NOC2L;SMAD5;PHIP;SPEN;IRF3;ZNF182;NFE2L2;BMP4;EAF2;POGZ;HMGA2;ZNF263;HSF2;MNAT1;KLF15;CTNNB1;MESP1;THAP3;PEX2;CNOT2;RPS6KA1;NOTCH4;SIRT7;DNAJB1;MYDGF;RPS6KA5;SMARCA2;ZNF776;HCFC1;DVL2;CHD1;PCGF1;PAX3;FSTL3;HDAC1;RFX5;ZNF654;NHLH1;PER3;PPP1R13L;ZNF786;HDAC9;ZNF234;ZNF12;MXI1;LCOR;WASL;CD81;CSRNP3;SUPT3H;IER5;GABPA;RUVBL2;F2RL1;AGO3;MIER3;CITED2;NUFIP1;ZNF276;EED;BHLHE22;ZNF623;JMY;TTC21B;NSD1;TEF;ZBTB4;KDM5B;NFIC;SHH;ZNF33A;CSRNP2;TGIF1;MED30;MED25;FUS;KLF10;BRWD1;JUP;ZNF782;NR3C1;UBE2D1;ABCA2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5254878121381502,1.041262344655051,0.38,0.9112432788766746,1.0,4/24,9.75%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.7381356014521862,1.0410073418407375,0.45614035087719296,0.9115788941887626,1.0,4/5,20.84%,DAND5;FOXH1;CITED2;SHH
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.7121353370051655,1.0406780904829747,0.45454545454545453,0.9120917455672995,1.0,3/6,16.08%,CCL5;HMGB1;TRPM2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.39941989084425217,1.0406707700227327,0.3584905660377358,0.9116442088226139,1.0,66/229,28.58%,CCNA2;CDC25A;TGFBR1;SHMT2;MYC;HIF1A;KAT2B;ESR1;ACTL6A;STAMBPL1;USP12;INO80E;SMAD1;KEAP1;INO80D;SENP8;SMAD2;PSMD13;SMAD4;NFRKB;PTEN;TNIP3;PSMA1;PSME4;USP45;CCP110;USP31;BAP1;STAM2;HCFC1;RNF128;MINDY2;SUPT3H;USP38;ARRB2;UBE2D1;RCE1;TAB1;BIRC3;TP53;PSMD4;USP18;BRCC3;ACTR5;USP9X;MDM4;BARD1;OGT;SMAD7;USP17L7;JOSD2;OTULINL;OTUD4;EP300;OTUD7B;PSMB5;YOD1;ASXL1;USP2;MINDY1;PSMC5;POLB;TRAF6;CLSPN;HGS;PSMB1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4273421984613004,-1.0404529114667367,0.2857142857142857,1.0,1.0,12/139,6.35%,CYP1A2;ALB;ASS1;CYP2E1;CYP2A6;HABP2;F7;FGL1;PAH;AHSG;HSD11B1;GPC3
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.47295491429012243,1.0403238121711371,0.41509433962264153,0.912149899499372,1.0,13/50,13.98%,C1GALT1C1;GALNT8;GALNT7;MUC20;MUC13;GALNT12;GALNT5;GALNT3;C1GALT1;MUC17;GXYLT1;GALNT1;MUC7
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4215766822082546,1.0400596004745946,0.3508771929824561,0.9124186281715386,1.0,23/118,17.42%,C1GALT1C1;PLOD2;GALNT7;GAL3ST1;GALNTL5;TET2;ST8SIA4;ALG6;FUT9;SLC39A8;MGAT2;MAGT1;ST3GAL6;NUS1;GALNT1;FUT8;POMT2;MGAT5;ALG9;B3GALNT2;MGAT4A;MGAT4C;POMK
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.4041140254273933,1.0398663759086195,0.38461538461538464,0.9124179611735399,1.0,25/154,15.59%,IGF1;PRDM14;PCBP3;MYC;HIF1A;LDLR;TFEB;BMI1;AFF2;ZNF462;SLC8A1;NFKBIZ;HMG20B;NOVA1;TOB1;NFKBID;PROX1;CIAO3;RO60;HNRNPD;TRIM26;CDK4;AFF1;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.70808347682092,1.0396263817667666,0.5,0.9126600148998038,1.0,1/5,5.12%,STAT5A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5818101111383963,1.0393469095441557,0.3968253968253968,0.9125797875845781,1.0,4/15,16.65%,DLC1;CORO1C;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5818101111383963,1.0393469095441557,0.3968253968253968,0.9125797875845781,1.0,4/15,16.65%,DLC1;CORO1C;PTEN;PHLDB2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.4221750198694819,1.0392929299427107,0.3898305084745763,0.9122450162083926,1.0,20/102,14.64%,LGR5;SLC35F1;LRRC4C;LRP4;SAG;CADM2;TMEM200C;VSX2;PCLO;NEFH;UNC5D;ZDHHC22;MEGF10;PAX6;STOX2;ANK2;PAK5;NOL4;GRIK3;ZNF536
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6335836118440195,1.0392206282791407,0.5172413793103449,0.912002247647686,1.0,2/7,4.99%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.66568418306199,1.0391817085797634,0.5777777777777777,0.9115961821199158,1.0,4/7,30.17%,LYN;PICALM;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.6565212965442611,1.0391362228757237,0.4642857142857143,0.9111970925077827,1.0,3/8,25.19%,IL23R;IL23A;JAK2
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6212441686605175,-1.0391073409773015,0.4666666666666667,1.0,1.0,2/9,7.55%,TAFA3;TTBK1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5672280460229061,-1.0389364770376113,0.4883720930232558,1.0,1.0,2/11,6.32%,UPB1;NT5C
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.6783883544892945,-1.0389321354400436,0.4444444444444444,1.0,1.0,1/5,8.71%,LRPAP1
prerank,MSigDB_Hallmark_2020__Apical Junction,0.4128599351395358,1.0388140162295958,0.35714285714285715,0.9116414857815082,1.0,16/180,6.42%,ACTG2;SYK;NRTN;COL9A1;CERCAM;IRS1;RRAS;ITGA10;CD99;ITGA2;NEGR1;INSIG1;CADM2;CDH6;CLDN6;VCAN
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4274007388199209,1.0385680030943818,0.375,0.9118175980258357,1.0,29/140,17.39%,GAS2L3;CGNL1;KASH5;RHOBTB3;LMOD3;CORO7;MYO1E;HIP1;EPS8;RHOD;GAS2;PROX1;EFS;MCU;CORO1C;GSN;CASS4;CARMIL1;ARHGAP25;PPP1R9A;BCAR1;RHOBTB1;SPIRE2;SHROOM4;OOEP;DBN1;LMOD2;RHOG;COBL
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5864839289501481,1.0381922952414866,0.5,0.9124896699212033,1.0,1/14,0.63%,SMYD1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.6293141921070975,-1.0376428290795947,0.5,1.0,1.0,2/9,7.70%,CAV1;SVIP
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5440748361637829,1.0375694440495975,0.48333333333333334,0.9138069720828681,1.0,9/22,20.84%,ITGB8;HAS2;APELA;AGGF1;EGFL7;VEGFA;TGFBR3L;RASIP1;SHH
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5577068980984669,1.0375425221159282,0.4,0.9134077668819524,1.0,4/15,13.98%,F2;H2BC21;FAM3A;MUC7
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5796724465318088,-1.0371903018849589,0.4,1.0,1.0,1/18,0.24%,ACTC1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6338218051695401,1.036798043164138,0.4909090909090909,0.9148795895283146,1.0,3/8,25.43%,PROX1;GRID2;CEND1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.6195639034700899,-1.036501850730971,0.5227272727272727,1.0,1.0,1/9,1.91%,MPO
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.7079271227045919,1.0363773573470911,0.46938775510204084,0.9155941780790733,1.0,2/6,18.59%,RNLS;SPX
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6197576258429155,1.036375786009796,0.4642857142857143,0.9146198667582592,1.0,4/8,26.93%,BCS1L;UQCC3;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6197576258429155,1.036375786009796,0.4642857142857143,0.9146198667582592,1.0,4/8,26.93%,BCS1L;UQCC3;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5568461743594224,1.036321762394974,0.3770491803278688,0.9142928368536556,1.0,4/23,17.12%,SYVN1;AUP1;LMAN1;DERL2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.4842186172707594,-1.0361123933755898,0.3541666666666667,1.0,1.0,8/36,18.52%,WDR77;PRPF19;PRMT7;USP4;SRSF10;PRPF6;COIL;SNRPD2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6054759421727894,1.0358973538897562,0.44642857142857145,0.9149997096624525,1.0,3/12,20.32%,SCRIB;SYNE4;RAP2A
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.4913621399609885,1.035791683865291,0.4406779661016949,0.9147702792337206,1.0,7/43,11.90%,CCL5;GRIN3B;F2R;CASR;ANK2;EPB41;GRAMD2A
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.5151688900986383,1.0355265518011671,0.4375,0.9145393007424503,1.0,11/30,20.07%,SCRIB;DLC1;PHACTR4;PLXNB2;PRICKLE1;LRP6;LRP2;DEAF1;COBL;DVL2;VANGL2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.5151688900986383,1.0355265518011671,0.4375,0.9145393007424503,1.0,11/30,20.07%,SCRIB;DLC1;PHACTR4;PLXNB2;PRICKLE1;LRP6;LRP2;DEAF1;COBL;DVL2;VANGL2
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.707331673357648,1.0354651802785055,0.5192307692307693,0.9142196733128798,1.0,2/5,19.23%,CBS;DCTPP1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.4443377409562318,1.0354499423009358,0.39344262295081966,0.91375127826874,1.0,5/71,11.50%,CPSF4L;U2AF1;THOC6;PAPOLA;PCF11
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6322567440566251,-1.0354465832258257,0.48717948717948717,1.0,1.0,1/8,4.02%,ACAN
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7030734797452717,1.0349217574321914,0.5740740740740741,0.9148967860083206,1.0,1/5,4.71%,ADIPOR2
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.503135638468324,1.0348516741092166,0.34,0.9147070006901519,1.0,5/30,15.20%,FERMT3;PDGFRA;MYL12A;HSPB1;CSRP1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.6168301461218085,1.0347406632108087,0.4642857142857143,0.9145691986070514,1.0,3/11,13.60%,ALDH9A1;ACADM;CPT1C
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.48103603681209006,-1.0344803371493927,0.5116279069767442,1.0,1.0,5/43,11.37%,ANXA8;ALS2CL;CAV1;CAV2;DNM1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5417015381721692,1.0344659210389333,0.43636363636363634,0.9147744098225017,1.0,3/25,4.85%,CXCL12;CCL5;F2R
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.5518111323370305,-1.0342159349494884,0.47058823529411764,1.0,1.0,4/15,7.08%,TNFSF18;BST1;RAC2;ZP3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5916360746762608,1.034170318473734,0.4807692307692308,0.915037594246762,1.0,5/17,11.84%,CD99;DAPK2;MOSPD2;MCU;CD74
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.660857071922451,1.0338857008474154,0.4489795918367347,0.9148720253133752,1.0,1/6,6.98%,IL21R
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.660857071922451,1.0338857008474154,0.4489795918367347,0.9148720253133752,1.0,1/6,6.98%,IL21R
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5822580994503714,-1.0338250996837666,0.5121951219512195,1.0,1.0,3/9,17.84%,PCCB;MCCC2;BTD
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.4312141529871107,1.0334030829990253,0.3684210526315789,0.9156705390722258,1.0,9/55,17.42%,LRP4;DCC;NLGN1;HDAC2;KANK1;EFNB2;PTEN;KIAA0319;RAB29
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5733284791504816,1.0332500198774581,0.4406779661016949,0.9157133204408885,1.0,8/21,22.31%,SEMA5A;DSCAM;DBN1;VEGFA;L1CAM;CDKL5;MACF1;GOLGA4
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.36690289256316205,1.0332411783647037,0.328125,0.915246618763688,1.0,86/461,19.66%,MKRN3;HIF3A;SIRT1;UHRF2;HIF1A;SPSB2;NEDD4;LZTR1;SYVN1;RNF152;RFWD3;PEX12;UBE2J1;PELI2;RNF182;TRIM50;KLHL21;ASB5;PELI1;KLHL8;RNF185;MARCHF1;SPSB4;UBE2E2;FBXL3;NEUROD2;UBE2D3;MSL2;ANKRD9;UBE2Z;GAN;PELI3;RNF217;UBE3D;FBXO30;RNF146;KEAP1;SPOP;RNF139;UBE2E3;ANAPC16;LNPEP;PSMD13;FBXO7;FANCL;AKTIP;FBXL14;RNF166;HECW2;SHPRH;KLHL42;TRIM26;RNFT1;CNOT4;UBE2J2;ARIH1;RBBP6;UBE2QL1;UBA6;PSMA1;PSME4;UBE4A;KLHL24;FBXL2;MARCHF7;RMND5A;TSPAN17;MIB1;FBXL15;RNF208;NFE2L2;RNF26;UBE2U;TRIM52;UBR5;KLHL13;CTNNB1;PEX2;PDZRN3;NHLRC3;KLHL12;FBXO11;ZNF738;MARCHF3;KLHL7;RNF38
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.4582679386621842,1.0330421026295784,0.36666666666666664,0.9152960247889923,1.0,20/83,17.72%,FLT1;PIK3R6;FGFR1;FGF2;KSR1;CD40;PIK3R5;TENM1;FLT3;PDGFC;EZH2;LYN;IRAK3;SPRY3;CDK12;KIT;PPEF2;VEGFA;IRAK1;BMP4
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.45842062624243557,1.033003218015703,0.423728813559322,0.9149008984146486,1.0,8/69,10.39%,ANGPT1;BMI1;SEPTIN4;SPSB4;HDAC3;DCUN1D1;ARRDC3;PAXIP1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.6434609526317346,1.032930154803491,0.48148148148148145,0.9145963273850455,1.0,3/6,32.23%,HTR6;PEX13;FGF13
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.47087392736161965,1.032726534899689,0.4166666666666667,0.9148068722229883,1.0,13/59,18.74%,NRG1;ERBB4;GAB1;NRG2;ERBIN;PIK3CA;FAM83A;NCK2;BCAR1;SOS1;CPNE3;SLC30A10;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.6653166902264166,1.0327249215856906,0.49056603773584906,0.9143354542071989,1.0,3/5,28.15%,FOXO1;LMNA;TRPC3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4717229418962202,1.0326581566040607,0.38095238095238093,0.9139995252708786,1.0,19/64,18.55%,RAPGEF3;FGFR3;GRIN3A;DCC;BMP2;ELAPOR2;ZNF706;NEUROD2;HYAL3;SINHCAF;KANK1;GREM1;SPRY3;KLF7;KIAA0319;LOXL2;ANP32B;BMP4;NOTCH4
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6806197710133643,1.0325869835994848,0.4915254237288136,0.9137988704657258,1.0,2/5,22.32%,ABL1;MAP2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.4755352745506129,1.0325178231555379,0.3620689655172414,0.9135213720386017,1.0,12/64,14.47%,FGF10;FGFR1;FGF2;FGFR3;HNRNPH1;GALNT3;SHOC2;FGF17;FGF5;TIAL1;FLRT2;KLB
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.6578445321487755,1.032140919716325,0.48148148148148145,0.9141362575018231,1.0,3/9,11.87%,C3;EPHA8;ADGRB3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.43928753199017395,1.0321252291102414,0.3620689655172414,0.9137177543046117,1.0,18/97,14.38%,NPC1L1;LDLR;SLC10A3;NPC2;MTTP;ABCC2;ABCA6;ABCG8;ABCA1;SLC10A5;ABCG5;NCOA2;SLC10A1;ABCD3;ABCD2;NR1H4;ABCC11;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6489447030693593,1.0320797568345086,0.4339622641509434,0.9133958599777802,1.0,1/10,2.18%,SIRT1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6522047671286036,1.0320532828166034,0.4807692307692308,0.9129845965084784,1.0,1/10,3.88%,EHD1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6652224676885088,-1.0319322209653679,0.46808510638297873,1.0,1.0,1/5,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.4917189861496963,1.0315999692633055,0.39215686274509803,0.9137841955823633,1.0,16/35,27.81%,CHD7;ZFP36L2;RAG2;LEPR;LIG4;LCK;KIT;PIK3CD;RAG1;SHH;GPR89A;FADD;MR1;PTPRC;ANXA1;SOX13
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6314865961329629,1.0315016222245745,0.4807692307692308,0.913597196284967,1.0,2/10,20.62%,TERF1;NDFIP2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6381158022029687,1.0314753386675626,0.5263157894736842,0.9131800788577412,1.0,2/7,11.07%,SLC8A1;EDNRA
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.4814622561720654,1.0314668232176147,0.42592592592592593,0.9127122463111828,1.0,8/42,18.16%,ZBTB1;PRIMPOL;POLE2;REV3L;PCLAF;REV1;POLD4;FAAP20
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4151788906157822,1.0314436076610651,0.38181818181818183,0.9123215968827061,1.0,21/149,9.76%,STK26;FLT1;MAP3K11;FGFR1;FGFR3;ERBB4;DAPK2;STK33;TNIK;FLT3;MEX3B;RIOK2;MAPKAPK2;EPHA8;MAPKAPK3;PDGFRA;EPHB4;FER;MAP3K9;ITK;SMG1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.45616151057639964,-1.03107212993869,0.3541666666666667,1.0,1.0,8/64,4.05%,P2RY10;SP140;SELL;SIRPG;TRAF3IP3;CD53;CYTH4;CNGB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.5442313088997162,1.0307907571166617,0.4307692307692308,0.9136623842957685,1.0,7/24,13.58%,SELPLG;RELA;ST18;FER;ST3GAL6;PTPRT;SMAD4
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6420433164600418,1.0307746186168463,0.4909090909090909,0.9132141884033335,1.0,2/11,14.12%,CCDC125;FRMD5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.41191812848755055,1.0305514618650875,0.3898305084745763,0.9134300707106948,1.0,35/156,19.50%,ESRRG;NR5A2;HNF4G;KAT2B;PPARG;RORB;RORA;WWTR1;TEAD2;RORC;RBPJ;ESR1;MED17;CAVIN1;HDAC3;TAF3;NPPA;NR4A2;TBL1X;NR1D2;NOTCH3;NR1H4;NR1H3;RARB;POLR1H;TAF5;THRB;CCNH;TAF1A;TAF2;NOTCH2;MNAT1;NOTCH4;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.6946718768773285,1.0304631137478535,0.5,0.9131482820783787,1.0,1/5,5.03%,SAMSN1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6048573980649876,1.0301328505697087,0.46774193548387094,0.9136826796804031,1.0,4/12,22.95%,ELOVL5;TECR;ELOVL4;ELOVL6
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5612691028656998,1.0300900976295562,0.46938775510204084,0.9133500876955479,1.0,4/12,22.68%,PCM1;BICD1;GCC2;SAXO2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6496391205335423,-1.0299062986097007,0.4857142857142857,1.0,1.0,5/7,28.75%,PINK1;MAPT;HAX1;PRKN;ATP5IF1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.40448293733684915,-1.029793531170152,0.34,1.0,1.0,11/111,2.73%,P2RY10;IRF4;SP140;TBC1D10C;SELL;CD24;BST1;CD86;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6096326558524192,1.0297572797524046,0.4074074074074074,0.9137819399495666,1.0,1/10,2.98%,IL4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.39739180288917764,1.0297488687355805,0.36363636363636365,0.9133287259845816,1.0,32/157,17.42%,RIT2;LRRC4C;ROR1;RETREG3;TOX;TENM3;ABI3;DCC;CDH2;ZNF804A;PDLIM5;FUT9;EPHA3;HDAC2;ABL2;MAGI2;CTNNA2;KANK1;FBXO7;LYN;EFNB2;NTNG2;PLXNB2;PTEN;PTK7;FZD1;RAP1A;LRRC7;RET;DBN1;CSMD3;RAB29
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.5839384925148084,1.0295781672734419,0.5,0.9133466854869303,1.0,1/14,0.38%,GATA4
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.6719211601751313,-1.0294205988312743,0.48936170212765956,1.0,1.0,1/5,3.01%,CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.45156452466147035,-1.0294007923646995,0.40476190476190477,1.0,1.0,11/58,8.06%,TEK;COL4A2;ALOX5;ADAMTS1;NIBAN2;FOXO4;ANGPT4;SPARC;NAXE;CLDN5;SARS1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5742691848537647,-1.0293875036453541,0.44680851063829785,1.0,1.0,1/17,0.91%,HK2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5562083335991327,1.029316368701152,0.4918032786885246,0.913612567421896,1.0,3/20,11.92%,RHOD;DLC1;PTPRK
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.607370644002651,1.0292568353622285,0.5,0.9133317149944518,1.0,4/11,17.72%,TGFBR1;SIX4;BMPR1A;BMP4
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3386786354290544,1.0288005513180198,0.2698412698412698,0.9141879531160709,1.0,294/1778,17.56%,DACH1;GATA4;MITF;ZSCAN4;CRX;IGF1;TIMELESS;RFPL2;TPRX1;ZNF300;SMAD6;EBF1;PKNOX1;PRDM14;FLI1;HIF3A;TGFBR1;RUNX1;SOX5;SIRT1;DUXA;TULP3;PRRX1;ESRRG;ZBTB7B;TSHZ3;DMRT3;ZNF792;NR5A2;DBX2;NRG1;FGF2;PBX3;ERG;IL4;ERBB4;ZBTB40;HNF4G;GDF6;MYC;DUX4;CTCFL;URI1;SNAI1;FOXP2;ZBTB1;PRDM8;HIF1A;PYHIN1;NFIL3;CDKN2A;ZNF493;TSHZ2;PPARG;MDFIC;TOX;CDK18;ZEB2;POU6F2;WNT4;MAFB;MYCN;TFEB;RORB;SFMBT2;ZNF518A;F2R;ZNF114;MLLT3;VSX2;FANK1;OLIG1;STAT5A;TENM1;HES6;BMP2;RORA;SIX4;MYRF;SP1;CHD7;HCLS1;SOX6;ZNF257;OLIG2;ZGLP1;ZNF582;WWTR1;GMNN;TEAD2;RORC;ZBTB20;RELA;LCORL;RBPJ;ZEB1;ZNF467;ZBTB2;IRF8;NHLH2;ESR1;MKX;ZNF283;ACTL6A;MED17;VEZF1;ST18;ZBTB26;MYPOP;ELAVL2;ZNF20;FBXO5;NFIA;ELF4;ELP4;BBX;FOXO1;LHX6;ZNF706;SLC39A8;MED13L;POU3F2;ZNF595;RFXAP;RPS6KA4;HDAC3;PPM1A;ZNF274;HDAC2;NEUROD2;ZNF230;HMGB1;RYBP;PAX6;ZNF669;CDK14;SSBP2;CBFA2T3;GBX1;TP53INP1;ELK1;ZSCAN23;FOXO3;ZSCAN20;ATXN1;ZNF41;TFCP2L1;ONECUT2;FOXH1;SMAD1;ZNF692;ZNF165;YAF2;HIVEP2;ZNF543;VRTN;ZNF195;KLF6;GPBP1L1;PROX1;KDM3A;ZNF599;ZNF426;TLE2;ZNF675;NPAS1;CTBP2;SMARCD3;ZNF771;TBX18;EZH2;ZNF607;SMAD2;NCOA2;ZNF561;CD74;PTPRK;SPINDOC;CDK11A;NR4A2;E2F4;TBL1X;TCF4;ZBTB41;ONECUT3;NR1D2;PASD1;EMX1;MBTD1;ZNF239;HNRNPD;FOXO6;HP1BP3;PLAGL1;ZNF292;CHEK2;MLXIPL;SP3;SMARCD2;ZNF202;ZNF347;NPAS3;NR1H4;PML;MYCL;ZNF704;DMTF1;SMAD4;SLTM;VGLL3;CREB3L2;MEF2C;NR1H3;DPF3;BCL3;BCL11B;ARID1A;ZNF442;ZNF117;STRA8;TIAL1;HSPA8;TSHZ1;DPF1;BCOR;CDC5L;ZNF536;TFEC;MAGEL2;PICALM;ZNF639;HDGFL3;ZNF175;PRRX2;MAGED1;MYT1L;ATF7IP;ZNF281;MAFF;MXD4;KLF7;FZD4;CD80;ETV3;ZNF584;FZD1;ARID1B;ZNF780B;KIT;SPIN1;ZXDC;ZBTB10;ZNF652;MLF1;ZNF212;POLR3G;ACVR1B;PRICKLE1;RUNX1T1;CREB1;DYRK1A;LRP6;ZNF502;RET;NFATC3;ZNF778;ZNF672;ZBTB33;PCGF5;TAF5;KAT6A;LOXL2;EPC1;LBHD1;POU2F1;NR2F2;ATF6;ZNF311;MYB;VEGFA;TRPS1;CCNH;ZFP30;RHOG;DEAF1;SMAD5;PHIP;ZNF280B;SPEN;PLCB1;NAA16;IRF3;ZNF182;NFE2L2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.4973553451095894,1.0286258075686026,0.36065573770491804,0.9142689011956625,1.0,10/41,15.70%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;RIMS2;HSPA8;GRM4;PPFIA3
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.5906952253854458,-1.0285580410499542,0.4883720930232558,1.0,1.0,2/9,5.21%,DRD4;DRD2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.4913359778679933,-1.0285115432137113,0.4090909090909091,1.0,1.0,2/38,2.56%,ANXA8;ALS2CL
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6427459643587756,1.0284186021080042,0.574468085106383,0.9142799786651542,1.0,2/7,12.38%,IDI2;MVD
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.701269401150633,1.0283789552068532,0.5081967213114754,0.9139169328326412,1.0,4/7,26.05%,DRD3;TMEM98;HES5;NOTCH1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.4829743766099093,1.0279894882307603,0.41935483870967744,0.914606302255522,1.0,15/43,26.33%,RAB31;LLGL1;GGA1;ARL3;GOLPH3L;EXOC6;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;ARFRP1;EXOC6B;COMMD1;RAB34
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5973873827048143,1.027956395226322,0.4444444444444444,0.9142497991176246,1.0,1/14,4.90%,SYVN1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6888167152577623,-1.0279292922300571,0.5813953488372093,1.0,1.0,3/5,19.57%,PER2;E2F1;E2F3
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.3958126854329607,-1.0277204202437116,0.3181818181818182,1.0,1.0,7/147,3.01%,SLC28A2;SELE;KCNMB2;SELL;NLRP3;KCNA3;GPR132
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.588280413336953,1.027668731053226,0.37777777777777777,0.9145774116585689,1.0,6/13,26.95%,SLC8A1;ATP1A2;GJC1;RYR2;ATP1B2;GJA1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4330922685765748,1.0276420322469513,0.46551724137931033,0.9141770012579029,1.0,5/120,3.34%,SGO1;ESPL1;NDC80;DLGAP5;NDE1
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.6903024957678502,1.027605154204591,0.5087719298245614,0.9137643589886295,1.0,4/5,29.57%,CD74;ABCD2;ANXA1;PTGS2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.446911741578938,1.0273555625334052,0.3870967741935484,0.9140348229971705,1.0,19/99,15.95%,SMAD6;TGFBR1;SOX5;SIRT1;WNT4;LTBP2;SOX6;ZFP36L2;FOXH1;SMAD1;CGN;SMAD2;PTPRK;BMPR1A;SMAD4;MEF2C;PXN;WWOX;GDF9
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5310583075846171,1.0270334474338885,0.39705882352941174,0.9144882217731243,1.0,4/25,11.59%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.5470800716775787,1.0269754370567674,0.3968253968253968,0.9141518352983792,1.0,7/17,26.36%,WNT4;PROX1;PRKCSH;COBL;CITED2;GFER;ARID5B
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4279689513983083,1.0269714529817526,0.41509433962264153,0.9136769512280943,1.0,24/91,16.99%,SYK;TRPM8;ESRRG;ZBTB7B;IL4;SCD;TRPV2;ADIPOR2;PLAC8;PRKAB2;ACHE;HDAC3;PDGFC;KDM3A;LEPR;GADD45G;SIRT6;IGF1R;ACACB;FASN;ADRB1;ACACA;PRLR;VEGFA
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6749324097077656,1.026928792992937,0.5510204081632653,0.9133539511935834,1.0,1/5,8.26%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5868278058366313,-1.0265180088448547,0.4772727272727273,1.0,1.0,1/15,0.27%,TERT
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4595928708768674,1.0265039331730241,0.38333333333333336,0.9140274259859575,1.0,12/77,13.80%,SMAD6;TGFBR1;SIRT1;LTBP2;FOXH1;SMAD1;CGN;SMAD2;PTPRK;BMPR1A;SMAD4;PXN
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4834631378723161,1.02637822543147,0.41818181818181815,0.9138243060391437,1.0,17/57,17.72%,LGALS9;RUNX1;SIRT1;IL4;PPARG;CBFA2T3;IL15;OSCAR;EFNA2;PML;CDK4;KIT;CSF1;PIK3CD;VEGFA;GAB2;BMP4
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.555265794571138,1.026070103899385,0.41379310344827586,0.9141504408028297,1.0,2/9,17.75%,EXOSC4;DXO
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.5573272855736753,-1.025483561685281,0.46296296296296297,1.0,1.0,2/15,9.27%,INSRR;TRPV1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.34619327930952515,1.0252412543575,0.3333333333333333,0.916106611764362,1.0,158/908,18.43%,STK26;DUSP29;SYK;CTDNEP1;ASB17;HS3ST5;CSTA;C3;MAP3K11;EGLN3;RAB38;HIF3A;FGFR1;TGFBR1;ASB18;SIRT1;PRKG1;ENGASE;PLOD2;ERG;HIF1A;SOCS2;SPSB2;DAPK2;CDK18;KNG1;ASB15;CDH2;BMP2;TNIK;PENK;EVA1A;PTAR1;ACVR2A;VCAN;MEX3B;KLHL21;FAM20A;MAPKAPK2;GALNTL5;ASB5;METAP1D;ST8SIA4;FUT9;DSP;SPSB4;UBE2E2;FER;FBXL3;RPS6KA4;PPP4R1;DYRK2;PPM1A;PTPRD;PPP1CC;UBE2D3;SOCS6;CDK14;FRK;MAP3K9;DCUN1D1;ANKRD9;GAN;MMP15;PTPN14;FBXO30;TF;IP6K3;KEAP1;ABL2;LATS1;ST3GAL6;QPCT;LTBP1;TNC;PTPRT;FASTK;SENP8;PSMD13;FBXO7;PPM1L;NUS1;ZC3HAV1;CEL;KCTD6;MAP3K21;MAP4K2;PTPRK;CDK11A;PAK5;NIM1K;LYN;STRADA;BMPR1A;FBXL14;TGM6;PRKCSH;LCK;IRAK3;PTP4A2;PTPRM;MAN2A1;SIRT6;CHEK2;PPM1E;KLHL42;VRK2;DUSP2;CDK4;MAPK8;PTEN;DNAJC3;PSMA1;CDK12;PPP3CA;PSME4;DCAF5;PPP3CC;MTMR3;CSF1;PIK3CD;UBA3;ACVR1B;ASB6;CREB1;NEK7;DYRK1A;PADI4;CSNK1G3;SGK1;RET;PPEF2;CD247;MAP3K1;B3GALNT2;UBXN7;LOXL2;FBXL2;HIPK1;MGAT4A;PTPRU;TIPARP;CPE;FBXL15;FBN1;LOX;IRAK1;MAPK10;BMP4;GLRX;PRKAA1;KTN1;PKN2;LIMK2;KLHL13;PXK;BAP1;CDKL5
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.4001806020864197,1.0252090395647582,0.37037037037037035,0.915745440118482,1.0,27/76,23.42%,LGALS9;MAPKAPK2;MAPKAPK3;PLCG2;TICAM1;TLR2;HMGB1;UBE2D3;TAB2;IRAK3;NR1H4;TNIP3;MAP3K1;IRAK1;TAB3;TLR5;ITGAM;LGMN;UBE2D1;TAB1;BIRC3;SCARA3;FADD;ITGB2;LBP;IKBKB;RIPK2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.642509711783535,1.0250698535587142,0.5535714285714286,0.9157179256743639,1.0,3/8,14.46%,NLGN1;NRXN1;PTEN
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6575574600220015,1.0249620416707328,0.5370370370370371,0.9155710225831273,1.0,2/7,9.05%,SAG;DRD3
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6036061129899792,1.024912042169376,0.5423728813559322,0.9152672248699795,1.0,1/10,7.16%,BDH2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.5008883139478827,-1.0246582153623818,0.3404255319148936,1.0,1.0,5/24,15.92%,KDM4D;KDM2B;KDM1B;HR;KDM4B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5227924027327231,1.02463660860313,0.44680851063829785,0.9155539309780567,1.0,4/39,6.55%,IGF1;FGF2;CCL5;CCN4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6277756350557255,-1.0243126275963697,0.4583333333333333,1.0,1.0,3/6,12.85%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6277756350557255,-1.0243126275963697,0.4583333333333333,1.0,1.0,3/6,12.85%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4185479033475757,-1.024128005945863,0.36363636363636365,1.0,1.0,14/82,8.89%,COL24A1;COL23A1;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;COL6A3;COL1A1;COL11A2;COL28A1;LAMB3;LOXL4;ADAMTS3
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6418016356177502,-1.0238899209839991,0.4222222222222222,1.0,1.0,3/8,13.91%,IL11;SCG5;EDN3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.43593900045484224,1.023735937239896,0.39344262295081966,0.9176225465510686,1.0,15/53,12.96%,SYK;FLT1;FGFR1;FGFR3;ERBB4;ABI3;FLT3;PDGFRA;FER;EPHA3;ABL2;LYN;TPST2;LCK;BLK
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.6962519552288395,1.0234363722108826,0.5166666666666667,0.9179265570611581,1.0,1/6,6.23%,JADE3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.590003424621007,-1.0234106067679434,0.5483870967741935,1.0,1.0,1/7,6.34%,OAS1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.590003424621007,-1.0234106067679434,0.5483870967741935,1.0,1.0,1/7,6.34%,OAS1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.6959868280452257,-1.023048858766557,0.5416666666666666,1.0,1.0,1/5,7.70%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6498385060877271,1.0230260385250962,0.4666666666666667,0.9180825096350549,1.0,4/5,32.11%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6498385060877271,1.0230260385250962,0.4666666666666667,0.9180825096350549,1.0,4/5,32.11%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6883937851364603,1.0230249053780838,0.46296296296296297,0.9176155336611184,1.0,2/6,17.68%,AKTIP;RNF26
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.6808564706294123,1.0229387194601962,0.5,0.9173806295054646,1.0,4/6,29.85%,VEGFA;HEY2;NOTCH1;EFEMP2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4436644913356291,-1.0228837088474885,0.4090909090909091,1.0,1.0,15/63,17.85%,DNASE1L1;RNASE1;REXO4;ERCC1;RFC3;IHO1;PARP1;GTF2H2;FAN1;RFC2;RPA3;RAD50;RFC1;EDC4;MUS81
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.43498090169648224,-1.0228705508017741,0.3888888888888889,1.0,1.0,9/59,14.43%,NTRK1;CRLF1;FOXQ1;WFS1;NRBP2;TYRO3;KDM2B;PTK2B;FGF20
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5369714259395404,1.0228637029757215,0.4791666666666667,0.9170333595644046,1.0,10/25,30.22%,KAT2B;CPA4;KAT6A;ATAT1;RUVBL2;NAA50;EP300;MSL3;KAT6B;PHF20L1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6029016110340715,-1.0227533081933053,0.5277777777777778,1.0,1.0,4/8,15.25%,IL11;ZFPM1;ZNF385A;MED1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.4267479928142579,-1.0226735944202232,0.4117647058823529,1.0,1.0,9/89,6.75%,EHF;DUOXA1;ANXA8;CLDN4;SERINC2;EPAS1;ADIRF;LAMB3;CLDN1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5676432517860933,1.0224213954561843,0.46938775510204084,0.9172523254274513,1.0,3/13,24.65%,COQ10A;FDXR;PDSS2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5676432517860933,1.0224213954561843,0.46938775510204084,0.9172523254274513,1.0,3/13,24.65%,COQ10A;FDXR;PDSS2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.4207341396770657,1.0223724102121587,0.43333333333333335,0.9169368887588297,1.0,32/164,17.37%,PIK3R6;PLD6;FGF2;PIK3R5;ABHD3;SLC44A5;LPIN3;PIP4K2A;PIK3C2B;ACHE;PCYT1B;PLCG2;SLC44A4;CHPT1;PLA2G10;CEPT1;ACP6;INPP4B;PIK3CA;SELENOI;CPNE1;CPNE7;ABHD8;PTEN;PI4K2B;MTMR9;CPNE3;MTMR3;PIK3CD;PLSCR1;ETNK1;DGKZ
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5102218551452279,1.0223168003628154,0.38596491228070173,0.9166280194044609,1.0,6/29,17.88%,LIN28A;ZBTB20;UNC13B;MLXIPL;IGF1R;PRKAA1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4217793940110463,1.0220607699164228,0.41818181818181815,0.9169434591197083,1.0,32/131,22.79%,LRP4;LLGL1;DCC;NLGN1;NYAP2;CNTNAP2;TNIK;NEFH;ALCAM;DSCAML1;CTNNA2;GPM6A;PLXNB1;CPNE1;NTNG2;PTEN;KLF7;SGK1;DBN1;LRP2;CNTN4;CTNNB1;FLRT3;FLRT1;ZDHHC17;WASL;FARP1;SLITRK6;PARD3;SLITRK5;MAP2;DIP2A
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6420981578849188,-1.0219458356983784,0.3829787234042553,1.0,1.0,2/7,2.91%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5226976282654409,1.0215848710500373,0.5,0.9177076184319014,1.0,6/22,13.90%,CHRM2;MYBPH;TNNT1;ATP1A2;KCNB2;PPP1R12B
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6851565405228734,1.0214918349073807,0.4067796610169492,0.9175421998948501,1.0,4/5,19.62%,HIBCH;BCAT1;HIBADH;ALDH6A1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.6779584694223434,1.0213190800940275,0.54,0.9175763211954504,1.0,1/5,2.18%,SIRT1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6144485669392696,1.0211923391811455,0.5161290322580645,0.9174983192740257,1.0,2/8,17.04%,CDK12;CCNH
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5950142886211109,-1.021096305824589,0.48214285714285715,1.0,1.0,2/9,8.96%,SLX4;RTEL1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6213957543696826,1.0207640028489415,0.4838709677419355,0.9183913310589453,1.0,4/9,23.34%,CPNE1;CPNE7;CPNE3;HDHD5
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.6195553068842912,1.0207479531048913,0.4897959183673469,0.9179770713306944,1.0,4/7,33.08%,GRIN2D;PDLIM4;GRIN2C;GRIN2A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.42377032762685934,1.0205631331000116,0.3877551020408163,0.9179798124073287,1.0,20/117,13.12%,MXRA5;FBLIM1;SCNN1B;GNG12;DOCK1;LRIG3;BCAM;WWTR1;FAM114A1;MEX3B;DSP;RHOD;SDC4;EDNRA;SERTAD4;GRAMD2A;EGFL6;NOTCH3;F3;PLXNB1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5316375255533969,-1.0202643251183594,0.40540540540540543,1.0,1.0,2/24,6.58%,PNPLA1;PNPLA4
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6587511341869563,1.0202634602137082,0.5283018867924528,0.9182559835640518,1.0,2/8,11.22%,EHD1;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.677921364416142,1.0202521714695774,0.5,0.9178237947796071,1.0,1/5,3.86%,MRAP2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6361070179564421,-1.0202413694206187,0.4418604651162791,1.0,1.0,5/9,27.66%,FLOT1;HTR2B;PDGFB;AZU1;PLEK
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4651047280430309,1.0200469812936195,0.41304347826086957,0.9178266099764874,1.0,16/56,21.02%,CDH7;CDH20;CDH6;CDH2;CDH12;CLDN12;GJB6;CDHR3;CDH10;GJC1;CDH8;PKN2;PKP4;CTNNB1;GJB1;JUP
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5171673829039587,1.0200030917503948,0.4032258064516129,0.917481950014276,1.0,3/22,15.87%,GSTM2;JPH1;DMD
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4887576934260677,1.0198729424610984,0.38333333333333336,0.9172802809068306,1.0,2/25,8.20%,FGF10;UBE2E2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.501296634912706,1.0196667522768585,0.39622641509433965,0.9173763470584337,1.0,10/26,22.05%,FLT1;MLLT3;FLT3;KIT;MLF1;BMP4;FSTL3;PRRC2C;SHH;TP53
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6279550638642203,1.0191174515475732,0.48333333333333334,0.9183458623766168,1.0,3/9,16.99%,TENM3;LRP6;VEGFA
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5505489598024389,1.0190422429282395,0.4489795918367347,0.9180883314002496,1.0,7/23,23.42%,TIFA;MAP2K6;TAB2;IRAK1;TAB3;TAB1;RIPK2
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.6876359192780632,1.0188446069174022,0.4426229508196721,0.9181528938076144,1.0,1/5,8.85%,DCP1B
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.39721907376353416,-1.0187926119693553,0.55,1.0,1.0,6/205,2.94%,CD44;NTRK1;TEK;CD24;IL11;FGF1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4904348729506158,1.0187835219622865,0.49206349206349204,0.9178895374291712,1.0,9/51,9.77%,PNP;IDO1;IL4;CCL5;IL23R;CCDC88B;SDC4;CLC;IL15
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6076550641830918,-1.018662419005644,0.4090909090909091,1.0,1.0,3/10,5.97%,XYLT2;CHST9;XYLT1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6448187580792226,-1.0185526719534073,0.5675675675675675,1.0,1.0,2/5,25.93%,RAC1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.6332290773008689,1.0184473348930287,0.47540983606557374,0.9182570904517396,1.0,2/6,19.50%,ANGPTL4;HDAC9
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4570308400131473,1.0183412806631973,0.4098360655737705,0.9180619247336702,1.0,14/64,15.01%,ATP6V0D2;IRS1;IRS4;TCIRG1;FOXO1;GAB1;FER;PIK3CA;ATP6V0A4;BCAR1;SOS1;SH2B2;IGF1R;ATP6V0B
prerank,MSigDB_Hallmark_2020__Complement,0.40653787278306613,1.018120133239063,0.45098039215686275,0.9181819575217277,1.0,30/158,13.10%,F2;CFH;C3;CCL5;KLKB1;EHD1;CBLB;GNB4;PIK3R5;C9;PCLO;CD59;PRSS3;ZEB1;ANXA5;DPP4;DYRK2;MMP15;GNAI3;MSRB1;FDX1;PIK3CA;CA2;PLAUR;CASP7;LYN;PLA2G7;F3;LCK;SIRT6
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.587301587241115,1.0180942485914524,0.5,0.917814174983949,1.0,1/10,3.11%,MYC
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5600547048280201,1.0180417194600675,0.42857142857142855,0.9174837872081133,1.0,7/17,22.40%,GSTM2;SLC8A1;CASP7;RYR2;CASP3;CRHBP;RYR3
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.5817013808471767,1.0179410886323732,0.4909090909090909,0.9173942504288701,1.0,2/7,9.35%,SLC22A3;SLC29A2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.45908875173801145,-1.0178597016910769,0.40816326530612246,1.0,1.0,8/56,10.42%,SELE;NMUR2;XCR1;P2RY11;BTK;CAMKK2;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.557391489246744,1.0177205674413214,0.4727272727272727,0.9176438210491537,1.0,1/11,3.11%,MYC
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.660300214844921,1.017648800144543,0.52,0.9173509871467727,1.0,4/8,29.87%,FOXO1;GSK3A;BAD;CLOCK
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6317708444690069,1.0170115781991644,0.5,0.9186594491994721,1.0,2/8,5.94%,SHMT2;CBS
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5717050121896952,1.0168099199171419,0.43859649122807015,0.9187048988080145,1.0,2/13,11.75%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5448976793325666,1.0168016870169376,0.4375,0.9182643375837033,1.0,5/13,15.46%,ADGRV1;WHRN;TMEM120A;COL11A1;KIT
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6739566048848454,1.0167724380428982,0.5306122448979592,0.9178672606528319,1.0,3/5,26.68%,HMGB1;TNFSF4;STOML2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6209998354981034,1.016405421040337,0.5094339622641509,0.9184415317974284,1.0,6/10,26.05%,SNAI1;RBPJ;NOTCH2;JAG1;HEY2;NOTCH1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.43612592008268425,1.0163933484451524,0.4666666666666667,0.9180140561601142,1.0,18/81,19.80%,SIPA1;ARHGAP24;TBC1D8B;TBC1D12;CCDC125;SYDE2;SCRIB;TBC1D3L;SGSM3;CORO1C;ARHGAP25;GRTP1;TBC1D4;RHOG;TBC1D5;RALGAPA2;RAP1GAP2;ARHGEF16
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.44732681356056636,1.016360515418367,0.4444444444444444,0.9176238466534037,1.0,20/68,22.82%,RAPGEF3;TMEFF2;DNAJB2;SACS;EPHA3;CRACD;CARMIL1;IRAK3;NR1H4;HSPA8;IAPP;VEGFA;DNAJB1;WASL;PON1;RIOK3;HSPA1A;HSPA5;MCTP1;FAP
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6110662483487486,-1.0163090835847737,0.47619047619047616,1.0,1.0,3/9,24.80%,CLTA;AP2A2;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6110662483487486,-1.0163090835847737,0.47619047619047616,1.0,1.0,3/9,24.80%,CLTA;AP2A2;VLDLR
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.6683361559570193,1.016178940963273,0.5454545454545454,0.9172861726734612,1.0,4/5,32.95%,FER;PDE1B;DCSTAMP;CSF1R
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.6683361559570193,1.016178940963273,0.5454545454545454,0.9172861726734612,1.0,4/5,32.95%,FER;PDE1B;DCSTAMP;CSF1R
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.5507044099233925,1.015986984555893,0.49122807017543857,0.9173627803448944,1.0,12/25,22.81%,LRP4;NLGN1;SCRIB;NRXN1;MAGI2;SAV1;LRRC7;DLG2;ITGAL;DLG3;ITGB2;MUSK
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.4878629670543627,1.0159655061959323,0.4642857142857143,0.9169553064676582,1.0,8/35,19.78%,EFNA5;BICD1;EPHA3;KLHL42;CDK2AP2;PHLDB2;PRKAA1;MACF1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6957283794100539,1.0159388289623141,0.5263157894736842,0.9165911081897881,1.0,4/5,30.40%,SETD2;ASH1L;SETD5;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6293139388927765,1.0155513926636195,0.4727272727272727,0.9171759487166026,1.0,4/10,13.71%,ELOVL5;MLXIPL;ABCD2;NR1H3
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.3965028956871844,-1.0154375911660876,0.36363636363636365,1.0,1.0,9/85,6.90%,SELP;NLRP1;MPO;CXCL13;PRKCD;OAS3;IL6R;OAS1;SLC11A1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6165244280169276,-1.0153772789469238,0.5106382978723404,1.0,1.0,2/10,8.45%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.4534163864167655,1.0151933157421091,0.43859649122807015,0.917766317661919,1.0,21/65,19.89%,FZD5;NLGN1;CDH2;SDK1;ACHE;NRXN1;NLGN4X;DSCAM;LRRTM3;GPM6A;PLXNB1;PLXNB2;PTEN;LGI2;FZD1;GABRB2;DNM3;RAB29;GRID2;FLRT3;FARP1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6107247365113639,1.0149275135350202,0.5185185185185185,0.9181604346775737,1.0,2/12,3.00%,FLT1;CCL5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5368558541522668,-1.0147880764320365,0.4444444444444444,1.0,1.0,8/36,16.02%,ERCC1;RFC3;PARP1;GTF2H2;FAN1;RFC2;RPA3;RFC1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.4240928801088018,1.0147130708725896,0.4375,0.9182547050515032,1.0,11/94,13.32%,F2;CCL5;GPSM3;CCN4;NAPEPLD;NFKBIZ;TLR2;SNCA;IL15;PLA2G7;OASL
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.4966993275658421,1.0142876882352765,0.4339622641509434,0.9187459107055455,1.0,2/25,3.00%,SYK;CCL5
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6913861568614742,1.0142841586280618,0.4576271186440678,0.9178474198262798,1.0,2/7,8.03%,ASF1B;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6913861568614742,1.0142841586280618,0.4576271186440678,0.9178474198262798,1.0,2/7,8.03%,ASF1B;ASF1A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.607350147430617,1.014240450347438,0.5087719298245614,0.91749643425587,1.0,4/9,8.60%,FERMT3;CCL5;DPP4;ADA
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4456671220606164,1.0139833812186894,0.375,0.9177614863729535,1.0,7/58,17.52%,MAP3K11;TNFRSF19;HMGB1;MAP4K2;GADD45G;MFHAS1;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.46515302320847185,-1.0139157256459654,0.425531914893617,1.0,1.0,8/52,12.85%,TERT;ALOX5;CLU;UBASH3B;WFS1;IGFBP3;APOA1;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4191849012861411,1.013675846050563,0.37254901960784315,0.9182517076691262,1.0,17/71,17.72%,TGFBR1;GDF6;ZEB2;BMP2;ACVR2A;RBPJ;ELAPOR2;SMAD2;INHBC;BMPR1A;SMAD4;CRB2;ACVR1B;GDF9;KIAA0319;FBXL15;BMP4
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.527164424462534,1.0136503910245755,0.4461538461538462,0.9179010472460188,1.0,5/23,13.71%,ADIPOR2;PRKAB2;ELOVL5;MLXIPL;NR1H3
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.4313582845046246,1.0135778329819451,0.4117647058823529,0.9176359524559893,1.0,24/105,13.58%,STAB1;RIN2;ITGA2;HIF1A;ANPEP;PTGS1;MAFB;CASR;TCN2;ESR1;SIGLEC1;ITGAV;GRM8;TLR2;ABCA1;CYP27A1;TMIGD3;OSCAR;CA2;GSN;EFNB2;EGFL7;IRAK3;SMAD4
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6703616765537409,-1.0133340914206759,0.48717948717948717,1.0,1.0,2/5,9.58%,HMGCL;MCCC2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.5783408183853063,1.0131898549645093,0.47058823529411764,0.9182045880899722,1.0,7/11,29.18%,F2R;NAPEPLD;CX3CR1;CARD9;NOTCH1;LRRC19;LPCAT3
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.6974280396092064,1.0131463774202771,0.5416666666666666,0.9178058326414705,1.0,3/5,21.66%,BMPR1A;BMP4;BMPR2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.6399493857282149,1.0130748540247942,0.4642857142857143,0.9176201921093464,1.0,4/8,21.17%,SCUBE1;CD34;MESP1;JAG1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.6724904501336119,1.0130007662580816,0.5306122448979592,0.9173436188162668,1.0,2/5,12.34%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.597190087447378,1.0129599525220474,0.5517241379310345,0.9170430358609148,1.0,1/11,1.30%,MOGAT2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5554901908354108,1.012893693917137,0.5172413793103449,0.9167852326294884,1.0,1/21,1.30%,MOGAT2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.34442093207523805,1.0127856517112033,0.3050847457627119,0.9166247342056687,1.0,201/966,19.18%,GATA4;MITF;CRX;IGF1;IL26;RFPL2;ZNF300;HGF;FLI1;TGFBR1;RUNX1;SIRT1;ESRRG;FZD5;NR5A2;FGF2;ERG;IL4;ERBB4;HNF4G;GDF6;MYC;DUX4;CTCFL;SNAI1;PADI2;HIF1A;PYHIN1;NFIL3;KAT2B;PPARG;MDFIC;ZEB2;CD40;WNT4;MAFB;MYCN;TFEB;RORB;NRIP1;F2R;PLAC8;MLLT3;FANK1;BMP2;RORA;SIX4;MYRF;LMO2;SP1;ACVR2A;HCLS1;ZGLP1;STING1;WWTR1;TEAD2;RORC;ZNF462;RELA;CDCA4;LMO1;RBPJ;LPIN3;IRF8;NHLH2;ESR1;MED17;VEZF1;TET2;ST18;HJV;NFIA;ELF4;ASF1A;FOXO1;POU3F2;RFXAP;RPS6KA4;TLR2;PTOV1;HDAC3;PPM1A;HDAC2;HMGB1;RYBP;PAX6;SSBP2;TP53INP1;ELK1;FOXO3;ONECUT2;FOXH1;SMAD1;YAF2;KLF6;AUTS2;PROX1;KDM3A;CTBP2;SMARCD3;SERTAD2;SMAD2;NCOA2;CD74;NR4A2;E2F4;TBL1X;TCF4;BMPR1A;ABRA;NR1D2;HNRNPD;NCK2;PLAGL1;CHEK2;MLXIPL;SP3;SMARCD2;NPAS3;GREM1;NR1H4;PML;SMAD4;CREB3L2;MEF2C;NR1H3;DPF3;ELOF1;BCL3;BCL11B;ARID1A;DPF1;SERTAD1;CDC5L;TNIP3;TFEC;PICALM;ZNF639;PPP3CA;ZNF175;ATF7IP;RARB;ZNF281;MAFF;KLF7;FZD4;CD80;FZD1;WWOX;ARID1B;SPIN1;ZXDC;NCOA3;CREB1;DYRK1A;LRP6;RET;NFATC3;PCGF5;KAT6A;EPC1;LBHD1;POU2F1;NR2F2;GABPB1;ATF6;THRB;MYB;VEGFA;PLSCR1;RHOG;DEAF1;SMAD5;PHIP;PLCB1;NAA16;IRF3;NFE2L2;BMP4;H1-10;EAF2;POGZ;HMGA2;ZNF263;HSF2;KLF15;CTNNB1;MESP1;THAP3;RPS6KA1;NOTCH4;SIRT7;MYDGF;RPS6KA5;SMARCA2;HCFC1;DVL2;PAX3;FSTL3;HDAC1;RFX5
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5924503625076027,-1.0126892290498437,0.5121951219512195,1.0,1.0,1/8,5.15%,OLFM1
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),-0.6678370232383477,-1.012633325632296,0.5,1.0,1.0,1/5,4.20%,IL6R
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6564537988581955,1.0125916729505748,0.5,0.9167857050270389,1.0,1/7,7.99%,MEGF10
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5532266187072067,1.0124228933686954,0.40350877192982454,0.9168192676360356,1.0,8/19,23.32%,RPS6KA4;PAXIP1;PRKAA1;DIP2B;RPS6KA5;RUVBL2;DIP2A;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42974598166538364,1.0122286288902613,0.42,0.917034488510602,1.0,12/79,15.04%,CDKN2C;CDKN2A;KANK2;SLFN11;ZFP36L2;FBXO5;PSMD13;CDK4;PTEN;PSMA1;CDK2AP2;PSME4
prerank,PanglaoDB_Augmented_2021__Myocytes,0.4246868261687227,1.01130985570142,0.375,0.9189262793170027,1.0,22/115,13.02%,PPP1R3A;GATA4;SMYD1;SYPL2;PRRX1;PRKG1;IL4;CHODL;DOCK1;SIX4;NMRK2;ASB5;TNNT1;IP6K3;SGCG;CKM;EDNRA;NPPA;SMPX;NOTCH3;WASHC1;SYNPO2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5670398956256831,1.0112258834358168,0.48214285714285715,0.9186743589023745,1.0,1/18,0.92%,FGF10
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.6148411802386669,1.0106420682510788,0.4423076923076923,0.9198619578745234,1.0,1/12,2.73%,THEM5
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.6207746566716634,-1.010434067561715,0.5135135135135135,1.0,1.0,1/7,4.04%,ALOX5
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.38379773055753885,1.0103973145959186,0.375,0.9200752366726037,1.0,35/201,17.87%,PCOLCE2;FSTL5;CARNS1;CCDC74B;NRG1;FAIM;EFNA5;CLSTN2;ASIC1;CYB561;ABHD3;PCLO;MEIG1;STOM;CNPPD1;CLGN;FGF12;H2BC21;SPEF2;LRRIQ1;AK1;RETREG1;MANEA;LRRC45;SCN9A;SGPL1;MAPK15;CERS5;MLF1;PTPRU;LMAN2L;CPE;MORN5;CNTN4;IMPDH1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.41561051841310903,1.010184934351236,0.45614035087719296,0.9202580966946582,1.0,13/85,15.71%,SMAD6;TGFBR1;SIRT1;ZEB2;IL17RD;PPM1A;DAND5;LATS1;FAM89B;SMAD2;SMAD4;NREP;VASN
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5081587648854341,1.0100255227847947,0.43636363636363634,0.9202717017039902,1.0,7/28,18.18%,SLC26A6;SLC4A1;SLC4A7;SLC9A2;CA2;SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5027575870025196,-1.0099917351549694,0.4166666666666667,1.0,1.0,2/18,6.50%,TIMP4;PTPN3
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3530184356109697,1.0099752168039875,0.4,0.9199171380386488,1.0,70/464,13.95%,SIPA1;ADRA1A;CDKN2C;SMAD6;SEMA5A;GNRH1;SIRT1;ENPP1;FGF2;ERBB4;MYC;DUX4;KAT2B;ANGPT1;CDKN2A;KNG1;AGR2;CDKN2AIP;F2R;CCN6;TENM1;BMP2;BTN2A2;SSTR3;NAIF1;KANK2;SMYD2;TDRD9;GMNN;CCN4;TEX15;ST18;DNAJB2;FBXO5;TLR2;P3H2;HTRA2;DLC1;FRK;ADAMDEC1;CBFA2T3;TOB1;TP53INP1;ASTL;TMIGD3;PTPN14;ITGA1;PROX1;RNF139;ARID2;DSCAM;MAGI2;TMEM115;CTBP2;SINHCAF;SERTAD2;RPS6KA2;PTPRK;LYN;GNG4;BNIP3L;FBP1;NCK2;TP53BP2;PLXNB1;PIWIL1;PML;SMAD4;NR1H3;TMEM98
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6409298794526685,1.009974929061431,0.5833333333333334,0.9190040689190077,1.0,1/7,8.61%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6409298794526685,1.009974929061431,0.5833333333333334,0.9190040689190077,1.0,1/7,8.61%,TLR2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.33988281384382435,1.0099105778521416,0.42105263157894735,0.9187290042052334,1.0,167/787,21.31%,DACH1;MITF;AASS;TIMELESS;RUNX1;SIRT1;ZBTB7B;TSHZ3;NRG1;IL4;MYC;URI1;SNAI1;FOXP2;ZBTB1;NFIL3;CDKN2A;PPARG;MDFIC;ZEB2;WNT4;RORB;SFMBT2;NRIP1;BMI1;VSX2;BMP2;SIX4;KANK2;SMYD2;ZGLP1;ZNF582;GMNN;RORC;RELA;RBPJ;ZEB1;ZBTB2;IRF8;ESR1;MYPOP;HJV;ZNF20;FOXO1;ZNF706;NCOA5;HDAC3;PPM1A;ZNF274;HDAC2;HMGB1;UBE2D3;PAX6;ZNF669;FRK;INSM2;CBFA2T3;SNCA;FOXO3;ATXN1;ZNF692;YAF2;PROX1;ZNF599;TAF3;TLE2;ZNF675;RIPPLY2;NPAS1;CTBP2;EZH2;SMAD2;PTPRK;SPINDOC;NR4A2;TBL1X;FBP1;NR1D2;PASD1;MBTD1;ZNF239;SIRT6;MLXIPL;PHF21A;SP3;ZNF202;NR1H4;PML;SMAD4;MEF2C;NR1H3;DPF3;BCL3;HSPA8;DPF1;BCOR;ZNF536;TFEC;MAGEL2;ZNF639;RNF2;ZNF175;MYT1L;ATF7IP;RARB;ZNF281;MXD4;KLF7;WWOX;PRICKLE1;RUNX1T1;CREB1;ZNF778;ZBTB33;KAT6A;LOXL2;EPC1;POU2F1;NR2F2;THRB;MYB;VEGFA;TRPS1;DEAF1;NOC2L;SPEN;PLCB1;BMP4;HMGA2;ZNF263;BAP1;CTNNB1;MESP1;PEX2;CNOT2;NOTCH4;SIRT7;FOXN3;DNAJB1;RPS6KA5;SMARCA2;HCFC1;PCGF1;HDAC1;ATP8B1;PER3;HDAC9;ZNF12;MXI1;LCOR;MTERF3;MIER3;CITED2;EED;PSPC1;NSD1;SFMBT1;ZBTB4;NFIC;SHH;TGIF1;MED25;KLF10;NR3C1;UBE2D1;ID4;HEXIM2
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.6509226676816953,1.009813939286656,0.5365853658536586,0.9184903524069861,1.0,1/5,10.86%,DSCAM
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.496468266517885,-1.009795338787612,0.4473684210526316,1.0,1.0,3/35,4.51%,TNFSF18;SIRPG;FGL1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.7075093229694234,1.0093166548542638,0.5344827586206896,0.9194861143571315,1.0,1/5,3.01%,SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.514703400894474,-1.0088905997008595,0.39473684210526316,1.0,1.0,1/21,0.10%,P2RY10
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4459580108643628,1.0082489491880116,0.39215686274509803,0.922075499550794,1.0,9/77,7.51%,FLT1;RRAS;RUNX1;SELPLG;TOX;BMI1;FLT3;ZFP36L2;TET2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.6402630307282499,1.0081614148389038,0.5535714285714286,0.921949819407902,1.0,4/5,27.07%,LRRC17;TP53;LRP5;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.4840125462824725,1.0073359125917865,0.42105263157894735,0.9235675812332459,1.0,7/30,15.94%,CTDNEP1;LDLR;ZBTB20;ELOVL5;MLXIPL;NR1H3;CREB1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5471644155290123,1.007036680736521,0.5245901639344263,0.9238198208980191,1.0,6/17,25.88%,SYT1;RIMS2;SYT17;SMURF1;CPNE9;SYT3
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6110213000775578,1.0069251510081525,0.4727272727272727,0.9236814538933794,1.0,5/14,24.90%,IRS1;ABCD2;IRS2;AKT2;PPARA
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5954901012289056,1.006923291267016,0.4375,0.9232310920684315,1.0,1/9,3.54%,KAT2B
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6223093369170007,1.0068876898357095,0.5166666666666667,0.9228831676592965,1.0,3/10,18.53%,KANK2;FOXH1;CNOT2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5577677127593844,-1.0066391701406574,0.47619047619047616,1.0,1.0,2/12,6.32%,UPB1;NT5C
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6354718203791938,1.0065572462642722,0.4838709677419355,0.9232191995934139,1.0,2/7,14.87%,RRS1;XPO1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.5501370527371718,1.0065504859125416,0.46,0.9227937069448683,1.0,2/14,17.15%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.6937093080930993,-1.0064317214462664,0.52,1.0,1.0,2/5,25.02%,VPS25;VPS36
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.6937093080930993,-1.0064317214462664,0.52,1.0,1.0,2/5,25.02%,VPS25;VPS36
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.5950204604135767,1.0063190034067604,0.5079365079365079,0.9229856750289295,1.0,5/13,18.48%,PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4750803349108961,1.006284931263828,0.3770491803278688,0.9226026310502953,1.0,11/47,19.68%,MME;FAIM;HES6;PCM1;PAX6;LIG4;LRP2;SPEN;CTNNB1;NUMB;RGS14
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5473948503763862,1.0062400821545665,0.5,0.9222439036079916,1.0,7/19,21.18%,ST8SIA4;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A;ST8SIA1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.6978649986862258,-1.0060576800751582,0.5384615384615384,1.0,1.0,3/5,27.78%,CGAS;PDE10A;THBS1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.6793504992596379,1.006040426079817,0.5714285714285714,0.9222922946434681,1.0,4/5,28.28%,IL23R;CSF1;IL23A;TRAF6
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6765754147011438,-1.0060039689313185,0.52,1.0,1.0,1/5,4.45%,ABCC4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.531493695941706,1.0059755415036922,0.4067796610169492,0.9220177775722608,1.0,3/27,5.49%,GATA4;WNT4;SIX4
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.4650465780360252,1.0055355181131267,0.4375,0.9227594432201192,1.0,11/44,16.68%,CDH7;CDH20;CADM2;CDH6;CDH2;CDH12;NECTIN2;CADM1;CDHR3;CDH10;CDH8
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.4692974930917858,-1.0055348094240841,0.42857142857142855,1.0,1.0,5/53,7.57%,H1-3;H1-4;H1-2;POLR1G;SMARCD1
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.6610264060538653,1.005324724073839,0.6,0.9227597252711781,1.0,3/6,23.50%,F2R;F2RL1;GAS6
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.649344143996287,-1.0048775477784258,0.5319148936170213,1.0,1.0,3/8,7.31%,PXDN;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.588919114253467,1.0048557666388576,0.5172413793103449,0.9229393030833374,1.0,6/7,39.41%,EXOSC4;EXOSC2;EXOSC5;EXOSC8;EXOSC7;EXOSC9
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.588919114253467,1.0048557666388576,0.5172413793103449,0.9229393030833374,1.0,6/7,39.41%,EXOSC4;EXOSC2;EXOSC5;EXOSC8;EXOSC7;EXOSC9
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5256192814818551,1.0046908157110777,0.5098039215686274,0.9229812459765033,1.0,7/21,11.33%,HS3ST5;HS3ST3B1;UGDH;HPSE;HS2ST1;HS3ST4;EXT1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5759976263017145,-1.0044633030407644,0.5,1.0,1.0,7/17,21.46%,CLDN4;DDRGK1;APH1B;PSME3;PINK1;GRN;APH1A
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.4875189910199988,1.0041399643310316,0.46,0.923857729076726,1.0,5/34,10.64%,SYT15;RAB27A;SYT1;SYT6;RIMS2
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.6255778902192672,-1.0038981757305994,0.6122448979591837,1.0,1.0,2/6,16.56%,CFAP73;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5277057737700108,-1.0037179909999403,0.5238095238095238,1.0,1.0,4/27,7.21%,KCNE2;SCN5A;KCNE1;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4324922442230384,1.003346371291865,0.4444444444444444,0.9254126068490481,1.0,17/80,13.10%,SYK;TRPM8;ESRRG;ZBTB7B;IL4;SCD;TRPV2;ADIPOR2;PLAC8;PRKAB2;ACHE;HDAC3;PDGFC;KDM3A;LEPR;GADD45G;SIRT6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.47357218623030245,1.0030725321308784,0.41509433962264153,0.9256795827986318,1.0,16/44,27.02%,SIRT1;BOK;DYRK2;HTRA2;CHEK2;PML;BCL3;HIPK1;ABL1;TP53;PHLDA3;TNFRSF1B;IKBKE;FNIP2;EP300;BCL2A1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5761711181950124,-1.0030322810098413,0.5333333333333333,1.0,1.0,2/9,12.35%,RAB7B;MTURN
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5245717427079599,1.002882088160697,0.5,0.9257974838060998,1.0,4/21,4.34%,GPR55;IL4;MYC;MAFB
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5593586062521557,1.0028474376188865,0.5,0.9254036021793502,1.0,7/16,23.21%,SP1;RELA;LRRTM3;PICALM;CASP3;ABCA2;GSK3A
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.47735546397737805,-1.0028090111910315,0.4090909090909091,1.0,1.0,5/29,10.05%,RTF1;COL4A2;LAMB3;LAMB1;NODAL
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.4158374175104144,1.0027163413172842,0.423728813559322,0.9252360809690423,1.0,9/85,7.89%,FGF10;RRAS;FGF2;RIN2;HIF1A;ANGPT1;DOCK1;ANXA3;PLCG2
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6079775143230727,1.0025124023261474,0.48214285714285715,0.9253243069265179,1.0,1/10,2.53%,CD99
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.6251787113770046,1.002428311702175,0.5,0.9250856976454489,1.0,2/5,25.43%,BBIP1;ARL13B
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6242214275511152,-1.0024004495358236,0.5263157894736842,1.0,1.0,5/6,34.63%,GRN;ATP6AP2;CLN6;PPT1;CLN3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.6478777180059331,-1.0020266225627898,0.6,1.0,1.0,1/6,4.20%,RNF8
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6635154729377886,1.0017418741225357,0.5666666666666667,0.9260514042732882,1.0,4/5,30.40%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6635154729377886,1.0017418741225357,0.5666666666666667,0.9260514042732882,1.0,4/5,30.40%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.6237811805092246,1.0015225690498792,0.5076923076923077,0.9257048520478599,1.0,2/6,23.50%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.6237811805092246,1.0015225690498792,0.5076923076923077,0.9257048520478599,1.0,2/6,23.50%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3752595325723357,1.001487916296175,0.37735849056603776,0.9253362583067523,1.0,54/246,21.16%,SYK;TOP2A;MAP3K11;PAWR;SIRT1;BOK;DAPK2;FGD4;KNG1;PLEKHG2;FANK1;BMP2;DKKL1;SEPTIN4;ARHGEF17;SCRIB;TNFRSF10A;UNC13B;FOXO1;HMGB1;RYBP;HTRA2;SNCA;UBE2Z;FOXO3;LATS1;BIN1;RPS6KA2;BNIP3L;GADD45G;MAPK8;PHLDA1;SOS1;ANO6;RBM5;ATF6;IAPP;ARHGEF6;FRZB;BMP4;HMGA2;VAV2;CTNNB1;ARHGEF4;TNFRSF10B;ARHGEF16;CSRNP3;JMY;RHOB;CASP3;MELK;NLRP2B;GNA13;MCF2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.5761071474287571,1.001266712485737,0.4915254237288136,0.9255544515413237,1.0,5/14,28.01%,INTS6L;INTS6;ERI1;INTS14;INTS8
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6216019024658901,1.0011819481340476,0.5510204081632653,0.9253283853210486,1.0,3/11,7.36%,CSPG4;VCAN;BGN
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.6009567978612517,1.0008459685632454,0.5272727272727272,0.925723902029788,1.0,1/7,2.28%,ALDH1A1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5054244651713331,1.0008189825269043,0.4307692307692308,0.9253382722440782,1.0,4/23,18.85%,PRR5L;SMG1;RICTOR;MLST8
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6452331751976348,1.0007911873407644,0.49056603773584906,0.9249707537090576,1.0,4/6,31.43%,NOC2L;IRS2;FOXP1;BCL10
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5274251119207993,1.0001621727216552,0.4339622641509434,0.9261163236019776,1.0,6/26,10.99%,TRPC4;CASR;SLC8A1;SMDT1;MCUB;MCU
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.6330697989980153,-0.9999694703216431,0.5306122448979592,1.0,1.0,1/6,4.70%,CRYM
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4421622036633404,0.9999408055039675,0.4107142857142857,0.9263216887057278,1.0,8/66,7.86%,IGF1;PLCH1;IRS1;FGFR1;PIK3R5;NYAP2;PIK3C2B;PDGFRA
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.466722053623676,-0.9998933169963952,0.4423076923076923,1.0,1.0,4/35,13.25%,CENPH;RNF8;ITGB3BP;SMARCA5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.4187435247982497,0.9998905465933515,0.421875,0.9260250684124581,1.0,23/124,14.73%,EPHA7;SIRT1;SLC35F1;ERBB4;POU6F2;SCGN;TMEM200C;UNC5D;ZDHHC22;ELAVL2;SPSB4;POU3F2;IGDCC3;EFNA2;B4GALNT4;GRM5;EZH2;PAK5;PPM1E;DLL3;NOL4;TSHZ1;MAGEL2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5840202946813751,0.999759208760603,0.5454545454545454,0.9259883580411475,1.0,4/10,18.46%,SIRT1;SNCA;NOC2L;KLF15
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.4437641331399333,0.9994893723838308,0.45098039215686275,0.9261934861887081,1.0,8/64,8.47%,SYK;CXCL12;TNFRSF18;CCL5;AGR2;ITGAV;MEGF10;RHOD
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.38169875181074564,-0.9994166014736913,0.4,1.0,1.0,7/216,2.70%,EPN1;TRIP10;SYNJ2;SUN3;RTP1;RTP5;M6PR
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.5873445082945765,-0.9992837417077705,0.49056603773584906,1.0,1.0,1/7,1.03%,FBXO43
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.4209073221226105,-0.9988419939949088,0.4,1.0,1.0,10/98,9.11%,MS4A8;TERT;CAPN9;HEPH;FAM3D;ITGA9;OLFM4;ZBTB7C;MYO5B;KCNQ1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6822658774277286,0.9987886196495851,0.49056603773584906,0.92762452736148,1.0,1/5,8.10%,UNC13B
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.49918458635726426,-0.9987195733936481,0.4722222222222222,1.0,1.0,1/24,1.58%,SYNJ2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.43209563154564423,0.9985989810808333,0.41818181818181815,0.9277638520426017,1.0,13/101,8.38%,MXRA5;MRGPRF;PRRX1;PRKG1;GNG12;CSPG4;POSTN;WWTR1;FAM114A1;ASB5;BGN;ACHE;OLFML3
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.49815688726915025,0.9984067622885099,0.5915492957746479,0.9277793715014608,1.0,3/26,5.30%,IRGM;F2;IL23R
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5314848191352699,0.998404557050149,0.46,0.9273357521936588,1.0,2/15,5.09%,SPR;GCH1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.618864044581575,0.9979813728672791,0.5,0.9279986325642609,1.0,3/6,33.49%,COLGALT1;EFEMP2;RB1
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5004852169480243,-0.9978508557829244,0.45454545454545453,1.0,1.0,4/36,2.46%,P2RY10;SELL;SIRPG;TRAF3IP3
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6121189364606848,0.9977731650317848,0.47058823529411764,0.9281669089380565,1.0,3/12,11.56%,KCNC2;NPPA;HTR2C
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4741485611591712,0.9977269619225727,0.47058823529411764,0.9278060332215772,1.0,11/34,29.30%,ACD;MAPK15;NEK7;HNRNPA2B1;CTNNB1;POT1;MAPK3;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5103045085504216,0.9973876550714805,0.4482758620689655,0.9282092326391487,1.0,4/25,5.48%,ATP6V0D2;RAB38;TCIRG1;RAB39A
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3969465056150072,0.9973150258277453,0.4583333333333333,0.927925021006918,1.0,42/174,20.99%,SLC7A11;CCNG1;CDKN2A;RRAD;CDKN2AIP;F2R;CTSF;BMP2;STOM;SP1;EPS8L2;TCN2;NHLH2;MAPKAPK3;ADA;HDAC3;TSC22D1;TOB1;FOXO3;PTPN14;DCXR;AK1;TPRKB;IRAG2;TAP1;PLXNB2;CCND3;MXD4;SLC3A2;ACVR1B;CCP110;FDXR;IRAK1;SEC61A1;KRT17;PERP;SAT1;CD81;IER5;SLC19A2;CSRNP2;CD82
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.46977192025706377,0.9971128062031246,0.4909090909090909,0.9279991015270365,1.0,3/45,3.66%,ATP6V0D2;REP15;TCIRG1
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.6118299197623215,-0.9970233701316881,0.5476190476190477,1.0,1.0,4/7,17.56%,CYP21A2;HSD11B1;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.49984555251374135,-0.9970226059100914,0.46808510638297873,1.0,1.0,2/19,7.75%,NUPR1;PGP
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5832730654242837,0.9970056473095638,0.5094339622641509,0.9278325919509832,1.0,4/10,22.80%,RELA;FUT9;IRAK1;ITGB2
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.46312312165482333,0.9968950161526867,0.45901639344262296,0.9276955604734549,1.0,4/42,12.29%,CTDNEP1;BIN1;CHMP6;IRAG2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.5525827888717373,0.9968336076218599,0.45454545454545453,0.9274004237463364,1.0,6/13,24.31%,PYHIN1;RO60;MX2;AXL;GAS6;KLHL20
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6423246864640632,0.9967950061081329,0.5081967213114754,0.9270821403425837,1.0,2/5,25.02%,VPS13D;VPS13A
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.49692745970353996,0.9966709319559461,0.4897959183673469,0.9269515236439658,1.0,7/32,14.76%,C3;IL4;HIP1;BICD1;TF;SMAP1;PICALM
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.5254146281452201,0.9966177994314757,0.5185185185185185,0.9266337631048136,1.0,4/15,14.09%,JAGN1;CBFA2T3;PML;CDK4
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.5992678884338055,-0.9964611682519982,0.525,1.0,1.0,2/7,16.12%,ATG14;CALM1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.4451812714224566,0.996394226035274,0.45098039215686275,0.926825202844108,1.0,9/47,6.66%,NXPH2;PNOC;UTS2R;GLRA1;SSTR3;PENK;OPRK1;NPY;NXPH4
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.6569803521859037,0.9961109084052724,0.5344827586206896,0.9271450823162632,1.0,3/5,33.96%,HSD17B10;SDS;SDSL
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.65932018838381,0.9961001069612151,0.5849056603773585,0.9267283437490076,1.0,1/5,21.19%,HEXB
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.43601402624312235,0.995722456096423,0.47619047619047616,0.9271414169823765,1.0,24/88,17.83%,F2;ACE2;STARD4;IL4;CCL5;ANGPT1;PPARG;SCRIB;RAMP3;SNCA;PLA2G10;DCXR;MAGI2;GREM1;NR1H3;AKR1C1;VAMP3;ACACB;FASN;CSF1;ACACA;VEGFA;RAB29;TBC1D5
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.6994771595258432,0.9955513106818716,0.5789473684210527,0.9272038062376736,1.0,1/5,3.01%,SLC7A2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.5745137009806747,0.9952208437322517,0.5263157894736842,0.9276629367969944,1.0,2/14,9.41%,SHMT2;CBFA2T3
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),0.6327776176032847,0.9948666315315812,0.5283018867924528,0.9280749664332686,1.0,3/7,9.71%,CYP4F12;CYP3A4;CYP4F3
prerank,MSigDB_Hallmark_2020__DNA Repair,0.4073582586526885,0.9947291337647717,0.39622641509433965,0.9279852453995189,1.0,17/140,17.89%,PNP;SAC3D1;AK3;CANT1;BCAM;HCLS1;RALA;ADA;AK1;NPR2;PDE4B;REV3L;NT5C3A;POLD4;SMAD5;NELFB;SEC61A1
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.6392173988192902,0.9946405969120743,0.5483870967741935,0.9278315143513258,1.0,1/5,2.68%,MLC1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.45460007556408843,-0.9946121552229135,0.5111111111111111,1.0,1.0,3/54,2.68%,P2RY10;NTRK1;PRAG1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5563365341900325,0.9944817331620595,0.546875,0.9278526543808159,1.0,6/19,27.98%,JADE3;MSL2;HCFC1;KANSL3;OGT;MSL3
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5589681177003021,0.9941179170821012,0.5094339622641509,0.9279821518549292,1.0,4/14,14.15%,ARID2;SMARCD3;SMARCD2;ARID1A
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5589681177003021,0.9941179170821012,0.5094339622641509,0.9279821518549292,1.0,4/14,14.15%,ARID2;SMARCD3;SMARCD2;ARID1A
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46201843183425695,0.99383737105691,0.48,0.9284219240513355,1.0,10/46,13.58%,SMAD6;TGFBR1;GDF6;BMP2;ACVR2A;BMPER;INHBC;BMPR1A;GREM1;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6185213752957751,0.9937273713969536,0.6166666666666667,0.9282276610104157,1.0,7/8,37.79%,GLRX;BAD;AKT2;STOML2;ANK3;MTLN;VCP
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.5370569817415666,0.9935883936362484,0.5344827586206896,0.9281614080940512,1.0,5/20,26.95%,TIMM22;TIMM10;BAD;MAIP1;TIMM9
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5838388740617909,-0.9933987969696826,0.47619047619047616,1.0,1.0,1/12,1.16%,NUPR1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6376647772416177,0.9932010668206924,0.52,0.9288269532899353,1.0,4/6,25.19%,IL4;PRLR;PIBF1;JAK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.4516033472767138,0.9927564945572309,0.44,0.9295441043106608,1.0,11/68,15.70%,FBLIM1;LRP4;SDK1;PPFIBP1;MARVELD3;SNCA;NLGN4X;GRM5;TJP2;SEMA3E;PPFIA3
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5961430466068081,0.9927017870523932,0.5,0.9292742521146912,1.0,5/7,36.86%,CORO1C;TMCC1;SLC25A46;SH3GLB1;SPAST
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4734988917912361,-0.992320664700842,0.45454545454545453,1.0,1.0,5/30,7.21%,KCNE2;DRD2;KCNA5;KCNE1;KCNN2
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.6578670988757881,0.9921528282748964,0.5614035087719298,0.9301702771808976,1.0,3/5,30.34%,TLR2;TLR1;CD36
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.6274586638914302,0.992036476949428,0.5409836065573771,0.9300394957942227,1.0,1/6,3.30%,HAS2
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.7078709914928029,0.9913864308653852,0.5692307692307692,0.9313340578179277,1.0,1/5,5.43%,SYNCRIP
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5863697045135476,0.9912651282466385,0.5483870967741935,0.9312318004460898,1.0,3/12,15.06%,PCSK5;PDGFRA;RARB
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.40225434599651694,0.9912202153405265,0.49122807017543857,0.9308981184467197,1.0,36/149,16.13%,PAWR;FRAS1;FBLIM1;FZD5;LRP4;MYC;ROR1;GNG12;TENM3;DOCK1;LRIG3;IL17RD;CD59;ALDH7A1;CLDN6;TEAD2;L1TD1;DSP;ADGRL2;EPHB4;LIFR;PTPN14;SMAD1;MAGI1;SMAD2;TSPAN6;PIWIL1;PML;SMAD4;BCL3;PTK7;FZD1;KIT;GJC1;LRP6;ANO6
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.4827554403403107,0.9911511233477232,0.3888888888888889,0.9306688895557158,1.0,4/32,5.48%,ATP6V0D2;RAB38;TCIRG1;RAB39A
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5558106507185203,-0.9910989184667317,0.5,1.0,1.0,3/18,12.49%,GINS3;RFC3;LIG1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.6714671892721594,0.9906852013090027,0.5614035087719298,0.9314344760535254,1.0,1/5,21.96%,TIMP1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4196961263370041,0.9905444223127571,0.48214285714285715,0.9312630080103611,1.0,22/115,15.66%,CWH43;PIK3R6;FGF2;SOCS2;ITPKB;PIK3R5;PIP4K2A;PIK3C2B;PIGQ;PLCG2;SOCS6;SMG1;IP6K3;INPP4B;PIK3CA;EFR3A;PIGF;PTEN;PI4K2B;MTMR9;MTMR3;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5671774491198284,0.9905415074868382,0.5192307692307693,0.9308317361284717,1.0,1/14,1.00%,TIMELESS
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6272298063096508,0.9905332190117311,0.5192307692307693,0.9304066484975146,1.0,3/6,11.94%,MAPKAPK2;MAPKAPK3;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.4564884810248722,0.9905311048904615,0.5,0.9299704216432156,1.0,7/40,18.13%,LDLR;ITGAV;BANP;PTX3;IRAK3;IAPP;FMN2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.5654022709580617,0.9904108801489501,0.4576271186440678,0.9298576625879746,1.0,7/11,37.39%,ITGAV;CTNNB1;GRB2;CDH1;CBLL1;CBL;CD4
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.534753688352404,0.990277786785521,0.40384615384615385,0.9297796070160275,1.0,2/16,6.08%,WNT4;DKKL1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5265479414165767,-0.9901089140987438,0.5789473684210527,1.0,1.0,1/20,0.91%,HK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5941073472870768,0.9900884230208373,0.4807692307692308,0.9298168922956511,1.0,5/14,26.60%,BOK;ACAA2;HSPA1A;GSK3A;ZNF205
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5656722413554163,0.9900734974184575,0.5370370370370371,0.9294105754767296,1.0,5/18,12.68%,TGFBR1;HIF1A;DNAJB2;DCUN1D1;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4796421924039104,0.9898322953971322,0.5576923076923077,0.9295401263412602,1.0,4/30,6.51%,IGF1;IL4;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6152197846243893,0.98959207927348,0.5714285714285714,0.9297040853628066,1.0,3/7,32.40%,AGO3;DICER1;TARBP2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.5730104103842031,0.989578012498981,0.5294117647058824,0.9292753894134854,1.0,1/12,5.31%,MID2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.45235610397327164,0.9895523535511135,0.5,0.9288585986379909,1.0,10/25,32.23%,NAV3;HDGFL3;CAMSAP2;ARHGEF2;CIB1;MID1IP1;MAP1B;CLASP2;CLASP1;FGF13
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5218418399084799,-0.9894685351075696,0.5348837209302325,1.0,1.0,7/34,16.02%,ERCC1;RFC3;PARP1;GTF2H2;RFC2;RPA3;RFC1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.48683872650417315,-0.9891344210047435,0.3958333333333333,1.0,1.0,8/30,23.72%,NDUFC1;NDUFS5;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4;NDUFA3
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.5524245396364972,0.9888321526311712,0.4444444444444444,0.9297035248139848,1.0,8/19,19.96%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ALDH6A1;BCKDHB;ACAD8
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.5524245396364972,0.9888321526311712,0.4444444444444444,0.9297035248139848,1.0,8/19,19.96%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ALDH6A1;BCKDHB;ACAD8
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.4853592782739305,-0.9884447958117647,0.475,1.0,1.0,7/34,17.34%,DDX11;TRAIP;RTEL1;NUCKS1;ZRANB3;ZGRF1;ALYREF
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.45250080437067347,0.9883946036217193,0.45161290322580644,0.9303952418056006,1.0,13/45,23.13%,EFNA5;EPHA5;FER;GSN;LYN;BLK;NR1H4;ADGRE2;REEP6;TRIM67;CDK16;MAP2;LRP5
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.5283638255400052,0.9882748660834073,0.49056603773584906,0.9303287786837711,1.0,2/26,2.82%,IGF1;NRG1
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.6469195152621966,0.9882547260792208,0.5483870967741935,0.92996409963934,1.0,2/5,4.99%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3874510031842517,0.9877707813269464,0.46551724137931033,0.9308209835776061,1.0,24/182,15.22%,KCTD21;SPSB2;NEDD4;SYVN1;KLHL8;RNF185;SPSB4;RNF217;RNF146;KEAP1;KLHL15;ANAPC16;PSMD13;FBXO7;KCTD6;FBXL14;RNF166;UBQLN4;CNOT4;ARIH1;RBBP6;RNF5;UBA6;UBE4A
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6446122100065307,-0.9876106511458682,0.5,1.0,1.0,2/6,12.01%,SPI1;AKNA
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.49153768121469,0.9874681033735747,0.5471698113207547,0.9312071403346739,1.0,1/33,1.00%,TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.6162683223343126,0.9873269886096319,0.49122807017543857,0.9311747878564786,1.0,4/7,17.72%,EFNB2;GREM1;MEF2C;BMP4
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5680018319595528,0.9873056377228232,0.48333333333333334,0.9307760456573889,1.0,1/13,3.94%,CYB561
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.5701495597740722,-0.9870146219029149,0.475,1.0,1.0,2/15,6.58%,PNPLA1;PNPLA4
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.6338261613047034,0.9866299890747372,0.5,0.9320429612360273,1.0,5/7,21.66%,GSN;RYR2;HIPK1;CAPN10;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.6006745160981959,0.9866188672590005,0.4666666666666667,0.9316441857558729,1.0,4/6,29.21%,RELA;PNPT1;ZSWIM8;NFKB1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5005496749768508,0.986607056807219,0.48333333333333334,0.9312515028268522,1.0,5/24,9.42%,SYT15;SYT1;SYT6;DRD3;SNCA
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5161626198455925,-0.9865842668876248,0.5238095238095238,1.0,1.0,3/15,13.53%,SARS1;DARS2;DTD1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.4906038384732978,0.9860086540666418,0.49122807017543857,0.9323106834426277,1.0,1/28,0.63%,SMYD1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.39979005728489925,0.9856416839711438,0.5,0.932809106117327,1.0,24/95,21.81%,SIRT1;MYC;ZBTB1;KAT2B;ESR1;ACTL6A;HDAC2;SMARCD3;SMARCD2;ARID1A;ARID1B;SMARCAD1;PADI4;MYB;HMGA2;KDM6A;SMARCA2;HCFC1;HDAC1;RUVBL2;BRDT;KDM5B;NPM3;SATB2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.4574749785894129,0.9855872052941923,0.49206349206349204,0.9325249036451643,1.0,6/45,11.67%,SLC7A11;SLC38A4;SLC7A2;SLC38A3;SLC7A9;SLC25A48
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.4744960042554667,0.985237229039879,0.48333333333333334,0.9328858016837379,1.0,11/33,14.38%,SLC10A3;NPC2;ABCC2;ABCG8;SLC10A5;ABCG5;NCOA2;SLC10A1;NR1H4;ABCC11;AKR1C1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.4330529658368449,0.9850633519557012,0.5535714285714286,0.9329155397375315,1.0,16/82,16.13%,TRPM8;MCOLN3;TRPV2;SLC35G1;TRPC4;SLC8A1;ITGAV;SMDT1;MCUB;SLC24A2;MCU;GRIN2D;TRPC5;TRPV3;TRPM2;ANO6
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5268010453095748,0.98504340949594,0.54,0.9325461703816622,1.0,5/19,20.17%,NLGN1;RIMS2;RAP1A;RIMS4;FMR1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5404797604338999,-0.985003980986985,0.4897959183673469,1.0,1.0,2/17,6.28%,FGF1;MBTPS2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.6042746975359465,0.9848706488646719,0.5636363636363636,0.9325247536856478,1.0,3/6,13.58%,SMAD1;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6403362597173057,0.9847548863153903,0.5490196078431373,0.932349570739299,1.0,3/5,15.78%,ACVR2A;SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4480144597518604,0.9846255944130351,0.4482758620689655,0.9322884143955088,1.0,26/87,23.70%,IRS1;ENPP1;INSIG1;KAT2B;PPARG;RAB31;RELA;LPIN3;FOXO1;FER;NR4A2;CPEB1;TBC1D4;CAPN10;DENND4C;SLC30A10;GCK;HDAC9;IRS2;CRHBP;SLC25A33;PRKACB;TRARG1;GSK3A;AKT2;CPEB2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.4601324191851386,-0.9846177195650787,0.3953488372093023,1.0,1.0,2/34,1.97%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.5893468393108175,-0.9843442624001892,0.5952380952380952,1.0,1.0,3/8,16.01%,PODXL;CDHR2;USH1C
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5784677307680626,-0.9843441450327117,0.5,1.0,1.0,1/13,2.91%,PRKCD
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6041819537595434,-0.9842006478758166,0.48717948717948717,1.0,1.0,2/8,7.14%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5151019038693941,0.9839449232125422,0.4909090909090909,0.9335702625854403,1.0,7/21,16.75%,FGF2;F2R;PLCG2;HTR2C;LCK;TRPM2;RYR2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.4214721628431778,0.9839065457431949,0.46153846153846156,0.9332355780821561,1.0,17/57,21.74%,SIRT1;PPARG;ZBTB20;TLCD3B;ABCA1;LIPG;NR1D2;MLXIPL;NR1H3;ABHD8;DGAT2;PRKAA1;PNPLA8;IRS2;ORMDL2;ABCA2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.6054031962845006,0.9837796558516215,0.5576923076923077,0.9332138888900159,1.0,1/6,3.40%,HIF1A
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.5637844399865501,0.9837021500892635,0.49122807017543857,0.932976286138871,1.0,1/10,4.88%,STEAP4
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.4660832046519702,0.9835902037467329,0.46774193548387094,0.9328184229334386,1.0,2/53,3.40%,SHMT2;HIF1A
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.5596766152361758,0.983456034439037,0.5,0.9327118016944527,1.0,1/12,2.96%,KCNK2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5197949757623509,0.983364707242847,0.46938775510204084,0.9325258369522914,1.0,3/20,4.85%,ACE2;ADRA1A;F2R
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.6134704193113832,-0.9833491945868517,0.5111111111111111,1.0,1.0,3/7,15.50%,ENPP2;RREB1;CORO1B
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5933366519948298,0.9830830676468718,0.49019607843137253,0.9327370759185187,1.0,4/13,12.42%,SPR;GCH1;CYB5B;MTARC2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5687994259458041,0.9829532797966398,0.532258064516129,0.932562611360985,1.0,5/15,23.52%,CD40;GSN;ANO6;AKR1C3;CD160
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5367941343057054,-0.9828642932598379,0.4883720930232558,1.0,1.0,6/23,18.38%,SIGIRR;DHX58;TYRO3;TRIB1;TRAF3IP1;CACTIN
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.501533978157717,0.9827809950085116,0.4426229508196721,0.9325639731351975,1.0,8/28,27.35%,METTL21C;TET2;ATPSCKMT;VCPKMT;KMT5B;SETD2;OGT;SETD5
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.44106533597181874,0.9825057717789412,0.5263157894736842,0.9327635710322041,1.0,12/50,23.62%,EHD1;SNX31;VPS26C;DENND1B;WASHC1;ANKRD50;VPS29;PTPN23;TRARG1;VPS50;EHD4;MICALL1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.5411850781991774,0.9824737797768647,0.46153846153846156,0.932402515576261,1.0,7/18,22.89%,LGALS9;NR1H4;TNIP3;IRAK1;ITGAM;ITGB2;LBP
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.47110377396701375,0.9824217210826007,0.4107142857142857,0.9320531137539037,1.0,3/36,6.93%,KAT2B;ROBO2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.33944268613869055,0.9824024363228822,0.4375,0.9316644451541982,1.0,150/735,19.18%,GATA4;MITF;CRX;IGF1;IL26;ZNF300;HGF;RUNX1;SIRT1;FZD5;NR5A2;DLGAP5;FGF2;ERG;IL4;HNF4G;MYC;DUX4;CTCFL;HIF1A;KAT2B;PPARG;ZEB2;CD40;MYCN;TFEB;RORB;NRIP1;PLAC8;BMP2;RORA;LMO2;SP1;ACVR2A;HCLS1;ZGLP1;STING1;WWTR1;ZNF462;RELA;LMO1;RBPJ;LPIN3;IRF8;NHLH2;ESR1;MED17;VEZF1;TET2;ST18;HJV;NFIA;ELF4;FOXO1;POU3F2;RFXAP;RPS6KA4;TLR2;PTOV1;HDAC3;HDAC2;HMGB1;PAX6;SSBP2;ELK1;FOXO3;ONECUT2;FOXH1;SMAD1;PAXIP1;KLF6;AUTS2;PROX1;CTBP2;SMARCD3;SMAD2;NCOA2;NR4A2;E2F4;TBL1X;TCF4;BMPR1A;ABRA;NR1D2;NOTCH3;NCK2;PLAGL1;MLXIPL;SP3;SMARCD2;GREM1;NR1H4;SMAD4;MEF2C;NR1H3;DPF3;BCL11B;DPF1;CDC5L;TNIP3;TFEC;ZNF639;CDK12;PPP3CA;ZNF175;RARB;MAFF;KLF7;WWOX;NCOA3;CREB1;LRP6;NFATC3;PCGF5;KAT6A;EPC1;POU2F1;NR2F2;GABPB1;ATF6;THRB;MYB;VEGFA;PLSCR1;SMAD5;PHIP;IRF3;NFE2L2;BMP4;EAF2;POGZ;HMGA2;ZNF263;HSF2;KLF15;CTNNB1;MESP1;THAP3;RPS6KA1;NOTCH4;SIRT7;MYDGF;RPS6KA5;SMARCA2;HCFC1;DVL2;PAX3;FSTL3;HDAC1;RFX5
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4631304163677786,-0.9823849506083313,0.43902439024390244,1.0,1.0,3/34,3.92%,ACTC1;OBSCN;TMOD1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5580078848759754,0.9823510369265619,0.45454545454545453,0.9313383254885931,1.0,4/12,28.51%,PLA2G10;PLBD1;PLA2G4E;LPGAT1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5826048060844978,0.9822844742854749,0.5714285714285714,0.9310690167259248,1.0,4/9,23.28%,B4GALNT2;CSGALNACT1;GFPT1;EXTL2
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.611108976218087,-0.9820933947396092,0.47619047619047616,1.0,1.0,1/5,9.07%,RABGGTA
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.5681176915093867,-0.9820176771114739,0.5686274509803921,1.0,1.0,3/12,17.78%,TRPV1;CTSS;CHP1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4782145739538317,0.9819752971083379,0.5,0.9314833816785169,1.0,9/21,32.23%,NAV3;HDGFL3;CAMSAP2;ARHGEF2;CIB1;MID1IP1;CLASP2;CLASP1;FGF13
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5912888596211223,-0.981742370913033,0.5813953488372093,1.0,1.0,3/11,15.57%,GUCA1B;SLC22A6;FBLN5
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.39987790733307355,0.9815397043786908,0.49056603773584906,0.9322135096428199,1.0,21/106,16.90%,SHMT2;ZBTB1;KCNC2;EHD1;ASIC1;PRMT1;C9;STEAP4;TIFA;VSTM5;TK1;TDO2;ALDH9A1;RS1;HCN1;TMEM120A;HSD17B10;ACACB;ACACA;TRPM2;CRYZ
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5287072029045943,0.9815121020296704,0.532258064516129,0.9318595264440896,1.0,6/12,25.59%,ACVR2A;MAGI2;ACVR1B;FSTL3;LEMD3;SMAD7
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.44093264569614743,0.9814870758119422,0.45614035087719296,0.9315058719205672,1.0,9/64,14.00%,ENPP1;SHMT2;PRSS3;TCN2;MTHFD2L;SLC52A1;MTHFD2;AOX1;SLC19A1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.5970064767815131,0.9812867407255781,0.5,0.9315697311806759,1.0,3/7,33.85%,ANO6;PMP22;MYLK
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.6220231139068638,0.9812658205076957,0.559322033898305,0.9311827289684337,1.0,2/7,18.92%,VSIR;HLA-E
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.39982035623900625,0.9810423474619456,0.3898305084745763,0.9313367974763889,1.0,19/103,13.12%,CXXC4;TSPAN12;C1QL1;FGFR3;SLC7A2;HNF4G;LRP4;CKMT1A;LRIG3;PCLO;NRARP;MMP15;EFNA2;ONECUT2;MAGI1;CGN;EFNB2;JPH1;PLXNB1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5234553297400946,0.9807235840645118,0.5,0.9315357616398448,1.0,3/21,9.16%,SOCS2;STAT5A;SOCS6
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5674081180229915,-0.9804990430681502,0.475,1.0,1.0,1/11,0.27%,TERT
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.39522547966098265,-0.9803106610522646,0.44680851063829785,1.0,1.0,13/128,8.86%,NTRK1;GFRA3;FGF1;TST;MAPK4;CAMK2A;NRN1;LGI4;TCEAL6;ARNT2;MPZ;CMTM5;TAGLN
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5525034869108165,0.9803092594827669,0.5245901639344263,0.9322409893000695,1.0,7/16,20.03%,SHMT2;CBS;SRR;GLYAT;PSPH;DAO;CTH
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6294351565974305,0.980235935147286,0.5185185185185185,0.9319893832153691,1.0,2/6,8.13%,ROBO2;LHX6
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5995309835488696,0.9793041817052772,0.5185185185185185,0.9337563043696203,1.0,3/8,19.34%,GALNT3;GALNT1;GALNT16
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.40342201828041274,0.9792069527465127,0.39215686274509803,0.9336109985535913,1.0,22/81,23.42%,PELI2;RELA;PELI1;ST18;RPS6KA4;PELI3;TAB2;PSMD13;IRAK3;PSMA1;PSME4;PLCB1;IRAK1;TAB3;RPS6KA5;TAB1;PSMD4;IL1RAP;IKBKB;IL1R1;MAPK3;RIPK2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.5951328654447056,0.9791350694489317,0.5636363636363636,0.9333366408869247,1.0,4/9,15.46%,ADGRV1;WHRN;COL11A1;KIT
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.651009573504309,0.9790670617442793,0.6428571428571429,0.9330962219617199,1.0,1/6,0.92%,VAPB
prerank,PanglaoDB_Augmented_2021__Neurons,0.37586416393544475,0.9789751984328106,0.4909090909090909,0.932839190323931,1.0,39/267,13.70%,IGF1;NXPH1;RIT2;GRM3;CHODL;CADM2;B3GAT2;PDE1A;SLC17A6;CNTNAP2;PCLO;RESP18;RORA;NPY;CACNB4;NEFH;NWD2;ZDHHC22;RAB3C;NRXN1;CNRIP1;SACS;SYNPR;OLFM3;GPR162;PROX1;ZCCHC7;GRM5;CTNNA2;LRRTM3;ADGRB3;SCN2B;PAK5;TMEM196;HAP1;GPATCH8;CTTNBP2;NOL4;PPP1R9A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.48905538448360275,0.9788261072383593,0.45098039215686275,0.9328067565029514,1.0,5/33,5.38%,FGF10;FGF2;MYC;BMP2;NRARP
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.5849620338706366,-0.9788230181730043,0.5306122448979592,1.0,1.0,2/7,13.15%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.518617871034477,0.9786968420868198,0.5,0.9327519269214036,1.0,5/23,12.34%,IGF1;CANT1;HPSE;HS3ST4;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5283321439097379,-0.9786220650352853,0.5348837209302325,1.0,1.0,3/14,10.75%,IL11;UBASH3B;IGFBP3
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.528239228082098,0.9786088191702416,0.5714285714285714,0.9324673905737263,1.0,2/10,17.75%,EXOSC4;DXO
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.483736001719205,0.9784904607900791,0.5,0.9323791604868314,1.0,6/24,21.26%,TIMELESS;KLK14;TBX18;LRP6;LAMA5;LAMA3
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.43293008957295703,0.9783787388621801,0.48333333333333334,0.9322238276431598,1.0,12/51,14.94%,LLGL1;MCTP2;SEPTIN4;RALA;SYT1;RAB3C;RIMS2;SNCAIP;HAP1;DNAJC1;MEF2C;VAMP3
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6547080501785181,0.9776377748248785,0.5967741935483871,0.9336467364216067,1.0,4/5,33.32%,PTGIS;CITED2;ASXL2;LMO3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.47167525519689213,0.9776319562267478,0.48484848484848486,0.9332168806497735,1.0,6/38,9.76%,MYC;RFWD3;SMYD2;WDR76;FBXO5;SMG1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.38004224152605454,0.9774797462618686,0.5344827586206896,0.9331396499511292,1.0,34/256,14.12%,SIPA1;CDC14A;FGF10;CDKN2C;CDC25A;TGFBR1;SIRT1;UHRF2;DLGAP5;MYC;KAT2B;CDKN2A;BMP2;GMNN;MAP2K6;FBXO5;FBXL3;HTRA2;INSM2;TP53INP1;PROX1;BIN1;MAGI2;RPS6KA2;PTPRK;CDK11A;GADD45G;PHACTR4;TP53BP2;PLAGL1;MLXIPL;PML;CDK4;PCLAF
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5547216551009583,-0.9774429184302643,0.5227272727272727,1.0,1.0,1/12,1.58%,SYNJ2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5834668790409688,-0.9773185424174685,0.5813953488372093,1.0,1.0,3/8,9.11%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.7008085224980776,0.9772596232835263,0.5869565217391305,0.9332469065698455,1.0,3/5,23.88%,IDI2;MVD;IDI1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4393145828023447,-0.9769811325597201,0.4888888888888889,1.0,1.0,5/51,8.32%,NTRK1;SLC6A6;FOS;CLU;EGR1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6222192108249284,0.9769767794469099,0.576271186440678,0.9336110114717283,1.0,3/8,15.66%,PIK3C2B;PIK3CA;PIK3CD
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3591134446274032,0.9766720788166731,0.4918032786885246,0.9340194476014526,1.0,63/322,23.52%,KCTD21;SIRT1;SPSB2;NEDD4;SYVN1;PELI1;KLHL8;RNF185;SPSB4;UBE2D3;ANKRD9;RNF217;UBE3D;RNF146;KEAP1;SPOP;KLHL15;SPOPL;ANAPC16;PSMD13;FBXO7;KCTD6;TBL1X;FBXL14;RNF166;HECW2;KLHL42;PML;UBQLN4;CNOT4;ARIH1;RBBP6;RNF5;UBA6;PSMA1;PSME4;UBE4A;MVB12A;RMND5A;MIB1;NFE2L2;UBE2U;CTNNB1;UBAP1;RNF128;NHLRC3;UBAP1L;FBXO11;PTPN23;ARRB2;NDFIP2;RNF144A;UBE2D1;SMURF1;UBE2A;FEM1B;UBE2E1;PSMD4;RNF130;FBXW5;GSK3A;FZR1;RNF19B
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5021523262760343,0.9766110135487959,0.5689655172413793,0.933752247343368,1.0,5/29,10.16%,CALCR;IRS1;STAT5A;RAMP3;ERBIN
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.6742984276256305,0.9764907515051137,0.5573770491803278,0.933613588942528,1.0,3/5,29.85%,MESP1;HEY2;EFEMP2
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.3956100476471108,0.9763894708031862,0.4642857142857143,0.933430453421548,1.0,28/146,16.28%,LRRC3B;FGFR3;AANAT;GFAP;CDH20;CADM2;SLC1A3;CD40;NTSR2;PMP2;NRXN1;SYNPR;ACSBG1;GRM5;LRRTM3;ADGRB3;ATP1A2;PLA2G7;GJB6;PLXNB1;SRR;SLC39A12;GPM6B;BAALC;HTRA1;GABRG1;NFATC3;LUZP2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.47869115781069976,0.9763836441674844,0.46774193548387094,0.9330078473053905,1.0,9/40,15.70%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;HSPA8;GRM4;PPFIA3
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6437449213280217,0.9763003196123478,0.5636363636363636,0.9327750235363107,1.0,3/6,11.18%,SIRT1;PPARG;CTBP2
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.6264334186657214,0.9762928861705434,0.5522388059701493,0.9323642409226806,1.0,1/5,20.84%,RPE
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4981396309668127,0.9762772114846823,0.4489795918367347,0.9319872266491406,1.0,2/17,4.85%,CHRM2;F2R
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.5987923809971047,-0.9761927554422747,0.5510204081632653,1.0,1.0,2/6,9.92%,ZP3;C1S
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.39969549505795265,-0.9752496404761416,0.4883720930232558,1.0,1.0,16/120,10.95%,NTRK1;TNFSF18;TERF2IP;NLRP3;TNFRSF11A;TRIM5;RAB7B;BTK;CAMK2A;CAV1;PRKD2;CLU;FLOT1;DDRGK1;NOD1;AR
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5887631921141528,0.9751995472089829,0.5892857142857143,0.9344809541571445,1.0,5/9,36.86%,AGO3;DHX9;DICER1;TARBP2;CLP1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.40517497510971967,0.975133170716183,0.5319148936170213,0.9342312017050576,1.0,25/109,16.23%,RIT2;ROR1;CHODL;RETREG3;TOX;TENM3;GRIP1;ROBO2;ZNF804A;FUT9;EPHA3;PTPRD;ABL2;MAGI2;CARMIL1;LYN;PLXNB1;PLXNB2;PTK7;FZD4;FZD1;RAP1A;LRRC7;CAPRIN1;RET
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.575628474713036,0.9749927938677181,0.5423728813559322,0.9341317355065201,1.0,2/13,14.87%,RRS1;XPO1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.4538751439285709,-0.9749426976762781,0.4222222222222222,1.0,1.0,7/62,9.96%,PLAAT4;PLA2G2C;ENPP2;PLCB2;AGPAT4;PGP;PLB1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.425067955443084,0.9749005085744058,0.4838709677419355,0.9338768159777786,1.0,7/80,13.23%,SYK;PEX12;GDAP1;NXT1;RANBP17;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.42793172697255627,0.9747267269009197,0.42857142857142855,0.9338109183529679,1.0,18/56,23.89%,BRINP3;RORB;HSD17B2;EPHA3;HTRA2;ABL2;LYN;STRA8;PTK7;FZD4;CREB1;RET;WNT8B;TMEM161A;ADNP2;WNT2;PTK6;TESC
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5731596682222448,-0.9744700934823824,0.5434782608695652,1.0,1.0,1/11,1.58%,SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5731596682222448,-0.9744700934823824,0.5434782608695652,1.0,1.0,1/11,1.58%,SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.5329887891685087,0.9742107883091892,0.5535714285714286,0.9347440949314243,1.0,2/22,5.30%,LGALS9;IL23R
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.4589759789389598,-0.9739775265201832,0.43137254901960786,1.0,1.0,5/25,14.58%,AK8;RRM2;AK7;CTPS1;RRM1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.48846447365721574,0.9737910533801346,0.43636363636363634,0.935349114229123,1.0,11/27,20.84%,FGF10;SCRIB;MTSS1;MEF2C;RYR2;BMP4;CTNNB1;MESP1;RASIP1;RHOB;SHH
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5340203477301487,0.9732592886138784,0.4716981132075472,0.9362363768365071,1.0,1/17,1.46%,MAP3K11
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.45954946483602,-0.9732401731248839,0.574468085106383,1.0,1.0,7/35,16.12%,PRKCD;PPP6R1;PTPA;ARPP19;ANKLE2;TGFB1;CALM1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.48750239056993,-0.9732237252229969,0.43243243243243246,1.0,1.0,2/24,3.31%,PLAAT4;ETV4
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6045347584045822,0.973174021888477,0.5882352941176471,0.9360642158658351,1.0,2/8,8.13%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.58932987119765,0.9731377032251269,0.6031746031746031,0.9357149333610065,1.0,2/11,13.46%,GSN;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.5583440855432671,-0.9729882391907315,0.5,1.0,1.0,1/8,7.24%,DAB2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.3885334311801483,0.9728648085971909,0.46551724137931033,0.9359916987811654,1.0,25/153,16.38%,SYK;THEMIS;ICOSLG;BLNK;BTN2A2;RELA;NFKBIZ;PLCG2;ITK;PAG1;PIK3CA;NFKBID;DENND1B;TAB2;PSMD13;PDE4B;LCK;BLK;MEF2C;BCAR1;PSMA1;SH2B2;PSME4;PIK3CD;CD247
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5973181030555619,0.9725948238345883,0.4909090909090909,0.9363235610902276,1.0,3/8,28.12%,SMG1;MLST8;CARD11
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.4035590108411747,0.9725913412525976,0.5384615384615384,0.9358971842409153,1.0,37/131,23.72%,RAPGEF3;FZD5;PRR5L;TENM1;HCLS1;TCAF2;PCM1;HDAC3;UBE2D3;HTRA2;ZDHHC2;TP53BP2;RHOU;UBE2J2;MAPK8;PPP3CC;ZFAND1;ANP32B;RAB29;GTSE1;UBR5;BAP1;MYO1C;MFF;CD81;ITGAM;JUP;TP53;TRIM28;ITGB2;SAR1A;GSK3A;PPP1R13B;GAS6;BAD;AKT2;SREBF2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.5863208069034305,-0.9724793801016014,0.46511627906976744,1.0,1.0,3/11,16.52%,CDC37;IFNGR2;STAT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.524272276187883,0.9723658726442003,0.5,0.9360241823454184,1.0,4/14,13.71%,PPARG;ELOVL5;MLXIPL;NR1H3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.48432624315297607,0.972178308962127,0.5471698113207547,0.9360681546086184,1.0,3/34,9.10%,EPHA7;ENPP1;PDGFC
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.48262162779375917,0.9718299154459218,0.5283018867924528,0.9365209249391905,1.0,15/47,11.33%,HPSE2;HS3ST5;B3GAT2;HS3ST3B1;HS3ST1;HS3ST2;UGDH;HPSE;SDC4;SLC35D2;GALNT5;HS2ST1;GPC5;GPC4;EXT1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.5107383286982985,0.9717536877157282,0.48484848484848486,0.936316126704188,1.0,9/19,18.98%,SLC39A8;SLC30A2;SLC39A12;SLC39A5;TRPM2;SLC30A6;SLC30A4;SLC30A10;SLC30A1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.42881234288337083,-0.9715085514172233,0.5178571428571429,1.0,1.0,7/62,2.73%,P2RY10;IRF4;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.5074563700039745,0.9714197332357897,0.5084745762711864,0.9367297342205188,1.0,2/21,7.04%,MOGAT2;LPIN3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.42539311774841315,0.9713974212624455,0.5,0.9363595078207745,1.0,8/74,14.87%,U2AF1;NXF1;THOC6;WASHC4;ATXN1;STRADA;RANBP17;XPO1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.49970059657370985,0.9713141406707961,0.5384615384615384,0.9361881505903172,1.0,11/32,30.28%,HDAC3;MARVELD3;ZNF675;NPPA;F2RL1;HIPK3;FKTN;ZMYND11;PDCD4;SIRPA;CYLD
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.5951812768339039,0.9711985329938561,0.5535714285714286,0.9360224611614296,1.0,2/6,9.74%,ALDH1A1;BCAT1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.582495997551457,0.9709824692055634,0.5357142857142857,0.9361103730513546,1.0,4/11,22.92%,INSIG1;CD81;GCC2;SAR1A
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),0.6188723668268841,0.9709325112503644,0.5319148936170213,0.935774142566369,1.0,1/5,10.55%,LIPG
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.6123856682659411,0.9708741943762645,0.6111111111111112,0.935069581352612,1.0,1/5,2.28%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.6123856682659411,0.9708741943762645,0.6111111111111112,0.935069581352612,1.0,1/5,2.28%,ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6701772889112148,0.9707382227722727,0.5660377358490566,0.9349982704025628,1.0,3/5,29.92%,ABCA2;APOE;LAPTM5
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5002553623737016,0.9706478450981204,0.5,0.9348115798587284,1.0,11/26,28.17%,CSTA;DSP;AKR1C3;CASP3;SCEL;JAG1;CERS3;LORICRIN;ACER1;ANXA1;CLIC4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.45520810909314136,0.9699029366290928,0.5,0.9361910913219567,1.0,16/39,23.89%,BRINP3;RORB;EPHA3;HTRA2;ABL2;LYN;STRA8;PTK7;FZD4;CREB1;RET;WNT8B;ADNP2;WNT2;PTK6;TESC
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3391629614166944,0.9694538819364683,0.5,0.9367729619842419,1.0,122/567,21.31%,DACH1;MITF;AASS;RUNX1;SIRT1;ZBTB7B;IL4;MYC;URI1;SNAI1;FOXP2;ZBTB1;NFIL3;NEDD4;PPARG;ZEB2;NRIP1;BMI1;VSX2;BMP2;KANK2;SMYD2;ZGLP1;ZNF582;RORC;RELA;RBPJ;ZEB1;ZBTB2;IRF8;ESR1;MYPOP;HJV;ZNF20;NCOA5;HDAC3;PPM1A;ZNF274;HDAC2;HMGB1;UBE2D3;PAX6;ZNF669;FRK;INSM2;SNCA;FOXO3;ATXN1;ZNF692;PROX1;ZNF599;TAF3;ZNF675;RIPPLY2;CTBP2;EZH2;SMAD2;NR4A2;TBL1X;FBP1;NR1D2;ZNF239;SIRT6;PHF21A;ZNF202;NR1H4;SMAD4;MEF2C;NR1H3;BCOR;ZNF536;TFEC;RNF2;ZNF175;MYT1L;RARB;ZNF281;MXD4;KLF7;WWOX;NFATC3;ZNF778;LOXL2;EPC1;NR2F2;THRB;MYB;VEGFA;TRPS1;DEAF1;NOC2L;SPEN;BMP4;HMGA2;ZNF263;PEX2;CNOT2;NOTCH4;SIRT7;DNAJB1;SMARCA2;HCFC1;PCGF1;HDAC1;PER3;HDAC9;MXI1;LCOR;MIER3;CITED2;EED;NSD1;ZBTB4;NFIC;SHH;TGIF1;MED25;KLF10;NR3C1;UBE2D1;ID4;HEXIM2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5888906409540925,-0.968894115789392,0.5686274509803921,1.0,1.0,7/9,37.54%,ATP5F1A;ATP5PB;ATP5MC3;VPS9D1;ATP5F1C;ATP5MC1;ATP5PD
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.5084792738093206,0.9688765248571964,0.5538461538461539,0.9376068415881444,1.0,10/24,25.31%,ITGAX;MYRF;TMEM98;TNFRSF21;PARD3;JAM2;TNFRSF1B;TENM4;EIF2AK3;HES5
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5426375967656613,-0.9685316150986815,0.5789473684210527,1.0,1.0,4/14,14.21%,ABCA4;RDH10;SDR16C5;CYP1B1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.528567958265877,0.9683876646059705,0.5517241379310345,0.938374119023308,1.0,1/15,1.59%,RENBP
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.5393441698281853,0.9683063645851894,0.5454545454545454,0.9381589011671064,1.0,1/13,3.54%,KAT2B
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.6348478882509133,0.9677714633430708,0.5789473684210527,0.9389910264488093,1.0,2/5,11.27%,ABCG8;ABCG5
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6156708658795511,0.967576292977488,0.5531914893617021,0.939137403297785,1.0,2/7,10.52%,ERBB4;LATS1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5999001863621523,-0.9675731731692377,0.5,1.0,1.0,2/6,18.83%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.49026599548930755,0.9672088701338399,0.5,0.9395630012362184,1.0,6/23,16.03%,SNX18;DOCK1;GSN;MSR1;ARHGAP25;SPIRE2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.5989820092301893,0.9672064804723499,0.5454545454545454,0.9391505340163717,1.0,4/8,22.40%,SNCA;FBP1;SLFN14;RYR3
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.5818405693942418,-0.9666782711267933,0.475,1.0,1.0,2/9,10.11%,PER2;PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5706612941777145,-0.9665120575732905,0.6046511627906976,1.0,1.0,1/9,4.39%,PIAS3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.37243181487582266,0.9656657358995909,0.46153846153846156,0.9425528243247615,1.0,28/215,12.89%,GATA4;CXXC4;IRS1;KCTD21;TULP3;ENPP1;FGF2;CCL5;NEDD4;DCC;BMP2;NRARP;KANK2;PIP4K2A;MOSMO;KLK14;SNCA;NLGN4X;PTPRT;EZH2;KANK1;KCTD6;NR4A2;LYN;EGFL7;NOTCH3;PHACTR4;IRAK3
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.5737269967699139,0.9655022811638267,0.5857142857142857,0.9425441707051078,1.0,2/8,13.08%,ENGASE;MAN2A1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.48170312406727095,-0.9654260169343084,0.4878048780487805,1.0,1.0,6/27,13.57%,NUPR1;KCNE2;CLU;DDRGK1;CCDC22;DAB2IP
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5225852831903737,0.965369343851763,0.4745762711864407,0.9424917836676562,1.0,5/20,21.14%,RORA;RORC;NR1H4;STAR;ABCA2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.6282843480496708,0.9651279694430512,0.5689655172413793,0.9426635166042067,1.0,4/6,31.08%,LRWD1;RUVBL2;NIPBL;PIH1D1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.5737372239355741,0.9650715737656852,0.5925925925925926,0.9423325235856669,1.0,4/9,15.98%,CYP4F12;CYP3A4;CYP4F3;LDHD
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5121869034263136,-0.9650426472530846,0.5217391304347826,1.0,1.0,1/12,4.04%,ALOX5
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.6196394290014663,0.9649566174212362,0.5660377358490566,0.9422093186810929,1.0,4/8,30.34%,SPX;ACSL1;SLC27A1;CD36
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.37247548569728317,-0.9649324416543112,0.45098039215686275,1.0,1.0,23/141,13.02%,SELE;NLRP1;TEK;BST1;PTGES;NLRP3;PRKCD;IL1RL2;CD200R1;ALOX5;AHSG;ZP3;HCK;MEFV;TMSB4X;TYRO3;CCN3;AKNA;FFAR4;WNT5A;APOA1;MAPK7;IL18
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5671971438713121,0.9649009023848243,0.5106382978723404,0.9419661523054704,1.0,4/14,16.75%,ADRA1A;NPPA;ADRB1;RYR2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.6358390015643751,0.9646951484344741,0.6296296296296297,0.9421487235626371,1.0,3/6,23.74%,SLC3A2;SLC6A15;SLC7A8
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6060702172774535,0.9645610450894918,0.5434782608695652,0.9420257670488789,1.0,1/5,12.84%,PDE4B
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.62739734452351,0.9645191145002394,0.5614035087719298,0.9416576492538741,1.0,4/7,33.60%,IGF1R;INSR;PICK1;PRNP
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5010922826049045,0.9645130535430071,0.5535714285714286,0.9412626214295413,1.0,7/20,16.33%,IL4;PLA2G10;CD74;NR1H3;LRFN5;GPR137B;MFHAS1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.5478265230210096,0.9644202673161693,0.5555555555555556,0.9410476523332201,1.0,1/11,2.18%,SIRT1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6412735266801685,0.9643462696021519,0.46808510638297873,0.9408111032446944,1.0,3/5,31.22%,DTYMK;DUT;TYMS
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5565633207856888,-0.9640560030951656,0.6,1.0,1.0,3/16,11.68%,FBXO43;CAV2;KIF20B
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5656972606325502,0.963958565579889,0.5918367346938775,0.941287499899187,1.0,4/14,12.42%,SPR;GCH1;CYB5B;MTARC2
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6210049323272226,0.9637742627429103,0.6078431372549019,0.9413447224048068,1.0,1/8,2.98%,IL4
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.37712394711521124,0.9636248171904563,0.4523809523809524,0.9413203559851532,1.0,22/112,22.93%,PRR5L;SAMD4A;ZFP36L2;MAPKAPK2;MOV10;EXOSC4;PSMD13;ZC3HAV1;HSPB1;HNRNPD;ANP32A;HSPA8;PSMA1;XPO1;PSME4;CNOT8;CSDC2;FMR1;EXOSC1;HSPA1A;PSMD4;PNPT1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.6227958496062806,-0.9634401481663918,0.5348837209302325,1.0,1.0,2/6,6.25%,CAMK2A;CAV1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.3797216664965767,-0.9633571552196718,0.46938775510204084,1.0,1.0,20/118,11.10%,P2RY10;CD86;ASS1;CD53;CYTH4;GPR132;XCR1;HLA-DRB1;RAB7B;BATF3;SLC11A1;DAB2;HCK;LAMP3;ADAM19;LY86;HLA-DQA1;S100B;CD163;SPI1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.49784100896351713,0.9632617487628816,0.46153846153846156,0.9417687186308374,1.0,4/21,14.40%,EFNA5;EPHA3;CORO1C;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5397370351003934,0.9628634017363037,0.5510204081632653,0.9422438353559583,1.0,7/20,16.75%,FGF2;F2R;PLCG2;HTR2C;LCK;TRPM2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6157123240174168,0.962815213207044,0.5614035087719298,0.9418988147337158,1.0,3/8,18.93%,GRIP1;FZD4;DVL2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5426157231378722,0.9627675802683642,0.5873015873015873,0.9415975113972397,1.0,9/15,37.34%,INTS6L;INTS6;INTS11;INTS14;INTS8;INTS3;INTS2;INTS1;INTS5
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.5245343687405423,-0.9626860231641311,0.5208333333333334,1.0,1.0,3/17,10.28%,SLX4;RTEL1;PARP1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.41759689512446374,0.9626436182748851,0.4696969696969697,0.9414591885128274,1.0,7/65,11.22%,ZDHHC11;ZDHHC12;FRMPD1;GRIN3B;ZDHHC22;RAB3IP;ZDHHC2
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.6138416126275258,0.9626245738582903,0.5555555555555556,0.9410607669565044,1.0,2/6,24.93%,BMPR2;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.6441104983066196,0.9624414893287935,0.6226415094339622,0.9411558185407534,1.0,1/6,2.98%,IL4
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4474224843849936,-0.9623369495222872,0.48717948717948717,1.0,1.0,7/38,9.11%,KCNMB2;STAC;KCNJ16;KCNN3;KCNE1;KCNN2;KCNQ1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.382972932908043,0.962247578549718,0.5,0.9412778676719588,1.0,30/127,14.51%,CXXC4;LSAMP;LRRC4C;EFNA5;CADM2;CD40;SCGN;MAFB;SLC17A6;ROBO2;CASR;NPY;PCDH17;UNC5D;RAB3C;PLPPR1;NRXN1;PAX6;NOVA1;FGF12;PROX1;PTPRT;RIPPLY2;ADGRB3;PAK5;TMEM196;NOL4;CNTN1;KCNB2;UBE2QL1
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),0.6113433702425204,0.9620746182811177,0.5964912280701754,0.9413023551891566,1.0,3/6,22.68%,IL23R;HLA-E;IL23A
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.593183083038321,0.9618313596925883,0.5357142857142857,0.9415216397451545,1.0,1/6,9.42%,SNCA
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.5972694911383534,0.9614248411532194,0.6166666666666667,0.942270833121422,1.0,3/7,27.18%,GALK1;LRP5;GALT
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.4813242070838253,-0.9610684483592545,0.47368421052631576,1.0,1.0,4/21,5.21%,STAC;DRD4;CBARP;DRD2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.4427503686768144,0.9608697661014609,0.4716981132075472,0.9433113278345644,1.0,6/33,12.14%,HIF1A;MAFB;PRMT1;ACVR2A;FOXO3;LYN
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.47360959053792556,0.9607312736127114,0.5370370370370371,0.9432213745446467,1.0,1/18,2.09%,EPHA7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.446040270852754,0.960650985590972,0.5172413793103449,0.9429910489921332,1.0,9/64,9.84%,IGF1;TGFBR1;FAIM;IL4;RELA;TNFRSF10A;ITGAV;EYA2;PELI3
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.47722629506949554,0.960569596485176,0.5263157894736842,0.9427555285644672,1.0,4/22,3.00%,SYK;FERMT3;CERCAM;CCL5
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.513106001340073,0.9601349128030112,0.5,0.9432380463541422,1.0,1/22,2.18%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.4572399559855149,0.9595186560446162,0.5666666666666667,0.9442650117923312,1.0,7/45,15.80%,TGFBR1;RAPGEF3;CARMIL1;SYNPO2;PPM1E;PXN;SORBS3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5143780505339954,0.959440047513222,0.4909090909090909,0.9440454167792581,1.0,5/18,9.04%,SYK;LGALS9;IL4;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.41709940853782057,0.9593154247274454,0.4444444444444444,0.9439284271227933,1.0,21/90,25.98%,MAP3K11;TNFRSF19;HDAC3;HMGB1;MARVELD3;ZNF675;MAP4K2;GADD45G;IGF1R;MFHAS1;PLCB1;F2RL1;RAP2A;PHLPP1;CARD9;MAPK8IP2;TRAF5;EGFR;ANKRD6;FKTN;ZMYND11
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.6328410219678965,-0.9592536591166231,0.6140350877192983,1.0,1.0,3/6,22.87%,XRCC1;FANCB;RAD21L1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.416983149784018,0.959046040553189,0.5,0.9441832881417156,1.0,12/72,12.26%,SYT15;NEDD4;KCNJ3;NKAIN2;SCN10A;SYT1;SYT6;DRD3;SNCA;TF;CA2;NKAIN3
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.544534820734187,0.9589786930829135,0.6363636363636364,0.943969406616625,1.0,3/19,11.62%,FZD5;HTRA2;FBXO7
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.4176738912868265,-0.9588028744704842,0.5106382978723404,1.0,1.0,6/78,10.17%,TRIM56;DDX41;POLR3H;POLR3E;DHX58;IRF5
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.6175352567307069,-0.9586657009489555,0.5,1.0,1.0,3/5,33.80%,SUCLG2;ACOT4;SUCLA2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.525846375423022,0.9586410573714079,0.5,0.9444285724055984,1.0,5/14,26.20%,LIN28A;CPEB1;FMR1;CPEB2;DHX9
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.38502904113519043,0.9584335983386355,0.5087719298245614,0.9446021661387304,1.0,28/152,17.83%,SMAD6;TGFBR1;SIRT1;ENPP1;PPARG;RORB;ADGRV1;CRIM1;IL17RD;RORA;WWTR1;ZFP36L2;ITGAV;FOXO1;ABCA1;SINHCAF;USH2A;GREM1;NR1H3;PTEN;ANKRD26;VASN;RUNX1T1;MYB;ANP32B;NELFB;BMP4;CNTN4
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5121047843911841,0.9580734170993176,0.5357142857142857,0.9450714014935724,1.0,3/32,5.49%,GATA4;WNT4;SIX4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.6237929760932,0.9579003052569879,0.5862068965517241,0.9450349042071073,1.0,3/5,28.43%,DOCK4;DOCK5;CHRM3
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.6171515062913655,0.9578732574526301,0.6290322580645161,0.9447297722389331,1.0,1/6,0.56%,PNP
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4171763731123256,0.957868397771517,0.43859649122807015,0.944338974638912,1.0,13/59,17.72%,ESPL1;DUX4;BMI1;FBXO5;RYBP;ZFYVE19;YAF2;EZH2;RNF2;TERF1;CCP110;EPC1;BMP4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5449683627359551,0.95738897758642,0.5423728813559322,0.9450920321857967,1.0,3/12,13.66%,PRKG1;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.5187967512697292,0.9573769394119404,0.5423728813559322,0.944712152242865,1.0,5/17,21.09%,URI1;ATP1A2;BMP4;AKR1C3;NR3C1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.47989972951493426,0.9571904207757125,0.5636363636363636,0.9448797204324352,1.0,7/29,9.04%,SYK;LGALS9;IL4;IL23R;PLCG2;VSIR;HMGB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.4651540796120726,0.9570993046178358,0.5666666666666667,0.9446932828543665,1.0,11/38,26.68%,CCN6;PYCR1;SPART;SLC25A33;PPA2;ABL1;BAD;AKT2;PID1;HEBP2;STOML2
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4222530474578726,0.9568430765002448,0.5686274509803921,0.9448392750634409,1.0,6/71,7.79%,DERL3;SYVN1;UBE2J1;AUP1;DNAJB2;RNF185
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6455527411893229,-0.9567334229194923,0.5588235294117647,1.0,1.0,4/5,28.75%,PINK1;HAX1;PRKN;ATP5IF1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.607082670007808,-0.9563554653817127,0.5,1.0,1.0,4/9,18.65%,TAF11;TAF7;TBP;TAF7L
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.5804857541195357,0.9562393232988934,0.5303030303030303,0.9459386409104724,1.0,1/10,2.06%,PLD6
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.6008256341055459,-0.9561463923063941,0.5384615384615384,1.0,1.0,1/5,13.83%,PRDX1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.4541918843226602,0.9558779988053959,0.5849056603773585,0.9463784472528366,1.0,8/36,20.29%,EFNA5;SKA3;BICD1;EPHA3;CDK2AP2;PHLDB2;PRKAA1;STMN4
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4017869156283199,0.9554792910559347,0.5230769230769231,0.94691420273656,1.0,35/100,23.33%,LSAMP;SLC35F1;TMEM200C;ROBO2;PCDH17;UNC5D;ZDHHC22;RAB3C;NRXN1;PTPRD;NOVA1;ANK2;MAGI2;GUCY1A2;CTNNA2;ADGRB3;ATP1A2;CPT1C;CNTN1;GPM6B;MAGEL2;RUNX1T1;GJC1;FAT3;CNTN2;FMN2;GRID2;CSRNP3;RBFOX1;TRPM3;CADPS;PLP1;ADGRL3;SH3GL2;ATP1B2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5731296360495574,0.9554415063549145,0.5666666666666667,0.9465881881353427,1.0,3/10,9.42%,THRSP;CCN6;SNCA
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.36811498814739857,0.9553597869729873,0.5636363636363636,0.946331975731212,1.0,28/111,22.14%,ACSM2A;CYP4F12;PPARG;ADIPOR2;MSMO1;LPIN3;GGT5;ACADM;LIPG;ACSBG1;CEL;ABCD3;ABCD2;CPT1C;SGPL1;OXSM;FASN;ACACA;ELOVL4;PNPLA8;PEX2;ALOX5AP;ACSL4;PON1;ACSL5;ACOX1;THEM4;SLC27A6
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6249520626224079,0.9553290722684465,0.6440677966101694,0.9459690893371301,1.0,2/6,34.62%,NDUFV1;COA6
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4523503363035478,0.9552795341948587,0.5925925925925926,0.9456759761775985,1.0,7/37,21.23%,FGF2;ITPKB;IP6K3;GPHN;MOCOS;CPS1;IP6K1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.42451764947335563,0.955266447613185,0.5510204081632653,0.9452816555202868,1.0,8/42,23.54%,ST6GALNAC3;ESYT3;ESYT2;ABCA2;ST8SIA1;HEXB;CTSA;A4GALT
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.451218992854607,0.9552356519489064,0.5098039215686274,0.9449303847763761,1.0,4/28,18.69%,RAB27A;CHMP6;MVB12A;STAM2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5649544623272292,0.9551662039182743,0.5208333333333334,0.9446541207185724,1.0,2/12,13.47%,AFF2;PML
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.37635119082624174,0.9550306196841238,0.5178571428571429,0.9445274299240121,1.0,51/225,22.24%,FGF10;LGR5;SEMA5A;LRP4;ZEB2;MLLT3;BMP2;NRARP;DKKL1;WWTR1;PPM1A;CDK14;RNF146;GPC5;LATS1;TLE2;KANK1;PSMD13;TBL1X;GREM1;LGR6;PSMA1;PTK7;RBMS3;PSME4;DACT3;FZD4;IGFBP6;TMEM170B;PRICKLE1;LRP6;NKD2;FZD6;CSNK1G3;PTPRU;FRZB;UBR5;CTNNB1;GPRC5B;DVL2;KLHL12;HDAC1;TLE4;RUVBL2;SCEL;JUP;RSPO1;WNK1;FRAT1;AMER2;PSMD4
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4833470777132607,-0.9546628484703271,0.5,1.0,1.0,3/30,6.42%,IFT27;GPC2;PTCH1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.4524720052954924,0.9546379487340255,0.5471698113207547,0.94499791106618,1.0,8/32,20.78%,TFEB;DEF8;KLC2;KIT;PIK3CD;BORCS6;MILR1;FAM98A
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4153000808539353,0.954483237273267,0.5166666666666667,0.9449457804795227,1.0,29/82,32.55%,AP1M2;LLGL1;CORO7;ACBD3;HSPA8;SORCS1;ARL3;EXOC6;SH3GL2;RP2;KLHL20;MON2;EXOC6B;COMMD1;VPS13A;CLVS2;VAMP8;HGS;PUM1;EPS15;FTL;EXOC4;MYO5A;APP;GBF1;SCFD1;KIF16B;AP1G2;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5028893282900786,0.9543048767647981,0.5192307692307693,0.9449363054048162,1.0,6/31,20.17%,ZBTB7B;RPS6KA4;PAXIP1;RPS6KA5;RUVBL2;FMR1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5600016992837981,0.9541717164355918,0.5833333333333334,0.9448256846974984,1.0,7/12,29.57%,FGF2;VEGFA;HDAC9;AKT3;CIB1;ANXA1;PTGS2
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.5701104999696505,0.9541432000134127,0.5272727272727272,0.9445022985208336,1.0,7/12,23.13%,UGDH;APELA;SMAD2;WNT8B;MESP1;LMBRD1;LRP5
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.6122640619326919,0.9540358930000117,0.5689655172413793,0.944344091634231,1.0,4/6,20.84%,FLT3;LIG4;BMP4;SHH
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3676792422087153,-0.9538602695910449,0.5625,1.0,1.0,10/103,6.53%,P2RY10;PTGDR;CXCL13;CD24;NMUR2;XCR1;DRD2;PLCZ1;CAV1;ADCYAP1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.4280621410607097,0.9538378884093638,0.47761194029850745,0.9444784528109468,1.0,4/69,4.93%,ATP6V0D2;TCIRG1;TFEB;RNF152
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5357643275064005,0.9533817286740505,0.5769230769230769,0.9451069519824533,1.0,3/16,11.26%,RUNX1;IL15;LEPR
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.6281125282524243,-0.9533051681017057,0.5454545454545454,1.0,1.0,2/5,6.05%,SCN5A;KCNA5
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6012132500554694,0.9530048912425417,0.5932203389830508,0.9455064746927129,1.0,4/8,24.80%,DAND5;MAGI2;FSTL3;LEMD3
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4497999008408661,0.9528340614769223,0.5074626865671642,0.9454808537573048,1.0,7/39,8.14%,SIRT1;HIF1A;LIN28A;ZBTB20;UNC13B;FOXO1;HKDC1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.5462877626656175,-0.9525556614539343,0.5238095238095238,1.0,1.0,2/15,6.34%,CRLF1;OAS1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.47934359916867875,0.9525178602539552,0.5208333333333334,0.9458161727150196,1.0,7/28,22.88%,MAP3K11;ZNF675;NPPA;PPEF2;DVL2;HIPK3;EDN1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6363108824325892,0.9524496044356255,0.6346153846153846,0.9455357848688379,1.0,6/6,36.38%,SNCA;AKT2;ANXA1;C2CD5;ANXA2;DOC2B
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.468826807444028,0.9524331876344851,0.5714285714285714,0.9451654911877895,1.0,11/34,22.32%,MLC1;NEFH;RNF139;HAP1;ATPSCKMT;REEP6;CAPN10;MX2;GAS1;TTC21B;MAP2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5786717063863052,-0.9523799072222161,0.6153846153846154,1.0,1.0,1/10,3.43%,WTIP
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.43867252177166527,-0.9522487566263333,0.4888888888888889,1.0,1.0,9/51,7.55%,ALB;UROC1;HABP2;F7;FGL1;PAH;AHSG;DBH;TTBK1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.3563061798082306,0.9521998663549447,0.4716981132075472,0.9453043842983653,1.0,44/303,13.47%,IL26;ADRA1A;CDKN2C;SMAD6;GNRH1;ERBB4;MYC;DUX4;KAT2B;CDKN2A;PPARG;F2R;CCN6;TENM1;BMP2;SSTR3;KANK2;SMYD2;ST18;DNAJB2;P3H2;DLC1;FRK;MARVELD3;CBFA2T3;TOB1;TP53INP1;TMIGD3;PTPN14;ITGA1;MTSS1;PROX1;RNF139;ARID2;MAGI2;TMEM115;CTBP2;RPS6KA2;PTPRK;LYN;NCK2;PLXNB1;GREM1;PML
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5060181621108096,-0.9520531665914684,0.5,1.0,1.0,3/14,9.74%,CD24;CAV1;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.3937444071256068,-0.9518463790968054,0.5,1.0,1.0,13/80,11.30%,DUSP4;PRKCD;DUSP6;SPRY4;CAV1;FOXM1;SPRED2;SPRED3;UCHL1;PEBP1;CAMK2N1;SPRED1;DUSP9
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.4489873023183316,-0.9518021854213737,0.5348837209302325,1.0,1.0,3/43,2.38%,MYH7;SCN5A;STAC
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5022972292655156,0.9517176718946937,0.5740740740740741,0.9460524666965939,1.0,6/17,31.12%,PLA2G10;PNPLA8;SLC27A1;PLA2G15;LPGAT1;CDS2
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.6245021637519674,0.9515111952621291,0.6226415094339622,0.9461431876870674,1.0,2/7,20.03%,CBS;CTH
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.41903052750293857,0.9510642209462026,0.5283018867924528,0.9468902526699651,1.0,17/47,31.02%,STK33;PAXIP1;CHEK2;BCL3;CDC5L;H2AX;ABL1;TP53;HINFP;GRB2;MDM4;DOT1L;CLSPN;SESN2;CLOCK;BID;MAP3K20
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5731056301215283,0.9508526631526953,0.5714285714285714,0.9470810668903226,1.0,8/9,36.57%,ZSWIM5;VEGFA;ZSWIM8;TUBB2B;ZSWIM6;YTHDF1;ZSWIM4;MYCBP2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5071790888972937,0.9508408899333971,0.543859649122807,0.94668462209002,1.0,7/17,28.30%,ANO6;AFDN;ADAM10;BAD;NUP153;AHCTF1;TSPAN33
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5263128497501259,0.9508376897990634,0.6086956521739131,0.9462726618541235,1.0,7/14,22.79%,TDO2;HMGCS1;MVD;ACACB;ACACA;ACSS1;DIP2A
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.6617808330654251,0.9507935588836699,0.6530612244897959,0.9459826040475587,1.0,2/5,9.05%,SAG;DRD3
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.39563179714162894,0.9507427468817558,0.5666666666666667,0.9457297740483862,1.0,25/98,25.59%,TGFBR1;ANGPT1;SEPTIN4;IVNS1ABP;DNAJB2;HDAC3;DCUN1D1;PAXIP1;SPOPL;WASHC1;BAG2;PRICKLE1;NXN;SIRT7;GNL3L;ARRB2;NDFIP2;UBE2D1;BIRC3;HSPA1A;GSK3A;RIPK2;COMMD1;OGT;SMAD7
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.556136978953624,0.9504253003577331,0.5396825396825397,0.9461107554719859,1.0,2/11,18.58%,EPS8;SIRT7
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.5702021924407185,0.9503364895172278,0.5441176470588235,0.9459108658336112,1.0,4/9,33.66%,SYNE4;RAP2A;MYO9A;OPHN1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6335377389500559,-0.9502919586224645,0.64,1.0,1.0,1/5,20.62%,PRKCA
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.49813992831778053,-0.949729618473252,0.5,1.0,1.0,2/21,12.94%,EML3;GPSM2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.5953832997531835,0.949695189903601,0.55,0.9470774642154917,1.0,4/9,23.13%,FGFR3;LRP6;BMPR2;LRP5
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.5266921656437074,0.9496065091748178,0.5714285714285714,0.9468667824026973,1.0,2/18,3.00%,CXCL12;CCL5
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.46047477630674805,0.9496028273282653,0.6071428571428571,0.9464665357467293,1.0,3/43,1.52%,CXCL12;SEMA5A;HGF
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4996663760613491,0.9494222326239646,0.5370370370370371,0.946488114810267,1.0,2/19,3.61%,HIF1A;NEDD4
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.37180137531819923,0.9493277079504587,0.5490196078431373,0.9463832863996443,1.0,30/125,12.96%,SYK;FLT1;EPHA7;FGFR1;BLNK;FGFR3;ERBB4;ROR1;ACVR2A;FLT3;EPHA8;PDGFRA;EPHA5;EPHB4;FER;LIFR;EPHA3;PTPRD;FRK;CLNK;MTSS1;EFS;PTPRT;NPPA;CASS4;LYN;MPZL1;NPR2;LCK;BLK
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.425912546542164,0.9492679883792575,0.6271186440677966,0.9461258952381851,1.0,9/66,8.13%,SIRT1;ENPP1;PPARG;BMP2;RORA;WWTR1;ZFP36L2;RORC;FOXO1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.5148447848214553,0.9491580207389617,0.5178571428571429,0.9460476226861094,1.0,6/11,35.14%,EXOSC4;TENT4B;FBLL1;EXOSC2;EXOSC5;FBL
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.48691490805389137,0.9491050341333249,0.5423728813559322,0.9457590435267482,1.0,7/25,13.73%,SCN7A;SCN10A;SLC8A1;SCN3A;SCN2B;ATP1A2;SCN9A
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.5512938253542953,0.9490798331633445,0.5423728813559322,0.9454076291081657,1.0,4/12,24.92%,MAGT1;MRS2;NIPAL1;TUSC3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.5492664175067217,0.9485114398046242,0.6140350877192983,0.9462283412609787,1.0,2/12,13.80%,SSC5D;BCL3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5021961437505502,-0.9485032087317996,0.4782608695652174,1.0,1.0,4/17,19.85%,DAB2IP;VPS35;AMER1;RGP1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.5018602597674613,0.9484578226786741,0.5098039215686274,0.9459715734894659,1.0,4/13,22.72%,RESF1;SIRT6;ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.5169292205788282,0.9483317185465138,0.5645161290322581,0.9458725356840263,1.0,2/23,3.34%,NDC80;NDE1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5670731845282879,0.9482751705320956,0.5254237288135594,0.94557415943715,1.0,1/11,7.25%,PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.5290389964290461,0.9479329191477537,0.6379310344827587,0.9458583173416163,1.0,6/20,23.32%,RPS6KA4;PAXIP1;SMAD4;RPS6KA5;RUVBL2;MAPK3
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.6331736955422621,-0.947030651821365,0.5789473684210527,1.0,1.0,2/5,6.76%,TEK;MFAP5
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.5091669601794566,0.9469675271681064,0.5882352941176471,0.9479302532658609,1.0,7/16,25.19%,IL4;SNCA;ITGAM;CX3CR1;ITGB2;FPR2;JAK2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.6298344490988422,0.9469479138851951,0.7,0.9475999282225948,1.0,3/6,14.53%,SLC22A3;SNCA;MAPK15
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5046191445758578,-0.9467348680347313,0.5227272727272727,1.0,1.0,1/11,3.66%,SLC19A3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6330022135721778,0.9466481634835324,0.6065573770491803,0.9478461723349578,1.0,5/8,33.22%,SLC39A8;SLC39A14;ABCB7;SLC25A28;SLC11A2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.37685067500814395,0.946504076952239,0.5294117647058824,0.9477780027834739,1.0,21/170,16.53%,CDC14A;NDE1;ZFP36L2;CEP70;RIOK2;CEP152;KCNH5;FBXO5;PCM1;ANAPC16;PSMD13;DCTN3;HECW2;CEP135;DYNC1I2;CNTRL;PSMA1;PSME4;NEDD1;ANLN;CCP110
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.40554657159676305,0.9463470152552392,0.5849056603773585,0.9478093462103923,1.0,17/65,18.00%,IRGM;FZD5;RELA;TICAM1;TLR2;HMGB1;NLRP7;PDE4B;MEF2C;NR1H3;MAPK8;TNIP3;CD80;IRAK1;CARD16;NFKBIB;AXL
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.41301588002270095,0.9462027237218733,0.5238095238095238,0.9477360190555618,1.0,18/67,30.93%,KAT2B;JADE3;ACTL6A;CPA4;TAF5;KAT6A;EPC1;SUPT3H;RUVBL2;NAA50;ING3;EP300;ZZZ3;MSL3;KAT6B;ATF2;PHF20L1;BRPF1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4725112368006123,-0.9461118361509622,0.6052631578947368,1.0,1.0,6/31,9.36%,SELE;RIN3;FLOT1;LRPAP1;ARF1;WDR54
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.5970117521471423,-0.9460888544075311,0.5116279069767442,1.0,1.0,1/6,2.37%,TNXB
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6155366852847918,0.9460704894135632,0.5964912280701754,0.9472706657918689,1.0,4/7,22.68%,IL23R;CD80;CARD9;IL23A
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6155366852847918,0.9460704894135632,0.5964912280701754,0.9472706657918689,1.0,4/7,22.68%,IL23R;CD80;CARD9;IL23A
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6117092356068249,0.9456833610384331,0.5660377358490566,0.9478456180204695,1.0,2/7,16.96%,ADARB2;ADAD2
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.543247024084544,0.9454900856419466,0.6166666666666667,0.9473807704988744,1.0,2/17,8.02%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.543247024084544,0.9454900856419466,0.6166666666666667,0.9473807704988744,1.0,2/17,8.02%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5851668581555043,0.9451599866868382,0.5909090909090909,0.947699218495898,1.0,4/11,23.52%,CD40;ANO6;AKR1C3;CD160
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5772049392015406,-0.9450387135152678,0.5609756097560976,1.0,1.0,7/14,23.81%,DMAC2L;ATP5F1E;ATP5ME;ATP5F1A;ATP5PB;ATP5MC3;ATP5F1B
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3795483373703579,-0.9450106008349513,0.475,1.0,1.0,11/91,10.15%,TRIM56;NLRP1;APOBEC3H;IFI27;RNASE1;OAS3;TRIM5;OAS1;IFIT2;IFIT3;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.48738524513927434,0.944901532556165,0.5471698113207547,0.9478974145991661,1.0,7/31,20.12%,RAPGEF3;RPS6KA4;SNCA;PAXIP1;NOC2L;RPS6KA5;RUVBL2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4200950777713053,0.9447176546331145,0.5517241379310345,0.9479390141367019,1.0,8/51,9.97%,CHRM2;HTR1F;HRH3;OPRK1;GNAT3;GRM8;DRD3;GNAI3
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.5384948002735199,0.9445108077025552,0.5660377358490566,0.9479857899595759,1.0,4/13,18.92%,H2BC21;TF;WFDC11;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4977597358906914,0.9443799691381162,0.5370370370370371,0.9478501846681328,1.0,3/17,13.55%,HELB;KLHL15;UBQLN4
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.49415155645831954,0.9442240991804413,0.543859649122807,0.947766770723696,1.0,4/20,13.23%,PEX12;GDAP1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.4940673348266708,0.9436918296457101,0.59375,0.9486307889574885,1.0,10/28,24.58%,CDKN2A;DLC1;CORO1C;PTEN;SEMA3E;PHLDB2;JAG1;ADAM15;NEXMIF;SERPINE1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.5384571137792818,0.9435334434260693,0.5576923076923077,0.9481722609590177,1.0,5/14,16.08%,TRPV2;SLC8A1;SLC24A2;TRPV3;TRPM2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.5384571137792818,0.9435334434260693,0.5576923076923077,0.9481722609590177,1.0,5/14,16.08%,TRPV2;SLC8A1;SLC24A2;TRPV3;TRPM2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.45130411589911346,0.9434876631545794,0.5166666666666667,0.9478757095098121,1.0,1/27,2.18%,SIRT1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.42846778703960564,0.943378764191536,0.5,0.947646964589895,1.0,4/68,4.93%,ATP6V0D2;TCIRG1;TFEB;RNF152
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.43647229741608456,-0.9433002293923182,0.4489795918367347,1.0,1.0,2/49,1.97%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5574563390383767,0.9432465589065553,0.5178571428571429,0.9475326865935364,1.0,2/9,11.07%,SLC8A1;EDNRA
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.46706679434160364,0.9432346689712211,0.5818181818181818,0.9471692935486616,1.0,12/42,11.33%,HS3ST5;HS3ST3B1;HS3ST1;HS3ST2;UGDH;SDC4;SLC35D2;GALNT5;HS2ST1;GPC5;GPC4;EXT1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.479308277704501,-0.9431948515427535,0.5227272727272727,1.0,1.0,5/29,13.01%,CD24;SFRP1;CAV1;AR;RARA
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.6201938168153601,0.942925273325622,0.5833333333333334,0.9475742886180306,1.0,3/6,27.54%,TCN2;TCN1;CBLIF
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5859490274957289,0.9425161206773256,0.5892857142857143,0.9480411878087666,1.0,2/10,8.04%,PCM1;CCDC120
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5738665070745593,0.9424087568462786,0.5660377358490566,0.9478647132466318,1.0,4/9,7.43%,TMEM100;APOLD1;ZEB1;VEZF1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.5422432280551472,0.9423746821328353,0.5098039215686274,0.9475328971073529,1.0,3/12,5.19%,FGF2;MYC;BMP2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.630234033189755,0.9422878225140799,0.5454545454545454,0.9473412472271929,1.0,3/5,24.20%,NCK2;PXN;MAPK8IP2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.5855594067167266,-0.9420699590334082,0.5641025641025641,1.0,1.0,4/7,15.47%,CBLN2;DCTN1;CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.5204196461362187,0.9420634118719114,0.5614035087719298,0.9475485170209597,1.0,2/15,4.41%,FGF10;CD22
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5424207491181288,0.9420262009876015,0.6140350877192983,0.9472276126350002,1.0,2/9,9.40%,HIF1A;DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5518106893676765,0.9419599861343293,0.6229508196721312,0.9470104664316378,1.0,8/11,28.96%,ZFP36L2;NELFB;JAG1;HNRNPU;HES5;NOTCH1;YTHDF2;N4BP2L2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41994584044637934,0.9417867059021061,0.56,0.9471193435849815,1.0,9/64,17.56%,EGLN3;HIF3A;HIF1A;RBPJ;PSMD13;PSMA1;PSME4;VEGFA;NFE2L2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5745052728174103,-0.9413483253749487,0.5909090909090909,1.0,1.0,1/8,2.28%,SCN5A
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.5188238910434113,-0.9412700286053846,0.47619047619047616,1.0,1.0,6/12,14.12%,SCN5A;KCNA5;KCNN2;KCNQ1;SCN3B;KCNJ5
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.39093922656144775,0.9406099422567636,0.5409836065573771,0.9494666680964424,1.0,13/76,12.52%,IGF1;FGF10;LZTR1;KANK2;EPS8L2;EPS8;DLC1;ERBIN;SHOC2;SGSM3;KANK1;LYN;FBP1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.6298885081476344,0.9405759661406077,0.5862068965517241,0.9491506614504515,1.0,1/6,8.78%,PTX3
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.36019388969443905,0.9405342900543721,0.5283018867924528,0.9487935999795052,1.0,64/238,28.58%,CCNA2;CDC25A;TGFBR1;MYC;HIF1A;KAT2B;ESR1;ACTL6A;STAMBPL1;USP12;INO80E;SMAD1;KEAP1;INO80D;SENP8;SMAD2;PSMD13;SMAD4;NFRKB;PTEN;TNIP3;PSMA1;PSME4;USP45;CCP110;USP31;BAP1;STAM2;HCFC1;RNF128;USP38;ARRB2;UBE2D1;RCE1;TAB1;SENP6;BIRC3;TP53;PSMD4;USP18;GPS1;BRCC3;ACTR5;USP9X;MDM4;BARD1;OGT;SMAD7;USP17L7;JOSD2;OTULINL;OTUD4;EP300;OTUD7B;PSMB5;YOD1;ASXL1;USP2;PSMC5;POLB;TRAF6;CLSPN;HGS;PSMB1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3431627656628867,0.9404868135375064,0.6164383561643836,0.9484988009672596,1.0,56/353,19.66%,MKRN3;HIF3A;SIRT1;UHRF2;HIF1A;SPSB2;NEDD4;LZTR1;SYVN1;RNF152;RFWD3;PEX12;RNF182;TRIM50;KLHL21;ASB5;KLHL8;SPSB4;FBXL3;NEUROD2;UBE2D3;MSL2;DCUN1D1;ANKRD9;UBE2Z;GAN;KEAP1;RNF139;UBE2E3;ANAPC16;FBXO7;UBA5;HECW2;SHPRH;TRIM26;CNOT4;UBE2J2;ARIH1;UBA6;KLHL24;UBA3;FBXL2;TSPAN17;MIB1;FBXL15;NFE2L2;RNF26;TRIM52;KLHL13;PEX2;PDZRN3;RANBP2;FBXO11;MARCHF3;KLHL7;RNF38
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),-0.6070822054366387,-0.9404359358190439,0.5609756097560976,1.0,1.0,1/5,4.34%,RFTN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.41522102619374174,-0.9404243101548252,0.5,1.0,1.0,9/75,9.14%,EHF;UPK1A;TST;TPP1;ACTL8;DAB2;PAX2;TAGLN;ZNF703
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.4918279036590246,0.9403760631456619,0.5652173913043478,0.948312634547278,1.0,2/18,2.42%,SYK;PRKG1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.5794831993371009,-0.9403457170721247,0.54,1.0,1.0,1/7,3.71%,SLX4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.38141502133207794,0.9402375156468478,0.6333333333333333,0.9482194857478525,1.0,26/143,16.45%,NRG1;DLGAP5;ANGPT1;DNAAF3;DNAI4;IMMP2L;HIP1;VAMP1;CHCHD4;SNCA;PDE4DIP;SMAD1;BIN1;SMAD2;PSMD13;TCF4;NCK2;SMAD4;PXN;PICALM;VAMP3;HIGD1C;PSMG2;ANLN;DMD;PRLR
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.5444730306963554,0.9400866842681459,0.5333333333333333,0.9481986094358532,1.0,3/12,24.24%,ELOVL5;ACOX1;ACSL1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5160294699096334,0.9399993315385335,0.5111111111111111,0.9480076528464157,1.0,4/14,17.52%,CCL5;TICAM1;LYN;IRAK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.46405821588525403,0.939996709411065,0.5,0.9476056139775243,1.0,8/29,23.55%,BOK;TP53BP2;MAPK8;PPP3CC;TP53;GSK3A;PPP1R13B;BAD
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.44222542758464894,0.9399685725161223,0.5510204081632653,0.947281167682059,1.0,2/30,8.08%,SHMT2;STAMBPL1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.4728110276185098,0.9395258111797248,0.5555555555555556,0.9478578844913824,1.0,2/23,6.18%,SGO1;TDRD9
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3401162553743667,0.9395102232779016,0.5714285714285714,0.9474975859217489,1.0,96/362,24.71%,STK26;SYK;MAP3K11;EPHA7;FGFR1;TGFBR1;PRKG1;ERG;DAPK2;CDK18;BMP2;TNIK;ACVR2A;MEX3B;FAM20A;MAPKAPK2;FER;RPS6KA4;PPP4R1;DYRK2;CDK14;FRK;MAP3K9;IP6K3;LATS1;PIK3CA;FASTK;MAP3K21;MAP4K2;CDK11A;PAK5;NIM1K;LYN;STRADA;BMPR1A;LCK;IRAK3;CHEK2;VRK2;CDK4;MAPK8;CDK12;PIK3CD;ACVR1B;CREB1;NEK7;DYRK1A;SGK1;RET;MAP3K1;HIPK1;DGKZ;POMK;IRAK1;MAPK10;PRKAA1;PKN2;LIMK2;PXK;CDKL5;RPS6KA5;MAST1;STK38L;MELK;PRKACB;ADAM10;CDK16;FAM20B;WNK1;TSSK4;ABL1;BMPR2;AKT3;STK36;PIM3;PDK1;HIPK3;PIM2;MKNK2;IKBKB;DGKD;CDK8;GSK3A;MAPK3;CAMK4;GAS6;PTK6;CILK1;PASK;IKBKE;RYK;LIMD1;CDC42BPA;MAP4K3;CDK6;DYRK3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.5510358157098418,-0.9394294906471616,0.5510204081632653,1.0,1.0,1/8,6.25%,CAV1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.5862516431256284,0.9394081834297061,0.6140350877192983,0.9473484789377511,1.0,2/7,35.29%,ATG2B;ATG9A
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.4394935279229428,0.9393945256511782,0.5,0.9469938422906278,1.0,9/44,22.51%,ZBTB1;PRIMPOL;PCLAF;REV1;POLD4;FAAP20;POLK;UBE2A;WDR33
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.556761410320687,0.9390551646359251,0.5272727272727272,0.9473538574966617,1.0,2/12,4.32%,TGFBR1;WNT4
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.46538898084546626,0.9389846042646063,0.5666666666666667,0.9471022594536406,1.0,9/31,21.85%,NEDD4;TNIK;PTPRD;ADGRB3;HECW2;CAPRIN1;CDKL5;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.418809832592362,0.9387504354703307,0.5614035087719298,0.947164101616953,1.0,17/73,16.90%,PCDH15;TYR;POU6F2;ADGRV1;TULP1;WHRN;RPE65;DHRS3;GRM8;PAX6;RS1;USH2A;CRYGS;COL11A1;RPGR;ATF6;CRYZ
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5107915152486506,0.9383869943643625,0.5909090909090909,0.9476467735951946,1.0,2/15,16.04%,TOB1;TENT4B
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.42519737828767473,0.9381577053762955,0.576271186440678,0.9478212054738346,1.0,1/67,0.57%,SYK
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.40206849902957975,-0.9381122841208541,0.5714285714285714,1.0,1.0,20/98,17.81%,UVSSA;SLX4;ERCC1;FANCC;RFC3;XPC;PRPF19;PARP1;GTF2H2;XRCC1;FAN1;COPS7A;LIG1;RFC2;RPA3;RFC1;COPS7B;PNKP;COPS6;LIG3
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5918029012830857,-0.9379178682407471,0.5454545454545454,1.0,1.0,1/8,2.65%,ASS1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.5739625517561195,0.9378275620868941,0.6229508196721312,0.9482929358361157,1.0,2/9,13.66%,CD40;MEF2C
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.4140859224265866,0.9377092831633418,0.5967741935483871,0.9481850062645839,1.0,7/76,5.49%,IGF1;IL26;FGF10;FGF2;MYC;ANGPT1;SIX4
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5430982590983618,0.9376762241759397,0.5740740740740741,0.9478619576761024,1.0,8/12,30.26%,FER;CD55;ENPP3;SLAMF8;APPL1;RPS19;RC3H1;CD47
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.42878169242892356,-0.9375313293606033,0.5294117647058824,1.0,1.0,10/60,6.52%,MS4A8;EHF;CAPN8;CLDN4;CAPN9;FAM3D;SLC9A8;SPDEF;CLCA1;MUC5B
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5165662475335191,0.9374570270980329,0.47540983606557374,0.9479438106866287,1.0,2/17,5.09%,SPR;GCH1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.5006179654611568,-0.9373814486140174,0.5652173913043478,1.0,1.0,1/17,4.57%,LDB1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4472561007363602,-0.93731671714535,0.5609756097560976,1.0,1.0,4/32,5.21%,IL11;DRD4;RHBDF1;DRD2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6001722468418477,0.9372940600730677,0.6041666666666666,0.9479129606417884,1.0,3/6,39.15%,BAP1;USP15;USP47
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6050781592133795,0.9368963614823478,0.640625,0.9483580709501646,1.0,3/6,24.34%,PCLO;ERC1;ERC2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.4180338208782737,-0.9368894877944903,0.5263157894736842,1.0,1.0,9/40,24.07%,ABRAXAS1;TICRR;CDC6;BRCA1;MRNIP;CDK1;BLM;TOPBP1;HUS1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.5734219592353786,0.9367025301726715,0.6037735849056604,0.9484038037443984,1.0,3/8,29.29%,PHACTR4;GDNF;SOX8
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5643437447896555,0.936687725087536,0.6521739130434783,0.9480250969586447,1.0,2/10,14.96%,ATP6V0A4;SLC26A4
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.472458223727142,0.9366257327834765,0.6304347826086957,0.9478000422635604,1.0,11/33,20.07%,SCRIB;DLC1;PHACTR4;PLXNB2;PRICKLE1;LRP6;LRP2;DEAF1;COBL;DVL2;VANGL2
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.4899310924809057,0.9366089133733518,0.5737704918032787,0.9474423437435112,1.0,4/26,8.51%,LGALS9;BTN2A2;SCRIB;SDC4
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3699913410001586,0.935940561491709,0.5254237288135594,0.948596564086745,1.0,48/177,23.01%,RAB38;FRMPD1;MRAP2;EHD1;NLGN1;DPP10;TNIK;SCRIB;ZDHHC22;RAB3C;NRXN1;RAMP3;ARL5A;LIN7A;ANK2;RAPGEF6;MAGI2;ZDHHC2;SAV1;EFR3A;ANK1;KCNB2;KCNIP4;PACS1;RAP1A;LRRC7;LRP6;NKD2;DLG2;TSPAN17;CPE;SYNE3;RAB29;DENND4C;PLEKHF1;ARL3;CD81;RAP2A;JUP;SMURF1;ITGAL;RAPGEF2;TRARG1;DLG3;EHD4;BSG;ITGB2;IKBKB
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.625995437146356,0.9356921591322707,0.5636363636363636,0.9486676239582412,1.0,1/6,2.53%,CD99
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4665046386433726,0.9356445090083502,0.559322033898305,0.9483661395650492,1.0,6/23,17.89%,SIRT1;CDKN2A;PML;SMC5;KAT6A;HMGA2
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.6295062616860584,0.9356308739001756,0.6065573770491803,0.9479782017400414,1.0,2/5,16.09%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5433595742959779,-0.9356193005321466,0.525,1.0,1.0,4/12,18.65%,TAF11;TAF7;TBP;TAF7L
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5965471407217218,0.9355617834248539,0.5901639344262295,0.9477282421445785,1.0,2/6,9.55%,GLRA1;FGF12
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5468581338216889,0.9354102875315726,0.5660377358490566,0.9476466637931328,1.0,3/12,13.79%,SLC8A1;ATP1A2;ATP12A
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.4977954199435152,0.9350489185539198,0.5,0.9480796448952444,1.0,7/18,21.51%,LMOD3;WASHC1;MAGEL2;SPIRE2;LMOD2;JMY;IQGAP2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.4025607212459286,0.9350195612049301,0.6226415094339622,0.947768855037104,1.0,5/98,3.58%,IRGM;SYK;FBLIM1;NRG1;GFAP
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5838498860091654,0.9345374410204909,0.5263157894736842,0.9484508175955502,1.0,3/7,17.72%,CDH2;PAX6;BMP4
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.5651786720872743,0.9343687960336442,0.6166666666666667,0.9484352117317646,1.0,6/10,31.56%,ROBO2;BMP4;NPNT;PKD1;SLIT2;PKD2
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.6379139592978119,-0.9342777784474187,0.6666666666666666,1.0,1.0,1/5,10.16%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.6379139592978119,-0.9342777784474187,0.6666666666666666,1.0,1.0,1/5,10.16%,KIF17
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5762819156081986,0.9340408712044882,0.5967741935483871,0.9488722232431906,1.0,2/10,7.76%,PCDH15;NRXN1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5133734543091867,0.9340281842848617,0.5714285714285714,0.9484955388321239,1.0,3/18,20.12%,ESR1;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.625463785289462,0.933988694699236,0.6206896551724138,0.9482055497001008,1.0,2/5,23.32%,MAPK8;MAPK3
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.35714198569423466,0.933808543389151,0.532258064516129,0.9481595980880546,1.0,38/234,13.97%,SCN7A;NOX5;TRPM8;MCOLN3;KCNK2;SLC12A1;SCNN1B;KCNC2;ASIC1;SLC1A3;TRPV2;SLC12A3;TRPC4;KCNH7;SCN10A;SLC8A1;KCNH8;KCNH4;KCNQ5;KCNH5;ITGAV;SLC39A8;SLC6A16;SLC24A2;LRRC55;SCN3A;SLC9A2;SCN2B;ATP1A2;KCND2;SLC30A2;ATP6V0A4;HCN1;KCNF1;SCN9A;ATP12A;KCNB2;KCNAB3
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5508447807639288,0.9336571273958505,0.5636363636363636,0.94809845405755,1.0,2/13,9.53%,YAE1;ISCA2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.5577301967930951,-0.9335504734815312,0.5581395348837209,1.0,1.0,7/15,23.81%,DMAC2L;ATP5F1E;ATP5ME;ATP5F1A;ATP5PB;ATP5MC3;ATP5F1B
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5481957125586768,-0.9333934765154636,0.5454545454545454,1.0,1.0,1/7,6.25%,CAV1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.4939875522077662,-0.9333637192132251,0.6363636363636364,1.0,1.0,7/20,18.65%,DUOX1;P2RY12;CCDC25;TGFB1;NTN1;TWIST1;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5504473687086747,0.9330124780156696,0.6274509803921569,0.9491132230471415,1.0,3/12,17.18%,CBLB;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5814557152044411,0.9328985780174786,0.5535714285714286,0.9489705686784025,1.0,6/7,39.53%,ABL1;APOE;EPHA4;APP;AGER;PTN
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.4216962257829248,0.9325911167344367,0.5964912280701754,0.9492336801379625,1.0,12/58,14.49%,RENBP;ANPEP;ALLC;TRHDE;NAALADL1;CYP3A4;PLA2G10;RIDA;LNPEP;PLA2G7;SGPL1;NPL
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4798818833396,0.9325197462188551,0.5925925925925926,0.9489998621013371,1.0,4/24,15.87%,CACNB4;ANK2;JPH1;DMD
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5642689430095811,0.9323886024922422,0.6,0.9489334288030847,1.0,5/9,23.39%,TICAM1;F2RL1;ITGAM;ITGB2;CAMK4
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.588939954385359,0.9323778628210448,0.6346153846153846,0.9485682605214621,1.0,1/10,3.00%,CCL5
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.525588148354756,-0.9322965867415449,0.5238095238095238,1.0,1.0,5/15,21.01%,ALOX5;ALOXE3;ALOX12B;ALOX15;LTC4S
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.530810386172521,0.9320399582839839,0.5555555555555556,0.9489171573583934,1.0,3/16,11.87%,C3;EPHA8;ADGRB3
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.543433970525031,0.931982443089369,0.5573770491803278,0.9486231403848857,1.0,4/15,8.35%,NOX5;SEMA5A;NRARP;BMPER
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6017704312959118,0.931870295639888,0.6296296296296297,0.9484811057760316,1.0,3/5,37.19%,VPS41;ARL8B;PLEKHM1
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.5844845977414287,-0.931838381158202,0.6136363636363636,1.0,1.0,1/6,1.95%,CXCL13
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.3848320093389035,-0.9317068919031214,0.6296296296296297,1.0,1.0,7/77,10.29%,NTRK1;NUPR1;CRLF1;FOXQ1;WFS1;NRBP2;TYRO3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5139839878421232,0.931428519987621,0.5614035087719298,0.9491683428200055,1.0,8/21,20.97%,RAB27A;CCN6;PLCG2;SNCA;ABCD2;SLC18A2;SLC30A10;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.4981681524650289,-0.9313035462202846,0.475,1.0,1.0,1/8,4.03%,CBARP
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.6352047788405264,0.9311071784110436,0.625,0.94918221950437,1.0,1/5,21.85%,RAPGEF2
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.6352047788405264,0.9311071784110436,0.625,0.94918221950437,1.0,1/5,21.85%,RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5039930167401238,0.9308629543983978,0.56,0.9492775156139854,1.0,3/14,17.02%,TLR2;HMGB1;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6400763092592748,0.9308509680363214,0.5925925925925926,0.9488881810084949,1.0,4/5,35.75%,NOTCH1;DICER1;SKI;RNF10
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.44350089085872363,-0.9307392979813741,0.5714285714285714,1.0,1.0,5/45,7.86%,CLDN4;CTNNA1;CLDN1;CLDN5;CLDN15
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6437814426963246,0.9303509425236619,0.6779661016949152,0.9496646376966207,1.0,2/5,26.05%,FLRT3;NOTCH1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4195552945043457,0.9300921668035743,0.5882352941176471,0.9499512572852797,1.0,10/65,12.87%,EGLN3;BOK;PPARG;F2R;HIP1;TNFRSF10A;DLC1;SNCA;F3;LCK
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5405759044415374,0.929894356104727,0.5357142857142857,0.9499654180648568,1.0,3/14,20.00%,EXOSC4;TENT4B;ERI1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.4670421871444156,0.9297742989314786,0.6071428571428571,0.9498888644167568,1.0,5/34,10.64%,PCLO;SYT1;UNC13B;SNCA;RIMS2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5527614033090884,-0.9297227961867761,0.5945945945945946,1.0,1.0,2/11,13.00%,IFI27;NUCKS1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.538126818851351,0.9294597010174394,0.5185185185185185,0.950240514883149,1.0,2/11,1.18%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.44482418085555453,-0.9291455441687204,0.5405405405405406,1.0,1.0,9/26,13.22%,TTC12;DNAAF1;DNAJB13;DRC1;RSPH9;CCDC40;CFAP74;CFAP46;RSPH1
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.616261674656319,-0.9291274445931527,0.6666666666666666,1.0,1.0,2/5,19.39%,GNMT;ACP3
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.44127125036493386,0.9291240759847527,0.5555555555555556,0.9506271179150013,1.0,10/40,21.85%,SNAI1;WNT4;DKKL1;PROX1;PTGIS;CD34;GCK;AKR1C3;ABCA2;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4054893177134273,0.928844535283436,0.52,0.9508221551748568,1.0,14/63,18.17%,PLEKHG2;TENM1;HCLS1;FER;LATS1;CRACD;BIN1;KANK1;CARMIL1;NCK2;FCHSD2;DBN1;LMOD2;WASHC5
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.3975477155052487,0.9284440082723314,0.5471698113207547,0.9512937189508155,1.0,14/67,17.52%,ABHD3;PRDX6;PIGQ;PLA2G10;IP6K3;ACP6;PLA2G7;PIGF;CPNE1;CPNE7;CPNE3;PNPLA6;PIGP;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4868468162076122,-0.9283495259854262,0.5294117647058824,1.0,1.0,4/16,16.12%,SPRED2;SPRED3;SPRED1;CALM1
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6168280019013744,0.9282762661874813,0.6666666666666666,0.9512972316895235,1.0,1/6,3.81%,PPARG
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.47483859502379494,-0.9281754009458483,0.5714285714285714,1.0,1.0,4/19,3.82%,IRF4;NLRP3;CD86;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.43673731005074723,0.9281287802186264,0.6101694915254238,0.9512353966466609,1.0,14/47,25.52%,RUNX1;KAT2B;PRMT1;MOV10;MEF2C;CNOT4;HDAC1;FAXDC2;AGO3;KMT2C;H3-3A;TESC;GP1BA;CIB1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.37776544739551765,0.9276982870675887,0.6470588235294118,0.9518870846551839,1.0,18/112,10.07%,CWH43;SLC5A8;ACE2;TMPRSS2;ITGB8;ESRRG;NPHS2;FGD4;SLC12A3;TRHDE;MUC20;SLC8A1;SLC44A4;FRK;SLC34A2;RBM47;LPP;TFCP2L1
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),0.6079587571812197,0.9276172263551472,0.6122448979591837,0.9516392290954883,1.0,1/6,1.30%,MOGAT2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.5607673117398989,0.9275550810752028,0.5882352941176471,0.9514267204583169,1.0,3/7,30.34%,SLC15A2;BIRC3;CD36
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.41203209644172484,0.9274306755126175,0.55,0.9513398429744839,1.0,14/72,19.80%,MRAP2;STAC2;ABI3;DPP10;AGR2;EPHA3;RAMP3;ZDHHC2;PICALM;NKD2;RHOG;STX8;NUMB;ARHGEF16
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.3968457682071777,0.927430186656293,0.6610169491525424,0.9509470519575662,1.0,9/76,3.81%,SASH3;FERMT3;PIK3R6;IL2RA;FLI1;CSF3R;SELPLG;ITGAX;PPARG
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.4027097900090694,0.9273138270256348,0.5789473684210527,0.950815317412934,1.0,11/62,22.93%,U2AF1;LIN28A;THOC6;PAPOLA;PCF11;TENT4B;SRSF11;CSTF3;WDR33;NCBP1;PNPT1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.40044978654213154,0.9272696724084413,0.5833333333333334,0.9505634032413749,1.0,11/84,15.22%,DERL3;SYVN1;UBE2J1;AUP1;DNAJB2;RNF185;RNF139;UBE2J2;POMT2;RNF5;UBE4A
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.5783056362186901,0.9272300428511917,0.5344827586206896,0.9502465675299251,1.0,2/8,9.42%,GFAP;SNCA
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5697216266889386,0.9272081127135886,0.6271186440677966,0.9498899299676243,1.0,3/7,15.92%,MLLT3;CDK2AP2;NCOA3
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5293164686005413,-0.9269259774993848,0.5652173913043478,1.0,1.0,4/13,7.55%,PAH;TPH1;SMOX;DBH
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.47694460575935727,-0.9267362593926609,0.5116279069767442,1.0,1.0,2/26,2.48%,RTP1;RTP5
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.4710734827671027,0.926689720867702,0.5384615384615384,0.9506699069748121,1.0,5/23,13.66%,SIX4;SGCZ;PGM5;SGCG;MEF2C
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5116609220058164,-0.9266787575236828,0.4782608695652174,1.0,1.0,1/12,1.10%,KCNMB2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.567334458407767,0.9265869762342007,0.5538461538461539,0.9504885202949749,1.0,1/7,8.85%,DCP1B
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.5738799379001305,0.9260887839107437,0.6595744680851063,0.9512926171278727,1.0,4/8,30.17%,LYN;PICALM;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5260658218983445,-0.9260827441682898,0.5853658536585366,1.0,1.0,1/9,0.70%,DDX11
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.5522582322525489,-0.9260391418995266,0.6097560975609756,1.0,1.0,1/11,3.38%,SLC17A9
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.48361544347443075,-0.9258844815898586,0.5581395348837209,1.0,1.0,1/16,0.58%,IL10RB
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.4491658899590632,0.925773291051558,0.5932203389830508,0.9516010879964489,1.0,4/32,11.36%,SOCS2;SLC8A1;ANK2;TBX18
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.5641095481828704,-0.9256913123947312,0.6122448979591837,1.0,1.0,3/7,23.16%,TLCD2;TLCD1;CLIP3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5100132315794205,0.9254928974405059,0.6481481481481481,0.9517843655508764,1.0,5/23,17.92%,CCL5;SNCA;DSCAM;CD244;BTBD10
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.45054839786131873,-0.9252674579559476,0.5106382978723404,1.0,1.0,4/24,9.39%,SCN5A;CAV1;DSG2;CTNNA3
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5739173085609424,0.9251341597357975,0.6065573770491803,0.9518258929251571,1.0,3/9,16.28%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5739173085609424,0.9251341597357975,0.6065573770491803,0.9518258929251571,1.0,3/9,16.28%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.48181943980915937,-0.9250254306406919,0.5957446808510638,1.0,1.0,1/17,3.36%,SPTLC3
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.5506212713996559,0.9248738593250392,0.6226415094339622,0.9519639294280737,1.0,4/11,19.17%,CCL5;ZNF639;HMGA2;HDAC1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.4339822887435811,-0.9248283646755137,0.49122807017543857,1.0,1.0,2/31,1.58%,SELP;SELL
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3668095761100643,-0.9247358565670327,0.6382978723404256,1.0,1.0,10/109,8.11%,GFRA3;COL4A2;COL4A1;GFRA2;SFRP1;BOC;OLFML2A;GULP1;ARNT2;MPZ
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.4915044725799974,-0.9245907128265906,0.5853658536585366,1.0,1.0,3/15,5.15%,ABCA4;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.616158391189739,0.9244134238066388,0.6607142857142857,0.9526207472154345,1.0,5/6,37.79%,BAD;AKT2;STOML2;MTLN;VCP
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5179276172409352,0.9241040047738988,0.5932203389830508,0.953022672241839,1.0,1/10,9.70%,PLA2G10
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.609358337184718,0.9240622761589514,0.7076923076923077,0.9527163580732425,1.0,4/5,36.67%,GPAA1;PIGT;PIGU;PIGK
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.5848438566071903,0.9239158604585362,0.6181818181818182,0.9526295574063128,1.0,4/10,15.34%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.5120074567822713,-0.9237664432872771,0.575,1.0,1.0,1/8,3.17%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.4848356060067642,0.9237109214580917,0.5961538461538461,0.9526623764548788,1.0,4/23,12.87%,FGF10;CCDC88B;TICAM1;LCK
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4402075481440124,0.9236342980906931,0.532258064516129,0.9524611486643387,1.0,12/40,24.82%,GAB1;ERBIN;PIK3CA;FAM83A;NCK2;BCAR1;SOS1;SLC30A10;RPS6KA5;DGKD;GRB2;EGFR
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.4390166819334074,-0.9234438693079207,0.6041666666666666,1.0,1.0,5/40,10.33%,BST1;RAC2;FBLN2;VIT;MYADM
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.48795725216021507,0.9234232256100908,0.6274509803921569,0.9525636893243028,1.0,5/18,16.26%,ABCC2;SLC22A3;SLC15A2;ABCC11;ABCA8
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.39540089459939254,0.9231561560639787,0.5344827586206896,0.9527706224670042,1.0,21/97,15.47%,GFAP;CDH20;SLC1A3;NDRG2;NTSR2;GLUL;PMP2;SLC8A1;NRXN1;SYNPR;RAMP3;CYP27A1;PLXDC2;TMIGD3;PTPRT;GRM5;ATP1A2;RTN1;SLC39A12;BAALC;SEZ6L
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.47800129693061993,-0.92312056984382,0.58,1.0,1.0,3/26,4.50%,PM20D1;SPTLC3;ARG2
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.6213832647725235,0.9231112787117418,0.6363636363636364,0.9524651637772393,1.0,1/6,5.13%,NPC2
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),0.6171151012473401,0.9228011060771183,0.6071428571428571,0.952771387862342,1.0,1/5,5.30%,IL23R
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5458458494058744,0.922562471322383,0.6491228070175439,0.9529431993938553,1.0,5/13,23.63%,SLC25A13;SLC1A6;SLC25A12;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3848752274534298,0.9222303120650803,0.5892857142857143,0.9532887131264642,1.0,19/85,22.05%,CDC25A;MYC;ZBTB1;NEDD4;RELA;PRIMPOL;PTPRK;BCL3;PCLAF;REV1;MAPK8;NOC2L;RUVBL2;FMR1;POLK;TMEM161A;UBE2A;SCARA3;TP53
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4211596400682363,0.9220784590969728,0.603448275862069,0.9533608747387727,1.0,17/64,21.09%,URI1;SOCS2;ROBO2;LMO2;RAMP3;LOC400499;NCOA2;ATP1A2;MEF2C;AKR1C1;NCOA3;THRB;SLC5A5;GCK;AKR1C3;CRHBP;NR3C1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.590413558855091,0.9218537637923784,0.6037735849056604,0.9534627546509039,1.0,1/7,4.75%,CDH2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.5860194610812232,0.9217076599278994,0.6818181818181818,0.953316508891438,1.0,1/6,3.32%,PADI2
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.528615296504801,-0.9216215029065907,0.5476190476190477,1.0,1.0,1/8,0.70%,DDX11
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.4669855422310746,0.921529174643181,0.5208333333333334,0.953259641358539,1.0,7/26,12.34%,CSPG4;UGDH;CHSY3;VCAN;BGN;DSEL;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.552751742430988,0.9215020437387585,0.6481481481481481,0.9529301961529175,1.0,2/18,5.19%,WNT4;BMP2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5384669568988248,0.9203037699486735,0.5686274509803921,0.9550932739286083,1.0,2/10,1.18%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5241798468216964,0.9201957660223434,0.5645161290322581,0.9550307988610021,1.0,5/15,28.29%,IRAK3;IGF1R;MTRF1;TBC1D25;INSR
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.3594330371742189,0.9198372858091353,0.6825396825396826,0.9554337444326703,1.0,18/154,12.26%,NXPH1;SLC35F1;HRH3;POU6F2;SLC17A6;DPP10;GRIP1;KCTD8;NHLH2;ZDHHC22;OLFM3;CDK14;FGF12;CPNE4;ADGRB3;PAK5;TMEM196;NKAIN3
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.5028691824297811,0.9197908774759525,0.5409836065573771,0.9551583863960629,1.0,5/19,13.43%,PLD6;TDRD9;TEX15;FKBP6;PIWIL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.48331395527800536,0.9197632682144915,0.55,0.9548634657516707,1.0,2/20,3.81%,SIRT1;PPARG
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.45678901392495164,-0.9193748048627872,0.5416666666666666,1.0,1.0,6/21,10.38%,GUCA1B;CNGB1;PDE6B;PPEF1;NMT1;GRK7
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4387590745664778,0.9190358283307026,0.5490196078431373,0.9561955904416469,1.0,9/49,19.72%,CORO7;MSRB1;GSN;ZNF207;HDGFL3;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.38921547032481013,-0.9187566426363796,0.5833333333333334,1.0,1.0,3/80,1.49%,TERT;DDX11;KDM4D
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.5454701483783275,-0.9187245319457134,0.6,1.0,1.0,1/7,7.12%,PRKD2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.5453988739679942,0.9187032375285978,0.5185185185185185,0.9565529222396568,1.0,2/7,13.05%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.5931596552649614,-0.9186909557162182,0.5625,1.0,1.0,1/5,1.28%,PGC
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.4589054993093857,0.9186531344201055,0.5636363636363636,0.9562923790118882,1.0,8/20,25.07%,SMDT1;MCUB;RAP1GDS1;MCU;MICU1;PDZD8;MAIP1;BCAP31
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4001972433966105,-0.91856130784615,0.6,1.0,1.0,9/62,9.10%,CLDN4;PTGES;LYPD6;CRABP2;RHBDF1;C6ORF132;ALOXE3;CDH3;WWC1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3605122882045337,0.9185026627931541,0.5172413793103449,0.9562740422784994,1.0,27/99,19.01%,ALDH1A1;NEDD4;ISOC1;PEX12;SLC35B2;IDH1;PECR;ABCA6;ALDH9A1;ABCG8;ABCA1;CYP39A1;CYP27A1;ATXN1;TFCP2L1;CYP7B1;LCK;ABCD3;ABCD2;NR1H4;ABCA8;FDXR;HSD3B7;ABCA9;SLCO1A2;PNPLA8;DIO1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.512777213579549,-0.9182488526503622,0.5909090909090909,1.0,1.0,1/17,1.26%,MTFR2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.42794077534288444,-0.9181287826257459,0.5957446808510638,1.0,1.0,7/72,2.73%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4363831656629857,0.9181226935825453,0.56,0.9567049565046865,1.0,6/48,7.86%,IGF1;PLCH1;IRS1;FGFR1;PIK3C2B;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5420547817932252,0.9180830917859724,0.5882352941176471,0.9563903877989476,1.0,3/12,3.59%,IGF1;IL4;LDLR
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.3578196955966495,-0.9180688013270283,0.575,1.0,1.0,13/112,9.32%,INSRR;CTNNA1;ASS1;RHBDF1;EPAS1;AGRN;GPC1;NFE2L1;C1ORF226;TSPAN15;SH3BP4;MYO5B;WFS1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.6015475548427244,0.9176607010433127,0.5873015873015873,0.9570330088844754,1.0,2/5,10.74%,HIF1A;CIAO3
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.43097603245829486,-0.9173637941884432,0.5909090909090909,1.0,1.0,5/41,6.08%,KCNMB2;KCNE2;SCN5A;CACNA1G;KCNE1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.625942849141124,0.9173219975328465,0.6896551724137931,0.9573694080972479,1.0,2/6,16.75%,ANK2;RYR2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.5964143833273111,0.917161082295786,0.6730769230769231,0.9573851721735833,1.0,3/9,22.05%,TERF1;POT1;TP53
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.47703678300948027,0.9165641531461919,0.5172413793103449,0.9582039675005989,1.0,5/21,15.51%,IL4;LATS1;SMAD2;SMAD4;NREP
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5254046532472094,0.9162622999517193,0.6206896551724138,0.9584902364506079,1.0,5/11,26.05%,FOXO1;SMAD4;GSK3A;LMNA;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.46381861751705084,0.9162129998978253,0.5714285714285714,0.9581904771017911,1.0,1/25,0.53%,SASH3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.4646635082924886,-0.9161039788736611,0.6190476190476191,1.0,1.0,4/31,14.53%,EML3;GPSM2;DCTN1;ANKRD53
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.6490355029012671,0.9161014729089867,0.6842105263157895,0.9576359546138241,1.0,1/5,6.74%,WHRN
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.6490355029012671,0.9161014729089867,0.6842105263157895,0.9576359546138241,1.0,1/5,6.74%,WHRN
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5079733682406493,0.916060785200128,0.5614035087719298,0.9573860717368269,1.0,4/20,15.59%,IL4;CCL5;LYN;CSF1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3680477424184093,0.9159944074885635,0.639344262295082,0.9571511351083527,1.0,13/153,7.56%,VEGFC;IGF1;FERMT3;SYT15;HGF;LHFPL2;RAB31;KNG1;PCLO;MANF;ANXA5;SYT1;SYT6
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.35441840199936825,0.9157771884199807,0.7083333333333334,0.9572160635042845,1.0,24/160,25.66%,PATL2;SAMD4A;EIF3E;DCP1B;SMG1;EXOSC4;CNOT6L;RPS5;CNOT4;RPL21;TENT4B;DXO;CNOT8;CNOT2;RPL7;ERI1;RPS3A;RPL23A;RPL18A;NCBP1;PAN3;PATL1;RPS29;RPS15A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.4532429058301647,0.9157377539837532,0.5789473684210527,0.9569224568835344,1.0,2/38,5.31%,MDFIC;MID2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3715762063590282,0.9155947653301543,0.6111111111111112,0.9568401631443074,1.0,19/83,17.69%,RHOBTB3;RAPGEF3;EFNA5;ABI3;EPS8;PDGFRA;EPHA5;RHOD;EPHA3;DLC1;ABL2;PIK3CA;GPM6B;SEMA3E;RHOBTB1;TRPM2;RICTOR;RHOG;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5010394016340676,-0.9155035947502901,0.6410256410256411,1.0,1.0,3/16,10.75%,IL11;UBASH3B;IGFBP3
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4020278693659381,-0.9154928526083831,0.5,1.0,1.0,9/80,6.75%,EHF;CLDN4;GPR39;TMEM184A;SERINC2;FOXQ1;C6ORF132;LAMB3;CLDN1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4490196189762694,-0.9153209136707765,0.5609756097560976,1.0,1.0,1/27,1.49%,KDM4D
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.5669790856067786,-0.9149420581350404,0.575,1.0,1.0,1/5,3.00%,CCBE1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.540563418037939,0.9147237954700711,0.5576923076923077,0.9583624440788837,1.0,3/7,22.87%,SGSM3;DENND4C;DENND4A
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.5277412490291609,0.9147151075106139,0.5932203389830508,0.9579951586677875,1.0,3/12,16.99%,ANGPT1;TJP2;VEGFA
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.39180796639491317,0.9146155549536423,0.5789473684210527,0.9578095730218894,1.0,33/95,22.40%,SYT15;NEDD4;ITPKB;NLGN1;ADGRV1;CASR;SYT1;SYT6;PLCG2;NEUROD2;CPNE4;SLC25A24;SLC25A13;CPNE1;MEF2C;CPNE7;PPP3CA;CPNE3;TRPM2;RYR2;PRKAA1;AKR1C3;SYT17;ALOX5AP;DPEP1;PPIF;CRHBP;LGMN;SLC25A12;CPNE9;KCNMB4;TRPC1;RYR3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4882032849760872,0.9141828796997326,0.5666666666666667,0.9583543585259892,1.0,5/24,15.59%,RUNX1;IL23R;HCLS1;CD74;CSF1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5257631577461521,0.9139556309701958,0.6166666666666667,0.9585312917777162,1.0,8/15,37.34%,INTS6;INTS11;ZCCHC8;INTS8;INTS3;INTS2;INTS1;INTS5
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.4956539426797068,0.9139375425498941,0.5818181818181818,0.9581792210601067,1.0,3/20,9.13%,IGF1;PCM1;PAX6
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.40861336717633495,0.9138660638109153,0.603448275862069,0.9579791756719023,1.0,19/87,17.32%,CRX;SV2C;CDH7;AANAT;SAG;CNGA1;RCVRN;GABRG3;SLC24A2;RS1;RGR;PDE6H;PDE6A;HCN1;MYT1L;TMEM145;ADRB1;SLC2A11;MGAT4C
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.4765487810376418,0.9134239573501267,0.5740740740740741,0.9587187320432061,1.0,6/31,16.50%,ABI3;NLGN1;PDLIM5;PTEN;CAPRIN1;DBN1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.48291364889654914,-0.9129014346783616,0.6222222222222222,1.0,1.0,4/15,15.70%,NUPR1;PARP1;PFKFB1;ACTN3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.35690849479866743,0.9128022270287668,0.6417910447761194,0.9594625839086545,1.0,22/173,9.04%,VEGFC;TDRD10;CXCL12;FLT1;LAMA4;CFH;FLI1;STAB1;ERG;ADGRL4;TMEM100;OIT3;PLAC8;APOLD1;BMP2;PLSCR4;POSTN;BGN;DPP4;PDGFRA;LIFR;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.5747221293182991,0.9127151073975001,0.5925925925925926,0.9592329296883076,1.0,2/7,1.18%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.42908173236440683,0.9126768509701131,0.6111111111111112,0.9589448160415975,1.0,14/48,25.52%,STAC2;DPP10;AGR2;EPHA3;RAMP3;ZDHHC2;NKD2;RHOG;ARHGEF16;ATP2C1;STX3;DLG1;EGFR;CIB1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3754123238125457,0.9126163153055316,0.5967741935483871,0.9586911294430104,1.0,21/98,17.98%,TRPM8;MCOLN3;CCL5;GRIN3A;TRPV2;TRPC4;CASR;SLC8A1;ITGAV;SLC24A2;RAMP3;ANK2;SLC3A2;TRPC5;TRPV3;TRPM2;ANO6;RYR2;CALCRL;TRPM7;CACNA1I
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.33299615669498583,0.9125959142374356,0.7142857142857143,0.9583399850346285,1.0,40/317,15.30%,TIMELESS;TOP2A;HELB;SIRT1;BOK;ZBTB40;MYC;ZBTB1;STK33;CDKN2AIP;RFWD3;SLFN11;MAPKAPK2;WDR76;MAP2K6;ASF1A;FOXO1;UBE2E2;DYRK2;HTRA2;MCM7;LYN;FANCL;POLE2;AKTIP;BLK;CHEK2;SHPRH;PAXX;PML;UBQLN4;BCL3;PCLAF;RBBP6;SMC5;MAPK15;UBA6;TANK;PSME4;SETD7
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.38003890151588854,0.9125349403676536,0.6290322580645161,0.9581111509090006,1.0,12/90,9.36%,ATP6V0D2;SLC5A8;ITGB8;ESRRG;ERBB4;SCNN1B;NPHS2;CYP4Z1;MUC20;SLC4A1;FRK;SLC34A2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.472124672781575,0.9122069499760412,0.5846153846153846,0.9584143295423568,1.0,4/27,13.79%,NOX5;ATP1A2;ATP6V0A4;ATP12A
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.40305056120782445,0.9121416720924248,0.6176470588235294,0.958210035330312,1.0,19/74,22.99%,SEMA5A;LLGL1;DCC;NEFH;DSCAML1;CTNNA2;NTNG2;KLF7;NREP;GRM7;VASH2;CNTN4;L1CAM;ZDHHC17;SLITRK6;PARD3;SLITRK5;CAMSAP2;PLP1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.4211377605003292,-0.9121332511118908,0.5652173913043478,1.0,1.0,14/54,17.42%,CLDN4;COL5A1;COL1A1;CLDN1;ALOXE3;FLG;HRNR;STMN1;WNT5A;FLG2;MED1;RYR1;WNT10A;ALOX12B
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.6391947022917523,0.9120205730518129,0.6538461538461539,0.9576947261364306,1.0,2/5,5.30%,CCL5;IL23R
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.6391947022917523,0.9120205730518129,0.6538461538461539,0.9576947261364306,1.0,2/5,5.30%,CCL5;IL23R
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.5897439477613133,0.9118784511174038,0.6551724137931034,0.957593264326233,1.0,3/6,13.58%,HIF1A;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4195198946257137,0.9117100987865364,0.5686274509803921,0.9575503164903844,1.0,7/41,14.87%,PYHIN1;LATS1;RNF139;PML;UBQLN4;PTEN;XPO1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5792699829153872,0.9114940584550935,0.6666666666666666,0.9571385364108882,1.0,3/6,31.18%,TACC3;CDC27;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5792699829153872,0.9114940584550935,0.6666666666666666,0.9571385364108882,1.0,3/6,31.18%,TACC3;CDC27;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.43392481134693883,0.9113385459902801,0.5833333333333334,0.9570958221905013,1.0,3/22,10.39%,ESR1;MED17;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.6005011703521563,0.9112608402004657,0.6491228070175439,0.9568586784465075,1.0,2/6,16.50%,NEUROD2;DBN1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.5464310227256937,0.9112493284627231,0.5636363636363636,0.9564953735674463,1.0,1/6,10.91%,LMAN1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.36911155849711363,0.9111353576158757,0.660377358490566,0.956316952005976,1.0,13/101,8.58%,F2;FLT1;EPHA7;FGFR1;FGFR3;ERBB4;ROR1;FLT3;EPHA8;PDGFRA;EPHA5;EPHB4;EPHA3
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.5147395104781534,0.9108431779723091,0.6166666666666667,0.9565854033067641,1.0,2/16,11.54%,CHMP6;CNTROB
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5372808629257018,-0.910836104532428,0.5333333333333333,1.0,1.0,1/10,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.4745495029512785,0.910737528579182,0.6153846153846154,0.9563925268722571,1.0,7/27,19.72%,CORO7;MSRB1;GSN;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5327808130718279,0.9107347737022552,0.640625,0.9556337899726378,1.0,4/15,25.53%,JADE3;HCFC1;KANSL3;OGT
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5327808130718279,0.9107347737022552,0.640625,0.9556337899726378,1.0,4/15,25.53%,JADE3;HCFC1;KANSL3;OGT
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.5631762490516867,-0.9106425646072924,0.5853658536585366,1.0,1.0,2/7,18.83%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5032304858010435,0.9105508938130304,0.625,0.9556548367350041,1.0,6/23,18.55%,RUNX1;SNAI1;PDLIM5;MEF2C;RAP1A;MYO1C
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.4421690562787133,0.9104557764360736,0.55,0.9554917157027705,1.0,6/23,12.10%,NLGN1;SYT1;SNCA;NLGN4X;CEL;STON2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.46362849456831173,0.9101365173247697,0.5535714285714286,0.9557356330831066,1.0,12/23,28.66%,HIF1A;RBPJ;ATF6;VEGFA;NFE2L2;HSPA5;TP53;CREB3L3;NOTCH1;DDIT3;ATF3;SESN2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.49342183225613256,0.90999982826825,0.5573770491803278,0.9556597697668106,1.0,5/15,24.53%,NXT1;ANP32A;XPO1;RGS14;BANF1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.4667926952922019,0.9099934782259073,0.6226415094339622,0.9552983899704066,1.0,4/27,9.42%,NLGN1;SLC17A6;PCLO;SNCA
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5397723214457881,-0.9099572605915744,0.5384615384615384,1.0,1.0,4/11,25.72%,STX11;STX1B;SNAP47;STX19
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.48047041139618585,0.9099571913222192,0.5849056603773585,0.9550050350415337,1.0,2/16,14.11%,CEP135;CEP120
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.45131072511590486,0.9096596880002074,0.6065573770491803,0.9552971220926992,1.0,6/39,15.80%,TGFBR1;RAPGEF3;CARMIL1;PPM1E;PXN;SORBS3
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.5573625235245577,0.9093890232377541,0.631578947368421,0.955506790036235,1.0,5/7,18.55%,GAB1;HSPB1;PIK3CD;VEGFA;MYO1C
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3575651794886284,0.9093770204764485,0.6851851851851852,0.9551557112499,1.0,30/169,16.64%,GRM3;GFAP;HEPACAM;NDRG2;NTSR2;OLIG1;MYRF;OLIG2;PMP2;DPY19L1;ST18;NRXN1;SYNPR;GAMT;TF;DSCAML1;PTPRT;GRM5;LRRTM3;ATP1A2;FAM163B;SLC39A12;GPM6B;CLDN14;GPR62;GABRG1;FASN;ANLN;MOBP;DLG2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.5954195152256815,0.9092309893825187,0.6842105263157895,0.9551285661458161,1.0,3/6,37.27%,NDP;VPS18;ULK3
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.6139655746745433,0.9091547837087501,0.6730769230769231,0.9549324365756218,1.0,2/5,18.37%,SLC22A3;SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5215199611734053,0.9090150239059359,0.6071428571428571,0.9548571334909655,1.0,2/12,9.42%,SIRT1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.4101269738350382,0.9086069760529519,0.5357142857142857,0.9554236030800775,1.0,3/43,9.04%,SMAD6;PPM1A;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5189313617962044,0.9082902418146634,0.603448275862069,0.9556713053518935,1.0,1/12,0.57%,SYK
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.5930628104280076,-0.9078971756222828,0.6046511627906976,1.0,1.0,2/6,10.05%,ARHGDIB;NODAL
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5147727111955646,0.9068400846293395,0.5862068965517241,0.9582859610415043,1.0,9/18,33.66%,SYNE4;FERMT1;RAP2A;PARD3;CYTH1;CYTH3;CLASP1;MYO9A;OPHN1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3610806797440468,-0.9068192720860803,0.625,1.0,1.0,16/162,13.75%,TERT;HK2;MTFR2;PTCD2;FANCG;BIK;AFG3L2;ADCK1;IFIT2;PARP1;CAV2;DNM1;NIPSNAP2;SPG7;SUPV3L1;TIMM44
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.43955481607890823,0.9067360728240822,0.603448275862069,0.9581419788632722,1.0,4/30,10.57%,ABI3;FER;PIK3CA;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5152797347384879,0.9066288632962107,0.6078431372549019,0.9580029281222151,1.0,3/11,20.87%,NR1H3;SGK1;PON1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5326485631982303,0.9065876223774441,0.6363636363636364,0.9576906351197001,1.0,2/11,6.96%,INSIG1;PDIA2
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.5989695894961699,-0.906419839796098,0.5957446808510638,1.0,1.0,2/5,8.26%,PTCH1;PAX2
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),-0.5989695894961699,-0.906419839796098,0.5957446808510638,1.0,1.0,2/5,8.26%,PTCH1;PAX2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4767047052701791,0.9063778855728577,0.5294117647058824,0.9577925453355142,1.0,5/25,14.46%,ZNF804A;CTNNA2;FBXO7;NTNG2;PTEN
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.37311961946944927,0.9062857568413862,0.6226415094339622,0.9575960597997523,1.0,21/98,18.36%,SYK;RELA;PLCG2;FER;ITK;PIK3CA;TAB2;PSMD13;LYN;MAPK8;SOS1;PSMA1;PPP3CA;PSME4;KIT;NFATC3;MAP3K1;GAB2;MAPK10;VAV2;TAB3
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4650040703403598,0.9062192657186536,0.6086956521739131,0.9573323950432047,1.0,4/20,9.42%,TMTC2;SLC8A1;FAM20A;SNCA
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.46739140512684935,-0.9061652141854537,0.6304347826086957,1.0,1.0,2/27,4.50%,TERT;ARG2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.5948276247023842,0.9061309816905789,0.6415094339622641,0.9571650934578007,1.0,3/8,23.20%,GLUL;CPS1;GLUD1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.5431230847123958,-0.9059778347522742,0.5365853658536586,1.0,1.0,1/6,6.79%,SLC13A3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.45720459294405896,-0.9058471543068307,0.5454545454545454,1.0,1.0,6/30,11.10%,KCNE2;SCN5A;CACNA1G;KCNE1;KCNQ1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.4969896789750017,-0.9057947703106799,0.5384615384615384,1.0,1.0,1/11,7.24%,DAB2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.368787304820552,0.9053244927633114,0.6779661016949152,0.9586270981818936,1.0,19/90,9.44%,MITF;SASH3;MME;IL2RA;PNOC;LY9;ADAM28;SLC12A1;PYHIN1;GPR174;CD22;IGLL3P;IL10RA;RALGPS2;IRF8;BTLA;CLEC17A;FRK;BANK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.5173947226967919,-0.9052196737301602,0.6111111111111112,1.0,1.0,3/8,26.00%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4954546368122722,0.905074273454652,0.639344262295082,0.9588004954632805,1.0,2/19,4.66%,MRAP2;ABI3
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.5761874408004243,-0.9045575545473116,0.5675675675675675,1.0,1.0,3/5,40.39%,LYPLA2;ABHD2;ABHD12
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.49021794619970005,-0.9044093310130029,0.6222222222222222,1.0,1.0,3/16,11.10%,SCN5A;PTPN3;SCN3B
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3458587842612277,0.9042827805272095,0.5961538461538461,0.9601214393584389,1.0,27/165,20.98%,U2AF1;APOBEC1;HNRNPH1;SF3B1;LIN28A;SYNCRIP;SNRPN;IVNS1ABP;RBMS1;BICD1;NOVA1;ATXN1;SNRNP48;HNRNPD;RRAGC;ADARB2;MRPL44;CDK12;TENT4B;RBM5;ADAD2;HNRNPA2B1;SRSF11;ZCCHC8;NUFIP1;FUS;CSTF3
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5423026247235595,0.9042484527252717,0.6363636363636364,0.9598044963016312,1.0,4/12,23.63%,SLC37A4;SLC20A1;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.456027055870236,0.9041951599292188,0.5769230769230769,0.9595357859020499,1.0,1/25,0.39%,CWH43
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5684072597966084,-0.9039658419716178,0.62,1.0,1.0,4/5,26.01%,MAPK7;CALM1;RACK1;CALM3
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.5469290425190034,0.9039525863487997,0.5967741935483871,0.9597661066597631,1.0,1/10,8.61%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.5319622961057473,0.9038186546481529,0.5660377358490566,0.959703784570746,1.0,2/7,17.89%,NUDT16L1;HMGA2
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4809791049990136,-0.9037493337048028,0.7021276595744681,1.0,1.0,4/21,10.28%,TERF2IP;PARP2;SMUG1;PARP1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.5800250217248861,0.9037222848586185,0.6557377049180327,0.959540868051754,1.0,4/7,37.26%,PPP3CA;ANXA1;LARGE1;EYS
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.5564932596763849,-0.9034463916557975,0.5897435897435898,1.0,1.0,3/14,13.01%,SFRP1;AR;RARA
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3765319818707537,0.903317271907543,0.7321428571428571,0.9600056568084008,1.0,18/111,11.07%,F2;ADRA1A;CALCR;PTGFR;KNG1;SCGN;GPR33;SLC35G1;F2R;TRPC4;SLC8A1;ESR1;PDGFRA;C5AR2;HMGB1;DRD3;ABL2;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5050984856111008,0.9032012470964506,0.6136363636363636,0.959823594637066,1.0,4/26,13.66%,FGF2;PPARG;HMGB1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4522267534600901,-0.9031133311014164,0.5869565217391305,1.0,1.0,4/20,19.25%,PTPA;ARPP19;PPP1R1B;ENSA
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3862241432690094,0.9030963149973528,0.62,0.9597278399077772,1.0,16/70,19.15%,PLOD2;ST8SIA4;UBE2D3;MMP15;ABL2;ST3GAL6;QPCT;UBA3;PADI4;CSNK1G3;LOXL2;FBXL2;CPE;LOX;BAP1;FBXO11
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5564063295799975,-0.9029484542169953,0.6190476190476191,1.0,1.0,3/11,9.36%,RIN3;LRPAP1;WDR54
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.3724899040261074,-0.9029138028811694,0.5853658536585366,1.0,1.0,9/105,5.46%,IRF4;KLRC1;ICAM3;SELL;CXCL13;CD200R1;HLA-DRB1;FGL1;COL1A1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.6108120875804801,0.9028805827224706,0.6607142857142857,0.9594552436322722,1.0,1/5,10.95%,NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.6108120875804801,0.9028805827224706,0.6607142857142857,0.9594552436322722,1.0,1/5,10.95%,NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.5001907971842556,0.9027404363061472,0.5490196078431373,0.9593836530966805,1.0,2/16,1.63%,LGALS9;TNFRSF18
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.41261527319408403,0.9024755176308459,0.5333333333333333,0.959531969213408,1.0,8/49,14.76%,MYC;BDH2;CYBRD1;HJV;NEO1;TF;SMAD4;PICALM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.4324374109411181,0.9024100354623646,0.6538461538461539,0.9593361904475107,1.0,3/32,3.52%,LGALS9;FZD5;PYHIN1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.4000669635291591,0.9023208094170243,0.6,0.9590975852176774,1.0,6/63,7.94%,BOK;FGFR3;IL4;DCC;TNFRSF10A;ITGAV
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.49595613735966904,0.9022067932811387,0.6153846153846154,0.9589355470344587,1.0,2/14,7.62%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5769319141639884,0.9021451794717845,0.673469387755102,0.9587211458324592,1.0,1/8,3.40%,HIF1A
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.4679372913352724,0.9019337620313643,0.603448275862069,0.9587549515612479,1.0,6/16,18.71%,FGF2;EPHB4;EFNB2;GREM1;VEGFA;PIK3R3
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4422189465520522,0.9018416958169364,0.6,0.958593238632427,1.0,5/26,9.00%,CLSTN2;NLGN1;VSTM5;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.38059078986174794,0.9017734330325206,0.6666666666666666,0.9583410942175679,1.0,11/69,16.80%,PLEKHH2;LDLR;NAV3;SNCA;PIK3CA;KANK1;SMAD4;HSPA8;HDGFL3;DYRK1A;IAPP
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5475657711696791,-0.9014773558426906,0.6818181818181818,1.0,1.0,2/8,14.79%,RNF8;GPR183
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3358968434026422,0.9014074994533736,0.7358490566037735,0.9587323362794173,1.0,50/299,18.21%,ASB17;C3;RAB38;HIF3A;ASB18;HIF1A;SOCS2;SPSB2;KNG1;ASB15;CDH2;PENK;EVA1A;VCAN;KLHL21;ASB5;SPSB4;FBXL3;SOCS6;DCUN1D1;ANKRD9;GAN;FBXO30;TF;KEAP1;LTBP1;TNC;SENP8;PSMD13;FBXO7;KCTD6;FBXL14;PRKCSH;PTP4A2;KLHL42;DNAJC3;PSMA1;PSME4;DCAF5;CSF1;UBA3;ESCO1;ASB6;UBXN7;MGAT4A;FBXL15;FBN1;BMP4;KTN1;KLHL13
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.38236870609327667,0.901172002503477,0.5901639344262295,0.9588327595187566,1.0,19/70,23.64%,SIRT1;CDKN2A;SLC8A1;LATS1;LYN;IRAK3;SPRY3;PTEN;LRP6;NR2F2;BMP4;RGS14;PKIA;RASIP1;DUSP7;HEXIM2;ABL1;LRP5;INCA1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.41929093151226327,-0.9011033120948956,0.5490196078431373,1.0,1.0,6/47,8.86%,PALM3;SIGIRR;OAS3;OAS1;RNF113A;TRAIP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.4345965882203898,0.9009692468855184,0.6274509803921569,0.9589378646835348,1.0,7/52,11.62%,PLD6;BOK;RALA;HTRA2;MCU;PLAUR;FBXO7
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.3558982250728966,-0.900904133102962,0.5714285714285714,1.0,1.0,15/109,9.13%,KCNMB2;KCNE2;KCNA3;KCNJ16;KCNJ1;SLC24A4;KCNN3;SLC9A8;KCNA5;KCNE1;KCNN2;KCNQ4;KCNV1;KCNQ1;KCNJ11
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4399333734997043,0.9007418625530917,0.6136363636363636,0.9590619225590312,1.0,6/31,18.20%,HELB;NUDT16L1;KLHL15;UBQLN4;HMGA2;UBR5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4803226425567219,0.9006292916671779,0.6065573770491803,0.9589623090308186,1.0,10/28,23.52%,KLRD1;IL23R;NECTIN2;CADM1;HLA-E;ITGAM;HLA-F;FADD;IL23A;CD160
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5209875511229229,0.9003240584231451,0.6,0.9591861160116248,1.0,2/11,5.40%,BMP2;ROBO2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4657641233108372,-0.9002640428805829,0.575,1.0,1.0,5/18,21.19%,SLX4;RAD50;BRCA1;BLM;UBE2V2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3398209987902963,0.9002529273473799,0.7368421052631579,0.9589249238241245,1.0,31/225,13.08%,C3;EPHA7;PHGDH;PBX3;IL1RAPL2;POU6F2;CDH2;CNTNAP2;ROBO2;MYRF;CHD7;AFF2;SOX6;THOC6;VCAN;NHLH2;CNTN6;ADGRL2;PDGFC;PAX6;ATXN1;SNTG2;DSCAML1;PROX1;NPAS1;GSN;NR4A2;HAP1;LIG4;EMX1;GRIN2D
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.612179474519521,0.9002130915505984,0.6470588235294118,0.9586069201160899,1.0,4/5,37.84%,NEXMIF;TNN;SRGAP2;ADGRG1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.613672426335159,-0.8999227341688537,0.6829268292682927,1.0,1.0,1/5,3.00%,CCBE1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.5958417189841484,0.8998695254382111,0.6530612244897959,0.9589303422228297,1.0,1/6,0.38%,GATA4
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3860583948474711,-0.8997374025558698,0.6666666666666666,1.0,1.0,6/69,5.18%,SELP;SELE;NMUR2;XCR1;P2RY11;BTK
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.44440718003168583,0.8996664242533995,0.546875,0.9589544124668461,1.0,4/42,9.46%,CSTA;URI1;PTX3;GPSM1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.5792066421300728,-0.8995592620809706,0.6578947368421053,1.0,1.0,1/6,13.83%,PRDX1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.40185706671749555,0.8992787376049225,0.6909090909090909,0.9594577846638096,1.0,19/57,25.52%,TGFBR1;AGR2;CDKN2AIP;LGI1;SLC44A4;EXOSC4;ZNF639;DERL2;PLCB1;RPS6KA1;SLC25A33;ADAM10;ADNP2;BRAT1;NCBP1;H3-3A;AKAP6;EGFR;CIB1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.41684000904314256,0.899117850806355,0.6363636363636364,0.9593820083216902,1.0,8/40,19.78%,CHODL;ROBO2;PLXNB1;PLXNB2;DBN1;L1CAM;CDKL5;MACF1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3994782260286813,-0.8989790176880654,0.6818181818181818,1.0,1.0,5/58,8.21%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3994782260286813,-0.8989790176880654,0.6818181818181818,1.0,1.0,5/58,8.21%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3994782260286813,-0.8989790176880654,0.6818181818181818,1.0,1.0,5/58,8.21%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4600766688022923,0.898924757539248,0.5689655172413793,0.9593679377232328,1.0,13/28,21.43%,SOCS2;NRIP1;ESR1;RAMP3;GGT5;LOC400499;NCOA3;WNT8B;CTNNB1;LCOR;RUVBL2;CRHBP;SSTR1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6030650258960908,0.8988071344157833,0.7254901960784313,0.9592258928352091,1.0,3/6,19.16%,SPIRE2;FMN2;ESPN
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.3834579648492962,0.8987886695313704,0.62,0.958875471504537,1.0,21/112,14.80%,NXPH1;LRRC3B;KCNC2;GFAP;CADM2;NTSR2;SLC17A6;NKAIN2;PARM1;SYNPR;OLFM3;ANK2;PTPRT;GRM5;LRRTM3;ADGRB3;PAK5;TMEM196;UBE2QL1;ZNF536;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.44048388124329957,0.8985923700984342,0.5789473684210527,0.9589279258305978,1.0,10/36,18.48%,TGFBR1;SNAI1;BMP2;WWTR1;EZH2;SMAD2;SMAD4;CRB2;LOXL2;CTNNB1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5326517057155591,0.8985262420965994,0.6140350877192983,0.9587151986914372,1.0,5/9,31.08%,RUVBL2;NUFIP1;NAF1;SHQ1;PIH1D1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.5660864542406319,0.898456387404467,0.6226415094339622,0.9581341195674334,1.0,2/6,12.42%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.5660864542406319,0.898456387404467,0.6226415094339622,0.9581341195674334,1.0,2/6,12.42%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3412193835984805,0.8984389034926638,0.6785714285714286,0.9578037217325631,1.0,50/317,19.78%,ATP6V0D2;REP15;RAB38;ACD;TVP23B;TCIRG1;TBC1D8B;PPARG;EHD1;RAB31;TBC1D12;LRP1B;LTBP2;SNX31;IL10RA;MTTP;RAB3C;VPS26C;ABCA1;RAMP3;ARL5A;TBC1D3L;TF;ARRDC3;SGSM3;RAB23;CD74;ATP6V0A4;TOM1;ATP6V0B;RABL2B;RPGR;GRTP1;LMAN2L;LRP2;TBC1D4;RAB29;MIA2;GGA1;CALCRL;TBC1D5;STX8;STXBP3;RAB28;TMED1;VPS29;ZDHHC17;GOLPH3L;STX5;MACF1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.5443362797904514,0.898412458866901,0.609375,0.9575255811419926,1.0,2/7,20.72%,ATPSCKMT;PPIF
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.45881359446603165,0.8982813546080948,0.6226415094339622,0.9573941457273578,1.0,12/37,27.57%,SIX4;HAP1;ROGDI;MESP1;TRAK2;WNT2;RYK;CDK6;SPOCK1;BTBD2;ANXA1;CHAC1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5444757203098356,-0.8980514054972493,0.5952380952380952,1.0,1.0,2/10,3.82%,IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4414278542168244,0.8980121465196278,0.52,0.9576312539543635,1.0,2/42,2.18%,FGF10;SIRT1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.4535503045136204,0.8975807167611207,0.5964912280701754,0.9582836938412993,1.0,11/20,36.81%,BICD1;G3BP1;PRRC2C;LSM14A;YTHDF2;CSDE1;RPS23;YTHDF3;YTHDF1;DYNC1H1;DDX3X
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.5061635916228236,0.8975769305369563,0.6779661016949152,0.9579208401297825,1.0,1/13,0.41%,FHDC1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5753410197654036,0.8973283915448608,0.625,0.9580300787395304,1.0,3/6,29.92%,CPNE1;HSPA1A;LAPTM5
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.5644647441740628,0.8972814602194905,0.7446808510638298,0.9577477818470728,1.0,1/6,10.90%,EXOSC4
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4738003253446424,-0.8971817967105992,0.5319148936170213,1.0,1.0,4/15,15.69%,WNT7A;EPHB1;SHANK1;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.541018299519115,0.8971800141919715,0.6440677966101694,0.9575552784655013,1.0,1/12,1.59%,IRS1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.4919306994487132,0.8970637481660388,0.6346153846153846,0.957362924427127,1.0,4/11,20.27%,HMGB1;RAG2;LIG4;RAG1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.549580403181208,-0.8967677823712353,0.58,1.0,1.0,1/6,2.76%,TIE1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5182978716035603,0.8967092970231452,0.6037735849056604,0.9578632052771722,1.0,3/10,10.99%,SMDT1;MCUB;MCU
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5423532316524791,0.8962412601047417,0.62,0.9584619865002657,1.0,4/8,26.80%,NFE2L2;HSPA5;EIF2AK3;DDIT3
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4477638656939337,0.8960528658086022,0.625,0.958476618762863,1.0,13/28,36.26%,DCP1B;EXOSC4;CNOT8;EXOSC1;PATL1;LSM2;DIS3;LSM3;DCP2;EXOSC2;EXOSC5;EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.5593376856865216,0.8957500425042391,0.6779661016949152,0.9588112010289316,1.0,2/13,4.75%,NRG1;CDH2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.48321662265302795,0.895705530910585,0.5625,0.9585058492990624,1.0,6/20,12.34%,CSPG4;UGDH;CHSY3;VCAN;BGN;CSGALNACT1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.4740268369653494,-0.8956154724199356,0.6,1.0,1.0,1/19,0.27%,TERT
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.4990401127642117,-0.8955350072877989,0.6304347826086957,1.0,1.0,5/12,20.36%,CAV1;PTK2B;ACTN2;CAV3;VIP
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.38502605939081047,0.8954976968480765,0.639344262295082,0.9585204475989714,1.0,11/75,17.47%,RUNX1;LMO2;ZFP36L2;LMO1;PDGFRA;PSMD13;BMPR1A;PSMA1;PSME4;MYB;NELFB
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4195328366432082,-0.8953093349463106,0.5813953488372093,1.0,1.0,5/39,10.12%,TRIM56;RNF8;TRIM5;ARIH2;PRPF19
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.47276076122118654,0.8952912726023662,0.5272727272727272,0.9585162351919585,1.0,5/14,20.93%,DMC1;TPRKB;SMC5;RAD54B;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.40716052277495957,-0.8951213002145694,0.5849056603773585,1.0,1.0,16/51,25.51%,GPR132;PSMB4;PSMC4;PSMD8;RFPL1;SKP1;ATF5;PSME3;PSMD12;PSMD2;PSMC2;PSMC3;PSMA5;PSMC1;AURKA;PSMD3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.3711068824473343,-0.8950254244277979,0.7804878048780488,1.0,1.0,2/58,2.91%,TERT;PRKCD
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.5393981800886164,0.8950085678108557,0.65,0.9587469278254448,1.0,1/6,5.72%,ABCC2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.35705529002825453,0.8947765314411074,0.6857142857142857,0.9588083782044254,1.0,15/137,10.13%,VAPB;GSTM2;ABHD3;GCH1;PCSK5;SLC44A5;LPIN3;ACHE;PCYT1B;NANP;HPGDS;ELOVL5;SLC44A4;CHPT1;CEPT1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.44322319698713697,0.8946075445972297,0.6612903225806451,0.9587477265641184,1.0,13/30,36.26%,DCP1B;EXOSC4;CNOT8;EXOSC1;PATL1;LSM2;DIS3;LSM3;DCP2;EXOSC2;EXOSC5;EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.38061883804826147,0.8944542515909589,0.6727272727272727,0.9587481254706867,1.0,11/79,13.46%,SEMA5A;TENM1;NAV3;FER;PROX1;CRACD;BIN1;CARMIL1;NCK2;SYNPO2;FCHSD2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.425608373515475,0.8941056229268403,0.5645161290322581,0.9591050233491702,1.0,12/46,27.98%,JADE3;ACTL6A;MSL2;EPC1;HCFC1;RUVBL2;KANSL3;OGT;ING3;EP300;ZZZ3;MSL3
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.43510470777325677,-0.8939587679649982,0.6222222222222222,1.0,1.0,10/35,14.87%,TERT;FOS;ATOH8;JUN;EGR1;SPI1;FOSL1;SMAD3;ETS1;TGFB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.5846548452488768,0.8937506207941684,0.6481481481481481,0.9594569567676171,1.0,2/5,25.74%,FBXO7;LANCL1
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.5806273760212183,0.8933287650425753,0.6041666666666666,0.9600757867850102,1.0,1/6,5.66%,MTTP
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.5223089759907583,0.89326433266216,0.5166666666666667,0.9598320345515238,1.0,2/12,11.56%,SLC26A6;SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.45448642443183074,0.8927962496611523,0.6101694915254238,0.9605626479717471,1.0,4/30,14.46%,LRP4;PCM1;PAX6;PTEN
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.5474835261012838,-0.8926767927985858,0.5853658536585366,1.0,1.0,2/7,12.55%,KDM2B;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.40736625903684565,0.8926637930461513,0.6730769230769231,0.960449984759006,1.0,3/36,3.52%,LGALS9;FZD5;PYHIN1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.41679170652476594,0.8926310837760782,0.6590909090909091,0.9601408509291984,1.0,10/51,12.89%,LGALS9;CCL5;HAS2;HIF1A;CD40;RELA;SNCA;NLRP7;HYAL3;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5810341229207182,0.8922616809405329,0.6521739130434783,0.9604775379908159,1.0,4/8,25.06%,NR1H3;F2RL1;LBP;NINJ1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.48697410205635927,0.8917753901905648,0.5901639344262295,0.9612582177563285,1.0,3/13,12.27%,STING1;UBA5;RETREG1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.4896361024920022,0.8916872119855974,0.5737704918032787,0.9610753422619758,1.0,4/13,20.46%,PCM1;CEP120;SYNE3;SUN2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.40770894239971267,0.8915997842632597,0.7241379310344828,0.9608832619640046,1.0,13/57,22.34%,HIF1A;NEDD4;SNCA;SLC30A2;SLC25A13;ZACN;PPP3CA;LOXL2;PLSCR1;SLC30A4;GPHN;SLC25A12;TRPC1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.45887774435801887,0.8912989139863959,0.5833333333333334,0.9610509918989701,1.0,3/22,11.50%,METTL21C;PRMT1;CAMKMT
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.3963303353686157,-0.8910436859133856,0.6326530612244898,1.0,1.0,8/81,2.73%,P2RY10;KLRC1;SPON2;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.45841056893109383,-0.8910433219714439,0.6666666666666666,1.0,1.0,4/34,10.29%,OAS3;OAS1;DHX58;TYRO3
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.5277667722455185,0.8909896775102486,0.6363636363636364,0.9609753380704519,1.0,6/9,46.44%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.5277667722455185,0.8909896775102486,0.6363636363636364,0.9609753380704519,1.0,6/9,46.44%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5940524543208139,0.890842989295693,0.6140350877192983,0.9609748792216034,1.0,1/6,10.95%,NECTIN2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.46274194968986615,0.8907163886156619,0.64,0.9608484989417924,1.0,6/21,23.64%,CDKN2A;LATS1;PTEN;NR2F2;HEXIM2;INCA1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5015786346475695,0.8906798329976827,0.7169811320754716,0.960545060409112,1.0,1/13,5.24%,PHKA1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.6218985047844525,0.8905786301178316,0.6545454545454545,0.9599714902734232,1.0,1/5,5.71%,DIPK2A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.6218985047844525,0.8905786301178316,0.6545454545454545,0.9599714902734232,1.0,1/5,5.71%,DIPK2A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.4455861663629575,0.8904550012049496,0.64,0.9599015677753092,1.0,10/29,30.57%,GPM6B;PICALM;LEPROTL1;CTNNB1;ABCA2;STX3;ABCA7;COMMD1;TMEM35A;GBF1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.4665897537522047,-0.8903228095440325,0.5681818181818182,1.0,1.0,5/15,10.15%,APOBEC3H;BTBD18;DDX4;PIWIL2;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.417362367427236,-0.8901722005257756,0.6326530612244898,1.0,1.0,5/40,10.49%,DDX11;TERF2IP;FOXM1;RTEL1;RAD51AP1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3659840646684669,0.8900781998935041,0.5517241379310345,0.960283217884182,1.0,34/122,21.81%,SIRT1;MYC;SNAI1;ZBTB1;PADI2;KAT2B;ESR1;ACTL6A;HDAC3;HDAC2;SMARCD3;EZH2;HP1BP3;SMARCD2;ARID1A;LRWD1;SETD7;SMARCAD1;PADI4;LOXL2;MYB;HMGA2;HMGN4;KDM6A;SMARCA2;HCFC1;CHD1;HDAC1;RUVBL2;BRDT;KDM5B;BRWD1;NPM3;SATB2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5264439662472735,-0.8898760661384868,0.6153846153846154,1.0,1.0,1/5,19.75%,RNF20
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5187184048780791,0.8895983761603574,0.6229508196721312,0.9608832691225471,1.0,2/13,2.87%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4083235365742091,0.8894349558110497,0.5789473684210527,0.9608270316739124,1.0,19/46,27.58%,FGFR1;CEP85L;AUTS2;NR4A2;GPM6A;MEF2C;LRP12;KIAA0319;VEGFA;CDKL5;RAPGEF2;ASTN2;ADGRL3;SPOCK1;USP9X;PEX13;NRCAM;SDCCAG8;DNER
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5250871443459872,0.8893719001229545,0.6363636363636364,0.9602778008952536,1.0,3/8,16.75%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5250871443459872,0.8893719001229545,0.6363636363636364,0.9602778008952536,1.0,3/8,16.75%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.4369647644639717,0.8890928591180706,0.5517241379310345,0.9605656586952808,1.0,9/29,31.02%,STK33;CHEK2;CDC5L;H2AX;HINFP;DOT1L;CLSPN;CLOCK;MAP3K20
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3913555304183828,0.889046955006708,0.6779661016949152,0.9602634882151896,1.0,13/70,11.77%,ACSM2A;IRS1;SIRT1;HIF1A;PPARG;ADIPOR2;FOXO1;HKDC1;PAX6;CYB5R4;MCU;LEPR;BACE2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.41316183257824457,0.8889747085528383,0.7090909090909091,0.9601193897365137,1.0,11/49,22.34%,EPS8L2;EPS8;ARHGAP5;RHOD;ROPN1B;PHACTR4;RHOU;RHOG;RHOB;GNA13;CNKSR1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5542324265445906,-0.8888851882534207,0.7297297297297297,1.0,1.0,1/7,5.08%,PAH
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.4807721057915908,0.8885812393529974,0.66,0.9605229934657683,1.0,4/27,13.22%,ABI3;ABHD17B;PDLIM5;ABHD17C
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.4952941920714059,0.8885469320472761,0.631578947368421,0.9602165465658495,1.0,6/17,16.12%,KLKB1;F12;ASTL;GSN;BAG2;NKD2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4473687855503549,0.8884460262871918,0.6181818181818182,0.9600401715206458,1.0,6/24,21.31%,SIRT1;ZNF692;FBP1;SIRT7;GCK;SDHAF3
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5077294331119163,0.8884403090219051,0.6833333333333333,0.9596877896774845,1.0,9/14,28.92%,TRPC4;SLC39A8;TRPC5;SLC30A10;ATP2C1;TRPC1;SLC39A14;TRPC3;TMEM165
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.6226117188691316,0.8884114028979576,0.6938775510204082,0.9593959125354158,1.0,2/5,26.94%,NR1H4;LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.5607317178196941,0.8882584247357861,0.5925925925925926,0.9594284815115968,1.0,2/8,8.92%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.5402506176219241,0.8881888364269901,0.6923076923076923,0.9592156356598565,1.0,1/7,13.48%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.5394848262688074,0.8880254170455459,0.5636363636363636,0.9591556837731634,1.0,2/9,8.92%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5374938005691746,0.8874439191297814,0.6078431372549019,0.959863772197475,1.0,2/13,3.00%,CXCL12;CCL5
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.4929416241528504,0.8872221488520365,0.7727272727272727,0.9599377359000426,1.0,7/21,17.88%,RUNX1;ASTL;NLRP7;RNF139;BAG2;NKD2;GAS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4108155452540446,-0.8872044523804472,0.5227272727272727,1.0,1.0,11/50,23.72%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4;NDUFA3
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.4108155452540446,-0.8872044523804472,0.5227272727272727,1.0,1.0,11/50,23.72%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4;NDUFA3
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5045729181309557,0.8870374835671538,0.6379310344827587,0.9600070203607518,1.0,6/11,25.31%,MYRF;PTEN;ABCA2;PLP1;TENM4;HES5
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.504905155573217,-0.8870303071769851,0.5476190476190477,1.0,1.0,1/13,2.40%,DRD4
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.4999662527239169,0.8869199784526017,0.6545454545454545,0.9599329950857938,1.0,3/22,17.42%,RAB38;PMEL;RAB29
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.37764810632563206,0.8865586155296987,0.6842105263157895,0.9603902613976641,1.0,10/74,14.76%,PRR16;SAMD4A;EIF3E;SP1;RELA;LRRTM3;HNRNPD;BCL3;PLXNB2;PICALM
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.4064756858596147,0.8863226425360463,0.7291666666666666,0.9605516484904857,1.0,4/51,4.50%,SASH3;CSF3R;ITGAX;PIK3R5
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34510582725509353,0.8862675773950492,0.7291666666666666,0.9603205591429406,1.0,28/215,12.74%,IGF1;C3;IRS1;RSPO3;TGFBR1;SIRT1;ZBTB7B;HIF1A;KAT2B;IL7R;RSPO2;NLGN1;CDKN2AIP;BMP2;RBPJ;KLK5;NRXN1;ITGAV;KLK14;TLR2;DRD3;PDE6H;RIMS2;CTBP2;KANK1;CD74;HAP1;F3
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5720730998781203,-0.8860316543364168,0.6,1.0,1.0,1/5,9.16%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5720730998781203,-0.8860316543364168,0.6,1.0,1.0,1/5,9.16%,NRDE2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.5825131886151179,0.8859643011757243,0.7142857142857143,0.9605372202085875,1.0,1/7,5.19%,BMP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.5113815077962226,0.8856803690330682,0.5818181818181818,0.9608459652081127,1.0,4/11,34.29%,STX3;ABCA7;TMEM35A;RANGRF
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.5557788886813542,0.8854809931902048,0.6491228070175439,0.9609377742913872,1.0,4/8,36.56%,EZH2;DOT1L;DPY30;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5140780217454026,0.8853642445786624,0.6078431372549019,0.9608497657320583,1.0,1/12,2.44%,ZBTB7B
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3828416335050117,-0.884981204666005,0.5952380952380952,1.0,1.0,9/75,6.75%,EHF;CLDN4;GPR39;TMEM184A;SERINC2;KIF12;FOXQ1;LAMB3;CLDN1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5467065041241825,0.8849230958781816,0.6222222222222222,0.961374578182778,1.0,1/9,2.68%,MLC1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37823128847078125,0.884841164416372,0.7017543859649122,0.9611621241980783,1.0,15/119,15.04%,FGF10;LGR5;SEMA5A;ZEB2;NRARP;PPM1A;RNF146;GPC5;KANK1;PSMD13;TBL1X;LGR6;PSMA1;PTK7;PSME4
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.36432301752257945,0.8847864625088634,0.6481481481481481,0.960917605441337,1.0,20/98,18.36%,SYK;RELA;PLCG2;FER;ITK;PIK3CA;TAB2;PSMD13;LYN;MAPK8;SOS1;PSMA1;PPP3CA;PSME4;NFATC3;MAP3K1;GAB2;MAPK10;VAV2;TAB3
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.3535617904363034,-0.8845182049249067,0.5909090909090909,1.0,1.0,17/123,13.42%,GFRA3;RFX6;TMEM179;ENPP2;TRPA1;ADCYAP1;SCG3;TTBK1;VWA5B2;GLP2R;CELF3;CNGA3;INA;LRRTM1;FFAR4;CDH22;SCG5
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.4953534084362079,0.884381210687757,0.5535714285714286,0.9613221453912163,1.0,7/19,18.93%,FZD5;FRAT2;FZD1;LRP6;WNT8B;CTNNB1;DVL2
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.5620024959274175,0.8843479515937253,0.6724137931034483,0.9610271490480069,1.0,2/6,10.90%,MYO1E;MAGI2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.44475611695940176,-0.884238083396245,0.6304347826086957,1.0,1.0,1/22,4.22%,CMTR1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.40324453998911103,0.8841954757052966,0.6551724137931034,0.960971495718802,1.0,4/40,10.55%,MOGAT2;SIRT1;LPIN3;LIPG
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.4438744896566955,0.8841878015039034,0.625,0.9606079045361615,1.0,5/27,13.23%,PEX12;GDAP1;ZFAND6;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.33731280557214605,0.8841027471392245,0.7368421052631579,0.9603870326835189,1.0,22/170,19.10%,PRR16;SHMT2;LIN28A;PATL2;SAMD4A;SYNCRIP;EIF3E;TOB1;FOXO3;RNF139;GRM5;RIDA;HSPB1;HNRNPD;BCL3;PLXNB2;EIF3H;CAPRIN1;MTRF1;CNOT8;RPS6KA1;METTL18
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4683228109350359,0.8840610488815541,0.6551724137931034,0.9601203954402228,1.0,7/20,21.72%,TOX;PROX1;SMARCD3;VEGFA;LRP2;CTNNB1;CX3CR1
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.5838845788749609,-0.8837010220731973,0.6666666666666666,1.0,1.0,1/6,1.35%,TEK
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5376563269210456,0.8836463245420372,0.6037735849056604,0.9606161494393345,1.0,4/9,24.81%,GPM6B;PICALM;LEPROTL1;COMMD1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.37407832107876415,0.883553745569614,0.5660377358490566,0.9604138838773786,1.0,17/69,18.00%,IRGM;CCL5;RELA;TICAM1;HMGB1;NLRP7;LYN;PDE4B;MEF2C;NR1H3;MAPK8;TNIP3;CD80;IRAK1;CARD16;NFKBIB;AXL
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.3600498901366493,-0.883343224229093,0.5909090909090909,1.0,1.0,9/90,5.18%,P2RY10;SELL;CD86;TRAF3IP3;CD53;CYTH4;CUX2;DOCK8;BTK
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.483466254741871,-0.8830077909068075,0.6595744680851063,1.0,1.0,4/16,10.90%,KIF2B;IHO1;CDC6;BUB1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.6115922674292169,0.8828630112163967,0.660377358490566,0.9614826571470182,1.0,1/5,21.20%,CTU1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.5154754606206012,-0.8826821887591131,0.6545454545454545,1.0,1.0,4/10,15.66%,DUSP6;WWC1;DUSP9;LATS2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.432174041935425,-0.8826200062707849,0.575,1.0,1.0,5/19,17.37%,NEMP1;TMEM43;DCTN1;EMD;AKAP8L
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.5564082408760741,0.8825845351566921,0.5892857142857143,0.9616883982747824,1.0,1/8,7.25%,PIP4K2A
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5307593254427636,0.8823706858292412,0.6129032258064516,0.9618160463740081,1.0,4/9,23.32%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.3749794659430873,0.8823611694395171,0.625,0.9614578166772236,1.0,10/87,6.49%,FGF10;PRRX1;STAB1;GNG12;PPARG;LRIG3;CSPG4;KANK2;WWTR1;TEAD2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4551834331840561,0.8823240443013991,0.6779661016949152,0.9612006416952796,1.0,4/25,14.46%,BMI1;DCUN1D1;ARRDC3;PTEN
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4624871644433802,-0.8820233201421435,0.5128205128205128,1.0,1.0,3/23,2.29%,NUPR1;TEK;IL11
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.4222862219594661,0.881892442536519,0.6181818181818182,0.96157561633163,1.0,10/49,18.93%,LIX1;FZD5;MYC;FRAT2;HSPA8;FZD1;LRP6;WNT8B;CTNNB1;DVL2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5752454194943777,0.8818776532995036,0.7,0.9612682364620175,1.0,3/7,32.03%,AXL;APPL1;APPL2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.37325026344689893,-0.8818690439491538,0.6666666666666666,1.0,1.0,15/96,16.79%,DDX11;INCENP;UCP3;NEMP1;FTSJ3;PDCD11;CHD4;SNRNP200;CHAF1A;DARS2;DHX38;MCM2;HNRNPL;ILF3;TTF2
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.5249670235922341,0.8817145712952813,0.6779661016949152,0.9612356445289927,1.0,2/8,3.88%,IL4;EHD1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4568143006468673,0.881712845653143,0.5692307692307692,0.9608737335182513,1.0,7/27,19.78%,IL4;MARVELD3;CORO1C;PTPRM;PTEN;NR2F2;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.380318153604747,0.8816152344542981,0.6727272727272727,0.9607590096782784,1.0,26/90,25.52%,STAC2;DPP10;AGR2;TCAF2;EPHA3;RAMP3;TP53BP2;MAPK8;PPP3CC;NKD2;RHOG;MYO1C;MFF;ARHGEF16;CD81;ITGAM;TP53;ITGB2;PPP1R13B;BAD;AKT2;STX3;MIEF2;DLG1;EGFR;CIB1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.4291301571353844,0.8811689332722005,0.6226415094339622,0.9612568560242567,1.0,7/39,17.19%,RHOBTB3;LLGL1;NLGN1;RHOD;FMNL3;RHOBTB1;RHOG
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.35662085346124156,0.8811573182999084,0.6896551724137931,0.9609044834723094,1.0,15/109,14.38%,FGF10;NRG1;FGF2;ERBB4;CCDC125;ABI3;CAVIN1;NRG2;ABL2;FGF17;FGF5;AMOTL1;PLXNB1;FRMD5;PLXNB2
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.42336484161063037,0.8811294638280225,0.6491228070175439,0.9606026165847554,1.0,6/35,14.16%,FZD5;UBE2D3;HTRA2;LMAN1;RHOU;UBE2J2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.39616348223958653,0.8809924593326337,0.6451612903225806,0.960538388924593,1.0,4/43,7.15%,ZBTB7B;PPARG;BMP2;NAPEPLD
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5401676327922731,-0.8804465062828696,0.6590909090909091,1.0,1.0,1/7,5.14%,GOLGA2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.5049265123849356,0.8803927766995631,0.7096774193548387,0.9612409458807496,1.0,1/14,1.10%,HS3ST5
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.572195735955902,0.8803064547780028,0.64,0.9603138716777859,1.0,2/5,31.67%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.572195735955902,0.8803064547780028,0.64,0.9603138716777859,1.0,2/5,31.67%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.572195735955902,0.8803064547780028,0.64,0.9603138716777859,1.0,2/5,31.67%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5271476060553004,0.8802468795412518,0.6440677966101694,0.9601086039415014,1.0,6/11,38.79%,PKD1;CPSF6;PKD2;CBR4;NUDT21;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.45697786521267186,0.8801571168034529,0.6909090909090909,0.9599900417992332,1.0,1/26,0.53%,SASH3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.48327959159567335,0.8801534628396532,0.6226415094339622,0.9596438863714956,1.0,3/14,10.14%,FGF2;BMPER;SMAD1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.5456620689925791,-0.8800504346720128,0.6153846153846154,1.0,1.0,2/7,9.36%,F7;NTRK3
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.5243818487957514,-0.8799805912530551,0.5833333333333334,1.0,1.0,1/7,3.17%,SFRP1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.37302635711502946,0.8797872972276881,0.7142857142857143,0.9600445080225827,1.0,9/78,13.23%,ZDHHC11;ZDHHC12;PEX12;GDAP1;ZDHHC22;RAB3IP;ZDHHC2;ABCD3;ABCD2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.34806563383296496,-0.8793503744957756,0.8125,1.0,1.0,14/169,8.55%,CYP1A2;PTGES;CYP2E1;SLC6A6;ARG2;UPB1;XDH;HSD11B1;ATOH8;SMOX;PTS;NMT1;ABCC3;ETS2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.532379995758776,0.8792883155874477,0.6538461538461539,0.9607041928227349,1.0,5/10,25.55%,LRRC55;ANK2;ATP1B2;GAL;AKAP9
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.552044833522819,0.8792205929871404,0.6938775510204082,0.9604536779189301,1.0,1/8,5.31%,MID2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.45685722911174187,-0.8791632841682671,0.6666666666666666,1.0,1.0,3/23,10.33%,PRKCD;TMSB4X;MYADM
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.569568572970447,0.8791347046309892,0.66,0.9599213945565261,1.0,3/7,20.10%,KIT;PIK3CD;MILR1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.569568572970447,0.8791347046309892,0.66,0.9599213945565261,1.0,3/7,20.10%,KIT;PIK3CD;MILR1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.35297539420429425,0.879092815977477,0.6779661016949152,0.959648736325117,1.0,32/113,18.57%,DEPP1;ALDH1A1;EDIL3;SCGN;MAFB;RESP18;PCDH17;DPP4;RAB3C;PLPPR1;PTPRD;PAX6;FGF14;PROX1;MAGI1;PTPRT;TMEM196;NOL4;KCNB2;TMEM98;MAGEL2;RUNX1T1;CNTN3;SEMA6D;FRZB;CPE;MAPK10;CNTN4;PRRG2;PCSK2;PDZRN3;HMGCLL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.45054897989721515,0.8790214761539106,0.68,0.9594126157677451,1.0,5/27,16.26%,SIRT1;PPARG;LIPG;NR1H3;ABCA8
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.5647233386602636,0.8789599008262836,0.7111111111111111,0.9591630515932281,1.0,2/6,16.11%,BMP2;LRP6
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.6183167939923362,0.8789239842484685,0.7547169811320755,0.9589045972012857,1.0,4/5,31.04%,GGT5;DPEP1;CHAC1;CHAC2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3731182549130713,-0.8788890177221578,0.673469387755102,1.0,1.0,8/87,5.03%,NTRK1;INSRR;TEK;DRD4;TIE1;HLA-DRB1;LDB1;TSPYL2
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5505772101630291,0.8786673856011897,0.6792452830188679,0.9590863898474401,1.0,2/10,15.06%,PPARG;RARB
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.539017175661965,0.8786522563437432,0.5961538461538461,0.9587692027223703,1.0,2/8,17.72%,FBXO5;BMP4
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.45606499467063255,0.8784946276501681,0.603448275862069,0.958683448248183,1.0,8/20,34.63%,AKTIP;STX8;PTPN23;SNX16;HOOK1;WDR81;KIF16B;RAB7A
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.3705706982480199,-0.8779562157332936,0.6590909090909091,1.0,1.0,6/68,6.87%,GOLGA8B;ABRAXAS1;HAUS7;GOLGA2;TUBGCP2;GOLGA8A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5594391131789637,0.8778206731053287,0.6842105263157895,0.9595357912712003,1.0,5/7,33.60%,VSIR;TNFSF4;DDIT3;IL12A;PRNP
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5905819402582096,0.8778036205188914,0.6666666666666666,0.9592006718863086,1.0,3/5,36.81%,STMP1;CD36;DDX3X
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.4545668995578744,0.8775268155412909,0.6666666666666666,0.9594952200177566,1.0,7/18,18.98%,SLC39A8;SLC30A2;TRPM2;SLC30A6;SLC30A4;SLC30A10;SLC30A1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3394014422961481,0.8772274981075523,0.8,0.959780495669078,1.0,27/191,18.97%,SIRT1;SPSB2;NEDD4;SYVN1;PELI1;RNF185;SPSB4;UBE2D3;SOCS6;ANKRD9;UBE3D;SPOP;RNF139;SPOPL;PSMD13;TBL1X;HECW2;KLHL42;PML;RNF5;PSMA1;PSME4;RMND5A;NFE2L2;UBE2U;CTNNB1;NHLRC3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.4327955866951201,0.8770951844272407,0.6515151515151515,0.9596628505572878,1.0,6/36,16.04%,PLD6;TDRD9;FKBP6;PIWIL1;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.505956302866373,0.8770169788097899,0.6792452830188679,0.9595091080250349,1.0,1/16,3.00%,CCL5
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.5499970015513578,0.8770161733418181,0.6607142857142857,0.959161057832393,1.0,2/7,16.28%,KIT;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.44409625262405905,-0.8770047915521287,0.6363636363636364,1.0,1.0,5/37,10.49%,DDX11;KDM4D;FOXM1;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5140005469254898,-0.8766377455155292,0.6222222222222222,1.0,1.0,2/8,10.27%,DDRGK1;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.5697475950196362,0.8764973716276125,0.6785714285714286,0.9598166537649065,1.0,2/5,36.81%,NCK1;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.4694192623112445,0.8761704008108877,0.7166666666666667,0.960042544375476,1.0,2/16,4.41%,MAFB;PRMT1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5871914390238497,0.8760726065772482,0.7090909090909091,0.959848241692489,1.0,1/5,4.65%,TENM3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.4303825326931676,-0.875466470974138,0.6818181818181818,1.0,1.0,3/32,12.50%,TRMO;METTL6;TARBP1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.4998411959502977,0.8747666517821289,0.5471698113207547,0.9619295039241548,1.0,4/9,27.18%,GALK1;GALK2;GALM;GALT
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.5556848234604842,0.8746788016035086,0.6304347826086957,0.9617436707382755,1.0,1/8,0.92%,FGF10
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3777378933038988,0.8746016316507744,0.6825396825396826,0.961625646118808,1.0,13/76,23.81%,SIRT1;MAPKAPK2;BAG2;HSPA8;CD34;DNAJB1;RANBP2;MLST8;IER5;CHORDC1;HSPA1A;MAPK3;NUP153
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.48329243994573406,0.8744842277190663,0.6956521739130435,0.9615031994240028,1.0,1/13,9.44%,TOB1
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.5508242559678377,0.8742171986932541,0.6739130434782609,0.9617189452740085,1.0,1/5,21.39%,IL5
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.5451090829030791,0.8742049529239819,0.7222222222222222,0.961371237297422,1.0,1/7,5.52%,SLC38A3
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3470603888936775,-0.8740978392096619,0.6585365853658537,1.0,1.0,13/123,8.74%,SELP;TRIM56;SELE;SIGIRR;IL1RL2;IL18BP;IL6R;TNFRSF11A;TIMP4;CIITA;SLC11A1;LAMP3;MEFV
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.3645216961612011,-0.8739442455137467,0.6956521739130435,1.0,1.0,8/78,9.32%,ALB;PM20D1;CD200R1;DUS2;CLU;PAX2;LRPAP1;WFS1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3400901701821516,0.8738707950235751,0.7049180327868853,0.9616724609947378,1.0,24/142,16.25%,DUSP29;CTDNEP1;DUSP23;PLPPR1;PPP4R1;PPM1A;PTPRD;PPP1CC;PTPN14;DUSP18;ACP6;PTPRT;PPM1L;PTPRK;FBP1;PTPRM;PPM1E;DUSP2;PTEN;PPP3CA;PPP3CC;MTMR3;DUSP28;PPEF2
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5071474464977431,0.8735038595979409,0.6981132075471698,0.9616935657262458,1.0,3/12,11.80%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5071474464977431,0.8735038595979409,0.6981132075471698,0.9616935657262458,1.0,3/12,11.80%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.6001905067742916,-0.8734267657793955,0.7560975609756098,1.0,1.0,2/5,34.83%,MAPT;DNM1L
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.5674741834330825,-0.8731531955502365,0.6521739130434783,1.0,1.0,2/7,4.18%,HLA-DRB1;IL18BP
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.5113812219711031,0.873131726843732,0.65625,0.9621023275292058,1.0,6/11,27.79%,KNG1;CD34;EDN1;SERPINE1;APOH;APOE
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4790864879011395,-0.8729429788747085,0.6511627906976745,1.0,1.0,2/11,10.27%,PER2;TMSB4X
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.5480597221688905,0.8726686142616696,0.673469387755102,0.9626772129618336,1.0,1/7,3.18%,CTCFL
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3796250211681049,-0.8725909450264432,0.6511627906976745,1.0,1.0,11/67,12.85%,TEK;NLRP3;PRKCD;ALOX5;MEFV;DHX58;TYRO3;CCN3;FFAR4;APOA1;MAPK7
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),-0.5599146524662513,-0.8722865376789611,0.6326530612244898,1.0,1.0,2/5,20.24%,PAX2;PAX8
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.4953266533251778,-0.8722123866735332,0.6428571428571429,1.0,1.0,2/15,6.32%,UPB1;NT5C
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.568459721373,-0.8721917596786006,0.6153846153846154,1.0,1.0,2/7,18.83%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5424813635756022,0.8720182111634885,0.6,0.9636473510986026,1.0,1/8,3.18%,CTCFL
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3753659582134371,0.8719885976646459,0.7333333333333333,0.9633627556757668,1.0,14/64,11.56%,GPR55;ADRA1A;DRD5;CHRM2;GPR174;GPR33;F2R;OPRK1;ESR1;C5AR2;DRD3;GPR17;GRM5;HTR2C
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.5461067572016928,-0.8718483270546297,0.6153846153846154,1.0,1.0,1/5,6.79%,SLC13A3
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.46231723230062105,0.8717374059340872,0.6779661016949152,0.9634467982141401,1.0,6/20,26.87%,TTLL2;TTLL9;TPGS1;NAA11;TTLL7;AGBL4
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4287758937053062,0.8714247301520202,0.7454545454545455,0.9637059415298365,1.0,12/54,23.23%,NEDD4;SEC22B;ASB5;FOXO1;VSIR;HECW2;TIPARP;STX5;SMURF1;C4BPB;GSK3A;FZR1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.37492801824475064,0.8712267027272557,0.6851851851851852,0.9636865320964831,1.0,25/125,18.21%,EPHA7;PHGDH;PBX3;CDH2;CNTNAP2;ROBO2;AFF2;SOX6;ADGRL2;ATXN1;SPEF2;DSCAML1;PROX1;CTNNA2;HAP1;EMX1;GRIN2D;PLXNB2;PTEN;PCDH18;SHROOM4;POMK;ROGDI;CNTN4;PITPNM1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.5068541589620602,0.8710890622596534,0.6792452830188679,0.9636626489648176,1.0,4/14,11.84%,DAPK2;MOSPD2;MCU;CD74
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.437712176452553,0.8710874424685567,0.7037037037037037,0.9633112776469569,1.0,1/28,0.39%,CWH43
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.44366894743902086,0.8710511139874159,0.6140350877192983,0.9630453755156612,1.0,2/25,2.87%,FGF10;FGF2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5111285304406601,-0.8707652036480118,0.625,1.0,1.0,2/7,15.35%,CTPS1;PRPS1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3663021936640601,0.8704972380894035,0.7115384615384616,0.9637166312905339,1.0,29/102,19.58%,ALDH1A1;GFAP;NDRG2;FREM1;PCDH17;PMP2;DHRS3;NRXN1;MEGF10;PTPRD;RAMP3;EFS;ANK2;PTPRT;ATP1A2;CNTN1;GRIK3;CRTAC1;INTS6;GPM6B;ZNF536;FRZB;L1CAM;CNTN2;SLC18A2;GPRC5B;SORCS1;ACKR1;CCDC3
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.368233640934805,0.8704299710046437,0.6545454545454545,0.963522478467166,1.0,13/81,8.90%,TMPRSS2;AP1M2;CAPN13;RUNX1;SCNN1B;HIF1A;ANPEP;AGR2;EPS8L2;ESR1;DSP;RHOD;SLC44A4
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5245002699003793,0.8704105358969477,0.7377049180327869,0.9632254342503929,1.0,4/9,27.09%,SNCA;RAB33B;IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.463126558825323,0.8701923199874715,0.6290322580645161,0.963327161056873,1.0,6/18,25.88%,SYT1;RIMS2;SYT17;SMURF1;CPNE9;SYT3
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.4641714090480612,0.8701491940755934,0.5932203389830508,0.9630259312415905,1.0,1/18,1.10%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.40913568604103184,0.8700780148032999,0.7090909090909091,0.9628233692362504,1.0,4/41,8.74%,RAPGEF3;NEDD4;HCLS1;HDAC3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.5875850664303789,0.8700680763188952,0.7058823529411765,0.9624867613980904,1.0,3/9,14.46%,MYRF;ABCD2;PTEN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3547702003285448,0.869971874893109,0.660377358490566,0.9624052779864971,1.0,31/160,21.27%,F2;PROZ;VAPB;SPTBN5;SEC22B;CD59;GOLT1A;TRAPPC3L;BET1;ANK2;LMAN1;TMEM115;COL7A1;DCTN3;ANK1;DYNC1I2;LMAN2L;RAB29;MIA2;COG5;VTI1A;TMED1;KLHL12;STX5;CD55;TRAPPC8;TMED3;TFG;STX17;VAMP4;ACTR10
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.44624720267878704,0.8698195521146729,0.6666666666666666,0.962341734033188,1.0,2/17,7.62%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.430099818876194,-0.8697257934018606,0.6326530612244898,1.0,1.0,5/33,5.21%,DRD4;SFRP1;RHBDF1;FAM3D;DRD2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.3825702473689615,-0.8694933394397042,0.5625,1.0,1.0,12/35,19.30%,ASS1;BMP6;ZNF703;MYADM;PODXL;AKNA;APOA1;MAPK7;TGFB1;RGCC;GTPBP4;ADTRP
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5115373492718646,-0.8690887596863093,0.6226415094339622,1.0,1.0,1/11,5.82%,RBM4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5115373492718646,-0.8690887596863093,0.6226415094339622,1.0,1.0,1/11,5.82%,RBM4
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.41015870260543474,-0.8690457952279848,0.6875,1.0,1.0,10/54,17.11%,HK2;DDX18;LAS1L;PLK4;RABEPK;SUPV3L1;MRTO4;SORD;GNL3;MYBBP1A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.5621003979122386,0.8688225916129838,0.6984126984126984,0.9638331812225526,1.0,2/6,14.46%,ZFP36L2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.45073646010246,-0.8687416134549111,0.5833333333333334,1.0,1.0,4/30,9.74%,CD86;HLA-DRB1;FGL1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.48365891125842975,0.868702555878558,0.6551724137931034,0.963675360673841,1.0,10/24,26.97%,NLGN1;TENM1;RALA;GPM6A;WASL;FMR1;FNBP1L;ARAP1;PLPPR5;DOCK11
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5036685376318466,0.8680502218970867,0.6440677966101694,0.9648080257474809,1.0,4/17,16.38%,CSTA;DSP;TGM6;CD247
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.4919321578821765,0.8678247915496565,0.6,0.9648954448782262,1.0,1/11,5.40%,ROBO2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.48592166230678957,0.8677690412749994,0.5964912280701754,0.9646660214190544,1.0,2/13,6.63%,EIF3E;C8ORF88
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.51290431324213,0.8676711963918028,0.6530612244897959,0.9645438071124813,1.0,2/10,8.89%,TMEFF2;HDAC2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4228314058829597,-0.8676681058114734,0.6176470588235294,1.0,1.0,2/30,5.70%,ABRAXAS1;TICRR
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.40308916730430927,-0.8676516298526965,0.6888888888888889,1.0,1.0,7/43,11.30%,DUSP4;DUSP6;SPRED2;SPRED3;CAMK2N1;SPRED1;DUSP9
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.40937917361035236,0.8676262626555472,0.6964285714285714,0.964265638758815,1.0,2/32,1.13%,IGF1;CALCR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.47749351587114913,-0.867608674083601,0.6153846153846154,1.0,1.0,3/14,2.34%,IRF4;NLRP3;CD86
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.46246156422915013,0.8674743763209117,0.6896551724137931,0.9641793150512367,1.0,6/20,16.57%,CSRP2;SIX4;TNNT1;MYPN;CSRP1;LMOD2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.5012327887833928,0.867057772031375,0.6060606060606061,0.964578663052142,1.0,2/12,2.98%,IGF1;IL4
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.4763729089327764,-0.8670475643555817,0.6363636363636364,1.0,1.0,2/11,2.34%,NLRP3;CD86
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.4268862295869572,0.8658962553532298,0.6458333333333334,0.9665676141376538,1.0,8/31,22.57%,PLEKHG2;HCLS1;LATS1;FCHSD2;DBN1;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.4080478024456497,-0.8658184632993547,0.5813953488372093,1.0,1.0,5/33,9.13%,KCNE2;KCNJ16;KCNJ1;KCNQ1;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.4139226435417674,0.8654816261687859,0.7076923076923077,0.9669969573185885,1.0,6/31,14.34%,GSTM2;STAC2;LRRC55;ANK2;HAP1;ATPSCKMT
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.3261407356123741,0.8654698542382758,0.711864406779661,0.9666694473419847,1.0,33/243,16.38%,MITF;CXCL12;FERMT3;BOK;MATN1;MYC;CD40;LLGL1;SEC22B;CD59;STING1;TEAD2;SLC7A9;BET1;PDE4DIP;WDCP;LIN7A;MAGI1;LMAN1;TLE2;MCU;COL7A1;CD74;RANBP9;PML;PYGO1;PICALM;CLDN14;VAMP3;IL2RB;DMD;ANO6;CD247
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.44698366222095753,0.8654071560479824,0.5636363636363636,0.9664667379459397,1.0,6/21,20.17%,LLPH;NLGN1;FOXO6;CAPRIN1;DBN1;FMR1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.5754217543208473,0.8653220490029611,0.7258064516129032,0.9662463890689281,1.0,3/7,29.85%,KIT;CTH;EFEMP2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.5507271482807442,-0.8652862540583601,0.6818181818181818,1.0,1.0,1/7,4.93%,SAPCD2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.39275413734283676,0.8648660460598071,0.6333333333333333,0.9668130270096483,1.0,11/51,18.53%,PRMT1;E2F4;CNOT6L;PLAGL1;CHEK2;PML;CNOT4;CDC25C;GTSE1;CNOT8;CNOT2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4813794150044654,-0.8646145242991357,0.574468085106383,1.0,1.0,2/17,6.37%,ENC1;PSMB4
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.35323746645152243,0.8645717181505265,0.7924528301886793,0.9670193094229554,1.0,17/85,22.93%,U2AF1;PCBP3;ZFP36L2;NUDT16L1;PCF11;RIDA;SLFN14;DXO;HNRNPA2B1;SRSF11;AGO3;CSTF3;HSPA1A;TP53;NCBP1;HIPK3;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.48776928076106874,-0.8645713693625873,0.6046511627906976,1.0,1.0,2/12,3.88%,TAFA3;IL31RA
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3768675832038305,0.8645082468580736,0.6981132075471698,0.9667901160248313,1.0,3/77,2.36%,IGF1;CDC14A;NDC80
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5044649627668288,0.8643571854507821,0.66,0.9667919944969959,1.0,3/10,22.53%,ADA;PRPS2;HPRT1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4995510686757958,0.8643008748145077,0.6557377049180327,0.9665142243285176,1.0,5/12,20.84%,CSRP2;PGM5;CSRP1;BMP4;SHH
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.505720409832772,-0.8641441160450237,0.6862745098039216,1.0,1.0,2/13,8.37%,NT5C;SMUG1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.38679770483461595,0.8640499341482438,0.6730769230769231,0.9666005094546344,1.0,14/48,23.72%,FZD5;UBE2D3;HTRA2;TP53BP2;RHOU;UBE2J2;MAPK8;PPP3CC;BAP1;TP53;GSK3A;PPP1R13B;BAD;SREBF2
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.572787700289392,-0.8638027775595958,0.6304347826086957,1.0,1.0,1/5,7.80%,SLC2A8
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.474014494945072,0.8636971971299746,0.6938775510204082,0.9669573034386724,1.0,6/21,23.42%,MAP2K6;TAB2;IRAK1;TAB3;TAB1;RIPK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.4495015002664131,0.8632922813672196,0.703125,0.9675488382192593,1.0,4/26,4.24%,SEMA5A;IL4;ANGPT1;CD40
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.41097413392639615,0.8632045979885556,0.6545454545454545,0.9673199533332084,1.0,6/43,9.77%,SYK;RAB27A;TULP1;ITGAV;TLR2;IL15
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3610031265887249,0.8629659485089051,0.7586206896551724,0.9674412647511111,1.0,20/81,17.39%,RIT2;ROR1;RETREG3;TOX;TENM3;ZNF804A;FUT9;EPHA3;ABL2;MAGI2;LYN;PLXNB2;PTK7;FZD1;RAP1A;LRRC7;CAPRIN1;RET;DBN1;COBL
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.34968104970522573,-0.8624602957763365,0.7142857142857143,1.0,1.0,11/126,8.31%,TRIP10;ARAP3;RAC2;OBSCN;RASGRF2;STARD8;VAV3;ARHGDIB;FOXM1;ARHGAP15;ARHGAP12
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.3794328770900035,-0.8622324429470005,0.6923076923076923,1.0,1.0,4/67,3.92%,ACTC1;FRMD6;OBSCN;TMOD1
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.41661670615518276,0.8621915937012745,0.640625,0.9686786300031907,1.0,10/24,28.53%,TCN2;SLC52A1;SLC19A1;SLC2A14;SLC19A2;TCN1;SLC27A1;TTPA;CBLIF;SLC46A1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.383819821699156,-0.861951991765408,0.6976744186046512,1.0,1.0,5/54,6.05%,RFX6;CELA2A;ALOX5;PER2;KCNA5
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.5444192755313095,-0.8619044051710419,0.5789473684210527,1.0,1.0,2/5,20.24%,PAX2;PAX8
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.41659819555135125,-0.8618963641340976,0.7142857142857143,1.0,1.0,4/30,7.67%,RIN3;VAV3;NEB;PPP1CA
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.5767101957222831,0.8618125681837303,0.734375,0.9690960018269912,1.0,4/6,42.06%,TTPA;GLTP;PLEKHA8;CERT1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.552832730827807,0.8617977211796566,0.74,0.9687827945701453,1.0,3/8,9.04%,CCL5;EPS8;HMGB1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.49755721409874354,-0.8617046259451564,0.717948717948718,1.0,1.0,1/8,3.23%,ENPP2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5395922107035547,0.8614725044539064,0.64,0.9690538226667935,1.0,4/5,32.03%,PTPRC;APPL1;CD47;APPL2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4286835217678171,0.8614685572617262,0.6666666666666666,0.9687098999939613,1.0,1/24,1.36%,MSH4
prerank,PanglaoDB_Augmented_2021__T Cells,-0.38004630493869973,-0.8613946424275054,0.7,1.0,1.0,7/91,2.73%,P2RY10;TBC1D10C;SELL;SIRPG;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5123502557511582,0.8613728753186974,0.660377358490566,0.9685784393352727,1.0,2/11,3.02%,ZBTB7B;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.4784751094782903,0.861268712410946,0.7017543859649122,0.9684205575052951,1.0,3/26,5.30%,FZD5;ZBTB1;IL23R
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.4213837919434558,0.8611595616959272,0.6438356164383562,0.9682583726365762,1.0,6/26,25.08%,TLR2;H2BC21;STAB2;HLA-E;LBP;MR1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3792228464201167,-0.861116246602135,0.7,1.0,1.0,3/50,4.57%,TEK;SFRP1;LDB1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5477233356214678,0.8610569419669475,0.6607142857142857,0.968100721933592,1.0,1/6,12.33%,BNIP3L
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.5734672098648863,0.8608247584252232,0.74,0.9679402207859454,1.0,1/5,8.26%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.5734672098648863,0.8608247584252232,0.74,0.9679402207859454,1.0,1/5,8.26%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4160930522842335,0.8607539850354584,0.6666666666666666,0.9677431543321169,1.0,6/31,20.41%,SIRT1;RNF152;EPM2A;PRKAA1;KPTN;DEPTOR
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.46561525855293145,-0.8606761443991848,0.6511627906976745,1.0,1.0,2/19,6.76%,COL5A1;MFAP5
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.5593366788487638,-0.8606277402763785,0.6875,1.0,1.0,1/6,15.69%,SHANK3
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5543270032592784,-0.8603946280947945,0.66,1.0,1.0,2/6,22.23%,BRCA1;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.4499265032616129,0.860378516638248,0.6122448979591837,0.9681283303461972,1.0,3/27,10.79%,TIMELESS;PAXIP1;ARID2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5623079291267715,-0.860364362160127,0.7446808510638298,1.0,1.0,1/5,18.54%,AMER1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5439010196369835,-0.8602446260716998,0.6744186046511628,1.0,1.0,2/6,8.26%,FGF1;PAX2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.33206129611016655,0.8601514695177895,0.7735849056603774,0.9681517508420291,1.0,31/250,16.81%,STK26;FHDC1;CDC14A;EHD1;FGD4;SSTR3;TNIK;VSTM5;SPAG16;PCM1;RHOD;RAB3IP;CEP20;MTSS1;RAPGEF6;BBS9;RAB23;GSN;CARMIL1;LZTFL1;TRAPPC14;BBIP1;SSX2IP;KIAA0586;RAP1A;KIT;ANO6;RABL2B;RPGR;DNM3;ARHGEF6
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3352160646946347,0.8600380928020408,0.7258064516129032,0.9679988885489871,1.0,22/172,14.93%,CGNL1;SIRT1;URI1;CD22;RORA;RELA;ESR1;PPM1A;DRD3;BANK1;MAGI2;EPM2A;PLAUR;LYN;TSPAN6;CPNE1;NR1H4;ARHGAP25;SPRY3;PTEN;TNIP3;TANK
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4578555021504883,-0.8600013725890243,0.6428571428571429,1.0,1.0,6/19,11.73%,NLRP3;ADGRG3;TMSB4X;HDAC7;SPI1;CCN3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.41112304158236135,0.8598125306881492,0.65,0.9680972247968777,1.0,12/36,26.05%,EFNA5;CDKN2A;KANK1;CORO1C;SEMA3E;FZD4;JAG1;ADAM15;NEXMIF;AP1AR;SPOCK1;NOTCH1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.5567484971491007,0.8592836138598464,0.7017543859649122,0.968803165943237,1.0,1/6,8.10%,UNC13B
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3908042988177602,0.8590076822966765,0.7115384615384616,0.9689539617898557,1.0,4/38,7.58%,TIMELESS;RFWD3;SLFN11;PRIMPOL
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.5473762785678522,0.8589455206746874,0.6530612244897959,0.9687306262317109,1.0,1/7,0.97%,TYR
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.550188311185167,0.8587889609075063,0.7017543859649122,0.9683328079332029,1.0,1/7,13.58%,RACGAP1
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.550188311185167,0.8587889609075063,0.7017543859649122,0.9683328079332029,1.0,1/7,13.58%,RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.4418383574660939,0.8585598169587623,0.6507936507936508,0.9685143241184657,1.0,11/22,28.00%,FGF2;KNG1;PTEN;PHLDB2;CD34;EDN1;CRK;SERPINE1;APOH;APOE;CASK
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.5133960697556794,0.8582522582181252,0.5925925925925926,0.9688011624926578,1.0,3/6,22.56%,TNFRSF10A;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.47931800847938993,-0.8581069564226123,0.7441860465116279,1.0,1.0,1/17,1.35%,TEK
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.44926172143172677,-0.8580763196765244,0.6428571428571429,1.0,1.0,4/17,15.78%,KIF2B;STMN1;STMN3;KATNB1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.42513127941183043,-0.8580446431219534,0.6,1.0,1.0,3/27,13.25%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.42513127941183043,-0.8580446431219534,0.6,1.0,1.0,3/27,13.25%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3132017011952226,0.857844740174132,0.82,0.9691976011301218,1.0,32/372,12.36%,IRGM;FHDC1;CDC14A;KASH5;RAB38;LMOD3;SAC3D1;DLGAP5;EHD1;PATL2;SSTR3;STING1;SPAG16;GOLGA8S;AUP1;PCM1;BICD1;HDAC3;STARD9;RAB3IP;PGM5;TP53INP1;CEP20;ATG101;BBS9;CHMP6;RAB23;GSN;LZTFL1;E2F4;TRAPPC14;BBIP1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3493945175924173,-0.8578002627625736,0.7727272727272727,1.0,1.0,14/91,12.85%,TEK;SIGIRR;NLRP3;PRKCD;ALOX5;DRD2;MEFV;DHX58;TYRO3;TRIB1;CCN3;FFAR4;APOA1;MAPK7
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.46982672504422673,-0.8577475484030399,0.625,1.0,1.0,2/14,8.32%,PIAS3;EGR1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.577593022070605,-0.8577336962929573,0.6511627906976745,1.0,1.0,4/5,35.54%,TBL3;NOP14;NOP9;UTP20
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.577593022070605,-0.8577336962929573,0.6511627906976745,1.0,1.0,4/5,35.54%,TBL3;NOP14;NOP9;UTP20
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.577593022070605,-0.8577336962929573,0.6511627906976745,1.0,1.0,4/5,35.54%,TBL3;NOP14;NOP9;UTP20
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3436858225979817,-0.8576236965871141,0.8235294117647058,1.0,1.0,11/89,11.84%,TMEM179;RGS8;DRD2;VGF;ZCCHC12;PCDH8;CELF3;ST8SIA2;C2CD4C;STMN1;INA
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.38950984304660885,0.857609132116272,0.7037037037037037,0.9693347007834958,1.0,9/43,20.22%,SIRT1;HDAC3;HDAC2;TBL1X;SIRT6;SIRT7;HDAC1;HDAC9;MIER3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.4467464392764161,0.8575873663664323,0.6296296296296297,0.9690459554735223,1.0,3/16,9.67%,SAMSN1;BANK1;PAG1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.34967907209696786,0.8575267580908837,0.7833333333333333,0.9687969066505135,1.0,26/130,11.56%,NPC1L1;GATA4;SLC26A3;ACE2;MOGAT2;NR5A2;SLC35F1;APOBEC1;CLDN2;CYP4F12;PPARG;ANPEP;SLC15A1;MTTP;ABCC2;MUC13;CYBRD1;DPP4;ABCG8;PPP1R14D;CYP3A4;MUC17;SLC52A1;ABCG5;TMEM45B;SLC2A5
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.5028379686683141,0.8572976607138413,0.6229508196721312,0.9688769849439384,1.0,2/9,13.90%,ATP1A2;PPP1R12B
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.42776997211932105,0.8572590685703384,0.6909090909090909,0.9686281768528586,1.0,5/29,18.62%,FGFR3;DCC;PTEN;KIAA0319;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.4297024408248037,-0.8572040289989196,0.675,1.0,1.0,4/23,7.08%,TNFSF18;F7;IL6R;ZP3
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.34021101460150704,0.8571807442529702,0.6792452830188679,0.9684014622744678,1.0,18/136,16.53%,CDC25A;NDE1;CEP70;CEP152;KCNH5;FBXO5;PCM1;PSMD13;DCTN3;CEP135;DYNC1I2;CDK4;CNTRL;CDC25C;PSMA1;PSME4;NEDD1;CCP110
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.5165955025514551,-0.8569018143153732,0.6521739130434783,1.0,1.0,2/7,11.37%,TMSB4X;CCDC22
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.48724167396091156,0.8567374193628743,0.7254901960784313,0.9688189504001206,1.0,1/13,3.59%,LDLR
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.4825932335337423,0.8566521405788855,0.75,0.968601089785683,1.0,2/17,11.32%,SDC4;CHMP6
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.5411800459795001,0.8565718212159923,0.711864406779661,0.9683702520039065,1.0,2/6,6.56%,ABI3;VSTM5
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3284697506674471,0.8562256882340066,0.875,0.9687260294174257,1.0,38/171,19.69%,SLC7A11;TYR;C3;KAT2B;SLC10A3;BCAM;LMO2;VEZF1;SELENBP1;PIGQ;SLC4A1;HTRA2;DCUN1D1;SNCA;FOXO3;NUDT4;EPB41;CA2;GMPS;FBXO7;BNIP3L;ANK1;CCND3;PICALM;CDR2;GYPA;NEK7;RBM5;MFHAS1;ELL2;GYPC;SLC30A10;ACKR1;SLC30A1;BPGM;MXI1;ALDH6A1;MOCOS
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.387299813965089,-0.8559681019800528,0.5918367346938775,1.0,1.0,5/49,4.29%,SELP;SELE;PALM3;CD24;TNFRSF11A
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3696808440497302,0.8557419056970413,0.7,0.9685895914588085,1.0,13/92,15.04%,SYK;KLRD1;MUC20;RELA;MUC13;PLCG2;TAB2;MUC17;PSMD13;LYN;MUC7;PSMA1;PSME4
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3696808440497302,0.8557419056970413,0.7,0.9685895914588085,1.0,13/92,15.04%,SYK;KLRD1;MUC20;RELA;MUC13;PLCG2;TAB2;MUC17;PSMD13;LYN;MUC7;PSMA1;PSME4
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3696808440497302,0.8557419056970413,0.7,0.9685895914588085,1.0,13/92,15.04%,SYK;KLRD1;MUC20;RELA;MUC13;PLCG2;TAB2;MUC17;PSMD13;LYN;MUC7;PSMA1;PSME4
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.3966154456181666,-0.8556078742802282,0.6222222222222222,1.0,1.0,4/50,5.03%,DDX11;ERN2;TPP1;TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.4050597687916749,0.8554956257015165,0.660377358490566,0.9686650860875066,1.0,6/48,10.94%,STAC2;DPP10;AGR2;EPHA3;RAMP3;EPB41
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.4634357242648359,0.8550893515195503,0.7288135593220338,0.9687722420703677,1.0,5/18,14.80%,IL1RAPL2;PTPRD;SNCA;GPC4;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.4634357242648359,0.8550893515195503,0.7288135593220338,0.9687722420703677,1.0,5/18,14.80%,IL1RAPL2;PTPRD;SNCA;GPC4;LRFN5
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3109275027415203,0.8549167366438181,0.9122807017543859,0.9687340873064483,1.0,58/327,25.82%,U2AF1;APOBEC1;NXF1;HNRNPH1;SYNCRIP;THOC6;MRPL28;RBMS1;ZAR1L;MRPS12;BICD1;NOVA1;SMG1;ATXN1;NXT1;NR4A2;DDX19B;HNRNPD;RPS5;RRAGC;BCL3;ADARB2;MRPL44;RPL21;MLF1;RBM5;EPC1;NXF5;THRB;ADAD2;TSPAN17;NFKBIB;HNRNPA2B1;MRPL11;RANBP2;RPL7;SRSF11;NUFIP1;RPS3A;RPL23A;RPL18A;ELAVL4;WDR33;NCBP1;POLR2H;MRPL10;MRPL18;MRPL41;NUP153;TESC;SRSF3;HNRNPU;DNAJB11;HNRNPF;RPS29;RPS15A;MEF2A;DDX39A
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5770661759404676,0.8547992700605911,0.7413793103448276,0.9686435930551536,1.0,3/8,17.03%,TGFBR1;VEGFA;LRP2
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.5313493813805482,-0.8547669340801011,0.5882352941176471,1.0,1.0,1/6,4.68%,RPF2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.33494889279931833,0.8544494135158773,0.8035714285714286,0.9689065134266842,1.0,37/141,15.68%,EMB;CDH7;CLDN2;LRRC4C;CDH20;CDH6;TENM3;NLGN1;CDH2;TENM1;ROBO2;SDK1;CLDN6;UNC5D;CDH12;CNTN6;MYPN;PTPRD;ALCAM;CLDN12;DSCAML1;DSCAM;NECTIN2;PTPRT;GPC4;HMCN1;CADM1;IGSF11;PTPRM;PLXNB2;CLDN14;LRFN5;ROBO3;CDHR3;CRB2;CLDN18;CDH10
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.42513229814286885,-0.8544430456600853,0.6585365853658537,1.0,1.0,6/22,13.57%,SFRP1;SPRED2;SPRED3;SPRED1;ZNF750;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4683891322557845,0.8542692876742135,0.6785714285714286,0.9689686493869203,1.0,4/18,10.78%,FZD5;IL4;IL18R1;DENND1B
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.5336748774483637,-0.8541821467524431,0.7,1.0,1.0,3/6,23.46%,MMP9;HFE;NRP1
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.5388999722671156,0.8539613009825555,0.711864406779661,0.9691527986566765,1.0,2/11,9.49%,COX19;ANKRD9
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.4810753764461551,0.853947878774895,0.6428571428571429,0.9688051828752358,1.0,4/13,27.09%,ZFP36L2;NR3C1;HNRNPU;ANXA1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.5283958144769666,0.8539177628495558,0.6842105263157895,0.9685449380638668,1.0,3/6,27.09%,HLA-E;STOML2;ANXA1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.38061182650360337,0.8538271691698262,0.7454545454545455,0.968337134088341,1.0,15/62,24.23%,SYK;DOCK1;PLCG2;PIK3CA;LYN;BLK;CD247;VAV2;MYO1C;WASL;ABL1;WIPF1;MAPK3;CRK;GRB2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.30774813284978586,0.8534113969845061,0.8958333333333334,0.9689173653560439,1.0,55/355,19.15%,F2;IGF1;C3;PLOD2;KNG1;MSRB3;CDH2;PENK;EVA1A;MRPL28;PCSK5;VCAN;ZAR1L;ST8SIA4;CSF2RA;MRPS12;UBE2D3;HTRA2;SLC34A2;MMP15;MSRB1;TF;ABL2;FDX1;ST3GAL6;QPCT;LTBP1;TNC;ZDHHC2;PRKCSH;RPS5;CHEK2;RNF5;DNAJC3;IGFBP6;RPL21;CSF1;UBA3;PADI4;CSNK1G3;LOXL2;FBXL2;MGAT4A;FDXR;CPE;FBN1;LOX;BMP4;KTN1;ADORA2B;BAP1;MRPL11;RPL7;FSTL3;FBXO11
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3524320978735389,0.8532909495731862,0.7894736842105263,0.9687617936953602,1.0,34/123,23.89%,MRAP2;EHD1;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;ANK2;RAPGEF6;ZDHHC2;EFR3A;ANK1;KCNB2;KCNIP4;PACS1;RAP1A;LRP6;NKD2;TSPAN17;DENND4C;PLEKHF1;CD81;GORASP2;RAP2A;AFDN;JUP;SMURF1;RAPGEF2;TRARG1;EHD4;BSG;IKBKB;GAS6;TESC
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.5170180764325619,-0.8530878606448928,0.6428571428571429,1.0,1.0,2/8,10.74%,DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.37443374681685215,0.8528996241911452,0.7115384615384616,0.9691544140462456,1.0,15/95,24.46%,U2AF1;NXF1;THOC6;SMG1;NXT1;DDX19B;NXF5;HNRNPA2B1;RANBP2;SRSF11;FMR1;WDR33;NCBP1;NUP153;SRSF3
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.4942814341679279,0.8526515252348896,0.7222222222222222,0.9692902042853185,1.0,3/16,13.79%,SLC8A1;ATP1A2;ATP12A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3964721554767099,0.8525312812808298,0.6551724137931034,0.9691868270140562,1.0,9/41,21.39%,PIP4K2A;SDC4;CNOT6L;CEP120;CCP110;CNOT2;G3BP1;STX18;IL5
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.42525603592573713,0.8524383466756948,0.7241379310344828,0.9686718968296101,1.0,2/28,2.73%,ACSM2A;THEM5
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.42525603592573713,0.8524383466756948,0.7241379310344828,0.9686718968296101,1.0,2/28,2.73%,ACSM2A;THEM5
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.5292459397599404,0.8521790017216427,0.7647058823529411,0.9688076653947232,1.0,2/8,9.14%,MYC;ZFYVE19
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.38577645036116165,0.8518345006807665,0.7457627118644068,0.9690778931198999,1.0,12/59,18.53%,PRMT1;RFWD3;E2F4;CNOT6L;PLAGL1;CHEK2;PML;CNOT4;CDC25C;GTSE1;CNOT8;CNOT2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4246206510164853,-0.8514475780372277,0.7,1.0,1.0,10/24,27.70%,LIMK1;SHANK1;RAC1;SHANK3;SYNPO;SYNPO2L;PFN2;FHOD1;PLEK;PRKN
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.4399829513151172,-0.8513379476120664,0.6428571428571429,1.0,1.0,5/28,6.39%,TTC12;DNAH17;DNAAF1;CFAP73;DRC1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.5039611097065715,0.8512394144026153,0.7115384615384616,0.9699727397211878,1.0,1/8,6.03%,F12
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.3559778790516036,0.8512134649064971,0.7704918032786885,0.9696741562090352,1.0,16/106,13.70%,TMPRSS2;CAPN13;FGFR3;NDRG2;BMI1;PIK3C2B;PLPPR1;NEO1;ZSWIM5;DSCAML1;PTPRT;CGN;PLXNB1;ZNF704;MYRIP;PPP1R9A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3737841811326641,0.8512061251386781,0.7413793103448276,0.968990941770212,1.0,14/60,24.23%,SYK;DOCK1;PLCG2;PIK3CA;LYN;CD247;VAV2;MYO1C;WASL;ABL1;WIPF1;MAPK3;CRK;GRB2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3737841811326641,0.8512061251386781,0.7413793103448276,0.968990941770212,1.0,14/60,24.23%,SYK;DOCK1;PLCG2;PIK3CA;LYN;CD247;VAV2;MYO1C;WASL;ABL1;WIPF1;MAPK3;CRK;GRB2
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.3772202191441312,0.851072815356252,0.7017543859649122,0.9689053341632685,1.0,12/84,10.40%,FAM83H;AP1M2;TUBA1C;PPP1R14B;SHMT2;DKKL1;TEAD2;TK1;EPHB4;PYCR1;MMP15;SLC25A1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.4258195378442647,0.8509760711941361,0.6538461538461539,0.9687548190384065,1.0,7/20,23.01%,PRDX6;LIPG;SMPDL3A;PNPLA6;PLBD2;GPCPD1;PLBD1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.41677684389721326,-0.8508385377126265,0.7391304347826086,1.0,1.0,3/26,4.74%,KCNMB2;PER2;SCPEP1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3782217320556571,0.8507298107251773,0.7254901960784313,0.9688728521967046,1.0,14/90,24.46%,U2AF1;NXF1;THOC6;SMG1;NXT1;DDX19B;NXF5;HNRNPA2B1;RANBP2;SRSF11;WDR33;NCBP1;NUP153;SRSF3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.376399632737659,0.8506109504190436,0.8225806451612904,0.9688479722688388,1.0,5/51,9.70%,LDLR;NPC2;MTTP;ABCA1;PLA2G10
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.4096672585016534,0.8505585481035056,0.72,0.968606779573857,1.0,3/41,3.69%,HELB;MYC;IL7R
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.43921010804218436,0.850387963705143,0.7,0.9686598633327299,1.0,6/28,16.67%,FGF2;PPARG;HMGB1;PTPRM;MEF2C;NR2F2
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5303181485180337,0.8501486098727397,0.7413793103448276,0.9687691152037239,1.0,1/7,2.44%,ZBTB7B
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.39830615142784437,0.8501316009034641,0.7241379310344828,0.9684460901186254,1.0,7/52,11.01%,SYVN1;RNF152;PELI1;UBE2E2;UBE2D3;RNF146;UBE2E3
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.343443481528338,0.8501119833604341,0.7592592592592593,0.9681405766021484,1.0,25/100,14.62%,IRGM;LGALS9;SMAD6;F2R;GCH1;IL23R;RELA;MAPKAPK2;PELI1;MAPKAPK3;TICAM1;FER;HMGB1;SNCA;NLRP7;GGT5;ERBIN;TAB2;PDE4B;IRAK3;MEF2C;NR1H3;SRR;MAPK8;TNIP3
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4747672868944305,-0.8494646598316653,0.7435897435897436,1.0,1.0,2/21,4.31%,DNASE1L1;REXO4
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.5386304732588214,0.8492383909644466,0.7254901960784313,0.9696276318412151,1.0,2/6,21.59%,FBP1;PFKP
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.48067940882079335,-0.8492288837097933,0.5416666666666666,1.0,1.0,1/10,0.73%,KLRC1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5235132256801314,0.8490419120238664,0.7543859649122807,0.9696716237338981,1.0,2/9,3.88%,IL4;EHD1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.4545784596129126,-0.8490213693355623,0.6363636363636364,1.0,1.0,6/20,21.48%,BUD23;FTSJ3;NHP2;NSUN4;GAR1;NAT10
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.5602586392113275,0.8488315911572912,0.7272727272727273,0.9694488828723759,1.0,4/6,26.68%,PPARG;SOAT1;SOAT2;EP300
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.5602586392113275,0.8488315911572912,0.7272727272727273,0.9694488828723759,1.0,4/6,26.68%,PPARG;SOAT1;SOAT2;EP300
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.4953456681630475,0.8486107468214423,0.6326530612244898,0.9695575831698389,1.0,4/11,23.33%,DMD;GLRX;WNK1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3672009037441832,0.848283457669894,0.8135593220338984,0.9699119479281646,1.0,8/63,15.84%,CCL5;EIF3E;C8ORF88;PPP1R15B;HSPB1;NCK2;DNAJC3;EIF3H
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.5035626740771444,0.8482313274201612,0.6379310344827587,0.9696497703247023,1.0,4/10,32.20%,RRAGD;SESN2;SESN1;GCN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.5152824803270518,0.8480846194231486,0.6545454545454545,0.9695557984102269,1.0,1/9,0.38%,GATA4
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5113958625478671,0.847869043886175,0.7017543859649122,0.9696040132771674,1.0,2/13,14.12%,CCDC125;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5149713897600486,0.8477393858367027,0.7,0.9695488704848257,1.0,5/10,35.01%,CPEB1;NCBP1;CPEB3;CDC73;NUDT21
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5408272242090679,0.8475817035576632,0.7407407407407407,0.9695841427862673,1.0,1/7,5.98%,ACADS
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3461450025631006,0.8474984559982462,0.7636363636363637,0.9693569622276869,1.0,35/127,23.89%,MRAP2;EHD1;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;LIN7A;ANK2;RAPGEF6;ZDHHC2;EFR3A;ANK1;KCNB2;KCNIP4;PACS1;RAP1A;LRP6;NKD2;TSPAN17;RAB29;DENND4C;PLEKHF1;ARL3;CD81;RAP2A;JUP;SMURF1;RAPGEF2;TRARG1;EHD4;BSG;IKBKB;GAS6;TESC
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.4057879702800432,0.8474553418197855,0.7142857142857143,0.9690740350491202,1.0,12/35,26.80%,SIRT1;DRD3;BANK1;MAGI2;PTEN;ARRB2;PHLPP1;THEM4;PHLDA3;PPARA;CIB1;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3749135588313677,-0.8474006030996916,0.6842105263157895,1.0,1.0,12/78,14.70%,NUPR1;KCNE2;TRIB2;DAB2;ARIH2;CLU;DDA1;DDRGK1;TRIB1;DAB2IP;CSNK1D;RFPL1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.5090910330550934,0.8472300101723328,0.6724137931034483,0.9691653256029005,1.0,2/8,19.80%,MFF;PEX11A
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.5036831401318203,-0.8472277290737736,0.6666666666666666,1.0,1.0,3/14,8.18%,SYCE1;STAG3;SYCE2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.5036831401318203,-0.8472277290737736,0.6666666666666666,1.0,1.0,3/14,8.18%,SYCE1;STAG3;SYCE2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4510021905114432,0.8467698709766656,0.7115384615384616,0.9697249824532893,1.0,2/20,4.12%,SLC7A2;SLC1A3
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5187805169636293,0.8467222383549585,0.7090909090909091,0.9694722973548848,1.0,4/11,23.01%,F2R;PLPP1;PARD3;DGKD
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4932577858054517,0.8466948603127195,0.7192982456140351,0.9691768459674076,1.0,3/11,25.42%,PAPOLA;NCBP1;BARD1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.38146401370626587,-0.8465276765583094,0.6808510638297872,1.0,1.0,13/79,9.94%,SELL;IFI27;WARS1;CMTR1;TRIM5;SP110;OAS1;LAMP3;IFIT2;PROCR;DHX58;C1S;IFIT3
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.5794470838451904,0.8463265387419928,0.7454545454545455,0.9694869129017469,1.0,1/5,14.87%,XPO1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.4688165447031869,0.8460471867333661,0.6304347826086957,0.9695221074141286,1.0,2/12,17.71%,TICAM1;TRPM7
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.4748615014132939,0.8460323678149638,0.6444444444444445,0.9692312413600912,1.0,3/14,20.72%,TICAM1;TRPM7;PPIF
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.4547175265900428,-0.8460021762882828,0.7021276595744681,1.0,1.0,1/17,0.70%,DDX11
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.35409446681186246,0.8459119968988873,0.7666666666666667,0.9691121178193054,1.0,12/79,17.76%,NDE1;CEP70;CEP152;KCNH5;PCM1;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110;GTSE1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.37241925670106457,-0.8456166653767052,0.7380952380952381,1.0,1.0,10/49,11.10%,CD86;CYTH4;LILRB3;MS4A4A;CLEC5A;SLC11A1;HCK;LY86;CD163;SPI1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.36555934882622104,0.8456121937753247,0.7358490566037735,0.9693703269618419,1.0,16/112,14.38%,CDKN2C;SIRT1;IL4;CCL5;HIF1A;CDKN2A;FER;ROPN1B;DSCAM;GRM5;MCM7;CORO1C;LYN;HSPB1;PML;PLXNB2
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.48847294959888643,-0.8454933573019097,0.6229508196721312,1.0,1.0,6/9,26.01%,PTCH1;MEOX1;SFRP2;PPP2R3A;SMO;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.46293050602132696,-0.8454611587690918,0.6976744186046512,1.0,1.0,10/25,14.87%,TERT;FOS;ATOH8;JUN;EGR1;SPI1;FOSL1;SMAD3;ETS1;TGFB1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4766312592103431,0.8453103601221837,0.6851851851851852,0.9695340750593525,1.0,4/13,12.73%,ENPP1;AK3;AK1;SMPDL3A
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.4137286398195661,0.844924252154144,0.7017543859649122,0.9699932962871489,1.0,3/41,9.88%,CSTA;KNG1;NLRP7
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.5478384701224255,0.8447814892225448,0.6607142857142857,0.9695580117131285,1.0,3/6,37.47%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.5478384701224255,0.8447814892225448,0.6607142857142857,0.9695580117131285,1.0,3/6,37.47%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.48490759999871236,-0.8447301422706174,0.6739130434782609,1.0,1.0,1/9,5.08%,PAH
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.5674467563804305,-0.8447142168100022,0.7551020408163265,1.0,1.0,1/5,1.55%,MRLN
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5197966540928823,-0.8445086462205019,0.6304347826086957,1.0,1.0,3/6,28.95%,CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.4973951264753685,-0.8444495984168577,0.7073170731707317,1.0,1.0,2/14,3.17%,INHA;SFRP1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3337474736599413,0.8443941872764557,0.8307692307692308,0.9699439900230986,1.0,29/148,16.21%,FGFR1;RUNX1;FZD5;WNT4;OLIG1;HES6;SIX4;ARTN;OLIG2;FUT9;LHX6;POU3F2;CEP85L;NEUROD2;PTPRD;INSM2;NLGN4X;AUTS2;NR4A2;GPM6A;EMX1;RACGAP1;MEF2C;PLXNB2;MYT1L;FZD4;FZD1;LRP12;KIAA0319
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.39419815148561554,0.8441800229211819,0.7021276595744681,0.9700302463716236,1.0,6/43,13.55%,TIMELESS;HELB;ARID2;KLHL15;SIRT6;UBQLN4
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4389714219377884,0.8441509023462596,0.7254901960784313,0.9697615046599024,1.0,7/26,20.33%,CDC14A;DRD3;RACGAP1;CXCR5;PKN2;PKP4;CENPV
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5622514709026072,0.8441312342719983,0.7678571428571429,0.9694673029771165,1.0,4/6,37.39%,CD34;DDAH1;HYOU1;ENO1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.39165305192306066,0.8439838901483965,0.7142857142857143,0.9693613354456115,1.0,10/45,18.08%,SMOC1;PBX3;PAX6;FREM2;SLC39A5;ATF6;HIPK1;FBN1;ABCB5;SCO2
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.5191206264293289,-0.8439567821136746,0.7111111111111111,1.0,1.0,2/7,5.34%,PRKCD;CAMK2A
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.4888065014834102,-0.8438018750692824,0.5102040816326531,1.0,1.0,1/9,4.68%,CUX2
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.42632980877320037,-0.8437340900883882,0.717391304347826,1.0,1.0,4/19,10.62%,KLRC1;HLA-DRB1;CEACAM1;AZGP1
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.4555360774993504,0.8435077187781627,0.7213114754098361,0.9698193256501279,1.0,11/16,32.95%,CYP3A4;HSD17B10;UGT2B7;SHH;CYP19A1;HSD17B6;CYP17A1;SPP1;HSD17B4;AKR1D1;HSD17B11
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.40328948823657124,0.8434716390379,0.7166666666666667,0.9695254138738648,1.0,6/27,19.77%,LIN28A;NUDT16L1;EXOSC4;TENT4B;SLFN14;ZCCHC8
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.4668562252535169,-0.8434231874137634,0.6444444444444445,1.0,1.0,2/12,10.62%,HLA-DRB1;AZGP1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.4130920800957982,0.8433219688462232,0.6666666666666666,0.9694366129876485,1.0,9/27,25.59%,FBXO5;TERF1;IRS2;ABL1;POT1;TP53;GSK3A;HNRNPU;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.5043823031620228,0.8429584589109558,0.68,0.9697788759376826,1.0,1/10,3.59%,LDLR
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.5210415197656517,-0.8425715934314764,0.6808510638297872,1.0,1.0,3/6,7.73%,COL5A1;WNT7A;PLET1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.3982794478344428,0.8424454700599284,0.7384615384615385,0.9703469882011341,1.0,12/46,14.38%,LRAT;ALDH1A1;RPE65;NAPEPLD;DHRS3;PECR;SDC4;OPN1SW;GPC5;GPC4;BCO1;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.5094502109438721,-0.8424149636000285,0.6666666666666666,1.0,1.0,1/5,11.67%,DCN
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4079795886283505,0.8423948309281493,0.6181818181818182,0.9700916829767624,1.0,3/49,3.11%,FGF10;SIRT1;MYC
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.4141126152197945,-0.8423868237638878,0.6346153846153846,1.0,1.0,5/29,14.16%,ASS1;CAV1;CLU;SMAD3;RAC1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.33174693345584977,0.8422347970366175,0.8135593220338984,0.9700838021671112,1.0,31/161,18.43%,SIPA1;ARHGAP24;RAPGEF3;CCL5;SNX18;TBC1D8B;CD40;TBC1D12;CCDC125;F2R;RGS10;SYDE2;SCRIB;TBC1D3L;RAP1GDS1;SGSM3;RAPGEF6;EZH2;CORO1C;PLXNB1;ARHGAP25;PICALM;RAP1A;ADRB1;GRTP1;TBC1D4;RHOG;TBC1D5;PKP4;RALGAPA2;CDKL5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.36631572962060965,-0.8421683226673515,0.7291666666666666,1.0,1.0,1/50,0.47%,AMACR
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.3655360246292195,0.8421601866790638,0.7288135593220338,0.9699012113727133,1.0,3/56,4.49%,STK26;SIRT1;TFEB
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.43345956340196773,0.8419869987841757,0.6545454545454545,0.9699104423141198,1.0,2/24,0.94%,GPR55;ADRA1A
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5156550172107637,-0.8418427272708633,0.6363636363636364,1.0,1.0,1/5,2.97%,COL4A1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.3907083108259546,0.841713419953027,0.6785714285714286,0.9700559345189208,1.0,15/38,26.07%,MYC;RBPJ;HDAC2;FZD1;CTNNB1;NOTCH4;DVL2;NUMB;JAG1;FRAT1;TP53;HEY2;GNAI1;NOTCH1;NKD1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.341239378112638,0.8409113977364507,0.7384615384615385,0.971244259051747,1.0,7/134,6.37%,STK26;ATP6V0D2;SIRT1;TCIRG1;TFEB;RNF152;TBL2
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.5508114394600457,0.840483228586389,0.6792452830188679,0.9717594005231358,1.0,1/5,7.99%,MEGF10
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3809155222268514,0.8401109085922358,0.7230769230769231,0.9720699943571076,1.0,3/39,7.05%,TENT5A;SYNCRIP;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.405063884796182,-0.8400642726405418,0.6666666666666666,1.0,1.0,6/31,16.64%,ENPP2;RAC2;RREB1;RAC1;CORO1B;CLRN1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.4124009552324486,-0.8399527672817171,0.62,1.0,1.0,1/16,3.03%,CHRNE
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4067059639981189,-0.8398371573619099,0.6666666666666666,1.0,1.0,3/23,5.21%,DRD4;CBARP;DRD2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.499638532105982,0.8397764904226971,0.7659574468085106,0.9723506039316966,1.0,3/10,15.01%,ESR1;HMGB1;ATF7IP
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.34630952890861255,0.8396366510918473,0.8275862068965517,0.9722951947117376,1.0,11/86,10.61%,NOX5;PRR5L;PRDX6;FOXO1;PYCR1;HTRA2;SNCA;FOXO3;KEAP1;PIK3CA;SLC25A24
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.4115987491394946,-0.8391515532186142,0.7307692307692307,1.0,1.0,6/35,9.66%,EPOP;SFRP1;WNT7A;FOXO4;PAX2;MEOX1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.4990299466807044,-0.8387068753554197,0.625,1.0,1.0,1/7,2.38%,STAC
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.49771738328012977,-0.8383767372444122,0.7,1.0,1.0,2/9,3.49%,F8;F7
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.39074438206262857,0.8383274689412179,0.7254901960784313,0.9743432920733176,1.0,12/57,15.66%,BLNK;IL4;CD40;CD22;FLT3;PLCG2;BANK1;RAG2;KLF6;MEF2C;KIT;PIK3CD
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.42820792297147886,-0.8383233095005821,0.7111111111111111,1.0,1.0,5/30,8.48%,HK2;BIK;CAMK2A;CLU;IFIT2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.389348255348879,0.8383072457880889,0.7719298245614035,0.9740238523211913,1.0,17/76,20.78%,NLGN1;TENM1;EPS8L2;EPS8;RALA;PIK3CA;AUTS2;DEF8;GPM6A;WASHC1;CEP120;ANLN;CCP110;WASL;F2RL1;FMR1;FAM98A
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3759350745144523,-0.8383030623775978,0.6511627906976745,1.0,1.0,1/34,3.27%,MAP1LC3B2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.5114906800997765,-0.8381885225057815,0.6666666666666666,1.0,1.0,2/8,13.38%,ZNF703;RREB1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5334311912547444,0.8380729864215803,0.7592592592592593,0.9742057180786448,1.0,3/10,31.77%,BNIP3L;BAD;RHOT1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5043261618252622,-0.8379322455455026,0.5789473684210527,1.0,1.0,1/7,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.4565667027204695,-0.837846796386084,0.5681818181818182,1.0,1.0,2/10,4.00%,RIN3;C5
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.36952880874367866,0.8376897222027007,0.8113207547169812,0.9745360308925021,1.0,12/78,9.74%,AASS;CARNS1;IDO1;SHMT2;HYKK;IDO2;ALDH7A1;CBS;GLUL;TDO2;HIBCH;BCAT1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.33069232921521263,-0.8376686792657603,0.7872340425531915,1.0,1.0,15/81,16.69%,KCNE2;STAC;CAMK2A;KCNE1;JPH2;CACNG8;CRH;KCNS1;PTK2B;SHANK1;CTSS;MMP9;SHISA7;CALM1;CACNB1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.4617595805209814,0.8374826012852477,0.6041666666666666,0.9745605814709741,1.0,9/14,33.30%,DPP4;FAP;DDR2;DDR1;MELTF;CLASP2;CLASP1;PDPN;CARMIL2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.37681192622934895,0.8374149216399053,0.6984126984126984,0.9743560462980955,1.0,8/60,8.61%,MITF;LGALS9;ITGAX;LAIR1;DDX60L;FGL2;CSF2RA;TLR2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.41745536223665236,-0.8371749001614895,0.6862745098039216,1.0,1.0,6/36,9.20%,HMGB3;RECQL5;ERCC1;RPAIN;RTEL1;EXO1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3425815976523271,0.8370741116185992,0.7758620689655172,0.9745460232539401,1.0,5/90,5.47%,PRR16;CCL5;LIN28A;SAMD4A;EIF3E
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.4196590543321268,-0.8366400335018856,0.7407407407407407,1.0,1.0,3/25,9.87%,NUPR1;LZTS1;NRBP2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.3953694343551338,0.8366082743889864,0.7857142857142857,0.9750071669016137,1.0,4/33,7.91%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5023369991034607,0.8364990055891266,0.7037037037037037,0.974874728716339,1.0,6/12,31.90%,ABL2;ABL1;EDN1;GDNF;PDP1;PDP2
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.5624952740470124,0.8361489637223247,0.7586206896551724,0.9752295338013502,1.0,2/6,14.16%,SNCA;CD244
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.40946314512154836,0.8358622943206604,0.6923076923076923,0.9753935337211137,1.0,3/31,8.47%,PAWR;EPS8;RHOD
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5550303454069131,0.835842109648828,0.7407407407407407,0.9750790742045523,1.0,2/6,12.14%,CEP152;E2F4
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.5517782845910066,0.8356777401687335,0.6458333333333334,0.9750568188721493,1.0,2/5,27.89%,VAMP3;VAMP8
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4628883513695244,0.8356194324781273,0.7291666666666666,0.9744541632946436,1.0,3/18,11.81%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4628883513695244,0.8356194324781273,0.7291666666666666,0.9744541632946436,1.0,3/18,11.81%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3682601452454733,0.835062006060214,0.8113207547169812,0.9751127360864023,1.0,21/90,10.93%,LGALS9;SMAD6;SOCS2;PPARG;SCD;F2R;GCH1;IL23R;HSD17B2;MAPKAPK2;ESR1;PELI1;MAPKAPK3;FOXO1;FER;SNCA;FOXO3;GGT5;ERBIN;LOC400499;TAB2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5294932044413794,-0.8350618143758961,0.6842105263157895,1.0,1.0,2/5,16.89%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5294932044413794,-0.8350618143758961,0.6842105263157895,1.0,1.0,2/5,16.89%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5294932044413794,-0.8350618143758961,0.6842105263157895,1.0,1.0,2/5,16.89%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5242801304421365,0.8348500302635893,0.7777777777777778,0.9752214992185545,1.0,5/10,25.53%,ZNF692;FBP1;SIRT7;SDHAF3;OGT
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.5055047276020844,0.8348397182534402,0.723404255319149,0.974903531242815,1.0,2/10,9.48%,LMOD3;PGM5
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.36531537814231263,0.8343019218214803,0.7254901960784313,0.9755105869929664,1.0,10/96,19.20%,U2AF1;NXF1;THOC6;SMG1;NXT1;DDX19B;NXF5;HNRNPA2B1;RANBP2;SRSF11
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.49268718363914277,0.8342980520448335,0.7222222222222222,0.9751800754062409,1.0,3/8,16.65%,FERMT1;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.3413686142875535,0.8340777390213266,0.6818181818181818,0.9752169255702723,1.0,26/142,19.42%,CCNG1;SMYD2;PIP4K2A;MAP2K6;PRKAB2;BANP;DYRK2;HDAC2;TP53INP1;RRS1;TAF3;TP53BP2;CHEK2;PML;SGK1;BOP1;TAF5;KAT6A;RICTOR;HIPK1;NOC2L;TAF2;PRKAA1;MLST8;HDAC1;PPP1R13L
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4336922159470331,-0.8340514168524672,0.6851851851851852,1.0,1.0,1/24,4.57%,LDB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.44984780771428057,-0.8337044686269954,0.6808510638297872,1.0,1.0,3/18,13.40%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.3833413401186548,0.8335524786315907,0.7321428571428571,0.9759033905989621,1.0,3/31,12.31%,NDE1;BICD1;HAP1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5319023716017228,-0.8334464381563017,0.6744186046511628,1.0,1.0,1/5,13.00%,NUCKS1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.33404305282934066,0.8333992593353065,0.7962962962962963,0.9759146622358464,1.0,18/133,10.10%,FLT1;EPHA7;FGFR1;ACD;FGFR3;ERBB4;MYC;ROR1;BMI1;FLT3;EPHA8;PARM1;PDGFRA;EPHA5;EPHB4;EPHA3;DCUN1D1;ARRDC3
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.5490379088396643,0.8333545674489513,0.7285714285714285,0.97566034847517,1.0,1/6,22.30%,MINPP1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.41213878428552836,-0.8331342244747874,0.5833333333333334,1.0,1.0,2/23,3.58%,ZC3H12D;RNASE1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5131134262040071,0.8330375799929237,0.7454545454545455,0.9758950415027453,1.0,3/12,25.78%,HAP1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.45347257455158874,-0.8330258592660245,0.6976744186046512,1.0,1.0,2/14,4.45%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.29769795503543633,-0.8329693878450127,0.9565217391304348,1.0,1.0,34/393,10.77%,TRIP10;NTRK1;ARAP3;TEK;PRDM1;CD24;BST1;FGF1;PAK6;RAC2;OBSCN;RASGRF2;RPF2;STARD8;VAV3;PLK3;IER3;NEK8;ARHGDIB;PRKD2;ARHGAP15;ARHGAP12;RFC3;WWC1;EXO1;WDR54;NTRK3;TAF11;TAF7;CEACAM1;TMSB4X;SPRED1;CHD4;PIP5K1B
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),-0.46168757273382377,-0.8329435616372485,0.64,1.0,1.0,2/6,10.15%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.34470048506916756,0.8329105023175417,0.7666666666666667,0.9757799264989346,1.0,22/120,13.97%,SLC12A7;KCNK2;SLC12A1;KCNC2;SLC1A3;KCNJ3;SLC12A3;KCNH7;KCNH8;KCNH4;KCNQ5;KCNH5;SLC24A2;LRRC55;SLC9A2;ATP1A2;KCND2;HCN1;KCNF1;ATP12A;KCNB2;KCNAB3
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.3691198892494066,0.8329007324922595,0.7857142857142857,0.9754585457551891,1.0,21/71,20.48%,SLC12A7;SLC12A1;TRPV2;KCNJ3;SLC12A3;SLC8A1;SLC39A8;SLC24A2;SLC9A2;ATP1A2;ATP12A;SLC39A12;SLC39A5;TRPV3;TRPM2;SLC9C2;SLC9A9;KCNJ10;KCNJ8;SLC12A9;SLC12A4
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4113771160759667,0.8328317499938375,0.7,0.9752300005644067,1.0,8/24,21.40%,TLR2;TAB2;IRAK3;MAP3K1;IRAK1;TAB3;TLR5;TAB1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.5055930558249275,0.8327862930855608,0.7090909090909091,0.9749805726196891,1.0,1/6,3.68%,HTR1F
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.5038387675315531,0.832669720648926,0.7368421052631579,0.9748617269402202,1.0,6/9,40.18%,CHAC1;GGCT;CHAC2;CNDP2;MGST2;GCLC
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.45598182185276387,0.8324670609191184,0.6724137931034483,0.9748733279265557,1.0,2/19,7.43%,CTDNEP1;TOR1B
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.42000629850864596,0.8324586976295492,0.6727272727272727,0.9745486130589668,1.0,1/24,3.19%,URI1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.33098818379909145,0.8319528077990274,0.8181818181818182,0.9751696614132259,1.0,7/123,4.47%,SYK;SCGB3A2;STAB1;LDLR;NEDD4;RAB31;LRP1B
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3337725489022128,0.831798855995708,0.7446808510638298,0.9750551156694842,1.0,29/155,13.56%,PNP;CFH;IDO1;CCL5;HIF1A;ISOC1;CD40;XAF1;GCH1;IL10RA;IFI44;IRF8;FGL2;PELI1;TOR1B;ST8SIA4;MARCHF1;BANK1;IL15;AUTS2;RAPGEF6;CD74;CASP7;MTHFD2;TAP1;PDE4B;OASL;PML;TRIM26
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.511974204679192,0.8317330764472003,0.76,0.974797866505329,1.0,1/8,5.31%,MID2
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.5748609132031961,0.8313685383300827,0.8,0.9750319654965071,1.0,1/5,5.49%,SIX4
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.38303851790467347,-0.8308967800884192,0.7,1.0,1.0,17/53,26.96%,NDUFC1;UQCRC1;NDUFS5;COX6C;COX7C;COX7A2L;UQCRH;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4;NDUFA3;SDHC;UQCR10;NDUFB9;AFG1L
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.32504208296073245,0.8308928449132664,0.8727272727272727,0.9756268092680219,1.0,29/143,20.12%,LRP4;MLLT3;BMP2;DKKL1;WWTR1;LATS1;TLE2;TBX18;PSMD13;GREM1;PSMA1;RBMS3;PSME4;DACT3;FZD4;IGFBP6;TMEM170B;PRICKLE1;LRP6;NKD2;FZD6;PTPRU;FRZB;MESP1;DVL2;KLHL12;HDAC1;TLE4;RUVBL2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.35352861903161176,0.8307923430282073,0.7611940298507462,0.9754073854269604,1.0,6/103,4.16%,VEGFC;IGF1;FERMT3;HGF;LHFPL2;KNG1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3662024474634969,0.8304077933286589,0.7321428571428571,0.9758087792031016,1.0,16/77,14.17%,SLC26A7;SLC26A6;SLC35B2;CA13;SLC39A8;SLC22A3;SLC4A1;SLC4A7;SLC44A4;CYB5R4;SLC25A24;SLC52A1;CA2;SLCO4C1;SLC19A1;ABCC11
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.42135418168281213,0.8302585763963034,0.6607142857142857,0.9757864794224503,1.0,7/28,23.54%,FZD5;ST3GAL6;NOTCH3;FZD1;NOTCH2;JAG1;WNT2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.4743911618032345,0.8301190731625737,0.7222222222222222,0.9757139054635241,1.0,5/16,12.64%,TGFBR1;NRG1;RBPJ;BMPR1A;ADGRG6
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.5462411513590889,0.8300023752554957,0.7735849056603774,0.9755952986858865,1.0,1/8,5.52%,SLC38A3
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.4111981577803868,0.8298915722735409,0.7586206896551724,0.9754893374008891,1.0,1/36,0.39%,CWH43
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.4933686842943008,-0.8297314114601295,0.7142857142857143,1.0,1.0,1/9,0.30%,DUSP4
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.5089796383049814,0.8297175619824045,0.711864406779661,0.9754881107566666,1.0,2/9,12.63%,SLC26A6;SLC5A11
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.5625221702397675,0.8294413209974936,0.7872340425531915,0.9756877660355613,1.0,2/5,36.06%,NAGA;GALC
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.494141025344933,-0.8294401328759892,0.6666666666666666,1.0,1.0,3/5,30.53%,CPSF3;CPSF2;SLBP
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.43073255453128295,0.8290857724886475,0.631578947368421,0.97592493604284,1.0,6/24,24.63%,RALA;MCU;INF2;MFF;MARCHF5;MIEF2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.4229733228814714,0.8290187481671792,0.7272727272727273,0.9757060893748576,1.0,6/20,18.71%,FGF2;EPHB4;EFNB2;GREM1;VEGFA;PIK3R3
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.4671923432547728,0.8288505532448506,0.7586206896551724,0.9757131512354525,1.0,2/16,4.74%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5421356329745881,0.8286966450901734,0.7222222222222222,0.9756742363344711,1.0,2/6,19.69%,GPHN;MOCOS
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.396962244297862,-0.8284760701763276,0.7142857142857143,1.0,1.0,1/25,2.17%,ARL5C
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3787163495900688,0.8280838892122089,0.74,0.9763831791863458,1.0,21/74,28.58%,EGLN3;HIF3A;HIF1A;PSMD13;PSMA1;PSME4;VEGFA;NFE2L2;DNAJB1;ARNT;HSPA1A;TP53;PSMD4;LIMD1;EP300;BACH1;DDIT3;ATF3;PSMB5;PSMC5;PSMB1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.5640784184358141,0.8278162671711152,0.7627118644067796,0.97657376219281,1.0,2/5,23.63%,SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.4804144363790278,0.8276444439983907,0.7457627118644068,0.9765763412216324,1.0,1/13,8.51%,SDC4
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.47458810525210515,-0.8276344083294197,0.7105263157894737,1.0,1.0,1/9,3.26%,TST
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.4094943151815778,-0.8273805848967342,0.7727272727272727,1.0,1.0,2/37,0.97%,ACTC1;F5
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.4963987455792467,-0.8269154808073965,0.7659574468085106,1.0,1.0,2/11,6.34%,RFTN1;OAS1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.4800764238462064,0.8268897146119761,0.7678571428571429,0.9775596959593359,1.0,7/14,34.98%,PUF60;RBM17;DHX9;SRSF9;CELF4;CDK13;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3674689807699813,0.8268385426459045,0.7741935483870968,0.9773491581537009,1.0,10/72,16.12%,CDC20B;DNAJB2;CBFA2T3;RNF217;KEAP1;SIRT6;BAG2;ARIH1;PRICKLE1;NKD2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.4196543623596632,0.8265634503717049,0.7575757575757576,0.9775266358832725,1.0,7/39,20.25%,LIN28A;ZBTB20;UNC13B;IGF1R;PRKAA1;GCK;IRS2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.38175369266729337,0.8261751013710493,0.7272727272727273,0.977933299150061,1.0,16/60,23.84%,UHRF2;RNF185;UBE2D3;UBE3D;RNF146;RNFT1;CNOT4;KLHL24;MARCHF7;RNF208;TRIM52;RAG1;UBE2A;RNF19B;TRIM68;MARCHF5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.36248216877707445,-0.8260307020948072,0.75,1.0,1.0,2/62,3.43%,DND1;WTIP
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.5227333771142144,-0.8260272244822868,0.7307692307692307,1.0,1.0,1/5,0.73%,KLRC1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4294220053743911,-0.8259694814886361,0.723404255319149,1.0,1.0,1/18,1.16%,NUPR1
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.49587469810614093,-0.8258023257958776,0.7045454545454546,1.0,1.0,3/6,17.56%,MED1;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4299659879810565,-0.8257862843159007,0.6326530612244898,1.0,1.0,2/24,3.82%,CD86;HLA-DRB1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5323396115931226,-0.8257080796900241,0.7222222222222222,1.0,1.0,3/12,16.62%,RAC2;RAC1;NTN1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.3701424467416903,0.8256593041638866,0.711864406779661,0.9785147307605193,1.0,11/63,8.61%,SASH3;LGALS9;PIK3R6;ITGAX;PIK3R5;IL10RA;IRF8;FGL2;ACHE;SIGLEC1;TLR2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.4901541120920268,0.8254185362678182,0.7446808510638298,0.9786541288990139,1.0,2/9,8.68%,SMAD6;ABCA1
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),-0.5569534993889617,-0.825250681599747,0.75,1.0,1.0,2/5,11.62%,SLC36A2;SLC6A20
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.35264971828266134,0.8252001049147056,0.7543859649122807,0.9786809781716765,1.0,9/75,8.61%,SASH3;LGALS9;TIMD4;CSF3R;ITGAX;IL10RA;FGL2;SIGLEC1;TLR2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.39790982408066417,0.824907098918628,0.7666666666666667,0.978807733265523,1.0,10/35,28.45%,ASF1B;ASF1A;H2BC21;PADI4;ANP32B;H2AX;H3-3A;RBBP4;KAT6B;BRD2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5226082262178104,-0.8249033854986519,0.7058823529411765,1.0,1.0,2/8,18.58%,SMUG1;MBD4
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.37954870919398176,0.8247365974789972,0.8,0.9787970527729589,1.0,8/50,14.26%,TYR;AANAT;PRIMPOL;OPN1SW;RGR;PCLAF;REV1;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4585204236575083,-0.8246827661317623,0.75,1.0,1.0,3/17,13.40%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.42284594628467137,0.8246563585532304,0.7580645161290323,0.97857418605809,1.0,2/25,5.49%,LMOD3;SIX4
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3426537389231623,0.8242119066711872,0.7966101694915254,0.9790585415846272,1.0,8/71,12.34%,IGF1;CANT1;GALNTL5;ST8SIA4;FUT9;ST3GAL6;NUS1;CSGALNACT1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.45232493140230534,-0.8242069966300593,0.65,1.0,1.0,2/15,4.45%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3566109498203815,0.8241312781019482,0.7368421052631579,0.978898105070851,1.0,20/75,22.40%,CCL5;GRIN3A;TRPC4;SLC8A1;SLC39A8;RAMP3;MAGT1;SLC3A2;TRPC5;TRPM2;RYR2;LRP2;CALCRL;TRPM7;SLC30A1;NDFIP2;MRS2;ATP2C1;TRPC1;RYR3
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.545767522683357,0.8241058176469191,0.8235294117647058,0.9785798356133492,1.0,3/6,18.37%,SLC22A3;MAPK15;SLC18A2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3343875614622175,-0.8237982596411559,0.7450980392156863,1.0,1.0,13/107,11.24%,LDHC;PARP2;CCT6B;YBX2;ADCYAP1;SCG3;PHF7;PEBP1;MEP1B;DDX4;BUB1;GAPDHS;OAZ3
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.47316304457242525,0.8233722588079637,0.6666666666666666,0.9795498232695278,1.0,2/14,9.49%,COX19;ANKRD9
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.4260295495702614,-0.823260955644148,0.66,1.0,1.0,4/21,7.31%,TNXB;PXDN;LAMB3;LAMB1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.3201404900718322,-0.8231975673195505,0.8,1.0,1.0,22/142,14.87%,GPX3;NPTX2;PARP2;PRKCD;NR4A1;TST;FOS;OLFM1;EIF2S3;RPN1;ENO2;NTRK3;TYRO3;ATP6V1F;TCHH;SLC6A12;DGAT1;ABCB1;CLTB;CDKN1C;MRPL23;STARD3
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.4703670198005664,-0.8231780544736592,0.6521739130434783,1.0,1.0,2/10,8.96%,TERF2IP;RTEL1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.5141402843592413,0.8230968902463562,0.7241379310344828,0.9796635173406907,1.0,2/7,14.89%,ABI3;RBMS3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3760498340625968,-0.822873175235137,0.6862745098039216,1.0,1.0,17/54,26.96%,NDUFC1;UQCRC1;NDUFS5;COX6C;COX7C;COX7A2L;UQCRH;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4;NDUFA3;SDHC;UQCR10;NDUFB9;AFG1L
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.3473657340828394,0.8225814330993525,0.7377049180327869,0.9801466728983574,1.0,12/91,10.43%,SGO1;CCNA2;PRDM14;NDC80;LIN28A;RFWD3;CLDN6;FBXO5;NCOA5;HDAC2;GINS1;VRTN
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.3259594005415212,0.8225471144724608,0.819672131147541,0.9798782203019362,1.0,20/134,16.38%,THEMIS;ICOSLG;BTN2A2;RELA;NFKBIZ;PLCG2;ITK;PAG1;PIK3CA;NFKBID;DENND1B;TAB2;PSMD13;PDE4B;LCK;BCAR1;PSMA1;PSME4;PIK3CD;CD247
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.38648572901517175,0.8224286113745254,0.7419354838709677,0.9797800719518691,1.0,3/33,4.85%,F2;FGF2;F2R
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.36861562642145007,0.8219970368564843,0.7708333333333334,0.9802212141181846,1.0,10/93,19.20%,U2AF1;NXF1;THOC6;SMG1;NXT1;DDX19B;NXF5;HNRNPA2B1;RANBP2;SRSF11
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.45318507619639503,0.8219597772052168,0.7446808510638298,0.9799654503194305,1.0,2/12,14.00%,SLC7A9;SLC19A1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.34919151472401766,0.8219538425113254,0.7543859649122807,0.9796352502750358,1.0,19/103,17.59%,SIPA1;RHOBTB3;FGD4;TNIK;PCLO;RHOD;BIN1;NECTIN2;PAK5;RANBP9;ANK1;RHOU;FMNL3;RHOBTB1;RHOG;ZMYM4;SYNE3;PHIP;DST
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3121575108960221,0.8215053009981284,0.9622641509433962,0.9801505757833526,1.0,30/162,20.12%,CXXC4;LRP4;MLLT3;BMP2;DKKL1;WWTR1;LATS1;TLE2;PSMD13;GREM1;PSMA1;RBMS3;PSME4;DACT3;FZD4;IGFBP6;WWOX;TMEM170B;PRICKLE1;LRP6;NKD2;FZD6;PTPRU;NXN;FRZB;DVL2;KLHL12;HDAC1;TLE4;RUVBL2
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),-0.5104573761263076,-0.8214405656700029,0.6444444444444445,1.0,1.0,1/5,5.90%,GPC1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4037118293277431,0.8207367773174907,0.7346938775510204,0.9812454601654342,1.0,4/32,9.75%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.4021165506278871,-0.8207115255026746,0.7307692307692307,1.0,1.0,2/25,9.71%,TRIM5;DHX58
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.3085847724560933,0.8206638845664094,0.9310344827586207,0.9810186815918116,1.0,60/298,24.44%,SYK;AP1M2;RAB38;ACD;TBC1D8B;EHD1;RAB31;TBC1D12;NLGN1;LTBP2;SNX31;VPS26C;ARL5A;TBC1D3L;NXT1;SGSM3;LMAN1;RAB23;CD74;STRADA;HAP1;RANBP17;BCS1L;XPO1;PRICKLE1;RABL2B;RPGR;GRTP1;TBC1D4;RAB29;GGA1;TBC1D5;STX8;MYO1C;STXBP3;RAB28;TMED1;VPS29;STX5;TMED3;STX17;SMURF1;RTN2;PPP1R10;TRARG1;RAB5B;SAR1A;RANBP3L;USP6NL;CTSA;TRAK2;AKT2;NUP153;AKAP6;STX3;ARFRP1;WLS;MAIP1;EVI5L;TBC1D25
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.37994496243946735,0.8205649523252594,0.7678571428571429,0.98087484542402,1.0,13/55,16.04%,ACSM2A;IRS1;PPARG;ADIPOR2;PAX6;CYB5R4;MCU;LEPR;BACE2;MLXIPL;IGF1R;KLF7;TENT4B
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.48214833408492275,-0.8203487524166547,0.7105263157894737,1.0,1.0,2/15,7.76%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.518512995969968,0.82028362233339,0.7843137254901961,0.9810704219022094,1.0,4/6,40.35%,PIH1D1;NOP58;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.46409859610303184,-0.8202251386250137,0.68,1.0,1.0,4/13,7.86%,CLDN4;CLDN1;CLDN5;CLDN15
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.38984726246309903,0.8202030223730635,0.7333333333333333,0.9809142563409655,1.0,4/38,11.10%,HRH3;CHD7;MAGT1;GRM5
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.4832698454915307,0.8200184559718338,0.676923076923077,0.9809939015974303,1.0,4/10,26.05%,DPP4;FAP;TNFRSF1B;NOTCH1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.465846710107359,-0.8198368850365122,0.6304347826086957,1.0,1.0,2/11,15.69%,DRD2;SHANK3
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.5310992502896604,0.8194307842982583,0.7288135593220338,0.9818093019082644,1.0,3/6,30.53%,CD74;CARD9;SLA2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.4681600987511978,0.8194247294104553,0.7666666666666667,0.9814918825813544,1.0,1/18,0.56%,IGF1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.5509527130867645,0.8193582543579672,0.7049180327868853,0.9812407742921284,1.0,2/5,9.05%,SLC26A6;DRD3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5387043268385319,-0.8192134411201516,0.6744186046511628,1.0,1.0,1/5,13.00%,NUCKS1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3410020948297083,-0.8189269057684546,0.8372093023255814,1.0,1.0,10/104,8.66%,ACTC1;MYH7;LTB4R;CHRNE;TMOD1;NEB;MYOM3;CHRNG;TRIM72;CALD1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.46018492186018894,0.8188945213130712,0.7647058823529411,0.9817827092709716,1.0,3/12,5.19%,SIRT1;WNT4;BMP2
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.3115380761580084,-0.8188187184672459,0.9636363636363636,1.0,1.0,41/195,26.52%,NARS1;WARS1;TMA7;SARS1;ZC3H15;CARS1;DARS2;PPA1;SARS2;RPL38;RPL12;MRPL23;MRPS21;ABCF1;GARS1;RPS8;MRPS18C;RPL37A;RPS27;RPL4;MRPL16;MRPL9;RPL5;RPL26L1;WARS2;RPL22;RARS1;GATC;RPS20;COPS5;MRPS11;RPL34;DRG1;RPL37;EEF2K;RPL31;GTPBP2;RPL7A;RPL35A;RPS25;RWDD1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3706653582531244,0.818804979393836,0.7580645161290323,0.9815688260825518,1.0,10/66,18.79%,IGF1;HIF1A;ZBTB20;CBFA2T3;FBP1;MLXIPL;PRKAA1;PFKFB4;GCK;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.41338196036236613,0.818743770777484,0.6739130434782609,0.9813550881952112,1.0,6/27,12.14%,IGF1;FGF10;ITGAV;ERBIN;SHOC2;LYN
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5052948888986987,0.8187320213428341,0.7,0.9810342366748037,1.0,1/10,0.30%,ESPL1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.41157056082860677,0.8184501280556775,0.7254901960784313,0.9812414669902512,1.0,6/23,27.74%,BAP1;MINDY2;OTUD4;OTUD7B;YOD1;MINDY1
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.5413247508328404,0.8183535962453774,0.7931034482758621,0.9810898958405182,1.0,2/5,22.05%,BMP4;TP53
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4131210241279263,0.8183211672033481,0.7049180327868853,0.9808147933259104,1.0,8/22,25.42%,RAPGEF3;PTPN14;ANP32B;GTSE1;SIRT7;TP53;GAS6;BARD1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.34751370058520786,0.8181401869054378,0.7868852459016393,0.9807499842447189,1.0,19/103,18.71%,PIK3R6;FGF2;PIK3R5;PIP4K2A;PIK3C2B;PLCG2;PLA2G10;IP6K3;INPP4B;PIK3CA;PTEN;PI4K2B;MTMR9;MTMR3;PIK3CD;MTMR11;PLCB1;PITPNM1;PIK3R3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4828579671021198,0.8180181540641724,0.7368421052631579,0.9806069705311186,1.0,1/10,3.61%,NEDD4
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3678915323822891,0.8179357530790055,0.8545454545454545,0.9804393520415904,1.0,3/29,9.24%,CDK18;FBXO5;CDK14
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.5531876583995418,0.81789713798112,0.7307692307692307,0.9801813048910244,1.0,4/6,42.60%,DLG1;CYLD;DUSP1;DUSP10
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.5433108099847705,-0.8174774767357792,0.8055555555555556,1.0,1.0,1/5,9.36%,NTRK3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.405809836781207,0.817424808293917,0.7719298245614035,0.9806927807920637,1.0,15/30,34.01%,GLUL;SLC39A8;PYCR1;CPS1;RIMKLA;GLUD1;OAT;RIMKLB;KYAT1;DDAH2;DDAH1;ALDH18A1;AADAT;ART4;CAD
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.41341083319768696,-0.8172748703193905,0.725,1.0,1.0,1/24,1.26%,MTFR2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3650871833924067,-0.8168533866928518,0.7142857142857143,1.0,1.0,6/61,6.53%,APIP;HLA-DRB1;GOLGA2;UPB1;TRPA1;TRPV5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.36883021835955443,0.8166615247685487,0.7368421052631579,0.9817632470096814,1.0,15/62,16.65%,TGFBR1;SNAI1;BMP2;IL17RD;WWTR1;EPHA3;EZH2;SMAD2;GREM1;SMAD4;PTEN;CRB2;VASN;LOXL2;PHLDB2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.37869272815410254,0.8164376908878236,0.7636363636363637,0.981833924008811,1.0,10/60,14.16%,LGALS9;FZD5;IL23R;SCRIB;VSIR;HMGB1;IL18R1;PDE4B;NR1H4;CD244
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.3847601552701754,0.8164153640400277,0.7540983606557377,0.9815428743734843,1.0,9/34,17.81%,NLGN1;SYT1;SNCA;NLGN4X;CEL;STON2;PICALM;DNM3;MX2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.4297856015355688,0.8162250619969891,0.6296296296296297,0.9815231889695956,1.0,5/18,21.02%,CDH2;PIEZO1;CTNNB1;PKD1L2;JUP
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.41245755504133014,-0.81616786281231,0.723404255319149,1.0,1.0,5/26,9.47%,PER2;PDE6B;RBM4;PPP1CA;RBM4B
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.4395365537880346,-0.8159940732826272,0.723404255319149,1.0,1.0,2/27,1.95%,UMODL1;CXCL13
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3564745486671606,-0.8158338342547892,0.6904761904761905,1.0,1.0,3/62,4.75%,P2RY10;PRAG1;STARD8
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.451854107478662,0.8152934701359122,0.7307692307692307,0.9828137161127246,1.0,5/18,21.54%,EPHA5;RPS6KA4;VEGFA;RPS6KA5;TSSK4
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.5128463219171812,0.8152496103451642,0.7586206896551724,0.9825554769939201,1.0,5/8,36.78%,CTNNB1;GRB2;CDH1;CBLL1;CBL
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.36573626275928806,-0.8151776207919003,0.8125,1.0,1.0,1/36,1.16%,NUPR1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.33113558711554003,0.8151081633341634,0.8813559322033898,0.9824862162559809,1.0,18/107,14.26%,NOX5;HIF1A;PRR5L;PRDX6;PDGFRA;FOXO1;FER;PYCR1;HTRA2;SNCA;FOXO3;KEAP1;SLC25A24;PTPRK;VRK2;PXN;ERMP1;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.44366934809884034,0.814662538388745,0.8269230769230769,0.9830611805746494,1.0,4/20,12.31%,GSTM2;STAC2;ANK2;HAP1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.4807651056369364,-0.8145354475446438,0.7291666666666666,1.0,1.0,1/11,11.79%,AP3S2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.4807651056369364,-0.8145354475446438,0.7291666666666666,1.0,1.0,1/11,11.79%,AP3S2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5360820919945419,-0.8141516925214208,0.75,1.0,1.0,2/6,18.65%,TGFB1;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4311375662197775,-0.814050692412108,0.7368421052631579,1.0,1.0,1/19,0.71%,SELE
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.4826913260238127,-0.8139735726388241,0.6041666666666666,1.0,1.0,1/10,2.41%,BUD23
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.3520422736707516,-0.8139544075287753,0.7368421052631579,1.0,1.0,18/53,28.73%,RPF2;LAS1L;NSA2;EBNA1BP2;RRP15;MRTO4;NHP2;BRIX1;RPL5;RPL26L1;RPL7A;RPL35A;SURF6;SNU13;NPM1;WDR12;EIF6;RPF1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.3479490923563403,-0.8137981587371869,0.8409090909090909,1.0,1.0,4/64,3.48%,PEAK3;BST1;PRKCD;RAC2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.4390743397019645,0.8137827839636346,0.7307692307692307,0.9843289373932785,1.0,3/11,22.72%,RESF1;ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.4687453689933153,0.8135220392462429,0.711864406779661,0.9844272595949096,1.0,3/11,19.78%,MOV10;NTNG2;MACF1
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.5429021197655749,0.8133920113996127,0.8,0.9843410652468345,1.0,2/5,13.71%,LIPG;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.5071713574144083,0.8132689215588409,0.7333333333333333,0.9842139539296911,1.0,3/7,23.10%,HTR2C;NR1H4;HTR2A
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.4529819028255578,-0.8128234745826736,0.7291666666666666,1.0,1.0,5/11,29.83%,ALOX12B;ATG10;WDR45B;PORCN;WIPI1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.46597283462601846,0.8126894589859789,0.6896551724137931,0.9847136361435597,1.0,2/9,2.91%,ITGA11;ITGA2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.3595864189338689,0.812441729764065,0.7547169811320755,0.984791222386799,1.0,11/68,12.88%,SIRT1;CCL5;HAS2;CD40;GCH1;ZFP36L2;RELA;GGT5;ERBIN;HYAL3;ZFAND6
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4239288447210478,0.8124098457797921,0.7384615384615385,0.9845208199543826,1.0,4/21,23.22%,CHMP6;MVB12A;LEPROTL1;VTA1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.49032832858447467,0.812312026560873,0.6666666666666666,0.9843528994383769,1.0,3/7,17.52%,GLRA1;PLA2G10;PLCB1
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.3443016662726131,0.8122769201743044,0.7906976744186046,0.9840664642271795,1.0,11/95,8.90%,ACE2;TMPRSS2;AP1M2;CAPN13;SCNN1B;VWA2;AGR2;PELI2;APELA;DSP;SLC44A4
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.49254173555181174,0.8122659324813486,0.7321428571428571,0.9837556864206377,1.0,4/10,25.60%,TSR3;RPUSD2;NOP10;NAF1
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.5415282346897977,0.8122595060468587,0.7377049180327869,0.9834369420310599,1.0,1/6,2.98%,IL4
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.3722378086386029,0.8121238476641688,0.8166666666666667,0.9833309092927072,1.0,3/52,4.89%,F2;ACE2;CCN6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.31547308949368363,0.8120617250030312,0.9482758620689655,0.9830983094189573,1.0,12/130,12.30%,IRGM;CCL5;IL23R;TNIK;TELO2;SNCA;TAB2;GRM5;EZH2;CASS4;PAK5;STRADA
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.5103550256979326,-0.8115806073237801,0.6444444444444445,1.0,1.0,1/6,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4010544504854908,0.8115477414360673,0.7291666666666666,0.9836785297533477,1.0,6/26,7.36%,B3GAT2;CSPG4;UGDH;CHSY3;VCAN;BGN
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.34752397317476763,0.8114416441715238,0.7959183673469388,0.9835031225079792,1.0,15/70,16.67%,C1QL1;TENM3;VSX2;EPHA8;SPSB4;POU3F2;EFNA2;ONECUT2;CDR2L;FOXO6;DLL3;BCAR1;FJX1;RIMS4;NR2F2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.3957259758279833,-0.8114170976403917,0.68,1.0,1.0,3/29,13.25%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.4574085670946053,0.8112055731768838,0.7169811320754716,0.9836053407204469,1.0,5/9,24.10%,HTR1F;HTR2C;HTR1E;HTR2A;HTR5A
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.44708438723785027,0.8111458780253745,0.7222222222222222,0.9833770407420179,1.0,2/15,7.62%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.4490556225083807,0.8109993611558247,0.7704918032786885,0.9832793981809449,1.0,2/18,8.29%,GSTM2;ELOVL5
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.40159545687728904,0.8107305828979019,0.6875,0.983454972511956,1.0,10/27,21.96%,FGFR1;POSTN;VCAN;ITGAV;VEGFA;VAV2;TNFRSF21;KCNJ8;JAG1;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.5453264043924099,-0.8106787083745136,0.7555555555555555,1.0,1.0,2/5,17.78%,SERPINE2;CTSZ
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.40357180766630546,0.8106434226584871,0.7090909090909091,0.9832758589510123,1.0,5/30,13.73%,SCN7A;SCN10A;CACNB4;SCN3A;SCN9A
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.5148795765173672,0.8104371405907815,0.7727272727272727,0.983333166315161,1.0,1/9,4.85%,F2R
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.4238498958056269,0.8102756285059922,0.703125,0.983382289684967,1.0,5/17,23.39%,LDLR;CALB1;SGK1;RGS14;CAMK4
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.48676114431206635,-0.8098539911154757,0.7209302325581395,1.0,1.0,3/10,21.45%,SCARF1;PTPRS;GRN
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.4692582622128224,0.8097846582233154,0.7254901960784313,0.9839606648574019,1.0,5/10,26.05%,BMP2;BMPR1A;BMPR2;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.3792409053109869,0.8096706011723714,0.7636363636363637,0.9837897620174949,1.0,5/38,9.77%,C3;RAB27A;RAB31;TULP1;IL15
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3500795258756914,-0.8096388971851404,0.8292682926829268,1.0,1.0,4/62,12.50%,TRMO;DUS2;METTL6;TARBP1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5359822486278066,0.8095074959935732,0.7037037037037037,0.9838183396515996,1.0,1/7,8.11%,PECR
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.44423238338065996,0.8094905621893204,0.75,0.9835174442722011,1.0,2/17,0.57%,F2;SYK
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4585772461443592,0.809369472138967,0.7090909090909091,0.9833834550905574,1.0,3/10,12.74%,CBLB;SNCA;F3
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.36462023511570696,-0.8092182194165629,0.803921568627451,1.0,1.0,7/44,10.49%,KDM4D;WARS1;ATG14;SPRED2;SPRED3;CCDC88C;SPRED1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.48391111194271563,-0.809026138851527,0.6739130434782609,1.0,1.0,5/8,35.00%,CDC7;DBF4B;DBF4;NUGGC;TIPIN
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5254123062869529,0.8089902526262958,0.7407407407407407,0.9836925980868936,1.0,6/9,24.16%,NR4A2;FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.578663317626771,0.8089227041304825,0.8387096774193549,0.9834814381831026,1.0,4/6,41.28%,TOR1AIP2;NUTF2;PLK1;NUP54
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.40093490234819296,0.8089022976516245,0.7272727272727273,0.9831810578431512,1.0,12/32,31.26%,RNF152;TELO2;RRAGC;GPR137B;KPTN;RRAGD;DYRK3;SIK3;SESN2;PIP4P1;PIH1D1;SESN1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.495910747133375,0.808775368641086,0.7166666666666667,0.9830554812897,1.0,2/12,9.42%,PCSK5;SNCA
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.4154934453295316,-0.808484327415803,0.7045454545454546,1.0,1.0,3/15,8.59%,PIGG;PIGH;PIGL
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.41114252113524336,0.8083479754520979,0.6896551724137931,0.9834170900275646,1.0,6/25,19.42%,PEX12;GDAP1;ABCD3;ABCD2;PEX2;ABCD4
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5356853670675469,0.8082421556005508,0.78125,0.9832834028797667,1.0,3/6,27.69%,TET2;PON1;PON2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.37972918079115847,0.8080913866688928,0.796875,0.9832147084857145,1.0,6/38,21.40%,KAT2B;JADE3;TAF5;KAT6A;SUPT3H;PHF14
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.38746042915995216,-0.8078712276674287,0.717391304347826,1.0,1.0,1/38,1.26%,MTFR2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.509056033239087,0.8070431714336891,0.7894736842105263,0.9845572394647638,1.0,1/5,10.62%,KDM3A
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.531628394818874,0.8069084561952948,0.74,0.9844435745101583,1.0,2/5,20.41%,PTEN;DEPTOR
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4093695332594058,0.8068858374233662,0.7058823529411765,0.9841597842325304,1.0,10/30,23.28%,CCL5;SP1;NAPEPLD;ZNF639;HMGA2;CHD1;HDAC1;CX3CR1;CARD9;RRP1B
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.39261589236268524,0.8067373935912552,0.7192982456140351,0.9841192466366151,1.0,3/37,2.89%,RRAS;UTRN;RIN2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.370285412913807,0.806728529460731,0.8181818181818182,0.983815505128133,1.0,11/46,30.54%,ST6GALNAC3;ESYT3;ST3GAL6;ESYT2;ABCA2;HEXB;CTSA;NAGA;GLB1;UGT8;ST6GALNAC4
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.46110194345505273,0.806511815438127,0.7288135593220338,0.9838034477706995,1.0,4/13,24.97%,PUS7L;RPUSD2;PUS10;NOP10
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.331766345859405,0.8062199406309888,0.847457627118644,0.98403017196104,1.0,24/111,18.37%,RAB38;LRP1B;TCN2;ABCA6;SLC22A3;ABCG8;ABCA1;RAMP3;ARRDC3;ABCG5;TAP1;TOM1;ABCD3;ABCD2;SLC19A1;ABCC11;ABCA8;LMAN2L;LRP2;SLC22A5;CALCRL;ABCA9;SLCO1A2;SLC18A2
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3981516392616333,0.8059196853183641,0.8113207547169812,0.9842081972200583,1.0,6/39,12.45%,ST6GALNAC3;ST8SIA4;FUT9;B4GALNT2;ST3GAL6;FUT8
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5387591578615288,0.8056970858032216,0.7936507936507936,0.9836503239762678,1.0,2/5,20.93%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5387591578615288,0.8056970858032216,0.7936507936507936,0.9836503239762678,1.0,2/5,20.93%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5387591578615288,0.8056970858032216,0.7936507936507936,0.9836503239762678,1.0,2/5,20.93%,SMC5;NSMCE2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.33456702554739887,-0.805515340247625,0.8780487804878049,1.0,1.0,12/80,16.57%,KDELR1;ARF3;KIF2B;COPG2;KIF22;KIF15;COPG1;RAB6C;ERGIC1;ATP9B;ARFGAP3;KIF1C
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5158584597699496,0.8054154457208351,0.7647058823529411,0.9834850124390494,1.0,2/8,11.72%,CYP27A1;CEL
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5158584597699496,0.8054154457208351,0.7647058823529411,0.9834850124390494,1.0,2/8,11.72%,CYP27A1;CEL
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.47261415422622516,0.8053955720986684,0.6792452830188679,0.9831783526147067,1.0,3/10,9.13%,TGFBR1;POU3F2;PAX6
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.43384544595389923,0.8052376302859977,0.7547169811320755,0.9830696729263664,1.0,6/17,26.56%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.3359324284584494,0.8051948938716649,0.8867924528301887,0.9828037038563061,1.0,15/133,13.80%,F2;LGALS9;SSC5D;BTN2A2;IL23R;NAV3;RPS6KA4;C5AR2;VSIR;HMGB1;NLRP7;IRAK3;ABCD2;NR1H4;BCL3
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.4670389362941822,-0.8051049737846133,0.6724137931034483,1.0,1.0,1/12,2.65%,ASS1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.47453687071413514,0.8050853540790639,0.7142857142857143,0.9826710192831535,1.0,3/9,22.49%,PTAR1;RCE1;PGGT1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.42063754638930984,-0.8050653568375424,0.6818181818181818,1.0,1.0,2/21,2.34%,IRF4;CD86
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.4853131712110809,0.8048441421094454,0.7115384615384616,0.9826997121335256,1.0,4/11,21.85%,RAPGEF6;TJP2;AFDN;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5218222424431729,0.8046053075553605,0.7450980392156863,0.9827928802783479,1.0,4/7,25.18%,LYN;MFHAS1;F2RL1;TLR1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.3645353304966483,-0.804390935665836,0.7755102040816326,1.0,1.0,2/45,4.65%,AMACR;PER2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4554706604963521,0.8039886490748416,0.6491228070175439,0.9834178883999168,1.0,3/13,17.38%,PPP1R15B;PPP3CA;PPP2R2B
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5358572784418933,0.803670532092268,0.7,0.9836396597721233,1.0,1/6,16.82%,MARCHF7
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.32980576757637503,0.8035919233120217,0.8461538461538461,0.9834585953595837,1.0,23/131,17.38%,DUSP29;CTDNEP1;PPP1R15B;PPP4R1;PPM1A;PTPRD;PPP1CC;EYA2;PTPN14;DUSP18;PTPRT;PPM1L;PTPRK;PTPRM;PPM1E;DUSP2;PTEN;PPP3CA;PPP3CC;MTMR3;PPEF2;PTPRU;PPP2R2B
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3720885269305714,0.8034540931156023,0.7454545454545455,0.9834064686459084,1.0,7/37,16.62%,DUX4;BMI1;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.43528112049976847,0.8032034882784876,0.7608695652173914,0.9834670546248402,1.0,6/17,18.74%,FDX1;HSD17B10;AKR1C1;FDXR;STAR;AKR1C3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.451207596120007,-0.8031557361167773,0.6857142857142857,1.0,1.0,6/11,31.51%,AKAP8L;PARG;MTHFR;AKAP8;NNMT;MYOCD
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.33628009678418164,0.8031227233261685,0.9019607843137255,0.9832942730065992,1.0,6/96,7.50%,IGF1;NRG1;IL4;ANGPT1;TNIK;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.2987387167025161,-0.8029462806986414,0.9736842105263158,1.0,1.0,19/140,10.75%,TERF2IP;PRKCD;SFRP1;WARS1;ATG14;XDH;MVP;CAV1;TRIB2;SPRED2;SPRED3;UBASH3B;NTRK3;TAF7;CEACAM1;MYADM;CAMK2N1;SPRED1;IGFBP3
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.36290671047968254,-0.8028810210133388,0.8181818181818182,1.0,1.0,11/32,21.71%,MBTPS2;AFG3L2;ADAM19;SPPL2B;MYH9;APH1B;TGFB1;MBTPS1;ADAM9;APH1A;RBMX
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.36722766908432763,0.8027621360527434,0.8431372549019608,0.9836645158140492,1.0,5/37,6.00%,CHRM2;HTR1F;HRH3;SSTR3;NPY
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.3728779250234816,-0.8024970271737585,0.7209302325581395,1.0,1.0,15/64,15.04%,EHF;CLDN4;FAM3D;CYP24A1;LAMB3;ST6GALNAC2;ABCC3;EXO1;CRH;F11R;IL18;SDR16C5;CXCL16;HRH1;VDR
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.3167768552967717,0.8023445266249333,0.9166666666666666,0.9840385338149419,1.0,30/145,30.61%,CARNS1;MRPL28;PCSK5;ZAR1L;MRPS12;GGT5;RPS5;RPL21;DMD;MRPL11;RPL7;RPS3A;RPL23A;RPL18A;MRPL10;MRPL18;MRPL41;RPS29;RPS15A;RPL9;GGTLC2;MRPL52;RPS23;MRPS15;RPS12;FURIN;RPS19;EEF1A1;MRPS33;RSL24D1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.45142302673379,-0.8021671516152217,0.7619047619047619,1.0,1.0,8/21,18.29%,CAV1;ABCB4;TGFB1;TGFBR3;HSD3B2;UBE3A;HSD3B1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.46868890730566304,0.8019918763109052,0.7692307692307693,0.9842997753019227,1.0,2/9,4.99%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.41999787931406934,0.8018241799309729,0.7735849056603774,0.9842876495083277,1.0,10/29,24.03%,SIRT1;PPARG;PLA2G10;NR1H3;ABCA8;SHH;PON1;ABCA2;SREBF2;ABCA7
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.48332842623590866,-0.8015945430860963,0.7142857142857143,1.0,1.0,4/5,32.17%,BAG3;MAPT;PRKN;HDAC6
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.4855301783667966,-0.801388503154957,0.7857142857142857,1.0,1.0,3/7,10.55%,CAV1;TPCN2;CAV2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.33380318782224216,0.8012935419953536,0.9107142857142857,0.9848619024917725,1.0,12/115,8.54%,CALCR;RUNX1;GNG12;BMI1;DOCK1;LRIG3;CSPG4;WWTR1;ARHGEF17;ASB5;SCRIB;LIFR
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),0.518811290004289,0.8012679603959447,0.7441860465116279,0.9845725700989415,1.0,4/5,48.07%,CHRNA3;ATP2B4;CHRNB2;CHRNA7
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.460154668150482,0.8012520981847226,0.7692307692307693,0.9842593473670275,1.0,1/12,2.98%,IL4
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.44824133536658206,0.8001873365643664,0.7213114754098361,0.9857959829101793,1.0,4/19,16.53%,HAP1;CEP135;CEP120;CCP110
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.44300839303731043,-0.8000668907016603,0.6666666666666666,1.0,1.0,4/16,15.04%,NMUR2;EDN3;ADGRB2;HRH1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.28729076046203234,-0.7998030744336421,0.9555555555555556,1.0,1.0,30/302,9.02%,ACTC1;COL24A1;COL23A1;COL4A2;COL27A1;COL5A1;TNXB;PXDN;COL4A1;RAC2;TMOD1;KIF2B;BFSP1;COL6A3;COL1A1;TGFBI;PLK3;COL11A2;COL28A1;LAMB3;TUBGCP2;TSPAN15;TRIOBP;ARHGAP12;CCDC88C;LOXL4;MYO15A;ADAMTS3;RND1;MYO5B
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.5107797558978849,-0.7996906498050819,0.7142857142857143,1.0,1.0,2/5,15.55%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.5107797558978849,-0.7996906498050819,0.7142857142857143,1.0,1.0,2/5,15.55%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.5107797558978849,-0.7996906498050819,0.7142857142857143,1.0,1.0,2/5,15.55%,CRYL1;SORD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.4564714391050212,-0.7996809781500668,0.6382978723404256,1.0,1.0,1/7,7.47%,DHX8
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.4267862840518212,0.7995567900384011,0.7619047619047619,0.9866256793889553,1.0,4/15,13.41%,BMP2;HPSE;PLXNB1;GREM1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3852429615085406,0.7995496793728455,0.7192982456140351,0.9863080795741065,1.0,4/35,15.84%,FHIT;RYBP;PML;EIF3H
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.4571074445181619,-0.7995152798482738,0.8108108108108109,1.0,1.0,1/12,4.65%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.4571074445181619,-0.7995152798482738,0.8108108108108109,1.0,1.0,1/12,4.65%,PER2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.49931353902746456,0.7992226973208484,0.7192982456140351,0.986531808174436,1.0,1/7,14.87%,XPO1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.4778082394629942,-0.7991604464501216,0.7674418604651163,1.0,1.0,2/9,11.62%,SLC36A2;SLC6A20
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3132780991568147,-0.7989291995370168,0.9302325581395349,1.0,1.0,24/252,11.12%,TERT;DNASE1L1;HMGB3;TERF2IP;PARP2;FANCG;SLX4;REXO4;RECQL5;TICRR;ORC6;ERCC1;RPAIN;FANCC;SMUG1;RFC3;POLQ;RTEL1;EXO1;XPC;PARP1;RAD51AP1;CDC6;XRCC1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.472946397613275,-0.7988398470400063,0.75,1.0,1.0,1/6,3.26%,TST
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3911039553998432,-0.7983322132218258,0.8076923076923077,1.0,1.0,4/23,14.49%,STAC;ABCB1;CTSS;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.43785550036758447,0.7983207179611304,0.7758620689655172,0.9876489425620445,1.0,1/21,0.56%,IGF1
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.5396616441254845,0.7983141661796072,0.8,0.9873313195148419,1.0,2/5,14.53%,SLC22A3;MAPK15
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3301382629824486,0.7982986997496463,0.8333333333333334,0.987013905843412,1.0,11/97,17.26%,TIMELESS;HELB;RBMS1;MCM7;POLE2;REV3L;PCLAF;REV1;TOP1MT;ORC4;POLD4
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.5189316002715357,0.7982508551538993,0.8181818181818182,0.9867687554309322,1.0,1/7,6.83%,HSD17B2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4601044389284946,0.7980885826524202,0.7777777777777778,0.9866598238549372,1.0,10/24,29.57%,FGF2;VEGFA;HDAC9;AKT3;MEOX2;CIB1;NOTCH1;ANXA1;STARD13;PTGS2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.4178855663374651,-0.7979624999249983,0.7777777777777778,1.0,1.0,1/17,2.05%,BST1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.46365215123839787,0.7977090211573006,0.7111111111111111,0.9869790034822268,1.0,2/10,9.04%,F2R;HMGB1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4063867549728211,-0.7976320222162365,0.782608695652174,1.0,1.0,5/27,9.47%,PER2;PDE6B;RBM4;PPP1CA;RBM4B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3479950871900057,0.7974825968156389,0.7543859649122807,0.9869860469229708,1.0,13/68,18.53%,PRMT1;PAXIP1;E2F4;CNOT6L;PLAGL1;CHEK2;PML;BCL3;CNOT4;CDC25C;GTSE1;CNOT8;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.42895428754172765,0.7973514750276086,0.711864406779661,0.986901137796606,1.0,6/22,14.46%,ACHE;SLC24A2;DRD3;NLGN4X;GRIK3;PTEN
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4450091914805638,0.7971683065264393,0.7592592592592593,0.9868482559004517,1.0,6/15,26.56%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.39725683102232,0.796933647330796,0.8,0.986883301136213,1.0,7/33,15.79%,ACSM2A;THEM5;HMGCS1;GLYAT;OXSM;ACACB;ACACA
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4159349384119097,-0.7968442259176495,0.7391304347826086,1.0,1.0,5/15,21.67%,WFS1;MAPK7;PDGFB;PAX8;MTPN
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.49595650597855295,0.7961580300388453,0.7413793103448276,0.9879047903557086,1.0,5/8,40.63%,ALDH6A1;DPYSL5;DPYSL3;DPYS;DPYD
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.3429677909027245,0.7961479794696541,0.7966101694915254,0.9875921194947948,1.0,14/94,16.08%,SLC26A3;RAPGEF3;AANAT;SLC26A6;GLRA1;RELA;HCN1;RRAGC;NR1H4;MEF2C;RAP1A;GABRB2;CPEB1;TRPM2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.36903563133892053,0.7960931611476306,0.7586206896551724,0.9873435127813498,1.0,5/41,17.37%,PLD6;PLA2G10;ACP6;ABHD8;DGKZ
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5359395420077482,0.7959378762333035,0.8333333333333334,0.9872985521577383,1.0,3/6,21.42%,NLGN1;GPHN;LHFPL4
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.49471856656397784,0.7959307997903696,0.75,0.9866704420483441,1.0,1/8,1.96%,GSTM2
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.49471856656397784,0.7959307997903696,0.75,0.9866704420483441,1.0,1/8,1.96%,GSTM2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3746626527476618,0.7959237936344679,0.7142857142857143,0.9863626750006883,1.0,6/36,22.53%,ATXN1;NXT1;ANP32A;XPO1;RGS14;NCBP1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5175793040760329,0.7957478149116374,0.7547169811320755,0.9863260643018623,1.0,2/6,34.36%,WASL;SH3GLB1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.393368648194866,-0.7951865357803076,0.725,1.0,1.0,6/28,15.25%,SOX30;PAQR7;CAV1;AR;TGFB1;MED1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.48135176477709724,-0.7951845533073975,0.7058823529411765,1.0,1.0,2/6,21.66%,SLC6A20;SLC6A7
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.31013680150820616,0.7948973784469336,0.8958333333333334,0.9875043896298864,1.0,42/161,24.93%,TGFBR1;POGLUT2;MAPKAPK2;MAPKAPK3;RPS6KA4;DYRK2;GALNT3;SMG1;MBOAT4;LATS1;POGLUT3;RPS6KA2;GALNT1;STK32B;VRK2;MAPK8;DYRK1A;CSNK1G3;SGK1;RICTOR;HIPK1;PKN2;RPS6KA1;RPS6KA5;GALNT16;MAST1;STK38L;NAA11;STK32C;WNK1;AKT3;STK32A;HIPK3;MKNK2;IKBKB;CAMK4;GAS6;AKT2;RPS6KA6;IKBKE;DYRK3;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.5239429942145659,0.794790856546839,0.7666666666666667,0.9873559323696759,1.0,2/5,14.16%,SNCA;CD244
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3147940248986516,-0.7945885656771227,0.9534883720930233,1.0,1.0,25/150,15.92%,KDM4D;PARP2;SLX4;ABRAXAS1;RNF8;RECQL5;ERCC1;EYA1;POLQ;MEIOB;RAD51AP2;PRPF19;PARP1;RAD51AP1;AP5S1;XRCC1;FAN1;CYREN;NUCKS1;SMARCA5;RPA3;TNKS1BP1;APTX;RAD50;KDM4B
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.46761139042787003,0.794364861000597,0.7,0.9877608907785641,1.0,3/9,17.27%,FDX1;FDXR;STAR
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.45073634791423023,-0.7941330746745145,0.75,1.0,1.0,1/10,3.00%,CCBE1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.4605025652947189,-0.7940343381214054,0.7777777777777778,1.0,1.0,3/14,18.04%,CLDN5;F11R;S1PR3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3803562988845664,0.7940001968953246,0.8571428571428571,0.9880143665525507,1.0,12/32,32.23%,NAV3;SNCA;HDGFL3;DYRK1A;MAP2;CAMSAP2;ARHGEF2;CIB1;MID1IP1;CLASP2;CLASP1;FGF13
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.42923532823914334,0.7939281585709282,0.8275862068965517,0.9877982604224927,1.0,6/26,14.76%,BDH2;CYBRD1;HJV;NEO1;TF;PICALM
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.37303292235967533,0.7934176380284087,0.8545454545454545,0.9883140267404723,1.0,4/38,4.60%,SLC12A7;SLC12A1;KCNJ3;SLC12A3
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.42255607174138277,0.7930178808374965,0.7777777777777778,0.988666460119719,1.0,2/14,13.05%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.49830891116468606,0.7925836127147402,0.7288135593220338,0.9890305855152681,1.0,1/7,7.31%,METAP1D
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.4450202436142007,-0.7923689053255433,0.7391304347826086,1.0,1.0,1/8,5.56%,FOXO4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.33897879306217926,0.7923109736919401,0.9076923076923077,0.9891322615374091,1.0,6/81,6.39%,MME;AANAT;CPN1;MMP16;F12;PCSK5
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.46414213536168525,0.7922046879619404,0.7924528301886793,0.9889836603694423,1.0,3/11,8.90%,ACHE;ALDH9A1;SLC44A4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.49563772908087106,0.7922001371768265,0.7962962962962963,0.9886961958012774,1.0,1/8,11.09%,PTPRT
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.4949195099912779,0.7921299125780619,0.7017543859649122,0.9885121131521893,1.0,1/7,12.83%,TAP1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.41016577182246505,-0.7917260951434124,0.74,1.0,1.0,7/24,26.58%,NCAPD3;TTN;AKAP8L;CDK1;NCAPG2;NCAPD2;SMC2
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.5223828788759433,-0.7915317287067131,0.6666666666666666,1.0,1.0,2/5,6.53%,DRD2;ADCYAP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.4656286786130401,0.7914433165081676,0.7857142857142857,0.9892288203301166,1.0,6/11,42.74%,TERF1;CCT3;CCT7;CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.39972647927769334,0.7914082082007668,0.7636363636363637,0.9889534565110014,1.0,11/34,20.46%,GABRE;GLRA1;GABRG3;INSYN1;GRIN2D;MEF2C;GABRA5;GABRG1;GRID2;ARRB2;GABRA4
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.35189608309766585,0.7911379399485251,0.7903225806451613,0.9890787493066612,1.0,15/72,16.90%,TYR;POU6F2;ADGRV1;TULP1;RPE65;DHRS3;GRM8;PAX6;RS1;CRYGS;REEP6;COL11A1;RPGR;ATF6;CRYZ
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3596690535775756,0.7910416388185699,0.8653846153846154,0.9888987459062807,1.0,7/43,10.93%,TIFA;MAPKAPK2;MAPKAPK3;PLCG2;TLR2;HMGB1;TAB2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4528933917352926,0.790741916065266,0.7192982456140351,0.9891111504988672,1.0,7/15,23.50%,PELI3;ZNF675;CARD16;CCDC3;F2RL1;NLRP2B;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.34063225149045256,0.790724786912753,0.9,0.9888163779820395,1.0,12/67,12.98%,SIPA1;CDKN2A;BRINP3;BMP2;GMNN;SCRIB;HTRA2;LATS1;RPS6KA2;PTPRK;HECA;TP53BP2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.514980960102953,0.7906173129270123,0.7450980392156863,0.9886722756453196,1.0,2/5,26.52%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.41280755027454963,0.7905815081671561,0.7627118644067796,0.988397631515875,1.0,3/17,17.14%,SLC22A3;SLC44A4;SLC22A5
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.46303948773084225,0.7905730451292844,0.6909090909090909,0.988095464730688,1.0,2/9,17.54%,METAP1D;NAA16
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41986156059498947,0.7903144759389064,0.7142857142857143,0.9882128391615853,1.0,4/14,25.59%,FBXO5;BAG2;ABL1;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.38911700790506953,0.7901792232305129,0.7241379310344828,0.9881323975902758,1.0,2/25,4.82%,MYCN;LIN28A
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.40664856189770787,-0.7900359188446304,0.775,1.0,1.0,2/37,5.15%,ACTC1;OLFM1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3108916205251936,0.7899860890918208,0.9473684210526315,0.9881547994970983,1.0,36/165,20.13%,CFH;PRRX1;ITGA2;ADGRL4;TMEM100;IL7R;MAFB;MYCN;BMP2;IL10RA;IRF8;SPON1;CSF2RA;HKDC1;GALNT3;USP12;ADAMDEC1;CA2;PLAUR;GADD45G;NR1H4;ANGPTL4;ZNF639;GUCY1A1;ANKH;MAP3K1;CAB39L;PTBP2;CPE;GLRX;GYPC;GPRC5B;BPGM;HDAC9;DCBLD2;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.39138603725734805,0.7899287922036814,0.7647058823529411,0.9879321492711586,1.0,5/28,14.16%,FZD5;UBE2D3;HTRA2;RHOU;UBE2J2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.2941147475990455,0.7897677887528517,0.9661016949152542,0.9879032395948679,1.0,64/287,24.44%,MKRN3;NEDD4;SYVN1;RNF152;UBE2J1;PELI2;PELI1;MARCHF1;UBE2E2;FBXL3;UBE2D3;PELI3;RNF217;UBE3D;FBXO30;RNF146;SPOP;UBE2E3;LNPEP;PSMD13;FBXO7;AKTIP;FBXL14;RNF166;HECW2;SHPRH;KLHL42;UBE2J2;ARIH1;RBBP6;UBE2QL1;RNF5;MAGEL2;PSMA1;PSME4;UBE4A;RMND5A;FBXL15;RNF26;UBE2U;UBR5;CTNNB1;NHLRC3;FBXO11;ZNF738;FBXL20;RNF144A;UBE2D1;SMURF1;UBE2A;MARCHF8;FBXO17;UBE2E1;PSMD4;FBXW5;FZR1;RNF19B;TRIM68;TPP2;MARCHF5;TRAF5;KLHL20;ANAPC13;FBXL22
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.44510015784829915,-0.7897428234696926,0.75,1.0,1.0,2/9,11.12%,TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4881648189103874,0.7895557225196075,0.8,0.9878980466092608,1.0,4/12,18.74%,DHRS3;CTBP2;EZH2;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.36035734135509784,0.7886692398328728,0.8846153846153846,0.9889352254528165,1.0,12/53,20.14%,HGF;IL10RA;SNCA;SMG1;PIK3CA;TAB2;LEPR;WASHC1;MTMR9;TAB3;DAPL1;RASIP1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.36887986379906484,0.7885630525599407,0.8148148148148148,0.988783658507747,1.0,6/39,21.63%,RIOK2;TSR3;RPS5;RIOK1;RIOK3;ERAL1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.4821759532451736,-0.7880335590844213,0.5909090909090909,1.0,1.0,4/7,16.72%,DRD2;TRPV1;HTR1B;RYR1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.4964048228909423,0.7879530599521237,0.8070175438596491,0.9893345425302627,1.0,1/7,5.81%,CHD7
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5230417898006494,-0.7878823857985031,0.7209302325581395,1.0,1.0,1/5,7.67%,PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.36036367512410133,0.7878240641169376,0.8,0.9891789998373406,1.0,6/46,9.00%,ACE2;CLSTN2;NLGN1;CNTNAP2;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.3297108781094217,-0.7876786328479679,0.8333333333333334,1.0,1.0,8/56,15.15%,NPTX2;CAMK2A;BEGAIN;CACNG8;CRH;PTK2B;SHANK1;SHISA7
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3293533600548897,-0.7875316789884083,0.9512195121951219,1.0,1.0,5/94,3.17%,TERT;SOX30;ATP6V1C2;RSPO4;SFRP1
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.5141255132812748,0.7874517533680194,0.7407407407407407,0.9894730873904416,1.0,1/6,4.75%,CDH2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.3809177382133989,0.7872278171976043,0.8153846153846154,0.9894673951543862,1.0,6/31,21.26%,RHOD;DLC1;PTPRK;DST;CD151;LAMA3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.46020674902285774,-0.7871171440985891,0.6304347826086957,1.0,1.0,1/11,0.36%,IRF4
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.3766087854032967,0.7871049570314805,0.8125,0.9893907743490481,1.0,8/48,12.29%,LGALS9;CSF3R;PTGS1;GNAT3;FGL2;DRD3;KLF6;IRAG2
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.43022684803126876,0.7870580570223243,0.7586206896551724,0.9891881423229785,1.0,1/16,2.87%,FGF2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.3874700387606566,0.787056090057933,0.75,0.9888793122478641,1.0,10/23,29.51%,PRDX6;PLA2G10;PLA2G7;PNPLA6;PNPLA8;GPCPD1;PLA2G15;PLA2G4E;INPP5F;PLA2G6
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.45064438951309993,0.7869928879942212,0.7419354838709677,0.9886612298800446,1.0,4/9,14.24%,FER;LYN;BLK;ADGRE2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.47092672584807505,0.786949298241922,0.6938775510204082,0.9884236109277561,1.0,1/11,5.38%,IDH1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3916674086698403,-0.7867759716362779,0.7441860465116279,1.0,1.0,4/20,19.75%,RNF8;ATXN7L3;PHC1;RNF20
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.46198921934734527,-0.7866619244170587,0.75,1.0,1.0,2/10,6.34%,OAS3;OAS1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.3158775725386299,0.7865708558365947,0.8909090909090909,0.98869760494946,1.0,13/95,9.98%,SLC12A7;HRH3;SCGN;MYCN;HGFAC;GOLT1A;GAL3ST1;SEMA6C;SYT1;PLPPR1;PTOV1;MMP15;EFNA2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4550936255815158,0.7861571229550562,0.6491228070175439,0.9890461490830854,1.0,1/9,13.58%,RACGAP1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.28613494404260315,-0.7861523005447529,1.0,1.0,1.0,14/370,6.87%,TERT;GOLGA8B;ARAP3;CFAP61;MTFR2;PAK6;PTCD2;WTIP;FANCG;ZMYM6;GOLGA2;CAV1;PEX7;GOLGA8A
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3816965303212514,0.7860021054140707,0.74,0.9889344523909912,1.0,3/45,2.18%,FGF10;TIMELESS;SIRT1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.457348623043024,0.7854107978676106,0.82,0.9894517051085118,1.0,5/14,22.99%,RBPJ;PROX1;BMPR1A;JAG1;HEY2
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.3772573560586505,-0.7852969455897527,0.78,1.0,1.0,2/37,2.34%,IRF4;CD86
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.2969401631666818,-0.7849421254074712,0.9512195121951219,1.0,1.0,2/151,0.27%,NTRK1;ALB
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.41990911154122995,-0.7848803805382771,0.7391304347826086,1.0,1.0,3/19,12.47%,WTIP;NRDE2;MOV10L1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.43569993062613677,-0.7845847820110432,0.7391304347826086,1.0,1.0,1/10,5.78%,OARD1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.36526626495362124,0.7844978720327934,0.8181818181818182,0.9906326598985049,1.0,10/44,20.22%,SIRT1;HDAC3;HDAC2;TBL1X;SIRT6;SMARCAD1;SIRT7;HDAC1;HDAC9;MIER3
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.3803270850765379,-0.784311476641895,0.8333333333333334,1.0,1.0,3/27,5.82%,CTNNA1;BOC;RBM4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3452153718562711,0.7841312430634121,0.8571428571428571,0.9908701453198647,1.0,4/75,4.80%,CTCFL;KAT2B;SF3B1;BMI1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.4196267715736347,-0.7838738997015076,0.7555555555555555,1.0,1.0,2/16,6.25%,CBARP;CAV1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.45117705730999086,0.783671504839175,0.8,0.9913470041611523,1.0,2/11,22.56%,LYN;FADD
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.45777182357976076,-0.7835709879224614,0.8095238095238095,1.0,1.0,1/10,2.76%,TIE1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.4555359330358458,-0.783472247096465,0.75,1.0,1.0,2/10,25.04%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.4555359330358458,-0.783472247096465,0.75,1.0,1.0,2/10,25.04%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4008636301832218,-0.7834705636978528,0.8181818181818182,1.0,1.0,3/23,5.21%,DRD4;CBARP;DRD2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.5065125733685871,0.7833980378229642,0.7884615384615384,0.991509522668498,1.0,1/7,5.81%,CHD7
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5104121420650252,0.7833977439819032,0.7741935483870968,0.9911892676547162,1.0,2/8,12.68%,PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.48236845352762175,0.7829672311745149,0.8,0.9916263328567265,1.0,3/12,23.20%,GLUL;DAO;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.4527775784072193,0.7822830180296977,0.7407407407407407,0.992463119211037,1.0,1/9,2.63%,ENPP1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.3874972017872671,-0.7822738136729993,0.7708333333333334,1.0,1.0,8/19,26.12%,ADAM19;SPPL2B;MYH9;ADAM9;APH1A;RBMX;HM13;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.43664773193803164,-0.782248260535603,0.7333333333333333,1.0,1.0,1/10,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.45316691296690137,-0.7819092156970772,0.7837837837837838,1.0,1.0,2/9,10.55%,IFI27;CAV2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.47469993696051327,0.7818345899580291,0.7547169811320755,0.9928054032363062,1.0,3/8,20.13%,CD74;CD244;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.42382384136130036,0.7817700750510692,0.765625,0.9925831202046036,1.0,5/22,18.19%,ARHGAP24;ABI3;KANK1;CCP110;LIMK2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.4539886862240485,0.7817133149495005,0.7735849056603774,0.9923453093061709,1.0,2/9,15.74%,MTTP;SOAT1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5317836373934381,0.78148962018434,0.8125,0.9923818098312331,1.0,4/6,38.09%,CDK6;HES5;EIF2B5;MT3
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4209827956593025,-0.7814597801380612,0.6956521739130435,1.0,1.0,3/17,11.10%,SCN5A;CACNA1G;SCN3B
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.5069133751701953,-0.7814152714603043,0.75,1.0,1.0,2/5,14.79%,P2RY12;GPR183
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4247796121810048,-0.7813653532057699,0.717391304347826,1.0,1.0,7/24,17.81%,RFC3;XRCC1;LIG1;RFC2;RPA3;RFC1;LIG3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.44707400845906786,0.7810390578634991,0.8571428571428571,0.9927550010865589,1.0,8/18,27.76%,TAF3;PML;BCL3;SUN2;HNRNPU;BARD1;RANGAP1;ARL2BP
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.5589560195595212,0.7808952386931782,0.8571428571428571,0.9926152151741997,1.0,1/5,7.69%,DNAJB2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.3385983144391842,-0.7807538898409149,0.8157894736842105,1.0,1.0,12/62,11.10%,NLRP3;CD86;CYTH4;LILRB3;MS4A4A;CLEC5A;KLHDC4;SLC11A1;PLET1;HCK;LY86;SPI1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.40647914973095645,0.7806925718547054,0.7758620689655172,0.9926515935068486,1.0,9/25,28.17%,DMC1;STRA8;HORMAD1;GDF9;FMN2;USP9X;TRIP13;TOB2;M1AP
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.5268359998715937,0.7805095138678739,0.7818181818181819,0.9926331874095421,1.0,4/5,38.09%,CDK6;EIF2B5;NF1;MT3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.41970290434317675,-0.7801536745296586,0.7954545454545454,1.0,1.0,3/20,4.98%,KCNMB2;SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.5140020959837378,0.7796557066664445,0.7857142857142857,0.9936940198017549,1.0,2/6,10.64%,DAND5;ANK2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.3860489080778083,-0.7794652394940977,0.75,1.0,1.0,4/38,7.86%,CLDN4;CLDN1;CLDN5;CLDN15
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.447579055159565,0.7794525651636602,0.7301587301587301,0.993714379981116,1.0,3/12,15.12%,SLFN11;GMNN;TERF1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.3879516717403714,0.7793999009891928,0.8166666666666667,0.993461186241454,1.0,13/38,20.17%,C3;IL4;ANGPT1;HIP1;BICD1;TF;MAGI2;GREM1;VEGFA;TBC1D5;WASL;ARRB2;FMR1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.46984975305431276,0.779205054224498,0.7666666666666667,0.9933761335165855,1.0,3/11,17.29%,PRKG1;MEF2C;DOCK4
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.46664423317417936,-0.7791235374204675,0.7608695652173914,1.0,1.0,2/7,10.49%,PRDM7;RAD51AP1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.48353259025673284,0.7790717612905477,0.8275862068965517,0.9932637989736718,1.0,1/11,0.65%,ZDHHC11
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.4815100015146072,-0.7787227421698941,0.8378378378378378,1.0,1.0,4/8,22.54%,ADAMTS1;PDGFB;FGF9;NR4A3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.41307442856130305,-0.7783411058215409,0.6818181818181818,1.0,1.0,2/13,16.56%,EPHB1;PAFAH1B1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.4194280460948698,0.7781344679462119,0.7457627118644068,0.9944905945390863,1.0,4/16,13.73%,MME;OPRK1;RETREG1;SCN9A
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.5125295052074454,0.7778760637347945,0.703125,0.9945340823591657,1.0,2/5,15.78%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3567770226310671,0.7777956991352974,0.7924528301886793,0.9943278493480523,1.0,7/57,16.94%,RUNX1;LMO2;LMO1;PSMD13;PSMA1;PSME4;MYB
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.3723558634318682,-0.7777609906451333,0.7804878048780488,1.0,1.0,5/28,10.20%,SOX30;RNF8;TOPAZ1;TTC21A;FAM9B
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.36232473126291226,0.7776152464870338,0.8070175438596491,0.9943206589039171,1.0,5/42,17.37%,PLD6;PLA2G10;ACP6;ABHD8;DGKZ
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.42744420645043835,-0.7775889369954512,0.7450980392156863,1.0,1.0,3/10,19.62%,CAV1;ACTN2;CAV3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4207799575521072,-0.7774616558310475,0.7959183673469388,1.0,1.0,3/16,7.12%,SPRY4;GPC1;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.49624385101183943,0.7771277366930861,0.7843137254901961,0.994789144661671,1.0,5/9,32.95%,LYN;CSF1;MAPK3;IL12A;CSF1R
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.29395002349481997,-0.776928279457924,1.0,1.0,1.0,7/179,7.51%,GOLGA8B;ANXA8;SUN3;ALS2CL;GOLGA2;GOLGA8A;TLCD2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.41732521924715227,-0.776723116133474,0.6976744186046512,1.0,1.0,3/13,16.20%,PTCD2;CDK11B;SRPK3
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.40801062663902843,-0.7766871536370085,0.7435897435897436,1.0,1.0,3/18,10.90%,ZWILCH;PLK3;BUB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.4324770675817844,0.7766247363439432,0.8245614035087719,0.9952963067846697,1.0,8/23,25.52%,TCAF2;MYO1C;MFF;ITGAM;ITGB2;AKT2;MIEF2;CIB1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4246713194987807,0.7764915951578828,0.7735849056603774,0.9951407476895915,1.0,4/16,35.29%,ATG2B;ATG3;ATG12;ATG9A
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.4439120545469213,0.7764509279267388,0.8181818181818182,0.9948762228210718,1.0,4/13,23.67%,GLUL;PM20D2;GLUD1;ASPA
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.47431347946846814,-0.776310491646148,0.7619047619047619,1.0,1.0,2/10,13.04%,GPC1;CD9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3564756590544349,0.7758835613733568,0.864406779661017,0.9953867633272981,1.0,10/58,20.40%,GLUL;RIOK2;DDX31;RRS1;XPO1;BOP1;NOC2L;BYSL;RPL7;RIOK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.4725424024668099,-0.7758225407704958,0.7045454545454546,1.0,1.0,1/9,0.36%,IRF4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.32126514537245915,-0.7753392208547328,0.9047619047619048,1.0,1.0,8/98,6.05%,RFX6;DRD4;CELA2A;RHBDF1;ALOX5;PER2;DRD2;KCNA5
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.43878234644248476,-0.7752409095410774,0.6829268292682927,1.0,1.0,2/18,5.58%,EEF1AKMT2;KMT2B
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.338808475406819,0.7748197784024468,0.8392857142857143,0.9967261220075821,1.0,7/61,16.94%,RUNX1;LMO2;LMO1;PSMD13;PSMA1;PSME4;MYB
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.45305285324492983,-0.7746903638951667,0.7547169811320755,1.0,1.0,3/12,5.15%,ABCA4;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.3989176818859183,0.7745747991093324,0.723404255319149,0.9967999000402615,1.0,8/29,23.12%,CCL5;POLR3G;PLSCR1;HLA-E;RIOK3;FADD;LBP;FPR2
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.4538668595729051,0.7745356987345828,0.7169811320754716,0.9965274022952534,1.0,1/11,2.13%,RUNX1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4084966295880297,0.7743365070994954,0.6964285714285714,0.9965195284839771,1.0,2/21,5.19%,URI1;BMP2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4255082513457884,0.7741872144553062,0.8596491228070176,0.9964533439349877,1.0,1/14,5.24%,PHKA1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.34886267628119555,-0.7740710363415648,0.84375,1.0,1.0,10/67,7.54%,ALB;CLDN4;HABP2;KIF12;FGL1;PAH;AHSG;CLDN1;DSG2;FOXM1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.36260686207170106,0.7737812786077198,0.8032786885245902,0.9967292115122146,1.0,5/46,11.73%,KCTD21;TULP3;RORA;MOSMO;KCTD6
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.48294199811534966,-0.7736576295145177,0.74,1.0,1.0,2/8,12.27%,MFAP5;KDM2B
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.36856291782855083,0.7736369088065079,0.8775510204081632,0.9966124942236957,1.0,10/37,19.03%,TGFBR1;GDF6;BMP2;ACVR2A;INHBC;BMPR1A;SMAD4;GDF9;BMP4;BMP8B
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.44208551180490163,-0.773399129732082,0.717391304347826,1.0,1.0,1/11,4.03%,CBARP
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.4701873325655122,-0.7733779015968016,0.7777777777777778,1.0,1.0,1/6,14.57%,FUCA1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.4701873325655122,-0.7733779015968016,0.7777777777777778,1.0,1.0,1/6,14.57%,FUCA1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3295225897975516,-0.7729317523338471,0.8636363636363636,1.0,1.0,8/86,7.06%,RFX6;CELA2A;SFRP1;ALOX5;PER2;FAM3D;KCNA5;NNAT
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.2942710227299266,-0.7728046704407315,0.975,1.0,1.0,20/174,12.12%,LDHC;HK2;INHA;COL5A1;SLC6A6;FOS;TGFBI;GPC1;IER3;CAV1;GPC3;JUN;CCNG2;ENO2;SAP30;IGFBP3;GAPDHS;DCN;MYH9;SLC2A1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.44764111992846045,0.772697366983254,0.75,0.9977814521973983,1.0,1/12,1.06%,TOP2A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.457025769814439,0.7726973278476522,0.8,0.997462570301522,1.0,2/11,8.85%,IL23R;VSIR
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.42488922162576387,-0.7725822517694698,0.8085106382978723,1.0,1.0,3/20,3.67%,CXCL13;SFRP1;WARS1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.3393983711991338,0.7724625064337135,0.9253731343283582,0.9975126354288513,1.0,13/67,16.57%,SEMA5A;TENM1;HCLS1;FER;PROX1;CRACD;BIN1;CARMIL1;NCK2;SYNPO2;FCHSD2;SORBS3;LMOD2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.32485006030851743,0.7722964281500354,0.9259259259259259,0.9974695421355436,1.0,15/135,7.46%,TMPRSS2;AP1M2;BOK;ITGA2;PRG4;SCNN1B;CDKN2A;ANPEP;THRSP;BMI1;AGR2;TM4SF20;LY6D;MUC13;SELENBP1
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.5459397067044556,-0.7722867189473677,0.8444444444444444,1.0,1.0,1/5,8.74%,MEFV
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4505803597570174,-0.7722565349354008,0.7555555555555555,1.0,1.0,1/15,1.16%,NUPR1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.31200035603218085,0.7721986363033873,0.8833333333333333,0.9973256215949273,1.0,30/152,19.55%,SLC5A8;SCN7A;TRPM8;SLC5A12;SCNN1B;ASIC1;KCNJ3;SLC12A3;SLC8A1;KCNH4;SLC22A3;SCN3A;ATP1A2;SLC5A4;KCNF1;SCN9A;KCNB2;KCNAB3;SLC3A2;TRPM2;ANO6;SGK1;PIEZO1;LRP2;SLC5A5;TRPM7;SLC18A2;SLC36A1;KCNJ10;KCNJ8
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.4103567630311425,-0.7719718563377778,0.6756756756756757,1.0,1.0,1/16,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3398707376790858,-0.7716837010951448,0.7916666666666666,1.0,1.0,7/53,13.57%,CELA2A;TPP1;CEACAM1;PRPF19;ADAMTS9;DENND3;DAB2IP
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.4546330474151927,0.7716322599729338,0.7142857142857143,0.9978953065307159,1.0,4/12,15.41%,NLGN1;NLGN4X;LRRTM3;FZD1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4664785567985945,-0.7714987838287508,0.7857142857142857,1.0,1.0,1/10,2.65%,ASS1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.4679247877330843,-0.7713740479163713,0.7142857142857143,1.0,1.0,2/5,14.48%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.44507591644334293,0.7711198679046193,0.7407407407407407,0.9983483312955338,1.0,2/11,20.88%,TRAPPC8;STX17
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.45041840100794284,0.7710814652516946,0.7192982456140351,0.9980880086389723,1.0,1/9,0.86%,NOX5
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.4230673680857415,-0.7706687537380196,0.6976744186046512,1.0,1.0,1/12,4.04%,ALOX5
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.33566263658205764,0.7705977823564878,0.9491525423728814,0.9984438309941613,1.0,11/59,13.71%,ABHD3;SLC44A5;LPIN3;ACHE;PCYT1B;SLC44A4;CHPT1;PLA2G10;CEPT1;PLA2G7;NR1H3
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.4123902320077366,0.7705970495340323,0.8070175438596491,0.9981294240095276,1.0,4/17,12.45%,FUT9;B4GALNT2;ST3GAL6;FUT8
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.4070586366294998,0.770529209258476,0.7833333333333333,0.9979042645005253,1.0,8/18,29.31%,ZDHHC2;STX8;ABCA2;LDLRAP1;VAMP8;SPTBN1;ZDHHC7;APPL1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.45838281413295034,-0.769847093232375,0.7631578947368421,1.0,1.0,2/7,15.67%,CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.3639423211323885,-0.7694596318122668,0.7894736842105263,1.0,1.0,1/38,1.58%,SYNJ2
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.4565544393911273,-0.7694363382654242,0.7631578947368421,1.0,1.0,1/5,13.87%,TCF7
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.32334944853183745,-0.7693639674890745,0.8913043478260869,1.0,1.0,3/97,1.02%,PM20D1;ACOT1;PLAAT4
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.4407253826279442,-0.7693632168361512,0.7959183673469388,1.0,1.0,1/9,3.23%,ENPP2
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.4145915412147577,0.7689726059026705,0.7592592592592593,0.999846660783205,1.0,6/22,22.88%,PRR16;PTEN;VAV2;RAP1GAP2;DEPTOR;EDN1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.3090260367608523,0.7685796374331515,0.9230769230769231,1.0,1.0,12/188,14.87%,CCNA2;U2AF1;MYC;SYNCRIP;ODC1;HDAC2;MCM7;HNRNPD;RPS5;CDK4;PSMA1;XPO1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.4847579681609163,0.7682683127937201,0.7358490566037735,1.0,1.0,2/5,32.95%,MAPK3;CSF1R
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.47125372597770215,0.7677647138897956,0.7962962962962963,1.0,1.0,3/9,17.52%,GLRA1;PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.3751845358395483,-0.7675666706220303,0.7906976744186046,1.0,1.0,6/35,12.55%,NUPR1;FOS;CLU;EGR1;DAXX;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.44568176104785545,-0.767566664656794,0.7317073170731707,1.0,1.0,5/11,13.04%,PRKCD;ZNF703;CEACAM1;SERPINE2;CD9
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.4558858410541743,0.7672321892533399,0.8035714285714286,1.0,1.0,3/11,17.39%,CARMIL1;SPIRE2;COBL
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.32807556813827465,0.7670136859963972,0.8888888888888888,1.0,1.0,14/62,24.71%,TGFBR1;DYRK2;GALNT3;GALNT1;MAPK8;ACVR1B;DYRK1A;HIPK1;GALNT16;WNK1;HIPK3;GSK3A;CDC42BPA;DYRK3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.32064647847069816,0.7669854638064062,0.9629629629629629,1.0,1.0,13/94,20.17%,PRR16;SAMD4A;EIF3E;HDAC2;PLA2G10;HNRNPD;NR1H3;BCL3;PLXNB2;CSF1;ASPH;PERP;FMR1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.463324922902773,0.7667334459287364,0.8103448275862069,1.0,1.0,3/11,11.65%,GCH1;NRXN1;UBA5
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.362445558839513,-0.7666708339390502,0.7555555555555555,1.0,1.0,8/45,13.10%,APIP;GOLGA2;UPB1;TRPA1;TRPV5;TRPV1;GNMT;CBY1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.45402086335760283,-0.7664596932038665,0.7647058823529411,1.0,1.0,1/12,0.99%,CLDN4
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.4612641274781088,0.7664340635637487,0.8076923076923077,1.0,1.0,7/12,29.10%,TLR2;OASL;TLR5;ANKRD17;PUM2;ZCCHC3;PUM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.42949590423375394,-0.7662255902034284,0.6341463414634146,1.0,1.0,2/5,14.48%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.42949590423375394,-0.7662255902034284,0.6341463414634146,1.0,1.0,2/5,14.48%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.42949590423375394,-0.7662255902034284,0.6341463414634146,1.0,1.0,2/5,14.48%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3074968700355026,0.7660730952418187,0.9272727272727272,1.0,1.0,15/118,16.96%,PCBP3;APOBEC1;HNRNPH1;SYNCRIP;RBMS1;BICD1;PAPOLA;NOVA1;ATXN1;HNRNPD;LSM8;ADARB2;MRPL44;RBM5;ADAD2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.32478744409893257,0.7660650115405999,0.9423076923076923,1.0,1.0,2/74,2.82%,SYK;NRG1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.486785709362559,0.7658292247154878,0.7580645161290323,1.0,1.0,5/9,27.79%,ABCA1;PRKACB;ABCA7;APOM;APOE
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.519062210458336,0.765622386051407,0.8076923076923077,1.0,1.0,2/5,24.82%,VEGFA;EGFR
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.45462864466784947,-0.765171225271895,0.7872340425531915,1.0,1.0,2/8,19.62%,ACTN2;CAV3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.29466052332417475,-0.7648185162547113,0.925,1.0,1.0,5/112,6.28%,NUPR1;ALOX5;CAMK2A;IER3;MBTPS2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.43481312879234424,-0.7647517586579617,0.6944444444444444,1.0,1.0,4/16,25.72%,STX11;STX1B;SNAP47;STX19
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.3927088586156582,-0.7646568548634394,0.85,1.0,1.0,5/25,15.69%,WNT7A;ARF1;EPHB1;SHANK1;SHANK3
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3585607539886415,0.7643751053818868,0.8113207547169812,1.0,1.0,7/38,16.62%,DUX4;BMI1;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.44320986216760394,0.7643435775513945,0.7192982456140351,1.0,1.0,1/11,5.02%,PEX12
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.38156130601398053,-0.7641207005382606,0.7636363636363637,1.0,1.0,1/26,1.02%,PLAAT4
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.3335444438686263,0.7639198649983577,0.7931034482758621,1.0,1.0,10/66,15.70%,PRKG1;EFNA5;FGD4;EPHA5;EPHA3;RAPGEF6;ADAP1;PLXNB1;PLXNB2;GPR137B
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.37648659036496973,-0.7635824890914078,0.75,1.0,1.0,7/25,19.62%,KCNE2;KCNE1;KCNS1;ATP1B1;KCNG1;ACTN2;CAV3
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.5070200308073209,-0.7631396100539746,0.7941176470588235,1.0,1.0,1/6,2.91%,PRKCD
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.30222563088138016,0.7625339421003574,0.9454545454545454,1.0,1.0,23/150,15.70%,RAPGEF3;PRKG1;CCL5;SNX18;EFNA5;FGD4;CD40;F2R;RGS10;EPHA5;EPHA3;GPSM1;RAP1GDS1;SGSM3;RAPGEF6;EZH2;ADAP1;PLXNB1;PLXNB2;PICALM;RAP1A;ADRB1;GPR137B
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.4315869097434092,0.7621697627781581,0.8363636363636363,1.0,1.0,1/13,5.24%,PHKA1
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.49240284237219334,-0.7619405153927234,0.78,1.0,1.0,3/6,21.94%,PAX2;PAX8;FZD7
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.4775676009656915,0.7617880246247117,0.7931034482758621,1.0,1.0,1/6,2.26%,LMOD3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.4393887941931496,0.7610727342569894,0.8333333333333334,1.0,1.0,1/14,2.13%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.3603308067066634,0.7610540463672087,0.8461538461538461,1.0,1.0,4/29,13.58%,PLEKHH2;PIK3CA;KANK1;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.47427733049300563,0.76089027810898,0.8245614035087719,1.0,1.0,3/9,28.97%,WASHC1;F2RL1;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.47427733049300563,0.76089027810898,0.8245614035087719,1.0,1.0,3/9,28.97%,WASHC1;F2RL1;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3649360578836474,0.760276700346483,0.796875,1.0,1.0,6/41,26.68%,HIF1A;GCK;RANBP2;NUP153;OGT;EP300
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.4700723641067659,0.7600512613496447,0.7735849056603774,1.0,1.0,2/9,11.72%,CYP27A1;CEL
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.31412004573453783,-0.759860869152652,0.9117647058823529,1.0,1.0,12/57,21.62%,NUPR1;MEIS2;RARA;EIF4EBP1;FGFR2;RGCC;PDGFB;NUDT16;USP19;PRKCA;CCND1;DUSP3
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.5066484227689888,0.7595925152955516,0.7936507936507936,1.0,1.0,1/6,19.63%,PUS10
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.32507945893250073,0.7594454271849088,0.8928571428571429,1.0,1.0,13/102,9.63%,SLC5A8;C6;MOGAT2;SLC5A12;CLDN2;OIT3;KNG1;ABCC2;AGXT2;DPP4;FUT9;ABCG8;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.5041551037155703,-0.7593358356829161,0.7906976744186046,1.0,1.0,2/6,14.99%,CARTPT;ID2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.3431714358788347,0.7588485968476226,0.8709677419354839,1.0,1.0,5/67,6.93%,RFNG;KAT2B;LLGL1;NRARP;RBPJ
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.4595924927455356,-0.7586288652257702,0.7083333333333334,1.0,1.0,1/7,3.89%,KDELR1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4733321841079958,0.7584870383008052,0.76,1.0,1.0,1/8,9.42%,SNCA
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.36052751165485236,0.7583657905376692,0.8421052631578947,1.0,1.0,3/29,7.56%,SYT15;SYT1;SYT6
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.45617163035935804,-0.7581975597425101,0.75,1.0,1.0,4/9,28.95%,E2F7;CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.3704797980318504,0.7579907033251853,0.86,1.0,1.0,17/42,24.04%,NAALAD2;CBS;GLUL;PYCR1;SLC25A13;SRR;THAP4;GPT;GADL1;CPS1;DPEP1;SLC25A12;RIMKLA;GLUD1;OAT;ASPA;RIMKLB
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3212328980234299,0.757732821589318,0.8793103448275862,1.0,1.0,19/96,17.40%,BOK;LRP4;GNG12;TENM3;CSPG4;TEAD2;ARHGEF17;GPR176;MAGI1;CDR2L;AMOTL1;FIGN;BCAR1;HTRA1;FJX1;NR2F2;PTPRU;NXN;LOX
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.34556818478277374,0.7576673600959045,0.9230769230769231,1.0,1.0,20/72,25.86%,LRP4;LLGL1;DCC;NEFH;DSCAML1;CTNNA2;MEF2C;NTNG2;KLF7;CNTN4;ZDHHC17;FARP1;SLITRK6;PARD3;SLITRK5;MAP2;RYK;MAPK8IP2;MEF2A;NRCAM
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3257770058946685,0.7576087490797401,0.8214285714285714,1.0,1.0,8/59,13.46%,TENM1;NAV3;FER;CRACD;BIN1;CARMIL1;NCK2;FCHSD2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.29402267942077026,-0.7575850010095054,0.95,1.0,1.0,24/146,12.85%,GPR39;TEK;PTGDR;CGA;NLRP3;HRH2;PRKCD;CD200R1;HLA-DRB1;ALOX5;P2RY11;ADCYAP1;HCK;MEFV;GPR83;TYRO3;GLP2R;CD163;CCN3;MYH9;CRH;FFAR4;APOA1;MAPK7
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4823998447597004,0.757235625359397,0.7741935483870968,1.0,1.0,1/8,7.99%,MEGF10
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.4788317916345284,-0.757168272048434,0.7333333333333333,1.0,1.0,2/5,17.80%,RCSD1;AQP1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.4469358939576195,-0.7570468228060273,0.7380952380952381,1.0,1.0,2/7,16.77%,KIF1C;KIF1A
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.4633700081244101,-0.7568599406082043,0.75,1.0,1.0,1/6,11.73%,CCN3
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.48839197928191086,0.7567645040958155,0.8076923076923077,1.0,1.0,1/6,1.13%,CALCR
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.4444847152196001,-0.7566103418997575,0.7619047619047619,1.0,1.0,2/9,9.23%,SLC6A6;SLC36A2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.46453360003811106,-0.75642425711866,0.8,1.0,1.0,3/10,24.18%,AR;ZNF143;MTOR
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.4096675714806187,0.7563978292504845,0.7903225806451613,1.0,1.0,1/25,3.96%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.43003957071834453,0.7562684249536739,0.8627450980392157,1.0,1.0,2/14,11.40%,PLCG2;EZH2
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),-0.4923363978707749,-0.7560937668857441,0.7291666666666666,1.0,1.0,1/5,6.54%,CYP24A1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.4933537918715448,0.7560890751822835,0.7936507936507936,1.0,1.0,1/7,13.17%,RHOU
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.48414667256891153,0.7560069266844043,0.8269230769230769,1.0,1.0,1/5,23.00%,MAF1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.36187226060188926,0.7559886319641622,0.8,1.0,1.0,1/41,3.40%,HIF1A
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.36603057506013525,-0.7558667055550934,0.7884615384615384,1.0,1.0,5/27,15.91%,KIF2B;STMN1;STMN3;KATNB1;DSTN
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.44477692120492934,-0.7558527438565864,0.7755102040816326,1.0,1.0,2/12,5.65%,ADSS1;XDH
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.4892929857122756,0.7554766786911449,0.7777777777777778,1.0,1.0,4/6,39.53%,TNFRSF1B;TENM4;PTPRZ1;PTN
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.4963668040371991,0.7552446878438799,0.8333333333333334,1.0,1.0,1/7,2.44%,ZBTB7B
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.43318563918895414,-0.7552365422063414,0.7575757575757576,1.0,1.0,5/11,22.74%,ZWILCH;BUB1;PLK2;PRCC;ZWINT
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.47615409189752816,-0.7551949657955398,0.8085106382978723,1.0,1.0,2/7,9.08%,FLOT1;ADAM19
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.37699087060138775,-0.7551910139386461,0.7777777777777778,1.0,1.0,8/38,15.49%,PNPLA1;SPTLC3;DEGS2;ALOXE3;B3GALT4;ST8SIA2;SGMS2;ST3GAL5
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.46615713679720117,0.7550721244482874,0.8545454545454545,1.0,1.0,3/7,33.55%,PIBF1;INPP5F;PARP14
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.4242644382841022,0.754758749625714,0.7719298245614035,1.0,1.0,3/13,17.56%,RNF185;RNFT1;NFE2L2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.4400566603351175,0.7547417330865432,0.7222222222222222,1.0,1.0,5/11,17.56%,HAS2;HDAC3;MTSS1;MEF2C;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.43316496987701003,0.7545927037173955,0.7758620689655172,1.0,1.0,4/11,13.56%,MID2;PTX3;GSN;TRIM26
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.34388537915682316,0.7545163812390232,0.8596491228070176,1.0,1.0,6/46,15.42%,TGFBR1;BOK;SEPTIN4;LCK;PML;WWOX
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.5019248085385569,0.754485610125886,0.7936507936507936,1.0,1.0,3/6,12.17%,SLC8A1;DRD3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4369538647614213,0.7543728349589782,0.7407407407407407,1.0,1.0,2/10,12.84%,NPPA;PDE4B
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.3994422760281634,0.7543676607444987,0.6909090909090909,1.0,1.0,7/20,17.72%,TGFBR1;WWTR1;FAM89B;BMPR1A;SMAD4;KIAA0319;BMP4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.49105986721170525,0.7543450570006749,0.8653846153846154,1.0,1.0,5/7,42.13%,RPUSD2;TRUB2;PUS3;DKC1;PUS7
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.42459605413771107,-0.7541495158023366,0.7560975609756098,1.0,1.0,2/10,15.02%,GOLGA2;SKP1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.4730019760022971,0.7537399302727424,0.819672131147541,1.0,1.0,4/8,25.34%,PICALM;DNM3;MX2;SNAP91
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.4055856019986091,0.7537180046021938,0.8620689655172413,1.0,1.0,10/23,19.26%,SLC10A3;ABCC2;SLC10A5;NCOA2;SLC10A1;NR1H4;ABCC11;AKR1C1;SLCO1A2;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.43330619743323684,-0.7535297160792864,0.7441860465116279,1.0,1.0,2/13,17.25%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.36660219023345314,0.7532201994852784,0.8095238095238095,1.0,1.0,3/32,17.59%,HIF1A;HAP1;DST
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.4023794456652685,0.7531569911807823,0.8431372549019608,1.0,1.0,8/29,18.58%,PRR5L;TENM1;PCM1;PTPN14;ZFAND1;RAB29;BMP4;SIRT7
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.3705879150960204,0.7528695403582991,0.8870967741935484,1.0,1.0,1/23,3.16%,CYP4F12
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.4645017764648151,0.7528376364966965,0.782608695652174,1.0,1.0,1/6,8.83%,SLC4A7
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.47895851675334605,0.7524334563851129,0.7962962962962963,1.0,1.0,1/7,4.32%,WNT4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.38526978019960245,0.7521870691632266,0.7777777777777778,1.0,1.0,3/19,10.99%,SMDT1;MCUB;MCU
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.4482812368889916,-0.7519159137170222,0.7435897435897436,1.0,1.0,3/8,18.64%,DAB2IP;PIK3IP1;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.3937657386564596,0.7518130611262378,0.7894736842105263,1.0,1.0,3/18,14.53%,ENPP1;GREM1;BCOR
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3427947100443221,-0.7515978325592109,0.8571428571428571,1.0,1.0,3/30,9.47%,PRKCD;RBM3;RBM4B
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.37914168713681695,0.7513753768514462,0.8032786885245902,1.0,1.0,4/21,14.25%,PRIMPOL;POLE2;REV3L;REV1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.3274352792517821,-0.7510387584377473,0.925,1.0,1.0,3/65,5.61%,DNASE1L1;DDX24;RECQL5
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.4805015761800102,0.7509699382223765,0.7959183673469388,1.0,1.0,3/8,20.10%,KIT;PIK3CD;MILR1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.4720377038650364,0.7508971432537691,0.8125,1.0,1.0,1/9,2.39%,SSC5D
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.31331445299469773,0.7508690991773728,0.9454545454545454,1.0,1.0,4/96,3.54%,SIRT1;PLOD2;METTL21C;KAT2B
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.43526412027180705,0.7508564066622371,0.8524590163934426,1.0,1.0,4/14,16.58%,TOP2A;HMGB1;TOP1MT;KAT6A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.44766174733397535,0.7508347771893715,0.8245614035087719,1.0,1.0,3/15,3.60%,SEMA5A;IL4;ANGPT1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.37030935510086554,0.7506220427752263,0.875,1.0,1.0,8/24,20.20%,ITGAV;MEGF10;HMGB1;XKR6;NR1H3;RHOBTB1;RHOG;XKR4
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.32701948481477744,-0.7505163909514722,0.8958333333333334,1.0,1.0,5/58,9.16%,NUPR1;GOLGA2;TIMP4;PTPN3;NRDE2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.3628459141572783,0.7503462426782128,0.864406779661017,1.0,1.0,4/26,11.84%,LGALS9;HIF1A;TLR2;CD74
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.40169782971937934,-0.7502693987419706,0.717391304347826,1.0,1.0,1/16,3.53%,CD200R1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4109127046541905,0.7500186549004905,0.7678571428571429,1.0,1.0,5/18,24.63%,RALA;MCU;MFF;MARCHF5;MIEF2
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.4563061892454797,0.749995051591091,0.8703703703703703,1.0,1.0,3/11,19.69%,TNFRSF10A;IRAK1;TNFRSF10B
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.40645891870910034,-0.7498248252462294,0.725,1.0,1.0,2/14,6.42%,SFRP1;PTCH1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.4492768502216431,0.7497941003143866,0.7551020408163265,1.0,1.0,5/7,32.16%,LNPEP;HLA-E;HLA-F;HLA-B;B2M
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.3856413621923317,-0.7497326671065307,0.782608695652174,1.0,1.0,12/31,28.21%,FGF1;TRPV1;DAXX;STUB1;SLU7;RBBP7;BAG3;MAPT;DHX36;CLPB;THBS1;PRKACA
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3822292903534186,-0.7492112338342848,0.8717948717948718,1.0,1.0,2/32,5.00%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.4081128059392733,-0.7491248276066325,0.8048780487804879,1.0,1.0,3/16,7.55%,DRD4;DRD2;DBH
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3449629840726084,0.748982342540234,0.8333333333333334,1.0,1.0,6/46,11.94%,EFNA5;DOCK1;KANK1;CORO1C;CASS4;CARMIL1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.36179687773514635,0.748611006030004,0.8103448275862069,1.0,1.0,6/28,18.76%,RHOD;CARMIL1;KIT;SNX2;ARHGEF6;ARHGEF4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3635569256337682,-0.7485453096703892,0.8571428571428571,1.0,1.0,4/24,14.26%,ALOX5;CLU;WFS1;CREB3L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.455336763511161,-0.7483256341511307,0.7555555555555555,1.0,1.0,6/6,54.48%,EHD3;TRDN;ATP2A2;SLC8B1;PLN;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.5310345160674658,0.7480992989501702,0.8333333333333334,1.0,1.0,1/5,9.04%,HMGB1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.5073567705034447,0.7479430763459866,0.8095238095238095,1.0,1.0,3/5,42.74%,CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.5073567705034447,0.7479430763459866,0.8095238095238095,1.0,1.0,3/5,42.74%,CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.34010075510744936,-0.7477890756436664,0.8648648648648649,1.0,1.0,1/44,0.91%,HK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.32819449800161454,0.7477713305991353,0.8666666666666667,1.0,1.0,15/74,18.14%,RRAS;FGF2;RIN2;ANGPT1;ANXA3;GLUL;BMPER;PROX1;PTPRM;BCAR1;PIK3CD;NR2F2;VEGFA;BMP4;GFUS
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4170116568873676,-0.7477611721885212,0.7857142857142857,1.0,1.0,3/13,6.49%,SFRP1;GPC3;RNF213
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.3624864351616949,0.7475872911061563,0.9016393442622951,1.0,1.0,1/28,0.91%,TENT5A
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.449699139892801,0.7475481948925283,0.8548387096774194,1.0,1.0,5/10,32.40%,TSPAN6;RNF26;PCBP2;MUL1;TARBP2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.35804599612204047,0.747541989078956,0.8596491228070176,1.0,1.0,4/42,6.27%,BOK;URI1;DAPK2;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.3957915381746284,-0.747461964979122,0.7073170731707317,1.0,1.0,5/20,10.15%,APOBEC3H;BTBD18;DDX4;PIWIL2;APOBEC3G
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.4784208053666372,0.7473399613434706,0.7818181818181819,1.0,1.0,1/5,4.34%,MAFB
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.3390553273867327,0.7472654390380679,0.8979591836734694,1.0,1.0,5/53,8.47%,FAM83H;AP1M2;EPS8L2;DSP;RHOD
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.41125108364820934,0.747251286824012,0.796875,1.0,1.0,4/24,14.76%,MRAP2;ABI3;LZTFL1;PICALM
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.3448248848858574,-0.7472027812100497,0.9534883720930233,1.0,1.0,9/78,10.74%,MS4A8;CHST9;CAPN9;PTPN3;AK7;ZBTB7C;MYO5B;ZBBX;CCDC40
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.4629166450178069,-0.7471325858132358,0.6730769230769231,1.0,1.0,3/5,20.36%,CARTPT;CRH;VIP
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.35834955399189977,-0.7470656380433544,0.75,1.0,1.0,2/33,6.25%,NUPR1;CAV1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.4740125606906801,0.7470385596780572,0.8148148148148148,1.0,1.0,3/7,31.08%,RUVBL2;NUFIP1;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.43437725937217775,0.7470350214176781,0.8214285714285714,1.0,1.0,4/10,13.56%,MID2;PTX3;GSN;TRIM26
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.3566995100597295,0.7470147880690057,0.819672131147541,1.0,1.0,11/34,26.02%,UNC5C;ACHE;RTN1;PML;VEGFA;L1CAM;SHH;HEY2;CDK6;NRCAM;SLIT1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.5227474907480142,0.746972308395662,0.8113207547169812,1.0,1.0,2/5,19.91%,PYCR1;DAO
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),0.4784161143681762,0.7469036489733292,0.8214285714285714,1.0,1.0,1/6,9.37%,ITK
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4466100374462461,0.746836197852281,0.84,1.0,1.0,5/10,25.79%,SMPDL3A;ABCA8;SAMD8;ABCA2;SGMS1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.3818632717707015,0.7467513915311714,0.8301886792452831,1.0,1.0,4/29,18.53%,PEX12;CHCHD4;DNAJC15;PEX2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.47811182689745224,0.7466057554544598,0.8333333333333334,1.0,1.0,4/7,25.34%,PICALM;DNM3;MX2;SNAP91
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.43988892437276983,0.7464530970016654,0.8867924528301887,1.0,1.0,3/12,15.63%,GFAP;DSP;KLHL24
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.41403592386988336,-0.7461522393389612,0.8461538461538461,1.0,1.0,10/22,30.81%,RFC3;RFC2;RPA3;RFC1;POLDIP2;RPA2;UBB;RPA1;NPLOC4;UFD1
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),-0.4752342880719897,-0.7457031379278518,0.7727272727272727,1.0,1.0,1/5,5.21%,DRD2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.37132587432120745,-0.7456422321979195,0.851063829787234,1.0,1.0,3/24,8.04%,DRD4;DRD2;NPAS4
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.32750600450060274,0.7456267187739603,0.9215686274509803,1.0,1.0,25/95,25.99%,IL4;MAP2K6;UBE2D3;FGF17;SMAD2;LCK;CDK4;MAPK8;PTEN;ACACA;CAB39L;PLCB1;MAPK10;NFKBIB;RPS6KA1;PIK3R3;THEM4;PDK1;PPP2R1B;MKNK2;CAMK4;GRB2;EGFR;PRKAR2A;PIKFYVE
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.4367023795320445,0.7454203411701259,0.8275862068965517,1.0,1.0,1/13,11.32%,CHMP6
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.4690780411547588,0.7453634762273695,0.8679245283018868,1.0,1.0,2/7,26.20%,AGO3;DHX9
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3448040951979258,0.7453274735098159,0.8653846153846154,1.0,1.0,8/34,17.69%,RAPGEF3;ABI3;HCLS1;PDGFRA;ABL2;SEMA3E;TRPM2;NOTCH2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.39060026867831216,-0.7451122190539841,0.6739130434782609,1.0,1.0,4/17,14.38%,LAS1L;FTSJ3;NSA2;RRP15
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.4962751961953801,-0.7450017097741237,0.7924528301886793,1.0,1.0,1/6,2.34%,CD86
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.37473980077933994,0.7446538144200706,0.8461538461538461,1.0,1.0,4/28,15.75%,IVNS1ABP;RO60;GTF3C4;POLR3G
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.42719374121081516,0.7445925481289345,0.8490566037735849,1.0,1.0,3/16,8.13%,TIMELESS;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.4217115745149306,0.7445426283865603,0.8245614035087719,1.0,1.0,3/12,14.46%,SPEF2;CTNNA2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.38057438153297973,0.7442709849349444,0.8360655737704918,1.0,1.0,2/29,3.81%,FLT1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.49745266677710787,0.7441569000867411,0.7636363636363637,1.0,1.0,1/6,10.57%,AUTS2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.35437673386616125,0.7441288089986574,0.8852459016393442,1.0,1.0,8/32,22.72%,MDFIC;HCLS1;HDAC3;RAB23;BMP4;UBR5;JUP;TRIM28
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.40066065266768414,0.7437600923459391,0.8181818181818182,1.0,1.0,1/18,4.41%,CD22
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.5100713615096297,-0.743728268624021,0.8571428571428571,1.0,1.0,3/5,26.64%,RFPL1;RNF34;RFFL
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.36420422343540215,-0.7433389516558885,0.8367346938775511,1.0,1.0,2/21,6.25%,NOSTRIN;CAV1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.37863688837862086,-0.7428090284427805,0.9142857142857143,1.0,1.0,4/23,17.49%,RHBDF1;PTK2B;PSME3;UBE3A
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.30833786844975214,0.7424969358671533,1.0,1.0,1.0,20/139,15.48%,FGF10;LGR5;SEMA5A;RSPO3;ZEB2;RSPO2;BMP2;NRARP;TLR2;PPM1A;RNF146;GPC5;KANK1;PSMD13;TBL1X;LGR6;PSMA1;PTK7;PSME4;SPIN1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.44827099169489737,0.7422987734126353,0.7843137254901961,1.0,1.0,4/12,21.26%,SCRIB;LAMA5;VANGL2;LAMA3
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.31685749737577795,0.7422557937751502,0.9245283018867925,1.0,1.0,19/111,17.46%,TSPAN12;FGF2;LRRC4C;NEDD4;EFNA5;ABI3;CDH2;TNIK;PDLIM5;BMPER;ADGRB3;HECW2;INF2;MEF2C;CRB2;PHLDB2;VASH2;ZMYM4;PHIP
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.45908131493606963,0.7421652445582999,0.8620689655172413,1.0,1.0,2/8,8.57%,CCNA2;RPS6KA4
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.4681072484750678,0.7421387077256981,0.875,1.0,1.0,2/8,9.04%,IL4;HMGB1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.47082418765361916,-0.742104742114941,0.6904761904761905,1.0,1.0,3/5,27.92%,PRKCH;CHRM1;PRKCI
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.2881379147773473,-0.7419642783300224,0.9787234042553191,1.0,1.0,11/182,7.76%,DUSP4;HK2;PLAAT4;PLA2G2C;PLCB2;PLCZ1;NT5C;INPP5D;PPP1CA;PGP;LHPP
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.32600546803169406,-0.7418773645122083,0.9148936170212766,1.0,1.0,9/58,17.81%,ABRAXAS1;RNF8;ERCC1;POLQ;PRPF19;CYREN;RAD50;BRCA1;LIG3
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4528595991306109,-0.7418358072864465,0.8292682926829268,1.0,1.0,3/9,22.88%,KDM2B;KDM4B;RIOX1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.4593726341295026,-0.7414891240527685,0.717391304347826,1.0,1.0,1/7,10.48%,GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.4342442006374267,-0.7412497637433088,0.7857142857142857,1.0,1.0,6/16,12.37%,SFRP1;FAM3D;KCNJ11;CCN3;CRH;FFAR4
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.42220666762745857,0.7411013780817619,0.7758620689655172,1.0,1.0,1/11,3.60%,ANGPT1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.30298756535568155,-0.7410964563797979,0.9230769230769231,1.0,1.0,5/59,13.75%,TBC1D10C;ENTR1;TCHP;DCDC2;TBC1D7
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.4198038029933273,0.7410333498526045,0.8225806451612904,1.0,1.0,1/13,2.12%,TGFBR1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.37428164513068046,0.7407497869558939,0.8421052631578947,1.0,1.0,2/23,7.84%,ENPP1;FBXO5
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.5205292769150888,0.7403033392223891,0.8431372549019608,1.0,1.0,1/5,11.81%,GSN
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.49955786884777803,-0.7400402534232756,0.7843137254901961,1.0,1.0,1/5,2.27%,DND1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.49955786884777803,-0.7400402534232756,0.7843137254901961,1.0,1.0,1/5,2.27%,DND1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.454137591362189,-0.7398764387884672,0.8055555555555556,1.0,1.0,1/6,13.87%,TCF7
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.4618836432848143,-0.7393048315913759,0.7291666666666666,1.0,1.0,2/6,19.13%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.4618836432848143,-0.7393048315913759,0.7291666666666666,1.0,1.0,2/6,19.13%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.4618836432848143,-0.7393048315913759,0.7291666666666666,1.0,1.0,2/6,19.13%,TAC4;TACR1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.38458779635297724,-0.7389226908007402,0.7954545454545454,1.0,1.0,2/19,14.06%,CLU;HOPX
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.4842196020552683,0.7383387712761894,0.851063829787234,1.0,1.0,2/5,2.87%,FGFR1;FGF2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.31240861664592634,0.7383027122528816,0.9361702127659575,1.0,1.0,14/108,20.88%,LIX1;TCIRG1;PIP4K2A;PRKAB2;ATG101;CHMP6;MTMR3;MVB12A;TMEM74;TBC1D5;PRKAA1;STAM2;MTERF3;STX17
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.44193839081500363,0.7382412292573493,0.8070175438596491,1.0,1.0,3/8,21.20%,PYCR1;NFE2L2;GPR37
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.44749301014968557,-0.7381396223628945,0.8372093023255814,1.0,1.0,2/11,13.46%,CLDN1;SUPV3L1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.289948896237984,-0.7380068483475072,0.9285714285714286,1.0,1.0,5/115,6.87%,GOLGA8B;STX16;GOLGA2;PLK3;GOLGA8A
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.29436172190589976,0.737640066514053,0.96875,1.0,1.0,3/97,3.71%,NXPH1;NGB;HRH3
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3371159670939947,-0.7374668124448464,0.8913043478260869,1.0,1.0,3/61,2.05%,PALM3;CD24;SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.42273553579258893,0.7371134823927344,0.7704918032786885,1.0,1.0,6/16,26.05%,BMP2;BIN1;CLCF1;TNFRSF1B;TENM4;NOTCH1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3929461424947141,-0.7370691181781488,0.8571428571428571,1.0,1.0,6/26,21.13%,ERN2;DAB2IP;DNAJC10;QRICH1;BRSK2;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.45001214270903434,0.7369502255397433,0.8571428571428571,1.0,1.0,4/10,20.10%,IL4;NR1H3;LRFN5;MILR1
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.46108778206835,0.7368064429641106,0.7547169811320755,1.0,1.0,2/6,32.95%,MAPK3;CSF1R
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.5115946994052186,-0.7365542600297773,0.8387096774193549,1.0,1.0,1/5,29.20%,ATCAY
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.4655421131384622,-0.7364013175292422,0.8301886792452831,1.0,1.0,1/8,6.25%,CAV1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.4655421131384622,-0.7364013175292422,0.8301886792452831,1.0,1.0,1/8,6.25%,CAV1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.30128282420770397,0.7362737614204625,0.9574468085106383,1.0,1.0,21/101,23.41%,VAPB;ST6GALNAC3;GAL3ST1;ESYT3;ELOVL5;TEX2;PPM1L;SGPL1;ESYT2;CERS5;TECR;ELOVL4;ORMDL2;PLPP1;SAMD8;ABCA2;HEXB;ALDH3B1;ELOVL6;CERS3;CTSA
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.40847148977232806,-0.7355897696188023,0.8095238095238095,1.0,1.0,5/12,16.50%,CACNA1G;ZP3;SYT10;CACNA1H;KCNB1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.4031597911422793,0.7353974142732183,0.8983050847457628,1.0,1.0,4/18,12.45%,FUT9;B4GALNT2;ST3GAL6;FUT8
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),0.4903577539402051,0.7350998785542106,0.8260869565217391,1.0,1.0,2/5,20.72%,MLXIPL;PPIF
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.5036335313180959,-0.7350853524260956,0.7954545454545454,1.0,1.0,1/5,5.21%,DRD2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4222041741493975,-0.734830991570007,0.75,1.0,1.0,2/8,12.76%,ARG2;AZIN1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.4126967776918567,0.7346621159467847,0.803921568627451,1.0,1.0,6/20,11.84%,DAPK2;DPP4;MOSPD2;C5AR2;MCU;CD74
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.28495156271455435,-0.7343982662762139,0.9777777777777777,1.0,1.0,42/269,17.85%,PARP2;FANCG;SLX4;ABRAXAS1;RNF8;REXO4;RECQL5;TICRR;ERCC1;RPAIN;FANCC;EYA1;SMUG1;RFC3;POLQ;TRAIP;EXO1;XPC;RAD51AP2;PARP1;GTF2H2;RAD51AP1;XRCC1;FAN1;TEX264;LIG1;NUCKS1;SMARCA5;RFC2;ZRANB3;RPA3;TNKS1BP1;APTX;RAD50;CDKN2D;KDM4B;FANCB;ENDOV;PNKP;BRCA1;LIG3;MUS81
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.4435495535298154,-0.734372430244878,0.7291666666666666,1.0,1.0,1/9,5.08%,PAH
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.40867524207374695,-0.734154709477372,0.7894736842105263,1.0,1.0,6/17,16.39%,CCBE1;XDH;ADAMTS3;DCN;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.459171653986721,0.7340686472952234,0.8545454545454545,1.0,1.0,4/8,20.57%,RBPJ;BMP4;CTNNB1;RHOB
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.35764942832791413,-0.7336570767855836,0.8723404255319149,1.0,1.0,4/41,7.86%,CLDN4;CLDN1;CLDN5;CLDN15
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.4003192925940664,-0.73364094604124,0.8444444444444444,1.0,1.0,3/18,12.12%,SLC5A10;SLC2A8;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4728119557636438,0.7331618619276558,0.8771929824561403,1.0,1.0,3/8,31.77%,BNIP3L;ATF2;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.33708750718445935,0.7328868833969422,0.8852459016393442,1.0,1.0,12/47,22.31%,AGR2;SYT1;RIMS2;DBN1;PLCB1;L1CAM;CDKL5;SYT17;MACF1;SMURF1;CPNE9;GOLGA4
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.42045663847019366,-0.7328203537485357,0.8421052631578947,1.0,1.0,2/10,8.78%,TESPA1;CLPTM1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.442859611534412,-0.7328050904299299,0.8181818181818182,1.0,1.0,2/11,2.22%,PTGES;NLRP3
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),0.5128043574339639,0.7325546525413649,0.8214285714285714,1.0,1.0,1/5,5.30%,IL23R
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.451753814154847,-0.7325532666307869,0.7368421052631579,1.0,1.0,2/8,12.94%,SAPCD2;GPSM2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.3780354919747849,-0.7321514615839751,0.7441860465116279,1.0,1.0,1/14,2.03%,CD24
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.36807518323801874,0.7321142423109872,0.9166666666666666,1.0,1.0,3/26,10.12%,SIRT1;KANK2;FOXH1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.41553191252821775,-0.7319020143573642,0.803921568627451,1.0,1.0,1/11,2.03%,CD24
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.36857207008437765,0.7314024303645151,0.864406779661017,1.0,1.0,1/23,0.73%,ACE2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.4803655409174775,0.7313302034377999,0.8113207547169812,1.0,1.0,4/6,18.79%,DRD3;CTNNA2;PTEN;GRID2
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.31741650472430594,-0.7312114124627983,0.9487179487179487,1.0,1.0,2/42,2.29%,INHA;IL11
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.30010950875806197,0.7312070496279542,0.9166666666666666,1.0,1.0,32/110,26.43%,RHOBTB3;CORO7;HEATR5A;WASHC2A;AKTIP;WASHC1;RAB9A;MAGEL2;VAMP3;SNX2;RAB29;GGA1;TBC1D5;STX8;VTI1A;VPS29;STX5;PTPN23;GCC2;SNX16;ERC1;TMEM87B;VPS50;SNX5;ARFRP1;KLHL20;MON2;VPS54;VPS13A;SNX1;PIKFYVE;MYO1D
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.3163585402046385,0.7309654931181199,0.8983050847457628,1.0,1.0,7/47,17.42%,DCC;HDAC2;KANK1;EFNB2;SPRY3;PTEN;RAB29
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.4600033714140229,0.730907640278285,0.8518518518518519,1.0,1.0,3/6,17.72%,MTSS1;MEF2C;BMP4
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.341722040362256,-0.7307657769015533,0.8490566037735849,1.0,1.0,4/46,7.46%,PNPLA1;SPTLC3;DEGS2;ALOXE3
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.330257594073536,-0.7306236164083513,0.8775510204081632,1.0,1.0,12/56,22.35%,GPR132;PSMB4;PSMC4;PSMD8;RFPL1;SKP1;PSME3;PSMD12;PSMD2;PSMC2;PSMC3;PSMA5
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.45262385280490136,0.730407149995289,0.8392857142857143,1.0,1.0,1/14,2.98%,IL4
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.3353192381155799,-0.7303565527274283,0.9047619047619048,1.0,1.0,4/45,10.28%,GPC2;GPC1;GPC3;PARP1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.47483790626987576,0.7303081420007218,0.8113207547169812,1.0,1.0,1/7,14.87%,XPO1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.4718799181205442,0.7301513821751128,0.9090909090909091,1.0,1.0,2/6,22.68%,IL15;IL23A
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.2969260803748713,0.7301205772391048,0.9655172413793104,1.0,1.0,19/111,18.13%,EGLN3;HIF3A;SIRT1;MYC;HIF1A;RORA;TBL2;PSMD13;BNIP3L;KCND2;HP1BP3;ACAA2;PSMA1;PSME4;CPEB1;VEGFA;CARD16;PTGIS;FMN2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.37134657028232104,0.7299686800626931,0.9038461538461539,1.0,1.0,3/24,8.03%,ITGAX;ITGAV;DSP
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-0.4730748454682401,-0.72983398006713,0.8125,1.0,1.0,3/5,23.40%,PAX2;PAX8;SMO
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.33874751853868423,-0.7298129536845114,0.8823529411764706,1.0,1.0,6/32,21.39%,DGAT2L6;CAV1;DGAT1;DGKA;CAV3;GK5
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.46010108319339704,-0.7296743989511943,0.7804878048780488,1.0,1.0,3/7,14.82%,HMGCL;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.3659162378540537,0.7291714133444676,0.85,1.0,1.0,8/33,22.34%,TRPC4;SLC39A8;TF;TRPC5;SLC30A10;SLC30A1;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.3081180081362433,0.7289656371297539,0.9411764705882353,1.0,1.0,24/116,18.74%,SYK;DRD5;CALCR;SAMSN1;RXFP2;GPHB5;PLCG2;FER;RAMP3;GPR176;GGT5;LYN;IRAK3;HTR7;GIP;ADRB1;CREB1;CD247;IAPP;RXFP1;CALCRL;RNF26;ADORA2B;INSL3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.33034636735388706,0.7288431551427845,0.8833333333333333,1.0,1.0,3/71,4.96%,SWSAP1;SEM1;RFWD3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4049605243709568,0.7283645333536843,0.7931034482758621,1.0,1.0,2/15,8.78%,PRDX6;TRA2A
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.45964669422380444,-0.7281755813129044,0.7272727272727273,1.0,1.0,1/5,1.95%,CXCL13
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4890282145327534,0.7281724843441435,0.8043478260869565,1.0,1.0,3/7,25.41%,USH2A;CTNNB1;ERCC3
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.41787235719501764,0.72809723949234,0.7192982456140351,1.0,1.0,3/13,15.59%,MYC;CD74;CSF1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3452828778295681,0.7278967686014065,0.8727272727272727,1.0,1.0,11/37,16.08%,SYVN1;GLRA1;RNF185;DRD3;RNF139;IRAK3;RRAGC;NR1H4;GLRB;RNF5;TRPM2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.49997607223244006,0.7277832761447851,0.90625,1.0,1.0,1/6,2.87%,FGF2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.34985101917193995,0.727706774122036,0.8983050847457628,1.0,1.0,13/35,25.79%,IDI2;NUS1;MVD;CPNE1;CPNE7;CPNE3;ABCA8;DOLK;SAMD8;HDHD5;IDI1;MBOAT1;SGMS1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),0.413033471445944,0.7276441357701401,0.8245614035087719,1.0,1.0,2/15,6.49%,SYK;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.4149401498004076,-0.7276356853403987,0.9047619047619048,1.0,1.0,1/16,6.93%,MLYCD
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.44447142463622263,0.7276070669166326,0.8148148148148148,1.0,1.0,4/10,34.17%,RRAGD;SESN2;SESN1;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.44447142463622263,0.7276070669166326,0.8148148148148148,1.0,1.0,4/10,34.17%,RRAGD;SESN2;SESN1;UBR2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.3587102460122299,0.7271534743936436,0.8135593220338984,1.0,1.0,5/27,14.46%,NLGN1;NRXN1;NLGN4X;RIMS2;PTEN
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.4452940739719108,-0.7270774477407436,0.6976744186046512,1.0,1.0,3/8,14.48%,SFRP1;MEOX1;UFL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3239578662079716,0.7268661253810229,0.9622641509433962,1.0,1.0,18/62,29.22%,SEC22B;ITGAV;LNPEP;PSMD13;TAP1;PSMA1;VAMP3;PSME4;HLA-E;HLA-F;PSMD4;IKBKB;PSMB5;VAMP8;PSMC5;HLA-B;PSMB1;CHUK
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.3241437058193319,-0.7266463183743062,0.8913043478260869,1.0,1.0,12/51,19.17%,PER2;OAS1;GOT2;ENO2;KCNJ11;GAPDHS;G6PC3;PFKFB1;SORD;APOD;RBP4;ALDOB
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.3957168637923473,0.7266185196549799,0.7424242424242424,1.0,1.0,2/12,16.94%,LMO2;THRB
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.3472640429877175,0.7264989700633927,0.8846153846153846,1.0,1.0,3/21,12.14%,TGFBR1;CAVIN1;LYN
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.28502289778814277,0.7264190152206988,1.0,1.0,1.0,14/138,15.04%,TENT5A;SAMD4A;ZFP36L2;MAPKAPK2;EXOSC4;RIDA;PSMD13;HSPB1;HNRNPD;ANP32A;HSPA8;PSMA1;XPO1;PSME4
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3855426714523891,0.7262054869619633,0.7741935483870968,1.0,1.0,3/20,17.44%,FBXO5;ZNF207;TEX14
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3656697091475948,0.7261744759678015,0.8448275862068966,1.0,1.0,2/32,7.50%,FAIM;TNFRSF10A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.3811156622167977,-0.7260208131326358,0.7727272727272727,1.0,1.0,2/17,6.32%,UPB1;NT5C
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.28567623971287986,0.7258986561361385,1.0,1.0,1.0,35/151,24.93%,TGFBR1;MAPKAPK2;MAPKAPK3;RPS6KA4;DYRK2;SMG1;LATS1;RPS6KA2;STK32B;VRK2;MAPK8;DYRK1A;CSNK1G3;SGK1;RICTOR;HIPK1;PKN2;RPS6KA1;RPS6KA5;MAST1;STK38L;STK32C;WNK1;AKT3;STK32A;HIPK3;MKNK2;IKBKB;CAMK4;GAS6;AKT2;RPS6KA6;IKBKE;DYRK3;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.4649319068965043,0.7256421001794064,0.75,1.0,1.0,1/7,11.32%,CTNNA2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.4099436733305887,0.7253459871196192,0.8490566037735849,1.0,1.0,3/15,21.17%,CADM1;CD55;JAG1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.31049722087902076,0.7252699313744242,0.9411764705882353,1.0,1.0,3/65,6.15%,U2AF1;NXF1;THOC6
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.3770806950484756,0.7251439736958354,0.8571428571428571,1.0,1.0,9/26,28.19%,SIGLEC1;FCHSD2;PICALM;LMBRD1;CANX;FNBP1L;SNAP91;SGIP1;INPP5F
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3744144550539333,0.7248779205316019,0.9047619047619048,1.0,1.0,8/28,22.12%,NEDD4;ZFYVE16;KPTN;RNF128;CD81;GCC2;SNX16;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.3949861392348738,-0.7241596447408024,0.7428571428571429,1.0,1.0,3/11,7.52%,RFLNB;AHSG;RFLNA
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.32151400284662207,0.7239961218885432,0.9056603773584906,1.0,1.0,15/75,22.24%,FZD5;PRICKLE2;MAGI2;PSMD13;PSMA1;PSME4;FZD4;FZD1;PRICKLE1;FZD6;DVL2;VANGL2;ARRB2;SMURF1;PSMD4
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.3801905889973195,-0.7238007247966887,0.8461538461538461,1.0,1.0,9/25,10.37%,HGSNAT;OVGP1;GPC2;AGRN;GPC1;GPC3;SGSH;IDUA;CHI3L1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.39347077569938754,0.7234686941035849,0.8135593220338984,1.0,1.0,1/13,2.18%,SIRT1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.38752049763551494,-0.7230240957654642,0.8269230769230769,1.0,1.0,2/12,8.42%,PTGES;PRXL2B
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.35603476183951926,0.7227877000843821,0.8,1.0,1.0,10/29,20.20%,DOCK1;MEGF10;GSN;XKR6;MSR1;ARHGAP25;RHOBTB1;RHOG;XKR4;ITGAM
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.41891890935252896,-0.7225065289425123,0.7857142857142857,1.0,1.0,4/12,8.74%,SIGIRR;OAS3;OAS1;MEFV
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.33226681707519706,0.7223738868032832,0.9682539682539683,1.0,1.0,11/44,23.13%,IGF1;FBXO5;DRD3;CDC25C;PHIP;BMP4;RCC1;BORA;EDN1;DMRT1;LRP5
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.35382424984343247,0.7221908740653482,0.85,1.0,1.0,5/31,10.59%,BTN2A2;ITGAV;PTX3;ANKRD13D;ANKRD13A
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.4301272399864971,0.7221140087016278,0.8653846153846154,1.0,1.0,4/11,26.80%,NFE2L2;HSPA5;EIF2AK3;DDIT3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.3463098511643288,0.7218518701909572,0.9107142857142857,1.0,1.0,9/31,22.21%,MCTP2;RIMS2;SNCAIP;MEF2C;RIMS4;SLC30A1;FMR1;MCTP1;KCNMB4
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3731751504090446,-0.7217727905966413,0.8085106382978723,1.0,1.0,3/30,10.39%,WTIP;RBM4;SNIP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3995623523879758,-0.7214737416073626,0.8571428571428571,1.0,1.0,4/26,14.77%,XPC;PARP1;GTF2H2;RPA3
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.48864410894412436,-0.7214380369051325,0.8048780487804879,1.0,1.0,4/5,14.12%,KCNA5;KCNN2;KCNQ1;KCNJ5
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.48864410894412436,-0.7214380369051325,0.8048780487804879,1.0,1.0,4/5,14.12%,KCNA5;KCNN2;KCNQ1;KCNJ5
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.448691310784349,0.7212342357743403,0.8983050847457628,1.0,1.0,2/6,32.01%,SCARA3;SDF4
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.3703403765610105,0.720556047923736,0.8392857142857143,1.0,1.0,1/20,0.86%,NOX5
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.5145047536580968,0.7205229301759926,0.847457627118644,1.0,1.0,1/5,13.21%,AOX1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.3933774991596096,0.7203870974849937,0.8245614035087719,1.0,1.0,3/13,18.58%,CAVIN1;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.30768851498684713,0.7203674358192448,0.8947368421052632,1.0,1.0,10/76,21.31%,COX19;IMMP2L;CHCHD4;SDHAF1;BCS1L;UQCC3;NDUFAF6;SCO2;SLC25A33;SDHAF3
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.45529415022025593,-0.7198791911842429,0.8541666666666666,1.0,1.0,2/7,18.38%,PTPRS;CACTIN
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.43813609549890753,-0.7196617724242047,0.8163265306122449,1.0,1.0,1/7,6.25%,CAV1
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.42275363395415766,-0.7194826031695187,0.8181818181818182,1.0,1.0,2/6,9.39%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.42275363395415766,-0.7194826031695187,0.8181818181818182,1.0,1.0,2/6,9.39%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.40613303511170834,-0.7194810773425735,0.813953488372093,1.0,1.0,7/15,28.29%,ADAMTS9;EDEM2;FBXO2;FBXO44;ADAMTS12;CTSL;FBXO27
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.3235590903465517,0.7192721047655025,0.8545454545454545,1.0,1.0,15/58,18.13%,EGLN3;SIRT1;MYC;HIF1A;RORA;TBL2;BNIP3L;KCND2;HP1BP3;ACAA2;CPEB1;VEGFA;CARD16;PTGIS;FMN2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.30371764232074694,0.7192293102988129,0.9215686274509803,1.0,1.0,8/89,7.16%,FGF10;TIMELESS;PPARG;WNT4;BMP2;KANK2;APELA;BDH2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.3499476406749832,0.7186792676348672,0.8703703703703703,1.0,1.0,13/35,28.67%,LRP4;CTNNA2;PTEN;KLF7;WASL;FARP1;MAP2;DIP2A;MAPK8IP2;MEF2A;DOCK10;MAP6;PHACTR1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3006680738873949,-0.718662568188859,1.0,1.0,1.0,20/77,19.33%,TERF2IP;WARS1;ATG14;XDH;NTRK3;PTPA;ARPP19;MYADM;IGFBP3;BEX4;XRCC1;DAB2IP;TGFB1;TRAF3IP1;PNKP;DNAJC10;CHP1;CACTIN;ENSA;G6PD
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.4308644457468343,-0.7183624882034703,0.7714285714285715,1.0,1.0,1/9,3.26%,TST
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.308528027128694,0.7182050117105861,0.9491525423728814,1.0,1.0,22/94,23.23%,NEDD4;PRMT1;SEC22B;IL23R;ASB5;FOXO1;PLA2G10;RANBP9;HECW2;NR1H3;MAPK8;CD80;CSF1;TIPARP;STX5;ABCA2;SMURF1;C4BPB;CARD9;IL23A;GSK3A;FZR1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.34251017887250246,0.7181923898066164,0.8793103448275862,1.0,1.0,6/30,12.10%,NLGN1;SYT1;SNCA;NLGN4X;CEL;STON2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.30727728942955684,0.7180577015336961,0.9636363636363636,1.0,1.0,23/86,20.38%,SYK;DRD5;CALCR;RXFP2;GPHB5;PLCG2;RAMP3;GPR176;GGT5;LYN;HTR7;GIP;ADRB1;CREB1;CD247;IAPP;RXFP1;CALCRL;ADORA2B;INSL3;CD81;CYSLTR1;DPEP1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.4499025823581097,-0.7179510770316208,0.8372093023255814,1.0,1.0,1/8,7.75%,PGP
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.3538459787271044,-0.7178434921321396,0.9047619047619048,1.0,1.0,4/27,10.95%,GPC2;GPC1;GPC3;AR
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.5111880789426971,0.7177428109406813,0.8301886792452831,1.0,1.0,2/5,20.16%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3435949283869174,0.7176258471347501,0.875,1.0,1.0,3/30,10.90%,PPP1R15B;ITGA1;MAGI2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.38980074727575653,0.7173847116240325,0.8412698412698413,1.0,1.0,5/21,20.22%,GAL3ST1;ST3GAL6;TEX2;TECR;AGMO
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.4701417771733013,-0.7173812042474401,0.85,1.0,1.0,1/6,8.40%,UBASH3B
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.4535446754791207,-0.7170040790371683,0.8918918918918919,1.0,1.0,2/7,28.64%,STAT1;DDB1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.272821252487836,-0.7168085081361081,1.0,1.0,1.0,10/290,4.13%,DUOXA1;STX16;TBC1D10C;IFT27;SEPTIN12;ARL5C;RTP1;RTP5;ARF3;STXBP2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.3884074347851913,0.7167921391835703,0.8245614035087719,1.0,1.0,10/19,30.45%,LIPG;NUS1;OSBPL6;NR1H3;ABCA8;ABCA2;ABCA13;YJEFN3;NFKB1;TTC39B
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.4182909104936189,0.7167514096879277,0.8571428571428571,1.0,1.0,4/13,29.12%,MAPKAPK2;ELAVL4;HNRNPC;ANGEL2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4106760641439347,0.716718667890571,0.896551724137931,1.0,1.0,4/19,14.76%,MRAP2;ABI3;LZTFL1;PICALM
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.33295898467214935,0.7164659031493329,0.9298245614035088,1.0,1.0,11/52,23.09%,VAPB;ELOVL5;PPM1L;SGPL1;CERS5;ELOVL4;PLPP1;SAMD8;ALDH3B1;ELOVL6;CERS3
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.43100300278990267,0.7163659305333426,0.8703703703703703,1.0,1.0,3/9,11.94%,MAPKAPK2;MAPKAPK3;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.4519274060862512,0.7162473140151958,0.859375,1.0,1.0,1/8,13.46%,FCHSD2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.4006270463741601,0.7162207399119254,0.8448275862068966,1.0,1.0,5/13,22.91%,GCH1;PYCR1;GPHN;MOCOS;LIAS
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.4306227168730861,-0.7161607047705165,0.9210526315789473,1.0,1.0,4/15,12.47%,HSF2BP;BTBD18;DDX4;MOV10L1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.40704624333835104,-0.7161204149426863,0.7692307692307693,1.0,1.0,4/13,15.47%,TRIM72;MYH9;FER1L5;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.484509188029671,-0.7158906373148851,0.7959183673469388,1.0,1.0,4/5,25.61%,CAV1;PROM2;STX1B;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.43256033568166574,0.7158314690064048,0.8235294117647058,1.0,1.0,4/11,29.29%,PRICKLE1;BMP4;NOTCH1;SOX8
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.341542321238254,0.7157550145183079,0.9090909090909091,1.0,1.0,14/39,31.48%,RALA;LMNB1;PLCB1;HNRNPA2B1;AIP;HNRNPF;JAK2;PAK2;PDCD4;IL12RB2;SIRPA;CD47;GSTO1;IL12A
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.4645508551316533,-0.715691193171915,0.8048780487804879,1.0,1.0,3/6,10.11%,BTBD18;DDX4;PIWIL2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.4517327242616619,0.7154927217679542,0.8421052631578947,1.0,1.0,4/8,22.32%,NEFH;HAP1;TTC21B;MAP2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2787814995883609,-0.7151770096956238,0.9777777777777777,1.0,1.0,15/198,8.30%,NTRK1;TNFSF18;TERF2IP;NLRP3;TNFRSF11A;TRIM5;RAB7B;BTK;CAMK2A;BEX1;CAV1;MBTPS2;PRKD2;CLU;FLOT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.41488033112502165,-0.7149982357616981,0.8636363636363636,1.0,1.0,2/10,5.97%,XYLT2;XYLT1
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.29598747210767107,-0.7148956306344408,1.0,1.0,1.0,6/117,7.98%,NTRK1;TMEM179;MAPK4;SHC3;RGS4;ARNT2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3567234811485683,0.7145113602623961,0.8571428571428571,1.0,1.0,13/28,33.74%,TAP1;TAPBPL;HLA-E;HLA-F;SEC24B;CANX;BCAP31;HLA-B;SEC31A;B2M;ACE;IDE;CALR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.44029262906482847,0.7145013981440163,0.8653846153846154,1.0,1.0,2/8,14.38%,PLXNB1;PLXNB2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3239754950328823,0.7144351653962081,0.9183673469387755,1.0,1.0,8/57,12.55%,GPSM3;CCN4;NAPEPLD;NFKBIZ;TLR2;SNCA;IL15;PLA2G7
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.41389209875521704,-0.7142265723917047,0.86,1.0,1.0,1/6,2.22%,NLRP3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.41389209875521704,-0.7142265723917047,0.86,1.0,1.0,1/6,2.22%,NLRP3
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3065192905601577,0.7142242266280976,1.0,1.0,1.0,11/63,20.98%,SIRT1;CDKN2A;TMIGD3;ERBIN;ZNF675;IRAK3;IRAK1;NFKBIB;PTGIS;ARRB2;NLRP2B
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.35001685303817814,0.7136217233551004,0.8947368421052632,1.0,1.0,1/33,0.91%,TENT5A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.2994264319729725,-0.7135002583474732,0.9428571428571428,1.0,1.0,12/82,14.27%,WARS1;MVP;CAV1;TRIB2;UBASH3B;TAF7;CEACAM1;CAMK2N1;SPRED1;TRIB1;DAB2IP;CDKN1C
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.3853972324988132,-0.7134901439937471,0.7959183673469388,1.0,1.0,1/12,3.64%,SPAAR
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.3092848178573808,-0.7133461774900476,0.9318181818181818,1.0,1.0,5/65,8.21%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3440686034323477,0.7132366678762286,0.9074074074074074,1.0,1.0,9/33,20.15%,FZD5;MOV10;PDE6A;PPP3CA;FZD4;FZD6;PLCB1;CTNNB1;AGO3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3571695933375269,0.713222684903466,0.8545454545454545,1.0,1.0,10/21,32.36%,TP53BP2;MAPK8;PPP3CC;TP53;PPP1R13B;BAD;YWHAH;BID;YWHAZ;TP63
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3571695933375269,0.713222684903466,0.8545454545454545,1.0,1.0,10/21,32.36%,TP53BP2;MAPK8;PPP3CC;TP53;PPP1R13B;BAD;YWHAH;BID;YWHAZ;TP63
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.33807780524640196,0.7130727920623435,0.9122807017543859,1.0,1.0,4/28,16.96%,SIRT1;ZC3HAV1;SIRT6;TIPARP
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.4243455698192462,-0.7129961861441784,0.8,1.0,1.0,2/8,8.54%,AK8;AK7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4165627904112547,-0.7129828812484363,0.8372093023255814,1.0,1.0,3/9,13.20%,CXCL13;WNT5A;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3075162995682552,-0.7128029897796744,0.9318181818181818,1.0,1.0,17/82,15.78%,NUPR1;INHA;TERF2IP;WARS1;ATG14;XDH;NTRK3;MYADM;IGFBP3;ANKLE2;PFKFB1;DAB2IP;CDKN1C;TGFB1;CDKN2D;ACTN3;TRAF3IP1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.36611479025376603,0.7127672556786161,0.8596491228070176,1.0,1.0,1/17,1.35%,C3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3598998788412718,0.7126617359312047,0.8769230769230769,1.0,1.0,2/20,6.37%,NEDD4;ZFYVE16
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.4953655723537119,0.7122091594990883,0.8245614035087719,1.0,1.0,1/5,7.86%,PDGFRA
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.4707639865017601,0.7121544736030074,0.8333333333333334,1.0,1.0,1/5,8.50%,SLC22A3
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.4707639865017601,0.7121544736030074,0.8333333333333334,1.0,1.0,1/5,8.50%,SLC22A3
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.40383467997845546,-0.7117591844472311,0.8,1.0,1.0,2/7,9.39%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.293639642013342,0.7117436646877948,0.9824561403508771,1.0,1.0,4/148,3.34%,SGO1;NDC80;DLGAP5;NDE1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3054431190001087,0.7116673264612198,0.9423076923076923,1.0,1.0,9/92,14.83%,U2AF1;SF3B1;SYNCRIP;SNRPN;IVNS1ABP;NOVA1;SNRNP48;RRAGC;CDK12
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.3837011542452342,0.7116063697190799,0.8709677419354839,1.0,1.0,2/20,8.78%,PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.4848117428789216,-0.711206766629699,0.8,1.0,1.0,2/5,11.10%,SCN5A;SCN3B
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.28542125113371536,-0.7109735254534705,0.9622641509433962,1.0,1.0,20/125,19.03%,RPF2;EIF2S2;EIF2S3;RPS27L;EIF2S3B;WDR77;PRPF19;CELF3;SNRNP200;PRMT7;RPL38;SRSF10;SRPK3;CRNKL1;PRPF6;COIL;EIF4H;RPS27;SNRPD2;BRIX1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.4421226674039652,-0.7103274819209673,0.7567567567567568,1.0,1.0,4/7,28.00%,P2RY12;NTN1;NRP1;SDCBP
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.46116782031017467,0.7101947009637456,0.8,1.0,1.0,1/5,7.58%,PRIMPOL
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.4055061995999346,0.7092171975446391,0.7755102040816326,1.0,1.0,2/10,10.67%,MUC13;CRACD
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.4564323658407211,0.7090291631262348,0.8301886792452831,1.0,1.0,2/6,15.93%,HSPA8;APBA1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.4575778703912745,0.7090234641350921,0.8823529411764706,1.0,1.0,3/7,20.17%,RAP1A;SLC30A1;FMR1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.37497528406544794,0.7088793569086952,0.8703703703703703,1.0,1.0,3/20,9.04%,LGALS9;VSIR;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.4441133230831268,-0.7084501166649355,0.8085106382978723,1.0,1.0,1/5,13.62%,PHF19
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.35297921122687903,-0.7082191817534647,0.9130434782608695,1.0,1.0,1/27,1.66%,CALB2
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.4677654705043058,0.7082029913672027,0.8363636363636363,1.0,1.0,2/6,21.93%,BMP4;TNFSF4
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.3871661107354602,-0.7081706769531358,0.7692307692307693,1.0,1.0,1/20,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.3871661107354602,-0.7081706769531358,0.7692307692307693,1.0,1.0,1/20,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.48139901714510525,0.7080519590766247,0.8235294117647058,1.0,1.0,1/6,11.32%,CTNNA2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.41390926149882845,0.707956026329153,0.8490566037735849,1.0,1.0,1/10,3.81%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.30851677219363716,0.707936327315629,0.9423076923076923,1.0,1.0,20/85,18.74%,SYK;DRD5;CALCR;RXFP2;GPHB5;PLCG2;RAMP3;GPR176;GGT5;LYN;HTR7;GIP;ADRB1;CREB1;CD247;IAPP;RXFP1;CALCRL;ADORA2B;INSL3
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.31932699464762926,-0.7076447100626246,0.8936170212765957,1.0,1.0,3/52,5.72%,AMACR;CYP21A2;HSD11B1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.4730547752076284,-0.7074827489414998,0.8571428571428571,1.0,1.0,2/6,17.56%,SMOX;SAT2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4123503333836888,-0.7074156594331965,0.813953488372093,1.0,1.0,2/13,7.12%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.45659056320279756,0.7073137891889791,0.8064516129032258,1.0,1.0,4/6,32.91%,TLR2;ERC1;CHUK;MAP3K7
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.3629425304008013,-0.7066840844272391,0.8181818181818182,1.0,1.0,8/29,19.77%,MAP1LC3B2;ATG14;RUBCNL;LIX1L;CALM1;TECPR1;GABARAPL1;CHMP3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3271531336131803,0.7066823033592997,0.9444444444444444,1.0,1.0,13/40,28.47%,ACTL6A;HDAC2;SMARCD2;ARID1A;ARID1B;SMARCAD1;SMARCA2;HDAC1;CECR2;ACTR5;RBBP4;HNRNPC;SRCAP
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.4154946638202141,-0.7065120261442225,0.8085106382978723,1.0,1.0,3/8,22.88%,KDM1B;KDM5D;RIOX1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4182450712236957,-0.7063950758124731,0.8780487804878049,1.0,1.0,6/9,34.63%,GRN;TASL;ATP6AP2;CLN6;PPT1;CLN3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.4082814463572821,0.7063923144024127,0.8064516129032258,1.0,1.0,2/11,10.55%,ABCA1;LIPG
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.48357844540343736,0.7062355263059724,0.803921568627451,1.0,1.0,1/5,9.46%,GPSM1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.3673421388494593,-0.7061022929099185,0.8571428571428571,1.0,1.0,1/18,7.24%,DAB2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3511194133434777,0.7055979178687233,0.8813559322033898,1.0,1.0,3/31,12.37%,TFEB;ABCA1;AKTIP
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.41584624736660303,0.7055197250475096,0.7719298245614035,1.0,1.0,1/15,1.59%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4499352139021018,0.7050192010398532,0.7543859649122807,1.0,1.0,2/7,10.77%,IL23R;IL18R1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.4076758697279096,-0.7049623581929193,0.8076923076923077,1.0,1.0,2/9,13.70%,CAV1;ATP6V0A2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.4663026978434015,-0.7048854319084539,0.8392857142857143,1.0,1.0,3/5,25.69%,SLIT3;MYO9B;RHOA
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.34270690476378474,0.7046864775809761,0.9298245614035088,1.0,1.0,8/33,28.93%,HAP1;HSPB1;RAB27B;DLG2;AP3M2;TRAK2;RAB21;KIF3B
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.320011595538541,-0.7046454318402751,0.9523809523809523,1.0,1.0,5/31,12.37%,DRD2;ADCYAP1;NNAT;CRH;FFAR4
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.4484764296863461,0.7045198507760192,0.8275862068965517,1.0,1.0,4/7,33.03%,SMS;MTR;MSRA;ADI1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.40092339385768827,0.7043026128310472,0.8135593220338984,1.0,1.0,7/12,42.61%,TRAPPC8;ACBD5;PIK3R4;PIK3C3;ATM;USP30;RB1CC1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.34619313083080616,0.7042210361594208,0.9122807017543859,1.0,1.0,9/41,23.57%,PEX12;CHCHD4;DNAJC15;SEC61A1;PEX2;SEC61A2;RTN2;HSPA5;AKT2
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.39671246835480056,0.7040254081753653,0.7727272727272727,1.0,1.0,2/11,16.94%,LMO2;THRB
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.3467277100189667,-0.7035119423801507,0.9056603773584906,1.0,1.0,1/29,0.40%,MYH7
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.40893729457027883,0.7034022857330771,0.8181818181818182,1.0,1.0,3/13,15.59%,PLA2G10;MSR1;CSF1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.42595506842612574,-0.70317117393855,0.875,1.0,1.0,2/7,8.38%,ABCC4;ABCC3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.4426261219436707,-0.7031587485732249,0.7906976744186046,1.0,1.0,7/7,55.75%,MSN;SORL1;ROCK2;RDX;EZR;MGAT3;EGF
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.4426261219436707,-0.7031587485732249,0.7906976744186046,1.0,1.0,7/7,55.75%,MSN;SORL1;ROCK2;RDX;EZR;MGAT3;EGF
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.4426261219436707,-0.7031587485732249,0.7906976744186046,1.0,1.0,7/7,55.75%,MSN;SORL1;ROCK2;RDX;EZR;MGAT3;EGF
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.42159585161855523,-0.7027789396156279,0.851063829787234,1.0,1.0,6/15,22.36%,WBP4;SNRNP200;RBM22;CACTIN;WBP11;CWC15
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.40974512358934323,0.701899093448849,0.803921568627451,1.0,1.0,1/11,11.81%,GSN
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.30749340390903734,-0.7016652014021204,0.9795918367346939,1.0,1.0,8/50,13.38%,SLC16A11;SLC6A6;SLC13A3;SLC36A2;SLC6A11;SLC6A20;SLC6A12;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4363145294437248,-0.701339862038712,0.85,1.0,1.0,1/8,1.95%,CXCL13
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4363145294437248,-0.701339862038712,0.85,1.0,1.0,1/8,1.95%,CXCL13
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.41560343771431024,-0.7012936963988867,0.8333333333333334,1.0,1.0,2/10,6.35%,SMOX;DMGDH
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.38629761850626315,0.7012737298015372,0.8888888888888888,1.0,1.0,5/21,18.51%,PDGFRA;DSCAML1;RYR2;FBN1;MESP1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.46903324184685674,-0.7012494317820503,0.8163265306122449,1.0,1.0,3/5,19.54%,SOX15;TGFB1;USP19
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.37611234908819724,-0.7011100230104536,0.8823529411764706,1.0,1.0,11/17,33.34%,TIMM44;TOMM20;PAM16;GRPEL1;TIMM23;ROMO1;TIMM17B;DNAJC19;TOMM40;TOMM70;TIMM17A
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.3627671552417677,-0.7010551222082657,0.8888888888888888,1.0,1.0,4/27,13.56%,PRKCD;MYADM;STMN1;TUBB4A
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.4218614069347857,0.7009665446442475,0.8431372549019608,1.0,1.0,1/7,7.22%,ESR1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.35747366646766227,0.7004774101855588,0.8235294117647058,1.0,1.0,10/24,22.88%,PTGS1;HPGDS;CD74;AKR1C1;CYP2S1;PTGIS;PNPLA8;AKR1C3;ACOX1;EDN1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.35606118964049827,-0.7003536843206306,0.9333333333333333,1.0,1.0,2/22,6.25%,SFRP1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.48026738988548096,0.6998445764292515,0.8367346938775511,1.0,1.0,1/5,4.41%,PRMT1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.35136245877158645,-0.6997379747170442,0.8823529411764706,1.0,1.0,2/24,6.95%,PER2;JUN
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.4724834161600016,0.6995830715833188,0.8775510204081632,1.0,1.0,2/6,20.89%,DLG2;CRHBP
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.4724834161600016,0.6995830715833188,0.8775510204081632,1.0,1.0,2/6,20.89%,DLG2;CRHBP
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.34159244934145944,0.6995656413239354,0.85,1.0,1.0,4/31,12.26%,NEDD4;NKAIN2;FGF12;NKAIN3
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.3811967553243751,0.6993462651209579,0.9245283018867925,1.0,1.0,1/21,4.30%,TBC1D12
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.39517316394141866,-0.6992444872376903,0.8085106382978723,1.0,1.0,1/12,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.37009122532203753,-0.6991437772758801,0.8695652173913043,1.0,1.0,3/12,9.39%,CAV1;DSG2;CTNNA3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.44685815343006485,-0.6990794722732974,0.8780487804878049,1.0,1.0,1/7,5.64%,LGI4
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.44685815343006485,-0.6990794722732974,0.8780487804878049,1.0,1.0,1/7,5.64%,LGI4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.41805378299040297,0.6984812571770856,0.8103448275862069,1.0,1.0,2/6,25.12%,DMD;KCNJ2
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.44668520997368644,0.6984438852147945,0.864406779661017,1.0,1.0,2/6,19.26%,CA2;ATP8B1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.35478170063265047,-0.6984051982728743,0.9,1.0,1.0,3/30,10.48%,CMTR1;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.35478170063265047,-0.6984051982728743,0.9,1.0,1.0,3/30,10.48%,CMTR1;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.3236988722609433,-0.69813445979031,0.9512195121951219,1.0,1.0,1/26,2.36%,UBE2L5
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.3855672632600295,-0.6977982835842444,0.875,1.0,1.0,2/15,12.76%,ERN2;DEDD2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3752111553190756,0.6977218838312297,0.8301886792452831,1.0,1.0,7/19,25.59%,NCK2;MLXIPL;PTEN;DMD;NLRP2B;INPP5J;SMAD7
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.3331928948627977,0.6976945974669975,0.8620689655172413,1.0,1.0,3/43,5.08%,MLC1;PTGFR;GLRA1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.28992488323481336,0.6976006678797863,1.0,1.0,1.0,13/111,14.14%,NXPH1;HRH3;SLC17A6;TENM1;ZDHHC22;NRXN1;OLFM3;NR4A2;PAK5;TMEM196;NOL4;KCNB2;GRIK3
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.33420273065208705,-0.6975498188201128,0.8863636363636364,1.0,1.0,6/35,13.44%,PER2;GOT2;ENO2;GAPDHS;G6PC3;PFKFB1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.33561898442259314,-0.6974830968312132,0.9767441860465116,1.0,1.0,5/42,13.57%,DNASE1L1;ADAMTS9;DENND3;SUPV3L1;DAB2IP
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.42893442469951226,0.697334999549951,0.8775510204081632,1.0,1.0,3/8,11.96%,SAG;CNGA1;PDE6A
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.45144046112310765,0.6972421284125337,0.8627450980392157,1.0,1.0,1/6,4.41%,PRMT1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.31020234606762664,-0.6972363533698087,0.9487179487179487,1.0,1.0,8/58,11.72%,WARS1;TRIB2;UBASH3B;TAF7;CEACAM1;CAMK2N1;SPRED1;TRIB1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.38046604483919605,0.6970357211418664,0.8852459016393442,1.0,1.0,4/16,21.27%,HAP1;DLG2;DST;ACTR10
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4178068334504901,0.696944640937575,0.82,1.0,1.0,1/9,8.71%,DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4178068334504901,0.696944640937575,0.82,1.0,1.0,1/9,8.71%,DYRK2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.3239750245047572,-0.6969188099700169,0.9210526315789473,1.0,1.0,1/31,1.16%,NUPR1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.4285332145104952,0.6968024758629149,0.8333333333333334,1.0,1.0,3/8,25.72%,VEGFA;RYK;GDNF
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.3946298086089389,0.6967446828094328,0.8484848484848485,1.0,1.0,5/11,28.17%,NOC2L;TP53;HIRIP3;RBBP4;M1AP
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.32133112860444546,-0.6963280840088977,0.9166666666666666,1.0,1.0,6/38,15.44%,INHA;ZFPM1;UFL1;ID2;MED1;TGFBR3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.4581564323758561,0.6963070333446405,0.8620689655172413,1.0,1.0,2/6,23.68%,CARD16;CARD18
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",0.46269181256964786,0.6963047795379522,0.8787878787878788,1.0,1.0,2/5,6.03%,KLKB1;F12
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",0.46269181256964786,0.6963047795379522,0.8787878787878788,1.0,1.0,2/5,6.03%,KLKB1;F12
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.39482049191736857,0.6959838910599294,0.8333333333333334,1.0,1.0,4/21,21.15%,NEDD4;MVB12A;LGMN;SMURF1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.30660209547839345,-0.695958370227537,0.9545454545454546,1.0,1.0,4/56,6.93%,AMACR;ALOX5;PER2;MLYCD
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.3640270441293584,0.695316107005382,0.8983050847457628,1.0,1.0,7/20,21.25%,MYC;SMG1;LIG4;HNRNPD;SHCBP1L;CENPV;YLPM1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.4457226761588774,0.6945926889569675,0.8095238095238095,1.0,1.0,1/7,7.58%,PRIMPOL
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.42937659854848287,0.694478949546805,0.8305084745762712,1.0,1.0,5/7,44.09%,DPYSL5;DPYSL3;DPYS;DPYD;DPYSL2
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),-0.4533486996181162,-0.6944342587812541,0.8125,1.0,1.0,1/5,5.21%,DRD2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.37136513452850867,0.6943880922953568,0.8888888888888888,1.0,1.0,3/19,13.56%,MID2;PML;TRIM26
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.40457509128578156,0.6941544268143558,0.8103448275862069,1.0,1.0,4/12,25.44%,LMAN1;SNX2;STX5;SNX1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.47061947903461043,0.6939760390075987,0.9591836734693877,1.0,1.0,1/5,18.19%,KDM6A
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.37981511535966583,-0.6935651099178791,0.875,1.0,1.0,1/15,4.69%,FCHSD1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.35754255494129855,-0.6934321845967439,0.9069767441860465,1.0,1.0,5/19,19.62%,CBARP;UBASH3B;PTK2B;CACNB1;CAV3
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3299971809514296,0.6933983453294968,0.9206349206349206,1.0,1.0,8/46,26.68%,HIF1A;GCK;RANBP2;PNPT1;NUP153;OGT;PRDM16;EP300
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.3386921187532682,0.6932730941082752,0.875,1.0,1.0,2/35,9.75%,MRPS12;FOXO3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.40208128248591335,-0.6929815833752889,0.8888888888888888,1.0,1.0,2/15,8.37%,TERF2IP;SMUG1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.3069119030557605,-0.6928493939625484,0.9736842105263158,1.0,1.0,15/95,14.20%,WARS1;TSPYL2;ADCYAP1;TRIB2;CAMKK2;UBASH3B;CAMKK1;TAF7;CEACAM1;CAMK2N1;SPRED1;TRIB1;DAXX;PTK2B;TTN
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),-0.41430605465313286,-0.6925925592717385,0.8,1.0,1.0,3/5,27.78%,LAPTM4B;ATP6AP2;THBS1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.4639742043210815,0.6925152182005697,0.873015873015873,1.0,1.0,1/5,23.55%,BAD
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.42322253824513323,0.6925071318584327,0.864406779661017,1.0,1.0,6/10,25.89%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.42322253824513323,0.6925071318584327,0.864406779661017,1.0,1.0,6/10,25.89%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2513408703758657,-0.6924372608659629,1.0,1.0,1.0,46/257,18.57%,SNRNP27;DDX41;PRPF4;RBM4;ZCRB1;WBP4;RNF113A;DHX8;WDR77;GTF2F1;RBM4B;PRPF19;SNIP1;RBMX2;RNPC3;SNRPA1;FIP1L1;CPSF4;SNRNP200;CWC25;PRMT7;CPSF3;ESS2;SF3A3;SUGP1;DHX38;MAGOHB;SYF2;DNAJC8;SRSF10;CWF19L1;SNW1;SRPK3;MFAP1;CSTF2;CRNKL1;HNRNPL;PRPF6;SF3A1;COIL;ALYREF;RBM22;SRSF7;CACTIN;SNRPD2;DHX35
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.26938791069053336,0.6922664821965127,1.0,1.0,1.0,35/198,22.87%,PKNOX1;SOX5;ZBTB7B;MLLT3;IVNS1ABP;TSC22D1;FOXO3;TAF3;RO60;NR4A2;RRAGC;BCL3;GTF3C4;MLF1;POLR3G;TAF5;EPC1;THRB;CCNH;TAF1A;DEAF1;NELFB;TAF2;NFKBIB;EAF2;MNAT1;ARRB2;GTF2B;NFIC;SLC25A33;TP53;NCBP1;POLR2H;HIPK3;TAF4
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.30758282071034304,0.6920681555876681,0.9841269841269841,1.0,1.0,19/74,29.77%,NEDD4;SEC22B;ASB5;FOXO1;HECW2;TIPARP;STX5;SMURF1;C4BPB;GSK3A;FZR1;TNFRSF1B;BARD1;NKD1;APOE;HECW1;WWP1;RNF41;FURIN
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.3794715774805335,0.691794447086643,0.8545454545454545,1.0,1.0,4/17,18.58%,CAVIN1;GTF3C4;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.28281765723214325,-0.6915481197582134,1.0,1.0,1.0,6/113,6.53%,NTRK1;SFRP1;DOCK8;RGS8;AGRN;ADCYAP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.27671491932842374,0.6912990069671242,1.0,1.0,1.0,14/114,11.04%,SIRT1;CDKN2A;HES6;ESR1;HDAC2;PLA2G10;TMIGD3;FOXH1;ERBIN;KEAP1;PAXIP1;PROX1;TAF3;ZNF675
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.315337256311195,-0.690981620227418,0.9714285714285714,1.0,1.0,6/30,15.05%,RAC2;P2RY12;KIF17;PARVB;RAC1;PARVG
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.3874267042145766,-0.6907377708640495,0.8823529411764706,1.0,1.0,5/12,15.45%,CLDN1;MYADM;CBLN2;DCTN1;CHCHD10
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.387391642912303,-0.6907203596365051,0.8611111111111112,1.0,1.0,1/12,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.3748829807260929,0.6898853672295095,0.864406779661017,1.0,1.0,8/16,21.43%,NRIP1;ESR1;RAMP3;NCOA3;LCOR;RUVBL2;CRHBP;SSTR1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.30370387179704067,0.6898446319461409,0.9649122807017544,1.0,1.0,17/60,29.22%,SEC22B;ITGAV;PSMD13;TAP1;PSMA1;VAMP3;PSME4;HLA-E;HLA-F;PSMD4;IKBKB;PSMB5;VAMP8;PSMC5;HLA-B;PSMB1;CHUK
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4630346357855131,0.6894049925371667,0.8775510204081632,1.0,1.0,2/5,39.65%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.36905530071418496,0.6894026112517105,0.9322033898305084,1.0,1.0,1/18,3.19%,URI1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3018500430494786,0.6892268541693573,0.9591836734693877,1.0,1.0,6/96,9.42%,SYK;NRG1;ESR1;UNC13B;ABCA1;SNCA
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3364930459189932,0.6889275792711272,0.9090909090909091,1.0,1.0,10/31,19.37%,SCD;BDH2;SCD5;GGT5;SLC25A1;FASN;ACACA;FAR2;HMGCLL1;ALOX5AP
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.38581359018424594,0.6884868407455053,0.875,1.0,1.0,4/13,21.09%,ESR1;BMP4;PLPP1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.38737826918684365,0.6883623949880304,0.9107142857142857,1.0,1.0,5/12,28.95%,GREM1;PLCB1;WASL;SLIT2;SLAMF8
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.29346465009379213,0.6883349570542695,1.0,1.0,1.0,14/100,13.70%,TOP2A;ALDH1A1;ISOC1;SLC35B2;IDH1;DHRS3;ELOVL5;ALDH9A1;ATXN1;CEL;CADM1;ABCD3;ABCD2;HSD11B2
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.4791876237932332,-0.6882762539939279,0.9,1.0,1.0,2/6,12.92%,TMEM107;NPHP4
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.35451022571125246,-0.6882719544652112,0.8888888888888888,1.0,1.0,1/33,1.16%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.4299863799752253,0.6876477819589837,0.8571428571428571,1.0,1.0,1/5,22.08%,ATP2C1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.40953594626708373,0.6873012732443451,0.9038461538461539,1.0,1.0,4/9,30.51%,HDAC3;HDAC1;NOTCH1;HDAC4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.4479505158507049,-0.6871140941955621,0.9583333333333334,1.0,1.0,1/8,4.99%,RAB7B
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.35476966661764237,0.6867777723351198,0.9259259259259259,1.0,1.0,8/22,29.51%,PLA2G10;NR1H3;PNPLA8;PLBD1;LPCAT2;PLA2G4E;LPCAT3;PLA2G6
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3123606123019373,0.6867094351053633,0.9259259259259259,1.0,1.0,15/66,25.77%,ANGPT1;SEPTIN4;HDAC3;DCUN1D1;PAXIP1;TANK;PRICKLE1;NDFIP2;UBE2D1;BIRC3;GSK3A;RIPK2;COMMD1;SMAD7;SAE1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.35676165737213794,0.6866604128905391,0.9298245614035088,1.0,1.0,6/25,11.75%,TCIRG1;RELA;VEZF1;ITK;KLRG1;RAB23
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.4105284176885475,-0.6862491205361235,0.8181818181818182,1.0,1.0,2/6,20.03%,DHX30;MPV17L2
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.44544086400276484,-0.6861401931543644,0.7894736842105263,1.0,1.0,2/6,22.90%,FFAR4;METRNL
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.33204148932476385,0.6860516963037826,0.8947368421052632,1.0,1.0,3/35,12.37%,TFEB;ABCA1;AKTIP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.4041697938296092,-0.6858266849585415,0.8727272727272727,1.0,1.0,2/8,10.12%,ARHGAP12;DLL4
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.4252776290976707,0.6857163748793713,0.8,1.0,1.0,3/11,21.02%,DSP;KIT;JUP
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.364895944591086,0.685598790465211,0.8852459016393442,1.0,1.0,2/19,3.77%,AMPD1;AK3
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.4145932164260055,-0.6854974693997543,0.8333333333333334,1.0,1.0,2/8,25.78%,ATP6V0A2;ATP6AP1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.42440713118225065,0.6851862886596976,0.8947368421052632,1.0,1.0,1/7,18.20%,UBR5
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.4465702596238459,-0.6850399917167819,0.8085106382978723,1.0,1.0,1/8,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.47705963124984174,-0.6848465552919493,0.8648648648648649,1.0,1.0,3/5,22.73%,SLC6A20;SLC25A29;PDZK1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.3514440249267008,-0.68450838071144,0.8979591836734694,1.0,1.0,1/36,1.72%,IFT27
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.4264994294841805,0.6842806084584703,0.8775510204081632,1.0,1.0,1/5,13.62%,FAH
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.4264994294841805,0.6842806084584703,0.8775510204081632,1.0,1.0,1/5,13.62%,FAH
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.41662410664176913,0.6841807925565685,0.8727272727272727,1.0,1.0,1/7,4.17%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.41662410664176913,0.6841807925565685,0.8727272727272727,1.0,1.0,1/7,4.17%,ZEB2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.31219172116879473,0.6840098834784544,0.9814814814814815,1.0,1.0,14/50,19.26%,SLC16A5;SLC26A6;SLC10A3;ABCC2;SLC10A5;NCOA2;SLC10A1;NR1H4;ABCC11;AKR1C1;SLC16A13;SLCO1A2;SLC16A6;ATP8B1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.43004087566163585,0.6838536864736734,0.8571428571428571,1.0,1.0,6/10,34.20%,DGKZ;DGKD;DGKK;DGKE;DGKI;DGKH
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.4257371848019257,0.6835226116219829,0.8837209302325582,1.0,1.0,2/11,10.55%,ABCA1;LIPG
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.40152967490023406,0.683435939590294,0.9444444444444444,1.0,1.0,4/8,15.46%,CD40;BTLA;LYN;KIT
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.32741865271578496,0.683266147223079,0.9310344827586207,1.0,1.0,12/37,31.48%,RALA;LMNB1;PLCB1;HNRNPA2B1;AIP;HNRNPF;JAK2;PAK2;PDCD4;IL12RB2;GSTO1;IL12A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3504888850835158,0.6830351425580521,0.9166666666666666,1.0,1.0,9/22,25.18%,TLR2;HMGB1;NR1H3;MFHAS1;TLR5;F2RL1;LBP;NINJ1;TLR1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2677144294903937,-0.6828971210273599,1.0,1.0,1.0,20/202,13.65%,TEKT3;CFAP61;CNGB1;ABCC4;DNAAF1;TEKT5;TTC8;TMEM107;CYS1;PLK4;TXNDC15;ATP6V1D;RAB8A;UBXN10;EXOC3;CFAP221;CFAP410;B9D1;DCDC2;CFAP52
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4557504279528311,0.6827567730163451,0.8627450980392157,1.0,1.0,5/9,24.16%,FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.441510917641851,-0.6824975923213887,0.8723404255319149,1.0,1.0,1/5,14.84%,ABCB4
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3007730799035302,-0.6821932422373685,0.9459459459459459,1.0,1.0,1/61,1.42%,CTSO
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3285663645109157,0.6821103852151457,0.8947368421052632,1.0,1.0,5/46,13.58%,MYC;CYBRD1;HJV;TF;SMAD4
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.2896722147326491,-0.6819163578239134,0.975,1.0,1.0,5/60,7.73%,BST1;SFRP1;LDB1;PLEKHA2;PLET1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.41133405843619275,0.6815903401753757,0.8727272727272727,1.0,1.0,1/7,16.37%,MVB12A
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.3492205874590551,0.6815049379350159,0.9272727272727272,1.0,1.0,14/34,36.64%,GRM5;CASS4;GPRC5B;DLG3;GAS6;EFNA1;EPHA4;ACE;ERBB3;CSF1R;PRNP;LRP8;ADRA2A;RELN
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.29415429746307503,0.6814626484950197,0.9807692307692307,1.0,1.0,11/90,16.53%,NDE1;CEP70;CEP152;PCM1;RAB3IP;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.37662253069244656,0.6814121937478625,0.8620689655172413,1.0,1.0,1/19,3.00%,CCL5
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.41551604961096866,-0.6813959442398566,0.8292682926829268,1.0,1.0,2/15,5.22%,DNAH17;DNAAF1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.3081629172745961,-0.6813750480251434,1.0,1.0,1.0,3/41,8.54%,PRKCD;SPRY4;UCHL1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.3734966510336768,-0.6809110155960121,0.8571428571428571,1.0,1.0,1/13,1.71%,ENTPD2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.26751760120989776,-0.6808653123838261,0.9772727272727273,1.0,1.0,4/99,3.48%,PEAK3;BST1;PRKCD;RAC2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3437971853003955,-0.6807544524685423,0.9347826086956522,1.0,1.0,1/23,3.48%,RAC2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.37661404514976443,-0.6806528511780997,0.95,1.0,1.0,1/23,0.40%,MYH7
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.39740731253926503,-0.6804294994496806,0.8181818181818182,1.0,1.0,4/11,14.49%,KCNE1;KCNQ1;KCNJ5;ATP1B1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.3979020835295149,0.6796964281407523,0.896551724137931,1.0,1.0,4/11,25.12%,ATP1A2;ATP12A;ATP1B2;KCNJ2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.3105324524908839,0.6796322186953145,0.95,1.0,1.0,5/55,13.68%,STING1;AUP1;UBA5;RETREG1;DYNC1I2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.33470510272431203,-0.6795501788124266,0.9444444444444444,1.0,1.0,3/40,4.98%,ACTC1;SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.4753263035729929,-0.6794705684591444,0.8333333333333334,1.0,1.0,1/6,1.47%,CGA
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3908243522920077,-0.6793038151753433,0.8541666666666666,1.0,1.0,3/16,14.25%,DNAAF1;CCDC40;SPA17
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3631744387110064,0.679174305970916,0.8846153846153846,1.0,1.0,2/19,13.47%,RAP1GDS1;PML
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.35224712525838703,0.6788925180273874,0.847457627118644,1.0,1.0,6/16,24.68%,NAIF1;SLC25A31;PPIF;THEM4;BAD;HEBP2
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.4182141364235475,0.6788366941743169,0.851063829787234,1.0,1.0,2/9,10.67%,MUC13;CRACD
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.3641301519365649,-0.6787263930657423,0.868421052631579,1.0,1.0,2/13,8.30%,CAV1;FLOT1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.42730065096881287,0.6785313429590738,0.8947368421052632,1.0,1.0,1/6,5.91%,ALDH7A1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.32513680252420224,-0.6783717178253252,0.8666666666666667,1.0,1.0,2/16,8.30%,CAV1;FLOT1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.34268383710297534,-0.6783435990205159,0.9761904761904762,1.0,1.0,1/18,3.48%,RAC2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.42500677008781773,-0.678331816526089,0.7555555555555555,1.0,1.0,6/6,57.51%,MSH3;TCF7L2;MSH2;MSH6;RMI2;AXIN2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.3177202314419736,-0.6781198886121955,0.9148936170212766,1.0,1.0,9/38,19.17%,PER2;GOT2;ENO2;GAPDHS;G6PC3;PFKFB1;SORD;RBP4;ALDOB
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.3951932880519317,-0.6780501445833159,0.7575757575757576,1.0,1.0,1/11,5.64%,LGI4
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.32165591907468805,0.6779021015433705,0.9090909090909091,1.0,1.0,4/21,20.00%,RPP40;RRS1;URB1;ERI1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.3389842756391171,0.677797767403713,0.875,1.0,1.0,8/26,33.64%,EXOSC4;TENT4B;ERI1;NCBP1;LSM11;TUT4;SNRPG;DCP2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.4272254118977937,-0.6777468522109773,0.875,1.0,1.0,1/5,12.73%,CTPS1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.46222553188415294,0.6775763005148948,0.8490566037735849,1.0,1.0,2/5,40.26%,TDG;FTO
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.33257601958594274,-0.6775653065931765,0.875,1.0,1.0,3/17,9.08%,FLOT1;BMP6;ADAM19
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3393787325383802,-0.6765828333905324,0.9574468085106383,1.0,1.0,9/24,24.91%,RRM2;B3GNT5;RRM1;ALG8;ALG11;G6PD;GK5;GCNT1;ST8SIA6
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.26741755318115396,-0.6760895501457033,1.0,1.0,1.0,35/154,27.40%,SENP3;ERN2;LAS1L;PDCD11;UTP11;DEDD2;RPL38;RPL12;EBNA1BP2;MRTO4;EMG1;UTP15;RPL37A;RPS27;RPL4;DDX49;RPL5;RPL22;WDR55;MAPT;UTP14A;EXOSC10;SBDS;RPL34;RPL37;RPL31;RPL7A;RRP12;FCF1;RPL35A;RPS25;BMS1;SNU13;WDR12;DHX37
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.47301648104142996,0.6760546091327281,0.86,1.0,1.0,1/5,13.58%,SMAD4
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.43102121773397223,-0.6757600390646278,0.9047619047619048,1.0,1.0,4/6,17.80%,SLC14A2;SLC14A1;UPK3A;AQP1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.29522281562461083,0.6756303558820881,1.0,1.0,1.0,3/89,4.96%,SWSAP1;SEM1;RFWD3
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.4598190611252565,0.6755282600017953,0.8163265306122449,1.0,1.0,3/5,25.23%,AKR1C1;AKR1C3;CYP17A1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.3839548815779734,0.6748832385862904,0.8064516129032258,1.0,1.0,3/10,19.18%,ODC1;SAT1;SMS
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.37108772879662943,0.6746920739652033,0.9423076923076923,1.0,1.0,3/16,10.33%,PCSK5;PDGFRA;DSCAML1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.39441114421272727,0.6744784594836712,0.8431372549019608,1.0,1.0,3/10,27.46%,WASHC2A;MICALL1;WASHC2C
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.3226957562515365,0.6742251471136668,0.9310344827586207,1.0,1.0,8/33,22.05%,TBL2;FOXO3;NIM1K;MTMR3;PRKAA1;KPTN;HSPA5;TP53
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.27714081972574306,0.6740210198310455,1.0,1.0,1.0,15/122,11.07%,LRP4;EDIL3;ASIC1;TENM3;CBS;ARHGEF17;BGN;ADGRL2;LIFR;PRICKLE2;ANK2;MAGI1;GUCY1A2;GFRA1;EDNRA
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.46594998716376457,0.6739661790430596,0.8305084745762712,1.0,1.0,2/5,26.05%,SLC5A5;NOTCH1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.416297913229136,-0.6733784606627098,0.8108108108108109,1.0,1.0,4/8,27.93%,EIF5A;MSX1;PRKN;UBB
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.442846373468163,0.6731287118287058,0.875,1.0,1.0,3/10,17.72%,SIX4;VEGFA;BMP4
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.3895065658586865,-0.6730978746292783,0.8888888888888888,1.0,1.0,1/9,6.93%,MLYCD
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.4078167426908434,-0.6728612494557696,0.8043478260869565,1.0,1.0,1/7,9.71%,DHX58
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.31263463370027644,0.6728038107879513,0.9285714285714286,1.0,1.0,5/47,14.00%,SHMT2;IDH1;MTHFD2L;MTHFD2;SLC19A1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.3165686927058997,0.6723822481167444,0.9344262295081968,1.0,1.0,8/67,16.98%,SYK;IL10RA;RALA;NXT1;RANBP17;PRICKLE1;RYR2;TSPAN17
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.3502318523543994,0.6721309706388048,0.9444444444444444,1.0,1.0,1/26,1.20%,KASH5
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.4444410587882286,0.6718482488300366,0.8490566037735849,1.0,1.0,2/6,20.72%,GABRB2;GABRB1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.35854303616088185,-0.6710220657547247,0.8837209302325582,1.0,1.0,2/20,7.12%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.4175223212362688,-0.6710127136983981,0.8409090909090909,1.0,1.0,1/6,5.18%,BTK
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3789564315744045,0.6707262753120943,0.8947368421052632,1.0,1.0,2/12,15.08%,ALG6;ALG9
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3396420361969614,-0.669558238959487,0.9534883720930233,1.0,1.0,4/22,20.63%,RPF2;DHX30;BRIX1;RPL5
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.30940249682433213,-0.6690957658020613,0.9148936170212766,1.0,1.0,9/46,19.05%,PIAS3;PER2;CAV1;CAMLG;USP4;UFL1;CHP1;GTPBP4;SH3RF2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.33182707739905815,-0.6688591438217262,0.9230769230769231,1.0,1.0,3/21,14.72%,BIK;PDCD5;MMP9
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.3530300648789879,-0.668717154577586,0.9047619047619048,1.0,1.0,3/22,5.82%,CTNNA1;BOC;RBM4
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.46964955778979034,0.6686759990020101,0.9215686274509803,1.0,1.0,1/5,7.89%,PLCG2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.3653448905227696,0.6686199563870772,0.9245283018867925,1.0,1.0,2/16,5.36%,CFH;CD59
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.36838506202303833,0.6685820865035303,0.9104477611940298,1.0,1.0,4/15,19.50%,PCSK5;NR1H3;ANGPTL4;HDAC9
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.38911007840182693,0.6685473305101365,0.9245283018867925,1.0,1.0,6/13,41.94%,TMEM33;RAB10;REEP3;ATL2;REEP1;REEP4
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.3936736137344641,-0.6681420202082086,0.8809523809523809,1.0,1.0,1/7,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.3936736137344641,-0.6681420202082086,0.8809523809523809,1.0,1.0,1/7,3.82%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.40300619197411686,-0.6680286161656517,0.782608695652174,1.0,1.0,1/5,15.39%,VDAC1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24469872446779953,-0.6677444699784786,1.0,1.0,1.0,44/234,19.26%,SNRNP27;DDX41;PRPF4;RBM4;ZCRB1;WBP4;RNF113A;DHX8;GTF2F1;RBM4B;PRPF19;SNIP1;RBMX2;RNPC3;SNRPA1;FIP1L1;CPSF4;SNRNP200;CWC25;CPSF3;ESS2;SF3A3;SUGP1;DHX38;MAGOHB;SYF2;DNAJC8;SRSF10;CWF19L1;SNW1;MFAP1;CSTF2;CRNKL1;HNRNPL;PRPF6;SF3A1;ALYREF;RBM22;SRSF7;CACTIN;SNRPD2;DHX35;PDCD7;WBP11
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.4431721470019342,-0.6665129535298762,0.875,1.0,1.0,5/5,55.70%,PRKN;UBE2D4;ITCH;UBE2T;UBE2S
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.28756834176908974,0.6662935560293528,1.0,1.0,1.0,8/84,13.86%,AP1M2;CTSF;MARCHF1;CD74;DCTN3;RACGAP1;DYNC1I2;KLC2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.3950017837688465,-0.6662322086211939,0.8571428571428571,1.0,1.0,1/10,6.59%,LAMB3
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3649967580579006,0.6662141812749938,0.8983050847457628,1.0,1.0,7/13,35.53%,GRIK2;PPFIA3;SHISA8;SLC4A10;SHISA9;SYP;SYNGR1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.3251949922979131,0.6660783683108188,0.9365079365079365,1.0,1.0,7/39,20.17%,NLGN1;TENM1;RALA;GPM6A;TRPM2;WASL;FMR1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.4451962313705712,0.6656258927162095,0.9090909090909091,1.0,1.0,2/5,22.93%,HSD17B10;PNPT1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.41992405371759295,-0.6655384676381111,0.8444444444444444,1.0,1.0,2/6,25.70%,SKP1;CAND2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.4124835321565343,0.6655310297132881,0.9,1.0,1.0,3/7,45.16%,SASH1;DDX3X;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.33326987427156146,-0.6655288836237435,0.9791666666666666,1.0,1.0,5/23,16.12%,PRKCD;PTPA;ANKLE2;TGFB1;CALM1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.3658950210738715,-0.665043059294166,0.9523809523809523,1.0,1.0,7/17,21.46%,MBTPS2;SPPL2B;APH1B;TGFB1;MBTPS1;ADAM9;APH1A
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.40221908020712516,-0.6650010594878529,0.8378378378378378,1.0,1.0,1/5,19.75%,RNF20
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28886299231056684,0.6648898014366501,1.0,1.0,1.0,11/72,16.12%,PYHIN1;DNAJB2;CBFA2T3;RNF217;KEAP1;RNF139;BAG2;ARIH1;PTEN;PRICKLE1;NKD2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.29953357844085216,0.6647167099789417,0.9811320754716981,1.0,1.0,13/60,21.74%,PPARG;ZBTB20;TLCD3B;SLC4A1;SLC4A7;NR1D2;NR1H3;ABHD8;TENT4B;PNPLA8;IRS2;WNK1;ACOX1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.4048958281089336,0.6644934272583187,0.8548387096774194,1.0,1.0,3/10,25.47%,MYOM1;PRKACB;GAL
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.31206500446123275,0.6642430370615715,0.9814814814814815,1.0,1.0,6/54,15.04%,SIRT1;ODC1;PSMD13;NR1H4;PSMA1;PSME4
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.419033433091177,0.6641256836221349,0.8852459016393442,1.0,1.0,2/8,10.72%,BMP2;BIN1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.3906961017545557,0.663811056663756,0.9245283018867925,1.0,1.0,1/9,3.21%,PTGFR
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.28316356277980637,-0.6637536961937703,1.0,1.0,1.0,5/69,8.13%,KDM4D;ABRAXAS1;RNF8;TICRR;EYA1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.3340818710330768,0.6636112501995244,0.9090909090909091,1.0,1.0,5/25,18.76%,RHOD;CARMIL1;KIT;ARHGEF6;ARHGEF4
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.3694081280209609,-0.6635631971957261,0.8780487804878049,1.0,1.0,4/15,11.73%,SFRP1;FAM3D;KCNJ11;CCN3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.41008235193555354,-0.6634047126049268,0.8947368421052632,1.0,1.0,1/9,4.03%,CBARP
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.3961462236849973,-0.6631999060587599,0.8292682926829268,1.0,1.0,6/13,20.24%,TMIE;PAX2;USH1C;FGFR2;TWIST1;PAX8
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.34600559874397663,0.6630496780938374,0.8846153846153846,1.0,1.0,5/33,12.78%,SEMA5A;FGF2;DSCAM;F3;HSPB1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.3993632981344435,-0.6629977764981844,0.8333333333333334,1.0,1.0,2/9,15.98%,KCNJ11;CACNA1H
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.3343754202308787,-0.6626847784289116,0.9019607843137255,1.0,1.0,5/27,14.00%,TTC8;TMEM107;TBC1D32;CSNK1D;DCTN1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2788633956756687,0.6621406946405779,0.9841269841269841,1.0,1.0,16/79,24.83%,PRDX6;TRA2A;NOVA1;KHDRBS2;NSRP1;PUF60;QKI;KHDRBS3;RBM5;FMR1;RBFOX1;SFSWAP;NCBP1;MBNL2;SRSF3;HNRNPU
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4375401741524075,0.6621096160367771,0.8679245283018868,1.0,1.0,1/6,7.89%,PLCG2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.36314614768423104,0.662069420643905,0.9259259259259259,1.0,1.0,2/15,10.64%,CYB5R4;RIMS2
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.36542209913563195,0.6617740508889154,0.9166666666666666,1.0,1.0,5/16,18.32%,ALG6;NUS1;MVD;ALG9;DOLK
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.2896035458677411,-0.6617454893151163,0.9787234042553191,1.0,1.0,6/91,11.16%,STX16;M6PR;ARF1;CLTA;CAV2;ICA1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.30792243716301665,0.6617316053189959,0.9310344827586207,1.0,1.0,8/42,18.48%,BRINP3;ZFP36L2;WEE2;SCRIB;HECA;BMP4;GAS1;CTNNB1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.25795833556248554,-0.6614841800340658,1.0,1.0,1.0,44/283,16.06%,TEKT3;IFT27;CNGB1;HAUS7;ABCC4;DNAAF1;TEKT5;TTC8;RSPH9;TMEM107;TBC1D32;CYS1;PLK4;TXNDC15;ATP6V1D;KIF17;CCDC40;RAB8A;TUBG1;UBXN10;TUBB;CFAP74;EXOC3;CFAP46;CFAP221;NPHP4;HAUS1;CFAP410;RSPH1;B9D1;DCDC2;HAUS8;TUBB4A;CSNK1D;CFAP52;DCTN1;DCTN2;DYNLRB1;AHI1;RSPH4A;TRAF3IP1;SPATA6;RAB11A;CNGA4
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.36775915325989783,-0.6614230652768971,0.7777777777777778,1.0,1.0,2/12,10.15%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.3602797796292019,0.661259292122197,0.90625,1.0,1.0,6/14,21.74%,PTGS1;HPGDS;AKR1C1;CYP2S1;AKR1C3;ACOX1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.37318415242769815,0.66104095050209,0.9607843137254902,1.0,1.0,1/14,4.81%,AGR2
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.4020439083520643,0.6610202370028287,0.90625,1.0,1.0,4/10,29.15%,NLRP7;GAS1;CHAC1;ACP4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3367401836733176,0.6607095953631864,0.9107142857142857,1.0,1.0,4/26,10.58%,FGF2;CHD7;SPEF2;PROX1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3040268289469995,-0.6606020409340553,0.926829268292683,1.0,1.0,2/40,5.14%,ABRAXAS1;GOLGA2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.360224355566565,0.6601290688297785,0.8615384615384616,1.0,1.0,4/14,22.12%,KPTN;RNF128;CD81;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.34634843305428603,-0.6598481350966919,0.95,1.0,1.0,4/18,13.57%,SH3BP4;GMIP;F11R;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3239438364314035,0.6596841556686791,1.0,1.0,1.0,3/30,14.46%,PLCG2;EZH2;PTEN
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.41995453693828383,-0.6593521737957306,0.8863636363636364,1.0,1.0,1/7,2.65%,ASS1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.38124081971058227,0.6590701293447064,0.9016393442622951,1.0,1.0,4/11,23.06%,SMYD2;SETD7;METTL18;SETD2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.3953667230379012,0.6588477485480246,0.8727272727272727,1.0,1.0,2/9,9.42%,GCH1;SNCA
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.3323748265314459,-0.6585214174873799,0.8863636363636364,1.0,1.0,1/31,0.84%,ACOT1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.3564775956283942,-0.6585136849605149,0.8837209302325582,1.0,1.0,2/11,12.06%,TST;NOX4
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.345600181328574,0.6584327842591062,0.8913043478260869,1.0,1.0,4/16,23.32%,HNRNPD;MAPK15;NEK7;MAPK3
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.41089692852032184,-0.6580656550869544,0.8947368421052632,1.0,1.0,1/6,4.23%,DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.41089692852032184,-0.6580656550869544,0.8947368421052632,1.0,1.0,1/6,4.23%,DHDDS
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.4460698405118029,-0.6577127886235211,0.8571428571428571,1.0,1.0,2/6,13.57%,RAB7B;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.3939109311407143,-0.657623466387063,0.8958333333333334,1.0,1.0,2/9,14.84%,APOA1;ABCB4
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.2938270475227272,-0.6576097805338305,0.975,1.0,1.0,2/41,4.04%,CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.32001472318520624,-0.6576026183362242,0.9375,1.0,1.0,6/33,19.60%,DHX58;TRAF3IP1;PTPRS;HAVCR2;CACTIN;NLRX1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.3769299466391983,0.6575295064397233,0.8958333333333334,1.0,1.0,2/15,11.81%,KANK1;GSN
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3435228461779375,0.6574650992057044,0.8867924528301887,1.0,1.0,5/17,31.56%,PROX1;CCND3;EGFR;PKD1;PKD2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.3753863992473085,-0.6573141652370886,0.9148936170212766,1.0,1.0,1/12,4.74%,SCPEP1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.40478130542097845,-0.6572710496637624,0.8461538461538461,1.0,1.0,4/9,13.04%,PRKCD;CEACAM1;SERPINE2;CD9
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3884280750627168,0.6569997099381096,0.8596491228070176,1.0,1.0,1/11,3.52%,PYHIN1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.38409964578696193,0.6569874121943492,0.9024390243902439,1.0,1.0,6/12,19.17%,BMP2;HDAC2;LRP6;ROGDI;EDA;HDAC1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.2927852691002583,0.6568255945451255,1.0,1.0,1.0,17/72,20.20%,EGLN3;CCL5;DCC;HTRA2;SNCA;EFNB2;MEF2C;GRM4;PICALM;CSF1;RAB29;BTBD10;NENF;CD34;GRID2;RRAS2;ITGAM
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.3859154237359708,-0.6567173573040455,0.84,1.0,1.0,1/11,8.52%,VIT
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.32643939610362804,-0.6565037358152404,0.96,1.0,1.0,6/19,17.40%,GOLGA2;TUBGCP2;TUBG1;CSNK1D;NDEL1;TUBGCP5
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.4584055341864382,-0.6562568222736775,0.8780487804878049,1.0,1.0,2/7,8.04%,DRD4;NPAS4
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.4411342609542415,-0.6559630304228109,0.8461538461538461,1.0,1.0,2/7,15.87%,LETM1;CLDN16
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.3955153099084446,-0.6556945960555455,0.7619047619047619,1.0,1.0,1/5,12.78%,APOA1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4242664299612152,-0.6552068409169577,0.8181818181818182,1.0,1.0,3/5,26.12%,APH1B;APH1A;NCSTN
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.4181136325390832,-0.6549905165047419,0.8636363636363636,1.0,1.0,3/8,23.65%,NOD1;VIM;LDOC1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.44601404214724477,0.65435797511269,0.9032258064516129,1.0,1.0,3/6,27.79%,ABCA1;ABCA7;APOE
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.38001232660017414,0.6542612751255736,0.8301886792452831,1.0,1.0,5/13,17.72%,TGFBR1;BMPR1A;SMAD4;KIAA0319;BMP4
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.3927239290010063,-0.6542426527543791,0.8048780487804879,1.0,1.0,1/9,9.09%,ERI2
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.4442110573772748,0.6542065171697494,0.9454545454545454,1.0,1.0,1/7,15.12%,GTF3C4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.3483659645552728,-0.6537113819146642,0.9459459459459459,1.0,1.0,1/8,10.28%,PARP1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.4380806537593948,0.6536124164464026,0.8888888888888888,1.0,1.0,1/6,4.90%,FHIT
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.4247036654448655,-0.6534859035444716,0.7555555555555555,1.0,1.0,2/5,21.45%,CYBA;GRN
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.4183458643061989,0.653340932094207,0.9137931034482759,1.0,1.0,1/11,3.41%,SLC26A6
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.4151663445380526,0.6529470373471441,0.9074074074074074,1.0,1.0,1/7,3.54%,KAT2B
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.41161141907946047,-0.6528802281299213,0.9090909090909091,1.0,1.0,4/7,29.32%,APH1B;APH1A;NCSTN;ADAM17
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3749801099530369,-0.6526033255805004,0.925,1.0,1.0,1/12,3.94%,ARPC5L
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2353288412346729,-0.6525685020541664,1.0,1.0,1.0,46/277,18.57%,SNRNP27;DDX41;CMTR1;PRPF4;RBM4;ZCRB1;WBP4;RNF113A;DHX8;GTF2F1;RBM4B;PRPF19;SNIP1;RBMX2;GTF2H2;RNPC3;SNRPA1;FIP1L1;CPSF4;SNRNP200;CWC25;CPSF3;ESS2;SF3A3;SUGP1;KIN;DHX38;MAGOHB;SYF2;DNAJC8;SRSF10;CWF19L1;SNW1;MFAP1;CSTF2;CRNKL1;HNRNPL;PRPF6;SF3A1;ALYREF;AKAP8L;RBM22;SRSF7;CACTIN;SNRPD2;DHX35
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.29287540373649423,-0.6525464284841528,0.9545454545454546,1.0,1.0,4/42,13.41%,ATG14;RBM3;RBM4B;ZNF385A
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.32147147838847584,-0.6522266977543186,0.9777777777777777,1.0,1.0,5/32,15.15%,SPAAR;GPRC6A;SH3BP4;GLRA3;MEAK7
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.38213048716665043,0.6519956948049396,0.9038461538461539,1.0,1.0,1/10,6.45%,GMNN
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3650000817978929,-0.651848269692096,0.8974358974358975,1.0,1.0,3/16,9.74%,RHBDF1;WDR54;CEACAM1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3475553807208693,-0.6516596818996219,0.9111111111111111,1.0,1.0,3/29,9.74%,TESPA1;PRKD2;CEACAM1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.39310552842010593,0.6515743227726188,0.875,1.0,1.0,2/10,17.37%,GAL3ST1;DGKZ
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.36058498723763965,0.6513248582208306,0.896551724137931,1.0,1.0,1/10,6.92%,SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.40338787406256027,-0.6512468843920591,0.925,1.0,1.0,1/9,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.40338787406256027,-0.6512468843920591,0.925,1.0,1.0,1/9,1.97%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4241392649903288,-0.6505779524376892,0.8636363636363636,1.0,1.0,5/5,57.60%,PPIA;GPS2;PLAA;PARP10;TRIM44
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.311630005650103,0.6504002764934607,0.967741935483871,1.0,1.0,2/36,5.51%,NDE1;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.387880189109732,-0.6503616780743732,0.8297872340425532,1.0,1.0,2/10,5.21%,SCPEP1;DRD2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.33775776053785017,0.6497330760788872,0.9655172413793104,1.0,1.0,6/29,21.79%,CHCHD4;SDF2L1;HSPA8;DNAJB1;HSPA1A;HSPA5
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.4146135188232755,0.6495927554212372,0.8666666666666667,1.0,1.0,3/5,22.99%,BMPR1A;BMPR2;HEY2
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.4052297093714766,-0.6494362760699667,0.9047619047619048,1.0,1.0,4/8,13.38%,SLC25A45;SLC22A1;SLC6A20;SLC25A29
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.43786778879798016,-0.6487253584962447,0.851063829787234,1.0,1.0,1/5,11.88%,PODXL
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.31669974850435356,-0.6480426710636508,0.9056603773584906,1.0,1.0,6/30,17.11%,SLX4;ERCC1;RTEL1;RAD50;GNL3;PNKP
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.3721846361266923,0.647831738341903,0.8870967741935484,1.0,1.0,1/12,5.48%,RAB39A
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),-0.40161044399822576,-0.6476423813598736,0.8301886792452831,1.0,1.0,1/6,8.26%,PAX2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4007688585448256,-0.6473763567353437,0.875,1.0,1.0,1/8,9.16%,NRDE2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.46708096445415936,-0.647123878670058,0.9090909090909091,1.0,1.0,1/6,7.70%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.46708096445415936,-0.647123878670058,0.9090909090909091,1.0,1.0,1/6,7.70%,DPH6
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.33257887135179287,-0.6468471879734004,0.9545454545454546,1.0,1.0,3/25,8.96%,TERF2IP;ERCC1;RTEL1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.40502140205799525,-0.6467955924355486,0.8431372549019608,1.0,1.0,2/9,14.64%,CAV1;PROM2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.281944219037939,-0.6467825073080711,0.975,1.0,1.0,5/64,14.16%,TBC1D10C;CAV1;PODXL;DCDC2;RAC1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.42160204125873924,0.646522588752836,0.8888888888888888,1.0,1.0,3/7,29.57%,CREB3L3;PTGER3;PTGS2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.28040759567292856,0.646340757533866,0.9814814814814815,1.0,1.0,6/75,9.77%,BOK;MLC1;RAB27A;TULP1;SNCA;IL15
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.2798337900878608,0.6461243895986075,0.9807692307692307,1.0,1.0,15/68,23.54%,VAPB;TLCD3B;ELOVL5;PPM1L;SGPL1;CERS5;ABCA8;ELOVL4;PLPP1;SAMD8;ST8SIA1;ALDH3B1;ELOVL6;CERS3;A4GALT
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.34758368675220225,0.6460229104523514,0.95,1.0,1.0,2/18,13.58%,ZEB2;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.34758368675220225,0.6460229104523514,0.95,1.0,1.0,2/18,13.58%,ZEB2;SMAD4
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.3289354767609971,0.6457165859213366,0.9411764705882353,1.0,1.0,7/23,29.18%,PLA2G10;PLSCR1;MBOAT1;SLC27A1;PLA2G15;PLA2G4E;LPCAT3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.44428767866708985,0.645535405629097,0.9272727272727272,1.0,1.0,1/6,15.12%,GTF3C4
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.290207406986891,-0.6454035561103033,1.0,1.0,1.0,8/35,26.90%,POM121C;TOMM20;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3181890527951462,-0.6453465357095051,0.9777777777777777,1.0,1.0,5/24,13.81%,SPI1;DAXX;DEDD2;DAB2IP;DELE1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.29412615518033386,-0.6452735489504817,0.9777777777777777,1.0,1.0,11/61,14.16%,SFRP1;FBLN2;PLEKHA2;OLFM4;TRIOBP;VIT;MYADM;APOA1;PTK2B;RREB1;RAC1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.29092682348632215,-0.6451356447537818,1.0,1.0,1.0,4/49,6.59%,CRABP2;HLA-DRB1;RBP2;LAMB3
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.3337349694812351,-0.6451283564814085,0.9038461538461539,1.0,1.0,3/18,10.59%,ASS1;GOT2;ASPG
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.40318185824796504,0.6449774792595927,0.8333333333333334,1.0,1.0,4/8,34.70%,SNAPC1;ICE2;SNAPC3;ZC3H8
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.395688156718938,0.6449442967513868,0.8367346938775511,1.0,1.0,2/8,17.72%,MEGF10;BMP4
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.38027059157861237,-0.6445628027177044,0.8541666666666666,1.0,1.0,1/6,9.80%,TXN
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3977340391685589,-0.644539275562407,0.8979591836734694,1.0,1.0,1/7,11.10%,SPI1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3359630171507075,0.6444453836037348,0.8846153846153846,1.0,1.0,6/24,22.93%,PAPOLA;PCF11;TENT4B;CSTF3;WDR33;PNPT1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3359630171507075,0.6444453836037348,0.8846153846153846,1.0,1.0,6/24,22.93%,PAPOLA;PCF11;TENT4B;CSTF3;WDR33;PNPT1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.34825814901214736,-0.6443008512864966,0.926829268292683,1.0,1.0,2/18,8.04%,DRD2;NPAS4
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.3459820802341215,0.6440189283657504,0.9387755102040817,1.0,1.0,2/17,8.54%,RUNX1;LIFR
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.3271491994911016,0.6438969129093793,0.9047619047619048,1.0,1.0,6/25,24.32%,PDGFRA;ZSWIM5;EFNB2;F2RL1;STX3;ZSWIM8
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.40129896936208054,0.6436807918733904,0.9333333333333333,1.0,1.0,1/10,3.32%,PADI2
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.39074949941227244,-0.643343472119486,0.8095238095238095,1.0,1.0,1/10,8.26%,PAX2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.35125181467124816,0.642314739952627,0.8909090909090909,1.0,1.0,5/11,29.00%,CD74;AXL;GAS6;DHX9;IFIH1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.2848011552710729,0.6423044687180489,1.0,1.0,1.0,10/67,18.23%,CDC14A;KLHL21;DRD3;ZFYVE19;RACGAP1;CCP110;CXCR5;PKN2;KLHL13;PKP4
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.44129173555570084,0.6421536009190882,0.92,1.0,1.0,2/6,9.77%,CCL5;IL15
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.23683860701362336,-0.6417679851619051,1.0,1.0,1.0,35/283,20.24%,TERT;INHA;WARS1;RECQL5;TICRR;ORC6;SARS1;RFC3;EXO1;CDC6;RFC2;RPL38;PTMA;RPL12;KIN;MRPL23;RPA3;MRPS21;RAD50;MCM2;ABCF1;RPS8;BRCA1;MRPS18C;RPL37A;E2F1;RPS27;RPL4;CDC7;POLR3A;MCM3;POLL;MRPL9;CDK1;PAX8
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3451764037442648,0.6416429357851563,0.9795918367346939,1.0,1.0,2/21,15.75%,TENM1;POLR3G
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.3828521923071466,-0.6416323806840657,0.9230769230769231,1.0,1.0,1/7,12.78%,APOA1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.2659527667337489,-0.6409656801376987,1.0,1.0,1.0,3/83,4.99%,STX16;TBC1D10C;RAB7B
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.377900152754911,0.6409325169424156,0.9107142857142857,1.0,1.0,1/15,4.32%,WNT4
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.3937974472249199,0.6407771739642957,0.9361702127659575,1.0,1.0,3/11,13.56%,MID2;PML;TRIM26
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.3884297583872303,0.6407614505096465,0.8703703703703703,1.0,1.0,1/8,11.90%,GRAMD2A
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.3210990053099948,-0.6407367174898613,0.8974358974358975,1.0,1.0,5/38,12.77%,APOBEC3H;OAS3;OAS1;APOBEC3G;MORC2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.39526584552570376,-0.6407164764243699,0.8717948717948718,1.0,1.0,1/8,9.09%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.39526584552570376,-0.6407164764243699,0.8717948717948718,1.0,1.0,1/8,9.09%,ERI2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.3817466425264455,-0.6402519946555576,0.8666666666666667,1.0,1.0,2/6,24.58%,HFE;TNFRSF14
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.36111236709026656,0.6400667184058372,0.9074074074074074,1.0,1.0,4/13,16.65%,NYNRIN;RPP40;ZC3H12C;SLFN14
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.3190552755317713,0.6398669283524054,1.0,1.0,1.0,1/24,3.61%,NEDD4
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.38869547135066307,0.6397307498734227,0.9230769230769231,1.0,1.0,3/8,24.63%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.38869547135066307,0.6397307498734227,0.9230769230769231,1.0,1.0,3/8,24.63%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.37994660620021814,-0.6394826572719731,0.9545454545454546,1.0,1.0,3/13,16.50%,MEAK7;SCTR;KCNB1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.269243630100976,-0.6392019076173796,1.0,1.0,1.0,4/56,7.55%,PRKCD;CAMK2A;PRKD2;TTBK1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.3692224343234336,0.6391412910730051,0.9230769230769231,1.0,1.0,8/14,38.40%,RNF26;ZMPSTE24;DHX9;ELMOD2;PCBP2;HERC5;RNF216;ILRUN
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.3667269961752099,0.6390733771304525,0.8333333333333334,1.0,1.0,3/12,13.58%,CHD7;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.4145447097147863,0.6390164187714793,0.9047619047619048,1.0,1.0,2/6,13.65%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2710796472605861,0.6386537184294921,0.9833333333333333,1.0,1.0,13/94,16.12%,FHIT;DNAJB2;RYBP;CBFA2T3;RNF217;KEAP1;UBQLN4;BAG2;ARIH1;XPO1;PRICKLE1;EIF3H;NKD2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.3123002499672638,0.6378236487426652,0.9818181818181818,1.0,1.0,11/26,25.23%,GCH1;FDFT1;PYCR1;PRLR;FDXR;STAR;GPHN;MOCOS;LIAS;CYP19A1;CYP17A1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.41409539832066766,0.6367360439140678,0.8823529411764706,1.0,1.0,2/5,17.81%,DNM3;MX2
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.41409539832066766,0.6367360439140678,0.8823529411764706,1.0,1.0,2/5,17.81%,DNM3;MX2
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.4120674412562277,-0.6364745162742131,0.9090909090909091,1.0,1.0,3/6,26.83%,CDHR2;SMO;PTPRJ
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.4070846803269341,-0.6364371321346567,0.8867924528301887,1.0,1.0,1/5,19.17%,ALDOB
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.301912045879402,-0.636304555202662,0.9777777777777777,1.0,1.0,5/33,11.67%,TST;ACAN;MLYCD;IDUA;DCN
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.37120435905810956,-0.6362576456562709,0.85,1.0,1.0,3/8,17.25%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.42357538009207324,-0.6358603012628317,0.8888888888888888,1.0,1.0,6/6,57.66%,SRC;BDNF;FYN;DOCK3;STAP1;NTRK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3477373418730646,-0.6358472218187565,0.8863636363636364,1.0,1.0,1/12,6.25%,CAV1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.3544633097882152,0.6354804650190193,0.8771929824561403,1.0,1.0,5/13,18.58%,NEDD4;PTPN14;BMP4;MX2;SIRT7
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.2940045952692798,-0.6353590048755632,1.0,1.0,1.0,4/52,6.34%,APOBEC3H;OAS3;TRIM5;OAS1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.34946540840622115,0.635261882006199,0.9444444444444444,1.0,1.0,1/15,4.75%,CDH2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.35760590829761674,0.6351489192621571,0.9629629629629629,1.0,1.0,2/12,10.12%,SIRT1;FOXH1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.32742778999309524,0.6350972012450152,0.9387755102040817,1.0,1.0,8/31,20.84%,CDC14A;DRD3;RACGAP1;CXCR5;PKN2;PKP4;CENPV;SHH
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.32071224845550417,0.6347952386187125,0.9649122807017544,1.0,1.0,12/32,29.91%,HES6;FOXO1;NOTCH2;CTNNB1;HDAC9;CX3CR1;HEY2;HES5;YTHDF2;SLAMF8;CLOCK;RPS19
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.3845684592660022,-0.6347628032852329,0.8936170212765957,1.0,1.0,2/10,16.36%,FOXM1;NEK6
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.35056564409069907,0.6344864373338331,0.8541666666666666,1.0,1.0,1/8,9.81%,ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.35056564409069907,0.6344864373338331,0.8541666666666666,1.0,1.0,1/8,9.81%,ALCAM
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.3182632469075603,-0.6342958007307024,0.95,1.0,1.0,3/23,11.10%,SCN5A;PTPN3;SCN3B
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.3285433031304447,-0.6342074368670408,0.972972972972973,1.0,1.0,3/18,8.30%,RFTN1;CAV1;FLOT1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.30096961463459243,-0.6333247761249863,0.9565217391304348,1.0,1.0,2/37,4.41%,KDM4D;ADIRF
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.2597294426217459,-0.6332744758379482,1.0,1.0,1.0,4/86,4.54%,CD24;PRKCD;ERN2;BCL2L2
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.40177769317628975,-0.6331598701565678,0.8297872340425532,1.0,1.0,2/5,15.25%,ZNF385A;MED1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.30082410535089443,0.6328902414099634,0.9836065573770492,1.0,1.0,2/24,13.66%,NLGN1;MEF2C
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3180209766777327,-0.6322180725584656,0.9210526315789473,1.0,1.0,4/16,15.02%,RNF8;KDM2B;RING1;SKP1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.3891024909615481,-0.6321892127762667,0.8909090909090909,1.0,1.0,1/8,4.23%,DHDDS
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),0.4353938807378258,0.6319496715598071,0.896551724137931,1.0,1.0,1/5,11.46%,PLAUR
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3172254287801798,0.631606982780607,0.9482758620689655,1.0,1.0,7/27,28.13%,BMI1;EZH2;EPC1;EED;H3-3A;RBBP4;PPM1D
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.30993891449591243,0.6312573069717532,0.9433962264150944,1.0,1.0,5/27,22.57%,SKA3;STMN4;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.34124757844219306,0.631192966419343,0.8983050847457628,1.0,1.0,6/17,29.10%,OASL;BIRC3;ANKRD17;PUM2;ZCCHC3;PUM1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.41496305432694636,0.6306290574023268,0.9454545454545454,1.0,1.0,3/7,21.79%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.2906809395265375,0.6303472557809751,1.0,1.0,1.0,13/56,21.56%,SIRT1;RELA;PDGFRA;FER;PTPRK;PXN;MAPK8;TRPM2;NFE2L2;AKR1C3;RHOB;PPIF;ABL1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.25365313587686017,-0.6302107956096167,1.0,1.0,1.0,21/102,19.66%,TTC23L;RASGRF2;ERN2;ERLEC1;MBTPS2;JUN;FLOT1;WFS1;DDRGK1;DAB2IP;SEC16A;CREB3L1;UFL1;DNAJC10;MBTPS1;ATG10;ALOX15;QRICH1;BRSK2;USP19;ANKS4B
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.30642518273128194,-0.6297373701692928,0.9791666666666666,1.0,1.0,2/28,6.42%,WNT7A;PTCH1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.400316770150488,0.6294859035820685,0.9074074074074074,1.0,1.0,1/8,15.12%,GTF3C4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.4159415158710505,0.6292527161389395,0.9019607843137255,1.0,1.0,3/6,25.18%,MFHAS1;F2RL1;TLR1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.30637300970905695,0.6290929264753327,0.9583333333333334,1.0,1.0,7/30,21.56%,SIRT1;RELA;TRPM2;NFE2L2;RHOB;PPIF;ABL1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.29123993067852905,-0.628802700235385,1.0,1.0,1.0,1/45,1.49%,KDM4D
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.35861736956191137,0.6284340216772675,0.9090909090909091,1.0,1.0,3/11,17.72%,PPARG;VEGFA;BMP4
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3060844256195679,0.6280647201032902,0.9827586206896551,1.0,1.0,6/44,13.23%,MYRF;GAL3ST1;MARVELD1;ACSBG1;ADGRG6;ABCD2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.31829255150155916,0.6280242742342814,0.9661016949152542,1.0,1.0,5/32,17.21%,GMNN;MCM7;POLE2;LRWD1;ORC4
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.3720864022708705,0.6279126157262482,0.8909090909090909,1.0,1.0,5/11,31.53%,TBCCD1;ARHGAP21;STK25;RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.34558461769466,0.6277876145437505,0.9411764705882353,1.0,1.0,3/16,13.58%,ST18;FER;SMAD4
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.3720196323342188,0.6277414873604635,0.8939393939393939,1.0,1.0,1/9,5.09%,GCH1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.363374106708507,0.6269449355704453,0.9622641509433962,1.0,1.0,3/12,22.32%,SNCA;DYRK1A;MAP2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.27735593547449167,-0.6269270324734824,1.0,1.0,1.0,16/71,16.58%,VWA3A;DNAAF1;DNAJB13;CFAP73;DRC1;TTC21A;ECT2L;GAS2L2;ANKUB1;CFAP52;DRC7;APOBEC4;RSPH4A;CNGA4;EFHB;ATP5MK
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3565155930442975,0.6264573840006952,0.9622641509433962,1.0,1.0,3/13,23.22%,CHMP6;LEPROTL1;VTA1
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.3812038159518061,-0.6263857111641838,0.8181818181818182,1.0,1.0,1/6,5.65%,XDH
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.36642213228653836,-0.6262196562865434,0.84,1.0,1.0,1/9,6.28%,MBTPS2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.3803860334268759,0.6261716737376,0.9047619047619048,1.0,1.0,2/12,13.15%,STK33;CHEK2
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.3581957459417327,0.6259905105684195,0.9310344827586207,1.0,1.0,5/13,17.72%,SIRT1;IL15;CSF1;VEGFA;BMP4
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.3841689879294336,-0.6256255912349201,0.8709677419354839,1.0,1.0,7/7,61.60%,MAP1LC3B;NBR1;PJVK;SQSTM1;PEX5;USP30;ATM
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.3987703097100487,0.6255817527284651,0.9272727272727272,1.0,1.0,1/6,16.13%,ANO6
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.3864257485510972,-0.6251240792896534,0.9148936170212766,1.0,1.0,2/6,13.72%,AZGP1;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.3864257485510972,-0.6251240792896534,0.9148936170212766,1.0,1.0,2/6,13.72%,AZGP1;HLA-C
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3431729078380802,-0.6238605390798333,0.975609756097561,1.0,1.0,3/19,12.11%,CAV1;SVIL;MSC
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.3822969865809837,0.6234760147929591,0.8837209302325582,1.0,1.0,3/8,24.72%,WNK1;ATP1B2;DLG1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.3942280717676068,0.6234566198196645,0.9444444444444444,1.0,1.0,1/8,4.83%,CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.30964306746869674,0.6229812268008553,0.9636363636363636,1.0,1.0,4/34,16.82%,FHIT;RYBP;EIF3H;MARCHF7
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.41845261121856864,-0.6225552205201573,0.9047619047619048,1.0,1.0,5/5,58.17%,PARN;TRIR;PDE12;TOE1;XRN1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.3874584725733022,0.6224140295116678,0.9516129032258065,1.0,1.0,1/10,5.48%,RAB39A
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3221147438597165,0.6221903727250623,0.9516129032258065,1.0,1.0,3/27,10.39%,TET2;WDR5B;PAXIP1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.41378457251071354,-0.6213271959266253,0.94,1.0,1.0,1/5,15.47%,RAB3A
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.4096968617936543,-0.6213134354127178,0.8863636363636364,1.0,1.0,2/5,21.43%,P2RY12;P2RX4
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3532604007896089,-0.6211922997971692,0.9318181818181818,1.0,1.0,3/18,9.36%,RIN3;LRPAP1;WDR54
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3492492497714823,-0.6208902677021175,0.9583333333333334,1.0,1.0,5/16,26.71%,RECQL5;MCM2;BLM;MCM4;MCM6
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.35653758393011425,-0.6208549793326361,0.85,1.0,1.0,3/9,17.25%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.4227168195345055,0.6206969488292363,0.9137931034482759,1.0,1.0,4/6,18.51%,TBX18;GJB6;BMP4;MESP1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.36481104907153145,0.620423909636616,0.9508196721311475,1.0,1.0,6/14,22.21%,MCTP2;SNCAIP;MEF2C;FMR1;MCTP1;KCNMB4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.2846539544708194,0.620069746651365,0.9791666666666666,1.0,1.0,5/34,20.33%,DLGAP5;CENPO;CENPP;POGZ;CENPV
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.352401625676978,0.620030766728265,0.9807692307692307,1.0,1.0,2/16,6.87%,KAT2B;RIOK2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.2998084263492257,0.6198572758143678,0.9636363636363636,1.0,1.0,8/28,19.17%,BMP2;HDAC2;BCOR;LRP6;ROGDI;BMP4;EDA;HDAC1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.4023357505221573,0.6197339097608081,0.8431372549019608,1.0,1.0,4/5,36.41%,NPNT;PLPP3;ITGA4;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.35506372067729186,-0.6193732197140192,0.8809523809523809,1.0,1.0,2/9,15.39%,CAMKK2;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.41784608854784683,-0.6192175045228211,0.8723404255319149,1.0,1.0,1/5,12.55%,WNT5A
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.2511219076737844,0.6191836579442319,1.0,1.0,1.0,16/110,20.33%,DMC1;GMNN;ASF1A;H2BC21;MCM7;PSMD13;TCF4;PSMA1;PSME4;PADI4;CCNH;ORC4;ANP32B;MNAT1;H2AX;CENPV
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.370185848719093,-0.6189980839684746,0.8909090909090909,1.0,1.0,1/9,12.12%,SLC2A1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.29287590353641213,0.6189947011076767,0.9583333333333334,1.0,1.0,9/52,23.12%,CCL5;IRAK3;POLR3G;PLSCR1;HLA-E;RIOK3;BIRC3;USP18;FPR2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.3562821424752485,-0.6188997876045781,0.9459459459459459,1.0,1.0,5/10,18.53%,DNAAF1;RSPH9;CCDC40;SPATA6;BBOF1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.30891130399435796,0.6181452701303559,1.0,1.0,1.0,8/27,27.07%,FGFR3;LRRC17;LRP6;TP53;RANBP3L;LRP5;GJA1;PTPRC
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.40165774727969045,0.6177087588173303,0.8979591836734694,1.0,1.0,1/7,12.39%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.32051052470238595,0.6175028732829968,0.9791666666666666,1.0,1.0,4/28,10.90%,PPP1R15B;DLC1;ITGA1;MAGI2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.3610029204290178,-0.6172674703744071,0.8809523809523809,1.0,1.0,3/14,12.78%,BTK;WNT5A;APOA1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.29533197307410025,0.6171245023759363,1.0,1.0,1.0,7/47,19.72%,CORO7;MSRB1;GSN;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.4064501329264719,-0.6169918485778394,1.0,1.0,1.0,1/5,8.10%,ENTR1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.30500608067205265,0.6166718695690263,0.9607843137254902,1.0,1.0,8/29,24.72%,NLGN1;MEF2C;LRRC7;DLG2;CRHBP;DLG3;MAPK8IP2;DLG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.26710623399783556,0.616458552853578,1.0,1.0,1.0,16/86,23.71%,AP1M2;CTSF;CD74;DCTN3;RACGAP1;DYNC1I2;KLC2;CTSV;HLA-E;LGMN;ACTR10;HLA-F;SEC24B;CANX;SH3GL2;KIF18A
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.34004142253037956,-0.6159425264402666,0.9111111111111111,1.0,1.0,3/17,14.53%,GPSM2;DCTN1;ANKRD53
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3641280393304922,0.6157438897997349,0.8928571428571429,1.0,1.0,3/11,21.79%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.2716608610273054,-0.6156265729837913,1.0,1.0,1.0,20/87,26.52%,TMA7;ZC3H15;RPL38;RPL12;RPS8;RPL37A;RPS27;RPL4;RPL5;RPL26L1;RPL22;RPS20;RPL34;DRG1;RPL37;RPL31;RPL7A;RPL35A;RPS25;RWDD1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.27516940918190425,-0.6156196393196972,1.0,1.0,1.0,1/64,1.25%,RTF1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.391887393117315,0.6144035639612957,0.9047619047619048,1.0,1.0,4/8,38.41%,DYRK1A;PIKFYVE;MARK3;ATM
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.4144566928921446,-0.6143841510080966,0.9047619047619048,1.0,1.0,2/5,16.18%,TTN;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.40099223428812353,0.6141637627453782,0.9259259259259259,1.0,1.0,1/5,16.13%,ANO6
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.3505431256001053,0.6141101808620908,0.9130434782608695,1.0,1.0,5/11,23.21%,NPPA;SLC2A5;SPX;BMPR2;GSK3A
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.25124184162319607,-0.6138181595429512,1.0,1.0,1.0,8/111,8.34%,SFRP1;FZD8;WNT7A;PLCB2;PDE6B;CAMK2A;PSMB4;CCDC88C
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.4253712306251624,0.6137148569759057,0.92,1.0,1.0,2/5,13.66%,MEGF10;MEF2C
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.37981294804503773,0.6133810597786343,0.8679245283018868,1.0,1.0,4/8,20.25%,LYN;BLK;NOC2L;IRS2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.36979950477662893,-0.6132120444406183,0.8958333333333334,1.0,1.0,3/9,22.13%,MBTPS2;MBTPS1;HSP90B1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.3444494373746168,0.613164624039408,0.8928571428571429,1.0,1.0,4/16,21.32%,SLC1A3;SLC25A13;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3339959856744056,0.6126455098552602,0.9180327868852459,1.0,1.0,5/23,21.85%,ACD;TERF1;TENT4B;GNL3L;POT1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.3516445277696735,-0.6119732762294254,0.9722222222222222,1.0,1.0,2/13,14.84%,ABCB1;ABCB4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.299980289729515,0.6114511326765224,0.9622641509433962,1.0,1.0,3/28,11.78%,SIRT1;FOXH1;NCOA2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.291427131246669,0.611391648416765,0.98,1.0,1.0,14/40,28.04%,ZFP36L2;NUDT16L1;RIDA;HNRNPD;SLFN14;DXO;AGO3;HSPA1A;NCBP1;PNPT1;LSM2;YTHDF2;RNASET2;DNA2
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.24396113184418672,0.6113652472964708,1.0,1.0,1.0,19/182,19.62%,TCIRG1;IDH1;BDH2;MRPS12;ECI1;HTRA2;FDX1;ACADM;MPC1;MTX2;CASP7;HSD17B10;ACAA2;ATP6V0B;TIMM10;MTRF1;COX10;MRPL11;ALDH6A1
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.40670018382340584,0.6112438953767885,0.8727272727272727,1.0,1.0,2/9,16.99%,SIX4;VEGFA
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2766019392708605,-0.6110306966418126,1.0,1.0,1.0,1/62,1.25%,RTF1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.39312424631455745,0.6108494799317448,0.9591836734693877,1.0,1.0,3/6,37.17%,RAB11FIP2;SELENOT;RAB11B
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.3115884302208005,0.6108450467805155,0.9836065573770492,1.0,1.0,10/22,23.50%,MYC;FBP1;PDE4B;PPM1E;MEF2C;RAP2A;DPEP1;CRHBP;TP53;GAS6
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.32619644924199476,0.6107931384661421,0.9298245614035088,1.0,1.0,6/23,17.72%,FGF2;PCSK5;PROX1;HECA;VEGFA;BMP4
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.27667201953492276,0.6106720882707135,1.0,1.0,1.0,7/51,16.72%,TCIRG1;CTSF;HTRA2;BNIP3L;CHEK2;RNF5;CTSV
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.3772881046558245,0.6103895796547824,0.896551724137931,1.0,1.0,2/8,25.90%,ABHD10;NAGA
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2646200608350383,0.610206619342361,1.0,1.0,1.0,7/82,13.86%,AP1M2;CTSF;CD74;DCTN3;RACGAP1;DYNC1I2;KLC2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.2752376029215535,0.6100515714148134,0.9855072463768116,1.0,1.0,8/56,17.02%,PLSCR2;PLSCR4;MYOF;ANK2;BIN1;ABCD2;ANO6;PLSCR1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3340964489218052,0.6098089091218485,0.9375,1.0,1.0,7/15,30.57%,ANK2;RYR2;HSPA5;BCAP31;UBAC2;VAPA;GBF1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.3265101249404723,-0.6091769612770866,0.9574468085106383,1.0,1.0,3/18,17.65%,CAV1;MYBBP1A;PTRH2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.33577177362198735,0.6091631540433121,0.9482758620689655,1.0,1.0,4/18,14.46%,NLGN1;NRXN1;RIMS2;PTEN
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.3979352430316836,0.6091198648966043,0.896551724137931,1.0,1.0,1/5,7.94%,ITGAV
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.36912826119602254,0.6087980297209096,0.9387755102040817,1.0,1.0,1/10,4.17%,ZEB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.3719971606081045,0.6087781986066076,0.9574468085106383,1.0,1.0,2/7,36.99%,IKBKB;ROCK1
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.3703244278538074,-0.6087197370645483,0.868421052631579,1.0,1.0,1/6,17.80%,AQP1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.28142146011968244,-0.6083903191877611,1.0,1.0,1.0,7/60,8.06%,SFRP1;FZD8;WNT7A;CAV1;WNT10B;PPP1CA;CDH3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.4143301622462446,0.6083871873245038,0.8627450980392157,1.0,1.0,2/5,23.10%,HTR2C;HTR2A
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.31497130585585176,-0.6076097341393997,0.918918918918919,1.0,1.0,4/17,19.51%,ADAMTS9;FUCA1;FBXO2;FBXO44
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.32835074194199726,0.6075450069000082,0.9607843137254902,1.0,1.0,5/25,20.62%,LLGL1;DNAJC1;HSPA8;STXBP5;NDFIP2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.3498811373468945,-0.6070665906714909,0.9523809523809523,1.0,1.0,2/11,13.00%,CAV2;NUCKS1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.3567090095460968,0.6068866229998807,0.9347826086956522,1.0,1.0,7/13,31.36%,ZFAND1;PPIF;MKNK2;CPEB2;ATF3;GSTO2;GSTO1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.36440314423047904,-0.6063737451134623,0.88,1.0,1.0,2/9,16.68%,AHR;ADCY1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.36440314423047904,-0.6063737451134623,0.88,1.0,1.0,2/9,16.68%,AHR;ADCY1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.2908791200504378,0.6055627911919599,0.9818181818181818,1.0,1.0,12/42,18.48%,CCL5;SOCS2;STING1;ESR1;DRD3;GGT5;LOC400499;TRPM2;TIPARP;ALPL;WNT8B;CTNNB1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.3050514924524853,0.6055148882627269,0.9534883720930233,1.0,1.0,9/39,25.55%,NAV3;SNCA;DYRK1A;TOGARAM1;ABL1;MAP2;CAMSAP2;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.31361153145433673,0.6053444202583425,0.9310344827586207,1.0,1.0,4/18,18.43%,PTPRD;CAPRIN1;DBN1;CDKL5
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.35189225925666423,-0.6048754707944262,0.8837209302325582,1.0,1.0,4/10,24.80%,DAB2IP;PACSIN1;ALK;VLDLR
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.40977902788148,0.6047549316814383,0.9607843137254902,1.0,1.0,1/5,12.89%,IRAK3
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.3644059835279745,0.6038989315814329,0.8863636363636364,1.0,1.0,3/11,18.82%,SPEF2;DYNC1I2;DNAAF2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.35194412468741,-0.6038572538784431,0.9545454545454546,1.0,1.0,1/11,8.74%,MEFV
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.3428989198547481,0.6036534573623842,0.9846153846153847,1.0,1.0,4/13,26.93%,SLC25A13;GPD2;SLC25A12;UQCRFS1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.3639708536860586,-0.6032138725733345,0.875,1.0,1.0,1/8,11.29%,CACNG8
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.3639708536860586,-0.6032138725733345,0.875,1.0,1.0,1/8,11.29%,CACNG8
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.3923001578251747,0.6030278997297104,0.8870967741935484,1.0,1.0,3/7,14.92%,SLC39A8;SLC39A12;SLC39A5
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.3419453994539052,0.6028898479006647,0.9074074074074074,1.0,1.0,5/13,20.20%,MEGF10;XKR6;RHOBTB1;RHOG;XKR4
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.3175031106339554,0.6019331221448799,0.9841269841269841,1.0,1.0,6/23,22.23%,RYBP;BCOR;RNF2;PCGF1;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3766749192820694,0.6004278093893252,0.8928571428571429,1.0,1.0,1/11,2.87%,FGF2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.2906914735790298,0.6004142542444203,0.967741935483871,1.0,1.0,6/34,13.96%,PAPOLA;KHDRBS2;CDK11A;QKI;SLTM;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.35830265566758246,0.5998423657594593,0.9482758620689655,1.0,1.0,1/8,17.66%,MTRF1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.32956084852262807,0.5997737089037566,0.9411764705882353,1.0,1.0,2/17,18.22%,NAV3;CD34
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.352164784016347,-0.5986458988432158,0.9743589743589743,1.0,1.0,2/14,9.74%,CIITA;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.32173732137005606,0.5985942946386251,0.9821428571428571,1.0,1.0,5/21,24.71%,PDGFC;GREM1;VEGFA;RAP2A;GPNMB
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.4060000752036881,-0.5984988347107679,0.9069767441860465,1.0,1.0,1/5,9.10%,WWC1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.28603413842554654,-0.5984436512864181,0.9777777777777777,1.0,1.0,8/37,17.78%,RSPH9;CCDC40;GAS2L2;CFAP74;CFAP46;RSPH1;RSPH4A;CHP1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.26055715738976304,-0.5982088428774154,1.0,1.0,1.0,4/51,16.74%,PIAS3;EYA1;POM121C;NUP133
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.3882798410790921,0.5981567207084081,0.8888888888888888,1.0,1.0,2/5,22.88%,BCAR1;EDN1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.3667208294645621,-0.5980513833260498,0.9387755102040817,1.0,1.0,7/7,63.34%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.3667208294645621,-0.5980513833260498,0.9387755102040817,1.0,1.0,7/7,63.34%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.3659825654243704,0.597928777611249,0.9056603773584906,1.0,1.0,4/8,33.60%,ABCD2;INSR;APP;PRNP
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3251897992218947,-0.59752430920135,0.9714285714285714,1.0,1.0,2/10,12.01%,WNT7A;AKNA
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.3589935620108861,-0.5974148791614742,0.9245283018867925,1.0,1.0,1/6,15.21%,VPS35
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),-0.38579873411367205,-0.596484986803826,0.8636363636363636,1.0,1.0,1/5,10.23%,IHO1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.3832753904846208,-0.596231133841429,0.9166666666666666,1.0,1.0,1/5,8.97%,BMP6
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.2874703255100194,0.5953974066139663,0.9824561403508771,1.0,1.0,8/45,22.09%,TOR1B;DNAJB2;HSPB1;HSPA8;DNAJB1;HSPA1A;HSPA5;STT3B
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.33092428666034857,-0.5952371660755149,0.9375,1.0,1.0,3/12,17.91%,COX6C;COX7C;COX7A2L
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.32433940609568085,0.5950070144898829,0.9473684210526315,1.0,1.0,7/16,41.65%,TP53;CRYAB;MAP3K20;ATM;WRN;TMEM109;XRCC5
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.3670948208794151,-0.5948449947593877,0.8936170212765957,1.0,1.0,1/6,13.62%,PHF19
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.31886117809768977,0.5946070245964796,0.9672131147540983,1.0,1.0,2/18,14.24%,LLGL1;FMNL3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3451336360294468,-0.5943376658746675,0.875,1.0,1.0,2/10,14.96%,JUN;HIF1AN
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.2841537262454904,0.5943235429360836,1.0,1.0,1.0,3/35,11.15%,ASF1B;ASF1A;CENPO
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.26540159112513234,-0.5942130862737267,1.0,1.0,1.0,15/42,23.93%,PRPF19;CELF3;SNRNP200;SF3A3;SRSF10;SRPK3;CRNKL1;PRPF6;SF3A1;SNRPD2;LUC7L2;SF3A2;KHDC4;DDX1;CELF5
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.3272454777360379,-0.5930895376052981,0.9459459459459459,1.0,1.0,1/14,4.63%,WNT7A
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.28722994950531466,-0.5926370453970933,1.0,1.0,1.0,4/31,14.84%,RCC1L;APOO;SPG7;DNAJC11
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.35948820949010885,-0.5921890511888795,0.8947368421052632,1.0,1.0,1/10,2.19%,PTGES
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.3844808208791948,-0.5920059404561667,0.9459459459459459,1.0,1.0,1/6,7.12%,PRKD2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.33658306299248153,0.5915855543922156,0.967741935483871,1.0,1.0,1/13,13.15%,CHEK2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.29510402190068125,0.5915760898438527,0.9318181818181818,1.0,1.0,15/30,34.80%,RACGAP1;CRB2;PHLDB2;PLCB1;RPS6KA6;PHLDB1;INSR;TDG;NIPBL;CLASP2;CLASP1;TLE6;ZBED3;SEPTIN7;B4GALT5
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.2971569536678353,0.5915260278606528,0.9814814814814815,1.0,1.0,1/25,4.73%,SF3B1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.29102079592941493,0.5905843024495318,0.9824561403508771,1.0,1.0,4/28,20.24%,FHIT;RYBP;EIF3H;STYX
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.3103931733872844,0.5904165782247,0.9827586206896551,1.0,1.0,3/19,14.46%,FBXO5;BAG2;PTEN
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.3702238140637293,0.5899904155236778,0.9433962264150944,1.0,1.0,1/12,7.51%,TET2
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.3695551257253385,-0.5897830757503979,0.9019607843137255,1.0,1.0,5/5,63.06%,USP17L2;PRMT6;SPHK2;KDM5A;FOXP3
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.26191908313514456,0.5897625286044438,1.0,1.0,1.0,14/77,22.24%,FZD5;PRICKLE2;PSMD13;PSMA1;PSME4;FZD4;FZD1;PRICKLE1;FZD6;DVL2;VANGL2;ARRB2;SMURF1;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.3444899289978095,0.5895838108556626,0.967741935483871,1.0,1.0,5/14,29.15%,NLRP7;GAS1;SERPINE1;CHAC1;ACP4
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.402669245647969,-0.5895810721254933,0.8571428571428571,1.0,1.0,5/5,59.74%,ALKBH1;ALKBH5;ALKBH3;JMJD6;FTO
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.2850684822134085,-0.5894344573594597,1.0,1.0,1.0,2/33,8.53%,SPAAR;SH3BP4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.35712025889440957,0.5894124101126886,0.9074074074074074,1.0,1.0,2/10,15.59%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.32305733053497176,0.5893208175125587,0.9215686274509803,1.0,1.0,2/12,14.38%,PLXNB1;PLXNB2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3571898332624086,-0.5886528247832399,0.9090909090909091,1.0,1.0,6/6,64.29%,ADAM17;FBXW7;BTC;EGF;TGFA;ADRA2A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.31464128334578184,0.5885672662602234,0.9215686274509803,1.0,1.0,13/21,33.06%,TLR2;IRAK3;GPR108;TLR5;NLRP2B;BIRC3;OTUD4;APPL1;LRRC14;CD36;APPL2;LGR4;FLOT2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.32745330952681556,0.5883902562768792,0.9333333333333333,1.0,1.0,1/17,3.11%,MYC
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.26919685914293934,0.5876595771152728,0.9818181818181818,1.0,1.0,11/46,21.75%,IVNS1ABP;FBXO5;SPOPL;BAG2;MARCHF7;NXN;SIRT7;GNL3L;ARRB2;ABL1;HSPA1A
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.30801908641106807,-0.5876487214870917,0.9767441860465116,1.0,1.0,4/33,12.33%,DNAAF1;DNAH11;CCDC40;MMP21
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2652850139407482,-0.5874117450473064,1.0,1.0,1.0,7/45,14.16%,CUX2;OLFM4;TRIOBP;MYADM;APOA1;RREB1;RAC1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.3850628582615523,0.5872233394419992,0.9423076923076923,1.0,1.0,3/7,20.64%,H6PD;AKR1C3;CLCN2
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.2919628418178807,-0.5871903813378636,1.0,1.0,1.0,4/24,15.78%,KIF2B;STMN1;STMN3;KATNB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.3980710912795349,0.5866374871858211,0.875,1.0,1.0,2/5,24.24%,EPB41;GNAI1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.31228666871781463,0.5861572057036938,1.0,1.0,1.0,12/31,27.18%,DCXR;FBP1;GALK1;SLC37A4;PGM1;GALK2;IRS2;CHST15;BRAT1;GAA;GALM;GALT
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.33235925105413555,-0.5859680945065653,0.9459459459459459,1.0,1.0,2/11,13.20%,UBASH3B;PTK2B
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.31952133069268973,-0.5856826418688923,0.94,1.0,1.0,3/13,17.32%,PEX7;PAFAH1B1;TMEM86B
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.3537320538527293,-0.5856198588920123,0.9318181818181818,1.0,1.0,1/8,9.46%,PDPR
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.3537320538527293,-0.5856198588920123,0.9318181818181818,1.0,1.0,1/8,9.46%,PDPR
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.263501169750367,0.5853060054815424,1.0,1.0,1.0,10/47,24.83%,NOVA1;KHDRBS2;NSRP1;PUF60;KHDRBS3;RBM5;FMR1;RBFOX1;MBNL2;HNRNPU
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.3791667571366317,0.5849586335078334,0.9411764705882353,1.0,1.0,2/6,25.71%,GFUS;GMDS
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.32873417724945186,-0.5847176674797244,0.9607843137254902,1.0,1.0,4/13,25.15%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.3872872027197151,0.5843145430319535,0.9491525423728814,1.0,1.0,3/6,40.32%,TRMT112;APEH;ETF1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.2900288088323391,0.5842206764256004,1.0,1.0,1.0,6/28,19.26%,PLSCR2;PLSCR4;ABCA1;ANO6;PLSCR1;ATP8B1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.25493948570257285,0.5841747265871216,1.0,1.0,1.0,17/63,30.79%,RELA;TNFRSF10A;PSMD13;PSMA1;PSME4;IRAK1;TNFRSF10B;BIRC3;PSMD4;PSMB5;PSMC5;TRAF6;PSMB1;REL;CHUK;DICER1;BTRC
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.2808362158806504,0.5839995313291146,0.9833333333333333,1.0,1.0,4/30,14.84%,SNCA;EPB41;LEPR;REEP6
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),0.37744491286216186,0.583115403368173,0.9591836734693877,1.0,1.0,1/6,7.33%,AGXT2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.29324463888219504,0.5827918803179161,0.9803921568627451,1.0,1.0,4/28,14.82%,NDE1;RANBP9;ZNF207;HDGFL3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.33422949011819497,-0.5827538973788104,0.9795918367346939,1.0,1.0,2/8,18.10%,WFS1;ATG10
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.24460139667874903,-0.5824500648532355,1.0,1.0,1.0,23/117,21.66%,GINS3;RECQL5;ORC6;PSMB4;RPAIN;RFC3;CDC6;PSMC4;PSMD8;RFC2;RPA3;RFC1;MCM2;PSME3;PNKP;CDC7;PSMD12;MCM3;BLM;PSMD2;PSMC2;PSMC3;NOC3L
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.3521817818337186,-0.5821810468500073,0.8461538461538461,1.0,1.0,2/7,22.95%,APOA1;APOB
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.30619733444614095,0.5820553514547347,0.9361702127659575,1.0,1.0,2/20,14.64%,PPP1R14D;MGAT5
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.2536977432959039,-0.5820133898009024,1.0,1.0,1.0,6/85,8.34%,CD24;SFRP1;FZD8;WNT7A;WNT10B;CCDC88C
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.32830649449752913,-0.5817881205458901,0.9787234042553191,1.0,1.0,1/14,6.10%,PCSK6
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.3232522596607955,0.5810841956775606,0.9807692307692307,1.0,1.0,4/13,21.96%,APELA;ACVR1B;VEGFA;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.3689758417072044,-0.5810203387641207,0.9333333333333333,1.0,1.0,1/8,15.09%,MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3142940981904855,0.5808382639146004,0.95,1.0,1.0,7/18,25.08%,IL23R;NECTIN2;HLA-E;HLA-F;FADD;IL23A;MR1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.31554716136994887,0.5803644755076768,0.9636363636363636,1.0,1.0,3/21,17.28%,TENM3;VEGFA;FBN1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.34113513963793274,-0.5802851213832547,0.926829268292683,1.0,1.0,2/13,13.57%,KIF20B;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.3402818373629188,-0.5800707929473526,0.9574468085106383,1.0,1.0,3/6,20.85%,FFAR4;SCTR;CGAS
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.36920586674597866,-0.5799938248547248,0.9512195121951219,1.0,1.0,1/5,21.39%,GK5
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),-0.40280945701493814,-0.5791036721194921,0.8837209302325582,1.0,1.0,2/5,22.95%,APOA1;APOB
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.2430638120045242,0.5790326191886396,1.0,1.0,1.0,12/68,23.02%,TBC1D12;ODAD3;SGSM3;GSN;MAPK15;MTMR3;TBC1D5;CDKL5;STX18;SENP6;IFT140;USP6NL
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.2814409334745427,-0.579014661733562,1.0,1.0,1.0,6/32,14.16%,OLFM4;TRIOBP;MYADM;APOA1;RREB1;RAC1
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.38819615526487705,-0.5788729736859224,0.8695652173913043,1.0,1.0,2/5,14.79%,CXCL16;GPR183
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.32546093337930065,0.5784487900479333,0.9803921568627451,1.0,1.0,6/16,18.74%,PTGS1;HPGDS;CD74;PTGIS;PNPLA8;AKR1C3
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3257744671709437,-0.5780779518252691,1.0,1.0,1.0,2/11,8.45%,PLK3;RPS27L
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.2514709427990213,-0.5776258323906991,1.0,1.0,1.0,12/67,16.79%,POLR1G;SSU72;GTF2H2;FIP1L1;CPSF4;POLR1A;CPSF3;TBP;CSTF2;POLR1C;TTF1;TTF2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.34375701952986903,-0.5773360660729056,0.9565217391304348,1.0,1.0,3/9,17.82%,SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.24513906711000355,-0.5768288219254398,1.0,1.0,1.0,3/49,5.63%,AHSG;TIMP4;SERPINI2
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.3811679340827996,-0.5766793297313919,0.9347826086956522,1.0,1.0,4/7,31.21%,MCTS1;EIF2D;MTIF3;MRRF
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2929953813311512,-0.5762075998071209,0.9782608695652174,1.0,1.0,5/22,27.04%,BTBD18;ALYREF;EAPP;SUPT5H;SUPT6H
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.36638544682377877,0.5760530505293888,0.9272727272727272,1.0,1.0,4/9,17.88%,WNT4;SNCA;CD244;PRKAA1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.25429369934566,-0.5753736611795128,1.0,1.0,1.0,12/65,16.91%,FGF1;PLK3;ORC6;ENTR1;PLK4;ESRRB;RFPL1;RAB11A;CALM1;HTR2B;SFRP2;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.2972015179732715,0.5753622766606259,0.9344262295081968,1.0,1.0,7/17,35.12%,RNF128;CD81;ABCA2;APOE;DACT1;CTSC;FAF1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.2874049259826852,-0.5747744008164138,0.9795918367346939,1.0,1.0,5/25,17.80%,PRKCD;PDCD5;SMAD3;TGFB1;RBM22
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.29852586719458324,-0.5746336690801552,0.9318181818181818,1.0,1.0,2/15,14.35%,CAMLG;EMC1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.3643253943825433,-0.5744848542886554,0.8979591836734694,1.0,1.0,2/7,21.48%,SUPV3L1;TRMT10B
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.26493631759049063,0.5738968506205206,1.0,1.0,1.0,9/42,22.93%,ZFP36L2;NUDT16L1;EXOSC4;RIDA;SLFN14;DXO;AGO3;HSPA1A;PNPT1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.31561072118086914,0.5723007174163235,0.9552238805970149,1.0,1.0,7/19,33.82%,SLC2A5;IRS2;LPL;SELENOT;ZBED3;EIF2B5;KHK
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.38054605228717525,0.5722561145249605,0.9122807017543859,1.0,1.0,1/5,11.68%,FAM3A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.2762763371761321,-0.5715253635015402,0.9777777777777777,1.0,1.0,2/29,5.34%,DRD2;CAMK2A
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.3361509466900488,-0.5712392886190917,0.975,1.0,1.0,1/11,8.52%,BTBD18
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.34606037981004306,-0.5706146670719981,0.8444444444444444,1.0,1.0,1/5,10.78%,BEX4
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.332951436303679,0.5705039630632899,0.9137931034482759,1.0,1.0,2/8,13.80%,PTPRT;BCL3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.34190782905005457,-0.570431358521135,0.972972972972973,1.0,1.0,3/7,16.91%,VDR;MED1;FGFR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.37047231201689446,-0.570412650493835,0.9,1.0,1.0,1/8,7.70%,DPH6
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.2894811988263533,0.5703068364079932,0.9824561403508771,1.0,1.0,10/33,26.57%,HES6;ELAPOR2;GBX1;CTNNB1;CX3CR1;HEY2;TNFRSF1B;TENM4;HES5;YTHDF2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.2820049016480701,0.570259569819148,0.9642857142857143,1.0,1.0,17/43,30.34%,SNCA;NPPA;GSN;SNCAIP;CALB1;IAPP;GGA1;ADAM10;ITM2B;H3-3A;USP9X;BACE1;TSPAN33;HSPG2;FURIN;APP;CD36
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.36096873095902426,0.5702327747347634,0.9622641509433962,1.0,1.0,1/6,12.95%,TMEM120A
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),0.3802245594857043,0.569664809737661,0.921875,1.0,1.0,1/5,9.05%,DRD3
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.3257564812948595,0.5694973471165374,0.9464285714285714,1.0,1.0,5/12,26.41%,TTC21B;IFT140;DYNC2I2;CILK1;WDR35
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.356276577384503,0.5694422458977824,0.9193548387096774,1.0,1.0,1/10,11.24%,MCM7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.2779994805385996,0.5689375925420249,0.9818181818181818,1.0,1.0,7/29,18.24%,LATS1;ANKRD13A;LZTFL1;GPM6B;PICALM;MFHAS1;LEPROTL1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.34216698619481534,-0.5687345528532469,0.9583333333333334,1.0,1.0,1/10,6.42%,PTCH1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.3010605919691083,0.568580884971575,0.9433962264150944,1.0,1.0,1/17,6.01%,GLUL
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.3586200405885127,0.5679379108796632,0.9814814814814815,1.0,1.0,4/7,20.94%,TICAM1;IRAK3;SLC3A2;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3287095534811348,0.5673183732354041,0.9818181818181818,1.0,1.0,5/15,27.57%,RUVBL2;NOP10;NAF1;SHQ1;CCT3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3095305534946644,-0.5672409280799564,0.9811320754716981,1.0,1.0,3/17,13.57%,RAB7B;FLOT1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.2672373673741838,0.5669405131842432,1.0,1.0,1.0,13/47,27.79%,HDAC2;ASTL;BAG2;TANK;NKD2;ASPH;PERP;FADD;TNFRSF1B;BAD;OGT;AURKAIP1;APOE
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.2269134189892618,0.56693374892766,1.0,1.0,1.0,47/150,31.18%,SIRT1;DLGAP5;BRINP3;SCRIB;FBXO5;ANAPC16;PSMD13;CDK11A;HECA;CDC25C;PSMA1;PSME4;NEK7;GAS1;PKN2;RCC1;BORA;LGMN;UBE2D1;UBE2E1;PSMD4;PIM3;PIM2;FZR1;HNRNPU;CKS1B;ERCC3;PKMYT1;AFAP1L2;CDK10;PRMT5;PSMB5;USP2;PSMC5;ANAPC15;TTC28;PSMB1;BTG3;THAP1;ANGEL2;EIF4E;APP;CYLD;GBF1;BTRC;CDC27;ANAPC7
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.31300886602994926,0.5668399101188516,1.0,1.0,1.0,6/17,22.61%,OSCAR;EFNA2;CSF1;GAB2;FARP2;OSTM1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.3654686835080661,-0.566668839913455,0.9791666666666666,1.0,1.0,6/6,63.47%,PRDM5;SETDB1;SUV39H1;SUV39H2;BEND3;SETDB2
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.34239923392700583,0.5666179912542204,0.90625,1.0,1.0,1/7,22.08%,ATP2C1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.330000740325742,0.5665372660079295,0.9333333333333333,1.0,1.0,1/11,6.59%,TK1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.330000740325742,0.5665372660079295,0.9333333333333333,1.0,1.0,1/11,6.59%,TK1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.30095472128960793,-0.5663621689931685,0.975609756097561,1.0,1.0,5/24,15.64%,NIBAN2;TSPAN15;DLL4;HIF1AN;RITA1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.3445394231465959,0.5660635805689623,0.9183673469387755,1.0,1.0,3/8,26.05%,HEY2;GAS6;NOTCH1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.27954000362774106,-0.5660618894910024,1.0,1.0,1.0,13/44,23.81%,AFG3L2;APOO;SPG7;LETM1;DNAJC11;DMAC2L;ATP5F1E;ATP5ME;SAMM50;ATP5F1A;ATP5PB;ATP5MC3;ATP5F1B
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.3352427641041043,-0.5658296678444048,0.9523809523809523,1.0,1.0,1/9,10.21%,ZFPM1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.3783074607432113,0.5658287017936522,0.9230769230769231,1.0,1.0,2/6,33.85%,STK39;MYLK
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.3639697919006807,0.565746748560056,0.8983050847457628,1.0,1.0,1/8,11.24%,MCM7
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.34625502940266173,-0.5638893973348487,0.9433962264150944,1.0,1.0,7/7,65.39%,SRC;BDNF;FYN;DOCK3;STAP1;NTRK2;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.36816247582205025,-0.5635626468113529,0.8823529411764706,1.0,1.0,5/5,63.19%,TASL;SLC15A4;PTPN22;RSAD2;DDX3X
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.36816247582205025,-0.5635626468113529,0.8823529411764706,1.0,1.0,5/5,63.19%,TASL;SLC15A4;PTPN22;RSAD2;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.3155351345790367,0.5631161581555981,0.9814814814814815,1.0,1.0,4/16,16.33%,MDFIC;LATS1;RAB23;MFHAS1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.28431183713930963,-0.5629703048961379,0.9736842105263158,1.0,1.0,5/33,14.48%,GOLGA2;PLK3;DDRGK1;TEX264;UFL1
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.2733680380085476,0.5624595137070019,0.9574468085106383,1.0,1.0,9/27,30.38%,STRADA;RANBP17;XPO1;STYX;SMURF1;RANBP3L;PKD1;XPO7;NUP42
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.23210642839073997,0.562296368363454,1.0,1.0,1.0,24/85,31.32%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL11;MRPL49;ERAL1;MRPS9;MRPL10;MRPL18;MRPL41;MRPL48;MRPL50;MRPS34;CHCHD1;AURKAIP1;MRPL58;MRPL52;MRPS15;TRMT112;MRPS33;MRPL33;GFM2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.29055482798816323,0.5618341459636659,0.9824561403508771,1.0,1.0,5/24,21.79%,SDF2L1;HSPA8;DNAJB1;HSPA1A;HSPA5
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.27192662872871326,-0.561261089692957,1.0,1.0,1.0,10/32,18.67%,NR4A1;CCN3;MYH9;LPXN;CYP1B1;CORO1B;SCG2;STAT1;EGR3;GIPC1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.3561666735941863,0.5612556511308684,0.953125,1.0,1.0,1/5,23.31%,SH3GL2
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.31452657633920056,-0.5612529856164696,0.918918918918919,1.0,1.0,3/9,26.00%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.23356077942185632,0.5612014564491891,1.0,1.0,1.0,23/79,31.32%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL11;MRPL49;ERAL1;MRPS9;MRPL10;MRPL18;MRPL41;MRPL48;MRPL50;MRPS34;CHCHD1;AURKAIP1;MRPL58;MRPL52;MRPS15;MRPS33;MRPL33;GFM2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.3283329150104062,0.5601476130445855,0.9411764705882353,1.0,1.0,1/10,6.48%,IMMP2L
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.37540525429168997,0.5591012663726207,0.94,1.0,1.0,1/5,13.47%,PML
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.2680621778535186,0.5589241865253927,1.0,1.0,1.0,6/27,29.47%,CHMP6;MVB12A;STAM2;VTA1;HGS;VPS37D
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.3616112896491692,0.5584269275021139,0.9655172413793104,1.0,1.0,3/6,30.47%,SLC3A2;SLC7A8;SLC16A10
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3329059323214861,0.5581544001961335,0.9454545454545454,1.0,1.0,5/16,27.98%,ACTL6A;EPC1;RUVBL2;ING3;MSL3
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.3401799276712667,0.5580637011148605,0.9838709677419355,1.0,1.0,4/10,20.96%,CYP3A4;LRP2;CYP2R1;LGMN
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3321291435701689,-0.5574153991598569,0.9459459459459459,1.0,1.0,1/7,12.73%,CTPS1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.3741538909812079,0.5572744039858826,0.9433962264150944,1.0,1.0,2/6,33.85%,STK39;MYLK
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.3392747155323218,0.5563498644049717,0.9107142857142857,1.0,1.0,1/6,12.52%,FBP1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.3547653195635785,0.5560386576586593,0.9354838709677419,1.0,1.0,4/8,26.97%,LYN;MEF2C;DOCK10;DOCK11
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.31854006628048864,-0.5540774664779633,0.9375,1.0,1.0,2/7,19.13%,TAC4;TACR1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.329113013782488,0.5540061175701391,0.9836065573770492,1.0,1.0,5/11,42.74%,CCT3;CCT7;CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.329113013782488,0.5540061175701391,0.9836065573770492,1.0,1.0,5/11,42.74%,CCT3;CCT7;CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.2683633040253418,0.5539564861172037,0.98,1.0,1.0,7/46,21.63%,EFL1;RRS1;RPS5;BOP1;MTERF3;RPL23A;ERAL1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.37083013908084717,-0.5535087381799454,0.8636363636363636,1.0,1.0,1/5,15.09%,MFSD2A
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.2978626008168008,0.5534186427203499,1.0,1.0,1.0,5/24,20.26%,WNT4;PROX1;PRKCSH;COBL;CITED2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.34592147548280255,-0.5530573234810663,0.9069767441860465,1.0,1.0,1/7,11.30%,FH
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.293531955781569,0.5529621248578399,1.0,1.0,1.0,5/28,20.34%,GLRA1;RRAGC;CPEB1;VEGFA;RRAGD
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.3150434812508651,-0.5528413256331064,0.9767441860465116,1.0,1.0,1/12,8.34%,CCDC88C
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.2604862186630836,-0.5527294207211328,1.0,1.0,1.0,12/46,22.35%,PSMB4;OAZ3;PSMC4;AZIN1;PSMD8;PSME3;PSMD12;BHMT;PSMD2;PSMC2;PSMC3;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.33810848186033304,0.5527184732922983,0.9636363636363636,1.0,1.0,5/10,42.74%,CCT3;CCT7;CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.3670175201605212,0.5519760021531188,0.9607843137254902,1.0,1.0,4/8,18.79%,NLGN1;PLXNB2;PTEN;GRID2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.3344903184093321,-0.5519447990505749,0.9444444444444444,1.0,1.0,1/9,9.14%,ZNF703
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3359121184890043,-0.5518453615188019,0.9811320754716981,1.0,1.0,2/6,19.33%,PRPS1;G6PD
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.36717162305898154,0.551673759273557,0.9454545454545454,1.0,1.0,3/6,37.56%,N4BP2L2;ACE;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.3521962955167325,0.5514634580738029,0.96,1.0,1.0,3/6,32.16%,ADAM15;ATP2A3;B2M
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.31028728259238697,-0.5506809538401021,0.8780487804878049,1.0,1.0,4/13,17.09%,SHISA7;SHANK3;ADCY1;AKAP5
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.2647144796480011,0.5502609085320104,1.0,1.0,1.0,6/43,16.54%,NPC2;BTN2A2;ACACB;FASN;ACACA;PM20D2
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.31539235412474853,-0.5501401438856496,0.9333333333333333,1.0,1.0,11/11,68.48%,ADCY1;ADCY7;PTHLH;ADCY8;ADCY6;ADCY9;ADCY3;ADCY10;ADCY5;ADCY2;PDE4D
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.260681349016289,-0.5497995779985141,0.9473684210526315,1.0,1.0,4/22,15.05%,RAC2;PARVB;RAC1;PARVG
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.334882752353998,-0.549634039300923,0.92,1.0,1.0,1/9,6.71%,PEX7
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.300598665388785,0.5495779462671435,1.0,1.0,1.0,2/16,15.46%,TLR2;KIT
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.30912938856442435,-0.5493835815215732,0.9761904761904762,1.0,1.0,1/14,6.25%,CAV1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.31597238277104966,0.5490219512687197,0.9322033898305084,1.0,1.0,2/12,12.55%,ADIPOR2;PLA2G7
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.2764028216938994,0.548850730309088,1.0,1.0,1.0,3/45,11.32%,NDC80;RRS1;CHMP6
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.3226444871352597,-0.5479077611228369,0.9814814814814815,1.0,1.0,3/12,26.13%,RAC1;AKAP13;FHOD1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.300860403516349,0.54755770206366,1.0,1.0,1.0,2/19,10.09%,SLC1A3;SFXN2
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.35332694272619014,0.5475360969136405,0.9516129032258065,1.0,1.0,1/6,8.03%,DSP
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.3549621806670522,0.5473883387365657,0.9298245614035088,1.0,1.0,3/5,23.99%,LOXL2;LOX;LOXL3
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.3485940256184332,-0.5468349772791493,0.9090909090909091,1.0,1.0,1/6,15.22%,NHP2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.3693230174081238,-0.5465318356194028,0.9574468085106383,1.0,1.0,5/5,63.08%,TMEM30A;ATP8A2;SCARB2;ATP11B;ATP8A1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3538713952909125,-0.5457601648472279,0.9565217391304348,1.0,1.0,3/6,27.87%,ATP9A;PRKN;EIPR1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.3289328766528746,0.5453389426159782,1.0,1.0,1.0,4/8,27.59%,ACHE;LRP5;LIMD1;TNN
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.3627366267608866,0.5453373650544189,0.9591836734693877,1.0,1.0,6/7,44.98%,KYNU;QPRT;NMNAT3;NADSYN1;NMNAT2;NMNAT1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.3361957986515808,0.5441812226889295,0.9824561403508771,1.0,1.0,2/9,27.86%,NREP;MTR
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3482726996058394,-0.5439990524032594,0.9285714285714286,1.0,1.0,1/8,5.90%,GPC1
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.3393423597678917,-0.5437341025350365,0.9024390243902439,1.0,1.0,5/5,66.08%,EXOSC10;EXOSC9;EXOSC7;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.3393423597678917,-0.5437341025350365,0.9024390243902439,1.0,1.0,5/5,66.08%,EXOSC10;EXOSC9;EXOSC7;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.3393423597678917,-0.5437341025350365,0.9024390243902439,1.0,1.0,5/5,66.08%,EXOSC10;EXOSC9;EXOSC7;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.3393423597678917,-0.5437341025350365,0.9024390243902439,1.0,1.0,5/5,66.08%,EXOSC10;EXOSC9;EXOSC7;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.333961060837041,0.5436155438346956,0.96,1.0,1.0,2/9,21.56%,ABL2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.3249988844539135,0.5431963117866923,0.95,1.0,1.0,3/6,28.95%,GREM1;SLIT2;SLAMF8
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.34532397140695026,-0.5430414437937788,0.9487179487179487,1.0,1.0,1/6,12.89%,CYBA
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.337178757534064,0.5427370805010022,1.0,1.0,1.0,5/9,29.10%,OASL;ANKRD17;PUM2;ZCCHC3;PUM1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.313625847804937,-0.5425385673041332,0.9428571428571428,1.0,1.0,3/10,12.78%,LOXL4;SUMF1;APOA1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.31621217849742334,-0.5425202301464425,0.9024390243902439,1.0,1.0,1/15,1.95%,CXCL13
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.2564545244019717,-0.5423096492005174,1.0,1.0,1.0,14/37,34.07%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214;NPM1;NDC1;TSC1;NUP37;NUP88;NUP35;NUP50
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.2625101730560823,-0.5419820072897905,1.0,1.0,1.0,6/32,16.79%,SSU72;FIP1L1;CPSF4;CPSF3;CSTF2;TTF2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.3038866647432286,-0.5416984438150311,1.0,1.0,1.0,3/17,17.49%,CAV1;TGFB1;UBE3A
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.2827091858007547,0.5413614019581927,1.0,1.0,1.0,3/22,16.03%,HNRNPD;MAPK15;NEK7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2251763359410401,0.5410879224851621,1.0,1.0,1.0,19/104,32.16%,EIF3E;SMG1;RPS5;RPL21;RPL7;RPS3A;RPL23A;RPL18A;NCBP1;RPS29;RPS15A;RPL9;RPS23;PABPC1;RPS12;RPS19;PPP2R2A;SMG9;PYM1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.28563410160878966,-0.5409973104559795,1.0,1.0,1.0,4/22,13.97%,MVP;CAV1;VPS25;ZGPAT
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.22795473742487052,-0.5406404707352693,1.0,1.0,1.0,19/82,22.35%,PSMB4;FBXO39;CCNF;FBXL18;PSMC4;PSMD8;SKP1;CUL2;FBXL16;PSME3;FBXO2;PSMD12;FBXL12;FBXO44;FBXL13;PSMD2;PSMC2;PSMC3;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3246554845356807,-0.5404362066426386,0.9534883720930233,1.0,1.0,2/11,14.26%,MBTPS2;CREB3L1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.2820418908078328,0.5401272014423795,1.0,1.0,1.0,7/23,20.38%,CBS;AHCY;GADL1;SMS;CPS1;CTH;DPEP1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.2838789264035801,0.5390519668830173,0.9661016949152542,1.0,1.0,5/13,32.91%,LIG4;BRCC3;ANXA1;NIPBL;IKBIP
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3085224941692448,0.5388889254307427,1.0,1.0,1.0,3/11,24.21%,MFF;PNPT1;PID1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.29907793198857385,-0.5387040355503134,0.9761904761904762,1.0,1.0,3/14,16.39%,DAB2;PROM2;PIK3CB
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.28561752148599373,-0.5383456498542675,1.0,1.0,1.0,1/20,4.61%,FOS
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.25970416324423246,0.538135496136601,1.0,1.0,1.0,8/53,24.97%,PUS7L;TSR3;TRDMT1;CTU1;CDKAL1;TFB1M;TRMT9B;NOP10
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.32887877654464315,-0.5377867029761492,0.9642857142857143,1.0,1.0,3/11,25.50%,CHMP3;ATP9A;SRC
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.30412382741506716,0.5376311219165556,1.0,1.0,1.0,2/15,14.76%,HIP1;PICALM
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.2365782281141392,0.5371295293728503,1.0,1.0,1.0,9/69,22.54%,SP1;INTS6;TAF5;POU2F1;ELL2;INTS11;GTF2B;NCBP1;POLR2H
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.2926785092525487,0.5364020430584331,0.9636363636363636,1.0,1.0,1/14,6.59%,TK1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.31535574728208304,-0.5361411613413479,0.8837209302325582,1.0,1.0,8/8,68.48%,UBE2B;RNF157;PDE3A;PDE2A;CDC34;PDE3B;MGRN1;PDE4D
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.3207459568211716,-0.5359771928824059,0.9772727272727273,1.0,1.0,9/9,67.94%,ADCY1;ADCY7;ADCY8;ADCY6;ADCY9;ADCY3;ADCY10;ADCY5;ADCY2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.24649264947383454,-0.5357491517468044,1.0,1.0,1.0,6/24,20.14%,PER2;CALM1;GYG2;PYGB;PHKG1;AGL
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.31707592556892794,0.5357039875497434,0.9649122807017544,1.0,1.0,6/12,20.84%,NRARP;SEMA3E;VEGFA;CTNNB1;NOTCH4;SHH
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.2952614921610377,-0.5352805442654687,1.0,1.0,1.0,1/18,4.61%,FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.2952614921610377,-0.5352805442654687,1.0,1.0,1.0,1/18,4.61%,FOS
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3221474237152184,0.5349936389433506,0.9482758620689655,1.0,1.0,3/8,29.36%,NFATC3;HEY2;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.33703574613673887,0.534853032958254,0.9558823529411765,1.0,1.0,3/8,24.58%,WNK1;NEXMIF;SERPINE1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.24351843367919201,0.5345701592213626,1.0,1.0,1.0,15/54,25.47%,KIAA0586;MAPK8;RAB9A;PICALM;SLC26A4;OOEP;DZIP1L;TRIM67;BORA;AFDN;MAP2;TRIM68;DLG1;RABGAP1L;CEP290
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.20425797916404662,0.5341247408340749,1.0,1.0,1.0,25/192,23.28%,LIN28A;SMAD1;EXOSC4;SMAD2;INTS6;FARS2;MRPL44;RPL21;PRKRA;BOP1;BYSL;HNRNPA2B1;MPHOSPH6;INTS11;RPL7;PUS10;ZCCHC8;AGO3;WDR36;EXOSC1;RPL23A;TEX10;RPL18A;C1D;RRP1B
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.3322142071544009,-0.5340894940882056,0.926829268292683,1.0,1.0,1/8,8.84%,CARTPT
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.3007276273080739,0.5339131750244851,1.0,1.0,1.0,6/16,30.33%,PCSK5;LRP6;SHH;MBNL1;NIPBL;MYH3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.23659005493579324,0.5338231605409473,1.0,1.0,1.0,9/68,22.54%,SP1;INTS6;TAF5;POU2F1;ELL2;INTS11;GTF2B;NCBP1;POLR2H
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.3062114381884049,0.5336862585217752,0.9444444444444444,1.0,1.0,2/10,13.79%,ATP1A2;ATP12A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.28732235453351196,-0.5335541402970617,1.0,1.0,1.0,2/14,14.00%,ARF1;DCTN1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.22536310446917132,0.5328352339907029,1.0,1.0,1.0,25/93,31.32%,MRPL28;MRPS12;MRPL54;MRPL44;EEF1D;MRPL11;MRPL49;ERAL1;MRPS9;MRPL10;MRPL18;MRPL41;MRPL48;MRPL50;MRPS34;CHCHD1;LTN1;AURKAIP1;MRPL58;MRPL52;MRPS15;EEF1A1;MRPS33;MRPL33;GFM2
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.327852998065764,-0.5318436125983226,0.9333333333333333,1.0,1.0,5/5,67.22%,DAGLA;DAGLB;ALOX15B;CNR2;CNR1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.31813366137353544,-0.5315075383738984,1.0,1.0,1.0,1/11,5.21%,DRD2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.27906730148595743,0.5313699895495019,0.9836065573770492,1.0,1.0,5/17,32.98%,CREB1;PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.3334751827923711,-0.5311790120411382,0.9743589743589743,1.0,1.0,6/6,66.66%,TRIM62;PRKN;UBE2D4;UBE2T;UBE2S;RNF6
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.23618242519970678,-0.5302835204627842,1.0,1.0,1.0,13/56,22.35%,ORC6;PSMB4;CDC6;PSMC4;PSMD8;MCM2;PSME3;PSMD12;MCM3;PSMD2;PSMC2;PSMC3;PSMA5
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.34137285845362414,0.5296252109741952,0.96875,1.0,1.0,1/7,8.76%,SLC24A2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.2739180128413083,0.529428717834512,1.0,1.0,1.0,5/18,35.01%,CPEB1;NCBP1;CPSF6;CPEB3;NUDT21
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.24491027427535755,-0.52926393262706,1.0,1.0,1.0,7/33,26.90%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.24491027427535755,-0.52926393262706,1.0,1.0,1.0,7/33,26.90%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.36137984608695484,0.5284317667128847,0.9591836734693877,1.0,1.0,3/6,26.05%,LRP6;FLRT3;NOTCH1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.25406716509790794,0.5281422112563378,0.9824561403508771,1.0,1.0,1/26,6.49%,ZFP36L2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.35032867328728146,0.5278665940031366,1.0,1.0,1.0,3/5,26.97%,NOTCH2;DOCK10;DOCK11
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.306899854165999,-0.527819032761117,0.9473684210526315,1.0,1.0,1/8,11.24%,OAZ3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.2642378961610374,-0.5274168209255211,1.0,1.0,1.0,1/24,2.91%,PRKCD
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.3479499285036001,0.5268854802263828,0.9814814814814815,1.0,1.0,3/5,25.79%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.3479499285036001,0.5268854802263828,0.9814814814814815,1.0,1.0,3/5,25.79%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.2880429170285179,-0.5264353793544354,1.0,1.0,1.0,4/16,18.13%,IRF5;STAT1;PTPRS;HAVCR2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3209413359739032,0.5258534826807664,0.9473684210526315,1.0,1.0,3/11,20.81%,KDM3A;ARID1A;PLPP1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.2162690289628032,0.5258072404796955,1.0,1.0,1.0,18/94,26.98%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL11;MRPL49;ERAL1;MRPS9;MRPL10;MRPL18;MRPL41;MRPL48;MRPL50;MRPS34;CHCHD1;AURKAIP1;MRPL58
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.29315094906410927,-0.5257505412139212,1.0,1.0,1.0,2/11,13.75%,TCHP;TBC1D7
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.3215244843974348,0.5255329510886667,0.9661016949152542,1.0,1.0,1/10,17.88%,PRKAA1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.2786276167603431,-0.5249460767837755,0.9767441860465116,1.0,1.0,6/25,15.66%,PCSK6;ZNF703;SMAD3;TGFB1;TGFBR3;LATS2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.315522711444711,-0.5247873808822301,0.9318181818181818,1.0,1.0,9/9,68.46%,UBB;DIS3L2;UBA52;CHFR;UBC;ISG15;TUT7;RPS27A;TUT4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.29259347412699077,-0.5247209043889279,0.9722222222222222,1.0,1.0,3/13,14.48%,WFS1;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.3081370441864224,-0.5246986418980343,0.9285714285714286,1.0,1.0,1/8,10.68%,CDC6
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.2667266947969208,0.5243718941314555,1.0,1.0,1.0,4/29,18.57%,TRAPPC3L;RAB33B;COG5;VTI1A
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3289975319968109,0.5239056439078662,1.0,1.0,1.0,2/9,20.94%,TSPAN6;RIOK3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.28651647522213664,-0.523897370877787,0.9772727272727273,1.0,1.0,5/16,17.53%,JUN;TAF11;NUCKS1;SNW1;CTDP1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.25680181544112135,-0.5237501450728254,0.9821428571428571,1.0,1.0,9/26,23.93%,CELF3;SF3A3;SRSF10;SF3A1;SLU7;LUC7L2;SF3A2;KHDC4;CELF5
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.27898306695659464,0.5236087889183922,1.0,1.0,1.0,6/22,28.53%,TAP1;SLC19A1;ABCA13;DISP1;SLC27A1;SLC46A1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.32198631082708773,-0.5226407924430941,0.9361702127659575,1.0,1.0,3/8,19.04%,PTK2B;GPR183;POU2AF1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.2819908274690818,-0.5220789329719944,0.9473684210526315,1.0,1.0,2/11,19.77%,CAV2;CHMP3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.2612937887981208,0.5220081507855008,0.9836065573770492,1.0,1.0,6/25,23.01%,LPIN3;LIPG;CEL;PLBD2;ACOX1;PLBD1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.25117905592452516,-0.5218448322778633,1.0,1.0,1.0,11/43,22.35%,PSMB4;OAZ3;PSMC4;AZIN1;PSMD8;PSME3;PSMD12;PSMD2;PSMC2;PSMC3;PSMA5
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.3024861158898069,0.5215082134111374,0.9821428571428571,1.0,1.0,3/12,22.53%,TK1;UCK2;HPRT1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.34249217255930964,0.5209336619821796,0.9464285714285714,1.0,1.0,1/6,10.95%,NECTIN2
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.34980434204530875,0.5209039186540951,0.9552238805970149,1.0,1.0,1/5,10.09%,TF
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.33021470464885516,0.5200204006869965,0.9482758620689655,1.0,1.0,4/8,37.24%,LIMK2;DLG1;CLASP1;TPPP
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.32308164721501953,-0.5198473224246839,0.9607843137254902,1.0,1.0,1/12,10.12%,DLL4
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.30954575623714337,0.5196744677609685,0.9814814814814815,1.0,1.0,3/12,23.29%,ADGRB3;CD81;JAM2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.2178698902641989,0.5193590695666184,1.0,1.0,1.0,22/79,31.32%,MRPL28;MRPS12;MRPL54;MRPL44;MRPL11;MRPL49;ERAL1;MRPS9;MRPL10;MRPL18;MRPL41;MRPL48;MRPL50;MRPS34;CHCHD1;AURKAIP1;MRPL58;MRPL52;MRPS15;MRPS33;MRPL33;GFM2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.3084585619167041,0.5188978907489771,0.9855072463768116,1.0,1.0,4/12,33.83%,PCGF5;HNRNPU;YTHDC1;RBM15B
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.33535221870431525,-0.5184431256177778,0.9795918367346939,1.0,1.0,1/6,14.00%,DCTN1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.3176912066230802,-0.5183621044740254,0.9767441860465116,1.0,1.0,6/6,68.24%,MAP1S;UBB;RHOT2;LRPPRC;UXT;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.3332301740812379,-0.5182452595775124,0.9767441860465116,1.0,1.0,5/5,66.69%,PAK1;YAP1;WBP2;KMT2D;LMO3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.2408907515876789,-0.5174225949604934,0.9791666666666666,1.0,1.0,4/35,13.57%,TIMP4;PTPN3;AZIN1;DAB2IP
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.26795654622409687,0.5170094696520867,1.0,1.0,1.0,4/15,32.98%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.2683176415668703,0.516987743969957,1.0,1.0,1.0,8/22,25.23%,HSD17B2;FDX1;FDXR;STAR;DHCR7;CYP19A1;HSD17B6;CYP17A1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.3291184470505951,0.5165449057077763,0.9361702127659575,1.0,1.0,1/6,23.01%,IKBKB
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.2523452120028878,0.5157576980903743,1.0,1.0,1.0,5/26,25.55%,NAV3;TOGARAM1;HSPA1A;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.34189139696875936,0.5156332320505987,0.9649122807017544,1.0,1.0,3/5,39.81%,GSK3A;EPM2AIP1;GSK3B
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.25103887063824687,-0.5148131155666922,1.0,1.0,1.0,7/35,19.21%,SFRP1;AR;AKR1C2;AHR;ADCY1;AQP1;NDOR1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.33226959524865773,0.514773289621062,1.0,1.0,1.0,3/7,31.66%,SMAD4;NOTCH1;RGS2
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.33568660711445203,-0.5144441028846203,0.9333333333333333,1.0,1.0,2/5,16.98%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.2841820934731024,0.5134694319340841,0.9642857142857143,1.0,1.0,4/14,29.18%,PLA2G10;MBOAT1;PLA2G4E;LPCAT3
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.3261104159770533,-0.5133773175190484,0.9333333333333333,1.0,1.0,1/9,9.06%,PCCB
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.3133570344994725,0.5132238455829949,0.9824561403508771,1.0,1.0,3/8,23.93%,IRAK3;TIGIT;PIBF1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.27424873112834874,0.5130599337849933,1.0,1.0,1.0,8/28,25.52%,TCAF2;MYO1C;MFF;ITGAM;ITGB2;AKT2;MIEF2;CIB1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.2992570809472218,-0.5128938478885248,1.0,1.0,1.0,11/11,70.09%,GAK;EHD3;LAMP1;CLN3;RBSN;AP1G1;ANKFY1;AP4M1;SORT1;CCDC91;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2677220742451616,0.5127751242944275,0.9795918367346939,1.0,1.0,7/26,20.98%,TICAM1;LYN;IRAK3;MFHAS1;GPR108;F2RL1;NLRP2B
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.2738074118489737,0.5126059668482216,0.9838709677419355,1.0,1.0,3/15,18.13%,STRA8;HORMAD1;FMN2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.2801680250184396,0.5125484969559041,1.0,1.0,1.0,5/13,34.47%,MFF;PNPT1;PID1;MTM1;CSPG5
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.30032109559364,-0.5123983754814466,1.0,1.0,1.0,6/6,69.98%,TMEM70;ATPAF1;OXA1L;ATPAF2;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2596864645886519,0.5122547647984762,1.0,1.0,1.0,7/31,25.52%,ABL2;PHACTR4;MAPK8;ABL1;POT1;MAPK3;CIB1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.2925454109231476,-0.5122410963737785,0.9777777777777777,1.0,1.0,5/14,21.78%,SLC2A8;SLC2A1;SLC5A1;HNF1A;SLC45A1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.29727793918411427,0.5113435370771714,0.9818181818181818,1.0,1.0,5/12,23.72%,H6PD;SEC14L2;CLCN2;ABCA2;SREBF2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.24849019673503747,0.5110368706267628,1.0,1.0,1.0,9/31,26.37%,CAVIN1;POLR1H;CCNH;TAF1A;MNAT1;POLR2H;MAPK3;ERCC3;TAF1B
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.3183183741182437,-0.5090286987422075,0.9555555555555556,1.0,1.0,1/5,13.94%,LETM1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.2896401518655602,-0.5084000021207254,0.9487179487179487,1.0,1.0,1/7,11.51%,COPG1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.3424822817129918,0.5080004274627997,0.9642857142857143,1.0,1.0,3/6,36.02%,TNFRSF21;EPHA4;NF1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.30635301400603576,-0.5077859183423516,1.0,1.0,1.0,9/9,69.38%,KIF11;NEK2;RANBP1;NSFL1C;CHEK1;KIF25;UBXN2B;MAP9;CEP85
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.3306682413247029,0.5075989445056688,0.9803921568627451,1.0,1.0,1/8,11.81%,GSN
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.30770327048131846,0.5065251242938987,0.9464285714285714,1.0,1.0,2/9,20.07%,ATP8B1;VANGL2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.3428600301876213,-0.5064270809378831,0.9607843137254902,1.0,1.0,3/6,19.46%,COX7A1;COX7A2L;RAB5IF
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.2667724008276749,0.5061331895290372,1.0,1.0,1.0,5/19,24.03%,EPHA3;NR1H3;PICALM;MCTP1;ABCA7
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.29510136549803206,-0.5059415102936419,0.9523809523809523,1.0,1.0,2/12,17.37%,NRDE2;AKAP8L
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.3213152050004914,-0.5058656395490178,0.9574468085106383,1.0,1.0,1/5,12.81%,JCHAIN
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.3145997902298825,0.5057121914361165,0.9818181818181818,1.0,1.0,3/11,15.47%,PLXNB1;LGI2;GABRB2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.33118399270756455,-0.5049633684306212,0.9545454545454546,1.0,1.0,2/6,25.84%,SEC16A;SEC16B
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.26840230880791327,0.5046376081199575,0.9814814814814815,1.0,1.0,6/18,27.09%,CYB5R4;RIMS2;CDK16;EDN1;GAL;ANXA1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.3197404080907599,0.5040805643922814,0.9811320754716981,1.0,1.0,2/8,29.07%,POMK;IPPK
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),-0.3400754836543492,-0.5037356083694423,0.9787234042553191,1.0,1.0,1/5,8.84%,CARTPT
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.33545283992751107,0.5034936814242673,0.96,1.0,1.0,2/7,17.19%,TBX18;MYO3A
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.30777882648972665,-0.5031913088483942,0.9795918367346939,1.0,1.0,3/10,21.03%,SLC2A1;SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.27393124306746025,-0.5030082414746778,0.925,1.0,1.0,4/15,21.77%,P2RY12;APOD;P2RX4;RTN4RL2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.2821562985581073,-0.5021382506241747,0.9787234042553191,1.0,1.0,2/13,11.51%,COPG2;COPG1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.24725846210487,-0.501630659964455,1.0,1.0,1.0,6/28,19.63%,CLDN1;CLDN5;F11R;MFSD2A;SLC1A1;LSR
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.25066087337305126,0.5001065513194681,1.0,1.0,1.0,6/26,23.74%,SLC38A3;SLC7A9;SLC3A2;SLC36A1;SLC6A15;SLC7A8
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.29654661205949584,0.4995819858491145,1.0,1.0,1.0,3/9,20.84%,PROX1;BMP4;SHH
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.31271070057768136,-0.49830660984135217,0.9183673469387755,1.0,1.0,1/5,7.08%,ZP3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.25563641122360486,0.496839465654158,1.0,1.0,1.0,3/25,14.76%,VSIR;LYN;PICALM
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),0.337373563739359,0.4964894823160829,1.0,1.0,1.0,1/5,11.56%,SLC2A5
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.26583471000070685,0.4957004645060113,0.9814814814814815,1.0,1.0,3/16,17.19%,CHD7;TBX18;MYO3A
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.2777932579467152,-0.4951179240701878,1.0,1.0,1.0,6/29,16.69%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.294693846132612,-0.4944914861119836,1.0,1.0,1.0,2/10,15.60%,ERCC1;RAD50
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.3142734270753778,0.4943447892929702,0.9767441860465116,1.0,1.0,2/7,23.33%,WNK1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.29843504018736033,0.4931889345728542,1.0,1.0,1.0,6/8,36.38%,AKT2;ANXA1;C2CD5;CPLANE2;ANXA2;DOC2B
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.24431624028289023,0.4924527387121829,1.0,1.0,1.0,7/44,19.10%,PLA2G10;FOXO3;GRM5;NR1H3;CSF1;PM20D2;METTL18
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.2321925343678236,0.49244834766574175,1.0,1.0,1.0,2/53,4.96%,STK33;RFWD3
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.3246646079158333,-0.49097722710970515,0.9545454545454546,1.0,1.0,1/6,15.13%,ARFGAP3
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.3246646079158333,-0.49097722710970515,0.9545454545454546,1.0,1.0,1/6,15.13%,ARFGAP3
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.3246646079158333,-0.49097722710970515,0.9545454545454546,1.0,1.0,1/6,15.13%,ARFGAP3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.248764396913509,-0.49072299249921214,0.9782608695652174,1.0,1.0,3/24,9.39%,CAV1;DSG2;CTNNA3
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.3039318732983994,0.4899015358685381,0.9772727272727273,1.0,1.0,4/10,30.06%,SPEF2;DNAAF2;ROPN1L;SPAG17
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.2701483422919876,0.4890672779572351,0.9642857142857143,1.0,1.0,4/21,22.66%,ISCA2;CIAO3;IBA57;NUBP2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.2610471298683888,0.48766396684972046,0.9795918367346939,1.0,1.0,6/13,29.22%,IRF3;SETD2;RIPK2;DHX9;IFIH1;CHUK
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.26862322393189264,-0.48746549903084124,1.0,1.0,1.0,7/17,21.97%,MYO15A;MYO5B;MYO7B;MYO1H;MYO5C;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.20301030997769356,-0.48663322516903723,1.0,1.0,1.0,8/61,23.38%,C2ORF49;SARS1;CPSF4;CSTF2;DTWD2;TRMT10B;DDX1;AARS2
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),0.31884586734581905,0.4864572349914598,1.0,1.0,1.0,1/6,13.00%,ADRA2C
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.2949043250509774,0.48560574942282053,0.9841269841269841,1.0,1.0,1/6,19.05%,SAT1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.24544664156759397,0.48546370492980534,0.9827586206896551,1.0,1.0,8/27,27.95%,SLC35D2;ST3GAL6;CHST6;B4GALT3;HEXB;B3GNT3;PRELP;GLB1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.2791958426607038,-0.48496391355670126,0.9722222222222222,1.0,1.0,2/12,13.94%,ADAM19;APH1B
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.25636727072536025,0.4845279293252396,0.9830508474576272,1.0,1.0,4/23,18.62%,SLC35D2;ST3GAL6;CHST6;B4GALT3
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.24887546727799864,-0.48395162583498663,1.0,1.0,1.0,2/20,9.57%,FLOT1;CDC37
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.31092183390444544,0.48350194277724806,0.9821428571428571,1.0,1.0,2/5,27.17%,ENPP3;DCK
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.30030947775628625,-0.4828624243236343,1.0,1.0,1.0,5/5,69.98%,TMEM70;ATPAF1;OXA1L;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.24207360560509245,0.4824323689201649,0.9787234042553191,1.0,1.0,11/35,29.10%,CCL5;OASL;POLR3G;PLSCR1;RIOK3;FPR2;ANKRD17;DHX9;PUM2;ZCCHC3;PUM1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.2862013858619036,-0.48197450642385,0.9555555555555556,1.0,1.0,1/6,16.12%,CALM1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.2549857444765832,-0.4811451123255383,1.0,1.0,1.0,6/33,16.69%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.23663916539564017,0.4808653671460872,1.0,1.0,1.0,8/25,33.66%,PML;MARCHF7;PSME3IP1;QRICH2;EFNA1;EPHA4;TRIM39;OPHN1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.3091941310018639,-0.48019423742517053,0.9607843137254902,1.0,1.0,1/8,7.86%,HCK
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.2937784071183347,-0.4798110590229476,1.0,1.0,1.0,2/8,16.18%,TTN;HTR2B
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.2776983784372793,-0.478934870319843,0.9642857142857143,1.0,1.0,1/9,14.00%,DCTN1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.3211167009735735,-0.47812292395944156,0.975609756097561,1.0,1.0,2/5,22.73%,SLC25A29;PDZK1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.2625447050424444,0.47797623369036973,0.9821428571428571,1.0,1.0,4/22,22.66%,ISCA2;CIAO3;IBA57;NUBP2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.2964911601996209,-0.4758743521840564,1.0,1.0,1.0,6/6,70.36%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.2964911601996209,-0.4758743521840564,1.0,1.0,1.0,6/6,70.36%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2675839515592048,0.47586011000073,1.0,1.0,1.0,2/17,13.46%,CTNNA2;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.2819384262423711,-0.4754955159018796,1.0,1.0,1.0,3/9,20.62%,TGFB1;ID2;PRKCA
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2261070713329521,-0.475262033471409,1.0,1.0,1.0,8/53,17.78%,PLK3;TUBGCP2;CCDC88C;STMN3;DCTN1;RAB11A;TUBGCP5;CHP1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.2558501947116395,0.47463586511285216,1.0,1.0,1.0,11/27,30.83%,CTNNA2;NTNG2;PLXNB2;RAPGEF2;NEXMIF;ARHGEF2;SEMA6A;TNN;PHACTR1;NIPBL;SRGAP2
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.3159580025411338,0.4745651328192622,0.9433962264150944,1.0,1.0,1/5,25.91%,LTN1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.27301099794825356,-0.4734630817046218,0.9743589743589743,1.0,1.0,2/15,14.87%,PTCH1;TGFB1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.24152112372329337,0.47127015305472847,1.0,1.0,1.0,4/32,17.81%,MYOF;VAMP3;DNM3;MX2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.312651434465277,0.4702204074149056,0.9807692307692307,1.0,1.0,1/5,18.19%,LIMK2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.2918031642194125,-0.469980086539052,0.9591836734693877,1.0,1.0,2/6,19.16%,BHMT2;BHMT
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.28683323919426595,-0.4697110273770397,1.0,1.0,1.0,1/8,14.87%,TGFB1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.2432137939740689,-0.46810174810058264,1.0,1.0,1.0,7/19,21.97%,MYO15A;MYO5B;MYO7B;MYO1H;MYO5C;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),-0.3223073934607387,-0.4678361559242478,0.9777777777777777,1.0,1.0,2/5,24.16%,TAMM41;CRLS1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.2778236789979285,-0.46671283365767285,0.9302325581395349,1.0,1.0,2/5,17.81%,XRCC1;LIG3
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.2620217416534489,-0.4657998438377216,0.9722222222222222,1.0,1.0,6/6,73.81%,DDX1;DCP1A;SSB;YBX1;DDX3X;DHX9
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.27975854008977513,0.4656500200218333,0.9818181818181818,1.0,1.0,2/9,27.60%,NUP153;AHCTF1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.2544530618300296,0.46502285908837565,0.9827586206896551,1.0,1.0,5/16,28.14%,ACHE;ADAM10;LDLRAP1;APOE;BACE1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.18961565709879538,0.4641798885963225,1.0,1.0,1.0,31/106,34.42%,EXOSC4;MTHFD2;CNOT4;DNAJC3;ATF6;VEGFA;CNOT2;TATDN2;H2AX;DNAJB9;EXOSC1;FUS;HSPA5;BANF1;CKS1B;EIF2AK3;EDEM1;ATF3;CHAC1;EIF4E;ALDH18A1;SEC31A;YWHAZ;CXXC1;SEC11A;SRPRB;HYOU1;DCP2;CALR;EXOSC2;EXOSC5
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.3206067073139458,-0.4639477021100182,0.9767441860465116,1.0,1.0,1/5,9.48%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.31211265757787465,0.4632622070499397,0.9811320754716981,1.0,1.0,2/5,26.61%,NR1H3;APOH
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.31211265757787465,0.4632622070499397,0.9811320754716981,1.0,1.0,2/5,26.61%,NR1H3;APOH
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.2330455815774275,0.46313885059740584,1.0,1.0,1.0,9/35,22.32%,KIAA0319;DBN1;L1CAM;CDKL5;DIP2B;MACF1;ABL1;GOLGA4;MAP2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.2671773444753946,-0.46300160729540374,0.9787234042553191,1.0,1.0,7/7,73.29%,RNF34;RFFL;CIDEA;DFFA;BCL2L1;PAK2;FZD3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.24859165034555564,-0.4628952444034751,1.0,1.0,1.0,4/17,25.27%,RPS27L;RPS27;MRPS11;PRKDC
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.17898298887276598,-0.4620450680400676,1.0,1.0,1.0,42/165,28.88%,SENP3;LAS1L;PDCD11;NSA2;UTP11;RPL38;RPL12;EBNA1BP2;RRP15;MRTO4;NHP2;EMG1;UTP15;RPL37A;RPS27;RPL4;DDX49;RPL5;NAT10;RPL22;WDR55;UTP14A;EXOSC10;SBDS;RPL34;RPL37;PRKDC;RPL31;RPL7A;RRP12;FCF1;RPL35A;RPS25;BMS1;SNU13;WDR12;DHX37;NOB1;EIF6;PIH1D2;RPF1;POP5
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.25594572193641374,-0.46122869012937,1.0,1.0,1.0,4/14,25.15%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.26408232745280097,-0.46010847789637155,0.9777777777777777,1.0,1.0,7/7,73.60%,SECISBP2;SEPSECS;DIO2;EEFSEC;SECISBP2L;SELENOT;TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.26408232745280097,-0.46010847789637155,0.9777777777777777,1.0,1.0,7/7,73.60%,SECISBP2;SEPSECS;DIO2;EEFSEC;SECISBP2L;SELENOT;TRNAU1AP
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.2867035475260165,-0.45835265928933594,0.9565217391304348,1.0,1.0,6/6,71.34%,NRP1;TAOK2;SEMA3A;CHRNA7;PTN;PHACTR1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.19920492265387454,-0.45803596321164874,1.0,1.0,1.0,21/97,26.47%,SRP68;SEC62;RPL38;RPL12;RPS8;SRPRA;RPL37A;RPS27;RPL4;RPL5;RPL22;SRP14;ZFAND2B;RPS20;RPL34;RPL37;RPL31;RPL7A;RPL35A;RPS25;SGTB
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.2511619639251724,0.45754504993310263,1.0,1.0,1.0,4/17,33.74%,CNTN4;HES5;B2M;CALR
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2573365101575512,0.45672870503089313,1.0,1.0,1.0,6/17,36.17%,RYR2;SEC61A1;EDEM1;SRPRB;RAB10;SEC61G
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2449715073706587,0.4555850420419883,1.0,1.0,1.0,5/18,27.57%,RUVBL2;NOP10;NAF1;SHQ1;CCT3
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.2014415669956631,-0.4538227512165459,1.0,1.0,1.0,19/88,26.40%,SRP68;SEC62;RPL38;RPL12;RPS8;SRPRA;RPL37A;RPS27;RPL4;RPL5;RPL22;SRP14;RPS20;RPL34;RPL37;RPL31;RPL7A;RPL35A;RPS25
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.2819560507582792,-0.4536882719289142,0.9787234042553191,1.0,1.0,7/7,71.82%,PTPRS;CERS2;RTN4RL1;RTN4R;THY1;EPHA4;INPP5F
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.28704692069571125,-0.4528314840472679,1.0,1.0,1.0,3/6,27.70%,D2HGDH;ADAM9;PRKN
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.21121858891882786,-0.4528083923177806,1.0,1.0,1.0,4/32,16.53%,CAMLG;OTOF;EMC1;EMD
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.2257506223953219,-0.45269144887646456,1.0,1.0,1.0,3/35,12.06%,MVP;CAV1;NOX4
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.28384815000536795,-0.4517499402965265,0.9761904761904762,1.0,1.0,1/7,10.78%,BEX4
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.2481393853609407,-0.4503866074847654,0.9743589743589743,1.0,1.0,6/14,27.66%,RAC1;CORO1B;ARFIP2;CYFIP1;INPP5K;PLEK
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.24679846790730067,-0.4499648138595714,1.0,1.0,1.0,8/8,75.33%,MAPT;ARL6IP5;BNIP3;RNF122;PIP5KL1;BAX;PRELID1;HEBP2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.2681162223855767,-0.44884557463842417,1.0,1.0,1.0,8/8,73.20%,OTUB2;VCPIP1;OTUD3;OTUD7A;USP37;USP30;YOD1;OTUD7B
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.2582570161971463,0.44848420118232957,1.0,1.0,1.0,7/12,41.21%,PTEN;SPTBN4;B4GALT5;ARHGAP35;MYCBP2;EPHB6;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.2874072803220402,0.44797781817662746,1.0,1.0,1.0,2/7,28.90%,LPL;OSBPL11
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.2393558513631451,-0.4477947269085648,1.0,1.0,1.0,2/20,11.74%,MBTPS2;GNB3
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.2988181897183694,-0.44665343368898774,0.9767441860465116,1.0,1.0,2/8,15.25%,ZNF385A;MED1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.27035289519064964,-0.44645501024961365,0.9795918367346939,1.0,1.0,2/9,19.85%,DAB2IP;RGP1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.2882390857891481,0.44551667674493123,0.9803921568627451,1.0,1.0,2/5,22.88%,PROX1;EDN1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.25057632183653605,0.44549454712515163,0.967741935483871,1.0,1.0,2/14,15.59%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.24832630316164236,-0.44520534302576464,1.0,1.0,1.0,14/14,75.18%,ATAD5;BRPF3;KAT7;STN1;NPM2;PCNA;GLI2;CTC1;EGF;BCAR3;FAF1;DNA2;DHX9;EGFR
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.29868471953578335,-0.4443192276506209,1.0,1.0,1.0,5/5,70.14%,PER1;CRY2;CRY1;LMO3;CLOCK
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.270172609138042,-0.44377129659684655,1.0,1.0,1.0,6/11,26.71%,MCM2;MUS81;CDC7;MCM3;MCM4;MCM6
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.2445499691915659,-0.44274699365755055,0.9459459459459459,1.0,1.0,4/10,26.30%,DCTN1;PAFAH1B1;MTOR;CLMN
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.28477349962037884,0.44109734390100014,0.96875,1.0,1.0,3/7,28.14%,DYRK1A;ABCA7;BACE1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.26165052904250474,-0.4408051669459843,1.0,1.0,1.0,2/10,17.25%,SLC2A1;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.2165404551564899,0.43788267022723565,1.0,1.0,1.0,2/20,14.67%,PROX1;CCND3
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.2726649538517647,-0.43736223849699607,0.9761904761904762,1.0,1.0,1/7,14.96%,PPIP5K1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.2381394628898692,-0.4350734348708563,1.0,1.0,1.0,13/13,76.20%,NUP133;NUP93;NDC1;RTN4;NUP35;NUP98;NUP107;SEH1L;TPR;NUP205;NUP54;AHCTF1;NUP153
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.24350681379659653,0.43465172102336813,1.0,1.0,1.0,6/18,29.11%,ABCD2;SLC18A2;SLC30A10;PPARA;ABCB7;SIRT5
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.2479944148803947,0.4343756975728781,1.0,1.0,1.0,3/14,26.28%,HEXB;NAGA;ACER1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.24646467458039328,-0.434108708228524,1.0,1.0,1.0,3/11,20.53%,ARF1;CORO1B;ARFIP2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.18263984501017946,0.4324302260097155,1.0,1.0,1.0,19/84,31.18%,FBXO5;ANAPC16;PSMD13;PSMA1;PSME4;GTSE1;UBE2D1;TP53;UBE2E1;PSMD4;FZR1;ERCC3;PSMB5;PSMC5;ANAPC15;PSMB1;BTRC;CDC27;ANAPC7
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.26212688290641245,0.4313598921189555,0.9803921568627451,1.0,1.0,5/8,34.69%,CX3CR1;JAK2;SIRPA;CD47;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.2819451429455685,-0.4313356388484348,1.0,1.0,1.0,6/6,71.82%,PTPRS;CERS2;RTN4RL1;RTN4R;EPHA4;INPP5F
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.2200945517502804,0.4311292241693601,0.9821428571428571,1.0,1.0,7/26,36.41%,DYNC1I2;ARL13B;ACBD5;WDR81;DYNC1I1;IFT88;DYNC1H1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.2353834129111598,0.43018928307367593,1.0,1.0,1.0,8/21,31.56%,ODAD3;CITED2;DNAI2;NOTCH1;KIF3B;CFAP53;TBX1;PKD2
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.267216032188177,-0.4286208056565332,0.9583333333333334,1.0,1.0,7/7,73.29%,TAMM41;CRLS1;GPAM;PGS1;CDS2;PLA2G6;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.25840204482810897,0.4285558397182082,0.9827586206896551,1.0,1.0,6/10,37.49%,CYP19A1;APOE;SPP1;PRELID1;TRIAP1;DBI
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.23878098627085392,0.42814705297541256,1.0,1.0,1.0,3/17,24.93%,SIRT7;MAF1;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.2508190226133794,0.42612627738222125,1.0,1.0,1.0,1/13,10.95%,NECTIN2
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.18826538521159508,-0.425817073646962,1.0,1.0,1.0,51/51,81.21%,POM121C;NUP133;SEC13;NUP93;NUP43;NUP214;POLR2I;POLR2B;NDC1;POLR2C;NUP37;NUP88;NUP35;NUP50;POLR2J;AGO2;NUP98;TRIM71;EIF4G1;NUP85;POLR2K;POLR2G;POLR2F;NUP210;POLR2A;NUP107;AGO1;POLR2L;POM121;NUP155;SEH1L;POLR2D;RAE1;TPR;NUP205;NUP54;TNRC6A;POLR2E;NUP58;NUP160;AAAS;NUP188;IPO8;NUP42;PUM1;PUM2;NUP153;H3-3A;POLR2H;FMR1;RANBP2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.18826538521159508,-0.425817073646962,1.0,1.0,1.0,51/51,81.21%,POM121C;NUP133;SEC13;NUP93;NUP43;NUP214;POLR2I;POLR2B;NDC1;POLR2C;NUP37;NUP88;NUP35;NUP50;POLR2J;AGO2;NUP98;TRIM71;EIF4G1;NUP85;POLR2K;POLR2G;POLR2F;NUP210;POLR2A;NUP107;AGO1;POLR2L;POM121;NUP155;SEH1L;POLR2D;RAE1;TPR;NUP205;NUP54;TNRC6A;POLR2E;NUP58;NUP160;AAAS;NUP188;IPO8;NUP42;PUM1;PUM2;NUP153;H3-3A;POLR2H;FMR1;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.25625158473098414,-0.4242377898028101,1.0,1.0,1.0,2/11,14.19%,EDEM2;SEC16A
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.16144577700953985,0.42359715241243884,1.0,1.0,1.0,20/184,23.28%,GLUL;RIOK2;DDX31;RRS1;EXOSC4;XPO1;RPL21;BOP1;NOC2L;BYSL;MPHOSPH6;RPL7;RIOK1;WDR36;EXOSC1;RPL23A;TEX10;RPL18A;C1D;RRP1B
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.21218800719241576,-0.4231883757274614,1.0,1.0,1.0,10/29,32.54%,DAXX;DAB2IP;STUB1;BAG3;HSPB8;PRKN;OPTN;HSPA9;HDAC6;BAK1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.23630242996440182,-0.42209400894506643,1.0,1.0,1.0,11/11,76.38%,PACSIN3;PACSIN1;SNX33;PACSIN2;WHAMM;BIN2;SNX9;BIN3;EHD2;FNBP1L;MICALL1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.25485470012534395,0.4214329331425693,1.0,1.0,1.0,6/12,31.56%,KEAP1;NFKBIB;PKD1;NFKBIA;SUFU;PKD2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.2790436767379782,0.4205933358685938,1.0,1.0,1.0,6/6,72.10%,FADD;TRADD;TRAF2;RIPK1;TNFRSF1A;CASP8
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.2417747576851014,0.4204090889318123,1.0,1.0,1.0,5/11,34.55%,CANX;JAK2;IL12RB2;IL12A;IL27RA
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.2324852774664035,-0.41776903765115475,1.0,1.0,1.0,1/12,10.28%,PARP1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2339898618581434,-0.4170108413185385,1.0,1.0,1.0,12/12,76.62%,PACSIN3;ADAM9;ADAM8;NRDC;SNX33;SH3D19;GPLD1;SNX9;ADRA2A;FURIN;APOE;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.25042668965957066,0.4154526284932753,0.9846153846153847,1.0,1.0,5/10,28.27%,VEGFA;NOTCH4;NEXMIF;NOTCH1;EPCAM
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.23957588778008154,0.4151299026861164,1.0,1.0,1.0,2/11,20.38%,GGT5;DPEP1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.2542654853561342,-0.41512898138962767,1.0,1.0,1.0,8/8,74.59%,BRCA1;PRKN;UBE2D4;UBE2T;RNF4;UBE2S;RNF6;BARD1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.24002539111807195,-0.4146305982983553,1.0,1.0,1.0,2/10,22.67%,MFSD2A;ALK
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.2841779497098646,-0.41267252261491516,1.0,1.0,1.0,5/5,71.59%,PLEKHA7;KIFC3;CAMSAP3;FERMT2;TJP1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.25149160740128335,0.4111672868878009,0.9814814814814815,1.0,1.0,2/7,24.72%,PARD3;DLG1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.2581725541465709,0.4109553925635115,1.0,1.0,1.0,2/7,32.73%,HEBP2;PRELID1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2548453142850391,-0.41037337631464427,1.0,1.0,1.0,2/11,18.96%,UQCRC1;UQCRH
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.20157477169961852,-0.40626719530941874,1.0,1.0,1.0,7/25,24.24%,DCTN1;RAC1;ANKRD53;KATNB1;CAV3;MAPT;DRG1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.2517989324851621,0.4041949331969678,1.0,1.0,1.0,3/7,30.05%,CD81;NFAM1;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.21869033938375243,-0.40349533578229374,1.0,1.0,1.0,3/13,22.67%,CEACAM1;APOD;ALK
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.24168052756750308,-0.40331748543315865,0.9791666666666666,1.0,1.0,4/8,26.01%,MTHFD1L;GLUD2;HAAO;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.2553775920767564,0.40296417447994404,1.0,1.0,1.0,7/7,74.47%,LOXL3;LIMS1;FLNA;EMP2;DMTN;CD63;LIMS2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.2113390092879257,-0.4029557070902436,1.0,1.0,1.0,15/15,78.88%,ADCY1;CYSLTR2;PRKACA;ADCY7;PRKAR1A;ADCY8;PRKAR1B;ADCY6;ADCY9;ADCY3;PRKAR2B;ADCY5;ADCY2;PRKAR2A;PRKACB
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.23157357717554766,-0.39830053968826423,1.0,1.0,1.0,1/15,9.74%,CEACAM1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.2526172003951658,0.3953259082976463,1.0,1.0,1.0,2/8,27.86%,NREP;MTR
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.20677481722377924,-0.39432024950230626,1.0,1.0,1.0,3/18,18.63%,RCSD1;AQP1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.24427196073759055,0.39247788046525317,1.0,1.0,1.0,2/9,20.17%,GRID2;FMR1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.24832656219771718,-0.39090838621248464,1.0,1.0,1.0,10/10,75.18%,BRCA1;MACROH2A1;MACROH2A2;RBM15;LRIF1;METTL3;SMCHD1;RBM15B;YTHDC1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.24080643156594117,-0.39035652185273556,1.0,1.0,1.0,2/7,20.31%,TWIST1;OTUB2
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),-0.25624189259092234,-0.3897533499362705,1.0,1.0,1.0,2/5,19.54%,CHCHD2;USP19
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.24480489252692772,0.3890637975983581,1.0,1.0,1.0,3/6,33.46%,CARD9;ACE;KMT2E
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.2195138298769873,0.386023648855182,1.0,1.0,1.0,4/12,32.44%,ALDH6A1;DPYSL5;CDA;DPYSL3
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.2214310591695368,-0.3858801509703112,1.0,1.0,1.0,14/14,77.87%,SEC24C;SEC13;SEC24A;SEC24D;SEC23B;RAB1A;TBC1D20;SEC31B;MIA3;SEC23A;SCAP;SEC31A;SAR1A;SEC24B
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.21073256867362034,0.3834300776799458,1.0,1.0,1.0,6/22,32.42%,GPR62;RAPGEF2;GNAI1;PRKAR2A;PDE4D;RASD2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.18267886152819873,-0.3821305899722856,1.0,1.0,1.0,3/27,16.34%,CCDC88C;SKP1;TNIP2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.24054671078829787,0.37803471081056106,1.0,1.0,1.0,2/8,26.71%,CTNNB1;FZD3
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.22361580102935472,-0.37714794289332454,1.0,1.0,1.0,3/8,26.74%,IRF1;HFE;HLA-A
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.2321503033449156,0.3761401608634119,1.0,1.0,1.0,2/10,21.14%,CSF1;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.22882569162313796,-0.37463467050496335,0.9767441860465116,1.0,1.0,10/10,77.13%,EDN3;HFE;VAMP7;TFR2;GRP;SNX4;SPP1;VAMP8;CYP19A1;EDN1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.24889585275329343,0.37327412514370845,1.0,1.0,1.0,4/5,41.15%,HNRNPU;CCNB1;SIRT2;RCC2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.21168293457666548,0.373228998227967,1.0,1.0,1.0,6/12,42.74%,GNL3L;CCT3;CCT7;CCT4;DKC1;TCP1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.16056525086376597,0.37300910022680117,1.0,1.0,1.0,14/85,29.91%,RPS5;RPL21;SEC61A1;RPL7;SEC61A2;RPS3A;RPL23A;RPL18A;RPS29;RPS15A;RPL9;RPS23;RPS12;RPS19
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.18290910156023088,-0.3726103355295296,1.0,1.0,1.0,2/25,13.57%,DAXX;DAB2IP
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.22452812587843443,0.37246749911049654,1.0,1.0,1.0,5/14,34.12%,PANK1;ACLY;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.23416341932925902,-0.3719737223316002,1.0,1.0,1.0,4/11,23.86%,APOA1;TGFB1;HFE;TGFB2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2313282002602848,0.3692474658656521,0.984375,1.0,1.0,1/11,14.53%,PANK1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.2313282002602848,0.3692474658656521,0.984375,1.0,1.0,1/11,14.53%,PANK1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2313282002602848,0.3692474658656521,0.984375,1.0,1.0,1/11,14.53%,PANK1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.21596955792117786,0.366916860980972,1.0,1.0,1.0,5/10,35.91%,EMC2;EMC9;EMC10;EMC6;MMGT1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.24621470292272699,-0.3653624568508231,1.0,1.0,1.0,2/5,24.79%,TMEM86B;PLAAT3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.2331501973226031,0.3640334164830993,1.0,1.0,1.0,9/9,76.69%,HSPA5;FICD;ERN1;BAX;XBP1;PIK3R1;BAK1;RACK1;COPS5
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.1905293896446314,0.36266598067834166,1.0,1.0,1.0,7/22,33.22%,PKN2;LGMN;PPP1R10;USP2;EIF4E;APP;CCNB1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.19930920612138525,0.3572619967230144,1.0,1.0,1.0,2/19,17.44%,ZNF207;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.19930920612138525,0.3572619967230144,1.0,1.0,1.0,2/19,17.44%,ZNF207;TEX14
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.19930920612138525,0.3572619967230144,1.0,1.0,1.0,2/19,17.44%,ZNF207;TEX14
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.16544191606999695,-0.34721597769081114,1.0,1.0,1.0,10/48,24.86%,ANKLE2;EMD;NUP133;CC2D1B;SEC13;CHMP3;CDK1;NUP93;NUP43;RAN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.16544191606999695,-0.34721597769081114,1.0,1.0,1.0,10/48,24.86%,ANKLE2;EMD;NUP133;CC2D1B;SEC13;CHMP3;CDK1;NUP93;NUP43;RAN
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.22137109254100884,0.34584847481898334,1.0,1.0,1.0,7/7,77.87%,PHF14;BRPF1;ING5;KAT7;BRPF3;MEAF6;BRD1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.1590693655756215,-0.3402268429886415,1.0,1.0,1.0,10/51,24.86%,ANKLE2;EMD;NUP133;CC2D1B;SEC13;CHMP3;CDK1;NUP93;NUP43;RAN
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.2006654029169407,-0.3301335431691524,1.0,1.0,1.0,6/6,79.94%,BRSK2;NPHP1;BRSK1;FUZ;CELSR1;VANGL2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.23064722039537314,-0.3293707297166642,1.0,1.0,1.0,6/6,76.94%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.23064722039537314,-0.3293707297166642,1.0,1.0,1.0,6/6,76.94%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.17125724320385616,-0.32130238307284986,1.0,0.999936596751376,1.0,4/18,25.15%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.18377358106045827,0.30871585220650055,1.0,0.9999843479513033,1.0,5/10,39.69%,IRAK1;TRAF6;PIK3R4;PIK3C3;IRAK4
